Part I - Synthetic Studies on the Teleocidin Alkaloids. Part II - Catalytic Asymmetric Reactions of Enecarbamates with Dicarbonyl Compounds. Part III - A Transannular Mannich Approach to the Polycyclic Alkaloids: Synthetic Studies on the Cylindricine Alkaloids by Vital, Paulo
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
General rights 
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners 
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. 
 
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research. 
• You may not further distribute the material or use it for any profit-making activity or commercial gain 
• You may freely distribute the URL identifying the publication in the public portal  
 
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately 
and investigate your claim. 
   
 
Downloaded from orbit.dtu.dk on: Dec 17, 2017
Part I - Synthetic Studies on the Teleocidin Alkaloids. Part II - Catalytic Asymmetric
Reactions of Enecarbamates with Dicarbonyl Compounds. Part III - A Transannular
Mannich Approach to the Polycyclic Alkaloids: Synthetic Studies on the Cylindricine
Alkaloids
Vital, Paulo ; Tanner, David Ackland
Publication date:
2007
Document Version
Publisher's PDF, also known as Version of record
Link back to DTU Orbit
Citation (APA):
Vital, P., & Tanner, D. A. (2007). Part I - Synthetic Studies on the Teleocidin Alkaloids. Part II - Catalytic
Asymmetric Reactions of Enecarbamates with Dicarbonyl Compounds. Part III - A Transannular Mannich
Approach to the Polycyclic Alkaloids: Synthetic Studies on the Cylindricine Alkaloids.
 Part I - Synthetic Studies on the Teleocidin Alkaloids 
 
 
Part II - Catalytic Asymmetric Reactions of Enecarbamates with 
 α,α’-Dicarbonyl Compounds 
 
 
Part III - A Transannular Mannich Approach to Polycyclic 
Alkaloids: Synthetic Studies on the Cylindricine Alkaloids 
 
 
 
 
 
 
 
 
 
 
 
 
 
Department of Chemistry 
The Technical University of Denmark 
Kemitorvet 201 
DK-2800 Kgs. Lyngby 
Denmark 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Para os meus pais, que abandonaram muitos dos seus sonhos para que eu pudesse 
perseguir os meus. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table of Contents 
 
 
 i
TABLE of CONTENTS 
 
Table of Contents i
Preface vii
English Abstract ix
Danish Abstract xi
List of Publications xiii
List of Abbreviations xv
 
Part I 
 Chapter 1: The Teleocidin Alkaloids – An Overview 1
 1.1 - Isolation and Structure 1
 1.2 - Biosynthesis 4
 1.3 - Biological Activity 5
 1.4 - Selected Total Syntheses of Indolactam Alkaloids 10
 Chapter 2: Synthetic Strategy Towards Lyngbyatoxin A 17
 2.1 - Installation of the Quaternary Centre 17
 2.2 - Construction of the Indole Ring 22
 2.3 - Retrosynthetic Analysis of Lyngbyatoxin A 25
 Chapter 3: Synthetic Studies on Lyngbyatoxin A – Results and 
Discussion 
29
 3.1 - Installation of the All-Carbon Quaternary Stereocenter 29
  3.1.1 - Preparation of Relevant Allylic Alcohols 29
  3.1.1.1 - Preparation of Allylic Alcohols Containing a 
para-Amino Phenyl Moiety 
30
  3.1.1.2 - Preparation of Allylic Alcohols Containing a 
para-Carboxy Phenyl Moiety 
35
  3.1.1.3 - Preparation of Allylic Alcohols Containing a 
para-Halogen Phenyl Moiety 
36
  3.1.2 - Evaluation of Relevant Substitution Patterns 38
  3.1.3 - Enantioselective Formation of the Quaternary 
Stereocenter 
41
 3.2 - Construction of the Indole Nucleus 45
  3.2.1 - Studies on the Construction of the Indole Nucleus 
Based on Quaternary Aldehyde (3.42) 
45
  3.2.1.1 - Model Studies  52
Table of Contents 
 
 
 ii 
  3.2.2 - Studies Towards the Construction of the Indole 
Nucleus Based on the Quaternary Aldehyde (3.43) 
58
   
 Chapter 4: Synthetic Strategy Towards the Teleocidins B 65
 4.1 - Installation of the All-Carbon Quaternary Stereocenters 65
 4.2 - Construction of the Indole Ring 69
 4.3 - Retrosynthetic Analysis of the Teleocidins B 70
 Chapter 5: Synthetic Studies on the Teleocidins B – Results 
and Discussion 
73
 5.1 - Studies on the Teleocidins B’s Carbocyclic Framework 73
  5.1.1 - Installation of the C-14 All-Carbon Quaternary 
Stereocenter 
73
  5.1.2 - Studies on the Construction of the Teleocidins B’s 
Carbocyclic Framework 
78
 Chapter 6: Concluding Remarks 81
 Chapter 7: Experimental 89
 7.1 - General 89
 7.2 - General Experimental Procedures 90
 7.3 - Experimental Procedures for Chapter 3  
(Lyngbyatoxin A) 
92
 7.4 - Experimental Procedures for Chapter 5 (Teleocidins B) 137
   
Part II 
 Chapter 1: Enecarbamates – An Overview 143
 1.1 - Introduction 143
 1.2 - Uses of Enecarbamates in Organic Synthesis 145
 Chapter 2: Aim of the Project 151
 Chapter 3: Preparation of Enecarbamates and Chiral Ligands 153
 3.1 - Preparation of Enecarbamates 153
 3.2 - Preparation of Chiral Ligands 155
 Chapter 4: Results and Discussion 157
 4.1 - Addition of Enecarbamates to Aldehydes 157
  4.1.1 - Use of Benzaldehydes as Substrates 157
  4.1.2 - Use of Ethyl Glyoxylate as Substrate 160
  4.1.2.1 - LA-Catalyzed Addition Reaction of 
Enecarbamates to Ethyl Glyoxylate 
161
  4.1.2.2 - Enantioselective LA-Catalyzed Addition of 
Enecarbamates to Ethyl Glyoxylate 
162
Table of Contents 
 
 
 iii
  4.1.2.2.1 - General Screening of Catalysts 162
  4.1.2.2.2. - Use of Copper(II)-Based Catalysts 164
   
  4.1.2.2.3 - Use of Copper(I)-Based Catalysts 166
  4.1.2.2.4 - Use of Nickel(II)-Based Catalysts 168
  4.1.2.2.5 - Effect of the Solvent and of the Catalyst 
Loading 
169
  4.1.2.3 - Extension to Other Enecarbamates 170
  4.1.2.4 - Mechanistic Considerations 172
  4.1.2.5 - Diastereoselective Reductions of Cbz-
Protected β-Hydroxy Imines to Cbz-Protected β-
Hydroxy Amines 
177
 4.2 - Additions to α,α’-Diketones 183
  4.2.1 - Use of Butane-2,3-dione as Substrate 183
  4.2.1.1 - LA-Catalyzed Addition Reaction of 
Enecarbamates to Butane-2,3-dione 
183
  4.2.1.2 - Enantioselective LA-catalyzed Addition 
Reaction of Enecarbamates to Butane-2,3-dione 
185
  4.2.1.2.1 - General Screening of Catalysts 185
  4.2.1.2.2 - Use of the Nickel(II)-Diamine (3.d) 
Catalyst 
186
  4.2.2 - Extension to Other Enecarbamates and α,α’-
Diketones 
189
  4.2.3 - Mechanistic Considerations 190
  4.2.3.1 - NLEs in Asymmetric Catalysis: A Brief 
Overview 
190
  4.2.3.2 - NLEs in the Addition Reaction of 
Enecarbamate (1.37) to Butane-2,3-dione Catalyzed by 
the Chiral Ni(II)-Diamine (3.d) Complex 
194
 Chapter 5: Concluding Remarks 199
 Chapter 6: Experimental 205
 6.1 - General 205
 6.2 - Preparation of Enecarbamates and Chiral Ligands 206
 6.3 - Compounds from Addition Reactions 215
 
Part III 
 Chapter 1: Transannular Reactions – An Overview 227
 1.1 - Introduction 227
Table of Contents 
 
 
 iv 
 1.2 - Selected Uses Of Transannular Reaction in Organic 
Synthesis 
229
  
 Chapter 2: A Transannular Mannich Approach to Polycyclic 
Alkaloids 
237
 2.1 - Introduction 237
 2.2 - Project Description 240
 Chapter 3: The Cylindricine Alkaloids: An Overview 243
 3.1- Isolation and Structure 243
 3.2 - Biological Activity 245
 3.3 - Selected Total Syntheses of the Cylindricine Alkaloids 245
 Chapter 4: Molecular Mechanics Calculations 253
 3.1 - Introduction 253
 3.2- Results and Discussion 256
 3.3 - Conclusion 264
 Chapter 5: Results and Discussion 267
 5.1 - Studies Towards Macrocycle (2.12) Based on a RCM 
Reaction 
267
  5.1.1 - Synthetic Studies Towards Diene (5.3) via a 
Displacement Reaction 
268
  5.1.1.1 Retrosynthetic Considerations 268
  5.1.1.2 Preparation of the Building Blocks Pertaining 
to the Displacement Approach 
269
  5.1.1.3 Model Studies Pertaining to the Displacement 
Reaction Strategy 
273
  5.1.2 - Synthetic Studies Towards Diene (5.3) via the 
Opening of a Lactam 
278
  5.1.2.1 Retrosynthetic Considerations 278
  5.1.2.2 Preparation of the Building Blocks Pertaining 
to the Lactam-Opening Approach 
279
  5.1.2.3 Implementation of the Lactam-Opening 
Approach 
281
  5.1.3 - Synthetic Studies Towards Diene (5.3) via the 
Addition of Organometallic Reagents to a Chiral Aldimine 
285
  5.1.3.1 Retrosynthetic Considerations 285
  5.1.3.2 Model Studies Pertaining to the Aldimine 
Approach 
286
  5.1.3.3 Implementation of the Aldimine Approach 293
Table of Contents 
 
 
 v
 5.2 - Studies Towards Macrocycle (2.12) Based on a Ring 
Enlargement Reaction 
295
  5.2.1 Retrosynthetic Considerations 296
  5.2.2 Model Studies Pertaining to the Ring-Enlargement 
Approach 
297
 Chapter 6: Concluding Remarks 303
 Chapter 7: Experimental 311
 7.1 - General 311
 7.2 – General Experimental Procedures 312
 7.3 – Preparation of Compounds 313
  
Appendix 1: List of Publications 347
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 vi 
Preface 
 
 
 vii
PREFACE 
 
The present thesis is submitted in candidacy for obtaining the Ph.D. degree from the 
Department of Chemistry, The Technical University of Denmark (DTU). The Ph.D. 
stipendium was kindly provided by the Portuguese Foundation for Science and 
Technology (FCT). 
 
The thesis is composed of three independent parts, the various chapters being 
independent with respect to the references presented therein. Part I and III deal with 
the total synthesis of the teleocidin and the cylindricine alkaloids, respectively, and 
the corresponding work was performed at the DTU over a period of approximately 
4½ years, under the supervision of Professor David Tanner. I would like to express 
my gratitude to Professor Tanner for the stimulating research projects provided and 
for allowing me to work as independently as I wished. Part II corresponds to the work 
performed during a 7 months stay at the Graduate School of Pharmaceutical Sciences, 
The University of Tokyo. This part of the thesis deals with the development of 
catalytic asymmetric addition reactions of enecarbamates to carbonyl compounds and 
it was carried out with the supervision of Professor Shū Kobayashi. I would like to 
thank Professor Shū Kobayashi for the opportunity to work in his research group. All 
the Kobayashi group members are acknowledged for making my stay in Japan a truly 
memorable life experience. In particular, I would like to thank Ryosuke Matsubara, 
with whom it was a pleasure to work and socialize. It should be mentioned that some 
of the results presented in Part II were obtained in collaboration with Matsubara-san. 
In particular, most of the experiments in Table 4.10, Chapter 4 (Part II) should be 
credited to him. Fabrice Robvieux, the other western in the Kobayashi group, also 
deserves a special mention for introducing me to the pleasures of Karaoke (!), exotic 
food and for the regular Saturday walk to the nearby sento. 
 
A very special note of appreciation goes to my laboratory partners during my various 
stays at the DTU, Thomas E. Nielsen, Jakob Feldthusen and Anne-Lene Hansen. 
They are to be credited, among countless other things, for stoically putting up with 
my latin temperament. The other members of the Tanner group with whom I 
overlapped are acknowledged for creating a great working atmosphere, where all sorts 
of topics could be discussed with a good dose of humor. In particular, Martin Juhl (the 
talented “Mr. Name Reactions”), “dating expert” Mikkel Jensing, “hard-disk” Jens 
Nolsøe, “dark-humor” Thomas Hjelmgaard and “multitask” Janne Tønder (who, 
among other things, is a sight for sorrow eyes!) are acknowledged for many good 
moments. 
Preface 
 
 
 viii
I would also like to express my gratitude to the entire staff in building 201 for all the 
help provided through the years and for creating a great working atmosphere. I am 
particularly grateful to Professor Per-Ola Norrby for the interest that he always 
showed for my research. Ulla Maximiling is acknowledged for preparing several 
batches of the Dess-Martin periodinane and for recording the MS spectra. 
 
The Kellys, Kreisers, Longins and Jørgensens are acknowledged for their friendship. 
 
Claudia Gomes and Margarida Santos, my two links to Portugal, are credited for 
making my stay here in Denmark a lot easier and for putting up with my distant self. 
 
The “usual suspects”, Alex, Beka, Sónia, Célia, John, Isabel, Lizete, São and Daniela, 
who, and in spite of the distance and the repeated absences never stopped caring, are 
also deeply acknowledged. 
 
Invaluable comments and corrections on parts of this thesis by Jens Nolsøe, Jakob 
Feldthusen and Morten Jørgensen are gratefully acknowledged. Furthermore, the 
“Danish Abstract” was kindly provided by Morten Jørgensen. 
 
       Paulo Jorge Vieira Vital 
       Copenhagen 
       November 2006 
 
English Abstract 
 
 
 ix
ENGLISH ABSTRACT 
 
Part I: Synthetic Studies on the Teleocidin Alkaloids 
 
The first stereocontrolled formation of the characteristic all carbon quaternary centre 
of lyngbyatoxin A (1.1) is described. Indole (3.78), an advanced intermediate in a 
projected enantioselective total synthesis of lyngbyatoxin A (1.1), was prepared from 
allylic alcohol (3.29) over 9 steps in 13% yield and >95% ee, key transformation 
being the enantiospecific rearrangement of vinyl epoxide (3.41), formylation of silyl 
ether (3.73) via chemo- and regioselective halogen lithium exchange, and the 
Hemetsberger-Knittel reaction of azide (3.74). 
 
In connection with studies towards the teleocidin B alkaloids (1.3) to (1.6), the first 
example of an intramolecular Heck reaction, that despite having the possibility for a 
6-exo-trig path occurs exclusively to afford the 5-endo-trig cyclized product, is 
described. Indole (5.7a) was obtained in 3 steps in 67% yield from p-
hydroxybenzaldehyde, the key step being the regioselective aromatic Claisen 
rearrangement of indole (5.3). The intramolecular Heck reaction of triflate (5.7e) is 
promoted only by bidentate phosphine ligands, and it affords indole (5.18) as the sole 
product in high yield (up to 94%). 
 
Part II: Catalytic Asymmetric Reactions of Enecarbamates with 
α,α’-Dicarbonyl Compounds 
 
Catalytic asymmetric addition reactions of enecarbamates (e.g., (1.37)) to ethyl 
glyoxylate using a catalyst derived from CuClO4·4CH4CN and a C2-symmetric 
diimine ligand (e.g., (3.u)) were developed. The β-hydroxy ketone adducts (e.g., 
(4.14)), obtained by in situ acidic hydrolysis of the intermediate 1,3-hydroxy amines, 
are formed in good yield (>90%) and high enantiomeric excess (up to 97%). A 
concerted aza-ene mechanism for the addition reaction is proposed. 
 
In the presence of a novel catalyst, generated from Ni(OTf)2 and the C2-symmetric 
diamine ligand (3.d), enecarbamates (e.g., (1.37)) react with α,α’-diketones (e.g., 
butane-2,3-dione) to afford, after in situ acidic hydrolysis, tert-alcohols (e.g., (4.41)) 
in high yield (94%) and good optical purity (up to 84% ee). This process displays a 
strong positive non-liner effect. 
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Part III: A Transannular Mannich Approach to Polycyclic 
Alkaloids: Synthetic Studies on the Cylindricine Alkaloids 
 
A transannular Mannich approach to the cylindricine alkaloids (3.1a) to (3.1k) was 
investigated. Macrocycle diketone (5.78), which contains the basic skeleton of the 
proposed macrocycle precursor for the cylindricines (2.12), was prepared from 
cycloheptanone in 7 steps and 26% yield, key transformations being the Miyaura-
Suzuki cross coupling reaction of bromocycloheptene (5.67) and N-Boc allyl amine 
(5.75), the formation of a 8-membered ring by an intramolecular displacement 
reaction, and the ring-enlargement reaction of [7,8]-bicyclic carbamate (5.77). 
Attempts to induce the desired transannular Mannich in macrocycle diketone (5.78) 
under acidic conditions resulted in the isolation of the dienol salt (5.79). 
 
Abstrakt 
 
 
 xi
ABSTRAKT 
 
1. Del: Syntetiske Studier af Teleocidin Alkaloiderne 
 
Den første stereokontrollerede dannelse af det karakteristiske kvaternære fuldt kul-
substituerede caron atom i lyngbyatoxin A (1.1) er beskrevet. Indol (3.78) et sent 
intermediat i en planlagt enantioselektiv totalsyntese af lyngbyatoxin A (1.1) blev 
fremstillet ud fra den allyliske alcohol (3.29) over 9 trin i et samlet udbytte på 13% 
med en optisk renhed på >95% ee. Nøgletrinnene var en enantiospecifik omlejring af 
det vinyliske epoxid (3.41), en formylering af silyletheren (3.73) via kemo- og 
regioselektiv halogen lithium udveksling samt en Hemetsberger-Knittel reaktion på 
azidet (3.74). 
 
I forbindelse med studierne mod teleocidin B alkaloiderne (1.3) to (1.6) observeredes 
det første eksempel på en intramolekylær Heck reaktion, som på trods af muligheden 
for en 6-exo-trig reaktionsvej, udelukkende giver anledning til dannelse af et 5-endo-
trig afledt produkt. Indol (5.7a) blev fremstillet over 3 trin fra p-hydroxybenzaldehyd 
i et godt udbytte (67%). Nøgletrinnet var en regioselektiv aromatisk Claisen-
omlejring af indol (5.3). Den intramolekylære Heck reaktion af triflat (5.7e) forløb 
kun med bidentate phosphinligander og gav udelukkende indol (5.18) i højt udbytte 
(op til 94%). 
 
2. Del: Katalytiske Asymmetriske Reaktioner med Ene-
Carbamater og α,α’-Dicarbonyl Forbindelser 
 
Katalytiske asymmetriske additionsreaktioner med enecarbamater (e.g., (1.37)) til 
ethylglyoxylat blev udviklet med en katalysator afledt fra CuClO4·4CH4CN og en C2-
symmetrisk diiiminligand (e.g., (3.u)). Reaktionen førte til dannelse af β-
hydroxyketoner (e.g., (4.14)) efter in situ sur vandig hydrolyse af de intermediære 
1,3-hydroxyaminer i højt udbytte (>90%) med høj optisk renhed (op til 97% ee). En ét 
trins aze-ene mekanisme er foreslået for denne reaktion. 
 
Det er endvidere fundet, at enecarbamater (e.g., (1.37)) reagerer i tilstedeværelse af en 
ny katalysator afledt fra Ni(OTf)2 og den C2-symmetriske diamineligand (3.d) med 
α,α’-diketoner (e.g., butane-2,3-dion) under dannelse af tertiære alkoholer (e.g., 
(4.41)) in højt udbytte (94%) og moderat-til-god optisk renhed (op til 84% ee) efter in 
situ sur hydrolyse. Denne process udviser en stærk positive ikke-lineær effekt.  
Abstrakt 
 
 
 xii 
3. Del: En Transannulær Mannich Syntesevej til Polycykliske 
Alkaloider: Syntesestudier mod Cylindricin Alkaloiderne 
 
En transannulær Mannich strategy til syntese af cylindricin alkaloiderne (3.1a) til 
(3.1k) har været undersøgt. Den makrocykliske diketon (5.78), som indeholder det 
basale carbonskelet til dannelse af nøgleintermediatet i syntesen af cylindricinerne 
(2.12), blev fremstillet fra cycloheptanon over 7 trin i et samlet udbytte på 26%. De 
vigtigste trin var en Miyaura-Suzuki krydskobling af bromocyclohepten (5.67) og N-
Boc allyl amine (5.75), dannelsen af en 8-ledet ring via en intramolekulær 
displaceringsreaktion, samt en ring-udvidelsesreaktion på det [7,8]-bicykliske 
carbamat (5.77). Forsøg på at få den ønskede transannulær Mannich til at forløbe med 
den makrocykliske diketon (5.78) under sure betingelser resulterede i dannelse af det 
tilsvarende dienol salt (5.79). 
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 1
                                               
CHAPTER 1 
The Teleocidin Alkaloids - An Overview 
 
1.1 - Isolation and Structure 
 
“Teleocidin”, isolated from the mycelia of the soil bacteria Streptomyces mediocidicus 
by Takashima and Sakai in 1960, has a strong skin-irritating action and shows a 
highly potent toxicity against aquatic animals.1.1 In 1983, Fujuki and co-workers 
disclosed that “teleocidin” was in fact a mixture of closely related compounds, 
namely two teleocidin A isomers, teleocidins A-1 (1.1) and A-2 (1.2), and four 
teleocidin B isomers, teleocidins B-1 (1.3) to B-4 (1.6), according to their order of 
elution on reverse phase HPLC.1.2 Meanwhile, in 1979, while studying the origin of a 
severe dermatitis condition known as swimmers’ itch, Moore and co-workers isolated 
lyngbyatoxin A (1.1), a highly inflammatory and vesicatory substance.1.3 
Lyngbyatoxin A was obtained from a Hawaiian shallow-water variety of the blue-
green algae1.4 Lyngbya majuscula Gomont. More recently, in 1986, the Fujiki group 
unveiled that teleocidin A-1 is identical to lyngbyatoxin A.1.5
 
Based on extensive chemical and spectroscopic studies and X-ray crystallographic 
analysis, the structures of all teleocidins have been unambiguously established,1. ,1.1 3 
including their absolute configuration.1. ,1.5 6 These efforts showed that the teleocidins 
are indole alkaloids containing a highly functionalized 9-membered lactam bridging 
the indole 3- and 4-positions. In addition, each member of the teleocidin family has a 
distinctive complex monoterpenoid moiety: whereas the teleocidins A are 
characterized by a linalyl (i.e., 1,5-dimethyl-1-vinyl-4-hexenyl) side chain at the 7-
1.1 (a) Takashima, M.; Sakai, H. Bull. Agric. Chem. Soc. Jpn. 1960, 24, 647. (b) Takashima, M.; Sakai, 
H. Bull. Agric. Chem. Soc. Jpn. 1960, 24, 652. (c) Takashima, M.; Sakai, H; Arima, K. Agric. Biol. 
Chem. 1962, 26, 660. (d) Takashima, M.; Sakai, H; Arima, K. Agric. Biol. Chem. 1962, 26, 669. 
1.2 Fujiki, H.; Sugimura, T. Cancer Surveys 1983, 2, 539. 
1.3 Cardellina II, J. H.; Marner, F.-J.; Moore, R. E. Science 1979, 204, 193. 
1.4 “Blue-green algae”, “cyanobacteria” or “seaweed” are some of the various names used in the 
literature to refer to cyanophytes. Cyanophytes can loosely be defined as prokaryotic, chlorophyll-
containing organisms which have no true roots, stems or leaves and thus are neither bacteria nor algae. 
1.5 Sakai, S.; Hitotsuyanagi, Y.; Aimi, N.; Fujiki, H.; Suganuma, M.; Sugimura, T.; Endo, Y.; Shudo, 
K. Tetrahedron Lett. 1986, 27, 5219. 
1.6 (a) Hitotsuyanagi, Y.; Fujiki, H.; Suganuma, M.; Aimi, N.; Sakai, S.; Endo, Y.; Shudo, K.; 
Sugimura, T. Chem. Pharm. Bull. 1984, 32, 4233. (b) Sakai, S.; Aimi, N.; Yamaguchi, K.; 
Hitotsuyanagi, Y.; Watanabe, C.; Yokose, K.; Koyama, Y.; Shudo, K.; Itai, A. Chem. Pharm. Bull. 
1984, 32, 354. 
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position of the indole nucleus, the teleocidins B contain a 6-membered carbocyclic 
framework bridging the 6- and 7-positions of the indole nucleus (Figure 1.1). 
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1.1: Lyngbyatoxin A (aka Teleocidin A-1) (14R)
1.2: Teleocidin A-2 (14S)
1.3: Teleocidin B-1 (14R,17S)
1.4: Teleocidin B-2 (14S,17R)
1.5: Teleocidin B-3 (14S,17S)
1.6: Teleocidin B-4 (14R,17R)  
 
Figure 1.1 The teleocidin alkaloids. 
 
The teleocidins are structurally related to several other alkaloids which also contain 
the (-)-indolactam V (ILV)1.7 (1.7) core and hence are often referred to as the 
indolactam alkaloids. Other members of this family include pendolmycin (1.8),1.8 
cytoblastin (1.9),1.9 blastmycetin F (1.10)1.10 and the olivoretins (e.g., olivoretin C 
(1.11) and olivoretin E (1.12)),1.11 (Figure 1.2). 
 
                                               
1.7 Irie, K.; Hirota, M.; Hagiwara, N.; Koshimidzu, K.; Hayashi, H.; Murao, S.; Tokuda, H.; Ito, Y. 
Agric. Biol. Chem. 1984, 48, 1269. 
1.8 Yamashita, T.; Imoto, M.; Isshiki, K.; Sawa, T.; Naganawa, H.; Kurasawa, S.; Shu, B.-Q.; 
Umezawa, K. J. Nat. Prod. 1988, 51, 1184. 
1.9 (a) Kumagai, H.; Iijima, M; Dobashi, K.; Naganawa, H.; Sawa, T.; Hamada, M.; Ishizuka, M.; 
Takeuchi, T. J. Antibiot. 1994, 44, 1029. 
1.10 Irie, K.; Kajiyama, S.-I.; Okuno, S.; Kondo, M.; Koshimizu, K. J. Nat. Prod. 1994, 57, 363. 
1.11 (a) Sakai, S.; Aimi, N.; Yamaguchi, K.; Hitotsuyanagi, Y.; Watanabe, C.; Yokose, K.; Koyama, 
Y.; Shudo, K.; Itai, A. Chem. Pharm. Bull. 1984, 32, 354. (b) Hitotsuyanagi, Y.; Yamaguchi, K.¸ 
Ogata, K.; Aimi, N.; Sakai, S.; Koyama, Y.; Endo, Y.; Shudo, K.; Itai, A.; Iitaka, Y.; Chem. Pharm. 
Bull. 1984, 32, 3774. (c) Sakai, S.; Hitotsuyanagi, Y.; Yamaguchi, K.; Aimi, N.; Ogata, K.; 
Kuramochi, T.; Seki, H.; Hara, R.; Fujiki, H.; Suganuma, M.; Sugimura, T.; Endo, Y.; Shudo, K.; 
Koyama, Y. Chem. Pharm. Bull. 1986, 34, 4883. 
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Figure 1.2 Selected examples of indolactam alkaloids. 
 
An important structural feature of the indolactam alkaloids with significant biological 
implications (vide infra, section 1.3) is that the nine-membered lactam ring present in 
this family of compounds exists in solution as an equilibrium between at least two 
stable conformational states.1.12 The two conformers, often called twist (1.13) and 
sofa (1.14), are mainly characterized by a cis and a trans amide bond, respectively, as 
illustrated in Figure 1.3 for ILV. 
 
                                               
1.12 (a) Endo, Y.; Hasegawa, M.; Itai, A.; Shudo, K.; Tori, M.; Asakawa, Y.; Sakai, S. Tetrahedron 
Lett. 1985, 26, 1069. (b) Endo, Y.; Shudo, K.; Itai, A.; Hasegawa, M.; Sakai, S. Tetrahedron 1986, 21, 
5905. (c) Kawai, T.; Ichinose, T.; Takeda, M.; Tomioka, N.; Endo, Y.; Yamaguchi, K.; Shudo, K.; 
Itai, A. J. Org. Chem. 1992, 57, 6150. 
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1.13: Sofa form 1.14: Twist form  
 
Figure 1.3 Conformational equilibrium for ILV. 
 
 
1.2 - Biosynthesis 
 
The metabolic pathway leading to the teleocidins alkaloids has already been 
elucidated in considerable detail (Scheme 1.1).1. ,1. ,1.13 14 15 Biosynthetic studies in 
Streptomyces blastmyceticum by Koshimidzu and co-workers showed that ILV (1.7) 
is the biosynthetic precursor of the teleocidins and that the ILV core is assembled 
from L-tryptophan (L-Trp), L-valine (L-Val) and L-methionine (L-Met).1. a13  The first 
step in the biosynthesis of ILV is the formation of the N-methyl-L-valyl-L-
tryptophanol (1.15). Activation of the 4-position of the indole ring of dipeptide (1.15), 
presumably via oxidation to epoxide (1.16), followed by subsequent cyclisation 
affords ILV (1.7).1.14 As for the monoterpenoid side chain, studies in Streptomyces 
blastmyceticum by Irie and co-workers showed that it is derived from D-glucose via 
the non-mevalonate pathway.1.15 The incorporation of the linalyl moiety into the 7-
positon of ILV is proposed to proceed in two steps: initial prenylation of the indole 
nitrogen with geranyl pyrophosphate (GPP) (1.17) affords (1.18)1.16 and a subsequent 
aza-Claisen-type rearrangement delivers the teleocidins A. Finally, methylation at C-
17 followed by an intramolecular cyclization delivers the teleocidins B.1. b13
 
                                               
1.13 (a) Irie, K.; Kajiyama, S.; Funaki, A.; Koshimidzu, K. Tetrahedron Lett. 1990, 31, 101. (b) Irie, K.; 
Kajiyama, S.; Funaki, A.; Koshimidzu, K. Tetrahedron 1990, 46, 2773. 
1.14 Edwards, D. J.; Gerwick, W. H. J. Am. Chem. Soc. 2004, 126, 11432. 
1.15 Irie, K.; Nakagawa, Y.; Tomimatsu, S.; Ohigashi, H. Tetrahedron Lett. 1998, 39, 7929. 
1.16 N-prenylated (1.18) is also an important intermediate in biosynthesis of the olivoretins alkaloids. 
See Ref. 1.13b. 
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Scheme 1.1 Biosynthesis of the teleocidins. 
 
 
1.3 - Biological Activity 
 
Upon their isolation it was found that the teleocidins, besides being highly 
inflammatory and vesicatory agents, also possess significant toxicity.1. ,1.1 3 Moore and 
co-workers found that the minimum lethal dose (LD100) of lyngbyatoxin A in mice is 
about 0.3 mgkg-1 (by intraperitoneal injection) and that this alkaloid was able to kill 
all bait fish within ½ h at a concentration in seawater of 0.15 μgmL-1.1.3 These values 
are comparable to those reported by the Hirata1.17 and the Takashima1. d1  groups for 
teleocidin B-4: the LD50 in mice is 0.22 mgkg-1 (by intravenous injection) and it 
causes the death of Japanese killifish within 1 h at a concentration of 0.01 μgmL-1. 
Lyngbyatoxin A has also been linked to a human fatality due to consumption of sea 
turtle flesh whose diet presumably included L. majuscula.1.18
                                               
1.17 Sakabe, N.; Harada, H.; Hirata, Y.; Tomiie, Y.; Nitta, I. Tetrahedron Lett. 1966, 2523. 
1.18 Ito, E.; Satake, M.; Yasumoto, T. Toxicon 2002, 40, 551. 
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More recently, and of greater importance, it was disclosed that these alkaloids are 
potent tumor promoters and that they exert their biological activity by activating 
protein kinase C (PKC).1. ,1. ,1.2 19 20 PKC is a complex phosphorylating serine/threonine 
enzyme system comprised of at least ten isoenzymes. The different isoenzymes play a 
specific role in the regulation of several essential cellular processes.1. ,1. ,1.21 22 23 
Therefore, the discovery of isoenzymes-selective activators and inhibitors of PKC is 
crucial to ascertaining the role of the individual isoenzymes in physiological 
processes and to manipulating their function.1. ,1.24 25
1.19 (a) Fujiki, H.; Mori, M.; Nakayasu, M.; Terada, M.; Sugimura, T.; Moore, R. E. Proc. Natl. Acad. 
Sci. U.S.A. 1981, 78, 3872. (b) Fujiki, H.; Suganuma, M.; Hakii, H.; Bartolini, G.; Moore, R. E.; 
Takayama, S.; Sugimura, T. J. Cancer Res. Clin. Oncol. 1984, 108, 174. (c) For a review see: Fujiki, 
H.; Sugimura, T. Adv. Cancer Res. 1987, 49, 223. 
1.20 For a review dealing with anticancer agents and tumor promoters derived from marine prokaryotes 
see: Moore, R. E. Pure & Appl. Chem. 1982, 54, 1919. 
1.21 (a) Newton, A. C. Chem. Rev. 2001, 101, 2353. (b) Stillman, B. Science 1996, 274, 1659. (c) 
Barinaga, M. Science 1997, 278, 1036. (d) Nishizuka, Y. Science 1992, 258, 607. 
1.22 Kishi, Y.; Rando, R. R. Acc. Chem. Res. 1998, 31, 163. 
1.23 According to the conditions required for activation (i.e., cofactors), the PKC isoenzymes are 
subdivided in three groups1.21a: the conventional PKC (cPKCs) (α, βI, βII, γ), the novel PKC (nPKCs) 
(δ, ε, η, θ) and the atypical PKC (aPKCs) (ζ, λ/ι). Regarding the primary structure of the PKC 
isoenzymes, a C-terminal moiety contains the kinase domain, which is common to all PKCs, whereas 
a N-terminal moiety contains the regulatory modules. The later possess two key functionalities: the 
pseudosubstrate and one or two membrane-targeting modules (the C1 domain which for cPKCs and 
nPKCs binds diacylglycerolds (DAGs) and the C2 domain which for cPKCs binds Ca2+) (Figure 1.A). 
 
COOHH2N C2C1B
Catalytic DomainRegulatory Domain
COOHH2N C2-like
COOHH2N
Conventional PKC
(PKC α, βΙ, βΙΙ, γ)
Novel PKC
(PKC δ, ε, η, θ)
Atypical PKC
(PKC ζ, λ/ι)
C1A
C1BC1A
C1
pseudosubstrate
C3 C4
C3 C4
C3 C4
Cofactors
DGA Ca2+
+ +
+
- -
-
 
 
Figure 1.A: Primary structure of PKC isoenzymes showing the domain composition and co-factors. 
 
1.24 Recent investigations suggested that the nPKCs are involved in mouse skin tumor promotion and 
that the C1B domains of these PKC isoenzymes are the main targets of tumor promoters.1.25 Thus, the 
design of new agents with high selectivity for C1B domains of nPKCs is indispensable in elucidating 
the precise mechanism of skin-tumor promotion. 
1.25 (a) Lu, Z.; Hornia, A.; Jiang, Y. W.; Zang, Q.; Ohno, S.; Foster, D. A. Mol. Cell. Biol. 1997, 17, 
3418. (b) Reddig, P. J.; Dreckschmidt, N. E.; Ahrens, H.; Simsiman, R.; Tseng, C. P.; Zou, J.; 
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Physiologically, PKC is activated by (S)-1,2-diacylglycerols (DGAs) (e.g., (1.19)).1.23 
The role of the DAGs can, however, be mimicked by various, structurally diverse, 
natural products, namely the phorbol esters (e.g., (1.20)), the bryostatins (e.g., (1.21)) 
and the indolactam alkaloids (e.g., (1.22)) (Figure 1.4). Analysis of these compounds 
led Kishi to propose that, regarding the activation of PKCs, the existence of three 
hydrophilic atoms separated by approximately 6 Å (three-point model), together with 
a hydrophobic moiety, constitute a possible pharmacophore.1.22
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(CH2)7CH=CH(CH2)7Me
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Figure 1.4 Structure of a representative DAG (1.19) and various tumor promoters ((1.20) to 
(1.22)); corresponding moieties in pharmacophores are indicated by the same outlining feature. 
 
 
 
                                                                                                                                            
Oberley, T. D.; Verma, A. K. Cancer Res. 1999, 59, 5710. (c) Reddig, P. J.; Dreckschmidt, N. E.; 
Bourguignon, S. E.; Oberley, T. D.; Verma, A. K. Cancer Res. 2000, 60, 595. (d) Chida, K.; Hara, T.; 
Hirai, T.; Konoshi, C.; Nakamura, K.; Nakao, K.; Aiba, A.; Katsuki, M.; Kuroki, T. Cancer Res. 2003, 
63, 2404. 
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With respect to the indolactam alkaloids, Fujiki and co-workers showed that the 
minimum structure for biological activity corresponds to (-)-ILV (1.7)1.26 and more 
recently, Irie and co-workers disclosed that (-)-IVL shows a biding preference for 
C1B domains over C1A domains of nPKCs.1.27 The hydrophobic moiety on the indole 
ring of the teleocidins plays a critical role in increasing the biological potency: the 
activity of teleocidin B-5 (1.6) in terms of the biding affinity to PKC and growth 
inhibition of HL-60 cells is 100-500 times higher than that of (-)-ILV, which lacks the 
hydrophobic moiey.1.28 However, there is not a great deal of (stereo)specificity 
directed towards the nature of this hydrophobic moiety as the teleocidins B, which are 
stereochemical isomers of the C-14 and C-17 positions of the terpenoid side chain, 
and their open-chain analogues, the teleocidins A, exhibit similar biological 
activity.1.29 Furthermore, the terpenoid substituents of the teleocidins can be replaced 
by a simple linear alkyl group without loss of activity.1.30
 
The biological activity of the indolactam alkaloids shows an interesting dependence 
on conformation. As mentioned before all the teleocidins exist in an equilibrium of 
two conformational states, the twist and sofa forms (vide supra, Section 1.1).1.12 The 
Erie group disclosed that, in the indolactam family, the biologically active form is 
(closer) to the twist conformer.1. c,1. e31 31
 
Aiming at finding teleocidin-analogues that were synthetically more accessible and/or 
isoenzymes selective, different analogues were synthesized and tested.1. ,1.12 31 A 
1.26 Fujiki, H.; Suganuma, M.; Hakii, H.; Nakayasu, M.; Endo, Y.; Shudo, K.; Irie, K.; Koshimizu, K.; 
Sugimura, T. Proc. Jpn. Acad. Ser. B 1985, 61, 45. 
1.27 Masuda, A.; Irie, K.; Nakagawa, Y.; Ohigashi, H. Biosci. Biotechnol. Biochem. 2002, 66, 1615. 
1.28 Fujiki, H.; Suganuma, M.; Nakayasu, M.; Tahira, T.; Endo, Y.; Shudo, K. Jpn. J. Cancer Res. 
(Gann) 1984, 75, 866. 
1.29 Fujiki, H.; Suganuma, M.; Ninomiya, M.; Yoshizawa, S.; Yamashita, K.; Takayama, S.; 
Hitotsuyanagi, Y.; Sakai, S.-I.; Shudo, K.; Sugimura, T. Cancer Res. 1988, 48, 4211. 
1.30 (a) Irie, K.; Hayashi, H.; Arai, M.; Koshimizu, K. Agric. Biol. Chem. 1986, 50, 2679. (b) Endo, Y.; 
Sato, Y.; Shudo, K. Tetrahedron Lett. 1987, 43, 2241. 
1.31 (a) Endo, Y.; Ohno, M.; Hirano, M.; Shudo, K. J. Am. Chem. Soc. 1996, 118, 1841. (b) Endo, Y.; 
Yamaguchi, M.; Hirano, M.; Shudo, K. Chem. Pharm. Bull. 1996, 44, 1138. (c) Kozikowski, A. P.; 
Ma, D.; Pang, Y.; Shum, P.; Likic, V.; Mishra, P. K.; Macura, A.; Basu, J. S.; Lazo, J. S. J. Am. Chem. 
Soc. 1993, 115, 3957. (d) Kozikowski, A. P.; Ma, D.; Du, L.; Lewin, N. E. Blumberg, J. Am. Chem. 
Soc. 1995, 117, 6666. (e) Irie, K.; Isaka, T.; Iwata, Y.; Yanai, Y.; Nakamura, Y.; Koizumi, F.; 
Ohigashi, H.; Wender, P. A. Satomi, Y.; Nishino, H. J. Am. Chem. Soc. 1996, 118, 10733. (f) Ma, D.; 
Tang, W.; Kozikowski, A. P.; Lewin, N. E.; Blumberg, P. M. J. Org. Chem. 1999, 64, 6366. (g) Wei, 
Z.-L.; Sakamuri, S.; Petukhov, P. A.; George, C.; Lewin, N. E.; Blumberg, P. M.; Kozikowski, A. P. 
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representative selection is shown in Figure 1.5. Accordingly, the Endo group reported 
that the benzo-derivative (1.23), containing a 8-membered lactam and which mimics 
the indolactam twist conformation, was a potent PKC activator,1. a31  On the other hand, 
Kozikowski disclosed that the analogue (1.24) that mimics the sofa conformation of 
the indole alkaloids was virtually incapable of activating PKC: whereas (1.23) caused 
growth inhibition and differentiation of HL-60 cells at a concentration of 10-8 M, 
(1.24) proved to be inactive at concentrations bellow 10-5 M.1. a,1. c31 31  The nature of the 
side chains appendages can alter isoform selectivity (e.g., the analogue (1.25) 
exhibited improved isoenzymes selectivity in comparison with its saturated side-chain 
counter part).1.32 By replacing the indole backbone with a benzofuran, as in (1.26), 
Kozikowski and co-workers showed that the indole nitrogen has a (modest) role in the 
isoenzymes selectivity but only plays a supporting role in the interaction with the 
PKC.1. d31  Interestingly, Irie and co-workers recently reported that analogues (1.27) 
and (1.28) with a sofa-like conformation show significant selectivity for nPKC 
isoenzymes.1. ,1. h27 31
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Figure 1.5 Examples of teleocidin-analogues. 
 
                                                                                                                                            
Org. Lett. 2002, 4, 2169. (h) Nakagawa, Y.; Irie, K.; Komiya, Y.; Ohigashi, H.; Tsuda, K. 
Tetrahedron 2004, 60, 7077. 
1.32 Kosikowski, A. P.; Wang, S.; Ma, D.; Yao, J.; Ahmad, S.; Glazer, R. I.; Bogi, K.; Acs, P.; 
Modarres, S.; Lewin, N. E.; Blumberg, P. M. J. Med. Chem. 1997, 40, 1316. 
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1.4 - Selected Total Synthesis of Indolactam Alkaloids 
 
The unusual structure of the indolactam alkaloids, together with their interesting 
biological profile, has made them worthy targets for the organic synthetic community 
over the past years.1. ,1. ,1. ,1.33 34 35 36 While several total syntheses of (-)-ILV (1.7) have 
been reported,1.33 at the time of this writing there has only been published one total 
synthesis1. a-1. c34 34  and a formal total synthesis1. d34  of the structurally more complex 
teleocidins A (1.1) and (1.2), and two total synthesis1.35 of teleocidins B-3 (1.5) and 
B-4 (1.6). Total syntheses of pendolmycin (1.8)1. c34  and cytoblastin (1.9) 1.36 have also 
been reported. 
 
In the Natsume total synthesis of teleocidins A,1. a-c34  B-3 and B-4,1.35 the indole 
nucleus is accessed from a preformed pyrrole ring system by construction of the 
benzenoid aromatic ring (Scheme 1.2). For lyngbyatoxin A, 1. a-c34  the linalyl side chain 
is installed at an early stage in the synthetic sequence via the Grignard reaction of 
geranly bromide with the enantiomerically pure L-valine ketoamide pyrrole derivative 
(1.30), affording the tertiary alcohol (1.32a) as a diasteromeric mixture. Dehydration 
and conversion into the corresponding thioamide (1.33a) followed by a Bischler-
Napieralski type cyclization produces the 7-alkyl 4-aminoindole (1.34a) as a mixture 
of epimers at C-14. After separation of the diastereoisomers, the indolic C-3 position 
was then functionalized via 3-bromo-2-hydroxyiminopropanoate. Reduction of the 
resulting oxime afforded a 1:1 inseparable mixture of diastereoisomeric amino esters 
(1.35a) at the newly installed chiral centre C-9. Finally, construction of the nine-
membered lactam ring, achieved with DPPA, and separation of the corresponding 
diastereoisomers afforded lyngbyatoxin A (as well as teleocidin A-2). Alternatively, 
1.33 For selected total synthesis of (-)-ILV (1.7) see: (a) Kogan, T. P.; Somers, T. C.; Venuti, M. C. 
Tetrahedron 1990, 46, 6623. (b) Nakatsuka, S.; Masuda, T.; Sakai, K.; Goto, T. Tetrahedron Lett. 
1986, 27, 5735. (c) Mascal, M.; Moody, C. J. J. Chem. Soc., Chem. Commun. 1988, 589. (d) Quick, J.; 
Saha, B.; Driedger, P. E. Tetrahedron Lett. 1994, 35, 8549. (e) Endo, Y.; Shudo, K.; Itai, A.; 
Hasegawa, M.; Sakai, S. Tetrahedron 1986, 42, 5905. 
1.34 For total synthesis of the teleocidins A (1.1) and (1.2) see: (a) Muratake, H., Natsume, M. 
Tetrahedron Lett. 1987, 28, 2265. (b) Muratake, H., Natsume, M. Tetrahedron. 1991, 47, 8535. (c) 
Muratake, H., Natsume, M. Tetrahedron 1991, 47, 8545. (d) Semmelhack, M. F.; Rhee, H. 
Tetrahedron Lett. 1993, 34, 1399. 
1.35 For total synthesis of teleocidins B-3 (1.5) and B-4 (1.6) see: (a) Nakatsuka, S.; Masuda, T.; Goto, 
T. Tetrahedron Lett. 1987, 28, 3671. (b) Okabe, K.; Muratake, H.; Natsume, M. Chem. Pharm. Bull. 
1989, 37, 563. (c) Okabe, K.; Muratake, H.; Natsume, M., Tetrahedron 1991, 47, 8559. 
1.36 For the total synthesis of cytoblastin (1.9) see: Moreno, O. A.; Kishi, Y. J. Am. Chem. Soc. 1996, 
118, 8180. 
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by starting with the homologue terpenoid moiety (1.31) and using the same sequence 
of steps plus a final acid-promoted intramolecular Friedel-Crafts cyclization, Natsume 
and co-workers also prepared teleocidins B-3 and B-4.1.35
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N CO2Me
Me
CO2Et
NH2
N CO2Me
Me
S
For R = H, lyngbytoxin A 1.1 and
                 teleocidin A-2
1.29 1.30
geranyl bromide:R = H
or
1.31: R = Me
1.32a: R = H
1.32b: R = Me
N
CO2Et
OH
Br
N
Ts
N
Ts
N
H
N
H
N
H
N CO2Me
Me
MeHN CO2Me
separate
diastereoisomers
HPLC separation
R
R
1.33a: R = H
1.33b: R = Me
RR
1.34a: R = H
1.34b: R = Me
R
1.35a: R = H
1.35b: R = Me
For R = Me, teleocidin B-3 1.5 and 
                    teleocidin B-4 1.6
9
14
 
 
Scheme 1.2 Highlights of Natsume’s total synthesis of the teleocidins A (1.1) and (1.2), B-3 (1.5) 
and B-4 (1.6). 
 
Semmelhack and Rhee1. d34  achieved a formal total synthesis of lyngbytoxin A in 
which a precursor of the linalyl side chain at C-7 is introduced as the nitrile-stabilized 
lithium anion (1.38) via nucleophilic attack onto the Cr(CO)3 complex of the 
protected 4-amino indole (1.37) affording, after oxidation, indole (1.39). The L-valine 
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unit was introduced by means of a stereospecific displacement of the triflate of (R)-2-
hydroxyvaleric acid methyl ester by the C-4 methylamino substituent in (1.40), thus 
obtaining the (S)-N-valylindole (1.34a), which has already been successfully 
converted into lyngbytoxin A (vide supra, Scheme 1.2) (Scheme 1.3). 
 
Li
CN
TfO CO2Me
 1.1
1.36 1.37
1.38
1.40
as in
 Scheme 1.2
N
H
NHTBDMS
N
NMeTBDMS
SEM
(OC)3Cr
1.39
N
NHMe
SEM
CN
N
H
NHMe
1.34a
N
H
MeN CO2Me
 and separate
diastereoisomers
 
 
Scheme 1.3 Highlights of Semmelhack and Rhee formal total synthesis of lyngbytoxin A (1.1). 
 
Besides the total syntheses of the teleocidins several groups have reported interesting 
approaches towards simplified analogues. 
 
The Kozikowski approach1.37 to this type of compounds is similar to that of Natsume 
in that the indolic system is constructed from a functionalized pyrrole. The synthesis 
of teleocidins A analogue (1.47) involved the condensation of N-(triisopropylsilyl)-β-
lithiopyrrole (1.43) with the imine (1.42), which was obtained from the reaction of L-
valine methyl ester with the isoxaline (1.41), affording pyrrole (1.44) as mixture of 
diastereomeric products at C-4. The indole nucleus is obtained via the hydrogenolysis 
of the N-O bond followed by cyclization using TBDMSOTf. Functionalization of the 
indole 3-position of (1.45) was achieved in the same manner as in Scheme 1.2. The 
formation of the nine-membered lactam ring was efficiently accomplished with Et3Al 
(Scheme 1.4). 
                                               
1.37 Kozikowski, A. P.; Sato, K.; Basu, A.; Lazo, J. S. J. Am. Chem. Soc. 1989, 111, 6228. 
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Me
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OH
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Me
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Si(iPr)3
Li
N
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Scheme 1.4 Highlights of Kozikowski’s synthesis of teleocidins analogue (1.47). 
 
In most of the approaches towards the indolactam core, the 9-membered lactam ring 
is obtained by formation of the amide bond, thus requiring functionality in both the 3-
and 4-positions of the indole nucleus (e.g., as in Scheme 1.2 to Scheme 1.4). Moody 
and Mascal1. c 33 prepared (-)-ILV (1.7) by a fundamentally different approach, in that 
only the indole 4-position is previously functionalized. The key step involves the 
photocyclization of trytophanol (1.48), easily obtained from (-)-tryptophan methyl 
ester, to afford the tertiary alcohol (1.49) as an epimeric mixture at C-12. Conversion 
into the corresponding azide (1.50) followed by a nitrene-mediated ring expansion 
afforded imine (1.51). A stereoselective reduction followed by N-methylation then 
delivered (-)-ILV (Scheme 1.5). 
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Scheme 1.5 Highlights of Moody and Mascal total synthesis of (–)-ILV (1.7). 
 
Waldmann and co-workers constructed a library of teleocidin A analogues.1.38 
Regioselective lithiation of dimethyl N-gramine derivative (1.52) followed by 
treatment with TMS-diazomethane afforded 4-amino indole (1.53) which was then 
converted into the corresponding substituted tryptophan (1.54) by treatment with TFA 
and diallyl phenylacetamidomalonate. Enantioselective enzymatic hydrolysis afforded 
enantiomerically pure amino-acid (1.55). The second stereocenter in the indolactam 
core was introduced by alkylation with different homochiral α-hydroxy acid ester 
triflates (1.56) and the primary hydroxyl group was used to link the indolactam core 
to solid phase via a tetrahydropyrane spacer. Reductive amination with different 
aldehydes (1.58) was achieved with NaHB(OAc)3 yielding resin-linked indolic 
tertiary amines derivatives (1.59). The C-7 position of the indole nucleus was then 
functionalized in a sequence that involved as the key step the Sonogashira coupling 
with acetylenes (1.60) affording immobilized alkynes (1.61) which were successfully 
released from the polymeric support as the corresponding ketones (1.62). 
 
                                               
1.38 (a) Meseguer, B.; Alonso-Díaz, D.; Griebenow, N.; Herget, T.; Waldmann, H. Angew. Chem. Int. 
Ed. 1999, 38, 2902. (b) Meseguer, B.; Alonso-Díaz, D.; Griebenow, N.; Herget, T.; Waldmann, H. 
Chem. Eur. J. 2000, 21, 2902. 
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Scheme 1.6 Highlights of solid phase synthesis of teleocidin A analogues by Waldmann and co-
workers. 
 
The teleocidins B core was recently accessed by Sames and co-workers in an 
impressive sequence involving two carbon-carbon bond formation reactions via C-H 
activation reactions. Treatment of the Schiff base (1.63) with stoichiometric amounts 
of PdCl2 and NaOAc, followed by transmetalation with vinyl boronic acid (1.64) 
afforded alkene (1.65) as a 3:1 E:Z mixture. The latter was then converted into 
racemic imine (1.66) via a Friedel-Crafts reaction. A diastereoselective one-carbon 
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homologation of (1.66) was achieved by treating it with PdCl2 and NaOAc followed 
by addition of CO and MeOH. Acid hydrolysis of the Schiff base accompanied by 
spontaneous cyclization furnished lactam (1.67). The highest selectivity in favour of 
the desired lactam (1.67) was obtained by performing this sequence at 70 oC: with 
these conditions a 6:1 diastereomeric ratio at C-14 was obtained. The latter was 
obtained diastereomeric pure by crystallization. The synthesis of the teleocidin B-4 
core (1.68) was then accomplished via the allylation of (1.67) with 2,3-
dibromopropene followed by a Pd-catalyzed intramolecular alkenylation. 
 
OMe
N
OMe
MeO
OMe
N
OMe
MeO
PdCl2, NaOAc,
MsOH
PdCl2, NaOAc
CO, MeOH, SiO2
then separation
NH
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1.63
1.64
1.66
1.68
OMe
N
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1.65; E:Z, 3:1
1.67
B(OH)2
, Ag2O
14
 
Scheme 1.7 Highlights of Sames and co-workers synthesis of teleocidin B-4 core. 
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CHAPTER 2 
Synthetic Strategy Towards Lyngbyatoxin A 
 
2.1 - Installation of the Quaternary Centre 
 
Although the field of stereoselective 
synthesis has witnessed spectacular progress 
in the past decades, the enantioselective 
formation of all-carbon quaternary centres 
still poses a considerable challenge to the 
synthetic organic chemist.2.1 Regarding the 
teleocidin alkaloids, all of the thus far 
reported total syntheses lack stereochemical 
control at the quaternary centre(s) (vide 
Chapter 1). 
N
H
N
H
N
O
Me
OH
14
1.1
Figure 2.1 Structure of lyngbyatoxin A. 
 
Therefore, a critical step in any enantioselective approach to lyngbyatoxin A concerns 
the installation of the quaternary stereocenter at C-14. 
 
A possible solution to the stereocontrolled generation of the characteristic all-carbon 
quaternary centre present in the teleocidins A involves the use of the so-called Jung 
rearrangement.2.2 The Jung rearrangement refers to the Lewis acid (LA) mediated 
stereospecific rearrangement of enantiomerically pure epoxides (2.1) into the 
corresponding carbonyl compound (2.5) and thus it has the potential to establish an 
acyclic quaternary carbon (marked * in (2.5)) (Scheme 1.1).2.3
 
2.1 For reviews on the synthesis of quaternary carbon centers see: (a) Corey, E. J.; Guzman-Perez, A. 
Angew. Chem. Int. Ed. 1998, 37, 388. (b) Christoffers, J.; Mann, A. Angew. Chem. Int. Ed. 2001, 40, 
4591. (c) Fuji, K. Chem. Rev. 1993, 93, 2037. (c) Christoffers, J.; Baro, A. in “Quaternary 
Stereocenters, Challenges and Solutions for Organic Synthesis” 2005, Wiley-VCH, New York. (d) 
Barriault, L.; Denissova, I. Tetrahedron 2003, 42, 1688. 
2.2 (a) Jung, M. E.; D´Amico, D. C. J. Am. Chem. Soc. 1995, 117, 7379. (b) Jung, M. E.; Anderson, K. 
L. Tetrahedron Lett. 1997, 38, 2605. 
2.3 For a review on the acid catalysed rearrangements of epoxides see: Rickborn, B. in 
“Comprehensive Organic Synthesis” (Trost, B. M., Fleming, I. ed.) 1991, 3, 733, Pergamon, New 
York. 
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Mechanistically, the Jung rearrangement is reminiscent of the better known pinacol 
rearrangement.2.4 It is a step-wise process that starts with the formation of the 
epoxide-L.A. complex (2.2), which undergoes rupture of the oxirane C-O bond to 
afford (the most) stabilized carbocation (2.3). Rotation around the carbon-carbon 
bond into conformer (2.4), a process required to align the migrating group with the 
adjacent vacant p orbital in a coplanar fashion, followed by a symmetry-allowed 1,2-
sigmatropic shift2.5 finally produces carbonyl compound (2.5).2. a2
 
R1
R4
R2
R1 R2
R4R3
O
2.1
O
R3 R4
R1 R2
LA
LA
O
R3 R4
R1 R2
LA
OR3
R4
R1 R2
LA
O
R3
R2R1
R4
*
2.2 2.3
2.4
[σ2s+ω0s]
+60o 
rotation
2.5
OR3
2.5
(4q+2)s: 1
     (4r)a: 0
      total: 1
 
 
Scheme 1.1 The Jung rearrangement. 
 
It should however be appreciated that the outcome of this sequence, being determined 
by a subtle combination of intrinsic factors (e.g., carbocation stability and migratory 
aptitude of the substituents) and reaction conditions, is often difficult to predict and 
control.2.6 This point is adequately illustrated in the initial studies by Tanner and 
Tønder towards the enantioselective total synthesis of lyngbyatoxin A where it was 
found that the result of the Jung rearrangement of enantiomerically pure indole-
                                               
2.4 (a) Mayo, P. in “Rearrangement in Ground and Excited States” 1980, 1, Academic Press, New 
York). (b) Isaacs, N. S. in “Reactive Intermediates in Organic Chemistry” 1974, Wiley, New York. (c) 
Coveney, D, J. in “Comprehensive. Organic Synthesis” (Trost, B. M.; Fleming, I. ed.) 1991, 3, 777, 
Pergamon, New York. (d) Rickborn, B. in “Comprehensive Organic Synthesis” (Trost, B. M.; 
Fleming, I. ed.) 1991, 3, 721, Pergamon, New York. 
2.5 (a) Woodward, R. B.; Hoffmann, R. in “The Conservation of Orbital Symmetry” 1970, Verlag 
Chemie, Academic Press, New York. (b) Fleming, I. in “Pericyclic Reactions”, 1999, 67, Oxford 
Science Publications, Oxford Chemistry Primers. 
2.6 See e.g., Collins, C. J. Acc. Chem. Res. 1971, 4, 315 and examples therein. 
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derived vinyl epoxides (2.6) is highly dependent of the nature of the indole protective 
group (PG) and of the substitution pattern of the oxirane ring.2.7
 
Table 2.1 Product distribution in the Jung rearrangement of indole-derived vinyl epoxides (2.6). 
 
BF3 OEt2
CH2Cl2, -78 oCN
O
R1
R2 PG
N
PG
O
N
PG
O
N
PG
OHC
+ +
2.6 2.7 2.8 2.9  
 
Product Distribution 
Substrate 
2.7 2.8 2.9 
2.6a: PG = Bn, 
R1 = H, R2 = Me 
>99% 
(via vinyl migration) - - 
    
2.6b: PG = Ts, 
R1 = H, R2 = Me 
- 
60% 
(via hydride migration) 
40% 
(via indole migration) 
    
2.6c: PG = Bn, 
R1 = Me, R2 = H 
- - 
>99% 
(via vinyl migration) 
 
Therefore, hoping to avoid the rearrangement capriciousness, it was decided to 
incorporate it at an early stage in the synthetic sequence, namely prior to formation of 
the indole moiety. In this approach, the substrate for the Jung rearrangement would 
then be an enantiomerically pure, conveniently functionalized vinyl phenyl epoxide 
(2.10) or (2.11)2.8 and the indole nucleus would be accessed at a later stage via some 
type of annulation strategy (vide infra, section 2.2).  
 
Furthermore, in order to circumvent the issue concerning the migratory aptitude of 
functionalized phenyl moieties,2.9 it was decided to investigate the feasibility of 
                                               
2.7 Tønder, J. E.; Tanner, D. Tetrahedron 2003, 59, 6937. 
2.8 Jung and Anderson already demonstrated that benzylic quaternary carbon centres could be obtained 
in high yield and with excellent optical purity from enantiomerically pure (non-substituted) phenyl 
vinyl epoxides via phenyl migration. See ref. 2.2b. 
2.9 For studies on the relative migratory aptitudes of substituted aryl groups in the pinacol 
rearrangement see: (a) Bachmann, W. E.; Ferguson, J. W. J. Am. Chem. Soc. 1934, 56, 2081; (b) 
Curtin, D. Y.; Crew, M. C. J. Am. Chem. Soc. 1955, 77, 354. 
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accessing the quaternary carbon via vinyl migration,2.10 as opposed to the alternative 
aryl migration (Scheme 2.2). 
 
O
FG(s) FG(s)
OHC
FG(s)
O
LA
(via vinyl migration)
LA
(via aryl migration)
2.10 2.112.12  
 
Scheme 2.2 Two possibilities for accessing the all-carbon quaternary centre via the Jung 
rearrangement. 
 
That the quaternary aldehyde (2.12) would be the exclusive/major product from the 
Jung rearrangement of (2.11) was expected on several grounds. Firstly, the anticipated 
preference for the tertiary benzylic carbocation (2.13) over the secondary allylic 
(2.14) finds good precedent in the work of Jung who already showed that a secondary 
benzylic carbonium ion is more stable than its secondary allylic counterpart.2. b2  
Secondly, the clock-wise rotation that correctly aligns the vinyl group for migration 
(conformer (2.15)), thus leading to quaternary aldehyde (2.12), is also expected to be 
favoured over the alternative counter clock-wise motion (Scheme 2.3). This is 
because such clock-wise rotation requires the hydrogen, the least steric demanding 
species, to eclipse with the aryl group. The opposite anti clock-wise process, that 
collinearly aligns the hydrogen with the adjacent p orbital (conformer (2.16)) and 
leads to α,β-unsaturated ketone (2.17) via a 1,2-hydride shift, would require the vinyl 
group to cross with the methyl group, thereby causing what is expected to be a more 
severe eclipsing interaction. Finally, migration of the vinyl group is also expected to 
be favoured over the hydride on the grounds of its (slightly) higher migratory 
aptitude.2.11
 
 
                                               
2.10 Jung and Anderson have previously reported that 1,2-vinyl shifts in these type of systems proceed 
with good chirality transfer. See refs. 2.2. 
2.11 Nakamura, K.; Osamura, Y. J. Am. Chem. Soc. 1993, 115, 9112 and references therein. 
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Scheme 2.3 Possible pathways during the Jung rearrangement of vinyl epoxide (2.11). 
 
In the context of asymmetric synthesis, besides the regiochemical aspects of the Jung 
rearrangement discussed above, an equally important feature concerns the 
rearrangement stereospecificity. Ideally, the enantiomeric purity of the starting 
epoxide will be reflected in that of the product. However, this is not always the case: 
Tanner and Tønder disclosed that their initial approach to the installation of the 
quaternary carbon in lyngbyatoxin A was plagued by a substantial loss of 
enantiomeric purity during the Jung rearrangement of vinyl epoxide (2.6c) (91% ee) 
to the quaternary aldehyde (2.9) (71% ee) (Scheme 2.4).2.7
 
BF3 OEt2
CH2Cl2, -78 oCN
O
Bn
N
Bn
OHC
(S,S)-2.6c, 91% ee (R)-2.9, 71% ee
88%
 
 
Scheme 2.4 Non-stereospecific Jung rearrangement of epoxide (2.6c) to aldehyde (2.9). 
 
In order to achieve complete chirality transfer from epoxide (2.11), the rate of vinyl 
migration has to be significantly higher than the rate of conformer equilibration. If 
not, conformer (2.19) will also be appreciably populated and thus vinyl migration 
onto the enantiotopic face of the planar carbocation becomes a significant competing 
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process. This would lead to enantiomeric quaternary aldehyde ent-(2.12) and 
therefore to a decrease in the optical purity (Scheme 2.5). Encouragingly, Jung and 
Anderson already reported that 1,2-vinyl shifts in (simple) phenyl-derived vinyl 
epoxides can proceed with good transfer of the chirality.2.2
 
Ar
OHC
OH
vinyl
O
H vinyl
LA
Ar Me
Ar Me
vinyl
migration
2.13
2.15
O H
vinyl
Ar Me
2.19
vinyl
migration
2.12
LA
Ar
CHO
LA
ent-2.12  
 
Scheme 2.5 Conformer equilibration leading to a stereochemical loss during the Jung 
rearrangement. 
 
 
2.2 - Construction of the Indole Ring 
 
Having defined a strategy to install the quaternary centre in lyngbyatoxin A, we 
turned our attention to the synthesis of the indole ring system. 
 
A variety of methods for preparing indoles from non-heterocyclic precursors by 
cyclization of suitably substituted benzenes is available (Scheme 2.6).2.12 As it can be 
seen, most of these annulation-based approaches require highly functionalized 
benzene-derived substrates, the synthesis of which presents a challenge on itself. 
Furthermore, the majority of these methods entails the pre-functionalization of the 
aromatic position ortho to the quaternary carbon, typically with a protected amino 
group or a synthetic equivalent. However, any such ortho functionality can 
conceivably interfere with the preparation of the rearrangement substrates (e.g., the 
                                               
2.12 For leading references see: (a) Sundberg, R. J. in “Indoles” 1996, Academic Press, San Diego. (b) 
Gribble, G. W. J. Chem. Soc., Perkin Trans 1 2000, 1045. (c) Gribble, G. W. Contemp. Org. Synth. 
1994, 145. (d) Gilchrist, T. L. J. Chem. Soc., Perkin Trans. 1 1999, 2848. (e) Moody, C. J. Synlett 
1994, 681. 
Part I                                        Chapter 2: Synthetic Strategy Towards Lyngbyatoxin A 
 
 
 23
fixed proximity between the nucleophilic (protected) amino group and the 
electrophilic oxirane ring presumably makes such benzylic epoxides rather labile) 
and/or the course of the Jung rearrangement itself. Therefore, these approaches were a 
priori considered to be highly risky. 
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NH2
X
R
FG(s)
NHX Y
X
+
Fisher, Gassman, 
Larok and Bartoli 
indole synthesis
R
FG(s)
N
H
X
Y
McMurry and Madelung
indole synthesis
R
FG(s)
N
H
X
( )n
Mori-Ban,
Heck-type and
Photochemical-approach
indole synthesis
R
FG(s)
1
2
3
4
5
6
7
4a
7a
N1-C2
disconnection
N1-C2 and
C3-C4a
disconnection
C2-C3
disconnection
C3-C4a 
disconnection
N1-C7a
disconnection
NH2
Hemetsberger-Knittel
indole synthesis
N
H
R
FG(s)
 
 
Scheme 2.6 Example of indole synthesis via cyclization of substituted benzenes. 
 
On the other hand, the Hemetsberger-Knittel indole synthesis2. ,2.13 14 emerged as being 
particularly suitable to our needs. The Hemetsberger-Knittel approach involves the 
formation of 2-azidocinnamates (2.22) by condensation of a benzaldehyde (2.20) with 
an azidoacetate (2.21) in the presence of sodium alkoxide at low temperatures as the 
first step and pyrolysis of (2.22) in a convenient solvent as the second step to give the 
                                               
2.13 (a) Hemetsberger, H.; Knittel, D.; Weidmann, H. Monatsh. Chem. 1969, 100, 1599-1603. (b) 
Hemetsberger, H.; Knittel, D.; Weidmann, H. Monatsh. Chem. 1970, 101, 161-165. (c) Hemetsberger, 
H.; Knittel, D. Monatsh. Chem. 1972, 103, 194-204. (d) Murakami, Y.; Watanabe, T.; Suzuki, H.; 
Kotake, N.; Takahashi, T.; Toyonari, K.; Ohno, M.; Takase, K.; Suzuki, T.; Kondo, K. Chem. Pharm. 
Bull. 1997, 45, 1739. 
2.14 For a general review dealing with nitrenes see: Moody, C. J. in “Comprehensive. Organic 
Synthesis.” (Trost, B. M.; Fleming, I. ed.) 1991, 1, 21, Pergamon, New York. 
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corresponding indole-2-carboxylate (2.23). Thus, this approach to indoles has the 
advantage of requiring less substituted benzene derivatives as starting materials and, 
since the indole-forming process can be seen as a formal nitrene insertion into the 
aromatic C-H bond corresponding to formation of the N1-C7a bond, it does not 
require pre-functionalization of the aromatic positions ortho to the quaternary carbon. 
Furthermore, the reaction is compatible with various functional groups (FGs) (e.g., 
halogens, ethers, amides, etc). 
 
CHO
FG(s)
N3 CO2R
RONa, ROH
-15 oC to 0 oC
N3
CO2R
N
H
FG(s)
CO2R
FG(s)Δ
2.20 2.22 2.23
2.21
17a
solvent
 
 
Scheme 2.7 The Hemetsberger-Knittel indole synthesis. 
 
These features are nicely illustrated in the synthesis of indole (2.25), an advanced 
intermediate in the total synthesis of the bacterial coenzyme methoxatin (2.26), which 
was prepared from the highly functionalized benzaldehyde (2.24) in good yield (74%) 
(Scheme 2.8). 
 
2.24
CHO
BnO NHAc
N3 CO2Me
NaOMe
MeOH, -15 oC
Δ
NH
CO2Et
BnO NHAc
2.25, 74%
1)
2)
PhMe
NH
CO2H
O N
CO2H
CO2H
O
2.26  
 
Scheme 2.8 Use of the Hemetsberger-Knittel reaction as the key step in the total synthesis of  
methoxatin (2.26). 
 
On the down-side, although the Hemetsberger-Knittel indole synthesis is simple and 
convenient, it is limited to aryl aldehydes and thus 3-substituted indoles are usually 
not available through this method. The overall reaction yields are typically good; 
when this is not the case, the reason for the low yields of indoles lies mainly in the 
first step, the preparation of azidocinnamates (2.22).2. d13
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2.3 - Retrosynthetic Analysis of Lyngbyatoxin A 
 
The retrosynthetic guidelines for lyngbyatoxin A based on the key steps discussed 
above, i.e., installation of the quaternary carbon centre via the Jung rearrangement 
and construction of the indole nucleus by a Hemetsberger-Knittel cyclization, are 
shown in Scheme 2.9. 
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Scheme 2.9 Retrosynthetic guidelines for lyngbyatoxin A. 
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Retrosynthetically, the 9-membered lactam ring in lyngbyatoxin A (1.1) would be 
accessed at a late stage by a macrolactonization protocol,2.15 while the L-valine unit 
would be introduced via a SN2 reaction of aminoindole (2.27, X = NHMe) with chiral 
triflate (2.28).2. d15  Importantly, delaying to a very late stage in the synthesis the 
construction of the 9-membered lactam, which is critical for the biological activity of 
lyngbyatoxin A, should reduce the risk of handling potential tumor promoting 
compounds. 
 
Several possibilities are available for the introduction of the amino-alcohol moiety at 
the (intrinsically nucleophilic) 3-position of the indole nucleus.2.16 Enantiomerically 
pure substituted tryptophanols have been prepared from indoles by reaction with 
chiral oxazolidinone-derivatives (2.29a)2. a,b16  and chiral azidirines (2.29b).2. c-g16  
Alternatively, a Heck-coupling with acetamidoacrylate (2.29c) followed by 
asymmetric reduction has also been reported.2. h-k16  Other possibilities include the use 
of Schöllkopf chiral auxiliary2. l,m16  and enzymatic resolution (not shown).2. n,o16
 
At a suitable stage, the linalyl side chain would be constructed via a Wittig-type 
homologation followed by a SN2 displacement with a 2-methylpropene 
organometallic reagent (not shown). 
 
2.15 For some examples see: (a) Muratake, H.; Natsume, M. Tetrahedron Lett. 1987, 28, 2265. (b) 
Muratake, H.; Natsume, M. Tetrahedron. 1991, 47, 8535. (c) Muratake, H., Natsume, M. Tetrahedron 
1991, 47, 8545. (d) Semmelhack, M. F.; Rhee, H. Tetrahedron Lett. 1993, 34, 1399. 
2.16 For leading references see: i) chiral oxazolidinone (a) Pyun, D. K.; Lee, C. H.; Ha, H.-J.; Park, C. 
S.; Chang, J.-W.; Lee, W. K. Org. Lett. 2001, 3, 4197. (b) Sibi, M. P.; Rutherford, D.; sharma, R. J. 
Chem. Soc. Perkin Trans. I 1994, 1675. ii) chiral aziridines (c) Ezquerra, J.; Pedragal, C.; Lamas, C.; 
Pastor, A.; Alvarez, P.; Vaquero, J. J. Tetrahedron Lett. 1996, 37, 683. (d) Ezquerra, J.; Pedragal, C.; 
Lamas, C.; Pastor, A.; Alvarez, P.; Vaquero, J. J. Tetrahedron 1997, 53, 8237. (e) Nenajdenko, V. G.; 
karpov, A. S.; Balenkova, E. S. Tetrahedron: Asymmetry 2001, 12, 2517. (f) Nishikawa, T.; Ishikawa, 
M.; Isobe, M. Synlett 2001, 945. (g) Yadav, J. S.; Reddy, B. V. S.; Abraham, S.; Sabitha, G. 
Tetrahedron Lett. 2002, 43, 1565. iii) Heck and asymmetric hydrogenation (h) Osanai, K.; 
Yokayama, Y.; Kondo, K.; Murakami, Y. Chem. Pharm. Bull. 1999, 47, 1587. (i) Wang, W.; Cai, M.; 
Xiong, C.; Zhang, J.; Trivedi, D.; Hruby, J. V. Tetrahedron 2002, 58, 7365. (j) Wang, W.; Xiong, C.; 
Yang, J. Hruby, J. V. Tetrahedron Lett. 2001, 7717. (k) Yokayama, Y.; Matsumoto, T.; Murakami, Y. 
J. Org. Chem. 1995, 60, 1486. iv) Schöllkopf chiral auxiliary (l) Ma, C.; Yu, S. Y.; He, X.; Liu, X.; 
Cook, M. J. Tetrahedron Lett. 2000, 41, 2781. (m) Zhang, P.; Liu, R.; Cook, J. M. Tetrahedron Lett. 
1995, 36, 7411. v) enzymatic resolution (n) Konda-Yamada, Y.; Okada, C. Yoshida, K.; Umeda, Y.; 
Arima, S.; Sato, N.; Kai, T.; Takayanagi, H.; Harigaya, Y. Tetrahedron 2002, 58, 7851. (o) 
Yokayama, Y.; hara, R.; Kato, N.; Murakami, Y.; Okuno, H. Heterocycles 2005, 65, 1455. 
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Depending on the initial functionalities present on the phenyl ring, it may be 
necessary to introduce the C-4 amino group. If so, this is planned to be accomplished 
at a convenient stage via a Buchwald-Hartwig coupling,2.17 a Curtius-type 
rearrangement2.18 or electrophilic amination.2.19
 
The indole nucleus is planned to be assembled via the Hemetsberger-Knittel reaction 
of the azidocinnamate obtained by condensation of arylaldehyde (2.30) with 
azidoacetate.2.13
 
The all carbon quaternary stereocenter was intended to be accessed via the 
enantiospecific Jung rearrangement2.2 of chiral vinyl epoxide (2.31), which in turn 
could be obtained from allylic alcohols (2.32) by means of the Sharpless asymmetric 
epoxidation reaction.2.20 The later could be obtained from the conveniently 
functionalized benzene derivative (2.33) via a coupling reaction2.21 with alkene 
(2.34a) or a Horner-Wadsworth-Emmons (HWE) reaction2.22 with phosponate 
(2.34b). 
 
 
 
2.17 For selected references see: (a) Hartwig, J. F. Acc. Chem. Res. 1998, 31, 852. (b) Wolfe, J. P.; 
Wagaw, S.; Marcoux, J.-F.; Buchwald, S. L. Acc. Chem. Res. 1998, 31, 805. (c) Frost, C. G.; 
Mendonça, P. J. Chem. Soc., Perkin Trans. I 1998, 2615. (d) Hartwig, J. F.; Kawatsura, M.; Hauck, S. 
I.; Shaughnessy, K. H.; Alcazar-Roman, L. M. J. Org. Chem. 1999, 64, 5575. (e) Huang, X.; 
Anderson, K. W.; Zim, D.; Jiang, L.; Klapars, A.; Buchwald, S. L. J. Am. Chem. Soc. 2003, 125, 6653. 
(f) Lee, S.; Jørgensen, M.; Hartwig, J. F. Org. Lett. 2001, 3, 2729. 
2.18 (a) Curtius, T. Ber. Dtsch. Chem. Ges. 1890, 23, 3023. (b) Smith, P. A. S. Org. React. 1946, 337. 
(c) Chen, J. J.; Hinkely, J. M.; Wise, D. S.; Townsend, L. B. Synth. Commun. 1996, 26, 617. (d) 
Migawa, M. T; Swayze, E. E. Org. Lett. 2000, 2, 3309. 
2.19 (a) Genet, J. P.; Greck, C. Synlett 1997, 741-749. (b) Zheng, N.; Armstrong III, J. D.; McWilliams, 
J. C.; Volante, R. P. Tetrahedron Lett. 1997, 38, 2817-2820. (c) Erdik, E.; Ay, M. Chem. Rev. 1989, 
89, 1947-1980. 
2.20 (a) Gao, Y.; Hanson, M.; Klunder, J. M.; Ko, S. Y.; Masumane, Sharpless, B. K. J. Am. Chem. 
Soc. 1987, 109, 5765. For a comprehensive review see (b) Katsuki, T.; Martin, V. S. Org. React. 1996, 
48, 1. 
2.21 For a general reference of coupling reactions see: “Metal-Catalyzed Cross-Coupling Reactions” 
(De Meijere, A.; Diederich, F. ed.) 2004, 1&2, Wiley-VHC, New York. 
2.22 (a) Horner, L.; Hoffmann, H.; Wippel, H. G.; Klahre, G. Chem. Ber. 1959, 92, 2499. (b) 
Wadsworth, W. S.; Emmons, W. D. J. Am. Chem. Soc. 1961, 62, 1733. For a review see (c) 
Maryanoff, B. E.; Reitz, A. B. Chem. Rev. 1988, 89, 863. 
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CHAPTER 3 
Synthetic Studies Towards Lyngbyatoxin A 
Results and Discussion 
 
3.1 - Installation of the All-Carbon Quaternary Stereocenter 
 
The implementation of the synthetic strategy previously discussed for lyngbyatoxin A 
(vide Chapter 2) implies firstly the identification of the functional groups (FGs) in the 
phenyl moiety that will allow the enantioselective installation of the all-carbon 
quaternary stereocenter by means of the Jung rearrangement3.1 (i.e., from (3.1) to 
(3.2)) and, at a later stage, permit the construction of the indole nucleus via the 
Hemetsberger-Knittel reaction3.2 (i.e., from (3.2) to (3.4)) (Scheme 3.1). 
 
OH
FG1(s) FG2(s) FG3(s)
N3
CO2R
N
H
FG4(s)
CO2Et
3.1 3.2 3.3 3.4
 
Scheme 3.1 
 
3.1.1 - Preparation of the Relevant Allylic Alcohols 
 
With this in mind, several allylic alcohols (3.1) with relevant phenyl substitution 
patterns were chosen. From a convergency point of view, it would be advantageous to 
have an amino group, embryonic to the N-methyl amino moiety at C-4 in 
lyngbyatoxin A, installed from the very beginning (as in allylic alcohols (3.5) and 
(3.6)). Alternatively, this amino functionality could be accessed by means of a Curtius 
                                               
3.1 (a) Jung, M. E.; D´Amico, D. C. J. Am. Chem. Soc. 1995, 117, 7379. (b) Jung, M. E.; Anderson, K. 
L. Tetrahedron Lett. 1997, 38, 2605. 
3.2 (a) Hemetsberger, H.; Knittel, D.; Weidmann, H. Monatsh. Chem. 1969, 100, 1599-1603. (b) 
Hemetsberger, H.; Knittel, D.; Weidmann, H. Monatsh. Chem. 1970, 101, 161-165. (c) Hemetsberger, 
H.; Knittel, D. Monatsh. Chem. 1972, 103, 194-204. (d) Murakami, Y.; Watanabe, T.; Suzuki, H.; 
Kotake, N.; Takahashi, T.; Toyonari, K.; Ohno, M.; Takase, K.; Suzuki, T.; Kondo, K. Chem. Pharm. 
Bull. 1997, 45, 1739. 
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rearrangement3.3 of a carboxylic acid derivative (as allylic alcohol (3.7)) or, e.g., via a 
Buchwald-Hartwig amination3.4 using a halogenated phenyl substrate (as allylic 
alcohols (3.8) and (3.9)) and hence these substitution patterns were also considered 
(Figure 3.1). 
 
NR1R2 NR1R2
CO2R3
CO2R1 X X
Y
OH OH OH OH OH
3.5 3.6 3.7 3.8 3.9  
 
Figure 3.1 Structure of the allylic alcohols (3.5) to (3.9) chosen to investigate the implementation 
of the synthetic strategy towards lyngbyatoxin A. 
 
We therefore started by preparing allylic alcohols of the type shown in Figure 3.1. 
Focus was put on the expeditious access of such test-compounds rather than on the 
reaction yields or selectivities. 
 
3.1.1.1 - Preparation of Allylic Alcohols Containing a para-AminoPhenyl 
moiety (Types (3.5) and (3.6)) 
 
Allylic alcohols with a para-amino phenyl moiety, i.e., of the type (3.5) and (3.6), 
were initially envisioned to be accessed by means of a stereospecific Stille cross-
coupling reaction3.5 between an enylstannane and a suitable N-Boc protected aniline. 
                                               
3.3 (a) Curtius, T. Ber. Dtsch. Chem. Ges. 1890, 23, 3023. (b) Smith, P. A. S. Org. React. 1946, 337. 
(c) Chen, J. J.; Hinkely, J. M.; Wise, D. S.; Townsend, L. B. Synth. Commun. 1996, 26, 617. (d) 
Migawa, M. T; Swayze, E. E. Org. Lett. 2000, 2, 3309. 
3.4 For selected references see: (a) Hartwig, J. F. Acc. Chem. Res. 1998, 31, 852. (b) Wolfe, J. P.; 
Wagaw, S.; Marcoux, J.-F.; Buchwald, S. L. Acc. Chem. Res. 1998, 31, 805. (c) Frost, C. G.; 
Mendonça, P. J. Chem. Soc., Perkin Trans. I 1998, 2615. (d) Hartwig, J. F.; Kawatsura, M.; Hauck, S. 
I.; Shaughnessy, K. H.; Alcazar-Roman, L. M. J. Org. Chem. 1999, 64, 5575. (e) Huang, X.; 
Anderson, K. W.; Zim, D.; Jiang, L.; Klapars, A.; Buchwald, S. L. J. Am. Chem. Soc. 2003, 125, 6653. 
(f) Lee, S.; Jørgensen, M.; Hartwig, J. F. Org. Lett. 2001, 3, 2729. 
3.5 (a) Milstein, D.; Stille, J. K. J. Am. Chem. Soc. 1978, 100, 3636. (b) Milstein, D.; Stille, J. K. J. Am. 
Chem. Soc. 1979, 101, 4992. (c) Stille, J. K. Angew. Chem., Int. Ed. Engl. 1986, 101, 4992. For a 
comprehensive review see: (d) Farina, V.; Krishnamurphy, V.; Scott, W. J. Org. React. 1997, 50, 1. 
For a review on the intramolecular Stille reaction see: (e) Duncton, M. A. J.; Pattenden, G. J. Chem. 
Soc., Perkin Trans. 1 1999, 1235. 
Part I                                            Chapter 3: Results and Discussion (Lyngbyatoxin A) 
 
 
 31
The choice of the Boc group as the amino protecting group was driven essentially by 
its efficiency in directed ortho metallation (DoM) reactions.3. ,3.6 7 This property was 
anticipated to be important since, in order to access the substrates for the 
Hemetsberger-Knittel reaction, the introduction of an ortho formyl group would be 
required for allylic alcohols (3.5) at a later stage. 
 
The one-pot preparation of enylstannane (3.11), previously reported by Pancrazi and 
co-workers,3.8 involved the regio- and stereoselective stannylcupration of 2-butyn-1-
ol using the “higher order” cyanocuprate (3.10), itself obtained from hexabutylditin 
and CuCN (Scheme 3.2). 
 
1) BuLi
THF, -78 oC to -40 oC
2) CuCN
THF, -78 oC to -40 oC
OH Bu3Sn
OH
3.11, 74%
3) MeOH
-78 oC to -40 oC
4)
THF, -78 oC to -10 oC
3.10
(Bu3Sn)2 "(Bu3Sn)2CuCNLi2"
 
 
Scheme 3.2 Preparation of enylstannane (3.11). 
 
We then attended to the preparation of several potential electrophilic coupling 
patterns of enylstannane (3.11). 
 
N-Boc-para-Bromoaniline (3.12a) was readily obtained in high yield (90%) from 
para-bromoaniline by treatment with Boc2O.3.9 Similarly, the corresponding triflate 
(3.12c) was prepared from para-aminophenol by treatment with Boc2O, followed by 
reaction with Tf2O in pyridine (89% over the 2 steps).The corresponding N,N-diBoc-
anilines (3.13a) and (3.13b) were then obtained, also in high yields (approximately 
                                               
3.6 For general reviews on DoM see: (a) Gschwend, H. W.; Rodriguez, H. R. Org. React. 1979, 26, 1. 
(b) Snieckus, V. Chem. Rev. 1990, 90, 879. (c) Narashimahn, N. S.; Mali, R. S. Synthesis 1983, 957. 
3.7 For selected examples where Boc group is used in DoM see: (a) Muchowski, J. M.; Venuti, M. C. J. 
Org. Chem. 1980, 45, 4798. (b) Fishwick, C. W. G.; Storr, R. C.; Manley, P. W. J. Chem. Soc., Chem. 
Commun. 1984, 1304. (c) Reed, J. N.; Snieckus, V. Tetrahedron Lett. 1984, 25, 1304. (d) Reed, J. N.; 
Rotchford, J.; Strickland, D. Tetrahedron Lett. 1988, 29, 5725-5728. 
3.8 (a) Betzer, J.-F.; Ardisson, J.; Lallemand, J.-Y.; Pancrazi, A. Tetrahedron Letts. 1997, 38, 2279. (b) 
Betzer, J.-F.; Delaloge, F.; Muller, B.; Pancrazi, A.; Prunet, J. J. Org. Chem. 1997, 62, 7768. (c) 
Betzer, J.-F.; Pancrazi, A. Synlett., 1998, 1129. (d) Betzer, J.-F.; Pancrazi, A. Synthesis, 1999, 629-
634. (e) Dominguez, B.; Pazos, Y.; de Lera, A. R. J. Org. Chem. 2000, 65, 5917. 
3.9 Lamothe, M.; Pauwels, P. J.; Belliard, K.; Schambel, P.; Halazy, S. J. Med. Chem. 1997, 40, 3542. 
N-Boc-para-Bromoaniline (3.12a) is commercially available from Aldrich. 
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90%), by exhaustive treatment with Boc2O in the presence of a catalytic amount of 
DMAP.3.10
 
NH2
X
Boc2O
THF, reflux
NHBoc
X
Tf2O, pyr.
 0 oC to rt
89% (2 steps)
3.12a: X=Br, 90%
3.12b: X=OH
3.12c: X=OTf
Boc2O, DMAP
THF, reflux
NBoc2
X
3.13a: X=Br, 90%
3.13b: X=OTf, 89%
X = Br, OH
 
 
Scheme 3.3 Preparation of aryl bromides (3.12a) and (3.13a) and aryl triflates (3.12c) and 
(3.13b). 
 
The preparation of aryl iodine (3.14) was accomplished according to Scheme 3.4. 
Treatment of antaranilic acid with ICl under acidic conditions delivered para-iodo 
antaranilic acid in good yield (65%).3.11 Reaction of the later with Boc2O produced 
the corresponding N-Boc aniline (70%), which was then subjected to nucleophilic 
estherification with MeI in the presence of CsCO33.12 affording iodinated-aniline 
(3.14) in moderate yield (40%). 
 
NH2
CO2H
ICl
HCl conc., 0o
1) Boc2O, TEA
MeOH, 45 oC
70%
NH2
CO2H
I
2) MeI, Cs2CO3
DMF, rt
40%
NHBoc
CO2Me
I
3.14
65%
 
 
Scheme 3.4 Preparation of aryl iodide (3.14). 
 
 
 
                                               
3.10 For a related example see: Grehan, L.; Gunnarsson, K.; Ragnarsson, U. Acta Chem. Scandinavica 
B 1986, 40, 745. 
3.11 Wallingford, V. H.; Krueger, P. A. Org. Synth. Coll., Vol. II, 349. para-Iodo antaranilic acid is 
commercially available from Aldrich. 
3.12 For related examples see: (a) Wang, S.-S.; Gisin, B. F.; Winter, D. P.; Makofske, R.; Kulesha, I. 
D.; Tzougraki, C.; Meienhofer, J. J. Org. Chem. 1977, 42, 1286. (b) Kruizinga, W. H.; Kellogg, R. M. 
J. Am. Chem. Soc. 1981, 103, 5183. (c) Kruizinga, W. H.; Strijtveen B.; Kellogg, R. M. J. Org. Chem. 
1981, 46, 4321. 
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Aryl triflate (3.16) was prepared using the methodology developed by Wu and co-
workers (Scheme 3.5).3.13 Treatment of 2-furoic acid with DPPA in tBuOH afforded 
2-N-Boc-aminofurane in good yield (70%), which then participates in a highly 
regioselective Diels-Alder reaction with methyl propiolate furnishing phenolic 
carbamate (3.15) in moderate yield (45%). Finally, treatment with Tf2O in pyridine 
produced aryl triflate (3.16) in high yield (93%). 
 
O
CO2H (PhO)2P(O)N3
TEA, tBuOH
CO2Me
PhH, reflux
NHBoc
CO2Me
OH
Tf2O, pyr.
0 oC to rt
O
NHBoc
NHBoc
CO2Me
OTf
3.15 3.16
70% 45% 93%
 
 
Scheme 3.5. Preparation of aryl triflate (3.16). 
 
The Stille coupling reaction between enylstannane (3.11) and the N-Boc anilines 
(3.12a), (3.12c), (3.13a), (3.13b), (3.14) and (3.16) was then investigated by 
screening some of the most common conditions3. d5  used for this reaction (Table 3.1). 
For N-Boc bromoanilines (3.12a) and (3.13a) and for the N-Boc iodoaniline (3.14) the 
use of Pd(PPh3)4, Pd2(dba)3·CHCl3 and Pd2(dba)3·CHCl3 in the presence of AsPh3 and 
CuI was examined. For aryl triflates (3.12c), (3.13b) and (3.16), we tested the use of 
Pd(PPh3)4, with and without LiCl, as well as Pd2(dba)3·CHCl3 in the presence of 
AsPh3, CuI and LiCl. 
 
As it can be seen, the use of mono-Boc aniline (3.12a) as well as triflates (3.12c), 
(3.13b) and (3.16) only lead to disappointing results since none of the conditions 
tested delivered the corresponding allylic alcohols (entries 1 to 3, 4 to 6, 10 to 12 and 
16 to 18, Table 3.1, respectively). More gratifying, di-Boc-bromoaniline (3.13a) and 
N-Boc-iodoaniline (3.14) proved to be somewhat better substrates for this coupling 
reaction, delivering the expected allylic alcohols (3.17) and (3.18) in low (32%) and 
moderate yield (56%), respectively, (entries 7 to 9 and 13 to 15, Table 3.1, 
respectively). The better results obtained with the later substrates can probably be 
ascribed to their less pronounced electronic richness, a feature that is likely to 
facilitate the oxidative addition of the Pd(0) species into the corresponding carbon-
halogen bond.3. a,3.5 14
                                               
3.13 Padwa, A.; Dimitroff, M.; Waterson, A. G.; Wu, T. J. Org. Chem. 1997, 62, 4088. 
3.14 Hegedus, L. S. in “Transition Metals in the Synthesis of Complex Organic Molecules” (2nd edition) 
1999, University Science Books, New York. 
Part I                                 3.1 - Installation of the All-Carbon Quaternary Stereocenter 
 
 
 34
Table 3.1 Stille coupling of enylstannane (3.11) and various N-Boc anilines. 
 
OH
3.11
SnBu3
NBocR1
R2
X
+
NBocR1
3.17: R1 = Boc, R2 = H
3.18: R1 = H, R2 = CO2Me
R2
OH
conditions
(table 3.1)
3.12a, 3.12c, 3.13a,
3.13b, 3.14 and 3.16  
a The reactions were performed in NMP at 75 oC-100 oC with 5 mol% of the palladium 
catalyst, unless otherwise stated. When appropriated, the following amounts of ligands and 
additives were used: AsPh3 (20 mol %); CuI (15 mol%); LiCl (3 eq.). 
Entry N-Boc aniline Conditionsa Yield (%) 
1 3.12a Pd(PPh3)4, PhH or PhMe, reflux 0 
2 X = Br Pd2(dba)3·CHCl3 0 
3 R1 = R2 = H Pd2(dba)3·CHCl3, AsPh3, CuI 0 
4 3.12c Pd(PPh3)4 0 
5 X = OTf Pd(PPh3)4, LiCl 0 
6 R1 = R2 = H Pd2(dba)3·CHCl3, AsPh3, CuI, LiCl 0 
7 3.13a Pd(PPh3)4, PhMe, reflux 22 
8 X = Br Pd2(dba)3·CHCl3 25 
9 R1 = Boc, R2 = H Pd2(dba)3·CHCl3, AsPh3, CuI 32 
10 3.13b Pd(PPh3)4 0 
11 X = OTf Pd(PPh3)4, LiCl Tracesb
12 R1 = Boc, R2 = H Pd2(dba)3·CHCl3, AsPh3, CuI, LiCl Tracesb
13 3.14 Pd(PPh3)4, PhH or PhMe, reflux 34 
14 X = I Pd2(dba)3·CHCl3 43 
15 R1 = H, R2 = CO2Me Pd2(dba)3·CHCl3, AsPh3, CuI 56 
16 3.16 Pd(PPh3)4 0 
17 X = OTf Pd(PPh3)4, LiCl 0 
18 R1 = H, R2 = CO2Me Pd2(dba)3·CHCl3, AsPh3, CuI, LiCl 0 
b As judged by TLC. 
 
In view of the unsatisfactory results obtained in the preparation of allylic alcohols of 
the type (3.5) when using the Stille coupling reaction (vide infra, Table 3.1), an 
alternative approach for this type of compounds was investigated. Accordingly, para-
aminoacetophenone was treated with PivCl in pyridine to afford the pivalamide (3.19) 
in excellent yield (97%). It is noted that the Piv protecting group is also a strong 
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directing ortho-metallating agent.3. ,3.6 15 The crude pivalamide (3.19) was subjected to 
a HWE reaction3.16 with the sodium salt of trietylphosponoacetate delivering a 
mixture of the corresponding α,β-unsaturated esters (3.20) in high yield (84%) and in 
a 3.9:1 E:Z ratio. Flash chromatography purification delivered the desired pure E-
(3.20) in 67%, after which it was reduced with Dibal to the allylic alcohol (3.21) in 
moderate yield (62%). Aniline (3.22), resulting from over-reduction of E-(3.20), was 
also obtained in 12% yield (Scheme 3.6). 
 
NHR
O
NHPiv
CO2Et
NHPiv
OH
PivCl
pyr., 0 oC to rt
97%
NaH, (EtO)2P OEt
OO
THF, 0 oC to reflux
E-3.20, 67%
Dibal
CH2Cl2, -78 oC
R = H
3.19: R = Piv
NH2
OH
+
84% overall
 E:Z ratio, 3.9:1
3.21, 62% 3.22, 12%
 
 
Scheme 3.6 Preparation of allylic alcohol (3.21). 
 
3.1.1.2 - Preparation of Allylic Alcohol Containing a para-Carboxy 
Phenyl Moiety (Type (3.7)) 
 
For convenience, our studies in the para-carboxy substitution pattern, i.e., 
corresponding to allylic alcohols of the type (3.7), were conducted using Z-(3.23).3.17 
Following a procedure by Dvořák and Havránek,3.18 allylic alcohol Z-(3.23) was 
obtained in one pot via the hydroalumination of 2-butyn-1-ol with LiAH4 followed by 
a Pd-catalysed coupling with methyl iodobenzoate in the presence of ZnCl2. The 
                                               
3.15 For selected examples where the Piv group is used in DoM see: (a) Fuhrer, W.; Gschwend, H. W.; 
J. Org. Chem. 1979, 44, 1133. (b) Ho, P.-T. Can. J. Chem. 1980, 58, 861. (c) Hillis, L. R.; Gould, S. J. 
J. Org. Chem. 1985, 50, 718. 
3.16 (a) Horner, L.; Hoffmann, H.; Wippel, H. G.; Klahre, G. Chem. Ber. 1959, 92, 2499. (b) 
Wadsworth, W. S.; Emmons, W. D. J. Am. Chem. Soc. 1961, 62, 1733. For a review see (c) 
Maryanoff, B. E.; Reitz, A. B. Chem. Rev. 1988, 89, 863. 
3.17 The preparation of allylic alcohol (E)-(3.23) has already been reported by Dvořák and Havránek, 
who obtained this compound in 53% via the stereospecific Stille cross-coupling reaction between 
enylstannane (3.11) and methyl para-iodobenzoate. See: Havránek, M.; Dvořák, D. Collect. Czech. 
Chem. Commun. 2000, 65, 434. 
3.18 Havránek, M.; Dvořák, D. J. Org. Chem. 2002, 67, 2125. 
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reaction proceeded stereoselectively affording (Z)-(3.23) in good yield (65% to 81%) 
(Scheme 3.7). 
CO2Me
OH
OH
65-81%
1) LiAH4  
2) Pd2dba3 CHCl3, AsPh3, ZnCl2
CO2MeI
THF, 0 oC to rt
Z-3.23
3)
 
 
Scheme 3.7 Preparation of allylic alcohol (Z)-(3.23). 
 
3.1.1.3 - Preparation of Allylic Alcohols Containing a para-Halogen 
Phenyl Moiety (Types (3.8) and (3.9)) 
 
Allylic alcohols with a para-halogented phenyl moiety, i.e., of the type (3.8) and 
(3.9), were planned to be accessed by means of a HWE reaction3.16 of the 
corresponding para-bromoacetophenones (i.e., X = Br).3.19 The bromine was chosen 
due to the versatility that it offers for further functionalization as it is both well suited 
to participate in metal catalysed cross-coupling3.4 and halogen-metal exchange 
reactions.3.14
 
For the preparation of allylic alcohol (3.25), para-bromoacetophenone was subjected 
to a HWE reaction3.16 with the sodium salt of triethyl phosphoacetate affording a E:Z 
mixture of the corresponding α,β-unsaturated esters (3.24), in a 3:1 ratio, respectively, 
which could be separated by flash chromatography. The desired isomer E-(3.24) was 
obtained in good yield (70%). Dibal reduction of the later proceeded uneventfully, 
affording the corresponding allylic alcohol (3.25) quantitatively (Scheme 3.8). 
 
 
                                               
3.19 For a related example see: Martín, R. M.; Islas, G.; Moyano, A.; Pericàs, M. A.; Riera, A. 
Tetrahedron 2001, 57, 6367. 
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Br
O
(EtO)2P
O O
OEtNaH,
THF, 0 oC to rt
Br
CO2EtE:Z ratio, 3:1
Dibal
Et2O, 0 oC to rt
Br
OH
E-3.24, 70% 3.25
91% overall quantitative
 
 
Scheme 3.8 Preparation of allylic alcohol (3.25). 
 
The more functionalized version, allylic alcohol (3.29), was prepared by the sequence 
shown in Scheme 3.9. The choice of iodine was driven essentially by the anticipated 
need to differentiate between the two halogen-substituted aromatic positions later on 
in the synthesis. In addition, iodine offers the same type of versatility as provided by 
bromine. 
 
Following a literature procedure,3.20 para-aminoacetophenone was treated with ICl in 
presence of CaCO3 to afford the corresponding iodinated aniline (3.26) in good yield 
(86%). The same transformation could also be accomplished, although in lower yield 
(62%) by using ICl with AcOH. Once the amino group fulfilled its activating role, 
amine-halogen exchange was accomplished under Sandmeyer conditions3.21 (NaNO2 
under acidic conditions, followed by CuBr) to afford dihalogenated acetophenone 
(3.27) in high yield (86%). A HWE reaction3.16 with the sodium salt of 
trietylphosponoacetate delivered a mixture of the corresponding α,β-unsaturated 
esters (3.28) in good yield (81%) and in a 3.7:1 ratio, in favour of the desired E-
(3.28). The double bond isomers could be separated by flash chromatography, 
allowing the isolation of pure E-(3.28) in 64% yield. Reduction of the ester 
functionality with Dibal delivered allylic alcohol (3.29) in excellent yield (96%). 
 
                                               
3.20 Fujita, K.; Takahashi, Y.; Owaki, M.; Yamamoto, K.; Yamaguchi, R. Org. Lett. 2004, 6, 2785. 
3.21 (a) Sandmeyer, T. Ber. Dtsch. Chem. Ges. 1884, 17, 1633. For related examples see: (b) Sugaya, 
T.; Mimura, Y.; Kato, N.; Ikuta, M.; Mimura, T.; Kasai, M.; Tomioka, S. Synthesis 1994, 73. (c) 
Kosuge, T.; Isida, H.; Inaba, A.; Nukaya, H. Chem. Pharm. Bull. 1985, 33, 1414. 
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(EtO)2P
O O
OEtNaH,
THF, 0 oC to rt
Br
CO2Et
Dibal
Et2O, 0 oC to rt
Br
OH
E-3.28, 64%3.29
81% overall
NH2
O
ICl, CaCO3 aq.
MeOH, rt
86%
ICl
AcOH
62%
or
NH2
O
I
i) NaNO2 aq.
HBr conc.
 -10 oC to 0 oC
ii) CuBr
HBr conc., 80 oC
86%
Br
O
I
96%
II
3.7:1, E:Z ratio
3.26 3.27
 
 
Scheme 3.9 Preparation of allylic alcohol (3.29). 
 
3.1.2 - Evaluation of the Relevant Substitution Patterns 
 
The allylic alcohols (3.17), (3.18), (3.21), Z-(3.23), (3.25) and (3.29) were then 
evaluated as potential starting materials for accessing the all-carbon quaternary 
stereocenter. For converting these allylic alcohols into the substrates for the Jung 
rearrangement, i.e., the corresponding vinyl epoxides, the following sequence of 
reactions was used:3.1 i) epoxidation of the allylic double bond with MCBPA (as an 
expedient achiral alternative to the Sharpless epoxidation); ii) Swern oxidation3.22 of 
the epoxy-alcohol into the corresponding epoxy-aldehyde; iii) Wittig 
olefination3. c,3.  16 23 into the corresponding vinyl epoxide; and iv) BF3·Et2O promoted 
Jung rearrangement.3. ,3.1 24
                                               
3.22 (a) Huang, S. L.; Omura, K.; Swern, D. J. Org. Chem. 1976, 41, 3329. (b) Huang, S. L.; Omura, 
K.; Swern, D. Synthesis 1978, 4, 297. 
3.23 (a) Wittig, G.; Schölkopf, U. Ber. Dtsch. Chem. Ges. 1954, 87, 1318. For selected reviews see: (b) 
Murphy, P.J.; Brennan, J. Chem. Soc. Rev. 1988, 17, 1. (c) Vedejs, E.; Peterson, M. J. Top. 
Stereochem. 1994, 21, 1. 
3.24 For a review on the acid catalyzed rearrangements of epoxides see: Rickborn, B. in 
“Comprehensive Organic Synthesis” (Trost, B. M., Fleming, I. ed.) 1991, 3, 733, Pergamon, New 
York. 
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MCPBA-epoxidation of N-Boc-amino allylic alcohols (3.17), (3.18) and (3.21) failed 
to deliver the corresponding epoxy alcohols (3.30), (3.27) and (3.32). To rule out the 
possibility that this outcome was a consequence of the acidic conditions of the 
reaction medium, allylic alcohols (3.17), (3.18) and (3.21) were also subjected to 
MCPBA epoxidation in the presence of a phosphate buffer (pH 8)3.25 (i.e., “buffered 
conditions”) (Scheme 3.10). Disappointedly, the reactions outcome remained 
unchanged. These findings suggested that epoxides with a 1,4-N-Boc/Piv-phenyl 
moiety are too labile to be manipulated, presumably because of direct conjugation 
between the electron releasing amino group and the oxirane ring. Therefore the para-
amino substitution pattern was abandoned. 
 
NR1R2
OH
3.17: R1 = R2 = Boc, R3 = H
3.18: R1 = Boc, R2 = H, 
         R3 = CO2Me
3.21: R1 = Piv, R2=H; R3 = H
NR1R2
OH
O
NR1R2
OH
O
R3 R3 R3
decomposition
products
?
Standard:
MCPBA
CH2Cl2
 0 oC to rt
Buffered:
MCPBA
Phospate Buffer
ClCH2CH2Cl
 0 oC to rt
3.30: R1 = R2 = Boc, R3 = H
3.31: R1 = Boc, R2 = H, 
         R3 = CO2Me
3.32: R1 = Piv, R2=H; R3 = H
(tentative structure)
 
 
Scheme 3.10 (Attempted) MCPBA epoxidation of allylic alcohols (3.17), (3.18) and (3.21). 
 
Better results were obtained with the allylic alcohol Z-(3.23) (Scheme 3.11). MCPBA 
epoxidation of the later delivered epoxy-alcohol rac-(3.33) as an oil, although only in 
modest yield (43%). Swern oxidation3.22 then produced the corresponding epoxy-
aldehyde in 52% yield which was then converted into vinyl-epoxide rac-(3.34) via a 
Wittig reaction3.23 with methyltriphenylphosphonium ylide, prepared in situ from 
methyltriphenylphosphonium bromide and KHMDS. Treatment of vinyl-epoxide rac-
(3.34) with BF3·Et2O at -78 oC3.1 afforded, as the sole product, the desired quaternary 
aldehyde rac-(3.35) in moderate yield (47%). 
 
                                               
3.25 Imuta, M.; Ziffer, H. J. Org. Chem. 1979, 44, 1351. 
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1) (COCl)2, DMSO
then Et3N
CH2Cl2, -78 oC
52%
CO2Me CO2Me
rac-3.33
O
CO2Me
O
CO2Me
CHO
MCPBA
CH2Cl2
 0 oC to rt
2) Ph3PCH3Br
KHMDS
THF, 0 oC to rt
51%
BF3 Et2O
CH2Cl2
 -78 oC
rac-3.34 rac-3.35
OH OH
47%43%
Z-3.23  
 
Scheme 3.11 Conversion of allylic alcohol Z-(3.23) into quaternary aldehyde rac-(3.35). 
 
Two important corollaries can be taken from this result: firstly that even a deactivated 
tertiary benzylic carbocation (3.36) is favoured over the alternative secondary allylic 
(3.37) (Scheme 3.12); secondly, that the installation of the desired benzylic 
quaternary carbon via vinyl migration in this type of substrates is a feasible process.  
 
MeOEWG
BF3
H
Me
EWG EWG
Me
O BF3
(deactivacted)
tertiary benzylic
secondary allylic
3.36 3.37
HH
O BF3
 
 
Scheme 3.12 Comparison between a (deactivated) tertiary benzylic (3.36) and a secondary allylic 
carbocation (3.37). 
 
Gratifyingly, similar results were obtained with the halogenated allylic alcohols (3.25) 
and (3.29) (Scheme 3.13). Suspecting that the labile nature of this type of substrates 
was responsible for the low yields previously obtained during the conversion of 
allylic alcohol (3.23) to the corresponding quaternary aldehyde rac-(3.35) (vide supra, 
Scheme 3.11), it was decided to use the crude products directly into the next step.3.  26
MCPBA epoxidation afforded the crystalline epoxy alcohols rac-(3.38) and rac-
(3.39) in high yields (93% and 91%, respectively) which, under Swern conditions,3.22 
were oxidized to the corresponding epoxy-aldehydes. Wittig olefination3.23 at -78 oC 
using the ylide prepared in situ from methyltriphenylphosphonium bromide and 
KHMDS, afforded the vinyl epoxides rac-(3.40) and rac-(3.41). After a rapid 
                                               
3.26 The labile nature of 2,3-epoxy-3-phenylbutan-1-ol type substrates has previously been noted to be 
detrimental to their isolation, see: Coghlan, D. R.; Hamon, P. G. D.; Massy-Westropp, R. A.; 
Slobedman, D. Tetrahedron: Asymmetry 1990, 1, 299. 
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filtration through a short column of silica gel to remove most of the Ph3P(O), the 
latter vinyl epoxides were treated with BF3·Et2O at -78 oC.3.1 We were happy to find 
that, in both cases, the desired quaternary aldehydes rac-(3.42) and rac-(3.43) were 
obtained as the only products in 63% and 52% yields over the last three steps, 
respectively. It is noted that these overall yields correspond to an average yield of 
86% and 80% per step, respectively. 
 
1) (COCl)2, DMSO
then Et3N
CH2Cl2, -78 oC
Br
OH
R
Br
OH
R
O
Br
R
O
Br
R
CHO
MCPBA
CH2Cl2
 0 oC to rt
2) Ph3PCH3Br
KHMDS
THF, 0 oC to rt
BF3 Et2O
CH2Cl2, -78 oC
3.25: R = H
3.29: R = I
rac-3.38: R = H, 93%
rac-3.39: R = I, 91%
rac-3.40: R = H
rac-3.41: R = I
rac-3.42: R = H, 63%
rac-3.43: R = I, 52%
(last 3 steps)
 
Scheme 3.13 Conversion of allylic alcohols (3.25) and (3.29) into quaternary  
aldehydes rac-(3.42) and rac-(3.43). 
 
In spite of the encouraging results obtained with allylic alcohol Z-(3.23) (vide supra, 
Scheme 3.11), we decided to focus our attention on allylic alcohols containing a para-
bromophenyl moiety, namely allylic alcohols (3.25) and (3.29). This decision was 
based on the higher yields obtained with the latter substrates (vide supra, Scheme 3.11 
vs. Scheme 3.13) and, perhaps more importantly, on the crystalline nature of epoxy 
alcohols rac-(3.38) and rac-(3.39) and of quaternary aldehydes rac-(3.42) and rac-
(3.43). The highly crystalline nature of these compounds was anticipated to be 
important since, in case of need, recrystallization would be a convenient way to 
increase the enantiopurity of these intermediates. 
 
3.1.3 - Enantioselective Formation of the Quaternary Stereocenter 
 
Having established that the all-carbon quaternary centre characteristic of the 
teleocidins A alkaloids can be accessed, in racemic form, via vinyl migration from a 
conveniently substituted para-bromophenyl vinyl epoxide (vide supra, Scheme 3.13), 
we then moved on to investigate the enantioselective version of this process. 
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Since the quaternary centre was planned to be installed by means of a chirality 
transfer process from a chiral epoxide, the enantiopurity of the latter is critical and 
this was the first issue to be addressed. 
 
The catalytic Sharpless-Katsuki asymmetric epoxidation3.27 of allylic alcohols (3.25) 
and (3.29) delivered the desired epoxy alcohols (S,S)-(3.38) and (S,S)-(3.39) in good 
yield (88% and quantitatively, respectively) and with high enantiomeric excess (83% 
ee and 92-94% ee, respectively),3.28 as determined by chiral HPLC (Scheme 3.14). 
The use of DIP as an alternative to DET as the source of chirality in these reactions 
did not lead to any improvement in the optical purity. Fortunately, one 
recrystallization from hexane:ether produced epoxy alcohols (3.38) and (3.39) with an 
enhanced enantiomeric excess of 96-98% and >99%, respectively. 
 
Having secured that epoxy alcohols (3.38) and (3.39) could be prepared with high 
enantiopurity, the latter were then subjected to the conditions previously used in the 
racemic series to access the quaternary aldehyde (3.42) and (3.43) (vide supra, 
Scheme 3.13).  
 
Accordingly, Swern oxidation3.22 of (3.38), followed by Wittig methelenation3.23 
afforded optically pure vinyl epoxide (3.40) which upon treatment with BF3·Et2O3.1 
delivered the quaternary aldehyde (3.42) in good yield (58%, based on allylic epoxide 
(3.38), i.e., with an average of 83% per step). Similarly, quaternary aldehyde (3.43) 
was also prepared from enantiopure epoxy alcohol (3.39) in 52% overall yield (i.e., in 
an average of 80% per step) (Scheme 3.14). Whereas quaternary aldehyde (3.42) 
could be stored neat under argon at low temperature, aldehyde (3.43) proved to be 
less stable and was best kept frozen in a benzene matrix under argon. 
 
3.27 (a) Gao, Y.; Hanson, M.; Klunder, J. M.; Ko, S. Y.; Masumane, Sharpless, B. K. J. Am. Chem. 
Soc. 1987, 109, 5765. For a comprehensive review see (b) Katsuki, T.; Martin, V. S. Org. React. 1996, 
48, 1. 
3.28 For examples of Sharpless-Katsuki asymmetric epoxidation of similar substrates see: (a) Takano, 
S.; yanase, M.; Sugihara, T.; Ogasawara, K. J. Chem. Soc., Chem. Commun. 1988, 1538. (b) Hamon, 
D. P. G.; Massy-Westropp, R. A.; Newton, J. L. Tetrahedron 1995, 51, 12645. (c) Boger, D. L.; 
Patane, M. A.; Zhou, J. J. Am. Chem. Soc. 1994, 116, 8544.s 
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1) (COCl)2, DMSO
then Et3N
CH2Cl2, -78 oC
Br
OH
Br
OH
O
Br
O
Br
2) Ph3PCH3Br
KHMDS
THF, 0 oC to rt
BF3 Et2O
CH2Cl2, -78 oC
3.25: R = H
3.29: R = I 83% ee
3.40: R = H
3.41: R = I
3.42: R = H, 58%
3.43: R = I, 52%
(last 3 steps)
L(+)-DET, 4Å MS
Ti(OiPr)4, tBuOOH
CH2Cl2, -20 oC
recrystallization
76%
CHO
96-98% ee
R
92-94% ee recrystallization
91%>99% ee
3.38: R = H, 88%
3.39: R = I, quant.
R R R
 
Scheme 3.14 Preparation of optical active quaternary aldehydes (3.42) and (3.43) from allylic 
alcohols (3.25) and (3.29), respectively. 
 
Unfortunately, our attempts to determine the enantiomeric excess of aldehydes (3.42) 
and (3.43) by chiral HPLC, and thus conclude about the stereospecificity of the 
respective Jung rearrangements, only lead to disappointing results as we could not 
observe any peak separation in the racemic series. 
 
Consequently, it was decided to determine the enantiomeric excess of chiral 
aldehydes (3.42) and (3.43) by means of chemical derivatization. Among the different 
reagents available for such purpose,3.29 we chose to use the optically active 
(dimethylamino)tetrahydro-1.3.2-diazaphosphole (3.44), often called Alexakis 
reagent,3.30 which had already been reported to be efficient in the determination of the 
optical purity of hindered primary alcohols.3.1 The Alexakis reagent (3.44) was 
prepared according to the sequence shown in Scheme 3.15. Treatment of (R,R)-
cyclohexane-1,2-diamine with ethylchloroformate afforded the corresponding 
dicarbamate, which was reduced with LiAH4 to (R,R)-cyclohexane-1,2-
dimethylamine. Upon reaction with P(NMe2)3, the latter diamine delivered the 
                                               
3.29 (a) For a general discussion see: Morrison, J. D. in “Asymmetric Synthesis” 1983, Vol I, Academic 
Press, New York. (b) Dale, J. A.; Dull, D. L.; Mosher, H. S. J. Org. Chem. 1963, 34, 2543. (c) Dale, J. 
A.; Mosher, H. S. J. Am. Chem. Soc. 1973, 95, 512. (d) Feringa, B. L.; Smaardijk, A.; Wynberg, H. 
Tetrahedron Lett. 1986, 27, 997. (e) Strigteveen, B.; Feringa, B. L.; Kellog, R. M. Tetrahedron 1987, 
43, 123. (f) Johnson, C. R.; Elliot, R. C.; Penning, T. D. J. Am. Chem. Soc. 1984, 106, 5019. (g) 
Anderson, R. C.; Shapiro, M. J. J. Org. Chem. 1984, 49, 1304. 
3.30 (a) Alexakis, A.; Mutti, S.; Mangeney, P. J. Org. Chem. 1992, 57, 1224. (b) Alexakis, A.; Chauvin, 
A.-S.; Stouvenel, R.; Vrancken, E.; Mutti, S.; Mangeney, P. Tetrahedron: Asymmetry 2001, 12, 1171. 
(c) Alexakis, A.; Mutti, S.; Normant, J. F.; Mangeney, P. Tetrahedron: Asymmetry 1990, 1, 437. 
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sensitive Alexakis reagent (3.44) in good overall yield, which was best kept frozen in 
a benzene matrix under argon. 
 
NH2
NH2
NHMe
NHMe
P(NMe2)3
150 oC
80%
N
P
N
Me
Me
N
Me
Me
3.44
1) EtOCOCl
NaOH aq.
PhMe, 0 oC to rt
84%
2) LiAH4
THF, reflux
80%  
 
Scheme 3.15 Preparation of the Alexakis reagent (3.44). 
 
In order to be derivatized, quaternary aldehydes (3.42) and (3.43) were first converted 
into the corresponding primary alcohols (3.45) and (3.46)3.31 by reduction with 
NaBH4, which proceeded in good yields (78% and 81%, respectively). When alcohol 
rac-(3.45) was allowed to react with the Alexakis reagent (3.44) and the 31P-NMR of 
the resulting alkoxytetrahydro-1.3.2-diazaphosphole derivative rac-(3.47) was 
recorded, two peaks with the same intensity, at δ = 138.9 ppm and δ = 138.7 ppm, 
corresponding to the two diastereoisomers, were observed. On the other hand, when 
the same procedure was applied to the optically active (3.45), only the higher field 
peak, at δ = 138.7 ppm, was present. A similar result was obtained for rac-(3.46) and 
(3.46): whereas the 31P-NMR of rac-(3.48) showed two peaks at δ = 139.0 ppm and δ 
= 138.8 ppm, for the optical active (3.48) only a peak at δ = 138.7 ppm was present. 
These results imply that the Jung rearrangement of vinyl epoxides (3.40) and (3.41) 
into quaternary aldehydes (3.42) and (3.43), respectively, proceeded in an 
enantiospecific manner. Thus, the enantiomeric compositions of (3.42) and (3.43) are 
> 95% ee. 
 
 
                                               
3.31 Attempts to determine the enantiomeric composition of alcohols (3.45) and (3.46) by chiral HPLC 
also failed as no peak separation was observed in the racemic series. 
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Me
Me
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31P NMR (rac-3.48): δ1 = 139.0 ppm
                                     δ2 = 138.8 ppm
31P NMR (3.48):        δ = 138.7 ppm
N
P
N
Me
Me
N
Me
MeBr
3.42: R = H
3.43: R = I
OHC
NaBH4
MeOH, 0 oC to rt
Br
HO
Br
O
3.47: R = H
3.48: R = I
3.44
R R
R
3.45: R = H, 78%
3.46: R = I, 81%
 
Scheme 3.16 Determination of the enantiomeric composition of alcohols (3.45) and (3.46) via 
derivatization with the Alexakis reagent (3.44). 
 
 
 
3.2 - Construction of the Indole Nucleus 
 
Having secured that the all-carbon quaternary centre could be accessed in an 
enantioselective manner, we then attended to the construction of the indole nucleus. 
 
3.2.1 - Studies Towards Construction of the Indole Nucleus Based on 
Quaternary Aldehyde (3.42) 
 
Regarding construction of the indole nucleus from quaternary aldehyde (3.42), we 
began by installing the amino functionality corresponding to the N-methyl amino 
group at C-4 in lyngbyatoxin A (Scheme 3.17). The quaternary aldehyde (3.42) was 
first treated with NaBH4 and the crude alcohol obtained was reacted with TBDMSCl 
in the presence of imidazole3.32 affording the corresponding TBDMS ether (3.49) in 
good overall yield (79%). The latter was then subjected to a Buchwald-Hartwig 
amination3.4 using tert-butylcarbamate in the presence of Pd2(dba)3.CHCl3 complex, 
P(tBu)3 and freshly prepared NaOPh.3. d4  Gratifying, not only was N-Boc aniline (3.50) 
                                               
3.32 Corey, E. J.; Venkateswarlu, A. J. Am. Chem. Soc. 1972, 94, 6190. 
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obtained in good yield (82%) but this key reaction could be reproduced on a 
multigram scale. 
 
2) TBDMSCl
imidazole
DMF, 0 oC to rt
3.42
H2N OtBu
O
Pd2(dba)3.CHCl3
NaOPh, P(tBu)3
PhMe, 100 oC
Br
OHC
3.49, 79% (based on 3.42)
Br
3.50
NHBoc
TBDMSO TBDMSO
1) NaBH4
MeOH, 0 oC to rt
82%
 
 
Scheme 3.17 Preparation of N-Boc aniline (3.50). 
 
Our annulation strategy calls for a benzaldehyde derivative (vide Chapter 2) and the 
required formyl group was planned to be accessed via DoM methodology3.6 using the 
newly installed N-Boc amino group as the directing metallating agent.3.7
 
Somewhat unexpectedly, however, this step proved to be non-trivial. When N-Boc 
aniline (3.50) was subjected to the original conditions developed by Muchowski and 
Venuti for this type of transformation (i.e., addition of 2.4 eq. of tBuLi to a 8% 
solution of (3.50) in THF at -78 oC, stirring for 2½ h at -20 oC, followed by addition 
of a DMF solution in THF),3. a7  the 1H-NMR of the product crude revealed that the 
reaction had proceeded only with a very low conversion, affording a 6.7:1 ratio of 
(3.50):(3.51) (entry 1, Table 3.2). 
 
This disappointing result prompted us to investigate conditions that would lead to an 
improvement in the reaction outcome. In particular, variables such as the reaction 
solvent, the use of additives and the amount of the lithiating agent were 
considered.3. ,3.33 34 The most relevant results obtained are present in Table 3.2. 
                                               
3.33 The organolithium base is also an important variable in these type of DoM processes. Although 
there are several examples in the literature where sBuLi or even nBuLi are used as alternatives to tBuLi 
in the directed ortho metallation of N-Boc anilines, invariable in theses cases the aryl substrate 
undergoing lithiation contains either an electron withdrawing group (see refs. 3.34a to 3.34c) or a 
second, cooperative, metallating-directing group (see ref. 3.34d). In addition, it has been reported that 
with nBuLi (with or without added TMEDA) or sBuLi in THF-hexane, the dilithiation of N-Boc-
aniline does not proceed even after several hours at room temperature (see refs. 3.7). Therefore, we 
focused exclusively on the use of tBuLi as the base. 
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Table 3.2 Directed-ortho formylation of (3.50). 
 
NHBoc
TBDMSO
3.50
NHBoc
TBDMSO
3.51
CHO
 tBuLi, (additive)
then 
DMF
ether, -20 oC to -10 oC
conditions
(table 3.2)
 
 
Conditions 
Entry tBuLi 
(eq.) 
TMEDA 
(eq.)a
DMF 
(eq.) 
(3.50):(3.51) 
ratiob
Yield of (3.51) 
(%)c
1d 2.4 - 6 6.7:1 ni 
2 2.4 - 6 1:1.3 ni 
3e 3.0 2.0 5 only (3.50) 0 
4f 3.0 2.0 5 8:1 ni 
5f 3.0 0.2 5 1:2 ni 
6 3.0 0.5 5 1:2 ni 
7 3.0 - 6 1:2.6 4.7 
8 5.0 - 12 1:10 53 
9 5.2 - 12 only (3.51) 58 
10 5.5 - 12 only (3.51) 59 
11g 5.2 - 1.1 -h -h
12g 5.2 - 12 only (3.51) 57 
a “-“ stands for “no TMEDA” added;  
b 1H-NMR ratio; 
c “ni” stands for “not isolated”; 
d THF was used as the reaction solvent; 
e TMEDA added before tBuLi; 
f TMEDA added adter tBuLi; 
g 20 eq. of MeI added after DMF; 
h a complex mixture was obtained. 
 
 
 
                                                                                                                                            
3.34 t For selected examples where other bases than BuLi are used in DoM of N-Boc anilines, see: (a) 
Frank, K. E.; Aubé, J. J. Org. Chem. 2000, 65, 655. (b) Thornton, T. J.; Jarman, M. Synthesis 1990, 
295. (c) Hewawasam, P.; Meanwell, N. A. Tetrahedron Lett. 1994, 35, 7303. (d) Jönsson, S.; 
Andersson, G.; Fex, T. J. Med. Chem. 2004, 47, 2075. 
Part I  3.2 - Construction of the Indole Nucleus 
 
 
 48
                                               
Concerning the reaction solvent, Stanetty and Mihovilovic reported that the half-life 
of tBuLi in THF is approximately 42 min..3.35 Hence, the large amount of unreacted 
starting material (3.50) observed, (entry 1, Table 3.2) could be accounted by the fact 
that, instead of being available for the desired reactions, a very substantial amount of 
tBuLi was actually consumed by THF. On the other hand, the half-life of tBuLi in 
Et2O is reported to be 489 min. at -20 oC,3.35 implying that the decomposition of this 
lithiating agent should be greatly suppressed in this solvent. As expected, a substantial 
improvement was obtained when the same reaction was performed in Et2O: the 
obtained conversion was significantly higher, with the desired aldehyde (3.46) being 
now the major product (entry 2, Table 3.2). 
 
In spite of this encouraging result, a 
significant amount of the starting N-Boc 
aniline (3.50) remained unreacted. This, 
together with the fact that a 
(approximately) 1:1 ratio of (3.50):(3.51) 
was produced (according to the 1H-NMR 
of the crude product), led us to 
hypothesize that a stable 1:1 aggregate of 
monoanion:dianion species (3.52) was 
present in solution (Figure 3.2). In this 
hypothesis, intermolecular chelation to 
the monoanionic component in (3.52) 
prevents it to coordinate to tBuLi, which is a necessary pre-requisite for the ensuing 
proximal deprotonation to take place. Hence, formation of the dianionic N-lithium 
amide does not occur which ultimately leads to the isolation of starting (3.50). 
Figure 3.2 Postulated (1:1) aggregate of 
monoanion:dianion species (3.52). 
N
tBuO
O
Li
N
OtBu
3.52
O
LiTBDMSO
OTBDMS
 
The reactivity of such aggregates can be modified by the addition of chelating 
additives, such as TMEDA, which presumably break up the lithium aggregates.3. ,3.6 36 
Hence, the effect of having TMEDA present was next investigated. Initial runs were 
performed using 2.0 equivalents of TMEDA, but this proved to have only a 
detrimental effect regardless of the order of addition: either only the starting TBDMS 
ether (3.50) was delivered or only a very small amount of the desired (3.51) was 
formed (entries 3 and 4, Table 3.2, respectively). However, when a sub-stoichiometric 
3.35 Stanetty, P.; Mihovilovic, M. D. J. Org. Chem. 1997, 62, 1514. 
3.36 For a leading reference see: Wakefield, B. J. in “Chemistry of Organolithium Compounds” 1974, 
Pergamon, Oxford. 
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amount of TMEDA was added (0.2 eq.), an improved ratio of 1:2 (3.50):(3.51) was 
obtained (entry 5, Table 3.2). Unfortunately, increasing the amount of TMEDA to 0.5 
equivalents gave no further increase in conversion (entry 6, Table 3.2). 
 
Eventually it was found that the amount of tBuLi added was critical for the reaction 
conversion and that the addition of TMEDA was not essential to obtain complete 
conversion: when 5.2 equivalents of tBuLi were used, (only) the desired benzaldehyde 
(3.51) was isolated in moderate yield (58%) (entry 9, Table 3.2). Increasing the 
amount of tBuLi to 5.5 equivalents did not lead to a significant increase in the isolated 
yield (entry 10, Table 3.2). 
 
An issue that remained undisclosed at this stage concerned the observation that a 
considerable excess of tBuLi was required for obtaining complete consumption of N-
Boc aniline (3.50). While several possibilities for why such an excess was necessary 
were considered (e.g., i) that some of the tBuLi used remained aggregated as 
(tBuLi)n;3.37 ii) that it is coordinated by the nucleophilic moieties present in the 
substrate; iii) that is being consumed by adventitious water; iv) that a stable complex 
between tBuLi and diethyl ether, (tBuLi·2Et2O)2, is being formed3.38), none of these 
satisfactorily explained the irregular relation observed between the conversion of N-
Boc aniline (3.50) and the amount of tBuLi added (e.g., compare entries 2, 7 and 8, 
Table 3.2).  
 
However, when this reaction was scaled-up and the conditions corresponding to entry 
10 in Table 3.2 were used, a more convincing explanation emerged. Under these 
reaction conditions, a more polar by-product, dialdehyde (3.55), was isolated in 22% 
yield (Scheme 3.18). Although the silyl moiety is commonly viewed as an alcohol 
protecting group that is relatively stable to basic conditions, metallation α to silicon is 
a well-known process.3. ,3.39 40 A posteriori examination of the TLC plates 
corresponding to entries 7 to 10 in Table 3.2 suggested that, although it could never 
3.37 Eastham, J. J. Am. Chem. Soc. 1964, 86, 1076. 
3.38 Bates, T. F.; Clarke, M. T.; Thomas, R. D. J. Am. Chem. Soc. 1988, 110, 5109. 
3.39 For leading references see: (a) Friesen, R. W.; Sturino, C.; F.; Daljeet, A.; K.; Kolaczewska, A. J. 
Org. Chem. 1991, 56, 1944. (b) Friesen, R. W.; Trimble, L. A. J. Org. Chem. 1996, 61, 1165. (c) 
Peterson, D. J. J. Organomet. Chem. 1967, 9, 373. (d) MacDonald, J. E.; Pointdexter, G. S. 
Tetrahedron Lett. 1987, 28, 1851. 
3.40 For general discussions concerning deprotonations α to silicon, see: (a) Colvin, E. W. in “Silicon 
in Organic Synthesis” 1981, Butterworths, London. (b) Weber, W. P. in “Silicon Reagents for Organic 
Synthesis” 1983, Springer-Verlag, Berlin,. 
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be isolated, variable amounts of dialdehyde (3.55) had been formed in all of these 
runs. In particular, entries 7 and 8 in Table 3.2, by corresponding to a situation where 
starting (3.50) was recovered, imply that the formation of the desired aryl dianion 
(3.53) occurred in competition with the generation of the anion (3.54). It is noted that 
although dialdehyde (3.55) is a by-product, its formation is not completely 
detrimental. In fact, since the formylated TBDMS protecting group can presumably 
be cleaved under the same conditions as a “normal” TBDMS,3.41 the desired 
benzaldehyde (3.56) could equally be accessed from (3.51) and (3.55). 
 
NHBoc
O
3.55
CHO
Si
tBuMe
OHC
NHBoc
TBDMSO
3.50
N
TBDMSO
3.53
OtBu
O
Li
Li
 tBuLi
tBuLi
N
O
Si
tBuMe
OtBu
O
Li
Li
NHBoc
TBDMSO
3.51
CHO
DMF
3.54
Li
NHBoc
HO
CHO
DMF
3.56
 
 
Scheme 3.18 Competitive formation of benzaldehydes (3.51) and (3.55). 
 
Having established conditions to successfully introduce the required formyl 
functionality, we turned our attention to the methylation of the N-Boc aniline (3.51). 
We began by briefly investigating the feasibility of a one pot sequential C-
formylation/N-methylation.3.42 Because of the existence in solution of anions (3.53) 
                                               
3.41 Greene, T. W.; Wuts, P. G. M. in “Protective Groups in Organic Synthesis” (3rd edition) 1999, 
John Wiley & Sons, New York. 
3.42 Michowski and Venuti already demonstrated that sequential C-methylation/N-methylation is feasible: 
these authors were able to obtain N-methyl-N-Boc-ortho-toluidine in high yield by quenching the obtained 
dianion of N-Boc aniline with excess of methyl iodide. See ref. 3.7a. 
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and (3.54) and due to the need of using two different electrophiles, this procedure was 
anticipated to be complex. Indeed, when aniline (3.50) was treated with 5.2 
equivalents of tBuLi, followed by 1.1 equivalents of DMF3.43 and finally by an excess 
of MeI (20 eq.), a very complex mixture of products was obtained (entry 11, Table 
3.2). On the other hand, using an excess of both DMF (12 eq.) and MeI (20 eq.), 
resulted in the isolation of aldehyde (3.51) in moderate yield (57%), but none of the 
desired N-methylated product (3.57) could be isolated (entry 12, Table 3.2). The 
preparation of N-Boc methyl aniline (3.57) was eventually achieved in 67% yield by 
treating N-Boc aniline (3.51) with NaH followed by MeI (Scheme 3.19). 
 
The next step in the planned synthetic sequence was the conversion of N-Boc 
benzaldehydes (3.51) or (3.57) into the corresponding N-Boc azidocinnamtes (3.58) 
or (3.59), respectively. Unfortunately, and regardless of extensive attempts, we never 
succeeded at this transformation. Instead a complex mixture was always obtained 
(Scheme 3.19). 
 
This serious setback prompted us to perform model studies using various protected 2-
aminobenzaldehydes. In particular, and suspecting that the Boc protecting group was 
at the origin of the problem, we were interested in investigating the influence of the 
amino protecting group in the convertion of protected 2-aminobenzaldehydes into the 
corresponding azidocinnamates and on the formation of the indole nucleus. 
 
 
 
 
 
 
3.43 The value of 1.1 eq. of DMF corresponds to the theoretical value required to achieve complete C-
formylation (i.e., in (3.51) plus (3.55)) and was calculated in the following way: let n1 be the initial 
number of mole of N-Boc aniline (3.50) and n2 the theoretical number of mole of DMF necessary to 
achieve complete C-formylation; assuming that the isolated yields of aldehyde (3.52) and dialdehyde 
(3.55) correspond to the amounts of dianion (3.53) and trianion (3.54) in solution and because the later 
possesses two carbon reactive sites where formylation can take place, it comes that n2 = 0.55n1 + 
2×0.22n1 = n1. 
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NHBoc
TBDMSO
3.51
CHO
NaH then 
MeI
DMF, 0 oC to rt
N
TBDMSO
3.57
CHO
Me Boc
67%
N
TBDMSO
3.58: R = H
3.59: R = Me
R BocN3 CO2Et
NaOEt
EtOH, -15 oC
N3
CO2Et
N3 CO2Et
NaOEt
EtOH, -15 oC
 
Scheme 3.19 Preparation of N-Boc methyl aniline (3.57) and attempted conversion of (3.51) and 
(3.57) into vinyl azides (3.58) and (3.59). 
 
3.2.1.1 - Model Studies 
 
For the purpose of the model studies, various 2-aminobenzaldehydes with different 
amino protecting groups were prepared and the corresponding Hemetsberger indole 
reactions were investigated. 
 
2-Aminobenzaldehydes with an electron withdrawing protecting group at the nitrogen 
were accessed according to Scheme 3.20. ortho-Antharanilic acid was treated with 
LiAH4 to afford the known benzylic alcohol (3.60)3.44, and the latter was then 
converted into several N-protected anilines. Accordingly, reaction with Boc2O 
afforded N-Boc aniline (3.61a) in quantitative yield, reaction with TsCl delivered N-
Ts aniline (3.61b) in 93% yield and reaction with BzCl in pyridine produced (3.61c) 
in 91% yield. Oxidation of the benzylic alcohols (3.61a), (3.61b) and (3.61c) with 
freshly prepared MnO2 followed by methylation with MeI delivered the 
corresponding protected methyl 2-formylanilines (3.62a), (3.62b) and (3.62c) in 
moderate to good yields (57%, 78% and 58%, respectively, over the last two steps). 
 
 
                                               
3.44 Nystrom, R. F.; Brown, W. G. J. Am. Chem. Soc. 1947, 69, 2548. 
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NH2
R
NHR
OH
LiAlH4
Et2O, reflux
88%
N
CHO1) MnO2CH2Cl2, reflux
R=CO2H
3.60: R=CH2OH
3.61a: R = Boc, quant.
3.61b: R = Ts, 93%
3.61c: R = Bz, 91%
3.62a: R = Boc, 57% 
3.62b: R = Ts, 78%
3.62c: R = Bz, 58%
Boc2O, THF, 0 oC to rt
or
TsCl, pyr. CHCl3 0 oC to rt 
or 
BzCl, pyr., 0 oC to rt
2) NaH then MeI
DMF, 0 oC to rt
Me R
 
 
Scheme 3.20 Preparation of N-protected 2-aminobenzaldeyhdes (3.62). 
 
2-Aminobenzaldehydes with a non-electron withdrawing protecting group at the 
nitrogen were best accessed via nucleophilic aromatic substitution of ortho-
fluorobenzaldehyde with N-methylamines (Scheme 3.21). Accordingly, reaction with 
allylmethylamine, benzylmethylamine and dimethylamine hydrochloride salt in the 
presence of potassium carbonate afforded methyl 2-formylanilines (3.62d), (3.62e) 
and (3.62f) in high yields (89%, 92% and 92%, respectively). 
 
F
CHO
N
CHO
Me R
3.62d: R=All, 89%
3.62e: R=Bn, 92%
3.62f: R=Me, 92%
AllNHMe or BnNHMe, K2CO3
DMF, 90 to 120 oC
or
(Me)2NH.HCl, K2CO3
DMSO, H2O
 
 
Scheme 3.21 Preparation of N-protected 2-aminobenzaldeyhdes (3.62d) to (3.62f). 
 
The ortho-formylated protected anilines (3.62a) to (3.62f) were then converted into 
the corresponding 2-azidocinamates (3.63a) to (3.63f) by reaction with excess of ethyl 
azidoacetate in freshly prepared ethanolic NaOEt at low temperature (Scheme 3.22). 
The stereochemistry about the vinyl azide double bond in the azidocinnamates (3.63a) 
to (3.63f) is assumed to be Z, presumably the more thermodynamically stable isomer. 
As a general trend, it was found that 2-aminobenzaldehydes containing an electron 
withdrawing group at nitrogen afforded the corresponding vinyl azides in lower yields 
and considerable less cleanly than the corresponding substrates with a non-electron 
withdrawing protecting group at nitrogen. Furthermore, it was also found that the 
yields for this step were greatly dependent on the work-up procedure adopted. 
Accordingly, it proved to be important that, after several aqueous washings, the 
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organic layer was concentrated to approximately 1/4 of its original volume, rapidly 
filtrated through a short column of silica gel and only then concentrated to dryness. 
 
N
CHO
Me R
N
Me R
N3
CO2Et
N3 CO2Et
NaOEt
EtOH, -15 oC
3.62a: R = Boc
3.62b: R = Ts
3.62c: R = Bz
3.62a: R = All
3.62b: R = Bn
3.62c: R = Me
3.63a: R = Boc, 35%-53%
3.63b: R = Ts, 43%-48%
3.63c: R = Bz, 41-49%
3.63d: R = All, 69%
3.63e: R = Bn, 72%
3.63f : R = Me, 65%  
 
Scheme 3.22 Preparation of ethyl azidocinammates (3.63a) to (3.63f). 
 
A mild thermolysis of 2-azidocinnamates (3.63a) to (3.63f) was then performed in 
refluxing toluene under argon. After some disappointing attempts to purify the crude 
materials by column flash chromatography, eventually it was found that somewhat 
better results were obtained by using (repeated) preparative thin layer 
chromatography. 
 
Invariably, vinyl-azides with an electron withdrawing protecting group at the 
nitrogen, i.e., Boc-(3.63a), Ts-(3.63b) and Bz-(3.63c), afforded at best very low 
yields of the corresponding 4-methylaminoindoles (3.64a), (3.64b) and (3.64c) 
(Scheme 3.23). Instead, a complex mixture of several unidentified by-products was 
produced. 
 
N
Me R
N3
CO2Et
N
H
CO2Et
N
Me R
PhMe, reflux
3.63a: R = Boc
3.63b: R = Ts
3.63c: R = Bz
3.64a: R = Boc, traces ?
3.64b: R = Ts, <5%
3.64c: R = Bz, traces ?
 
 
Scheme 3.23 (Attempted) Hemetsberger reaction of ethyl azidocinammates (3.63a) to (3.63c). 
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Somewhat better results were obtained with 2-azidocinnamates with a non-electron 
withdrawing protecting group at the nitrogen, namely All-(3.63d) and Bn-(3.63e) 
(Scheme 3.24). Thermolysis of azidocinammate All-(3.63d) afforded, after 
purification by repeated PTLC, the desired indole (3.64d) in 18% yield together with 
dihydrocinnoline (3.65) in 20% yield. Similarly, the Hemetsberger reaction of azide 
Bn-(3.63d) delivered the expected indole (3.64e) in 15% yield together with 
benzodiazepine (3.66) in 20% yield. A mixture of several unidentified by-products 
was also produced in these reactions. In contrast, thermolysis of azidocinammate 
(3.63f) only afforded trace amounts of the corresponding indole (3.64f) together with 
a complex mixture of unidentified by-products. 
 
N
Me R
N3
CO2Et
N
H
CO2Et
N
Me R
3.63d: R = All
3.63e: R = Bn
3.63f : R = Me
3.64d: R = All, 18%
3.64e: R = Bn, 15% 
3.64f : R = Me, traces
N
N
Me CO2Et
3.65, 20% 3.66, 20%
For 3.63d For 3.63e
+ and
PhMe
reflux N N
Me
CO2Et
Ph
 
 
Scheme 3.24 Hemetsberger reaction of ethyl azidocinammates (3.63a) to (3.63f). 
 
The formation of the (identified) products in these reactions was rationalized 
according to Scheme 3.25. The thermal decomposition of 2-azidocinammates, e.g., 
(3.63d) and (3.63e), typically proceeds with the generation of the 2H-azirine 
(3.67),3. ,3.2 45 which serves as a reversible source of the reactive singlet nitrene 
(3.68).3.46 The desired indole carboxylates, e.g., (3.64d) and (3.64e), are almost 
certainly formed by electrocyclization of the singlet vinyl nitrenes (3.68) into (3.69) 
followed by an aromatising [1,5]-hydrogen shift, a pericyclic sequence that 
constitutes the core of the Hemetsberger indole synthesis.3.2 Thermolysis of 2-
azidocinammates such as (3.63d) and (3.63e) can also proceed with the participation 
of the ortho-amino group, in which case the zwitterionic species (3.70) is formed.3.47 
                                               
3.45 (a) Knittel, D.; Hemetsberger, H.; Leipert, R.; Weidmann, H. Tetrahedron Letts. 1970, 1459. (b) 
Isomura, K.; Okada, M.; Taniguchi, H. Tetrahedron Letts. 1969, 4073 and references therein. 
3.46 Hassner, A.; Wiegand, N. H.; Gottlieb, H. E. J. Org. Chem. 1986, 51, 3176. 
3.47 For some examples involving cyclic sulphur-nitrogen ylides see: (a) Grant, R. D.; Moody, C. J.; 
Rees, C. W.; Tsoi, S. C. J. Chem. Soc. Chem. Commun. 1982, 884. (b) Grains, R. S. G.; Grant, R.; 
Moody, C. J.; Rees, C. W.; Tsoi, S. C. J. Chem. Soc. Perkin Trans 1 1986, 483. (c) Grains, R. S. G.; 
Grant, R.; Moody, C. J.; Rees, C. W.; Tsoi, S. C. J. Chem. Soc. Perkin Trans 1 1986, 491. 
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For the case of All-(3.63d), a sequence of symmetry-allowed sigmatropic 
rearrangments involving the allyl group leads to dihydrocinnoline (3.65): a [2,3]-allyl 
shift first affords (3.71) which then undergoes a [3,3]-allyl shift (Claisen-Cope type 
rearrangement) delivering (3.65). 
 
N
Me R
N
CO2Et
N2
N
Me R
N
CO2Et
N
Me R
CO2Et
N
-N2
N
H
CO2Et
N
Me R
N
NMe
CO2Et
R
-N2
R = All
N
N
Me CO2EtNN
Me CO2Et
..
other
pathways
by-products
R = Bn
N CO2EtH
N
Me R
[2,3] - sigmatropic
[3,3] - sigmatropic
[1,5] H-shift
electrocyclization
N N
Me
CO2Et
Ph
N NH
Me
CO2Et
Ph
C-H insertion
tautomerization
3.65
3.66
3.64d: R = All
3.64e: R = Bn
3.63d: R = All
3.63e: R = Bn
3.67 3.68
3.693.70
3.71
3.72
[σ2s + π4s][ω2s + σ2s + π2s]
[π2s + σ2s + π2s]
[ω0s + σ2s + π4s]
 
 
Scheme 3.25 (Proposed) formation of indoles (3.64d) and (3.64e), dihydrocinnoline (3.65) and 
benzodiazepine (3.66). 
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On the other hand, Bn-(3.63e) cannot participate in these types of pericyclic 
processes. Instead, the corresponding nitrene (3.68) (presumably a singlet) undergoes 
a C-H insertion reaction into the benzylic position3.48 affording (3.72) which then 
(intermolecularly) tautomarizes into benzodiazepine (3.66). Other reaction pathways 
are likely to be responsible for the formation of the unidentified by-products. 
 
Efforts to avoid the formation of ylide species (3.70), and thus to prevent some of the 
competitive pathways in these processes, were attempted by “tightening up” the 
nitrogen lone pair. Hence azidocinnamates (3.63d) and (3.63e) were converted into 
the corresponding (highly hygroscopic) hydrochloride salts (3.73a) and (3.73b) by 
treatment with 2 M HCl/ether solution. The crude salts obtained were subjected to 
mild thermolysis in refluxing toluene (Scheme 3.26). Disappointedly, only a complex 
mixture was obtained in both cases. 
 
N
N3
CO2Et
Me R N
N3
CO2Et
HCl
Et2O, 0 oC to rt
Me
R
H
Cl
N
H
CO2Et
NMe
R
H
Cl
PhMe
reflux
3.63d: R = All
3.63e: R = Bn
3.63g: R = All
3.63h: R = Bn
3.64g: R = All
3.64h: R = Bn  
 
Scheme 3.26 (Attempted) preparation of hydrochloride salts (3.64g) and (3.64h). 
 
These model studies suggested that the presence of a (protected) amino moiety ortho 
to the vinylnitrene functionality is not compatible with the Hemetsberger-Knittel 
indole synthesis since the desired indole products, if formed, were always delivered in 
poor yields. Furthermore, these results imply that construction of the indole nucleus in 
the Hemetsberger-Knittel sense has to take place prior to the installation of the amino 
functionality. Therefore we concentrated on accessing the indole nucleus from 
quaternary aldehyde (3.43). It is noted that, as a consequence of the more 
functionalized nature of the phenyl moiety in quaternary aldehyde (3.43), the 
installation of the amino moiety can be delayed to after construction of the indole 
nucleus. 
 
                                               
3.48 Henn, L.; Hickey, D. M. B.; Moody, C. J.; Rees, C. W. J. Chem. Soc., Perkin Trans. 1 1984, 2189. 
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3.2.2 – Studies Towards the Construction of the Indole Nucleus based on 
Quaternary Aldehyde (3.43) 
 
The first issue to be addressed when attempting to access the indole nucleus from 
quaternary aldehyde (3.43) concerns the formylation of the C-3a position (indole 
numbering). This was intended to be achieved via a regioselective lithium-iodine 
exchange followed by trapping the transient lithium species with DMF. 
 
To this end, quaternary aldehyde (3.43) was first reduced to the corresponding alcohol 
with NaBH4 and the crude material obtained was then treated with TBDMSCl in the 
presence of imidazole3.32 delivering the silyl ether (3.73). Unexpectedly, when the 
latter was subjected to the standard conditions for formylation via metal-halogen 
exchange (i.e., nBuLi, DMF in THF at -78 oC) a very complex mixture was obtained 
with the corresponding 1H-NMR showing, at best, trace amounts of the desired 
benzaldehyde (3.74) (Scheme 3.27). 
 
2) TBDMSCl
imidazole
DMF, 0 oC to rt
3.43
Br
OHC
3.73, 80% (based on 3.43)
Br
3.74
Br
TBDMSO TBDMSO
1) NaBH4
MeOH, 0 oC to rt
I nBuLi
THF, -78 oC then 
DMF
I CHO
 
Scheme 3.27 (Attempted) preparation of benzaldehyde (3.74). 
 
This disappointing result prompted us to carry out model studies for this 
transformation. ortho-Iodobromobenzene was used as a surrogate for (3.43). The most 
relevant results obtained are shown in Table 3.3. 
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Table 3.3 Studies for the conversion of ortho-iodobromobenzene into ortho-bromobenzaldehyde. 
 
Br
I
Br
CHO
conditions
(table 3.3)
 
 
Entry Conditionsa Yield (%)b  
nBuLi, THF, -78 oC i)  tracesc1 
ii) after t = 2 min., DMF  
DMF present at t = 0 Br
OHC
tracesc2 nBuLi, THF, -78 oC i) 
n
3 
i) BuLi, Et2O:THF (1:1), -110 oC 15% 
5% of (3.75) ii) after t = 2 min., DMF  
DMF present at t = 0  4 24% ni) BuLi, Et2O:THF (1:1), -110 o (3.75) C 
DMF present at t = 0 
tracesc5 ni) BuLi, Et2O:hexane (1:1), -110 oC 
nBuLi, PhMe, -100 oC i) 
45% 6 
ii) after t = 1 min., DMF 
DMF present at t = 0 
7 60% ni) BuLi, PhMe, -100 oC 
 
a 1.05 eq. of nBuLi and 2.5 eq. DMF were used;  
b Isolated yields of ortho-bromobenzaldehyde, unless otherwise stated; it is 
noted that, due to the volatility of ortho-bromobenzaldehyde, the reaction 
yields are probably slightly higher; 
c 1 As judged by the H-NMR of the crude product obtained. 
 
Performing the reaction in THF at -78 oC only led to disappointing results since a 
complex mixture of products was obtained (entries 1 and 2, 1Table 3.3). H-NMR 
analysis of the crude mixtures showed that the expected ortho-bromobenzaldehyde 
was, at best, present in only trace amounts. Somewhat better results were obtained 
when the reaction was carried in THF:Et 3.49O (1:1).2  With these conditions, the 
desired benzaldehyde could be isolated in 15% and 24% yields, depending on the 
order of addition of DMF (entries 3 and 4, Table 3.3, respectively). Additionally, 
when the conditions corresponding to entry 3 were used, a compound tentatively 
assigned as biphenyl (3.75) was also isolated, although in very low yield (5%). 
Formation of the latter was rationalized by means of a benzyne intermediate, thus 
suggesting that at the origin of the low yields thus far obtained is the short life of the 
                                               
3.49 (a) Chen, L. S.; Chen, G. J.; tamborski, C. J. Organomet. Chem. 1980, 193, 283. (b) Leroux, F.; 
Sclosser, M. Angew. Chem. Int. Ed. 2002, 41, 4272. 
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lithiated species (3.76) (Scheme 3.28). Furthermore, that the desired ortho-
bromobenzaldehyde was formed, albeit in low yields, when a less polar solvent was 
used (i.e., THF:Et2O (1:1) vs. THF) was interpreted in the following way: 
decomposition of the lithiated (3.76) occurs as its solvated complex (by R2O 
molecules) via concerted elimination of LiBr owing to intramolecular coordination of 
Br→Li between the ortho-disposed Br and Li; less polar solvents will coordinate to 
lithium less efficiently hence retarding the elimination of LiBr.3.50
 
Br
OHC
Br
I nBuLi
Br
Li
-LiBr
Br
Li
(3.76)
(3.76)
then
DMF
(3.75)
O
R
R
n
 
 
Scheme 3.28 Formation of biphenyl (3.75) via benzyne. 
 
We therefore investigated other less polar solvent systems. The use of Et2O:hexane 
(1:1) resulted in a complex mixture, presumably due to the low solubility of the 
lithiated specie (3.76) in this solvent system (entry 5, Table 3.3). After considerable 
experimentation, eventually it was found that by performing the reaction in toluene at 
approximately -100 o 3.51C,  the competing benzyne formation was comparatively slow 
and thus the lithiation primary product (3.76) could be successfully trapped with 
DMF. With these conditions the expected benzaldehyde was isolated in 45% yield 
(entry 6, Table 3.3). A better result was obtained by using Barbier-type conditions, 
i.e., by adding nBuLi to a solution containing ortho-iodobromobenzene and DMF 
(entry 6, ): the ortho-bromobenzaldehyde was isolated in 60% yield (entry 7, Table 3.3
Table 3.3). 
 
These newly found conditions were then applied to the formylation of the TBDMS 
ether (3.73) (Scheme 3.29). Unexpectedly, when the conditions that delivered the 
highest yields in the model studies were used, i.e., Barbier-type conditions and 
performing the reaction in toluene at approximately -100 oC, the desired 
                                               
3.50 Nefedov, O. M.; D’yachenko, A. I. Doklady Akademii Nauk SSSR 1971, 198, 593. 
3.51 Similar conditions for the lithium-iodine exchange of a 2,6-dibromoiodobenzene derivative have 
been reported recently, see: Yamada, K.; Kurokawa, T.; Tokuyama, H., Fukuyama, T. J. Am. Chem. 
Soc. 2003, 125, 6630. 
Part I                                            Chapter 3: Results and Discussion (Lyngbyatoxin A) 
 
 
 61
                                               
benzaldehyde (3.74) was obtained in only 15% yield while the starting silyl ether 
(3.73) was recovered in approximately 75% yield. This somewhat surprisingly result 
implies that the lithium-iodine exchange is considerably slower for the TBDMS ether 
(3.73) than for ortho-iodobromobenzene. Fortunately, when the TBDMS ether (3.73) 
was treated with n oBuLi in toluene at -100 C and DMF was added after approximately 
2 minutes, the elusive benzaldehyde (3.74) could be obtained in reproducible 65-71% 
yield. Subsequent condensation with excess of ethyl azidoacetate in freshly prepared 
ethanolic NaOEt at low temperature afforded vinylazide (3.77) in 60 % yield, hence 
setting the stage for the planned Hemetsberger-Knittel reaction. This was then 
accomplished by heating (3.77) in xylene, cleanly delivering indole (3.78) in good 
yield (69%).3.52
3.52 Interestingly, thermolysis of the model vinyl azide (3.79) afforded the expected indole (3.79) 
together with enamide (3.81) in 81% and 8% yields, respectively (Scheme 3.A). 
 
Br
N3
CO2Et
xylene
135 oC
N
H
Br
CO2Et
Br
HN
CO2Et
Me
+
3.80, 81% 3.81, 8%3.79  
 
Scheme 3.A Thermolysis of model azidocinnamate (3.79). 
 
The latter is presumably formed via a nitrene insertion into the C-H bond of one of the methyl groups 
of the solvent. In addition to the concerted pathway involving the singlet nitrene, the enamide (3.81) 
may also arise from a radical-type process involving the corresponding triplet nitrene. 
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3.73
Br
3.74: 15%, conditions I
         65-71%, conditions II
Br
TBDMSO TBDMSO
conditions I:
DMF then
nBuLi
PhMe, -100 oC
I CHO
conditions II:
nBuLi then
DMF
PhMe, -100 oC
Br
TBDMSO
N3
CO2Et
N3 CO2Et
NaOEt
EtOH, -15 oC
60%
3.77
xylene
135 oC
N
H
CO2Et
Br
TBDMSO
3.78
69%
 
 
Scheme 3.29 Conversion of TBDMS ether (3.73) into indole (3.78). 
 
In summary, indole (3.78), an advanced intermediate in a planned enantioselective 
total synthesis of lyngbyatoxin A, was prepared in 9 steps and with >95% ee from 
readily available allylic alcohol (3.22). The key features of this route are: i) a 
Sharpless-Katsuki asymmetric epoxidation of (3.22) for initial introduction of 
chirality, ii) complete enantiospecific Jung rearrangement of chiral vinyl epoxide 
(3.36) to install the all-carbon quaternary centre of the target molecule, iii) 
formylation of (3.38) via chemo-and regioselective iodine-lithium exchange and iv) 
clean formation of the indole nucleus through the Hemetsberger-Knittel reaction. 
 
It is noted that indole (3.78) is conveniently functionalized so as to allow its 
conversion into lyngbyatoxin A: the C-3 indolic position is intrinsically nucleophilic, 
whereas the bromine at C-4 provides a suitable handle for insertion of the required 
amino functionality; the TBDMS-protected alcohol should allow the construction of 
the linalyl appendage by simple functional group manipulation (Figure 3.3). 
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Figure 3.3  
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CHAPTER 4 
Synthetic Strategy Towards the Teleocidins B 
 
4.1 - Installation of the All-Carbon Quaternary Stereocenters 
 
The teleocidins B (1.3) to (1.6), which 
possess two all-carbon quaternary 
stereocentres4.1 embedded within a 6-
membered carbocyclic framework, 
present a significantly greater synthetic 
challenge than the previously 
discussed lyngbyatoxin A (1.1). 
Figure 4.1 Structure of the teleocidins B. 
N
H
N
H
N
O
Me
OH
6
7
14
17 1.3: Teleocidin B-1 (14R,17S)
1.4: Teleocidin B-2 (14S,17R)
1.5: Teleocidin B-3 (14S,17S)
1.6: Teleocidin B-4 (14R,17R)
 
 
The benzylic tetrasubstituted carbon at C-17 was envisioned to be stereoselectively 
installed during the formation of the C-6–C-17 bond, which was to take place via an 
intramolecular asymmetric Heck reaction (IAHR).4.2
 
The (Mizoroki)-Heck reaction4.3 refers to the palladium-catalyzed arylation or 
vinylation of olefins. Its intramolecular asymmetric variation is currently one of the 
most reliable methods for the enantioselective construction of congested quaternary 
stereogenic centres.4. ,4. ,4.1 2 4 In the IAHR, higher asymmetric induction is typically 
4.1 For reviews on the synthesis of quaternary carbon centres see: (a) Corey, E. J.; Guzman-Perez, A. 
Angew. Chem. Int. Ed. 1998, 37, 388. (b) Christoffers, J.; Mann, A. Angew. Chem. Int. Ed. 2001, 40, 
4591. (c) Fuji, K. Chem. Rev. 1993, 93, 2037. (c) Christoffers, J.; Baro, A. in “Quaternary 
Stereocenters, Challenges and Solutions for Organic Synthesis” 2005, Wiley-VCH, New York. (d) 
Barriault, L.; Denissova, I. Tetrahedron 2003, 42, 1688. 
4.2 For selected reviews on the IAHR see: (a) De Meijere, A.; Bräse, S. in “Handbook of 
Organopalladium Chemistry for Organic Synthesis” (Negishi, E., ed.) 2002, 1223, John Wiley & 
Sons. (b) Shibasaki, M.; Vogl, E. M. J. Organomet. Chem. 1999, 576, 1. (c) Link, J. T. Organic 
Reactions 2002, 60, 157.  
4.3 (a) Mizoroki, T.; Mori, K.; Ozaki, A. Bull. Chem. Soc. Jpn. 1971, 44, 581. (b) Heck, R. F.; Nolley, 
Jr., J. P. J. Org. Chem. 1972, 37, 2320. 
4.4 For selected examples where the IAHR was use in the construction of tetrasubstituted carbon 
centers within total synthesis see: (a) Abelman, M. M.; Overman, L. E.; Tran, V. D. J. Am. Chem. Soc. 
1990, 112, 6959. (b) McClure, K. F.; Danishefsky, S. J. J. Am. Chem. Soc. 1993, 115, 6094. (c) 
Overman, L. E. Pure Appl. Chem. 1994, 66, 1423. (d) Hong, C. Y.; Kado, N.; Overman, L. E. J. Am. 
Chem. Soc. 1993, 115, 11028. (e) Trost, B. M.; Tasker, A. S.; Rüther, A.; Brandes, A. J. Am. Chem. 
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obtained when the so-called cationic mechanism operates.4.5 This cationic pathway is 
usually invoked when discussing the IAHR of unsaturated triflates4.6 in the presence 
of a bidentate chiral ligand. Importantly, under these conditions, the chiral ligand is 
believed to remain fully chelated to palladium in all the steps of the catalytic cycle4.7 
thus ensuring a high chiral induction. 
 
These points are nicely illustrated in the preparation of the pentacycle (4.2), an 
advanced intermediate in the total synthesis of (+)-xestoquinone (4.3), reported by 
 
Soc. 1991, 113, 670. (f) Kojima, A.; Takemoto, T.; Sodeoka, M.; Shibasaki, M. J. Org, Chem. 1996, 
61, 4876. (g) Takemoto, T.; Sodeoka, M.; Sasai, H.; Shibasaki, M. J. Am. Chem. Soc. 1993, 115, 8477. 
4.5 For a notorious example in the IAHR were the so-called neutral pathway proceeds with higher 
enantioselectivity than the corresponding cationic, see: Overman, L. E.; Poon, D. J. Angew. Chem. Int. 
Ed. Engl. 1997, 36, 518. 
4.6 Addition of halogen scavengers (e.g., Ag(I) and Tl(I)) to the reaction mixture often allows the use 
of aryl and vinyl halides in the IAHR. See refs. 4.2. 
4.7 The catalytic cycle for the cationic IAHR is shown in Scheme 4A (see also refs. 4.2). Oxidative 
addition of aryl triflate (4.b) to the Pd(0) species (4.a), bearing a chiral bidentate ligand, affords the 
Pd(II) intermediate (4.c). The latter undergoes triflate dissociation, thus liberating a coordination site 
at palladium. This allows the alkene to complex onto the metal to form the cationic intermediate (4.d) 
which undergoes syn insertion into the Pd-Ar bond to give the σ-complex (4.e). β-Hydride elimination 
then delivers the desired alkene (4.f) (the newly formed quaternary carbon centre is marked ☼). Base-
promoted reductive elimination of the Pd(II) species (4.g) finally regenerates the Pd(0) species (4.a). 
 
Pd
X X*
ArOTf
Ar
Pd
X X*
OTf
Pd
X X*
Pd
X X*
Solv
Ar
R
R
RArR
OTf
Pd
X X*
H Solv
OTf
Ar
R
base
base-HOTf
OTf
4.a
4.b
4.c
4.d4.e4.f
4.g
¤ ¤
 
 
Scheme 4.A Cationic pathway for the IAHR. 
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Keay and co-workers.4.8 The benzylic quaternary carbon center together with the C 
and D rings of (4.2) were created via two tandem intramolecular Heck reactions. 
When naphthyl bromide (4.1a) was used, either under neutral or cationic conditions, 
poor enantiomeric excesses (5-13% ee) were obtained. On the other hand, the use of 
triflate (4.1b) dramatically improved the cyclization process, yielding the pentacycle 
(4.2) in 82% yield and with good enantiomeric excess (68% ee). 
 
MeO
MeO
O
O
R
For 4.1b
Pd2(dba)3 
(S)-BINAP, PMP
PhMe, reflux
82%, 68% ee
MeO
MeO
O
O
4.1a: R = Br
4.1b: R = OTf
4.2
O
O
O
O
4.3
1) H2, Pd/C
quantitative
2) CAN
CH3CN/H2O, 0 oC
C
D
For 4.1a
Pd2(dba)3
(R)-BINAP, PMP
with and without 
Ag3PO4 or AgOTf
PhMe, reflux
82%, up to 13% ee
 
Scheme 4.1 Synthesis of (+)-xestoquinone (4.3) via a cascade IAHR as the key step. 
 
In view of this, aryl triflate (4.4) was thought to be a suitable precursor to 
stereoselectively access the quaternary carbon at C-17 in the teleocidins B. 
Concerning the regioselectivity in the cyclization step we expected that, in accordance 
with the Balwin rules for ring-closing reactions4.9 and in line with what is usually 
observed in metal-catalyzed cross coupling reactions,4.10 the desired 6-exo-trig 
cyclization to C-17 would be favoured over the alternative 5-endo-trig to C-14. The 
presence of a chiral bisphospine ligand in the reaction would hopefully provide an 
efficient discrimination between the Re and the Si faces of the tetrasubstituted double 
bond (as in intermediate (4.5)). It is noted that due to the two freely rotating methyl 
groups in the σ-complex (4.6), β-hydride elimination was anticipated to proceed faster 
than the policyclization cascade process4.11 involving the vinylic double bond at C-14. 
                                               
4.8 (a) Maddford, S. P.; Andersen, W. A. Cristofoli, W. A.; Keay, B. A. J. Am. Chem. Soc. 1996, 118, 
10766. For an alternative total synthesis of (+)-xestoquinone (4.3) also based on an IAHR see: (b) 
Miyazaki, F.; Uotsu, K.; Shibasaki, M. Tetrahedron 1998, 54, 13073. 
4.9 (a) Baldwin, J. E. J. Chem. Soc., Chem. Commun. 1976, 734. (b) Baldwin, J. E. J. Chem. Soc., 
Chem. Commun. 1976, 736. 
4.10 Grigg, R.; Sridharan, V.; Stevenson, P.; Sukirthalingam, S.; Worakun, T. Tetrahedron 1990, 46, 
4003. See also refs. 4.2. 
4.11 For selected examples of Heck-type polyene cyclization see: (a) Overman, L. E.; Abelman, M. M.; 
Kucera, D. J.; Tran, V. D.; Ricca, D. J. Pure Appl. Chem. 1992, 64, 1813. (b) Burns, B.; Grigg, R.; 
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Scheme 4.2 Planned construction of the carbocyclic framework and the all-carbon quaternary 
stereocenter at C-17 of the teleocidins B using an IAHR. 
 
On the other hand, the C-14 quaternary carbon in the teleocidins B was planned to be 
installed via a regioselective aromatic Claisen rearrangement4. ,4.12 13 of a suitable 6-
allyoxyindole. 
 
Moody and co-workers already showed that the Claisen rearrangement of 6-
allyoxyindoles is completely regioselective to the 7-position of the indole nucleus.4.14 
These authors reported that the Claisen rearrangement of (4.8) occurred readily in 
                                                                                                                                            
Santhakumar, V.; Sridharan, V.; Steveson, P.; Worukun, T. Tetrahedron 1992, 48, 7297. (c) 
Carpenter, N. E.; Kucera, D. J. Overman, L. E. J. Org. Chem. 1989, 54, 5846. (d) Trost, B. M.; Shi, Y. 
J. Am. Chem. Soc. 1993, 115, 9421. (e) Kucera, D. J.; O’Connor, S. J.; Overman, L. E. J. Org. Chem. 
1993, 58, 5304. 
4.12 For selected reviews on the Claisen rearrangement see: (a) Bennett, G. B. Synthesis 1977, 589. (b) 
Lutz, R. P. Chemical Reviews 1984, 84, 205. (c) Ito, H.; Taguchi, T.; Chem. Soc. Rev. 1999, 28, 43. 
13 For (rare) examples of enantioselective aromatic Claisen rearrangement see: (a) Ito, H.; Taguchi, T. 
Tetrahedron Letts. 1997, 38, 4815. (b) Trost, B. M.; Toste, F. D. J. Am. Chem. Soc. 1998, 120, 815. 
4.14 For examples of applications in synthesis of the 6-allyloxyindole→7-ally-6-hydroxyindole Claisen 
rearrangement see: (a) Moody, C. J. J. Chem. Soc., Chem. Commun. 1983, 1129. (b) Martin, T.; 
Moody, C. J. J. Chem. Soc., Chem. Commun. 1985, 1391. (c) Martin, T.; Moody, C. J. J. Chem. Soc., 
Perkin Trans. 1 1988, 241. 
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refluxing toluene to give 7-allyl-6-hydroxyindole (4.9) with no evidence for products 
from the alternative rearrangement to C-5.4. a 14
 
N
H
CO2EtO NH
CO2EtHO
PhMe, reflux
71%
4.8 4.9
5
6
 
 
Scheme 4.3 Preparation of 7-allyl-6-hydroxyindole (4.9) via a regioselective Claisen 
rearrangement of 6-allyloxyindole (4.8). 
 
Thus, indole ether (4.10) was envisioned to be a convenient precursor to the desired 
6-hydroxyindole (4.11). Regarding the double bond regioselectivity, it was 
anticipated that, due to the pericyclic nature of the Claisen rearrangement, only the 
trisubstituted double bond at C-14 would be involved in this process. 
 
N
H
HO
17
6
14
4.11
N
HO
1417
4.10
6
[3,3]-sigmatropic
[π2s+σ2a+π2a]
(4q+2)s: 1
     (4r)a: 0
      total: 1
 
 
Scheme 4.4 Planned construction of the all-carbon quaternary stereocenter at C-14 of the 
teleocidins B using regioselective Claisen rearrangement. 
 
 
 
4.2 - Construction of the Indole Ring 
 
The indole nucleus of the teleocidins B was planned to be accessed using the 
previously discussed Hemetsberger-Knittel reaction.4.15 The reader is referred to 
Chapter 2, Section 2.2 of the present thesis for further details. 
                                               
4.15 (a) Hemetsberger, H.; Knittel, D.; Weidmann, H. Monatsh. Chem. 1969, 100, 1599-1603. (b) 
Hemetsberger, H.; Knittel, D.; Weidmann, H. Monatsh. Chem. 1970, 101, 161-165. (c) Hemetsberger, 
H.; Knittel, D. Monatsh. Chem. 1972, 103, 194-204. (d) Murakami, Y.; Watanabe, T.; Suzuki, H.; 
Kotake, N.; Takahashi, T.; Toyonari, K.; Ohno, M.; Takase, K.; Suzuki, T.; Kondo, K. Chem. Pharm. 
Bull. 1997, 45, 1739. 
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It is noted that since the Hemetsberger-Knittel reaction and the aromatic Claisen 
rearrangement are to take place under purely thermal conditions, it is possible to 
envision that the 6-hydroxyindole (4.14) could be obtained from azidocinnamate 
(4.12) in one pot via a tandem process (Scheme 4.5). 
 
4.12, R = Me or Et
N
H
HO
4.14, R = Me or Et
CO2R
4.13, R = Me or Et
Δ
O
N3
CO2R
O NH
CO2R
 
 
Scheme 4.5 (Potential) tandem Hemetsberger-Knittel/aromatic Claisen rearrangement. 
 
 
4.3 - Retrosynthetic Analysis of Teleocidins B 
 
The retrosynthetic guidelines for the teleocidins B, exemplified for teleocidins B-1 
and B-3, are shown in Scheme 4.6. The key steps considered are an IAHR and a 
regioselective Claisen rearrangement for accessing the two quaternary carbons at C-
17 and C-14, respectively, and the Hemetsberger-Knittel reaction for the construction 
of the indole nucleus. 
 
Regarding the construction of the 9-membered lactam ring as well as the installation 
of the amino-alcohol moiety at the C-3 indolic position, these were planned to be 
accessed in the same manner as previously described for lyngbyatoxin A (1.1) (vide 
Chapter 2, section 2.3). 
 
The key indole intermediate (4.15) was envisioned to arrive via the IAHR4.2 of the 
triflate of (racemic) 6-hydroxyindole (4.16). The latter could in turn be obtained by 
means of a regioselective Claisen rearrangement4.12 of indole ether (4.17). 
 
Indole (4.17) was planned to be assembled via the Hemetsberger-Knittel reaction4.15 
of the vinyl azide obtained by condensation of benzaldehyde (4.18) with an 
azidoacetate. 
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Scheme 4.6 Retrosynthetic guidelines for teleocidins B. 
 
The aryl ether (4.18) would arrive via a Williamson ether synthesis4.16 type reaction 
or, alternatively, by means of a Mitsunobu reaction4.17 of phenol (4.19) and allylic 
                                               
4.16 (a) Williamson, W. J. Chem. Soc. 1852, 106, 229. For reviews see: (b) Hill, M.; Dronsfield, A. 
Educ. Chem. 2002, 39, 47. (c) Feuer, H.; Hooz, J. in “The Chemistry of Functional Groups” (Patai, S., 
ed.) 1967, 445, Wiley, New York. 
4.17 (a) Mitsunobu, O.; Yamada, M. Bull. Chem. Soc. Jpn. 1967, 40, 2380. (b) Mitsunobu, O.; Yamada, 
M.; Mukayaima, T. Bull. Chem. Soc. Jpn. 1967, 40, 935. For selected reviews see (c) Mitsunobu, O. 
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halide/alcohol (4.20). Phenol (4.19) should be readily available from para-
anisaldehyde via DoM methodology.4.18 The allylic substrate (4.20) could be obtained 
by a Michael addition4.19 of (4.22) to methyl vinyl ketone followed by a Wittig-type 
reaction.4.20
 
 
Synthesis 1981, 1. (d) Hughes D. L. Org. React. 1992, 42, 335. (d) Lawrence S. PharmaChem 2002, 1, 
12. 
4.18 For general reviews on DoM see: (a) Gschwend, H. W.; Rodriguez, H. R. Org. React. 1979, 26, 1. 
(b) Snieckus, V. Chem. Rev. 1990, 90, 879. (c) Narashimahn, N. S.; Mali, R. S. Synthesis 1983, 957. 
4.19 Michael, A. J. Prakt. Chem./Chem.-Ztg. 1887, 35, 349. For selected reviews see: (b) Hunt, D. A. 
Org. Prep. Proced. Int. 1989, 21, 705. (b) Kozlowski, J. A. in “Comprehensive Organic Synthesis”. 
(Trost, B. M., Fleming, I., ed.) 1991, 4, 169, Pergamon, New York. 
4.20 (a) Wittig, G.; Schölkopf, U. Ber. Dtsch. Chem. Ges. 1954, 87, 1318. For reviews see: (b) Murphy, 
P.J.; Brennan, J. Chem. Soc. Rev. 1988, 17, 1. (c) Vedejs, E.; Peterson, M. J. Top. Stereochem. 1994, 
21, 1. (d) Horner, L.; Hoffmann, H.; Wippel, H. G.; Klahre, G. Chem. Ber. 1959, 92, 2499. (e) 
Wadsworth, W. S.; Emmons, W. D. J. Am. Chem. Soc. 1961, 62, 1733. For a review see (f) 
Maryanoff, B. E.; Reitz, A. B. Chem. Rev. 1988, 89, 863. 
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CHAPTER 5 
Synthetic Studies Towards the Teleocidins B 
Results and Discussion 
 
5.1 - Studies Towards the Teleocidins B’s Carbocyclic Framework 
 
To test the feasibility of the discussed approach towards the teleocidins B (vide Chapter 
4), and in particular to investigate the construction of the carbocyclic framework in this 
family of compounds, we began by performing various model studies. 
 
5.1.1 - Installation of the C-14 All-Carbon Quaternary Stereocenter 
 
We started by investigating the construction of the tetrasubstituted carbon at C-14. To 
this end we turned our attention to a simplified model compound, 6-allyloxyindole (5.3), 
which lacks a methyl group at C-17 (indole numbering). 
 
Following a literature procedure,5.1 para-hydroxybenzaldehyde was etherified with 
geranyl bromide in the presence of K2CO3 in refluxing acetone, affording aryl ether 
(5.1) quantitatively and with high purity (Scheme 5.1). The latter was subjected to the 
reaction with excess of ethyl azidoacetate in the presence of freshly prepared 
ethanolic NaOEt at low temperature to produce vinyl azide (5.2) in good yield (76%). 
The Hemetsberger-Knittel reaction of azidocinnamate (5.2) was then accomplished in 
refluxing toluene delivering the known indole (5.3) in excellent yield and high 
purity.5.2
 
CHO
RO
       R = H
Br5.1: R = geranyl
K2CO3
acetone, reflux
quantitative (crude)
N3 CO2Et
EtOH, -15 oC
, NaOEt
76%
N
H
O CO2EtN3
CO2Et
O
PhMe
reflux
quantitative
(crude)
5.2 5.3
1717
 
Scheme 5.1 Preparation of indole ether (5.3) via the Hemetsberger-Knittel reaction. 
                                               
5.1 Shinmon, N.; Cava, M. J. Chem. Soc., Chem. Commun. 1980, 1020. 
5.2 Moody, C. J. J. Chem. Soc., Chem. Commun. 1983, 1129. 
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We next attended to the installation of the C-14 quaternary carbon, which was to take 
place via an aromatic Claisen rearrangement of (5.3).5. ,5.3 4 Not entirely unexpectedly 
this step proved not to be straightforward. The different reaction conditions tested and 
the respective product distribution obtained are shown in Table 5.1. 
 
Table 5.1 Aromatic Claisen rearrangement of 6-oxyallylindole (5.3). 
 
N
H
O CO2Et
5.3
conditions
(Table 5.1)
N
H
HO CO2Et
5.4
N
H
HO CO2Et
5.5
NO CO2Et
5.6
Ac
NR1O CO2Et
5.7a: R1 = R2 = H
5.7b: R1 = R2 = Ac
5.7c: R1 = Ac, R2 = H
5.7d: R1 = TMS, R2 = H
R2
 
 
Entry Reaction Conditionsa Product Distributionb
1 N,N-dimethylaniline 55% of (5.4) and (5.5) as a 
(1:1) inseparable mixture 
   
2 NaOAc (1.5 eq.) in Ac2O at 170 oC 45% of (5.6), 33% of (5.7c), 
5% of (5.3) 
3 Ac2O in N,N-dimethylaniline (1:1, v:v) <5% of (5.6), 61% of (5.7b) 
   
4 i) HMDS (10 eq.) in N,N-dimethylaniline 
ii) HCl/EtOH (0 oC) 
88% of (5.7a) 
 
a All reactions performed at 195 oC in a sealed tube; 
b Isolated yields. 
 
 
 
                                               
5.3 For selected reviews on the Claisen rearrangement see: (a) Bennett, G. B. Synthesis 1977, 589. (b) 
Lutz, R. P. Chem. Rev. 1984, 84, 205. (c) Ito, H.; Taguchi, T.; Chem. Soc. Rev. 1999, 28, 43. 
5.4 For (rare) examples of enantioselective aromatic Claisen rearrangement see: (a) Ito, H.; Taguchi, T. 
Tetrahedron Lett. 1997, 38, 4815. (b) Trost, B. M.; Toste, F. D. J. Am. Chem. Soc. 1998, 120, 815. 
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When 6-allyoxoindole (5.3) was subjected to the usual conditions for the aromatic 
Claisen rearrangement (i.e., refluxing in dimethylaniline), only an equimolar 
inseparable mixture of (5.4) and (5.5) was obtained (entry 1, Table 5.1). These 
products presumably arrive via the so-called abnormal Claisen rearrangement.5.5 The 
abnormal Claisen rearrangement consists of a sequence of back-to-back symmetry 
allowed sigmatropic rearrangements5.6 by which the normal Claisen product (e.g., 
(5.7a)) is converted into the thermodynamic more favourable, abnormal products 
(e.g., (5.4) and (5.5)) via a spiro intermediate (e.g., (5.9) and (5.10)) (Scheme 5.2). 
 
N
H
O CO2Et
5.3
N
H
HO CO2Et
N
H
HO CO2Et
N
H
HO CO2Et
[3,3]-sigmatropic
[σ2s+π2s+π2s] N
H
O CO2Et
[1,5]-homosigmatropic
[σ2s+π2s+π2s]
[1,5]-homosigmatropic
[σ2s+π2s+π2s]
[1,5]-sigmatropic
[σ2s+π2s+π2s]
[1,5]-sigmatropic
[σ2s+π2s+π2s]
5.8 5.7a
5.4
5.105.5
N
H
O CO2Et
H
5.9
N
H
O CO2Et
H
 
Scheme 5.2 (Proposed) formation of 6-hydroxyindoles (5.4) and (5.5) via the abnormal Claisen 
rearrangement. 
 
                                               
5.5 (a) Scheinmann, F.; Barner, R.; Schmid, H. Helv. Chim. Acta 1968, 51, 1603. (b) Hansen, H.-J. in 
“Mechanisms of Molecular Migrations” (Thyagarajan, B. S., ed.) 1971, 3, 177, Wiley-Interscience, 
New York. 
5.6 (a) R. B. Woodward and R. Hoffman in “The Conservation of Orbital Symmetry” 1970, Verlag 
Chemie, Academid Press, New York. (b) Ian Fleming in “Pericyclic Reactions” 1999, 67, Oxford 
Science Publications, Oxford Chemistry Primers. 
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The abnormal Claisen rearrangement can in principle be blocked by trapping the 
desired Claisen product, 6-hydroxyindole (5.7a), before it undergoes the subsequent 
[1,5]-hydrogen shift.5.7 Traditionally this has been accomplished by in situ conversion 
into the corresponding acetate, indole (5.7c).5.7 When the conditions developed by 
Kishi (i.e., NaOAc in refluxing Ac2O)5. a7  were used, we hoped to obtain the 
rearranged indole as the corresponding N,O-diacetate (5.7b). The desired rearranged 
product was indeed formed, but as the O-acetate (5.7c) and in only in low yield 
(33%). The main product was instead the N-acylated compound (5.6), which was 
isolated in 45% (entry 2, Table 5.1). This result implied that the N-acylated indole 
(5.6) does not undergoes the desired Claisen rearrangement, presumably due to steric 
reasons. Performing the reaction in a refluxing mixture of Ac2O and dimethylaniline 
inverted the previous ratio, delivering the known indole (5.7c) as the main product 
(61% yield) as well as a small amount of the N-acylated by-product (5.6) (<5% yield) 
(entry 3, Table 5.1).5.  8 The highest selectivity for the desired rearranged product was 
obtained using the conditions developed by Fukuyama (i.e., reflux in a mixture of 
HMDS and dimethyaniline)5. c7  thus trapping (5.7a) as the corresponding TMS ether 
(5.7d). Subsequent in situ acidic hydrolysis yielded (5.7a) in high yield (88%) over 
the two steps (entry 4, Table 5.1). 
 
As expected the Claisen rearrangement of 6-allyloxyindole (5.3) was completely 
regioselective for the 7-position of the indole nucleus.5.9 In order to rationalize this 
result the relative energies of (5.16) and (5.17), simplified versions of the two 
possible intermediates in this process, corresponding to the Claisen rearrangements to 
the C-7 and C-5 positions, respectively, were calculated.5.10 In accordance with the 
Bell-Evans-Polanyi principle, the relative energies of high-energy intermediates such 
as (5.16) and (5.17) should correlate well with the relative barriers for the two 
possible rearrangements (5.14) and (5.15), respectively.5.11  
5.7 (a) Karanewsky, D. S.; Kishi, Y. J. Org. Chem. 1976, 41, 3026. (b) Falling, S. N.; Rapoport, H. J. 
Org. Chem. 1980, 45, 1260. (c) Fukuyama, T.; Tangquing, L.; Peng, G. Tetrahedron Lett. 1994, 35, 
2145. 
5.8 The acetylated indole (5.7c) has previously been used in synthetic studies towards lyngbyatoxin A, 
see: Moody, C. J. J. Chem. Soc., Chem. Commun. 1983, 1129. 
5.9 For examples of applications in synthesis of the 6-allyloxyindole→7-ally-6-hydroxyindole Claisen 
rearrangement see: (a) Moody, C. J. J. Chem. Soc., Chem. Commun. 1983, 1129. (b) Martin, T.; 
Moody, C. J. J. Chem. Soc., Chem. Commun. 1985, 1391. (c) Martin, T.; Moody, C. J. J. Chem. Soc., 
Perkin Trans. 1 1988, 241. 
5.10 The calculations were performed by Associate Professor Per-Ola Norrby. 
5.11 For a discussion see: Jensen, F. in “Introduction to Computational Chemistry”, 1999, Wiley, 
Chichester. 
Part I                                                Chapter 5: Results and Discussion (Teleocidins B) 
 
 
 77
The structures were optimized at the B3LYP/6-31G* level of theory and the 
conformations where chosen to represent the immediate product from a chair 
transition state. A difference of 40 kJmol-1 in favour of (5.16) was found, in good 
agreement with the observed selectivity.5. ,5.  12 13 The reason for the high energy 
difference between superficially similar intermediates was ascribed to the fact that 
that only the latter intermediate preserves an aromatic pyrrole moiety in its structure 
(Scheme 5.3). 
 
N
H
O
N
H
O
40 kJmol-1
N
HO
NO
H
5.16
5.17
N
HO N
H
O
5.12 5.13
5.14
5.15
 
 
Scheme 5.3 B3LYP/6-31G* potential energy surface diagrams for the competitive aromatic 
Claisen rearrangement of model compound (5.11). 
 
 
 
 
 
                                               
5.12 Gozzo, F. C.; Fernandes, S. A.; Rodrigues, D. C.; Eberlin, M. N.; Marsaiolo, A. J. J. Org. Chem. 
2003, 68, 5493. 
5.13 The relative ground states energies of the conformers leading to the two high energy intermediates 
can also be an important factor in determining the regioselectivity in the aromatic Claisen 
rearrangement (see ref. 5.11). However, for the case in study, the energy difference between the two 
hypothetical transition states (5.14) and (5.15) is expected to be much larger than the energy 
difference between the two ground states conformers (5.12) and (5.13). 
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5.1.2 – Studies Towards the Construction of Teleocidins B’s Carbocyclic 
Framework 
 
Having installed the C-14 quaternary carbon we then focused on the key 
intramolecular (asymmetric) Heck reaction (IAHR) which would result in the 
construction of the carbocyclic framework. In particular we wished to investigate how 
the severe steric bulk, derived from the newly installed neighbouring quaternary 
carbon at C-14, would affect this transformation. 
 
The required triflate (5.7e) for the IHR was prepared in good yield (75%) by treating 
(5.7a) with Tf2O in the presence of pyridine at low temperature. With triflate (5.7e) in 
hand, we then addressed the cyclization reaction. The different conditions tested are 
presented in Table 5.2. 
 
For the cyclization of (5.7e) we started by investigating the use of rac-BINAP (entry 
1, Table 2). To our surprise, the product obtained was not the expected 
cyclohexadieno-indole (5.19). Instead, NMR analysis showed the cyclopentadieno-
indole (5.18), presumably formed via what is normally considered to be a disfavoured 
5-endo-trig cyclization mode.  
 
In order to obtain a better understanding of this process and, in particular to see if the 
regioselectivity of the cyclization could be reversed into the desired 6-exo mode, we 
went on to screen several readily available ligands. 
 
We started by investigating the use of the classic PPh3 (with and without LiCl as 
additive, entries 2 and 3 and in the form of Pd(PPh3)4, entry 4, Table 5.2, 
respectively), AsPPh3 (entry 5, Table 5.2) and then moved on to bulkier ligands such 
as PtBu3 (entry 6, Table 5.2) and Buchwald’s biphenyl dicyclohexyl phosphine (entry 
7, Table 5.2). However, all of these monodentate ligands failed to deliver product and 
only starting material was recovered. This suggests that for this system, and in line 
with the generally accepted mechanism for the cationic pathway in the Heck reaction, 
a bidentate ligand is required for the stability of the active catalyst. 
 
Hence we subsequently investigated bidentate ligands other than rac-BINAP. In 
contrast to the monodentate ligands, all the bidentate phosphines screened succeeded 
in promoting the cyclization reaction, but again only the 5-endo product (5.18) was 
obtained (entries 8 to 13, Table 5.2). The incomplete conversion, even after long 
reaction times, observed when dppbz and triphos were used (entries 12 and 13, Table 
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5.2, respectively) together with the fact that a slightly faster reaction was observed for 
dppe and dppp (entries 10 and 11, Table 5.2, respectively) suggests that ideally the 
ligand bite angle should be slightly less than 90o.  
 
Table 5.2 Intramolecular Heck reaction of triflate (5.7e). 
 
N
H
RO CO2Et
5.7a: R = H Tf2O, pyr.
CH2Cl2, -30 oC to 0 oC
75%
5.7e: R = Tf
conditions
(table 5.2)
N
H
CO2Et NH
CO2Et
5.18 5.19
 
Entry Conditionsa Outcomeb
1 Pd(OAc)2, rac-BINAP, 3½ h 88% of 5.18 
2 Pd(OAc)2, PPh3, NEt3, 28 h only 5.7e 
3 Pd(OAc)2, PPh3, NEt3, LiCl, 28 h only 5.7e 
4 Pd(PPh3)4, LiCl, NEt3, 28h only 5.7e 
5 Pd2(dba)3, AsPh3, 30 h mainly 5.7e 
traces of 5.18 
6 Pd(OAc)2, PtBu3, 30 h mainly 5.7e 
traces of 5.18 
7 Pd(OAc)2, biphenyl dicyclohexyl 
phosphine, 43 h 
mainly 5.7e 
traces of 5.18 
8 Pd(OAc)2, dppf, 3½ h 88% of 5.18 
9 Pd(OAc)2, dppb, 3½ h 85% of 5.18 
10 Pd(OAc)2, dppp, 3½ h 88% of 5.18 
11 Pd(OAc)2, dppe, 3½ h 94% of 5.18 
12 Pd(OAc)2, dppbz, 24 h 2.6:1, 5.18:5.7ec
13 Pd(OAc)2, triphos, 24 h 1:1.8, 5.18:5.7ec
PPh2
PPh2
rac-BINAP
Fe
PPh2
PPh2
dppf
Ph2P
PPh2
dppe, n = 1
dppp, n = 2
dppb, n = 3
( )n
PPh2
PPh2
dppbz
Ph2P
PPh( )2
triphos  
 
a All reactions were performed in refluxing THF and, unless stated otherwise, 
K2CO3 was used as the base; 
b Isolated yields; 
c Ratio based on crude 1H-NMR. 
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Whereas 5-endo type products in intramolecular Heck reactions are not 
unprecedented they are rare, being confined to special substrates such as N-vinyl-2-
haloarylamines,5.14 aryl/alkenyl halides containing an appropriate α, β-unsaturated 
carbonyl group5.15 or 1,1-difluoro-1-alkenes.5.16 Furthermore, their formation can 
frequently be rationalized by alternative mechanisms other than a direct 5-endo 
cyclization.5.17 Additionally, when this cyclization mode operates it typically requires 
harsher conditions and often produces only low yields of the products,5.18 whereas in 
our case indole (5.18) was obtained in high yield and the reaction was complete in 
about 3½ h. 
 
To the best of our knowledge, this is the first example where, having available the 
possibility for a 6-exo-trig path, the IHR occurs exclusively to afford high yields (up 
to 94%) of the 5-endo-trig cyclized product. This result is likely to be a consequence 
of two factors: i) the steric bulk of the neighboring quaternary carbon which positions 
and eventually locks the vinylic double bond of (5.7e) in the proximity of the 
oxidatively-added Pd and ii) in the migratory insertion step, occurring in the 
coordination sphere of Pd, the bond formation is initiated at a long C-C distance, and 
can thus occur in geometries that are distinctly different from those allowed in 
systems for which the Baldwin ring closing rules5.19 were originally developed. 
 
 
 
 
 
 
 
 
 
 
5.14 For representative examples see: (a) Ackermann, L.; Kaspar, L. T.; Gschrei, C. J. J. Chem. Soc., 
Chem. Commun. 2004, 2824. (b) Watanabe, T.; Arai, S.; Nishida, A. Synlett 2004, 907. (c) Chen, C.; 
Lieberman, D. R.; Larsen, R. D.; Verhoeven, T. R.; Reider, P. J. J. Org. Chem. 1997, 62, 2676. 
5.15 O’Connor, B.; Zhang, Y.; Negishi, E. Tetrahedron Lett. 1988, 29, 3903. 
5.16 Sakoda, K.; Mihara, J.; Ichikawa, J. J. Chem. Soc., Chem. Commun. 2005, 4684. 
5.17 Grigg, R.; Savic, V. J. Chem. Soc., Chem. Commun. 2000, 871. 
5.18 (a) Wiedenau, P.; Monse, B.; Blechert, S.; Tetrahedron 1995, 51, 1167 (in particular Scheme 7). 
(b) Gaudin, J.-M. Tetrahedron Lett. 1991, 32, 6113. 
5.19 (a) Baldwin, J. E. J. Chem. Soc., Chem. Commun. 1976, 734. (b) Baldwin, J. E. J. Chem. Soc., 
Chem. Commun. 1976, 736. 
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CHAPTER 6 
Concluding Remarks 
 
Indole (3.78), a late key intermediate in a projected enantioselective total synthesis of 
lyngbyatoxin A, was prepared according to Scheme 6.1. 
 
OHC
N
H
CO2Et
3.43, 52% (based on 3.39) 
>95% ee
3.78: P = TBDMS 
42% (based on 3.74)
3.29
NH2
O
OH
3.39
Br
I
O
3.41
Br
I
O
Br
I
3.74: P = TBDMS
Br
CHO
Br
PO PO
1) ICl, CaCO3 aq.
MeOH, rt
86%
2) NaNO3 aq.
HBr conc., -10 oC to 0 oC
then CuBr, 80 oC
86%
Br
O
I
(EtO)2P OEt
OO
1) NaH,
THF, 0 oC to rt
64% (E)
2) Dibal
Et2O,  0oC to rt
96%
Br
I
OH
L(+)-DET, 4 ÅMS
Ti(OiPr)4, tBuOOH
CH2Cl2, -20 oC
quantitative, 92-94% ee
1) (COCl)2, DMSO
then NEt3
CH2Cl2, -78 oC
2) Ph3PCH3Br
KHMDS
THF, 0 oC to rt
BF3 OEt2
CH2Cl2, -78 oC
Br
I
TBDMSO
1) NaBH4
MeOH, 0 oC to rt
2) TBDMSCl
imidazole, DMF, 0 oC to rt
nBuLi 
then DMF
PhMe, -100 oC
1) N3 CO2Et
NaOEt
EtOH, -15 oC
2) xylene
135 oC
3.27
3.73, 80% (based on 3.43)
65-71%
 
 
Scheme 6.1 Preparation of key indole (3.78). 
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para-Aminoacetophenone was treated with ICl to afford the corresponding iodinated 
aniline in high yield (86%). The latter underwent amine-bromine exchange using 
Sandmeyer conditions delivering di-halogenated acetophenone (3.27) in 86% yield. A 
HWE reaction with the sodium salt of triethylphosphonoacetate afforded, after 
column chromatography, the corresponding pure E-α,β-unsaturated ester in moderate 
yield (64%), which was then reduced with Dibal to the allylic alcohol (3.29) in 96% 
yield. Sharpless-Katsuki asymmetric epoxidation produced the epoxy alcohol (3.39) 
quantitatively and with high enantiomeric excess (92-94% ee) as a highly crystalline 
product. The latter was oxidized under Swern conditions to the corresponding epoxy-
aldehyde and the crude product obtained was then subjected to Wittig methelenation 
delivering vinyl-epoxide (3.41). After a rapid filtration through a short column of 
silica gel, the crudely purified vinyl-epoxide (3.41) was treated with BF3·Et2O at -78 
oC producing the key quaternary aldehyde (3.43) in good yield (52%, based on epoxy-
alcohol (3.39)) and with complete transfer of chirality (> 95% ee), as determined by 
derivatization using the Alexakis reagent and 31P-NMR. Reduction of aldehyde (3.43) 
with NaBH4 and conversion of the crude alcohol obtained into the corresponding 
TBDMS ether (3.73) proceeded with good overall yield (80%). After extensive model 
studies with ortho-iodobenzene, we found that formylation at the C-3a position 
(indole numbering) of silyl ether (3.73) could be accomplished via a regio- and 
chemoselective lithium-iodine exchange followed by quenching with DMF if the 
reaction was carried in toluene at approximately -100 oC. Under these conditions 
benzaldehyde (3.74) was prepared in 65-71% yield. Subsequent NaOEt-promoted 
condensation with ethylazidoacetate at -15 oC afforded the corresponding 
azidocinnamate which, upon heating in xylene, underwent the expected 
Hemetsberger-Knittel reaction finally furnishing the key indole (3.78) in moderate 
yield (42%, based on (3.74)). 
 
In a related approach, benzaldehydes (3.51) and (3.57), putative intermediates to 
lyngbyatoxin A, were also prepared (Scheme 6.2). Accordingly, starting from para-
bromoacetophenone and using a similar sequence of reactions as in Scheme 6.1, the 
quaternary aldehyde (3.42) was obtained in good yield (58%, based on the readily 
prepared epoxy alcohol (3.38)) and with high enantiomeric excess (>95% ee). 
Following functional group manipulation, which included a key high yielding 
Buchwald-Hartwig amination, N-Boc aniline (3.50) (not shown) was prepared. After 
extensive experimentation, the latter was converted into the required benzaldehyde 
(3.51) using DoM methodology. A large excess of tBuLi was necessary for achieving 
complete conversion in this formylation reaction, the reason being that competitive 
metallation of the TBDMS protecting group, to afford dialdehyde (3.55), was 
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proceeding. Although we never succeeded in converting benzaldehydes (3.51) and 
(3.57) into the corresponding vinyl-azides (3.58) and (3.59), respectively, it is likely 
that the success of this transformation would be irrelevant. This is because extensive 
studies in related systems suggested that the presence of a (protected) amino moiety 
ortho to the vinylnitrene functionality is not compatible with the Hemetsberger-
Knittel indole synthesis. 
 
OHC
3.42
58% (based on 3.38)
        >95% ee
3.58: R = H
3.59: R = Me
OH
3.25
70% (based on p-Bracetophenone)
Br
O
Br
OH
3.38, 83% ee
         96-98% ee
Br
O
3.40
Br
O
Br
3.51: R = H, 48%
3.57: R = Me, 32% 
(based on 3.42)
NRBoc
CHO
NRBoc
TBDMSOTBDMSO
Sharpless
Katsuki
asymmetric 
epoxidation
Swern oxidation
and Witting 
methelenation
Jung
rearrangment
88%
HWE
Hartwig-Buchwald
amination and DoM
formylation
N3
CO2Et
NHBoc
CHO
O
SiOHC
Me tBu
3.55, 22%
recystallization
76%
 
Scheme 6.2 Preparation of benzaldehydes (3.51) and (3.57). 
 
As is often the case when dealing with asymmetric synthesis, the enantioselective 
construction of the all-carbon quaternary center in lyngbyatoxin A was the 
constraining factor in the chosen strategy. While this work was in progress an 
interesting alternative approach for the catalytic enantioselective installation of 
benzylic quaternary carbons has been reported. Accordingly, the Hoveyda group 
disclosed that aromatic allylic phosphates undergo efficient enantioselective Cu-
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catalyzed allylic alkylations in the presence of chiral amino acid-based ligands.6. ,6.1 2 
As a pertinent application of this methodology, a very efficient total synthesis of (-)-
sporochnol (6.2) from the readily accessible allylic phosphate (6.1) was accomplished 
(Scheme 6.3). This type of reactions might prove useful for later generation syntheses 
towards the enantioselective total synthesis of lyngbyatoxin A. 
 
OPO(OEt)2
OTs
CuCN (10 mol%)
Zn
2
THF, -78 oC, 48h
H
N
NHBu
N
OiPr
O
Ph
O
1) 6.3, 10 mol%
6.1 6.2, 82% overall, 82% ee 6.3
2) KOH, EtOH aq., 80 oC
OH
 
 
Scheme 6.3 Preparation of (6.2) via a Cu-catalyzed asymmetric allylic substitution. 
 
The construction of the teleocidins B’s core was also investigated (Scheme 6.4). para-
Geranyloxybenzaldehyde (5.1), readily obtained from para-hydroxybenzaldehyde and 
geranyl bromide in excellent yield, was converted into the corresponding 
azidocinnamate (5.2) in 76% yield upon treatment with ethyl azido acetate. 
Thermolysis of the latter in toluene afforded the test indole (5.3) quantitatively. A 
regioselective, high-yielding aromatic Claisen rearrangement afforded 6-
hydroxyindole (5.7a), which contains the C-14 quaternary stereocenter characteristic 
of the teleocidins B. Importantly, and in order to suppress the abnormal Claisen 
rearrangement of (5.7a), we found that the rearrangement reaction had to be 
performed in the presence of HMDS. The precursor of the key IHR, triflate (5.7e), 
was prepared from 6-hydroxyindole (5.7a) in good yield (75%) upon treatment with 
Tf2O in the presence of pyridine at low temperature. The IHR of (5.7e), which was 
expected to deliver the cyclohexadieno-indole (5.19) via a 6-exo-trig cyclization, 
afforded exclusively and in high yield (up to 94%) the product of a rare 5-endo-trig 
path, cyclopentadieno-indole (5.18). 
 
                                               
6.1 (a) Luchaco-Cullis, C. A.; Mizutani, H.; Murphy, K. E.; Hoveyda, A. H. Angew. Chem. Int. Ed. 
2001, 40, 1457. (b) Kacprznski, M. A.; Hoveyda, A. H. J. Am. Chem. Soc. 2004, 126, 10676. (c) 
Cesati, R. R.; de Armas, J.; Hoveyda, A. H. J. Am. Chem. Soc. 2004, 126, 96. 
6.2 The Knochel group has also disclosed a similar approach based on a copper mediated SN2’ 
substitution of pentafluorobenzoates with diorganic zinc reagents: Leuser, H.; Perrone, S.; Liron, F.; 
Kneisel, F. F.; Knochel, P. Angew. Chem. Int. Ed. 2005, 44, 4627. 
Part I  Chapter 6: Concluding Remarks 
 
 
 85
CHO
RO
       R = H
Br5.1: R = geranyl
K2CO3
acetone, reflux
quantitative (crude)
N3 CO2Et
EtOH, -15 oC
, NaOEt
76%
N
H
O CO2EtN3
CO2Et
O
PhMe
reflux
quantitative
(crude)
5.2 5.3
17
i) HMDS
dimethylaniline, 195 oC
(closed vessel)
ii) HCl aq.
EtOH, 0 oC
88%
N
H
RO CO2Et
5.7a: R = H Tf2O, pyr.
CH2Cl2
 -30 oC to 0 oC
75%
5.7e: R = Tf
N
H
CO2Et
5.18
Pd(OAc)2, dppe
K2CO3
THF, reflux
94%
N
H
CO2Et
5.19
 
Scheme 6.4 Preparation of cyclopentadiene-indole (5.18). 
 
Although mechanistically interesting, the formation of cyclopentadieno-indole (5.18) 
represents a setback with respect to the planned construction of the carbocyclic 
framework of the teleocidins B and, from a synthetic point of view, it implies that the 
vinylic double bond at the C-14 quaternary carbon has to be installed at a later stage 
with respect to the key IHR. 
 
Some initial experiments towards such type of approach have already been performed 
and an example is shown in Scheme 6.5. In this particular case the vinyl double bond 
at C-14 in indole (6.8) was envisioned to participate in a Suzuki cross-coupling 
reaction which would install the required tetrasubstituted double bond at C-17. The 
“final” vinylic moiety at C-14 in the teleocidins B would then be obtained by 
functional group manipulation of the TBDMS ether appendage. 
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Scheme 6.5 Preparation of indole (6.8). 
 
Finally, some considerations regarding potential future work are presented. One of the 
main limitations of the Hemetsberger-Knittel indole synthesis in its traditional form is 
that only C-3 unsubstituted 2-indole carboxylates are available. Whereas 
functionalization of the indolic C-3 position and decarboxylation of the C-2 positions 
in indoles are well precedented, it would be advantageous, if only for the sake of 
convergence, to avoid these steps. A possible strategy that meets these requirements is 
shown in Scheme 6.6 exemplified for lyngbyatoxin A. The required vinyl-azide 
functionality for the Hemetsberger-Knittel reaction would now be accessed via the 
ring-opening of the functionalized epoxide (6.14) followed by an elimination reaction. 
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This would eliminate the need to use a benzaldehyde derivative as the starting 
material and, at the same time, avoid the use of an azidocarboxylate as the azide 
functionality precursor. An important open question at this planning stage concerns 
the fate of the nitrene species formed from vinyl-azide (6.15), which has the potential 
to participate in aromatic (at *) and/or aliphatic (at **) (formal) C-H insertions. In yet 
another bold hypothesis, the 9-membered lactam ring in (6.18) could conceivably be 
accessed via an intramolecular Buchwald-Hartwig amination of (6.17). 
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Scheme 6.6 Alternative strategy to the construction of the indole nucleus and the 9-membered 
lactam ring in the teleocidins alkaloids. 
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CHAPTER 7 
Experimental 
 
7.1 - General 
 
All moisture- and air- sensitive reactions were carried out under an argon atmosphere 
using oven-dried or flame-dried glassware. Reaction solvents were distilled prior to 
use by standard procedures. Et2O, THF and toluene were distilled under nitrogen from 
sodium-benzophenone. CH2Cl2, NEt3, pyridine and iPr2NH were distilled under 
nitrogen from CaH2. Anhydrous DMSO, DMF and NMP were purchased from 
Aldrich and stored over 4Å MS under argon. 1H-NMR (200 MHz, 300 MHz and 500 
MHz) and 13C-NMR (75 MHz and 125 MHz) spectra were recorded on either a 
Bruker AC-200 (200 MHz), a Varian Mercury 300 (300 MHz) or a Varian Inova 500 
(500 MHz) spectrometers at ambient temperature. 31P-NMR (202 MHz) spectra were 
recorded on a Varian Inova 500 (500 MHz) spectrometer at ambient temperature. 
Chemical shifts (δ) are reported in ppm. Undeuterated solvents residues were used as 
internal standard (for CHCl3, 1H: 7.27 ppm and 13C: 77.0 ppm; for benzene, 1H: 7.16 
ppm and 13C: 128.0 ppm); for acetone, 1H: 2.13 ppm and 13C: 30.7 ppm). H3PO4 (30% 
aq., 0.0 ppm) was used as external standard for 31P-NMR. Coupling constants (J) are 
given in Hertz (Hz). Multiplicities of peaks are reported in the following way: s 
(singlet), d (doublet), t (triplet), q (quartet), m (multiplet), br (broad), ´d´ (pseudo-
doublet), ´t´ (pseudo-triplet), ´q´ (pseudo-quartet) and combinations of these. 
Hydrogen-tin coupling constants (JH-Sn) are given as the average of the 117Sn and 119Sn 
values. Optical rotations were measured with a Perkin Elmer 241 Polarimeter at 
ambient temperature and the concentration (c) is given in g per 100 mL. Analytical 
high performance liquid chromatography (HPLC) was performed using a Varian 9012 
Solvent Delivery System with a Varian 9065 Polychrom Diode Array Detector. 
HPLC grade solvents were obtained from LAB-SCAN. Electron impact (EI) low 
resolution mass spectra (LRMS) were performed with a VG Trio-2 single quadropole 
instrument at the Department of Chemistry, Technical University of Denmark. 
Melting points of crystalline materials were determined on a Heidolph capillary 
melting point apparatus and are uncorrected. Analytical thin layer chromatography 
(TLC) analyses were performed using 0.25 mm Merk Kiselgel aluminum-backed 60 
F254 silica gel plates. Visualization was achieved by using (some of) the following 
sequential steps: i) exposure to UV light, ii) brief exposure to iodine vapors, iii) 
deeping on a solution of either 5-10% of phosphormolybdic acid in EtOH, basic 
KnMnO4 or ninydridin and iv) gentle heating. Merk silica gel 60 (40-63 µm, 230-400 
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mesh) was used for flash chromatography purification. Preparative thin layer 
chromatography (PTLC) was performed on 20×20 cm, 1500 µm glass-backed plates 
with fluorescent indicator (Aldrich). Materials to be separated by PTLC are applied as 
long streaks, developed and recovered by scraping the adsorbent from the plate and 
eluting with EtOAc or CH2Cl2. New compounds are characterized by 1H- and 13C-
NMR and, when relevant, microanalyses. Known compounds were characterized by 
1H- and/or 13C-NMR. Microanalyses were performed at the Microanalysis 
Laboratory, Institute of Physical Chemistry, University of Vienna, Austria. Molecular 
sieves were dried at 150-160 oC for at least 12 h and then allowed to reach room 
temperature under argon. Unless otherwise stated, commercially available reagents, 
purchased from Aldrich, Fluka, Merk or TCI were used without further purification. 
“Aqueous ½ saturated brine” and “aqueous 1/3 saturated NaHCO3” refer to a 
water:brine, 1:1 (v:v) and water:saturated NaHCO3, 2:1 (v:v) solutions, respectively. 
The following cooling baths were used: a slurry of liquid nitrogen in ether 
(approximately -110 oC to -85 oC); a slurry of dry ice in acetone (approximately -78 
oC); a slurry of liquid nitroge in ortho-dichlorobenzene (approximately -25 oC). 
Commercial NaH (as a 60% dispersion in oil) was washed with pentane (2 portions 
that cover the amount of NaH dispersion used) and the last traces of pentane are 
removed under high vacuum. 
 
 
7.2 – General Experimental Procedures 
 
Procedure for the preparation of demetallated silica gel: 
Silica gel (1 Kg) was slurried in aqueous 10% HCl (2 L). The resulting yellow 
aqueous layer was decanted off and the remaining silica gel was washed with 1 L 
batches of distilled water until the washings reached pH 4 (typically 15-20 washes are 
required). The obtained silica gel was then treated with a solution of aqueous 25% 
ammonia (1 mL) in water (1 L). The aqueous phase was decanted off and the 
remaining silica gel was oven-dried at 160 oC for 2 days with occasional manual 
stirring.  
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Tetrakis(triphenylphosphine)palladium Pd(PPh3)4
 
Following a literature procedure,7.1 a vigorously stirred yellow suspension of PdCl2 
(500 mg, 2.8 mmol, 1.0 eq.), PPh3 (3.70 g, 14.1 mmol, 5.0 eq.) in dry DMSO 
(previously degassed by bubbling argon for approximately ½ h) was inserted in an oil 
bath previously heated to 150 oC. After 10-15 min. at this temperature, an orange 
solution is obtained. The oil bath was then removed and N2H4·H2O (565 mg, 11.3 
mmol, 4 eq.) was immediately added dropwise with vigorous gas evolution observed. 
After addition, the mixture was allowed to slowly reach room temperature. An initial 
transient black color faded away into a golden and then into a bright yellow 
coloration. After 5-10 min., some crystals started forming. The stirring was stopped, 
the reaction flask was covered with silver foil and this mixture was left to rest at room 
temperature under argon overnight. The obtained mixture was filtered and the 
resulting crystals were rinsed with cold EtOH (2 portions of 35 mL) and cold Et2O (3 
portions of 15 mL). The title compound was obtained as bright yellow crystals (3.0 g, 
92%) which were best kept refrigerated, under argon and protected from light. Mp 
116-118 oC (lit. 116 oC). 
 
Procedure for the preparation of a 3.8 M solution of tBuOOH in toluene: 
Following a literature procedure,7.2 an aqueous solution of 70% tBuOOH (165 mL) 
was gently swirled/extracted with toluene (2 portions of 200 mL) (note: strong 
shaking should be avoided). The combined cloudy organic layers were then heated to 
105-115 oC in a Dean Stark apparatus behind a safety screen until no more water 
condensed (typically this process was completed over 4 h, with the side-arm of the 
Dean Stark being empty 2-3 times during this period). The obtained solution of 
tBuOOH in toluene was then allowed to reach room temperature, transferred into a 
dark bottle and kept refrigerated under argon. 1H-NMR showed the concentration to 
be approximately 3.8 M. 
 
Procedure for the preparation of sodium phenoxide: 
To an ice cold suspension of NaH (486 mg, 20.2 mmol, 1.0 eq.) in THF (13 mL) was 
dropwise added, over 15 min., a solution of phenol (2.0 g, 21.3 mmol, 1.05 eq.) in 
THF (7 mL), during which period gas evolution was observed. The resulting solution 
was stirred at ice bath temperature for 10 min. and at room temperature for 3 h 
further, after which period most of the solvent was removed under vacuum and 
 
7.1 Komiya, S. In ”Synthesis of Organometallic Compounds: A Practical Guide” 1997, Wiley: England. 
7.2 Hill, J. G.; Rossiter, B.; Sharpless, K. B. J. Org. Chem. 1983, 48, 3607. 
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pentane (35 mL) was added. The obtained suspension was rapidly filtrated under 
argon and the resulting solid was dried at 40 oC under high vacuum for 1½ h. The title 
compound was obtained as a white solid (2.23 g, 91%) that was stored under argon. 
 
Procedure for the preparation of MnO2: 
Following a literature procedure,7.3 to a vigorously stirred solution of KMnO4 (67 g) 
in H2O (300 mL) was added absolute EtOH (100 mL) in three portions at room 
temperature (note: a large beaker covered with a watch glass was used). The viscous 
brownish mixture obtained was stirred at room temperature for 1 h, after which the 
stirring was stopped and the obtained suspension was allowed to rest for 45 min.. The 
suspension is vacuum-filtered and the dark brown solid obtained was rinsed with 
water (1.5 L), triturated and then heated at 125 oC under argon for 24 h, after which it 
was allowed to reach room temperature, triturated again and heated at 125 oC under 
argon for another 24 h. Obtained a dark brown/black powder (39 g) which was kept in 
a dark glass bottle under argon. 
 
 
7.3 – Experimental Procedure for Chapter 3 (Lyngbyatoxin A) 
 
(E)-3-(Tributylstannyl)but-2-en-1-ol (3.11) 
 
Following a literature procedure,7.4 to a -78 oC cold solution of 
(BuSn)2 (30.16 g, 52.0 mmol, 8.0 eq.) in THF (155 mL) was dropwise added a 
solution of nBuLi in hexanes (1.6 M; 32.5 mL, 52 mmol, 8.0 eq.) over 15 min., during 
which period a pale yellow color developed. After stirring at -78 oC for 15 min., the 
temperature was allowed to reach -45 oC (by means of a cooling bath at this 
temperature) and stirring continued for further 35 min. at this temperature. The 
resulting solution was re-cooled to -78 oC and cannulated over 40 min. into a -78 oC 
cold, vigorously stirred, suspension of CuCN (2.3 g, 26 mmol, 4.0 eq.) in THF (26 
mL). The bright yellow mixture obtained was stirred at -78 oC for 50 min., after 
which the temperature was allowed to reach -45 oC (by means of a cooling bath at this 
temperature) and stirring continued for further 45 min. at this temperature. The 
Bu3Sn
OH
 
7.3 King, R. B.; Stone, F. G. A. Inorg. Synth. Vol. VIII, 194. 
7.4 (a) Betzer, J.-F.; Ardisson, J.; Lallemand, J.-Y.; Pancrazi, A. Tetrahedron Letts. 1997, 38, 2279. (b) 
Betzer, J.-F.; Delaloge, F.; Muller, B.; Pancrazi, A.; Prunet, J. J. Org. Chem. 1997, 62, 7768. (c) Betzer, J.-
F.; Pancrazi, A. Synlett., 1998, 1129. (d) Betzer, J.-F.; Pancrazi, A. Synthesis, 1999, 629-634. (e) 
Dominguez, B.; Pazos, Y.; de Lera, A. R. J. Org. Chem. 2000, 65, 5917. 
 92 
Part I Chapter 7: Experimental 
 
 
resulting turbid yellow solution was then re-cooled to -78 oC and MeOH (29 mL, 715 
mmol, 110 eq.) was added dropwise over 10 min., during which a tanned orange color 
developed. After stirring at -78 oC for 5 min., the obtained solution was allowed to 
reach -45 oC gradually over 15 min. and then stirred at this temperature for ½ h 
further. The deep reddish solution obtained was re-cooled to -78 oC and a solution of 
freshly distilled 2-butyn-1-ol (456 mg, 6.5 mmol, 1.0 eq.) in THF (13 mL) was added 
dropwise over 10 min.. The resulting solution was stirred at -78 oC for 10 min., after 
which the temperature was allowed to reach -30 oC (by means of a cooling bath at this 
temperature) and the temperature was then allowed to reach -10 oC over ½ h. The 
deep red mixture thus obtained was left stirring at -10 oC overnight and then quenched 
at this temperature with brine (150 mL). The resulting mixture was extracted with 
Et2O (3 portions of 130 mL) and the combined organic phases were washed with 
brine (150 mL) and dried (MgSO4). Removal of the solvent under vacuum afforded a 
colorless residue that was purified by flash chromatography (demetallated silica gel; 
hexane→hexane: Et2O, 1:1 (v:v) with 2% Et3N; fast elution) to afford the title 
compound as a very pale yellow oil (1.73 g, 74%). 
 
Rf (hexane:EtOAc, 3:1 (v:v)) 0.77; 1H-NMR (CDCl3, 300 MHz) δ 5.75 (tq, J = 1.9, 
6.0 Hz, JH-Sn = 64.7 Hz, 1H), 4.25 (´d´, J = 6.0 Hz, 2H), 1.88 (dt, J = 0.9, 1.9 Hz, JH-Sn 
= 45.1 Hz, 3H), 1.42-1.55 (m, 6H), 1.24-1.38 (m, 7H), 0.82-0.94 (m, 15H); 13C-NMR 
(CDCl3, 75 MHz) δ 142.7, 139.4 (JC-Sn = 24.2 Hz), 59.1 (JC-Sn = 60.6 Hz), 29.4 (JC-Sn = 
19.7 Hz), 27.6 (JC-Sn = 55.1 Hz), 19.7, 13.9, 9.3 (JC-Sn = 323.9 Hz). 
 
N,N-(di-tert-Butoxycarbonly)-4-bromo-aniline (3.13a) 
 
A solution of N-(tert-butoxycarbonly)-4-bromo-aniline (3.12a) (1.0 g, 3.7 
mmol, 1.0 eq.), DMAP (91 mg, 0.74 mmol, 0.2 eq.) and Boc2O (921 mg, 
4.2 mmol, 1.14 eq.) in THF (7.5 mL) was refluxed for 2 days, cooled to 
room temperature, diluted with Et2O (70 mL) and washed with aqueous 1 M HCl (2 
portions of 30 mL). The combined organic layers were washed with aqueous NaHCO3 
(2 portions of 30 mL), water (20 mL), brine (20 mL) and dried (MgSO4). Removal of 
the solvent under vacuum afforded the title compound as a white solid (1.2 g, 90%) 
which was used without further purification. 
NBoc2
Br
 
Rf (hexane:EtOAc, 3:1 (v:v)) 0.43 (note: the Rf values of the starting material and the 
product are very similar); mp 108-110 oC;  1H-NMR (CDCl3, 300 MHz) δ 7.38-7.44 
(m, 2H), 6.92-6.98 (m, 2H), 1.35 (s, 18H); 13C-NMR (CDCl3, 75 MHz) δ 151.7, 
138.7, 132.1, 129.9, 121.4, 83.3, 28.1; LRMS (EI) m/z = 371 [M]+; Anal. Calcd. for 
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C16H22BrNO4: C, 51.62; H, 5.96; N, 3.76. Found: C, 51.66; H, 5.77; N, 3.57. 
 
4-N-(tert-Butoxycarbonly)aminophenyl trifluorosulfonate (3.12c) 
 
To an ice cold tanned solution of 4-N-(tert-butoxycarbonly)amino phenol 
(3.12b) (3.2 g, 15.3 mmol, 1.0 eq.) in pyridine (22 mL) was dropwise 
added Tf2O (2.98 mL, 17.6 mmol, 1.15 eq.). The resulting solution was 
stirred at 0 oC for 45 min., after which it was allowed to reach room temperature and 
stirred for further ½ h. The obtained solution was re-cooled to 0 oC, after which water 
(50 mL) was added and this mixture was vigorously stirred for 45 sec., during which 
period a heavy precipitate formed. The mixture was partitioned between Et2O (200 
mL) and water (30 mL) and the aqueous layer was further extracted with Et2O (20 
ml). The combined organic layers were washed with aqueous 10% HCl (2 portions of 
100 mL), water (50 mL), brine (30 mL) and dried (Na2SO4). Removal of the solvent 
under reduced pressure afforded the title compound as a beige solid (4.7 g, 90%) 
which was used without further purification. 
NHBoc
OTf
 
Rf (hexane:EtOAc, 1:1 (v:v)) 0.6; mp 96-98 oC; 1H-NMR (CDCl3, 300 MHz) δ 7.41-
7.47 (m, 2H), 7.15-7.21 (m, 2H), 6.63 (brs, 1H), 1.51 (s, 9H); 13C-NMR (CDCl3, 75 
MHz) δ 152.6, 144.7, 138.7, 122.2, 119.7, 81.5, 54.7, 28.5; Anal. Calcd. for 
C12H14F3NO5S: C, 42.23; H, 4.13; N, 4.10. Found: C, 42.34; H, 3.98; N, 4.01. 
 
4-N,N-(di-tert-Butoxycarbonly)aminophenyl trifluorosulfonate 
(3.13b) 
 
A solution of 4-N-(tert-butoxycarbonly)aminophenyl trifluorosulfonate 
(3.12c) (1.25 g, 3.7 mmol, 1.0 eq.), DMAP (91 mg, 0.74 mmol, 0.2 eq.) 
and Boc2O (921 mg, 4.2 mmol, 1.14 eq.) in THF (7.5 mL) was refluxed for 2 days, 
cooled to room temperature, diluted with Et2O (70 mL) and washed with aqueous 1 M 
HCl (2 portions of 30 mL). The combined organic layers were washed with aqueous 
NaHCO3 (2 portions of 30 mL), water (20 mL), brine (20 mL) and dried (MgSO4). 
Removal of the solvent under vacuum afforded the title compound as a light tanned 
solid (1.4 g, 86%) which was used without further purification. 
NBoc2
OTf
 
Rf (hexane:EtOAc, 5:1 (v:v)) 0.37 (note: the Rf values of the starting material and the 
product are very similar); mp 68-70 oC; 1H-NMR (CDCl3, 300 MHz) δ 7.19-7.30 (m, 
4H), 1.40 (s, 18H); 13C-NMR (CDCl3, 75 MHz) δ 151.4, 148.4, 139.6, 130.1, 121.9, 
121.1, 83.6, 28.1; Anal. Calcd. for C17H22F3NO7S: C, 46.26; H, 5.02; N, 3.17. Found: 
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C, 46.44; H, 4.89; N, 3.07. 
 
2-N-(tert-Butoxycarbonyl)amino-5-iodobenzoic acid 
 
To a deep tanned solution of para-iodo anthranilic acid (5.0 g, 19.0 
mmol, 1.0 eq.), NEt3 (2.8 ml, 38 mmoL, 2 eq.) in MeOH (25 mL) 
was added Boc2O (5.0 g, 22.8 mmol, 1.2 eq.). The resulting solution 
was refluxed for 7 h, after which it was concentrated under vacuum to afford an oily 
residue, which was then taken in aqueous 1 M HCl (400 mL) and extracted with 
EtOAc (2 portions of 150 mL). The combined organic phases were washed with 
aqueous 1 M HCl (2 portions of 150 mL), water (2 portions of 150 mL), dried 
(Na2SO4) and concentrated under reduced pressure affording the title compound as a 
pale yellow solid (4.86 g, 70%) which was used without further purification. 
NHBoc
I
CO2H
 
Rf (iPrOH:aqueous 25% ammonia, 7:3 (v:v)) 0.66; mp 189-190 oC; 1H-NMR (CDCl3, 
300 MHz) δ 10.39 (brs, 1H), 8.37 (d, J = 2.2 Hz, 1H), 8.26 (d, J = 9.0 Hz, 1H), 7.77 
(dd, J = 2.2, 9.0 Hz, 1H), 1.52 (s, 9H); 13C-NMR (CDCl3, 75 MHz) δ 168.6, 152.7, 
143.0, 142.5, 139.9, 120.7, 116.3, 83.1, 80.8, 28.3; Anal. Calcd. for C12H14INO4: C, 
39.69; H, 3.89; N, 3.86. Found: C, 39.60; H, 3.65; N, 3.71. 
 
Methyl 2-N-(tert-butoxycarbonyl)amino-5-iodobenzoate (3.14) 
 
To an ice cold suspension of 2-N-(tert-butoxycarbonyl)amino-5-
iodobenzoic acid (3.0 g, 8.26 mmol, 1.0 eq.) and Cs2CO3 (1.35 g, 
4.13 mmol, 0.5 eq.) in DMF (17 mL) was dropwise added MeI (0.51 
mL, 8.26 mmol, 1.0 eq.). The temperature was allowed to reach room temperature and 
stirring continued for 20 h (for convenience), after which most of the DMF was 
removed under reduced pressure. The obtained residue was taken up in EtOAc (120 
mL), the cesium salts were removed by filtration and the filtrate was concentrated 
under vacuum to afford the title compound as a viscous oil that upon standing 
crystallizes as a light tanned solid (1.87 g, 60% crude) which was used without further 
purification. 
NHBoc
I
CO2Me
 
Rf (iPrOH: aqueous 25% ammonia, 7:3 (v:v)) 0.69; mp 78-80 oC; 1H-NMR (CDCl3, 
300 MHz) δ 10.19 (brs, 1H), 8.26 (d, J = 2.2 Hz, 1H), 8.22 (d, J = 9.0 Hz, 1H), 7.73 
(dd, J = 2.2, 9.0 Hz, 1H), 3.90 (s, 3H), 1.51 (s, 9H); 13C-NMR (CDCl3, 75 MHz) δ 
167.5, 152.8, 143.1, 142.2, 139.5, 121.0, 116.3, 83.4, 81.1, 52.7, 28.5; LRMS (EI) m/z 
= 377 [M]+; Anal. Calcd. for C13H16INO4: C, 41.40; H, 4.28; N, 3.71. Found: C, 
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41.13; H, 3.98; N, 3.54. 
 
2-N-tert-butoxycarbonly-aminofurane 
 
Following a literature procedure,7.5 to a pale yellow solution of 2-
furanoic acid (2.0 g, 17.8 mmol, 1.0 eq.) and NEt3 (5.0 mL, 35.9 mmol, 
2.0 eq.) in tBuOH (40 mL, 418 mmol, 23.5 eq.) was dropwise added DPPA (8.0 mL, 
37.1 mmol, 2.1 eq.). The resulting solution was heated to 85 oC for 12 h, after which a 
short path-distillation adaptor was inserted, the temperature of the heating bath was 
increased to 105-110 oC and most of the tBuOH was distilled off. The viscous tanned 
oil residue obtained was then purified by flash chromatography on silica gel (1st 
column eluted with hexane:EtOAc, 1:1 (v:v); 2nd column eluted with hexane:EtOAc, 
5:1 (v:v)) affording the title compound as a white solid (2.27 g, 70%; minor impurity 
contamination) that is best used immediately. 
O
NHBoc
 
Rf (hexane:EtOAc, 5:1 (v:v)) 0.32; mp 97-99oC (lit.: 98-99 oC); 1H-NMR (CDCl3, 300 
MHz) δ 7.05 (dd, J = 1.0, 2.0 Hz, 1H), 6.77 (brs, 1H), 6.33 (dd, J = 2.0, 3.2 Hz, 1H), 
6.03 (brs, 1H), 1.50 (s, 9H); 13C-NMR (CDCl3, 75 MHz) δ 151.9, 145.3, 136.0, 111.1, 
95.0, 81.3, 28.2. 
Methyl 2-N-(tert-butoxycarbonyl)amino-5-hydroxybenzoate 
(3.15) 
 
Following a literature procedure,7.5 a pale yellow solution of 2-N-
Boc-aminofurane (1.5 g, 8.2 mmol, 1.0 eq.) and methylpropiolate 
(1.44 g, 17.1 mmol, 2.0 eq.) in benzene (15 mL) was refluxed for 20 h, after which a 
second amount of methypropiolate (0.7 g, 8.2 mmol, 1.0 eq.) in benzene (5 mL) was 
added and reflux continued for 20 h further. Upon reaching room temperature, the 
deep reddish solution becomes a suspension which was then diluted with cold toluene 
(5 mL) and filtered. The solid thus obtained was rinsed with cold toluene (2 portions 
of 3 mL) affording the title compound a white solid (695 mg). The mother liquor was 
concentrated under vacuum and the residue obtained was purified by flash 
chromatography on silica gel (hexane:EtOAc, 2:1 (v:v)) further delivering the wanted 
compound as a very pale yellow solid (302 mg). Combined yield: 997 mg, 45%. 
NHBoc
OH
CO2Me
 
Rf (hexane:EtOAc, 2:1 (v/v)) 0.27; mp 137-139 oC (lit.: 138-139 oC); 1H-NMR 
 
7.5 Padwa, A.; Dimitroff, M.; Waterson, A. G.; Wu, T. J. Org. Chem. 1997, 62, 4088. 
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(CDCl3, 300 MHz) δ 9.94 (brs, 1H), 8.23 (d, J = 9.1 Hz, 1H), 7.45 (d, J = 3.1 Hz, 1H), 
7.01 (dd, J = 3.1, 9.1 Hz, 1H), 5.46 (brs, 1H), 3.89 (s, 3H), 1.52 (s, 9H); 13C-NMR 
(CDCl3, 75 MHz) δ 168.3, 153.5, 149.9, 135.8, 122.3, 120.9, 116.8, 115.8, 80.7, 52.5, 
28.6. 
 
Methyl 2-N-(tert-butoxycarbonyl)amino-5-(trifluoromethyl-
sulfonyloxy)benzoate (3.16) 
 
To an ice cold yellow solution of methyl 2-N-(tert-
butoxycarbonyl)amino-5-hydroxybenzoate (3.15) (300 mg, 1.1 
mmol, 1.0 eq.) in pyridine (2 mL) was dropwise added Tf2O (217 µL, 1.29 mmol, 
1.15 eq.) and the resulting orange solution was stirred at ice bath temperature for 10 
min., after which it was it was allowed to reach room temperature and stirred for 
further 1½ h. The obtained solution was re-cooled to 0 oC, water (10 mL) was added 
and this mixture was vigorously stirred for 45 sec. during which period a heavy 
precipitate formed. The mixture was partitioned between Et2O (40 mL) and water (5 
mL) and the aqueous layer was extracted with Et2O (2 portions of 10 ml). The 
combined organic layers were washed with aqueous 10% HCl (2 portions of 25 mL), 
water (20 mL), brine (20 mL) and dried (Na2SO4). Removal of the solvent under 
reduced pressure afforded the title compound as a yellow solid (414 mg, 93%), which 
was used without further purification. 
NHBoc
OTf
CO2Me
 
Rf (hexane:EtOAc, 2:1 (v:v)) 0.41; mp 78-80 oC; 1H-NMR (CDCl3, 300 MHz) δ 10.32 
(brs, 1H), 8.59 (d, J = 9.4 Hz, 1H), 7.90 (d, J = 3.0 Hz, 1H), 7.39 (dd, J = 3.0, 9.4 Hz, 
1H), 3.95 (s, 3H), 3.89 (s, 3H), 1.53 (s, 9H); 13C-NMR (CDCl3, 75 MHz) δ 167.2, 
152.8, 142.7, 142.6, 127.4, 123.8, 120.7, 115.4, 81.5, 53.0, 28.5; Anal. Calcd. for 
C14H16F3NO7S: C, 42.11; H, 4.04; N, 3.51. Found: C, 42.29; H, 3.91; N, 3.42. 
 
(E)-4-(4-Hydroxybut-2-en-2-yl)-N,N-di-tert-butoxy-phenyl 
carbamate (3.17) 
 
A solution of N,N-(di-tert-butoxycarbonly)-4-bromo-aniline (3.13a) 
(118 mg, 0.32 mmol, 1.15 eq.), Pd2(dba)3·CHCl3 complex (20 mg, 0.02 
mmol, 6 mol%), AsPh3 (19 mg, 0.06 mmol, 20 mol%), CuI (10 mg, 
0.05 mmol, 15 mol%) and (E)-3-(tributylstannyl)but-2-en-1-ol (3.11) (100 mg, 0.28 
mmol, 1.0 eq.) in toluene (1.3 mL) was heated to 95 oC to 100 oC for 24 h (for 
convenience). The resulting tanned mixture was concentrated under vacuum and the 
resulting residue was purified by flash chromatography on silica gel (hexane:EtOAc, 
NBoc2
OH
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1:1 (v:v)) to afford the title compound as a pale yellow oil (37 mg, 32%). 
 
Rf (hexane:EtOAc, 2:1 (v:v)) 0.13; 1H-NMR (CDCl3, 300 MHz) δ 7.36-7.41 (m, 2H), 
7.05-7.12 (m, 2H), 5.99 (tq, J = 1.3, 6.8 Hz, 1H), 4.35 (dd, J = 0.6, 6.8 Hz, 2H), 2.06 
(dt, J = 0.6, 1.3 Hz, 3H), 1.42 (s, 18H); 13C-NMR (CDCl3, 75 MHz) δ 152.2, 142.0, 
138.5, 137.2, 127.9, 127.1, 126.3, 83.0, 60.2, 28.1, 16.2; LRMS (EI) m/z = 363 [M]+. 
(E)-Methyl 2-N-(tert-butoxycarbonyl)amino-5-(4-hydoxybut-2-
en-yl)benzoate (3.18) 
 
A suspension of methyl 2-N-(tert-butoxycarbonyl)amino-5-
iodobenzoate (3.14) (95 mg, 0.25 mmol, 1.0 eq.), (E)-3-
(tributylstannyl)but-2-en-1-ol (3.11) (100 mg, 0.27 mmol, 1.1 eq.), 
Pd2(dba)3·CHCl3 complex (31 mg, 0.03 mmol, 12 mol%), AsPh3 (37 mg, 0.12 mmol, 
48 mol%) and CuI (15 mg, 0.08 mmol, 30 mol%) in NMP (1.5 mL) was inserted into 
an oil bath previously heated to 50 oC to 60 oC and stirred at this temperature for 20 h. 
The resulting black mixture was poured into aqueous KF (15 mL) and stirred 
vigorously for 4 min., after which Et2O (15 mL) was added and the layers separated. 
The aqueous layer was further extracted with Et2O (2 portions of 5 mL), the combined 
organic layers were dried (MgSO4) and the solvent was removed under vacuum to 
afford an oily residue that was purified by flash chromatography on silica gel 
(hexane:EtOAc, 1:1 (v:v) with 2% NEt3). The title compound was obtained as a tan 
oil (36 mg, 56%). 
NHBoc
OH
CO2Me
 
Rf (hexane:EtOAc, 1:1 (v:v)) 0.28; 1H-NMR (CDCl3, 300 MHz) δ 10.24 (brs, 1H), 
8.38 (d, J = 8.9 Hz, 1H), 8.03 (d, J = 2.4 Hz, 1H), 7.55 (dd, J = 2.4, 8.9 Hz, 1H), 5.97 
(tq, J = 1.2, 6.7 Hz, 1H), 4.35 (d, J = 6.7 Hz, 2H), 3.91 (s, 3H), 2.05 (d, J = 1.2 Hz, 
2H), 1.52 (s, 9H); 13C-NMR (CDCl3, 75 MHz) δ 168.8, 153.1, 141.5, 136.5, 135.7, 
131.9, 128.1, 126.2, 118.8, 114.3, 80.8, 60.1, 52.5, 28.5, 16.0; LRMS (EI) m/z = 321 
[M]+. 
 
N-(4-Acetylphenyl)pivalamide (3.19) NHPiv
O
 
Following a literature procedure,7.6 to an ice cold tanned solution of 4-
aminoacetophenone (15 g, 111 mmol, 1.0 eq.) in pyridine (110 mL) was 
dropwise added PivCl (15 mL, 122 mmol, 1.1 eq.). Towards the end of 
 
7.6 Akama, T.; Shida, Y.; Sugaya, T.; Ishida, H.; Gomi, K.; Kasai, M. J. Med. Chem. 1996, 39, 3461. 
 98 
Part I Chapter 7: Experimental 
 
 
addition, a precipitate started to form. The suspension was allowed to reach room 
temperature and stirring continued for further 4 h, after which it was partitioned 
between EtOAc (300 mL) and water (300 mL). The aqueous layer was further 
extracted with EtOAc (2 portions of 200 mL). The combined organic layers were 
washed with aqueous 2 M HCl (3 portions of 300 mL), aqueous NaHCO3 (100 mL), 
brine (120 mL) and dried (Na2SO4). Removal of the solvent under vacuum delivered 
the title compound as a tan solid (23.6 g, 97%) which was used without further 
purification. 
 
Rf (hexane:EtOAc, 1:1 (v:v)) 0.34; mp 137-140 oC; 1H-NMR (CDCl3, 300 MHz) δ 
7.92 (´d´, J = 8.6 Hz, 2H), 7.65 (´d´, J = 8.6 Hz, 2H), 7.56 (brs, 1H), 2.57 (s, 3H), 
1.33 (s, 9H); 13C-NMR (CDCl3, 75 MHz) δ 197.2, 177.1, 142.7, 133.0, 129.9, 119.2, 
40.1, 27.8, 26.7; Anal. Calcd. for C13H17NO2: C, 71.21; H, 7.81; N, 6.39. Found: C, 
71.41; H, 7.78; N, 6.36. 
 
General procedure for the Horner-Wadsworth-Emmons reaction of substituted 
acetophenones with triethylphosphonoacetate (GP 1): 
To an ice cold suspension of NaH in THF (0.5 M) was dropwise added a solution of 
triethylphosphonoacetate (1.15 eq.) in THF (just enough to transfer it quantitatively) 
with concomitant gas evolution. After stirring for 15-20 min. at 0 oC and for further 
15-20 min. at room temperature, a solution of the acetophenone derivative (1.0 eq.) in 
THF (1 M) was added dropwise and the resulting mixture was stirred at room 
temperature (or, for less reactive substrates, at reflux temperature) overnight, after 
which it was partitioned between Et2O and aqueous ½ saturated brine. The aqueous 
layer was further extracted with Et2O and the combined organic phases were washed 
with brine, dried (MgSO4) and the solvent removed under vacuum to afford a mixture 
of the (E)- and (Z)- isomers, which could be separated by (repeated) flash 
chromatography on silica gel. 
 
(E)-Ethyl 3-(4-pivalamidophenyl)but-2-enoate 
(3.20) 
NHPiv
CO2Et
and
NHPiv
CO2Et
and 
(Z)-Ethyl 3-(4-pivalamidophenyl)but-2-enoate 
(3.20) 
 
Following GP 1, using N-(4-acetylphenyl) pivalamide (3.19) (1.5 g, 6.84 mmol) and 
refluxing the reaction mixture overnight. Purification by (repeated) flash 
chromatography on silica gel (hexane:Et2O, 1:1 (v:v)→hexane:Et2O, 1:2 (v:v)) 
 99
Part II 7.3 – Experimental Procedure for Chapter 3 (Lyngbyatoxin A) 
 
 
delivered pure (E)-(3.20) (1.32 g, 67% as a white solid) and (Z)-(3.20) (340 mg, 17% 
as a white solid) isomers. Combined yield: 84%. 
For (E)-Ethyl 3-(4-pivalamidophenyl)but-2-enoate (3.20): Rf (hexane:EtOAc, 1:1 
(v:v)) 0.49; mp 101-102 oC; 1H-NMR (CDCl3, 300 MHz) δ 7.52-7.58 (m, 2H), 7.44-
7.50 (m, 2H), 7.37 (brs, 1H), 6.13 (´d´, J = 1.2 Hz, 1H), 4.20 (q, J = 7.1 Hz, 2H), 2.56 
(d, J = 1.2 Hz, 3H), 1.28-1.34 (m, 12H); 13C-NMR (CDCl3, 75 MHz) δ 176.9, 167.2, 
154.8, 139.1, 137.8, 127.3, 119.8, 116.4, 60.1, 39.9, 27.8, 17.9, 14.6; LRMS (EI) m/z 
= 289 [M]+; Anal. Calcd. for C17H23NO3: C, 70.56; H, 8.01; N, 4.84. Found: C, 70.75; 
H, 7.99; N, 4.76. 
 
For (Z)-Ethyl 3-(4-pivalamidophenyl)but-2-enoate (3.20): Rf (hexane:EtOAc, 1:1 
(v:v)) 0.45; mp 82-84 oC; 1H-NMR (CDCl3, 300 MHz) δ 7.49-7.56 (m, 2H), 7.32 (brs, 
1H), 7.16-7.22 (m, 2H), 5.88 (´d´, J = 1.4 Hz, 1H), 4.01 (q, J = 7.1 Hz, 2H), 2.15 (d, J 
= 1.4 Hz, 3H), 1.31 (s, 9H), 1.13 (t, J = 7.1 Hz, 3H); 13C-NMR (CDCl3, 75 MHz) δ 
177.0, 166.2, 155.0, 137.9, 136.6, 128.0, 119.4, 117.8, 60.0, 39.9, 27.9, 27.2, 14.3; 
LRMS (EI) m/z = 289 [M]+ ; Anal. Calcd. for C17H23NO3: C, 70.56; H, 8.01; N, 4.84. 
Found: C, 70.79; H, 8.14; N, 4.82. 
 
General procedure for the Dibal reduction of α,β-unsaturated esters to the 
corresponding allylic alcohols (GP 2): 
To an ice cold solution of the α,β-unsaturated ester (1.0 eq.) in Et2O (0.4 M) was 
dropwise added a solution of Dibal in hexane (2.0 eq.). The obtained solution was 
allowed to reach room temperature and stirred for approximately 2 h, after which it 
was re-cooled to ice bath temperature and diluted with Et2O, followed by slow 
addition of brine. After vigorous stirring for 5-10 min., a gel-like biphasic system 
typically formed. Aqueous 4 M HCl was then carefully added and the mixture was 
stirred at 0 oC for 10 min. and then at room temperature until a clear biphasic system 
was obtained (typically 15 min. further). After separation of the layers, the aqueous 
layer was further extracted with Et2O and the combined organic phases were washed 
with brine and dried (MgSO4). Evaporation of the solvent under vacuum followed by 
purification by flash chromatography on silica gel afforded the corresponding allylic 
alcohol. 
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(E)-N-(4-(4-Hydroxybut-2-en-2-yl)phenyl)pivalamide 
(3.21) 
and 
(E)-3-(4-Aminophenyl)but-2-en-1-ol (3.22) 
 
The following modification of GP 2 was used: to a -78 
oC cold solution of (E)-ethyl 3-(4-pivalamidophenyl)but-
2-enoate (3.20) (1.2 g, 4.15 mmol, 1.0 eq.) in CH2Cl2 (19 mL) was dropwise added in 
three portions a solution of Dibal in hexane (1.0 M, 10.4 mL, 2.5 eq.), with 5 min. 
intervals between portions. The resulting reddish mixture was then stirred at -78 oC 
for 4½ h, after which it was quenched at this temperature by slow addition of MeOH 
(6 mL). The cooling bath was replaced by an ice bath, and after stirring at 
approximately 0 oC for 10 min, a saturated Rochelle salt aqueous solution (25 mL) 
was added. The resulting yellow gel-like mixture was left stirring overnight after 
which a homogenous biphasic system was obtained. The phases were separated and 
the aqueous layer was extracted with CH2Cl2 (3 portions of 15 mL). The combined 
organic layers were washed with Rochelle salt (30 mL), water (20 mL), brine (30 mL) 
and dried (Na2SO4). Removal of the solvent under vacuum afforded a tanned oil 
residue. Purification by flash chromatography on silica gel (hexane:EtOAc, 1:2 (v:v)) 
delivered (E)-N-(4-(4-hydroxybut-2-en-2-yl)phenyl) pivalamide (3.21) as tan solid 
(636 mg, 62%) and (E)-3-(4-aminophenyl)but-2-en-1-ol (3.22) as a deep tan solid (82 
mg, 12%). 
NHPiv
OH
and
NH2
OH
 
For (E)-N-(4-(4-hydroxybut-2-en-2-yl)phenyl) pivalamide (3.21): Rf (hexane:EtOAc, 
1:2 (v:v)) 0.35; mp 121-123 oC; 1H-NMR (CDCl3, 300 MHz) δ 7.45-7.50 (m, 2H), 
7.41 (brs, 1H), 7.32-7.37 (m, 2H), 5.94 (tq, J = 0.5, 6.7 Hz, 1H), 4.34 (´d´, J = 6.7 Hz, 
2H), 2.03 (td, J = 0.5, 0.7 Hz, 3H), 1.84 (brs, 1H), 1.30 (s, 9H); 13C-NMR (CDCl3, 75 
MHz) δ 176.9,138.9, 137.4, 137.2, 126.4, 126.1, 120.0, 60.1, 39.8, 27.8, 16.1; LRMS 
(EI) m/z = 247 [M]+; Anal. Calcd. for C15H21NO2: C, 72.84; H, 8.56; N, 5.66. Found: 
C, 72.81; H, 8.62; N, 5.62. 
 
For (E)-3-(4-aminophenyl)but-2-en-1-ol (3.22): Rf (hexane:EtOAc, 1:2 (v:v)) 0.29; 
mp 64-66 oC; 1H-NMR (CDCl3, 300 MHz) δ 7.21-7.26 (m, 2H), 6.61-6.67 (m, 2H), 
5.89 (tq, J = 0.6, 6.9 Hz, 1H), 4.32 (´d´, J = 6.9 Hz, 2H), 2.03 (´d´, J = 0.6 Hz, 3H); 
13C-NMR (CDCl3, 75 MHz) δ 145.9, 137.7, 133.3, 126.9, 123.9, 115.1, 60.1, 16.0; 
LRMS (EI) m/z = 163 [M]+. 
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Methyl 4-iodobenzoate 
 
A solution of 4-iodobenzenzoic acid (15.0 g, 60.48 mmol), MeOH (240 
mL) and concentrated H2SO4 (approximately 60 drops) was refluxed for 
17 h, after it was allowed to slowly reach room temperature without 
stirring, during which period crystal formation occurred. An ice bath was then 
inserted for ½ h to complete this process. After filtration and washing of the crystals 
with cold MeOH (2 portions of 20 mL), the title compound was obtained as white 
needles (11.9 g). The mother liquor from filtration was concentrated under vacuum 
almost to dryness and the solid residue obtained was dissolved in Et2O (200 mL) and 
washed with saturated aqueous NaHCO3 (2 portions of 50 mL) followed by water (2 
portions of 50 mL), brine (50 mL) and dried (Na2SO4). Removal of the solvent under 
vacuum afforded a second crop of white crystals (3.6 g). Combined yield: 15.5 g, 
98%. 
CO2Me
I
 
Rf (iPrOH:ammonia, 7:3 (v:v)) 0.83; mp 114-116 oC; 1H-NMR (d-acetone, 300 MHz) 
δ 7.92-7.96 (m, 2H), 7.75-7.80 (m, 2H), 3.89 (s, 3H); 13C-NMR (CDCl3, 75 MHz) δ 
166.1, 138.1, 131.1, 130.1, 100.4, 51.9; LRMS (EI) m/z: 262 [M]+. 
 
(Z)-Methyl 4-(4-hydroxybut-2-en-2-yl)benzoate (3.23) 
 
Following a literature procedure,7.7 NaOMe (155 mg, 2.87 mmol, 
0.11 eq.) was added to a solution of LiAlH4 in THF (1 M, 38.2 mL, 
38.2 mmol, 1.43 eq.). The mixture was cooled to ice bath 
temperature and a solution of but-2-yn-1-ol (2.7 g, 38.2 mmol, 1.43 eq.) in THF (38 
mL) was added dropwise over 25 min. with concomitant gas evolution. After stirring 
at 0 oC for 5 min, the mixture was allowed to reach room temperature and stirred for 
further 4½ h. The white suspension obtained was re-cooled to ice bath temperature 
and dimethyl carbonate (3.8 g, 41.9 mmol, 1.57 eq.) was added. The resulting mixture 
was stirred without cooling for 10 min. during which period a pale yellow color 
developed. Methyl 4-iodobenzoate (7.0 g, 26.7 mmol, 1.0 eq.) was then added in one 
portion, immediately followed by Pd2dba3·CHCl3 complex (692 mg, 0.67 mmol, 2.5 
mol%), ZnCl2 (2.18 g, 16.0 mmol, 60 mol%) (slightly exothermic process) and AsPh3 
(818 mg, 2.67 mmol, 10 mol%). The resulting dark mixture was left stirring at room 
temperature over 2 h and then heated to gentle reflux for 2 h further. MeOH (25 mL) 
was then added at 0 oC and the obtained mixture was left stirring at room temperature 
CO2Me
OH
 
7.7 Havránek, M.; Dvořák, D. J. Org. Chem. 2002, 67, 2125. 
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overnight, after which it was poured into ½ brine (80 mL), acidified with aqueous 5% 
HCl to pH 5-6 (approximately 40 mL) and, after stirring for 5 min., extracted with 
Et2O (2 portions of 150 ml followed by 3 portions of 80 mL). The combined reddish 
organic layers were dried (MgSO4) and the solvent removed under vacuum to afford a 
dark tan oil which was purified by flash chromatography on silica gel (hexane:EtOAc, 
1:1 (v:v)). The tan oil obtained was taken up in MeOH (200 mL) and to this solution 
was added enough charcoal. The resulting black suspension was refluxed for 40 min, 
allowed to reach room temperature, filtered through a Celite pad and concentrated 
under reduced pressure to afford a pale tan oil (4.44 g, 81%). 
 
Rf (hexane:EtOAc, 1:1 (v:v)) 0.31; 1H-NMR (CDCl3, 300 MHz) δ 7.97-8.03 (m, 2H), 
7.21-7.27 (m, 2H), 5.76 (tq, J = 1.3, 7.0 Hz, 1H), 4.04 (d, J = 7.0 Hz, 2H), 3.91 (s, 
3H), 2.08 (d, J = 1.3 Hz, 3H); 13C-NMR (CDCl3, 75 MHz) δ 167.1, 145.8, 139.3, 
129.7, 129.1, 128.1, 127.5, 60.3, 52.4, 25.2. 
 
(E)-Ethyl 3-(4-bromophenyl)but-2-enoate (3.24)  
and 
(Z)-Ethyl 3-(4-bromophenyl)but-2-enoate (3.24) 
 
Following GP 1, using 4-bromo-acetophenone (16.0 g, 
80.4 mmol, 1.0 eq.). Purification by (repeated) column 
flash chromatography on silica gel (hexane: Et2O, 3:1 (v:v)) delivered pure (E)-(3.24) 
(15 g, 70% as a colorless oil) and (Z)-(3.24) (4.5 g, 21% as a colorless oil) isomers. 
Combined yield: 91%. 
Br
CO2Et
Br
CO2Et
and
 
For (E)-Ethyl 3-(4-bromophenyl)but-2-enoate (3.24): Rf (hexane: Et2O, 3:1 (v:v)) 
0.50; 1H-NMR (CDCl3, 300 MHz) δ 7.47-7.52 (m, 2H), 7.31-7.35 (m, 2H), 6.11 (q, J 
= 1.3 Hz, 1H), 4.21 (q, J = 7.2 Hz, 2H), 2.54 (t, J = 1.3 Hz, 3H), 1.31 (t, J = 7.2 Hz, 
3H); 13C-NMR (CDCl3, 75 MHz) δ 166.8, 154.4, 141.9, 137.8, 128.2, 117.8, 95.2, 
60.2, 17.9, 14.5; LRMS (EI) m/z = 268 [M-H]+; Anal. Calcd. for C12H13BrO2: C, 
53.55; H, 4.87. Found: C, 53.44; H, 4.59. 
 
For (Z)-Ethyl 3-(4-bromophenyl)but-2-enoate (3.24): Rf (hexane: Et2O, 3:1 (v:v)) 
0.42; 1H-NMR (CDCl3, 300 MHz) δ 7.45-7.49 (m, 2H), 7.06-7.10 (m, 2H), 5.92 (q, J 
= 1.4 Hz, 1H), 4.01 (q, J = 7.1 Hz, 2H), 2.15 (d, J = 1.4 Hz, 3H), 1.12 (t, J = 7.1 Hz, 
3H); 13C-NMR (CDCl3, 75 MHz) δ 165.9, 154.5, 139.9, 131.3, 128.8, 122.0, 118.5, 
60.1, 27.3, 14.3. 
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(E)-3-(4-Bromophenyl)but-2-en-1-ol (3.25) Br
OH
 
Following GP 2, using (E)-ethyl 3-(4-bromophenyl)but-2-enoate (3.24) 
(14.9 g, 55.4 mmol, 1.0 eq.). Purification by flash chromatography on 
silica gel (hexane:EtOAc, 1:1 (v:v)) delivered the title compound as a 
white solid (12.6 g, quantitative). 
 
Rf (hexane:EtOAc, 1:1 (v:v)) 0.29; mp 60-62 oC; 1H-NMR (CDCl3, 300 MHz) δ 7.42-
7.46 (m, 2H), 7.24-7.29 (m, 2H), 5.96 (tq, J = 1.3, 6.6 Hz, 1H), 4.35 (d, J = 6.6 Hz, 
2H), 2.05, (d, J = 1.3 Hz, 3H), 1.56 (brs, 1H); 13C-NMR (CDCl3, 75 MHz) δ 141.9, 
136.9, 131.6, 127.6, 127.3, 121.4, 60.1, 16.2; EI-MS m/z: 226 [M+]; Anal. Calcd. for 
C10H11BrO: C, 52.89; H, 4.88. Found: C, 52.99; H, 4.84. 
4-Acetyl-2-iodoaniline (3.26) 
 
Procedure 1 (to be preferred): Following a literature procedure,7.8 a 
solution of CaCO3 (11.6 g, 116.0 mmol, 1.57 eq.) in water (29.5 mL) was 
added to a solution of para-acetylaniline (10 g, 74.0 mmol) in methanol 
(49 mL), followed by a solution of ICl (12.7 g, 78.5 mmol, 1.06 eq.) in methanol (49 
mL). The mixture was stirred at room temperature for 15 h, then diluted with Et2O 
(300 mL) and water (50 mL). The aqueous layer was extracted with Et2O (2 portions 
of 100 mL) and the combined organic phases were dried (Na2SO4). Removal of the 
solvent in vacuum afforded a residue that was purified by column chromatography 
(hexane:EtOAc, 1:1 (v:v)). The title compound was obtained as a tan viscous oil 
which upon standing in the cold crystallizes as a yellow solid (16.6 g, 86%). 
NH2
O
I
 
Procedure 2: a solution of ICl (13.2 g, 81.3 mmol, 1.1 eq.) in glacial acetic acid (420 
mL) was added to a solution 4-acetylaniline (10 g, 74.0 mmol) in glacial acetic acid 
(500 mL) over 15 min.. After stirring at room temperature for 1½ h, the deep tanned 
solution was concentrated to 1/3 of its original volume and then diluted with iced 
water (600 mL) and CH2Cl2 (450 mL). To this biphasic system was then added, with 
vigorous stirring, solid NaHCO3 (caution: strong gas evolution!) until the aqueous 
layer reaches neutral pH. The aqueous layer was extracted with CH2Cl2 (2 portions of 
100 mL) and the combined deep red organic layer was washed with aqueous saturated 
NaHCO3 (2 portions of 150 mL), aqueous ½ saturated Na2S2O3 (200 mL), water (120 
mL), brine (120 mL) and dried (Na2SO4). The solvent was removed under vacuum 
 
7.8 Fujita, K.; Takahashi, Y.; Owaki, M.; Yamamoto, K.; Yamaguchi, R. Org. Lett. 2004, 6, 2785. 
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and the tan paste obtained was purified by flash chromatography (hexane:EtOAc, 1:1 
(v:v)) to afford a tanned thick oil which upon standing in the cold crystallizes as a 
yellow solid (11.9 g, 62%). 
 
Rf (hexane:EtOAc, 1:1 (v:v)) 0.44; mp 50-53 oC (lit. 50-52 oC); 1H-NMR(CDCl3, 300 
MHz) δ 8.26 (d, J = 2.0 Hz, 1H), 7.75 (dd, J = 8.3, 2.0 Hz, 1H), 6.70 (d, J = 8.3 Hz, 
1H), 2.48 (s, 3H); 13C-NMR (CDCl3, 75 MHz) δ: 195.5, 151.2, 140.6, 130.5, 129.4, 
113.3, 82.8, 26.3;  
4-Bromo-3-iodoacetophenone (3.27) 
 
Part I-Preparation of the diazonium salt: To a -10 oC cold suspension 
of 4-acetyl-2-iodoaniline (3.26) (8.45 g, 32.3 mmol) in aqueous 47% HBr 
(77 mL) was dropwise added over 15 min. a solution of NaNO2 (2.65 g, 
38.0 mmol, 1.18 eq.) in water (35 mL). The deep tanned mixture obtained was stirred 
for 10 min. at this temperature, after which the temperature was allowed to increase to 
-5 oC→0 oC and stirring continued for further 1½ h. The obtained mixture was then 
kept at ice bath temperature. 
Br
O
I
 
Part II-Sandmeyer reaction: To a vigorously stirred (purple) mixture of CuBr (5.57 
g, 38.8 mmol, 1.2 eq.) in aqueous 47% HBr (42 mL) at 60 oC was portionwise added 
over 50 min. the above diazonium suspension (caution: significant frothing occurred 
during additions), after which the temperature was increased to 80 oC and stirring 
continued for further 25 min.. The resulting dark mixture was cooled to ice bath 
temperature and partitioned between water (400 mL) and EtOAc (400 mL). The 
aqueous layer was extracted with EtOAc (2 portions of 150 mL) and the combined 
organic layers were washed with aqueous 1 M HCl (300 mL), aqueous saturated 
NaHCO3 (200 mL), aqueous ½ saturated brine (250 mL), dried (MgSO4) and 
concentrated under vacuum to afford a light tan solid residue which was purified by 
flash chromatography (hexane:EtOAc, 1:1 (v:v)). The title compound was obtained as 
a pale yellow solid (9.0 g, 86%). 
 
Rf (hexane:EtOAc, 1:1 (v:v)) 0.55; mp 79-82 oC; 1H-NMR(CDCl3, 300 MHz) δ 8.39 
(d, J = 2.0 Hz, 1H), 7.76 (dd, J = 8.2, 2.0 Hz, 1H), 7.71 (d, J = 8.2 Hz, 1H), 2.57 (s, 
3H); 13C-NMR (CDCl3, 75 MHz) δ 196.0, 140.3, 137.1, 135.7, 133.1, 129.1, 101.9, 
26.8; LRMS (EI) m/z = 324 [M]+; Anal. Calcd. for C8H6BrIO: C, 29.57; H, 1.86. 
Found: C, 29.18; H, 2.01. 
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(E)-Ethyl 3-(4-bromo-3-iodophenyl)but-2-enoate 
(3.28) Br I
CO2Et
Br
I
CO2Et
and
and 
(Z)-Ethyl 3-(4-bromo-3-iodophenyl)but-2-enoate 
(3.28) 
 
Following GP 1, using 4-bromo-3-iodoacetophenone 
(3.27) (7.98 g, 24.6 mmol, 1.0 eq.). Purification by (repeated) flash chromatography 
(hexane: Et2O, 3:1 (v:v)) delivered pure (E)-(3.28) (6.2 g, 64% as a white solid) and 
(Z)-(3.28) (1.7 g, 17% as a yellow oil) isomers. Combined yield: 81%. 
 
For (E)-Ethyl 3-(4-bromo-3-iodophenyl)but-2-enoate (3.28): Rf (hexane: Et2O, 3:1 
(v:v)) 0.51; mp 39-42 oC; 1H-NMR (CDCl3, 300 MHz) δ 7.93 (d, J = 2.2 Hz, 1H), 
7.59 (d, J = 8.3 Hz, 1H), 7.28 (dd, J = 2.2, 8.3 Hz, 1H), 6.08 (q, J = 1.3 Hz, 1H), 4.21 
(q, J = 7.1 Hz, 2H), 2.50 (d, J = 1.3 Hz, 3H), 1.31 (t, J = 7.1 Hz, 2H); 13C-NMR 
(CDCl3, 75 MHz) δ 166.5, 152.8, 142.8, 138.2, 132.8, 130.5, 127.5, 118.6, 101.7, 
60.4, 18.0, 14.6; LRMS (EI) m/z = 394 [M]+; Anal. Calcd. for C12H12BrIO2: C, 36.49; 
H, 3.06. Found: C, 36.63; H, 3.15. 
 
For (Z)-Ethyl 3-(4-bromo-3-iodophenyl)but-2-enoate (3.28): Rf (hexane: Et2O, 3:1 
(v:v)) 0.40; 1H-NMR (CDCl3, 300 MHz) δ 7.68 (d, J = 2.1 Hz, 1H), 7.58 (d, J = 8.2 
Hz, 1H), 7.05 (dd, J = 2.1, 8.2 Hz, 1H), 5.91 (q, J = 1.5 Hz, 1H), 4.03 (q, J = 7.2 Hz, 
2H), 2.13 (d, J = 1.5 Hz, 3H), 1.13 (t, J = 7.2 Hz, 2H); 13C-NMR (CDCl3, 75 MHz) δ 
165.6, 152.7, 141.5, 138.6, 132.3, 129.1, 128.5, 119.1, 100.9, 60.3, 27.1, 14.3; LRMS 
(EI) m/z = 394 [M]+; Anal. Calcd. for C12H12BrIO2: C, 36.49; H, 3.06. Found: C, 
36.63; H, 3.15. 
 
(E)-3-(4-Bromo-3-iodophenyl)but-2-en-1-ol (3.29) Br
I
OH
 
Following GP 2, using (E)-ethyl 3-(4-bromo-3-iodophenyl)but-2-
enoate (3.28) (5.83 g, 14.8 mmol). Purification by flash 
chromatography (hexane:EtOAc, 1:1 (v:v)) afforded  the title 
compound as a white solid (5.0 g, 96%). 
 
Rf (hexane:EtOAc, 1:1 (v:v)) 0.30; mp 62-64 oC; 1H-NMR (CDCl3, 300 MHz) δ 7.81 
(d, J = 2.2 Hz, 1H), 7.47 (d, J = 8.4 Hz, 1H), 7.15 (dd, J = 2.2, 8.4 Hz, 1H), 5.88 (tq, J 
= 1.4, 6.6 Hz, 1H), 4.26-4.30 (m, 2H), 1.94-1.95 (m, 3H); 13C-NMR (CDCl3, 75 
MHz) δ 143.6, 137.8, 135.5, 132.5, 128.4, 128.3, 127.1, 101.5, 60.1, 16.1; LRMS (EI) 
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m/z = 352 [M]+; Anal. Calcd. for C10H10BrIO: C, 34.03; H, 2.86. Found: C, 33.98; H, 
2.72. 
 
General procedure for the MCPBA epoxidation of allylic alcohols to the 
corresponding epoxides (GP 3): 
To an ice cold suspension of (commercial)7.9 MCPBA (1.3 eq.) in CH2Cl2 (0.6 M) was 
dropwise added a solution of the allylic alcohol (1.0 eq.) in CH2Cl2 (0.5 M). The 
suspension thus obtained was stirred at ice bath temperature for 15 min. and then allowed 
to reach room temperature and stirred for further 2½ h, after which it was re-cooled to -5 
oC and filtered through a short pad of Celite. To the filtrate was added Ca(OH)2 and this 
suspension was stirred for 5 min. at -5 oC, after which a small portion of Na2SO4 was 
added and stirring continued for further 5 min. at this temperature. After filtration through 
a short pad of Celite, the solvent was removed under vacuum. The obtained residue was 
usually pure enough so that it can be used directly. Occasionally, this residue was further 
filtered through a short column of demetallated silica gel (fast elution) affording the pure 
epoxide. 
 
(Z)-Methyl 4-(3-(hydroxymethyl)-2-methyloxiran-2-yl)benzoate 
(3.33) 
CO2Me
OH
O
 
Following GP 3, using (Z)-methyl 4-(4-hydroxybut-2-en-2-
yl)benzoate (3.23) (650 mg, 3.2 mmol). The title compound was 
obtained as a viscous yellow oil (663 mg, 93% crude). 
 
Rf (hexane:EtOAc, 1:1 (v:v)) 0.22; 1H-NMR (CDCl3, 300 MHz) δ 7.96-8.02 (m, 2H), 
7.37-7.42 (m, 2H), 3.90 (s, 3H), 3.42 (dd, J = 4.2, 11.6 Hz, 1H), 3.33 (dd, J = 4.2, 6.6 
Hz, 1H), 3.22 (dd, J = 6.6, 11.6 Hz, 1H), 1.67 (s, 3H); 13C-NMR (CDCl3, 75 MHz) δ 
167.0, 144.2, 129.9, 129.7, 126.5, 64.8, 62.9, 61.8, 52.5, 24.5; LRMS (EI) m/z = 222 
[M]+. 
 
General procedure for the Swern oxidation of allylic epoxides to the 
corresponding epoxy-aldehydes (GP 4): 
A solution of oxalyl chloride (2.0 eq.) in CH2Cl2 (0.25 M) at -78 oC was treated 
dropwise with a solution of DMSO (4.0 eq.) in CH2Cl2 (5 M), during which period 
gas evolution was observed. After stirring at this temperature for further 15-20 min. a 
solution of the alcohol (1.0 eq.) in CH2Cl2 (0.2 M) was slowly added. The turbid 
mixture obtained was stirred at -78 oC for 2 h, after which pre-cooled NEt3 (8.0 eq.) 
 
7.9 For acid-sensitive suspected substrates, recrystallized MCPBA was used. 
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was added dropwise, and the resulting mixture was allowed to warm to -30 oC over 1 
h. The mixture obtained was poured at this temperature onto hexane and CH2Cl2 and 
gently shaken with pH 7 phosphate buffer. The layers were separated and the aqueous 
layer extracted with CH2Cl2. The combined organic phases were washed with aqueous 
1 M KHSO4, aqueous 1/3 saturated NaHCO3, brine and dried (Na2SO4). Removal of 
the solvent under vacuum affords a residue that was either used without further 
purification or crudely purified in a short flash chromatography column. 
(Z)-Methyl 4-(3-formyl-2-methyloxiran-2-yl)benzoate 
 
Following GP 4, using (crudely purified) (Z)-methyl 4-(3-
(hydroxymethyl)-2-methyloxiran-2-yl)benzoate (3.33) (663 mg, 3.0 
mmol, 1.0 eq.). Purification by flash chromatography (demetallated 
silica gel; fast elution; hexane:EtOAc, 1:1 (v:v) with 2% Et3N), 
afforded the title compound as a pale yellow oil (343 mg, 52%). 
CO2Me
OO
 
Rf (hexane:EtOAc, 1:1 (v:v)) 0.38; 1H-NMR (CDCl3, 300 MHz) δ 8.73 (dd, J = 0.5, 
5.9 Hz, 1H), 8.00-8.05 (m, 2H), 7.48-7.53 (m, 2H), 3.90 (s, 3H), 3.44 (d, J = 5.9 Hz, 
1H), 1.74 (s, 3H); 13C-NMR (CDCl3, 75 MHz) δ 199.0, 166.6, 142.0, 130.4, 130.2, 
126.5, 64.8, 64.6, 52.5, 24.7. 
 
General procedure for the Wittig reaction of epoxy-aldehydes to the 
corresponding vinyl epoxides (GP 5): 
To an ice cold slurry of methyltriphenylphosphonium bromide (1.5 eq.) in THF (0.15 
M) was dropwise added a solution of KHMDS in toluene (0.5 M, 1.3 eq.). The bright 
yellow suspension obtained was allowed to reach room temperature and stirred for 
further 1½ h, after which it was re-cooled to 0 oC and a solution of the epoxy-
aldehyde (1.0 eq.) in THF (0.45 M) was then added dropwise. The suspension thus 
obtained was allowed to reach room temperature, stirred for 1½ h further, re-cooled to 
ice bath temperature and filtrated through a short Celite pad to afford a tan solution. 
Removal of the solvent under vacuum delivered a tan solid that was triturated with 
Et2O. The combined mother liquors were concentrated under vacuum and the 
obtained residue was filtrated through a short chromatography column (demetallated 
silica gel; fast elution; Et2O). The obtained material was usually used without further 
purification. 
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(Z)-Methyl 4-(2-methyl-3-vinyloxiran-2-yl)benzoate (3.34) 
 
Following GP 5, using (Z)-methyl 4-(3-formyl-2-methyloxiran-2-
yl)benzoate (343 mg, 1.55 mmol). Purification by flash chromatography 
(demetallated silica gel; fast elution; hexane:EtOAc, 1:1 (v:v) with 2% 
Et3N) afforded the title compound as a yellow oil (not completely pure) 
(173 mg, 51%). 
CO2Me
O
 
Rf (hexane:EtOAc, 1:1 (v:v)) 0.54; 1H-NMR (CDCl3, 300 MHz) δ 7.92-7.97 (m, 2H), 
7.34-7.39 (m, 2H), 5.39 (dd, J = 1.8, 15.9 Hz, 1H), 5.12 (dd, J = 1.8, 10.4 Hz, 1H), 
5.02 (ddd, J = 7.9, 10.4, 15.9 Hz, 1H), 3.85 (s, 3H), 3.46 (d, J = 7.9 Hz, 1H), 1.64 (s, 
3H). 
 
General procedure for the Jung rearrangement (GP 6): 
To a -78 oC cold solution of vinyl epoxide (1.0 eq.) in CH2Cl2 (0.07 M) was added 
BF3·Et2O (1.2 eq.) and the resulting solution was stirred at this temperature for 10-15 
min.,7.10 after which it was partitioned between Et2O and 1/3 saturated aqueous NaHCO3. 
The layers were separated and the aqueous phase was extracted with Et2O. The combined 
organic phases were washed with brine, dried (Na2SO4) and concentrated. The obtained 
residue was purified by flash chromatography to afford the pure quaternary aldehydes. 
Methyl 4-(2-methyl-1-oxobut-3-en-2-yl)benzoate (3.35) 
 
Following GP 6, using (Z)-methyl 4-(2-methyl-3-vinyloxiran-2-
yl)benzoate (3.34) (119 mg, 0.55 mmol, 1.0 eq., not entirely pure). 
Purification by flash chromatography (hexane:EtOAc, 1:1 (v:v)) 
delivered the title compound as a yellow oil (56 mg, 47%) that was best 
kept frozen in a benzene matrix under argon. 
CO2Me
CHO
 
Rf (hexane:EtOAc, 1:1 (v:v)) 0.53 (note: Rf values of the starting material and 
product are very similar); 1H-NMR (CDCl3, 300 MHz) δ 9.51 (s, 1H), 7.95-8.00 (m, 
2H), 7.23-7.28 (m, 2H), 6.13 (dd, J = 10.7, 17.6 Hz, 1H), 5.38 (d, J = 10.7 Hz, 1H), 
5.13 (d, J = 17.6 Hz, 1H), 3.85 (s, 3H), 1.49 (s, 3H); 13C-NMR (CDCl3, 75 MHz) δ 
199.0, 166.9, 145.4, 137.9, 130.3, 129.5, 127.8, 118.4, 58.3, 52.4, 20.4; LRMS (EI) 
m/z = 218 [M]+. 
 
7.10 Such long reaction time is probably not required. However, because the Rf values of both the starting 
vinyl epoxide and the rearranged quaternary aldehyde are very similar, the TLC plate typically has to be 
eluted twice which requires the time periods mentioned. 
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rac-(3-(4-Bromophenyl)-3-methyloxiran-2-yl)methanol (3.38) Br
OH
O
 
Following GP 3, using (E)-3-(4-bromophenyl)but-2-en-1-ol (3.25) (1.0 
g, 4.4 mmol). Purification by flash chromatography (short column; 
demetallated silica gel; fast elution; hexane:EtOAc, 1:1 (v:v)) afforded 
the title compound as a white solid (1.0 g, 93%). 
 
For physical data see bellow; HPLC retention times (Rt): for the (2R,3R) enantiomer, 
Rt (OD-H column; hexane:iPrOH, 9:1 (v:v); 0.6 mLmin.-1) = 14.5 min; for the (2S,3S) 
enantiomer, Rt (OD-H column; hexane:iPrOH, 9:1 (v:v); 0.6 mLmin.-1) = 15.9 min. 
 
rac-(3-(4-Bromo-3-iodophenyl)-3-methyloxiran-2-yl)methanol 
(3.39) 
Br
I
OH
O
 
Following GP 3, using (E)-3-(4-bromo-3-iodophenyl)but-2-en-1-ol 
(3.29) (1.0 g, 2.83 mmol). Purification by flash chromatography (short 
column; demetallated silica gel; fast elution; hexane:EtOAc, 1:1 (v:v)) 
afforded the title compound as a white solid (1.1 g, quantitative). 
 
For physical data see bellow; HPLC retention times (Rt): for the (2R,3R) enantiomer, 
Rt (OD-H column; hexane:iPrOH, 97:3 (v/v); 0.6 mLmin.-1) = 51.7 min; for the 
(2S,3S) enantiomer, Rt (OD-H column; hexane:iPrOH, 97:3 (v:v); 0.6 mLmin.-1) = 
57.7 min. 
 
General procedure for the Sharpless-Katsuki asymmetric epoxidation (GP 7): 
To a -25 oC cold suspension of powder 4Å molecular sieves (55 mg per mmol of the 
allylic alcohol) in CH2Cl2 (0.16 M with respect to the allylic alcohol) was dropwise 
added a solution of L-(+)-diethyl tartrate (7.5 mol%) in CH2Cl2 (1.1 M), followed by 
Ti(OiPr)4 (5 mol%) and finally a solution of freshly prepared tBuOOH in toluene (3.8 
M, 2.0 eq.) with 5 min. intervals between additions. After aging for 1½ h at -25 oC, a 
solution of the allylic alcohol (1.0 eq.) in CH2Cl2 (1.29 M) was added dropwise, over 
20 min., and the resulting suspension stirred for further 4 h at this temperature. The 
reaction was quenched at -25 oC by addition of an aqueous 10% NaOH in brine 
solution (0.1 mL per mmol of the allylic alcohol) followed by Et2O (0.6 mL per mmol 
of allylic alcohol). After stirring at -25 oC for 5 min., this suspension was allowed to 
reach 5 oC over 10 min. and then MgSO4 (79.5 mg per mmol of allylic alcohol) and 
Celite (10.5 mg per mmol of the allylic alcohol) were simultaneously added. After 
stirring at room temperature for 10 min., the suspension was filtrated through a short 
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pad of Celite, and the filtrate was concentrated under vacuum to afford a turbid pale 
yellow oil which was then taken up in toluene (2 times) and concentrated under 
vacuum affording the crude epoxide which, if necessary, was further purified by 
recrystallization. 
((2S,3S)-3-(4-Bromophenyl)-3-methyloxiran-2-yl)methanol (3.38) 
 
Following GP 7, using (E)-3-(4-bromophenyl)but-2-en-1-ol (3.25) (5.0 
g, 22.0 mmol). The crude product was obtained as a pale yellow solid 
(4.7 g, 88%, 83% ee). Re-crystallization from hot hexane: Et2O, 2:1 
(v:v) (approximately 500 mL) afforded the title compound as white 
needles (4.1 g, 76%, 96-98% ee). 
Br
OH
O
 
Rf (hexane:EtOAc, 1:1 (v:v); double elution) 0.42; mp 130-132 oC; 1H-NMR (CDCl3, 
300 MHz) δ 7.38-7.42 (m, 2H), 7.13-7.17 (m, 2H), 3.90 (dd, J = 4.4, 12.2 Hz, 1H), 
3.77 (dd, J = 6.4, 12.2 Hz, 1H), 2.98, (dd, J = 4.4, 6.4 Hz, 1H), 1.65 (brs, 1H), 1.61 (s, 
3H); 13C-NMR (CDCl3, 75 MHz) δ 141.3, 131.7, 127.1, 121.8, 66.2, 61.5, 60.6, 17.9; 
LRMS (EI) m/z = 243 [M]+; -9.20 (c 1.8, CHCl[ ]25Dα 3); Anal. Calcd. for C10H11BrO2: 
C, 49.41; H, 4.56. Found: C, 49.30; H, 4.39. 
 
((2S,3S)-3-(4-Bromo-3-iodophenyl)-3-methyloxiran-2-yl) 
methanol (3.39) 
 
Following GP 7, using (E)-3-(4-bromo-3-iodophenyl)but-2-en-1-ol 
(3.29) (2.8 g, 7.93 mmol). The crude product was obtained as white 
solid (2.91 g, quantitative, 92-94% ee) which typically was used 
without further purification. If desired, it can be recrystallized from hot 
hexane: Et2O, 2:1 (v:v) (approximately 300 mL) affording the title compound as 
white needles (2.6 g, 91%, >99% ee). 
Br
I
OH
O
 
Rf (hexane:EtOAc, 1:1 (v:v); double elution) 0.50; mp 59-61 oC; 1H-NMR (CDCl3, 
300 MHz) δ 7.75 (d, J = 2.1 Hz, 1H), 7.50 (d, J = 8.3 Hz, 1H), 7.11 (dd, J = 2.1, 8.3 
Hz, 1H), 3.88 (dd, J = 4.4, 12.2 Hz, 1H), 3.75 (dd, J = 6.3, 12.2 Hz, 1H), 2.96 (dd, J = 
4.4, 6.3, 1H), 1.93 (bs, 1H), 1.59 (s, 3H); 13C-NMR (CDCl3, 75 MHz) δ 143.1, 137.2, 
132.7, 129.0, 126.7, 101.5, 66.1, 61.3, 59.9, 17.7; LRMS (EI) m/z = 368 [M]+; [ ]25Dα -
9.2 (c 2.2, CHCl3); Anal. Calcd. for C10H10BrIO2: C, 32.55; H, 2.73. Found: C, 32.61; 
H, 2.67. 
 111
Part II 7.3 – Experimental Procedure for Chapter 3 (Lyngbyatoxin A) 
 
 
(2R,3S)-3-(4-Bromophenyl)-3-methyloxirane-2-
carbaldehyde 
Br
O
O
Br
O
O
and
and 
rac-3-(4-Bromophenyl)-3-methyloxirane-2-
carbaldehyde 
 
Following GP 4, using (2R,3S)-3-(4-bromophenyl)-3-
methyloxirane-2-carbaldehyde (3.38) (2.1 g, 8.6 mmol). The residue obtained from 
work up was crudely purified via a short chromatography column filtration 
(demetallated silica gel; fast elution; hexane:EtOAc, 1:1 (v:v)) to afford a pale thick 
yellow oil that crystallized upon standing in the cold (2.0g) and was used without 
further purification. 
 
Rf (hexane:EtOAc, 1:1 (v:v)) 0.52; 1H-NMR (CDCl3, 300 MHz) δ 9.55 (d, J = 4.9 Hz, 
1H), 7.46-7.50 (m, 2H), 7.19-7.23 (m, 2H), 3.27 (d, J = 4.9 Hz, 1H), 1.80 (s, 3H); 13C-
NMR (CDCl3, 75 MHz) δ 197.6, 139.4, 132.0, 127.1, 122.7, 66.6, 63.2, 18.1. 
 
(2R,3S)-3-(4-Bromo-3-iodophneyl)-3-methyloxirane-2-
carbaldehyde 
Br
I
O
O
Br
I
O
O
and and 
rac-3-(4-Bromo-3-iodophneyl)-3-methyloxirane-2-
carbaldehyde 
 
Following GP 4, using ((2S,3S)-3-(4-bromo-3-
iodophenyl)-3-methyloxiran-2-yl)methanol (3.39) (3.76 g, 10.19 mmol). The residue 
obtained from work up was crudely purified via a short chromatography column 
filtration (demetallated silica gel; fast elution; hexane:EtOAc, 1:1 (v:v)) to afford a 
pale thick yellow oil that crystallized upon standing in the cold (3.40 g) and was used 
without further purification. 
 
Rf (hexane:EtOAc, 1:1 (v:v)) 0.57; 1H-NMR (CDCl3, 300 MHz) δ 9.64, (d, J = 4.0 
Hz, 1H), 7.96 (d, J = 2.2 Hz, 1H), 7.73 (d, J = 8.3 Hz, 1H), 7.40 (dd, J = 2.2, 8.3 Hz, 
1H), 3.48 (d, J = 4.0, 1H), 1.82 (s, 3H); 13C-NMR (CDCl3, 75 MHz) δ 205.6, 142.2, 
137.5, 132.9, 129.2, 127.3, 101.1, 66.2, 62.0, 16.9; LRMS (EI) m/z = 366 [M]+. 
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(2R,3S)-3-(4-Bromophenyl)-2-methyl-3-vinyloxirane 
(3.40) 
and 
rac-3-(4-Bromo-3-phenyl)-2-methyl-3vinyloxirane (3.40) 
 
Following GP 5 using (2R,3S)-3-(4-bromophenyl)-3-
methyloxirane-2-carbaldehyde (2.0 g crudely purified, 8.3 mmol). The residue 
obtained from work up was crudely purified in a short chromatography column 
(demetallated silica gel; fast elution; Et2O). The yellow oil obtained was used without 
further purification (2.0 g). 
Br
O
Br
O
and
 
Rf (hexane: Et2O, 3:1 (v:v)) 0.57; 1H-NMR (CDCl3, 300 MHz) δ 7.44-7.48 (m, 2H), 
7.21-7.26 (m, 2H), 5.84 (ddd, J = 7.1, 10.4, 17.4 Hz, 1H), 5.50 (d, J = 17.4 Hz, 1H), 
5.42 (d, J = 10.4 Hz, 1H), 3.26 (d, J = 7.1 Hz, 1H), 1.64 (s, 3H);13C-NMR (CDCl3, 75 
MHz) δ 141.6, 132.8, 131.7, 127.1, 121.6, 121.3, 67.1, 62.1, 17.6. 
 
(2R,3S)-3-(4-bromo-3-iodophenyl)-2-methyl-3-vinyl 
oxirane (3.41) 
Br
I
O
Br
I
O
and and 
rac-3-(4-bromo-3-iodophenyl)-2-methyl-3-vinyloxirane 
(3.41) 
 
Following GP 5, using (2R,3S)-3-(4-bromo-3-iodophenyl)-
3-methyloxirane-2-carbaldehyde (3.33 g crudely purified, 9.1 mmol). The residue 
obtained from work up was crudely purified in a short chromatography column 
(demetallated silica gel; fast elution; Et2O). The yellow oil obtained was used without 
further purification (2.97 g). 
 
Rf (hexane: Et2O, 3:1 (v:v)) 0.60; 1H-NMR (CDCl3, 300 MHz) δ 7.84 (d, J = 2.2 Hz, 
1H), 7.57 (d, J = 8.3 Hz, 1H), 7.19 (dd, J = 2.2, 8.3 Hz, 1H), 5.82 (sept., J = 7.0, 10.5, 
17.3 Hz, 1H), 5.51 (ddd, J = 0.9, 1.4, 17.3 Hz, 1H), 5.44 (ddd, J = 0.8, 1.4, 10.5 Hz, 
1H), 3.24 (d, J = 7.0 Hz, 1H), 1.62 (s, 3H); 13C-NMR (CDCl3, 75 MHz) δ 143.4, 
137.2, 133.8, 132.7, 132.5, 126.7, 121.7, 121.7, 101.5, 67.0, 61.3, 17.5; LRMS (EI) 
m/z =364 [M]+. 
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(R)-2-(4-Bromophenyl)-2-methylbut-3-enal (3.42) 
and  
rac-2-(4-Bromophenyl)-2-methylbut-3-enal (3.42) 
 
Following GP 6, using (2R,3S)-3-(4-bromophenyl)-2-
methyl-3-vinyloxirane (3.40) (2.0 g crudely purified, 
8.3 mmol). Purification by flash chromatography (hexane: Et2O, 5:1 (v:v)) delivered 
the title compound as a pale yellow oil (1.19 g, 58% based on allylic alcohol (3.38)) 
that was best kept frozen in a benzene matrix under argon. 
Br
OHC
Br
OHC
and
 
Rf (hexane: Et2O, 3:1 (v:v)) 0.52; 1H-NMR (CDCl3, 300 MHz) δ 9.54 (s, 1H), 7.48-
7.53 (m, 2H), 7.09-7.14 (m, 2H), 6.16 (dd, J = 10.8, 17.6 Hz, 1H), 5.43 (d, J = 10.8 
Hz, 1H), 5.18 (d, J = 17.6 Hz, 1H), 1.52 (s, 3H); 13C-NMR (CDCl3, 75 MHz) δ 199.0, 
139.2, 138.0, 132.2, 129.5, 121.9, 118.2, 57.7, 20.4; [ ]25Dα +47.4 (c 2.0, CHCl3); Anal. 
Calcd. for C11H11BrO: C, 55.25; H, 4.64. Found: C, 55.25; H, 4.50. 
 
(R)-2-(4-bromo-3-iodophenyl)-2-methylbut-3-enal 
(3.43) 
Br
I
OHC
Br
I
OHC
and and 
rac-2-(4-bromo-3-iodophenyl)-2-methylbut-3-enal 
(3.43) 
 
Following GP 6, using (2R,3S)-3(4-bromo-3-iodophenyl)-2-methyl-3-vinyloxirane 
(3.41) (2.81 g crudely purified, 7.70 mmol, 1.0 eq.). Purification by flash 
chromatography (hexane: Et2O, 3:1 (v:v)) delivered the title compound as a pale 
yellow oil (1.9 g, 52% based on allylic alcohol (3.39)) that was best kept frozen in a 
benzene matrix under argon. 
 
Rf (hexane: Et2O, 3:1 (v:v)) 0.47; 1H-NMR (CDCl3, 300 MHz) δ 9.52, (s, 1H), 7.71 
(d, J = 2.2 Hz, 1H), 7.60 (d, J = 8.3 Hz, 1H), 7.07 (ddd, J = 0.4, 2.2, 8.3, Hz, 1H), 
6.12 (ddd, J = 0.40, 10.7, 17.6 Hz, 1H), 5.46 (d, J = 10.7, 1H), 5.20 (d, J = 17.6, 1H), 
1.51 (s, 3H); 13C-NMR (CDCl3, 75 MHz) δ 198.5 141.1, 139.5, 137.4, 133.1, 129.2, 
129.0, 118.7, 102.2, 57.4, 20.4; LRMS (EI) m/z = 337 [M-C2H3]+; +27.8 (c 1.3, 
CHCl
[ ]25Dα
3). 
 
 
 
 114
Part I Chapter 7: Experimental 
 
 
(R,R)-(2-Ethoxycarbonylaminocyclohexyl)carbamic acid ethyl 
ester 
NHCO2Et
NHCO2Et  
Following a literature procedure,7.11 to an ice cold solution of 
(R,R)-cyclohexane-1,2-diamine (2.8 g, 24.5 mmol, 1.0 eq.) in toluene (41 mL), were 
simultaneously added freshly distilled ethyl chloroformate (5.78 mL, 60.4 mmol, 2.4 
eq.) and a solution of NaOH (62.4 mmol 2.5 eq.) in water (2.6 mL) through two 
syringes. The addition rate was such as to keep the internal temperature bellow 10 oC. 
The thick suspension thus obtained was allowed to reach room temperature and 
stirred for 4 h further, after which the heavy precipitate was filtrated off and rinsed 
with CH2Cl2 (15 mL). The filtrate was dried (Na2SO4) and the solvent removed under 
vacuum to afford a light pinkish solid residue, which was recrystallized from CH2Cl2 
(approximately 90 mL) to which a minimum amount of pentane was carefully added 
(8-10 Pasteur pipettes). The title compound was obtained as a white solid (5.3 g, 
84%). 
 
Rf (hexane:EtOAc, 1:1 (v:v)) 0.35; mp 165-167 oC (lit. 166-167 oC); 1H-NMR 
(CDCl3, 300 MHz) δ 4.99 (brs, 2H), 4.06 (q, J = 7.0 Hz, 4H), 3.26-3.38 (m, 2H), 
1.98-2.06 (m, 2H), 1.67-1.75 (m, 2H), 1.16-1.26 (m, 10H); 13C-NMR (CDCl3, 75 
MHz) δ 158.4, 62.1, 56.6, 34.2, 26.1, 15.9; [ ]25Dα +45.4 (c 1.0, CHCl3) (lit. [ ] +45.6 
(c 1.05, CHCl
25
Dα
3). 
 
(R,R)-1,2-N,N´-(dimethyl)aminocyclohexane 
 
Following a literature procedure,7.11 to a stirred ice cold suspension 
of LiAlH4 (3.1 g, 82.0 mmol, 4.0 eq.) in THF (108 mL) was 
portionwise added (R,R)-(2-ethoxycarbonylaminocyclohexyl)carbamic acid ethyl 
ester (5.3 g, 20.5 mmol, 1.0 eq.). The suspension was stirred at ice bath temperature 
for 15 min., refluxed for 36 h, after which it was re-cooled to 0 oC and 
ethylenediamine (7.1 mL) was slowly added (gas evolution) followed by an aqueous 
15% NaOH solution (3.4 mL) and finally water (7.0 mL), with 3 min intervals 
between additions. The obtained suspension was stirred at room temperature for 5 
min., filtered through a pad of Celite and the precipitate rinsed with Et2O (120 mL). 
The filtrate was dried (Na2SO4), concentrated under vacuum, affording a pale yellow 
NHCH3
NHCH3
                                                 
7.11 (a) Alexakis, A.; Mutti, S.; Mangeney, P. J. Org. Chem. 1992, 57, 1224. (b) Alexakis, A.; Chauvin, A.-
S.; Stouvenel, R.; Vrancken, E.; Mutti, S.; Mangeney, P. Tetrahedron: Asymmetry 2001, 12, 1171. (c) 
Alexakis, A.; Mutti, S.; Normant, J. F.; Mangeney, P. Tetrahedron: Asymmetry 1990, 1, 437. 
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oil residue which was purified by bulb-to-bulb distillation at reduced pressure (20-22 
mmHg; oven temperature: 90-95 oC). The title compound was obtained as a colorless 
oil, which crystallized upon cooling (2.3 g, 80%). 
 
Rf (iPrOH: aqueous 25% ammonia, 7:3 (v:v)) 0.55; 1H-NMR (CDCl3, 300 MHz) δ 
2.37 (s, 6H), 1.98-2.11 (m, 4H), 1.67-1.73 (m, 2H), 1.56 (brs, 2H), 1.16-1.24 (m, 2H), 
0.87-0.98 (m, 2H); 13C-NMR (CDCl3, 75 MHz) δ 63.5, 33.9, 31.0, 25.2; -144.8 
(c 4.45, CHCl
[ ]25Dα
3) (lit. [ ] -145.7 (c 4.47, CHCl25Dα 3)).  
 
Alexis reagent (3.44) 
 
Following a literature procedure,7.11 (R,R)-1,2-N,N´-
(dimethyl)aminocyclohexane (1.5 g, 10.5 mmol, 1.0 eq.) and 
hexamethylphosphorous triamide (2.39 mL, 13.2 mmol, 1.25 eq.) 
were heated neat under argon at 150 oC for 96 h (gas evolution) during which period a 
black precipitate formed. A stream of argon was passed occasionally through the 
reaction flask to remove the dimethyamine being formed. The obtained tanned 
suspension was allowed to reach room temperature under argon without stirring and 
the supernatant solution was carefully decanted off and bulb-to-bulb distilled under 
reduced pressure (0.5-0.7 mm Hg; oven temperature: 80-85 oC) delivering the desired 
diazaphospholidine (3.44) as a colorless oil (1.8 g, 80%) which was stored as a 0.2 M 
solution in benzene and kept under argon in the refrigerator. 
N
P
N
N
Me
Me
Me
Me
 
31P-NMR (C6D6, 202 MHz) δ 123.15; 1H-NMR (C6D6, 300 MHz) δ 2.11-2.66 (m, 
14H), 1.78-1.88 (m, 2H), 1.47-1.61 (m, 2H), 0.78-1.15 (m, 4H); 13C-NMR (C6D6, 75 
MHz) δ 68.8 (d, JCP = 3.5 Hz), 66.7 (d, JCP = 9.1 Hz), 38.0 (d, JCP =17.6 Hz), 33.9 (s), 
33.4 (s), 29.9, 29.6, 24.6, 24.2; [ ]25Dα -100.1o (c 2.7, C6H6) (lit. [ ]25Dα -100.4o (c 2.7, 
C6H6). 
 
ra
(R)-2-(4-Bromophenyl)-2-methylbut-3-en-1-ol (3.45) Br Br
HO HO
and
and 
c-2-(4-Bromo-3-iodophenyl)-2-methylbut-3-en-1-ol 
(3.45) 
 
A solution of (R)-2-(4-bromophenyl)-2-methylbut-3-
enal (3.42) (1.28 g, 5.35 mmol, 1.0 eq.) in MeOH (62 mL) at 0 oC was treated with 
NaBH4 (181 mg, 4.76 mmol, 0.9 eq.). After stirring for 15 min. at ice bath 
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temperature, the solution was allowed to warm to room temperature and stirred for 
further 2 h, at which time it was concentrated to ½ of its initial volume and partitioned 
between water (15 mL) and Et2O (120 mL). The aqueous layer was extracted with 
Et2O (20 mL) and EtOAc (20 mL) and the combined organic phases were washed 
with brine (10 mL), dried (NaSO4) and concentrated under vacuum to afford a yellow 
oil residue which typically was used without further purification. For analytical 
purposes, the crude product was purified by flash chromatography on silica gel 
(hexane:EtOAc, 1:1 (v:v)) (1.0 g, 78%). 
 
Rf (hexane:EtOAc, 1:1 (v:v)) 0.53; 1H-NMR (CDCl3, 300 MHz) δ 7.43-7.47 (m, 2H), 
7.20-7.25 (m, 2H), 6.02 (dd, J = 10.8, 17.6 Hz, 1H), 5.28 (dd, J = 0.9, 10.8 Hz, 1H), 
5.13 (dd, J = 0.9, 17.6 Hz, 1H), 3.76 (s, 2H), 1.40 (s, 3H); 13C-NMR (CDCl3, 75 
MHz) δ 143.8, 143.2, 131.7, 129.1, 120.7, 115.4, 69.9, 47.0, 22.9; LRMS (EI) m/z = 
242 [M]+. 
(R)-2-(4-Bromo-3-iodophenyl)-2-methylbut-3-
en-1-ol (3.46) 
Br
I
Br
I
HO HO
and and 
rac-2-(4-Bromo-3-iodophenyl)-2-methylbut-3-
en-1-ol (3.46) 
 
A solution of (R)-2-(4-bromo-3-iodophenyl)-2-methylbut-3-enal (3.43) (1.18 g, 3.23 
mmol, 1.0 eq.) in MeOH (35 mL) at 0 oC was treated with NaBH4 (114 mg, 3.0 mmol, 
0.9 eq.). After stirring for 15 min. at ice bath temperature, the solution was allowed to 
warm to room temperature and stirred for further 2 h, at which time it was 
concentrated to ½ of its initial volume and partitioned between water (15 mL) and 
Et2O (50 mL). The aqueous layer was extracted with Et2O (20 mL) and EtOAc (20 
mL) and the combined organic phases were washed with brine (10 mL), dried 
(NaSO4) and concentrated under vacuum to afford a yellow oil residue which 
typically was used without further purification. For analytical purposes the crude 
product was purified by flash chromatography on silica gel (hexane:EtOAc, 1:1 (v:v)) 
(960 mg, 81%). 
 
Rf (hexane:EtOAc, 1:1 (v:v)) 0.52; 1H-NMR (CDCl3, 300 MHz) δ 7.81 (d, J = 2.3 Hz, 
1H), 7.55 (d, J = 8.4 Hz, 1H), 7.20 (dd, J = 2.3, 8.4 Hz, 1H), 5.98 (dd, J = 10.8, 17.6 
Hz, 1H), 5.30 (dd, J = 0.9, 10.8, 2H), 5.14 (dd, J = 0.9, 17.6, 1H), 3.74 (s, 2H), 1.38 
(s, 3H); 13C-NMR (CDCl3, 75 MHz) δ 145.9, 142.6, 139.3, 132.6, 128.7, 127.9, 115.9, 
101.7, 69.7, 46.8, 22.9; LRMS (EI) m/z = 368 [M]+. 
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Determination of the ee of 
alcohol (3.45) using the Alexis 
reagent (3.44) 
 
To the Alexis reagent (3.44) 
(0.58 mL of a 0.2 M solution in 
benzene, 0.12 mmol, 1.1 eq.) was added a solution of (R)-2-(4-bromophenyl)-2-
methylbut-3-en-1-ol (3.45) (25 mg, 0.10 mmol, 1.0 eq.) in benzene (0.2 mL). After 
stirring at room temperature under argon for 15 h, the resulting solution was then 
transferred into an NMR tube and C6D6 (100 µl) was added for locking. 
N
P
N
Me
Me
Br
O
N
P
N
Me
Me
Br
Oand
 
For rac-(3.47): 31P-NMR (C6D6, 202 MHz) δ 138.9 and 138.7 (equal intensities). 
 
For (3.47): 31P-NMR (C6D6, 202 MHz) δ 138.7. 
Determination the ee of 
alcohol (3.46) using the 
Alexis reagent (3.44) 
 
To the Alexis reagent (3.44) 
(0.10 mL of a 0.2 M solution 
in benzene, 0.02 mmol, 1.1 eq.) was added a solution of (R)-2-(4-bromo-3-
iodophenyl)-2-methylbut-3-en-1-ol (3.46) (7.0 mg, 0.018 mmol, 1.0 eq.) in benzene 
(0.2 mL) and the resulting solution was left stirring at room temperature under argon 
over 15 h. After stirring at room temperature under argon for 15 h, the resulting 
solution was then transferred into an NMR tube and C6D6 (100 µl) was added for 
locking. 
N
P
N
Me
Me
Br
O
N
P
N
Me
Me
Br
Oand
I I
 
For rac-(3.48): 31P-NMR (C6D6, 202 MHz) δ 139.0 and 138.8 (equal intensities). 
 
For (3.48): 31P-NMR (C6D6, 202 MHz) δ 138.8. 
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(R)-(2-(4-Bromophenyl)-2methylbut-3-enyloxy)(tert-butyl) 
dimethylsilane (3.49) 
 
To a solution of TBDMSCl (1.11 g, 7.34 mmol, 1.5 eq.) and 
imidazole (900 mg, 13.2 mmol, 2.7 eq.) in DMF (5.3 mL) was 
added a solution of (crude) (R)-2-(4-bromophenyl)-2-methylbut-
3-en-1-ol (3.45) (1.18 g, 4.9 mmol, 1.0 eq.) in DMF (7.5 mL). After stirring at room 
temperature overnight, the resulting solution was partitioned between aqueous 1 M 
HCl (75 mL) and Et2O (150 mL). The aqueous layer was extracted with Et2O (2 
portions of 30 mL) and the combined organic phases were washed with ½ saturated 
NaHCO3 (100 mL), brine (50 mL) and dried (Na2SO4). Removal of the solvent under 
vacuum afforded a yellow oil residue that was purified by flash chromatography on 
silica gel (hexane:Et2O, 5:1 (v:v)). The title compound was obtained as a pale yellow 
oil (1.6 g, 79% based on quaternary aldehyde (3.42)). 
Br
TBDMSO
 
Rf (hexane:EtOAc, 1:1 (v:v)) 0.80; 1H-NMR (CDCl3, 300 MHz) δ 7.43-7.48 (m, 2H), 
7.26-7.31 (m, 2H), 6.10 (dd, J = 10.9, 17.7 Hz, 1H), 5.20 (dd, J = 1.2, 10.9 Hz, 1H), 
5.10 (dd, J = 1.2, 17.7 Hz, 1H), 3.76 (d, J = 12.3 Hz, 1H), 3.72 (d, J = 12.3 Hz, 1H), 
1.42, (s, 3H), 0.88 (s, 9H), 0.02 (s, 3H), 0.00 (s, 3H); 13C-NMR (CDCl3, 75 MHz) δ 
150.3, 149.5, 136.4, 134.8, 125.5, 119.2, 76.0, 52.1, 31.4, 28.2, 23.8, 0.03; [ ] -9.95 
(c 2.0, CHCl
25
Dα
3). 
 
(R)-tert-Butyl 4-(1-(tert-butyldimethylsilyloxy)-2-methylbut-
3-en-2-yl)phenylcarbamate (3.50) 
 
A reddish suspension of (R)-(2-(4-bromophenyl)-2-methylbut-
3-enyloxy)(tert-butyl)dimethylsilane (3.49) (975 mg, 2.74 
mmol, 1.0 eq.), Pd2(dba)3.CHCl3 complex (117 mg, 0.11 mmol, 
4 mol%), tBu3P (56 mg, 0.27 mmol, 9.8 mol%), freshly prepared NaOPh (491 mg, 
4.23 mmol, 1.5 eq.) (for the preparation of NaOPh see section 7.2) and tert-
butylcarbamate (495 mg, 4.23 mmol, 1.5 eq.) in toluene (8.5 mL) was stirred at 100 
oC for ½ h, during which period a tan color developed. The solvent was then removed 
under vacuum and the dark tan residue obtained was purified by flash 
chromatography on silica gel (hexane: Et2O, 3:1 (v:v) with 0.5% Et3N) delivering the 
title compound as a yellow oil (880 mg, 82%). 
NHBoc
TBDMSO
 
Rf (hexane:Et2O, 3:1 (v:v)) 0.53; 1H-NMR (CDCl3, 300 MHz) δ 7.32 (s, 4H), 6.48 
(brs, 1H), 6.10 (dd, J = 10.8, 17.6 Hz, 1H), 5.16 (dd, J = 1.2, 10.8 Hz, 1H), 5.08 (dd, J 
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= 1.2, 17.6 Hz, 1H), 3.76 (d, J = 9.6 Hz, 1H), 3.70 (d, J = 9.6 Hz, 1H), 1.56 (s, 9H), 
1.41 (s, 3H), 0.89 (s, 9H), 0.01 (s, 3H), 0.00 (s, 3H); 13C-NMR (CDCl3, 75 MHz) δ 
158.4, 150.1, 145.8, 141.8, 133.4, 123.6, 118.7, 85.9, 76.1, 51.8, 33.9, 31.4, 28.2, 
23.8, 0.0; LRMS (EI) m/z = 391 [M]+; [ ]25Dα -10.2 (c 2.0, CHCl3); Anal. Calcd. for 
C22H37NO3Si: C, 67.47; H, 9.52; N, 3.58. Found: C, 67.74; H, 9.54; N, 3.30. 
 
(R)-tert-Butyl 4-(2-((tert-butyl 
dimethylsilyloxy)methyl)but-3-en-
2-yl)-2-formylphenylcarbamate 
(3.51) 
NHBoc
TBDMSO
CHO
NHBoc
O
CHO
Si
Me
OHC
tBu
and
and 
tert-Butyl 4-((R)-2-(tert-
butyl(methyl (2-
oxoethyl)silyloxy)but-3-en-2-yl)-2-
formylphenylcarbamate (3.55) 
 
To a solution of (R)-tert-butyl 4-(1-(tert-butyldimethylsilyloxy)-2-methylbut-3-en-2-
yl)phenylcarbamate (3.50) (663 mg, 1.69 mmol, 1.0 eq.) in Et2O (5.1 mL) at -78 oC 
was dropwise added, over 5 min., a solution of tBuLi in pentane (1.7 M, 5.6 mL, 9.5 
mmol, 5.5 eq.) The dark mixture obtained was stirred at -78 oC for 15 min., after 
which the temperature was increase to -25 oC (a cooling bath at this temperature was 
inserted) and stirring continued for 4 h further, during which period the temperature 
was slowly allowed to rise to -15 oC. The mixture was then re-cooled to -78 oC and 
DMF (1.57 mL, 20.3 mmol, 12 eq.) was added in a dropwise manner. After stirring at 
-78 oC for 25 min., the temperature was increase to -25 oC (a cooling bath at this 
temperature was inserted) stirring continued for 2 h further, during which period the 
temperature was allowed to slowly reach -10 oC. The turbid mixture obtained was 
partitioned between a solution of aqueous 5% HCl:½ brine (1:1 (v:v)) (50 mL) and 
Et2O (90 mL). The aqueous layer was extracted with Et2O (2 portions of 30 mL), the 
combined organic layers were dried (MgSO4) and concentrated under vacuum to 
afford a yellowish oil residue. Purification by flash chromatography on silica gel 
(hexane: Et2O, 3:1 (v:v)) delivered (R)-tert-butyl 4-(2-((tert-butyl 
dimethylsilyloxy)methyl)but-3-en-2-yl)-2-formylphenylcarbamate (3.51) as a viscous 
yellow oil (418 mg, 59%) and tert-butyl 4-((R)-2-(tert-butyl (methyl) (2-
oxoethyl)silyloxy)but-3-en-2-yl)-2-formylphenylcarbamate (3.55) as a viscous yellow 
oil (166 mg, 22%). 
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For (R)-tert-butyl 4-(2-((tert-butyl dimethylsilyloxy)methyl)but-3-en-2-yl)-2-
formylphenylcarbamate (3.51): Rf (hexane: Et2O, 3:1 (v:v)) 0.63; 1H-NMR (CDCl3, 
300 MHz) δ 10.36 (brs, 1H), 9.91 (s, 1H), 8.40 (d, J = 8.8 Hz, 1H), 7.66 (d, J = 2.2 
Hz, 1H), 7.61 (dd, J = 2.2, 8.8 Hz, 1H), 6.10 (dd, J = 10.9, 17.7 Hz, 1H), 5.22 (d, J = 
10.9 Hz, 1H), 5.10 (d, J = 17.7 Hz, 1H), 3.76 (s, 2H), 1.57 (s, 9H), 1.43 (s, 3H), 0.87 
(s, 9H), 0.01 (s, 3H), 0.00 (s, 3H); 13C-NMR (CDCl3, 75 MHz) δ 200.9, 158.6, 149.3, 
145.3, 144.5, 140.8, 140.7, 126.4, 123.4, 119.5, 86.4, 75.8, 51.7, 33.9, 31.4, 28.3, 
23.8, 0.0. LRMS (EI) m/z = 419 [M+]; [ ]25Dα -11.9 (c 2.3, CHCl3); Anal. Calcd. for 
C23H37NO4Si: C, 65.83; H, 8.89; N, 3.34. Found: C, 65.99; H, 8.62; N, 3.12. 
 
For tert-butyl 4-((R)-2-(tert-butyl (methyl) (2-oxoethyl)silyloxy)but-3-en-2-yl)-2-
formylphenylcarbamate (3.55): Rf (hexane: Et2O, 3:1 (v:v)) 0.22; 1H-NMR (CDCl3, 
300 MHz) δ 10.22 (s, 1H), 9.78 (s, 1H), (9.54 (t, J = 4.3 Hz, corresponding to one of 
the diastereomers, partial overlap with t at δ = 9.52 ppm) and 9.52 (t, J = 4.3 Hz, 
corresponding to the other diastereomer, partial overlap with t at δ = 9.54 ppm), 1H), 
8.27 (d, J = 8.9 Hz, 1H), 7.48 (d, J = 2.3 Hz, 1H), 7.44 (dd, J = 2.3, 8.9 Hz, 1H), 5.93 
(dd, J = 10.8, 17.6 Hz, 1H), (4.97 (dd, J = 1.1, 10.8 Hz, corresponding to one of the 
diastereomers, partial overlap with dd at δ = 4.96 ppm) and 4.96 (dd, J = 1.1, 10.8 Hz, 
corresponding the other diastereomers, partial overlap with dd at δ = 4.97 ppm), 1H), 
(5.11 (dd, J = 1.1, 17.6 Hz, corresponding to one of the diastereomers, partial overlap 
with dd at δ = 5.10 ppm) and 5.10 (dd, J = 1.1, 17.6 Hz, corresponding to the other 
diastereomer, partial overlap with dd at δ = 5.11 ppm), 1H), (3.70 (d, J = 9.7 Hz, 
corresponding to one of the diastereomers, partial overlap with d at δ = 3.69 ppm) and 
3.69 (d, J = 9.7 Hz, corresponding to the other diastereomers, partial overlap with d at 
δ = 3.70 ppm), 1H), (3.68 (d, J = 9.7 Hz, corresponding to one of the diastereomers, 
partial overlap with d at δ = 3.67 ppm) and 3.67 (d, J = 9.7 Hz, corresponding to the 
other diastereomers, partial overlap with d at δ = 3.68 ppm), 1H), (2.26 (dd, J = 4.3, 
10.5 Hz, corresponding to one of the diastereomers, partial overlap with dd at δ = 2.25 
ppm) and 2.25 (dd, J = 4.3, 10.5 Hz, corresponding to the other diastereomers, partial 
overlap with dd at δ = 2.26 ppm), 1H), (2.14 (dd, J = 4.3, 10.5 Hz, corresponding to 
one of the diastereomers, partial overlap with dd at δ = 2.12 ppm) and 2.12 (dd, J = 
4.3, 10.5 Hz, corresponding to the other diastereomer, partial overlap with dd at δ = 
2.14 ppm), 1H), 1.43 (s, 9H), (0.77 (s) and 0.76 (s), 1H), (0.01 (s) and 0.00 (s), 3H); 
13C-NMR (CDCl3, 75 MHz) δ 200.1, 195.5, 153.2, 143.4, 140.2, 138.5, 135.2, 135.1, 
121.1, 118.2, 114.6, 81.1, 71.1, 46.3, 36.8, 28.5, 25.8, 22.8, 19.2, -6.3; LRMS (EI) m/z 
= 447 [M]+; Anal. Calcd. for C24H37NO5Si: C, 64.39; H, 8.33; N, 3.13. Found: C, 
64.13; H, 8.03; N, 2.95. 
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2-Aminobenzyl alcohol (3.60) 
 
Following a literature procedure,7.12 a one-liter three-necked-flask 
was equipped with an efficient magnetic stirrer bar, a solid Soxhlet 
extractor and an efficient reflux condenser, with the extractor inserted between the 
flask and the reflux condenser. A suspension of LiAlH4 (10.0 g, 0.26 mol, 2.35 eq.) in 
Et2O (620 mL) was placed in the flask and anthranilic acid (15.4 g, 0.12 mol, 1.0 eq.) 
was placed in the extractor thimble. The suspension was refluxed until all the 
anthranilic acid has been transferred to the reaction flask (6½ h) (caution: the first 
discharges from the extractor into the reaction flask proceed with substantial gas 
evolution). The obtained suspension was then cooled to ice bath temperature and 
excess of hydride was decomposed by slow addition of iced water (10 mL), followed 
by aqueous 15% NaOH (10 mL) and finally water (30 mL). After stirring at 0 oC for 
15 min., the granular suspension obtained was filtered and the filtrate was washed 
with an aqueous 10% NaOH solution (200 mL). The resulting aqueous layer was 
extracted with Et2O (2 portions of 100 mL); the combined organic phases were 
washed with brine (50 mL) and dried (Na2SO4). Removal of the solvent under 
vacuum delivered the title compound as a pale yellow solid (12.2 g, 88%) which was 
used without further purification. 
NH2
OH
 
Rf (hexane:EtOAc, 1:1 (v:v)) 0.22; mp 81-83 oC (lit.: 82 oC); 1H-NMR (CDCl3, 300 
MHz) δ 7.14 (´t´d, J = 1.6, 7.7, 7.7 Hz, 1H), 7.07 (dd, J = 1.6, 7.9 Hz, 1H), 6.70-6-76 
(m, 2H), 4.67 (s, 2H), 3.30 (brs, 3H); 13C-NMR (CDCl3, 75 MHz) δ 146.1, 129.6, 
129.4, 125.1, 118.5, 116.3, 64.5. 
 
tert-Butyl 2-(hydroxymethyl)phenylcarbamate (3.61a) 
 
Following a literature procedure,7.13 a solution of 2-aminobenzyl 
alcohol (3.60) (2.0 g, 16.3 mmol, 1.0 eq.) and Boc2O (5.3 g, 24.3 
mmol, 1.5 eq.) in THF (45 mL) was stirred at room temperature for 62 h, after which 
the solvent was removed under vacuum affording a deep tanned oil residue. 
Purification by flash chromatography on silica gel (hexane: Et2O, 1:1 (v:v)) afforded 
the title compound as a yellow oil (5.6 g, quantitative), which was used without 
further purification. 
NHBoc
OH
 
 
7.12 Nystrom, R. F.; Brown, W. G. J. Am. Chem. Soc. 1947, 69, 2548. 
7.13 Nugent, B. M.; Williams, A. L.; Prabhakaran, E. N.; Johnston, J. N. Tetrahedron 2003, 59, 8877. 
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1H-NMR (CDCl3, 300 MHz) δ 7.85 (d, J = 8.1 Hz, 1H), 7.72 (brs, 1H), 7.29 (ddd, J = 
8.7, 8.7, 1.3 Hz, 1H), 7.13 (dd, J = 7.5, 1.2 Hz, 1H), 7.00 (ddd, J = 7.4, 7.4, 0.8 Hz, 
1H), 4.61 (d, J = 2.8 Hz, 2H), 2.90 (brs, 1H), 1.52 (s, 9H); 13C-NMR (CDCl3, 75 
MHz) δ 153.8, 138.1, 129.5, 129.1, 123.4, 121.4, 80.7, 64.3, 28.6. 
N-(2-(Hydroxymethyl)phenyl)-4-methylbenzenesulfonamide 
(3.61b) 
NHTs
OH
 
Following a literature procedure,7.14 a solution of TsCl (9.65 g, 50.6 
mmol, 1.1 eq.) in CHCl3 (47 mL) was dropwise added over 40 min. to a solution of 2-
aminobenzyl alcohol (3.60) (5.61 g, 45.6 mmol, 1.0 eq.) and pyridine (4.4 mL, 54.7 
mmol, 1.2 eq.) in CHCl3 (168 mL) at room temperature. The deep yellow solution 
obtained was stirred at room temperature overnight, after which it was concentrated 
under vacuum to a golden thick oil which was then partitioned between EtOAc (100 
mL) and aqueous saturated NH4Cl (80 mL). The aqueous layer was extracted with 
EtOAc (50 mL) and the combined organic phases were washed with brine (30 mL) 
and dried (Na2SO4). Removal of the solvent under vacuum afforded the title 
compound as a beige solid (11.8 g, 93%) which was used without further purification. 
 
Rf (hexane:EtOAc, 1:1 (v:v)) 0.35; mp 143-146 oC; 1H-NMR (CDCl3, 300 MHz) δ 
7.90 (brs, 1H), 7.61-7.66 (m, 2H), 7.43 (d, J = 7.9 Hz, 1H), 7.19-7.28 (m, 3H), 7.07-
7.09 (m, 2H), 4.38 (s, 2H), 2.38 (s, 3H), 2.08 (brs, 1H); 13C-NMR (CDCl3, 75 MHz) δ 
143.8, 137.1, 136.6, 132.3, 129.7, 129.0, 128.9, 127.1, 125.3, 123.4, 63.6, 21.6; Anal. 
Calcd. for C14H15NO3S: C, 60.63; H, 5.45; N, 5.05. Found: C, 60.35; H, 5.61; N, 4.82. 
N-(2-(Hydroxymethyl)phenyl)benzamide (3.61c) 
 
A solution of BzCl (1.0 mL, 8.9 mmol, 1.1 eq.) in CHCl3 (9 mL) was 
dropwise added over 10 min. to an ice cold solution of 2-
aminobenzyl alcohol (3.60) (1.0 g, 8.1 mmol, 1.0 eq.) and pyridine (0.78 mL, 9.7 
mmol, 1.2 eq.) in CHCl3 (40 mL). The obtained solution was stirred at room 
temperature for 20 h after which it was washed with aqueous 1 M HCl (2 portions of 
50 mL), aqueous ½ saturated NaHCO3 (50 mL), ½ brine (50 mL) and dried (Na2SO4). 
Removal of the solvent under vacuum afforded the title compound as a tanned solid 
(1.84 g, 91%) which was used without further purification. 
NHBz
OH
 
 
7.14 Consonni, R.; croce, P. D.; Ferraccioli, La Rosa, C. J. Chem. Soc., Perkin Trans. 1, 1996. 
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Rf (hexane:EtOAc, 1:1 (v:v)) 0.28; 1H-NMR (CDCl3, 300 MHz) δ 9.67 (s, 1H), 8.24 
(d, J = 8.1 Hz, 1H), 7.88-7.93 (m, 2H), 7.50-7.57 (m, 1H), 7.42-7.49 (m, 2H), 7.34 
(´t´d, J = 1.7, 7.6, 8.1 Hz, 1H), 7.16 (dd, J = 1.7, 7.6 Hz, 1H), 7.06 (´t´d, J = 1.1, 7.6, 
7.6 Hz), 4.76 (s, 2H), 0.73 (brs, 1H); 13C-NMR (CDCl3, 75 MHz) δ 165.8, 138.1, 
134.8, 132.1, 129.6, 129.4, 129.0, 128.9, 127.3, 124.4, 122.4, 65.0; LRMS (EI) m/z = 
227 [M]+. 
 
General procedure for the benzylic oxidation of N-protected 2-amino benzylic 
alcohols to the corresponding aldehydes with MnO2 (GP 8): 
A suspension of the benzylic alcohol (1.0 eq.) and MnO2 (4-5 eq.) (for the preparation 
of MnO2 see Section 7.2) in CH2Cl2 (0.2 M in the benzylic alcohol) was refluxed 
under argon until TLC showed complete disappearance of starting material (typically 
20-35 h), after which it was allowed to reach room temperature, diluted with 
Et2O:CH2Cl2, 1:1 (v:v), stirred for 10 min. and filtrated through a pad of Celite. The 
filtrate was concentrated under vacuum, affording the crude aldehyde which was used 
without further purification. 
tert-Butyl 2-formylphenylcarbamate 
 
Following GP 8, using tert-butyl 2-(hydroxymethyl)phenylcarbamate 
(3.61a) (2.0 g, 8.96 mmol). The title compound was obtained as a tan 
oil (1.22 g, 62%) which was used without further purification. 
NHBoc
CHO
 
Rf (hexane: Et2O, 3:1 (v:v)) 0.43; mp 55-57 oC; 1H-NMR (CDCl3, 300 MHz) δ 10.39 
(brs, 1H), 9.89 (s, 1H), 8.45 (d, J = 8.4 Hz, 1H), 7.62 (dd, J = 1.6, 7.7 Hz, 1H), 7.57 
(ddd, J = 1.6, 7.4, 8.4 Hz, 1H), 7.13 (´t´d, J = 0.9, 7.4, 7.7 Hz), 1.53 (s, 9H); 13C-NMR 
(CDCl3, 75 MHz) δ 195.3, 153.1, 142.0, 136.3, 136.2, 121.7, 121.4, 118.4, 81.2, 28.5; 
LRMS (EI) m/z = 221 [M]+;; Anal. Calcd. for C12H15NO3: C, 65.14; H, 6.83; N, 6.33. 
Found: C, 65.21; H, 6.84; N, 6.20. 
 
N-(2-Formylphenyl)-4-methylbenzenesulfonamide 
 
Following GP 8, using N-(2-(hydroxymethyl)phenyl)-4-
methylbenzenesulfonamide (3.61b) (1.5 g, 5.4 mmol). The title 
compound was delivered as a beige solid (1.19 g, 80%) which was used without 
further purification. 
NHTs
CHO
 
Rf (hexane:EtOAc, 1:1(v:v)) 0.56; mp 126-129 oC; 1H-NMR (CDCl3, 300 MHz) δ 
 124
Part I Chapter 7: Experimental 
 
 
 
10.79 (s, 1H), 9.83 (s, 1H), 7.75-7.78 (m, 2H), 7.69 (d, J = 8.3 Hz, 1H), 7.59 (dd, J = 
1.5, 7.6 Hz, 1H), 7.51 (ddd, J = 1.5, 7.5, 8.3 Hz, 1H), 7.21-7.26 (m, 2H), 7.16 (´t´d, J 
= 0.9, 7.5, 7.6 Hz, 1H), 2.36 (s, 3H); 13C-NMR (CDCl3, 75 MHz) δ: 195.3, 144.4, 
140.1, 136.5, 136.4, 136.1, 130.0, 127.5, 123.2, 122.0, 117.9, 21.8; LRMS (EI) m/z = 
275 [M] +; Anal. Calcd. for C14H13NO3S: C, 61.07; H, 4.76; N, 5.09. Found: C, 60.92; 
H, 4.76; N, 4.95. 
N-(2-Formylphenyl)benzamide 
 
Following GP 8, using N-(2-(hydroxymethyl)phenyl)benzamide 
(3.61c) (1.29 g, 6.6 mmol). The title compound was delivered as a tan 
solid (1.18 g, 79%) which was used without further purification. 
NHBz
CHO
 
Rf (1st elution: hexane:Et2O, 3:1 (v:v); 2nd elution: hexane:Et2O, 1:1 (v:v)) 0.45; mp 
67-70 oC; 1H-NMR (CDCl3, 300 MHz) δ 12.10 (brs, 1H), 10.00 (d, J = 0.4 Hz, 1H), 
8.96 (d, J = 8.4 Hz, 1H), 8.06-8.09 (m, 2H), 7.73 (dd, J = 1.1, 7.6 Hz, 1H), 7.68 
(dddd, J = 0.4, 1.5, 7.6, 7.9 Hz, 1H), 7.50-7.59 (m, 3H), 7.27 (´t´d, J = 1.1, 7.9, 8.4 
Hz, 1); 13C-NMR (CDCl3, 75 MHz) δ 196.2, 166.4, 141.5, 136.6, 136.5, 134.5, 132.5, 
129.1, 127.7, 123.3, 122.2, 120.2; LRMS (EI) m/z = 225 [M]+; Anal. Calcd. for 
C14H11NO2: C, 74.65; H, 4.92; N, 6.22. Found: C, 74.55; H, 5.10; N, 6.07. 
 
General procedure for the N-methylation of N-protected 2-amino benzaldehydes 
(GP 9): 
To a stirred ice cold suspension of NaH (1.15 eq.) in DMF (0.32 M) was dropwise 
added, over 15 min., a solution of the N-protected 2-aminobenzaldehyde (1.0 eq.) in 
DMF (0.4 M). After stirring at ice bath temperature for 10 min., the obtained solution 
was allowed to reach room temperature and stirred for further 15-20 min. after which 
it was re-cooled to 0 oC and a solution of MeI (1.3 eq.) in DMF (just enough to 
transfer the MeI quantitatively) was slowly added. Stirring continued at room 
temperature for 3 h, after which the solution was re-cooled to ice bath temperature 
and the reaction was quenched by slow addition of water. After partition between 
water and EtOAc:Et2O (1:1, (v:v)), the organic layer was further washed with water, 
dried (Na2SO4) and concentrated under vacuum to afford the N-methyl 2-
aminobenzaldehydes which typically were used without further purification. 
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tert-Butyl 2-formylphenyl(methyl)carbamate (3.62a) 
 
Following GP 8, using tert-butyl 2-formylphenylcarbamate (700 
mg, 3.16 mmol). The title compound was obtained as a viscous oil 
(202 mg, 96 %), which was used without further purification. 
N
CHO
Boc Me
 
Rf (1st elution: hexane:EtOAc, 1:1 (v:v); 2nd elution: hexane: Et2O, 3:1 (v:v)) 0.70; 1H-
NMR (CDCl3, 300 MHz) δ 10.09 (s, 1H), 7.88 (dd, J = 1.6, 7.7 Hz, 1H), 7.60 (´t´d, J 
= 1.6, 7.7, 7.7 Hz, 1H), 7.37 (´t´, J = 7.7, 7.7 Hz, 1H), 7.24 (d, J = 7.7 Hz, 1H), 3.30 
(s, 3H), 1.31 (s, 9H); 13C-NMR (CDCl3, 75 MHz) δ 190.2, 155.7, 146.0, 136.2, 135.0, 
132.4, 128.6, 127.3, 81.5, 38.2, 28.3; Anal. Calcd. for C13H17NO3: C, 66.36; H, 7.28; 
N, 5.95. Found: C, 66.31; H, 7.21; N, 6.14. 
 
N-(2-Formylphenyl)-N,4-dimethylbenzenesulfonamide (3.62b) 
 N
CHO
Ts Me
Following GP 8, using N-(2-formylphenyl)-4-
methylbenzenesulfonamide (700 mg, 2.54 mmol). The title 
compound was obtained a tan solid (723 mg, 98 %), which was 
used without further purification. 
 
Rf (1st elution: hexane:EtOAc, 1:1 (v:v); 2nd and 3rd elutions: hexane: Et2O, 3:1 (v:v)) 
0.53; mp 134-136 oC; 1H-NMR (CDCl3, 300 MHz) δ: 10.46 (s, 1H), 8.00-8.03 (m, 
1H), 7.42-7.46 (m, 4H), 7.26-7.30 (m, 2H), 6.67-6.73 (m, 1H), 3.24 (s, 3H), 2.44 (s, 
3H); 13C-NMR (CDCl3, 75 MHz) δ: 190.1, 144.5, 143.9, 135.1, 134.2, 132.8, 129.8, 
128.6, 128.5, 128.4, 126.2, 39.1, 21.9; Anal. Calcd. for C15H15NO3: C, 62.26; H, 5.23; 
N, 4.84. Found: C, 62.25; H, 5.23; N, 4.68. 
 
N-(2-Formylphenyl)-N-methylbenzamide (3.62c) 
 
Following GP 8, using N-(2-formylphneyl)benzamide (700 mg, 3.1 
mmol). The crude yellowish oil obtained was purified by flash 
chromatography on silica gel (hexane:EtOAc, 1:1 (v:v) with 1% 
Et3N) affording the title compound as a yellow viscous oil (538 mg, 73%). 
N
CHO
Bz Me
 
Rf (hexane:EtOAc, 1:1 (v:v)) 0.22; mp 70-73 oC; 1H-NMR (CDCl3, 300 MHz) δ 10.12 
(s, 1H), 7.75 (d, J = 7.2 Hz, 1H), 7.53 (´t´, J = 7.0, 7.2 Hz, 1H), 7.35 (´t´, J = 7.0, 7.4 
Hz, 1H), 7.07-7.26 (m, 6H), 3.52 (s, 3H); 13C-NMR (CDCl3, 75 MHz) δ: 190.0, 170.1, 
144.8, 144.3, 142.9, 138.3, 137.7, 130.1, 129.2, 128.3, 125.0, 122.1, 39.4. LRMS (EI) 
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m/z = 239 [M]+. 
 
General procedure for the preparation of the ortho-formyl-N-methylaniline 
derivatives (GP 10): 
A suspension of 2-fluorobenzaldehyde (1.0 eq.), the N-methyamine derivative (2.0 
eq.) and K2CO3 (2.0 eq.) in DMF (0.5 M with respect to 2-fluorobenzaldehyde) was 
heated to 105 oC to 110 oC for 30-40 h. The suspension obtained was allowed to reach 
room temperature, filtered and concentrated to 1/3 of its original volume, after which 
it was partitioned between EtOAc and water. The aqueous layer was extracted with 
EtOAc and the combined organic phases were washed with brine, dried (Na2SO4) and 
the solvent removed under vacuum. Purification by flash chromatography delivered 
the ortho-formyl-N-methylanilines. 
2-(Ally(methyl)amino)benzaldehyde (3.62d) 
 
Following GP 10, using N-methylallyamine (5.8 mL, 60.4 mmol, 
3.0 eq.). Purification by flash chromatography (hexane:Et2O, 3:1 
(v:v)) delivered the title compound as a lemon oil (3.1 g, 89%). 
N
CHO
Me
 
Rf (hexane:Et2O, 3:1 (v:v)) 0.44; 1H-NMR (CDCl3, 300 MHz) δ 10.26 (d, 0.5 Hz, 
1H), 7.78 (dd, J = 1.8, 7.8 Hz, 1H), 7.46 (ddd, J = 1.8, 7.1, 8.3 Hz, 1H), 7.08 (dd, J = 
0.4, 8.3 Hz, 1H), 7.03 (dd´t´, J = 0.4, 0.5, 7.1, 7.8 Hz, 1H), 5.91 (ddt, J = 5.9, 5.9, 
10.2, 17.2 Hz, 1H), 5.28 (d´q´, J = 1.6,1.7, 1.7, 17.2 Hz, 1H; partial overlap with d´q´ 
at δ = 5.23 ppm), 5.23 (d´q´, J = 1.4, 1.4, 1.6, 10.2 Hz, 1H; partial overlap with d´q´ at 
δ = 5.28 ppm), 3.73, (d´t´, J = 1.4, 1.6, 5.9 Hz, 2H), 3.85 (s, 3H); 13C-NMR (CDCl3, 
75 MHz) δ 191.6, 155.7, 134.8, 134.3, 130.4, 127.9, 121.4, 119.1, 118.2, 62.3, 41.2; 
LRMS (EI) m/z = 175 [M]+; Anal. Calcd. for C11H13NO: C, 75.40; H, 7.48; N, 7.99. 
Found: C, 75.26; H, 7.37; N, 8.00. 
2-(Benzyl(methyl)amino)benzaldehyde (3.62e) 
 
Following GP 10, using N-methylbenzylamine (5.2 mL, 40.2 
mmol, 2.0 eq.). Purification by flash chromatography (hexane: 
Et2O, 3:1 (v:v)) delivered the title compound as a lemon yellow oil (4.2 g, 92%). 
N
CHO
Me
 
Rf (hexane: Et2O, 3:1 (v:v)) 0.38; 1H-NMR (CDCl3, 300 MHz) δ 10.40 (d, J = 0.5 Hz, 
1H), 7.83 (dd, J = 1.7, 7.7 Hz, 1H), 7.48 (ddd, J = 1.7, 7.1, 8.3 Hz, 1H), 7.27-7.36 (m, 
5H), 7.10 (dd, J = 0.6, 8.3 Hz, 1H, partial overlap with ´t´t at δ = 7.07 ppm), 7.07 (´t´t, 
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J = 0.6, 0.6, 7.1, 7.7 Hz, 1H, partial overlap with dd at δ = 7.10 ppm), 4.34 (s, 2H), 
2.82 (s, 3H); 13C-NMR (CDCl3, 75 MHz) δ 191.6, 155.9, 137.6, 134.9, 130.4, 128.8, 
128.7, 128.2, 127.7, 121.9, 119.7, 62.6, 42.5; LRMS (EI) m/z = 225 [M]+; Anal. 
Calcd. for C15H15NO: C, 79.97; H, 6.71; N, 6.22. Found: C, 80.23; H, 6.50; N, 6.33. 
 
2-(Dimethylamino)benzaldehyde (3.62f) 
 
The following modification of GP 10 was used:7.15 a suspension of 
2-fluorobenzaldehyde (1.0 g, 8.0 mmol, 1.0 eq.), dimethylamine 
hydrochloric salt (855 mg, 10.5 mmol, 1.3 eq.) and K2CO3 (1.11 g, 
8.0 mmol, 1.0 eq.) in DMF (17 mL) and water (7 mL) was heated to gentle reflux 
(105-110 oC). After approximately 4 h a second portion of dimethylamine 
hydrochloric salt (400 mg, 4.9 mmol, 0.6 eq.) and K2CO3 (1.11 g, 8.0 mmol, 1.0 eq.) 
were added and heating continued for further 4 h. The suspension obtained was 
allowed to reach room temperature, filtered and the filtrate partitioned between Et2O 
(100 mL) and aqueous saturated NaHCO3 (40 mL). The aqueous layer was further 
extracted with Et2O (2 portions of 30 mL) and the combined organic layers were 
washed with water (30 mL), brine (15 mL), dried (Na2SO4) and solvent removed in 
vacuum. The residue obtained was purified by flash chromatography (hexane: Et2O, 
3:1 (v:v)) to afford the title compound as a bright yellow oil (1.1 g, 92%). 
N
MeMe
CHO
 
Rf (hexane: Et2O, 3:1 (v:v)) 0.30; 1H-NMR (CDCl3, 300 MHz) δ 10.21 (s, 1H), 7.75 
(dd, J = 1.7, 7.7 Hz, 1H), 7.45 (ddd, J = 1.7, 7.2, 8.9 Hz, 1H), 7.03 (´d´, J = 8.9 Hz, 
1H), 6.98 (´t´, J = 7.2, 7.7 Hz, 1H); 13C-NMR (CDCl3, 75 MHz) δ 191.4, 156.0, 
134.8, 131.2, 127.2, 120.8, 117.8, 45.8; EI-MS m/z: 149 [M+]; Anal. Calcd. for 
C9H11NO: C, 72.46; H, 7.43; N, 9.39. Found: C, 72.23; H, 7.22; N, 9.16. 
 
General procedure for the preparation of the azido carboxylates (Hemetsberger 
substrates) (GP 11): 
Sodium metal (9 eq.) is dissolved in EtOH (1.5 M). To the resulting solution was 
slowly added, at -15 oC, over 1 h, a solution of protected N-methyl 2-
aminobenzaldehyde (1.0 eq.) and ethyl azido acetate (commercially available as a 
2.39 M solution in EtOH, 10 eq.), during which period a turbid suspension formed. 
After stirring at -15 oC to -10 oC for 5-7 h, the temperature was allowed to slowly 
reach 0 oC to room temperature and stirring continued for further 3-5 h. The 
 
7.15 Rodríguez, J. G.; Lafuente, A.; Martín-Vilamil, R.; Martínez-Alcazar, M. P. J. Phys. Org. Chem. 2001, 
14, 859. 
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suspension obtained was then re-cooled to 0 oC and quenched with aqueous saturated 
NH4Cl and gently partitioned between Et2O:EtOAc, 1:1 (v:v) and aqueous ½ 
saturated NH4Cl. The aqueous layer was further extracted with Et2O:EtOAc, 1:1 (v:v) 
and the combined organic layers were washed with aqueous ½ saturated brine and 
dried (Na2SO4). The obtained solution was then concentrated to 15-20 mL and filtered 
through a short column of silica gel (Et2O). Removal of the solvent under vacuum and 
purification by flash chromatography on silica gel delivered the azido carboxylates. 
 
(Z)-Ethyl 2-azido-3-(2-(N,4-dimethylphenylsulfonamido) 
phenyl)acrylate (3.63b) 
 
Following GP 11, using N-(2-formylphenyl)-N,4-
dimethylbenzenesulfonamide (3.62b) (185 mg, 0.63 mmol). Purification by flash 
chromatography on silica gel (hexane:EtOAc, 1:1 (v:v)) afforded the title compound 
as a pale yellow solid (121 mg, 48%). 
N
Ts Me
N3
CO2Et
 
Rf (hexane:EtOAc, 1:1 (v:v)) 0.58; 1H-NMR (CDCl3, 300 MHz) δ 8.24 (dd, J = 1.4, 
7.9 Hz, 1H), 7.56 (d, J = 8.3 Hz, 2H), 7.53 (´t´dd, J = 0.8, 1.2, 7.6, 7.9 Hz, 1H), 7.28 
(d, J = 8.3 Hz, 2H), 7.26 (s, 1H), 7.22 (´t´d, J = 1.4, 7.6, 7.9 Hz, 1H), 6.81 (dd, J = 
1.2, 7.9 Hz, 1H), 4.36 (q, J = 7.1 Hz, 2H), 3.14 (s, 3H), 2.44 (s, 3H), 1.41 (t, J = 7.1 
Hz, 3H); 13C-NMR (CDCl3, 75 MHz) δ 163.6, 144.0, 140.9, 134.7, 133.5, 131.1, 
129.9, 129.7, 128.4, 127.8, 127.0, 120.8, 62.6, 39.5, 21.8, 14.4. 
 
(Z)-Ethyl 2-azido-3-(2-(N-methyl benzamido)phenyl) 
acrylate (3.63c) 
 
Following GP 11, using N-(2-formylphenyl)-N-
methylbenzamide (3.62c) (300 mg, 1.25 mmol). Purification by flash chromatography 
in silica gel (hexane:EtOAc, 1:1 (v:v)) afforded the title compound as a viscous 
yellow oil (215 mg, 49%). 
N
Bz Me
N3
CO2Et
 
Rf (1st elution: hexane:Et2O, 3:1 (v:v); 2nd elution: hexane: Et2O, 1:1 (v:v)) 0.34; 1H-
NMR (d-acetone, 300 MHz) δ 8.03 (d, J = 6.6 Hz, 1H), 7.12-7.38 (m, 8H), 6.96 
(s,1H), 4.40 (q, J = 7.1 Hz, 2H), 3.36 (s, 3H), 1.40 (t, J = 7.1 Hz, 3H); 13C-NMR (d-
acetone, 75 MHz) δ 170.2, 163.0, 144.5, 136.5, 130.7, 130.6, 130.4, 129.7, 129.0, 
128.5, 128.1, 127.7, 127.5, 119.4, 62.5, 37.8, 13.8. 
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(Z)-Ethyl 3-(2-allyl(methyl)amino)phenyl)-2-azido 
acrylate (3.63d) 
 
Following GP 11, using 2-(ally(methyl)amino) 
benzaldehyde (3.62d) (300 mg, 1.7 mmol). Purification by flash chromatography in 
silica gel (hexane: Et2O, 3:1 (v:v)) delivered the title compound as a yellow solid (337 
mg, 69%). 
N
N3
CO2Et
 
Rf (hexane: Et2O, 3:1 (v:v)) 0.55; mp 38-40 oC; 1H-NMR (CDCl3, 300 MHz) δ 8.03 
(ddd, J = 0.4, 1.8, 8.4 Hz, 1H), 7.32 (s, 1H; partial overlap with ddd at δ = 7.29 ppm), 
7.29 (ddd, J = 1.8, 7.3, 8.2 Hz, 1H; partial overlap with s at δ = 7.32 ppm), 7.01-7.06 
(m, 2H), 5.92 (ddt, J = 6.0, 6.0, 10.2, 17.1 Hz, 1H), 5.28 (d´q´, J = 1.6,1.6, 1.6, 17.2 
Hz, 1H), 5.20 (d´q´, J = 1.2, 1.2, 1.2, 10.2 Hz, 1H), 4.37 (q, J = 7.1 Hz), 3.46 (´d´, J = 
6.0 Hz, 2H), 2.72 (s, 3H), 1.41 (t, J = 7.1 Hz, 3H); 13C-NMR (CDCl3, 75 MHz) δ 
164.2, 153.1, 135.3, 130.8, 130.1, 126.7, 124.9, 123.6, 121.9, 118.9, 117.7, 62.3, 61.8, 
40.0, 14.5; LRMS (MS) m/z = 286 [M]+; Anal. Calcd. for C15H18N4O2: C, 62.92; H, 
6.34; N, 19.57. Found: C, 63.13; H, 6.23; N, 19.33. 
(Z)-Ethyl 2-azido-3-(2-(benzyl(methyl)amino)phenyl) 
acrylate (3.63e) 
 
Following GP 11, using 2-
(benzyl(methyl)amino)benzaldehyde (3.62e) (385 mg, 1.7 mmol). Purification by 
flash chromatography on silica gel (hexane: Et2O, 3:1 (v:v)) delivered the title 
compound as a tanned oil (417 mg, 72%). 
N
Me
N3
CO2Et
 
Rf (hexane: Et2O, 3:1 (v:v)) 0.54; 1H-NMR (CDCl3, 300 MHz) δ 8.07 (ddd, J = 0.4, 
1.9, 8.2 Hz, 1H), 7.53 (s, 1H), 7.27-7.39 (m, 6H), 7.07-7.12 (m, 2H), 4.31 (q, J = 7.1 
Hz, 2H), 4.05 (s, 2H), 2.64 (s, 3H), 1.37 (t, J = 7.1 Hz, 3H); 13C-NMR (CDCl3, 75 
MHz) δ 164.1, 153.1, 138.5, 130.9, 130.3, 128.6, 128.5, 127.4, 127.2, 125.3, 123.3, 
122.5, 119.6, 62.6, 62.3, 40.8, 14.5; LRMS (EI) m/z = 336 [M]+; 
(Z)-Ethyl 2-azido-3-(2-dimethylamino)phenylacrylate 
(3.63f) 
 
Following GP 11, using 2-(dimethylamino)benzaldehyde 
(3.62f) (400 mg, 2.7 mmol). Purification by flash chromatography on silica gel 
(hexane: Et2O, 3:1 (v:v)) delivered the title compound as a tanned oil (456 mg, 65%). 
N
MeMe
N3
CO2Et
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Rf (hexane: Et2O, 3:1 (v/v)) 0.46; 1H-NMR (CDCl3, 300 MHz) δ 8.01 (dd, J = 1.6, 8.3 
Hz, 1H), 7.25-7.32 (m, 2H), 7.00-7.06 (m, 2H), 4.38 (q, J = 7.2 Hz, 2H), 2.74 (s, 6H), 
1.40 (t, J = 7.2 Hz, 3H); 13C-NMR (CDCl3, 75 MHz) δ 164.2, 153.7, 130.8, 130.2, 
126.5, 124.9, 123.9, 121.8, 118.0, 62.3, 45.2, 14.5; LRMS (EI) m/z = 232 [M-N2]+. 
 
Ethyl 4-(allyl(methyl)amino)-1H-
indole-2-carboxylate (3.64d) NNMe O
O
and
N
H
N
Me
CO2Et
and 
Ethyl 4-allyl-1-methyl-1,4-dihydro-
cinnoline-3-carboxylate (3.65) 
 
A solution of (Z)-ethyl 3-(2-allyl(methyl)amino)phenyl)-2-azidoacrylate (3.63d) (98 
mg, 0.34 mmol) in toluene (2.2 mL) was inserted in an oil bath previously heated to 
115 oC and refluxed for 6½ h, after which the solvent was removed under vacuum. 
The tanned oil obtained was then purified by (repeated) PTLC (hexane:Et2O, 1:1 
(v:v), double elution) affording the desired ethyl 4-(allyl(methyl)amino)-1H-indole-2-
carboxylate (3.64d) as a pale yellow solid (13 mg, 15%), ethyl 4-allyl-1-methyl-1,4-
dihydrocinnoline-3-carboxylate (3.65) as a yellow oil (18 mg, 20%) and other 
unidentified by-products. 
 
For Ethyl 4-(allyl(methyl)amino)-1H-indole-2-carboxylate (3.64d): Rf (hexane:Et2O, 
3:1 (v:v); double elution) 0.42; 1H-NMR (d-acetone, 300 MHz) δ 10.87 (brs, 1H), 
7.24 (s, 1H), 7.14 (´t´, J = 7.8, 8.1 Hz, 1H), 7.03 (d, J = 8.1 Hz, 1H), 6.45 (d, J = 7.8 
Hz, 1H), 6.04 (ddt, J = 5.3, 5.3, 10.4, 17.2 Hz, 1H), 5.37 (d´q´, J = 1.8, 1.8, 1.9, 17.2 
Hz, 1H), 5.24 (d´q´, J = 1.6, 1.6, 1.9, 10.4 Hz, 1H), 4.34 (q, 7.1 Hz, 2H), 3.98 (d´t´, J 
= 1.6, 1.8, 5.3 Hz, 2H), 1.35 (t, J = 7.1 Hz, 3H); 13C-NMR (d-acetone, 75 MHz) δ 
161.5, 147.2, 139.5, 135.6, 126.0, 125.9, 119.9, 116.1, 107.7, 105.4, 104.5, 60.4, 58.1, 
38.7, 14.1. 
 
For ethyl 4-allyl-1-methyl-1,4-dihydrocinnoline-3-carboxylate (3.65): Rf 
(hexane:Et2O, 3:1 (v:v); double elution) 0.39; 1H-NMR (CDCl3, 300 MHz) δ 7.28 
(´t´d, J = 8.2, 7.6, 1.4 Hz, 1H), 7.19 (dd, J = 7.4, 0.8 Hz, 1H), 7.11 (´t´, J = 7.3 Hz, 
1H), 7.03 (d, J = 8.1 Hz, 1H), 5.65 (ddt, J = 7.3, 7.3, 10.1, 17.3 Hz, 1H), 4.89 (d, 10.1 
Hz, 1H), 4.81 (d, J = 17.0 Hz, 1H), 3.70 (s, 2H), 4.25 (q, J = 7.1 Hz, 1H, partial 
overlap to t at δ = 4.19 ppm), 4.19 (t, J = 6.4 Hz, 1H, partial overlap to q at δ = 4.25 
ppm), 3.56 (s, 3H), 2.17 (´t´, J = 6.9 Hz, 2H), 1.30 (t, J = 7.1 Hz, 3H). 
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Ethyl 4-(benzyl(methyl)amino)-1H-
indole-carboxylate (3.64e) 
N
H
N
Me
CO2Et
N
NMe
Ph
CO2Etand and 
(Z)-Ethyl 1-methyl-2-phenyl-4,5-
dihydro-1H-
benzo[d][1,3]diazepine-4-
carboxylate (3.66) 
 
A solution of (Z)-ethyl 2-azido-3-(2-(benzyl(methyl)amino)phenyl) acrylate (3.63e) 
(120 mg, 0.35 mmol) in toluene (2.2 mL) was inserted in an oil bath previously 
heated to 115 oC and refluxed for 6½ h, after which the solvent was removed under 
vacuum. The tanned oil obtained was then purified by (repeated) PTLC (hexane:Et2O, 
1:1 (v:v), double elution) affording the desired ethyl 4-(benzyl(methyl)amino)-1H-
indole-carboxylate (3.64e) (17 mg, 15%), (Z)-Ethyl 1-methyl-2-phenyl-4,5-dihydro-
1H-benzo[d][1,3]diazepine-4-carboxylate (3.66) (21 mg, 20%), and other unidentified 
by-products. 
 
For ethyl 4-(benzyl(methyl)amino)-1H-indole-carboxylate (3.64e): Rf (hexane:Et2O, 
1:1 (v:v); double elution) 0.56; 1H-NMR (d-acetone, 300 MHz) δ 10.90 (brs, 1H), 
7.30-7.45 (m. 6H), 7.16 (dd, J = 7.6, 8.2 Hz, 1H), 7.07 (d, J = 8.2 Hz, 1H), 6.40 (dd, J 
= 0.7, 7.6 Hz, 1H), 4.60 (s, 2H), 4.31 (q, J = 7.1 Hz, 2H), 3.18 (s, 3H), 1.32 (t, J = 7.1 
Hz, 3H); 13C-NMR (d-acetone, 75 MHz) δ 161.5, 147.2, 139.6, 139.4, 128.6, 127.7, 
127.1, 126.1, 120.0, 107.5, 105.8, 104.8, 104.7, 60.4, 59.2, 39.2, 14.0. 
 
For (Z)-Ethyl 1-methyl-2-phenyl-4,5-dihydro-1H-benzo[d][1,3]diazepine-4-
carboxylate (3.66): Rf (hexane:Et2O, 1:1 (v:v); double elution) 0.49; 1H-NMR 
(CDCl3, 300 MHz) δ 6.81-7.30 (m, 9H), 4.34 (dd, J = 5.7, 7.5 Hz, 1H), 4.18 (q, J = 
6.9 Hz, 1H), 4.17 (q, J = 6.9 Hz, 1H), 3.47 (s, 3H), 2.73 (dd, J = 5.7, 12.8 Hz, 1H), 
2.62 (dd, J = 7.5, 12.8 Hz, 1H), 1.27 (t, J = 6.9 Hz); 13C-NMR (CDCl3, 75 MHz) δ 
163.9, 138.8, 138.1, 132.7, 129.8, 128.6, 128.0, 127.7, 126.4, 123.8, 121.6, 111.4, 
60.5, 40.9, 38.1, 14.0. 
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(R)-(2-(4-Bromo-3-iodophenyl)-2-methylbut-3-enyloxy)(tert-
butyl)dimethylsilane (3.73) 
 
To a solution of TBDMSCl (131 mg, 0.89 mmol, 1.3 eq.) and 
imidazole (122 mg, 1.77 mmol, 2.6 eq.) in DMF (0.65 mL) was 
added a solution of (crude) (R)-2-(4-bromo-3-iodophenyl)-2-
methylbut-3-en-1-ol (3.46) (245 mg, 0.66 mmol, 1.0 eq.) in DMF (1.35 mL) at room 
temperature. After stirring at this temperature over 7 h, the resulting solution was 
partitioned between aqueous 1 M HCl (15 mL) and Et2O (25 mL). The organic layer 
was washed with a second portion of aqueous 1 M HCl (15 mL) and the combined 
acidic layers were extracted with Et2O (10 mL). The combined organic layers were 
washed with aqueous ½ saturated NaHCO3 (25 mL), brine (15 mL), dried (Na2SO4) 
and concentrated under vacuum to afford a pale yellow residue. Purification by flash 
chromatography on silica gel (hexane: Et2O, 3:1 (v:v)) delivered the title compound 
as a clear oil (254 mg, 80%). 
Br
I
TBDMSO
 
Rf (hexane: Et2O 3:1 (v:v)) 0.69; 1H-NMR (CDCl3, 300 MHz) δ 7.89 (d, J = 2.2 Hz, 
1H), 7.55 (d, J = 8.4 Hz, 1H), 7.23 (dd, J = 2.2, 8.4 Hz, 1H), 6.04 (dd, J = 10.9, 17.6 
Hz, 1H), 5.21 (dd, J = 1.2, 10.9 Hz, 1H), 5.10 (dd, J = 1.2, 17.6 Hz, 1H), 3.70 (s, 2H), 
1.37 (s, 3H), 0.88 (s, 9H), 0.01 (s, 3H), 0.00 (s, 3H); 13C-NMR (CDCl3, 75 MHz) δ 
152.3, 148.8, 145.1, 137.5, 134.5, 132.5, 119.7, 106.3, 75.7, 51.9, 31.4, 28.2, 23.8, 
0.0; LRMS (EI) m/z = 482 [M]+; [ ]25Dα -10.9 (c 2.3, CHCl3). 
 
2-Bromobenzaldehyde Br
CHO and
CHO
Br
and 
2-Bromo-2’-formylbiphenyl (3.75) 
 
Procedure I: To a slurry of ortho-iodobromobenzene (200 mg, 0.71 mmol, 1.0 eq.) 
and DMF (115 µL, 1.56 mmol, 2.2 eq.) in toluene (7 mL) at -105 oC to 100 oC was 
added in a dropwise manner over 3-4 min. a solution of nBuLi in hexanes (1.6 M, 0.55 
mL, 0.88 mmol, 1.25 eq.). After stirring at -105 oC to -100 oC for 2 h, the temperature 
was allowed to increase to -30 oC over 1 h, after which period the cooling bath was 
replaced by a water bath and the pale yellow solution was stirred at room temperature 
for 20 min.. The resulting solution was partitioned between water (20 mL) and Et2O 
(45 mL); the aqueous layer was further extracted with Et2O (10 mL) and the 
combined organic layers were washed with aqueous ½ saturated brine (20 mL), dried 
(MgSO4) and concentrated under vacuum to afford a yellow oil. Purification by PTLC 
(1st elution: hexane:CH2Cl2, 2.5:1, (v:v); 2nd elution: hexane:ether, 3:1 (v:v)) delivered 
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toluene (14.8 mL) was a
                                                
2-bromobenzaldeyhde as yellow oil (78 mg, 60%). 
 
Procedure II: To a slurry of ortho-iodobromobenzene (200 mg, 0.71 mmol, 1.0 eq.) 
in a mixture of Et2O:THF, 1:1 (v:v) (23 mL) at -115 oC to -110 oC was added in a 
dropwise manner over 3-4 min. a solution of nBuLi in hexanes (1.6 M, 0.47 mL, 0.74 
mmol, 1.05 eq.). After stirring at this temperature for approximately 2 min., DMF 
(250 µL, 3.2 mmol, 4.5 eq.) was added dropwise over 8-10 min. and stirring 
continued at -110 oC for 3 h further. The temperature was gradually increased to -35 
oC over 20 min., at which time the cooling bath was removed and stirring continued 
for further 15 min. The resulting solution was subjected to similar work-up and 
purification procedures as described in procedure I above affording 2-
bromobenzaldeyhde as a pale yellow oil (20 mg, 15%) and 2-bromo-
2’formylbiphenyl (3.75) (9 mg, 5%). 
 
For 2-bromobenzaldehyde: Rf (hexane:CH2Cl2, 2.5:1 (v:v)) 0.25; 1H-NMR (d-
acetone, 300 MHz) δ 10.33 (d, J = 0.7 Hz, 1H), 7.88-7.91 (m, 1H), 7.77-7.80 (m, 1H), 
7.55-7.65 (m, 2H). 
 
For 2-bromo-2’-formylbiphenyl (3.75): Rf (hexane:CH2Cl2, 2.5:1 (v:v)) 0.2; 1H-NMR 
(d-acetone, 300 MHz)7.16 δ 9.78 (s, 1H), 8.00 (dd, J = 1.5, 7.7 Hz), 7.75-7.82 (m, 2H), 
7.62-7.68 (m, 1H), 7.52-7.58 (m, 1H), 7.37-7.48 (m, 3H). 
 
(R)-2-Bromo-5-(2-((tert-butyldimethylsilyloxy)methyl) 
but-3-en-2-yl)benzaldehyde (3.74) 
 
To a -105 oC to -100 oC cold slurry of (R)-(2-(4-bromo-3-
iodophenyl)-2-methylbut-3-enyloxy) (tert-butyl) 
dimethylsilane (3.73) (429 mg, 0.89 mmol, 1.0 eq.) in 
dded a solution of  nBuLi in hexanes (1.6 M, 1.02 mmol, 0.64 
mL, 1.15 eq.) over 8 sec.. After stirring at this temperature for 2 min., DMF (193 µL, 
2.49 mmol, 2.8 eq.) was added over 5 sec.. The resulting pale yellow solution was 
stirred at -103 oC to -95 oC for 1½ h and then allowed to reach -40 oC over ½ h, after 
which the cooling bath was replaced by a water bath and stirring continued for further 
10 min.. The resulting pale yellow solution was then partitioned between Et2O (80 
mL) and water (15 mL) and the aqueous layer was extracted with Et2O (2 portions of 
20 mL). The combined organic layers were washed with ½ brine (20 mL), dried 
Br
CHO
TBDMSO
 
7.16 Oba, M.; Iida, M.; Nishiyama, K. Organometallics 2001, 20, 4287. 
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(Na2SO4) and concentrated under vacuum affording a pale yellow oil. Purification by 
flash chromatography on silica gel (hexane→hexane: Et2O, 6:1 (v:v)) delivered the 
title compound as a colorless oil (242 mg, 71%). 
 
Rf (1st elution: hexane: Et2O, 6:1 (v:v); 2nd elution: hexane) 0.71; 1H-NMR (d-acetone, 
300 MHz) δ 10.34 (s, 1H), 7.95 (d, J = 2.5 Hz, 1H), 7.73 (d, J = 8.4 Hz, 1H), 7.65 
(dd, J = 2.5, 8.4 Hz 1H), 6.16 (dd, J = 10.9, 17.6 Hz, 1H), 5.23 (dd, J = 1.2, 10.9 Hz, 
1H), 5.17 (dd, J = 1.2, 17.6 Hz, 1H), 3.86 (d, J = 0.8 Hz, 2H), 1.45 (s, 3H), 0.84 (s, 
9H), 0.02 (s, 3H), 0.00 (s, 3H); 13C-NMR (CDCl3, 75 MHz) δ 191.3, 146.5, 143.6, 
135.3, 133.6, 133.1, 129.0, 124.0, 113.9, 70.2, 46.8, 25.5, 22.2, 18.0, -6.2; LRMS (EI) 
m/z = 384 [M]+. 
 
(R,Z)-Ethyl 2-azido-3-(2-bromo-5-(2-((tert-butyl 
dimethylsilyloxy)methyl)but-3-en-2-yl)phenyl) 
acrylate (3.77) 
 
Sodium metal (35.9 mg, 1.56 mmol, 6.0 eq.) was 
dissolved in EtOH (1.0 mL). To the resulting solution 
was slowly added, at -15 oC and over 1 h, a solution of (R)-2-Bromo-5-(2-((tert-
butyldimethylsilyloxy)methyl)but-3-en-2-yl)benzaldehyde (3.74) (100 mg, 0.26 
mmol, 1.0 eq.) and ethyl azido acetate (0.71 mL of a 2.39 M solution in EtOH, 1.69 
mmol, 6.5 eq.). During addition a milky pale yellowish suspension formed. The 
temperature was then allowed to rise to -15 oC to -10 oC and stirring continued for 18 
h further. The orange suspension obtained was then stirred at room temperature for ½ 
h, re-cooled to ice bath temperature, quenched with aqueous saturated NH4Cl (0.7 
mL) and gently partitioned between Et2O:EtOAc (1:1 (v:v)) (30 mL) and aqueous ½ 
saturated NH4Cl (10 mL). The deep tan aqueous layer was further extracted with Et2O 
:EtOAc (1:1 (v:v)) (3 portions of 10 mL); the combined organic layers were washed 
with aqueous ½ saturated brine (10 mL) and dried (Na2SO4). The obtained tan 
solution was then concentrated to 5 mL and filtered through a short column of silica 
gel (Et2O). After removal of the solvent under vacuum, a reddish oil was obtained 
which was purified by PTLC (hexane:Et2O, 3:1 (v:v)). The title compound was 
obtained as a colorless oil (78 mg, 60%). 
Br
TBDMSO
N3
CO2Et
 
Rf (1st elution: hexane: Et2O, 3:1 (v:v); 2nd elution: pentane) 0.63 (note: the Rf values 
the starting material and the product are very similar); 1H-NMR (CDCl3, 300 MHz) δ 
8.14 (d, J = 2.4 Hz, 1H), 7.55 (d, J = 8.5 Hz, 1H), 7.30 (d, J = 2.6 Hz, 1H), 7.23 (dd, J 
= 2.6, 8.5 Hz, 1H), 6.11 (dd, J = 10.9, 17.6 Hz, 1H), 5.23 (dd, J = 1.2, 10.9 Hz, 1H), 
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5.13 (dd, J = 1.2, 17.6 Hz, 1H), 4.43 (q, J = 7.1 Hz, 2H), 3.77 (d, J = 1.6 Hz, 2H), 
1.46 (t, J = 7.1 Hz, 3H; partial overlap with s at δ = 1.43 ppm), 1.43 (s, 3H; partial 
overlap with s at δ = 1.46 ppm), 0.88 (s, 9H), 0.02 (s, 3H), 0.00 (s, 3H); 13C-NMR 
(CDCl3, 75 MHz) δ 169.0, 150.6, 149.3, 137.8, 137.7, 136.0, 135.4, 132.7, 129.6, 
128.3, 119.5, 76.0, 68.1, 52.3, 31.4, 28.2, 23.9, 19.9, 0.0. 
 
(R)-Ethyl-4-bromo-7-(1-tert-butyldimethylsilyoxy)-
2-methylbut-3-en-2-yl)-1H-indole-2-carboxylate 
(3.78) 
 
A solution of (R,Z)-ethyl 2-azido-3-(2-bromo-5-(1-tert-
butyldimethylsilyoxy)-2-methylbut-3-en-2-yl)phenyl) 
acrylate (3.77) (74 mg, 0.14 mmol) in meta-xylene (1.3 mL) was dropwise added over 
1 h to refluxing meta-xylene (3.7 mL). The obtained solution was refluxed for 3½ h 
further, after which the solvent was removed under vacuum to afford a tanned oil. 
Purification by PTLC (hexane:Et2O, 5:1 (v:v)) afforded the title compound as a pale 
yellow oil (45 mg, 69%). 
Br
TBDMSO
N
H
CO2Et
 
Rf (hexane: Et2O, 5:1) 0.27; 1H-NMR (CDCl3, 300 MHz) δ 9.87, (brs, 1H), 7.33 (d, J = 
7.9 Hz, 1H), 7.28 (d, J = 2.3 Hz, 1H), 7.18 (d, J = 7.9 Hz, 1H), 6.24 (dd, J = 10.8, 
17.7 Hz, 1H), 5.40 (dd, J = 1.1, 10.8 Hz, 1H), 5.31 (dd, J = 1.1, 17.7 Hz, 1H), 4.45 (q, 
J = 7.1 Hz, 2H), 4.02 (d, J = 10.0 Hz, 1H), 3.87 (d, J = 10.0 Hz, 1H), 1.51 (s, 3H), 
1.46 (t, J = 7.1 Hz), 0.87 (s, 9 H), 0.01 (s, 3 H), 0.00 (s, 3 H); 13C-NMR (CDCl3, 75 
MHz) δ 167.3, 149.3, 141.7, 134.5, 134.0, 133.0, 129.8, 129.0, 120.5, 120.4, 113.9, 
76.2, 66.8, 52.3, 31.6, 28,8, 24.1, 20.1, 0.0; LRMS (EI) m/z = 465 [M]+; +22.7 (c 
2.15 in CHCl
[ ]25Dα
3). 
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7.4 – Experimental Procedure for Chapter 5 (Teleocidins B) 
 
(E)-4-(3,7-dimethylocta-2,6-dienyloxy)benzaldehyde (5.1) 
 
Following a literature procedure,7.17 a suspension of para-
hydroxybenzaldehyde (1.0 g, 8.2 mmol, 1.0 eq.), geranyl bromide 
(2.3 g, 10.6 mmol, 1.3 eq.) and K2CO3 (2.0 g, 14.7 mmol, 1.8 eq.) 
in acetone (54 mL) was refluxed for 4 h. The resulting suspension 
was cooled to ice bath temperature, quenched with H2O (10 mL), concentrated to 1/3 
of its initial volume and partitioned between water (50 mL) and Et2O (60 mL). The 
aqueous layer was further extracted with EtOAc (2 portions of 60 mL). The combined 
organic layers were washed with ½ brine (50 mL), dried (MgSO4) and concentrated 
under vacuum. Purification by flash chromatography (hexane:Et2O, 3:1 (v:v) with 1% 
NEt3) afforded the title compound as a light yellow oil (2.10 g, quantitative). 
CHO
O
 
Rf (hexane: Et2O, 1:1 (v:v)) 0.50;1H-NMR (CDCl3, 300 MHz) δ 9.87 (s, 1H), 7.82 (d, J 
= 8.8 Hz, 2H), 7.0 (d, J = 8.8 Hz, 2H), 5.47 (tq, J = 6.5, 1.2 Hz, 1H), 5.05-5.12 (m, 
1H), 4.62 (d, J = 6.5 Hz, 2H), 2.06-2.16 (m, 4H), 1.74 (s, 3H), 1.66 (s, 3H), 1.59 (s, 
3H); 13C-NMR (CDCl3, 75 MHz) δ 191.1, 164.2, 142.4, 132.2, 130.0, 123.9, 118.8, 
115.2, 65.5, 39.7, 34.5, 26.4, 25.9, 18.0, 17.0. 
 
(Z)-Ehtyl 2-azido-3-(4-((E)-3,7-dimethylocta-2,6-
dienyloxy)phenyl)acrylate (5.2) 
 
Following GP 11, using (E)-4-(3,7-dimethylocta-2,6-
dienyloxy)benzaldehyde (5.1) (2.10 g, 8.1 mmol). 
Purification by flash chromatography on silica gel (hexane: 
Et2O, 3:1 (v:v)) delivered the title compound as a viscous yellow oil (2.3 g, 76%). 
O
N3
CO2Et
 
Rf (hexane: Et2O, 1:1 (v:v)) 0.58;1H-NMR (CDCl3, 300 MHz) δ 7.78 (d, J = 8.7 Hz, 
2H), 6.91 (d, J = 8.7 Hz, 2H), 5.48 (tq, J = 6.5, 1.2 Hz, 1H), 5.05-5.12 (m, 1H), 4.57 
(d, J = 6.5 Hz, 2H), 4.35 (q, J = 7.1 Hz, 2H), 2.06-2.16 (m, 4H), 1.75 (s, 3H), 1.68 (s, 
3H), 1.61 (s, 3H), 1.39 (t. J = 7.1 Hz, 3H); 13C-NMR (CDCl3, 75 MHz) δ 164.1, 
160.0, 141.9, 132.6, 132.1, 126.1, 125.7, 124.0, 123.4, 119.3, 114.8, 65.2, 62.3, 39.8, 
26.5, 25.9, 18.0, 16.9, 14.5. 
 
 
7.17 Shinmon, N.; Cava, M. J. Chem. Soc., Chem. Commun. 1980, 1020. 
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Ethyl 6-((E)-3,7-dimethylocta-2,6-dineyloxy)-1H-indole-2-
carboxylate (5.3) 
 
A solution of (Z)-ehtyl 2-azido-3-(4-((E)-3,7-dimethylocta-
2,6-dienyloxy)phenyl)acrylate (5.2) (550 mg, 1.48 mmol) in 
toluene (17 mL) was inserted in an oil bath previously heated to 115 oC. The obtained 
solution was refluxed for 3 h, after which the solvent was removed under vacuum to 
afford the title compound as a pale yellow solid (506 mg, quantitative), which was 
used without further purification. 
N
H
O CO2Et
 
Rf (hexane: Et2O, 3:1 (v:v)) 0.23; mp 111-113 oC; 1H-NMR (CDCl3, 300 MHz) δ 8.80 
(brs, 1H), 7.53 (d, J = 9.5 Hz, 1H), 7.16 (d, J = 1.56 Hz, 1H), 6.82-6.86 (m, 2H), 5.53 
(td, J = 6.5, 1.0 Hz, 1H), 5.06-5.14 (m, 1H), 4.57 (d, J = 6.5 Hz, 2H), 4.38 (q, J = 7.1 
Hz, 2H), 2.05-2.17 (m, 4H), 1.76 (s, 3H), 1.67 (s, 3H), 1.61 (s, 3H), 1.40 (t, J = 7.1 
Hz, 3H); 13C-NMR (CDCl3, 75 MHz) δ 162.2, 158.3, 141.6, 138.1, 132.1, 126.6, 
124.0, 123.6, 122.0, 119.6, 113.0, 109.2, 94.9, 65.4, 61.0, 39.8, 26.5, 25.9, 18.0, 17.0, 
14.7. 
Ethyl 6-acetoxy-7-(3,7-dimethylocta-1,6-dien-3-yl)-
1H-indole-2-carboxylate (5.7c) 
 
A solution of ethyl 6-((E)-3,7-dimethylocta-2,6-
dineyloxy)-1H-indole-2-carboxylate (5.3) (100 mg, 0.29 
mmol) in dimethylaniline (2.0 mL) and Ac2O (2.0 mL) in a closed, thick wall glass 
container was inserted in a salt bath (53% KNO3, 40% NaNO2 and 7% NaNO3, by 
weight) at 195 oC until TLC showed no more starting material (approximately 6-7 h). 
After reaching room temperature, the reaction mixture was poured into iced-water 
(approximately 100 mL), stirred vigorously for 10 min and extracted with Et2O (2 
portions of 50 mL). The combined organic layers were washed with aqueous 5% HCl (2 
portions of 30 mL), aqueous saturated NaHCO3 (2 portions of 30 mL), brine (15 mL) and 
dried (MgSO4). After removal of the solvent under vacuum, the obtained tan residue was 
purified by flash chromatography (hexane:Et2O, 2:1 (v:v)) affording the title compound 
as a pale yellow oil (71 mg, 61%). 
N
H
CO2EtAcO
 
Rf (hexane: Et2O, 3:1 (v:v)) 0.25 (note: the Rf values the starting material and the 
product are very similar; ;1H-NMR (CDCl3, 300 MHz) δ 9.6 (brs, 1H), 7.53 (dd, J = 
0.6, 8.6 Hz, 1H), 7.13 (d, J = 2.2 Hz, 1H), 6.76 (d, J = 8.6 Hz, 1H), 6.50 (dd, J = 10.8, 
17.8 Hz, 1H), 5.38 (dd, J = 0.8, 17.8 Hz, 1H), 5.36 (dd, J = 0.8, 10.8 Hz, 1H), 5.00-
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5.07 (m, 1H) 4.37 (q, J = 7.1 Hz, 2H), 2.31 (s, 3H), 1.96 (s, 3H), 1.63 (s, 3H), 1.59 (s, 
3H), 1.45 (s, 3H), 1.40 (t, J = 7.1 Hz, 3H); 13C-NMR (CDCl3, 75 MHz) δ 170.4, 
162.0, 148.8, 146.8, 132.1, 127.6, 127.0, 124.4, 121.9, 118.7, 112.2, 108.2, 61.2, 45.6, 
40.2, 26.1, 25.9, 23.9, 21.9, 17.8, 14.6. 
Ethyl 6-hydroxy-7-linalyl-1H-indole-2-carboxylate 
(5.7a) 
 
A solution of ethyl 6-((E)-3,7-dimethylocta-2,6-
dineyloxy)-1H-indole-2-carboxylate (5.3) (1.42 g, 4.16 
mmol, 1.0 eq.), HMDS (8.7 mL, 41.8 mmol, 10 eq.) and dimethylaniline (30 mL) in a 
closed, thick wall glass container was inserted in a salt bath (53% KNO3, 40% NaNO2 
and 7% NaNO3, by weight) at 195 oC until TLC showed no more starting material 
(approximately 6-7 h). After reaching room temperature, the reaction mixture was 
partitioned between Et2O (150 mL) and aqueous 3 M HCl (150 mL); the organic layer 
was further washed with aqueous 3 M HCl (100 mL), aqueous NaHCO3 (two portions 
of 120 mL), brine (50 mL) and dried (Na2SO4). The solvent was removed under 
reduced pressure to afford a tan oil, which was dissolved in EtOH (20 mL). The 
resulting solution was cooled to ice bath temperature and treated with aqueous 3 M 
HCl (2.5 mL). After approximately 10 min., the reaction mixture was diluted with 
Et2O (90 mL), washed with aqueous NaHCO3 (two portions of 40 mL), brine (20 mL) 
and dried (NaSO4). The resulting solution was concentrated under vacuum to 
approximately 1/5 of its original volume and filtered through a short column of silica 
gel (hexane:Et2O, 2:1 (v:v)). The title compound was obtained as a pale tan viscous 
oil (1.25 g, 88%). 
N
H
CO2EtHO
 
Rf (hexane: Et2O, 3:1 (v:v)) 0.30; 1H-NMR (300 MHz, CDCl3): δ = 9.38 (brs, 1 H), 
7.41 (d, J = 8.5 Hz, 1 H), 7.11 (d, J = 2.1 Hz, 1 H), 6.67 (d, J = 8.5 Hz, 1 H), 6.57 (dd, 
J = 10.8, 17.8 Hz, 1 H), 5.63 (s, 1 H), 5.43 (d, J = 17.8 Hz, 1 H), 5.41 (d, J = 10.8 Hz, 
1 H), 5.07 (m, 1 H), 4.37 (q, J = 7.1 Hz, 2 H), 2.18-1.76 (m, 4 H), 1.70 (s, 3 H), 1.62 
(s, 3 H), 1.44 (s, 3 H), 1.40 (t, J = 7.1 Hz, 3 H). 13C-NMR (75 MHz, CDCl3): δ = 
162.2, 153.0, 148.7, 137.3, 131.9, 126.1, 124.5, 123.8, 122.1, 114.5, 113.3, 113.1, 
108.7, 61.0, 45.5, 39.9, 25.9, 25.6, 24.0, 17.4, 14.7. 
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Ethyl 6-(trifluoromethylsulfonyloxy)-7-linalyl-1H-
indole-2-carboxylate (5.7e) 
 
To a -30 oC cold solution of ethyl 6-hydroxy-7-linalyl-
1H-indole-2-carboxylate (5.7a) (1.1g, 3.2 mmol, 1.0 
eq.) and pyridine (0.39 mL, 4.8 mmol, 1.5 eq.) in CH2Cl2 (16 mL), was dropwise 
added over 35 min. a solution of Tf2O (0.65 mL, 3.9 mmol, 1.2 eq.) in CH2Cl2 (5.5 
mL). The reddish suspension obtained was stirred at -30 oC to -20 oC for 2 h, after 
which it was allowed to warm up to 0 oC over 1 h, quenched with water (15 mL) and 
partitioned between aqueous 3 M HCl (100 mL) and Et2O (150 mL). The organic 
layer was washed with aqueous 3 M HCl (100 mL), saturated NaHCO3 (two portions 
of 70 mL), brine (50 mL), dried (MgSO4) and concentrated under vacuum. The deep 
reddish residue obtained was crudely purified by flash chromatography (hexane:Et2O, 
3:1 (v:v); short column; fast elution) affording the title compound as tan oil (1.2 g, 
75%). 
N
H
CO2EtTfO
 
Rf (hexane: Et2O, 3:1 (v:v)) 0.52; 1H-NMR (300 MHz, CDCl3): δ = 9.70 (brs, 1 H), 7.53 
(d, J = 8.8 Hz, 1 H), 7.08 (d, J = 1.8 Hz, 1 H), 7.02 (dd, J = 0.4, 8.8 Hz, 1 H), 6.46 (dd, J 
= 10.7, 18.0 Hz, 1H), 5.37 (dd, J = 18.0 Hz, 1 H), 5.34 (d, J = 10.7 Hz, 1H), 4.90-4.98 
(m, 1H), 4.32 (qd, J = 0.4, 7.0 Hz, 2H), 1.82-2.10 (m, 4H), 1.64 (s, 3H), 1.54 (s, 3H), 
1.35 (s, 3H), 1.33 (td, J = 0.4, 7.0 Hz, 3H). 
 
Ethyl 8-methyl-8-(4-methylpent-3-enyl)-1,8-
dihydrocyclopenta[g]indole-2-carboxylate (5.18) 
 
A mixture of indole (5.7e) (50 mg, 0.1 mmol, 1.0 eq.), 
Pd(OAc)2 (2.5 mg, 0.01 mmol, 10 mol%), K2CO3 (44 mg, 0.3 
mmol, 3.0 eq.), and the dppe (13 mg, 0.03 mmol, 30 mol%) in degassed THF (2.1 
mL) was refluxed for 2½ h. After cooling to room temperature, water (2 mL) was 
added and the mixture was partitioned between Et2O (15 mL) and water (10 mL). The 
organic layer was washed with brine (5 mL), dried (MgSO4) and concentrated under 
vacuum. The obtained residue was purified by flash chromatography (hexane: Et2O, 
2:1 (v:v)) to afford the title compound as a faint yellow oil. 
N
H
CO2Et
 
1H-NMR (300 MHz, CDCl3): δ = 8.63 (brs, 1 H), 7.58 (dd, J = 0.75 Hz, J = 8.1 Hz, 1 
H), 7.29 (d, J = 2.0 Hz, 1 H), 7.19 (d, J = 8.1 Hz, 1 H), 6.78 (d, J = 5.4 Hz, 1 H), 6.39 
(d, J = 5.4 Hz, 1 H), 4.94 (m, 1 H), 4.43 (q, J = 7.1 Hz, 2 H), 2.1-1.59 (m, 4 H), 1.55 
(brs, 3 H), 1.44 (s, 3 H), 1.43 (t, J = 7.1 Hz, 3 H), 1.36 (brs, 3 H). ). 13C-NMR (75 
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MHz, CDCl3): δ = 162.5, 144.7, 141.4, 134.1, 132.7, 131.9, 130.1, 127.6, 126.7, 
124.4, 121.4, 116.1, 109.9, 61.2, 54.1, 38.0, 25.8, 23.9, 22.8, 17.7, 14.7. 
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CHAPTER 1 
Enecarbamates - An Overview 
 
1.1 - Introduction 
 
Enecarbamates (1.1) are a class of 
compounds in which a carbon-carbon 
double bond occurs next to the 
nitrogen of a carbamate group. 
Scheme 1.1 Typical reactivity pattern of 
enecarbamates (1.1). 
R3
N
R2
R4
R5
OR1
O
1.1
R1 = alkyl, aryl
R2 to R5 = H, alkyl, aryl
enamine
like
alkene
like
R3
N
R2
R4
R5
OR1
O
1.2
E
[2+2] cycloadditions
double bond
isomerizations
products
(carbonyl compounds,
carbamates etc.)
E
products
(cyclobutanones,
oxetanes, 
policyclic 
aromatic etc.)
electrocyclization
reactions
others
hydrolysis
others
reduction
 
Like the structurally related enamines, 
enecarbamates can react with 
electrophiles (E+) at the α position 
leading to N-acyl-iminium ion-type 
intermediates (1.2) which can then be 
converted to a variety of products.1.1 
On the other hand, enecarbamates can 
also participate in a range of processes 
where the carbamate functionality is 
not directly involved (although it can 
play a secondary role) and that are 
more characteristic of isolated carbon-
carbon double bonds (Scheme 1.1). 
Several examples of this double 
reactivity pattern will be illustrated 
later (vide infra, section 1.2). 
1.1 For the purpose of the present thesis, enecarbamates (1.1) will be considered as formal derivatives 
of the corresponding ketones. Hence, the enecarbamate α-position corresponds to the α-position of the 
parent ketone and aromatic/aliphatic enecarbamates refer to those derived from aromatic/aliphatic 
ketones, respectively (Scheme 1.A). 
 
R3
N
R2
R4
R5 R3
R4
R5
O
α α
aromatic enecarbamate (R3 = aryl)
aliphatic enecarbamate (R3 = alkyl)
CO2R1
 
 
Scheme 1.A Enecarbamates as formal derivatives of ketones. 
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Enecarbamates (1.1) have been prepared by different methods and a representative 
selection is shown in Scheme 1.2. α-Methoxy carbamates (1.4a), obtained by anodic 
methoxylation of the corresponding carbamates (1.3), can be converted into 
enecarbamates by elimination of methanol upon heating in the presence of acid or 
base.1.2 A related approach involves the base-assisted elimination of phenylsulfinic 
acid from α-amidoalkylphenyl sulfones (1.4b), which are available from the Mannich 
condensation of aldehydes (1.5), carbamates (1.6), and the sodium salt of 
phenylsulfinic acid.1.3 Enecarbamates have also been obtained via the Curtius 
rearrangement of unsaturated acyl azides (1.8) in the presence of an alcohol (1.9);1.4 
the former can in turn be prepared from the corresponding carboxylic acid (1.7). 
 
N
R2
R4
N
R2 CO2R1
R
N
R2 CO2R1
R
X
-2e-
MeOH H2N OR1
OPhSO2Na
aq. HCO2H
1.4a: X = OCH3
1.4b: X = SO2Ph
Acid 
or base
N
R2 CO2R1
R4
R3
1.12a: R2 = MgX
1.12b: R2, R3 = alkyl, aryl
R1OCOX
1.15
N
CO2R
N
CO2R
HO
( ) ( )n n
R3
R5
R´CHO +
1.1
1.3 1.5 1.6
1.13
[H-]
CO2H
R
NaN3
CON3
R
1.7 1.8
O
1.17 1.16
R3CN R3
O
1.10
-H2O
RMgX
x.11
R2NH2
1.14
ROH
1.9
R4
 
 
Scheme 1.2 Some preparative methods available for the synthesis of enecarbamates (1.1). 
 
                                               
1.2 Shono, T.; Yoshihiro, M.; Tsubata, K.; Sugihara, Y.; Yamane, S.; Kanazawa, T.; Aoki, T. J. Am. 
Chem. Soc. 1982, 104, 6697. 
1.3 (a) Mecozzi, T.; Petrini, M. Synlett 2000, 73. (b) Engberts, J. B. F. N.; Olijnsma, T.; Strating, J. 
Rec. Trav. Chim. 1966, 85, 1211. 
1.4 Overman, L. E.; Taylor, G. F.; Jessup, P. J. Tetrahedron Lett. 1976, 36, 3089. 
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Another route to enecarbamates involves the acylation of intermediates such as 
metallo-imine (1.12a) or imine (1.12b) with a formate-type reagent (1.15);1.5 imines 
(1.12a) are typically prepared by addition of a Grignard reagent (1.11) to nitriles 
(1.10) whereas imines (1.12b) are available via condensation of a ketone (1.13) with 
an amine (1.14). Finally, endocyclic enecarbamates are available from carbamate-
protected lactams (1.16) via reduction to the parent lactamol (1.17) and subsequent 
dehydration.1.6
 
In spite of the variety of routes available for the preparation of enecarbamates, each 
one of them has intrinsic limitations either with respect to the accessibility of the 
required starting material and/or functional group compatibility with the (often harsh) 
reaction conditions. Furthermore, the stereoselectivity of the process is frequently 
rather poor and, when efficient, the thermodynamic more stable E isomer is often the 
major product. Thus, it can be argue that the lack of a versatile, high yielding 
synthesis of enecarbamates is one of the main limitations to a more generalized use of 
these compounds. 
 
 
1.2 - Uses of Enecarbamates in Organic Synthesis 
 
The reduced alkene-nucleophilicity of enecarbamates, a direct consequence of their 
acylated nature, has to some extent limited their application in thermal carbon-carbon 
bond forming processes, and until fairly recently their use in organic synthesis was 
restricted to Friedel-Crafts acylations and Vilsmeier formylations. Two such 
examples are shown in Scheme 1.3 where the endocyclic enecarbamate (1.18) upon 
treatment with acid chloride (1.19) or DMF undergoes acylation or formylation at the 
α-position affording, after treatment with base, the parent carbonyl compounds 
(1.20a) and (1.20b), respectively.1.2
 
1.5 (a) Sven, Y. H.; Kagan, H. B. Bull. Soc. Chim. Fr. 1965, 5, 1454. (b) Chupp, J. C.; Weiss, E. R. J. 
Org. Chem. 1967, 33, 2357. 
1.6 (a) Dieter, R. K.; Sharma, R. R. J. Org. Chem. 1996, 61, 4180. (b) Yu, C.; Hu, L. Tetrahedron Lett. 
2001, 42, 5167. 
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N
CO2CH3
N
CO2CH3
or
1b) DMF, POCl3
CH2ClCH2Cl, 0 oC
1.20a: R=C8H17, 85%
1.20b: R=H, 94%
O
R
1.18
2) AcONa, H2O, Δ
1a) C8H17COCl
1.19
CH2Cl2, -70 oC to rt
 
 
Scheme 1.3 Use of enecarbamate (1.18) in Friedel-Crafts and Vilsmeyer reactions. 
 
Lately, there has been a growing interest in the use of enecarbamates as carbon 
nucleophiles, partyl because these compounds have proven to be compatible with in 
situ formation and activation of highly reactive cyclization initiators. A recent 
example by Funk and Cossey involving an oxocarbenium ion intermediate is shown 
in Scheme 1.4.1. a7  Regioselective lithiation of enecarbamate (1.21) followed by in situ 
alkylation with chiral epoxide (1.22) afforded trisubstituted E-enecarbamate (1.23) 
which, upon treatment with crotonaldehyde and InCl3, delivered the all-cis-
trisubstituted tetrahydropyran-4-one (1.24) by means of a diastereoselective Prins 
cyclisation. 
 
N
Me
Boc C8H17
N
Me
Boc C8H17
HO
OTBS
Me
CHO, InCl3
O
O
Me
Me
OTBS
 i) tBuLi
THF, -78 oC to -50 oC
OTBS
O
ii)
CH2Cl2, 0 oC
62%
84%
, BF3 Et2O
1.21
1.22
1.23 1.24
 
Scheme 1.4 Use of enecarbamate (1.23) in an intramolecular Prins cyclisation. 
 
Enecarbamates have also proved to be excellent substrates for the Paternò-Büchi 
reaction, particularly with aromatic aldehydes.1.8 Bach and Schröder reported that the 
photocyclisation of tertiary enecarbamate (1.25) and benzaldehyde proceeded in a 
regiospecific manner and with good diastereoselectivity to afford the cis-amino-
                                               
1.7 (a) Cossey, K., N.; Funk, R. L. J. Am. Chem. Soc. 2004, 126, 12216. (b) For a related example 
where quinone methides are used as cyclisation initiators, see: Angle, S. R.; Arnaiz, D. O.; Boyce, J. 
P.; Frutos, R. P.; Louie, M. S.; Mattson-Arnaiz, H. L.; Rainier, J. D.; Turnbull, K.; Yang, W. J. Org. 
Chem. 1994, 59, 6322. 
1.8 (a) Bach, T.; Schröder, J. J. Org. Chem. 1999, 64, 1265. (b) Bach, T.; Schröder, J. Synthesis, 2001, 
1114. (c) Bach, T. Angew. Chem. 1996, 108, 976. 
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oxetane (1.26) (Scheme 1.5). Upon treatment with TFA oxetane (1.26) underwent a 
ring-expansion to deliver an oxazolidinone ring system which was then converted into 
the corresponding tosylate (1.27). Subsequent reductive dehydrotosylation followed 
by basic hydrolysis delivered rac-ephedrine (1.28).1. a8
 
N
Boc
Me
O
Ph N
O N
Ph
OTs
O
Ph
Me
OH
NHMe
Me56%
1) TFA
CH2Cl2, -78 oC
58%
2) TsCl
py, 25 oC
86%
1) NaBH4
DMSO, 150 oC
81%
2) KOH
EtOH/H2O, reflux
77%
Me
Boc
1.25
PhCHO,
1.26 1.27 1.28
υh
MeCN, 30 oC
rac-ephedrine
 
Scheme 1.5 Use of enecarbamate (1.25) in a Paternò-Büchi reaction. 
 
Endocyclic enecarbamates have been employed as ketophiles in [2+2] cycloadditions 
with free ketenes to deliver functionalized cyclobutanones.1.9 Correia and co-workers 
reported that the reaction of enecarbamate (1.29) with ketene (1.30) affords the endo-
azabicyclic cyclobutanone (1.31) regiospecifically. Upon treatment with m-CPBA, the 
latter undergoes a regioselective Baeyer-Villiger ring expansion to γ-lactone (1.32). 
Subsequent hydrogenolysis of the Cbz protective group followed by reduction of the 
lactone ring delivered rac-platynecine (1.33) (Scheme 1.6).1. a9
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H N
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Cl
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HO OHH
Cl
Et3N
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Scheme 1.6 Total synthesis of rac-platynecine (1.33) using the [2+2] cycloaddition of 
enecarbamate (1.29) with ketene (1.30) as the key step. 
 
                                               
1.9 (a) de Faria, A. R.; Salvador, E. L.; Correia, C. R. D. J. Org. Chem. 2002, 67, 3651. (b) Miranda, P. 
C. M. L.; Correia, C. R. D. Tetrahedron Lett. 1999, 40, 7735. 
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Enecarbamates have also been extensively used in photochemical electrocyclization 
reactions, notably for the preparation of polycyclic aromatic compounds.1.10 Lenz and 
Koszyk used such a reaction in the total synthesis of duguenaine (1.36) (Scheme 
1.7).1.11 Irradiation of tetrahydroisoquinoline (1.34) in the presence of iodine affords 
N-carbethoxynorneolitsine (1.35) by means of a sequence that includes the cis-trans 
isomerisation of the enecarbamate double bond, an electrocyclization reaction and an 
oxidative re-aromatization. Saponification of the carbamate moiety followed by 
double condensation with formaldehyde finally delivers duguenaine (1.36). 
 
N
CO2Et THF/EtOH, rt
N
CO2Et
O
O
O
O N
O
O
1) KOH
EtOH, reflux
97%
2) CH2O
H2O/dioxane, rt
76%
O54%
1.34 1.35 1.36
duguenaine
υh , I2
 
Scheme 1.7 Total synthesis of duguenaine (1.36) from enecarbamate (1.34) by means of a tandem 
cis-trans isomerization/electrocyclization/aromatization sequence. 
 
Recently Kobayashi and co-workers reported the first examples of the use of 
enecarbamates as carbon nucleophiles in asymmetric catalysis.1.12 In the presence of a 
catalyst derived from Cu(OTf)2 and the C2-symmetric diamine (1.a), secondary 
enecarbamates such as (1.37) added to the double activated imine (1.38) affording, 
after acidic hydrolysis, the β-keto carbamate (1.39) in excellent yield and high 
enantioselectivity (Scheme 1.8). 
 
 
                                               
1.10 For reviews see: (a) Lenz, G. R. Synthesis 1978, 489. (b) Campbell, A. L.; Lenz, G. Synthesis 
1987, 421. Note: in these reviews no distinction is made between enecarbamates and enamides. 
1.11 Lenz, G. R.; Koszyk, F. J. J. Chem. Soc. Perkin Trans. 1 1984, 1273. 
1.12 Matsubara, R.; Nakamura, Y.; Kobayashi, S. Angew. Chem. Int. Ed. 2004, 43, 1679. 
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HN OBn
O
Ph
EtO
N OC11H23
O
O
1.37
2) HBr aq.
EtOH, 0 oC
CH2Cl2, 0 oC
EtO
Ph
NH
O
OC11H23O
O
1.39
94% , 93% ee
+
1.38
NH HN
R
PhPh
RR = 1-Naph
1.a
Cu(OTf)2, (10 mol%)
1)
 
 
Scheme 1.8 Use of enecarbamate (1.37) as carbon nucleophile in asymmetric catalysis. 
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CHAPTER 2 
Aim of the Project 
 
The good results obtained with the catalytic asymmetric addition reaction of 
enecarbamates to imines2.1 (vide section 1.2, Chapter 1) prompted us to investigate 
the corresponding reaction with carbonyl compounds. 
 
The catalytic asymmetric addition reaction of enecarbamates (1.1) to 
aldehydes/ketones (2.1), if successful, would provide an entry to a range of important 
1,3-bifunctional chiral compounds, obtainable by intercepting the chiral N-acyl-
iminium ion-type intermediate (2.2) using different conditions. Accordingly, 
hydrolysis of (2.2) would afford β-hydroxy ketones (2.3) which could then be reduced 
to the parent 1,3-diols (2.4); on the other hand, direct reduction of the imino linkage 
in (2.2) would allow access to β-hydroxy carbamates (2.5), which can be viewed as 
masked 1,3-amino alcohols (2.6). Furthermore, the chiral center(s) formed during the 
catalytic asymmetric step (*1 and *2) could be used to control the configuration at the 
keto/imino position (*3) upon reduction by means of 1,2- and/or 1,3-chiral induction 
and thus up to three contiguous chiral centers could in principle be constructed 
(Scheme 2.1).2.2
 
N
1.1
R1 = alkyl, aryl
R2, R3, R4, R5 = H, alkyl, aryl
R' R''
O
R2
R3
R4
R5
R1O
O
R3 OH
NR1O
O
R5R4
R' R''
R2
R3 OH
O
R5R4
R' R''
R3 OH
OH
R5R4
R' R''
R3 OH
NR1O
O
R5R4
R' R''
R2
R3 OH
NH
R5R4
R' R''
R2
2.1
2.2
2.3 2.4
2.5 2.6
H3O
chiral
catalyst
*1
*2
*1
*1 *1
*2 *2
*2*2
*1
*3
*3 *3
"H   "
"H   "
 
Scheme 2.1 Aimed catalytic asymmetric addition reaction of enecarbamates (1.1) to 
aldehydes/ketones (2.1) and the 1,3-bifunctional products that can be obtained. 
 
 
                                               
2.1 Matsubara, R.; Nakamura, Y.; Kobayashi, S. Angew. Chem. Int. Ed. 2004, 43, 1679. 
2.2 For a general review on substrate-directable chemical reactions, see: Hoveyda, A. H.; Evans, D. A.; Fu, 
G. C. Chem. Rev. 1993, 93, 1307. 
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CHAPTER 3 
Preparation of Enecarbamates and Chiral Ligands3.1
 
3.1 - Preparation of Enecarbamates 
 
The enecarbamates used through out this work were prepared by two different 
methods, depending on their substitution pattern. Aromatic enecarbamates (i.e., those 
with an aryl moiety at the same carbon as the carbamate group) were obtained via 
addition of a Grignard reagent to an aromatic nitrile and subsequent trapping of the 
metallo-imine intermediate with a chloroformate reagent (one pot) (Scheme 3.1).3.2
 
1) RMgBr
(R = Et, Bu, iPr)
THF, 0 oC to reflux
2) BnOCOCl
0 oC to rt
Ar
HN OR1
O
ArCN
1.37: Ar = Ph, 48%
3.1: Ar = p-OMePh, 43% 
3.2: Ar = p-ClPh, 47%
3.3: Ar = p-MePh
3.4: Ar = 2-Nap
Me Ar
N OBn
O
+
3.5
ArCN
1) MeMgBr
THF, 0 oC to reflux
Ar
HN Bn
O
2) R1OCOCl
(R1 = Bn, Et)
0 oC to rt
R2
3.6: Ar = Ph, R1 = Bn, R2 = Me, R3 = H,
         31% E plus 14% Z   
3.7: Ar = p-OMePh, R1 = Bn, R2 = Me, R3 = H,
         33% E plus 9% Z  
3.8: Ar = p-ClPh, R1 = Bn, R2 = Me, R3 = H, 
         33% E plus 12% Z
3.9: Ar =p-OMePh, R1 = Et, R2 = Me, R3 = H, 
         24% E plus 9% Z
3.10: Ar = Ph, R1 = Bn, R2 = R3 = Me
3.11 : Ar = Ph, R1 = Bn, R2 = Et, R3 = H
R3 Ar
N OBn
O
+
3.12
R3
R2
 
 
Scheme 3.1 Preparation of aromatic enecarbamates (1.37), (3.1) to (3.4) and (3.6) to (3.11). 
                                               
3.1 Some of the enecarbamates and chiral ligands described in this chapter and used occasionally 
during this work were available “on the shelf” in the Koyahashi’s group; for these no yields are 
reported. 
3.2 Sven, Y. H.; Kagan, H. B. Bull Soc. Chim. Fr. 1965, 5, 1454. 
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The enecarbamates thus obtained were isolated in moderate yields (typically around 
40%) by standard column flash chromatography; imines of the type (3.5) and (3.12) 
were common by-products. In those cases where E/Z isomerism is possible (i.e., for 
enecarbamates (3.6) to (3.11)), a mixture of isomers was always obtained and a 
modest E-selectivity was observed. The two geometric isomers could be separated by 
careful flash chromatography. 
 
On the other hand, aliphatic enecarbamates (i.e., those containing an alkyl group at 
the same carbon as the carbamate moiety) were prepared from the corresponding α,β-
unsaturated acid chlorides using the Curtius rearrangement to access the carbamate 
functionality.3.3 Angelic acid methyl ester was first hydrolyzed with LiOH to afford 
angelic acid (90% yield) which was converted into its acid chloride by treatment with 
oxalyl chloride; subsequent reaction with NaN3 afforded the corresponding acyl azide 
which was thermolysed into the parent isocyanate; reaction with BnOH then delivered 
Z-(3.13) in high yield (85% based on the angelic acid). The latter, upon treatment with 
KOtBu, afforded a 1:1 mixture of the both E and Z isomers which could be separated 
by careful preparative thin-layer chromatography (PTLC) (Scheme 3.2). 
 
Me
Me
O OH 2) NaN3
THF/H2O, 0 oC to rt Me
Me
HN OBn
O
Me
HN OBn
O
Me
KOtBu
THF, rt
Z-3.13
E-3.13
Me
Me
O OMe LiOH
MeOH/H2O, reflux
1) KOH, (COCl)2
Et2O, 0 oC
85% (based on angelic acid)
90% 3) Δ, THF
4) BnOH
-78 oC to rt
78% as a 1:1 mixture
Me
Me
HN OBn
O
Z-3.13
+
 
 
Scheme 3.2 Preparation of aliphatic enecarbamates Z- and E-(3.13). 
 
 
 
                                               
3.3 Overman, L.E.; Taylor, G. F.; Jessup, P. J. Tetrahedron Lett. 1976, 36, 3089. 
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The cyclohexyl-derived enecarbamate (3.14) was prepared in a similar manner from 
cyclohex-1-ene carboxylic acid (Scheme 3.3). 
 
HN OBn
O
CO2H 2) NaN3
THF/H2O, 0 oC to rt
1) KOH, (COCl)2
Et2O, 0 oC
3) Δ, THF
4) BnOH
-78 oC to rt
68% 
(based on cyclohex-1-ene-carboxylic acid)
3.14
 
 
Scheme 3.3 Preparation of aliphatic enecarbamate (3.14). 
 
Notably, all the enecarbamates are solid/crystalline materials which could be stored at 
room temperature for a long period of time without special precautions. 
 
 
3.2 - Preparation of Chiral Ligands 
 
The chiral ligands used in these studies were mainly bidentate, C2-symmetric 
diamines and diimines prepared from (R,R)-1,2-diphenyl-1,2-diaminoethane and 
(1R,2R)-cyclohexanediamine. The diamine ligands (1.a) and (3.b) to (3.i) were 
obtained via reaction of the starting diamine with the appropriated acid chloride 
followed by borane reduction (Scheme 3.4).3.4
 
H2N NH2
R1 R1'
NH HN
R1 R1'
R2 R2
1) R2COCl, Et3N
CH2Cl2, 0 oC to rt
2 i) BH3 THF
THF, reflux
ii) HCl aq.
 0 oC to reflux
For R1 = R1' = Ph
1.a: R2 = 1-Naph, 53%
3.b: R2 = 3,5-tBu2Ph, 48%
3.c: R2 = tBu
3.d: R2 = Ph, 67%
3.e: R2 = o-FPh
3.f: R2 = o-OMePh
R1 = R1' = Ph
R1 and R1' = cHexyl
For R1 and R1' = cHexyl
3.g: R2 = Ph
3.h: R2 = 2-Naph
3.i: R2 = 3,5-tBu2Ph
 
 
Scheme 3.4 Preparation of the chiral diamine ligands (1.a) and (3.b) to (3.i). 
                                               
3.4 Kobayashi, S.; Matsubara, R.; Nakamura, Y.; Kitagawa, H.; Sugiura, M. J. Am. Chem. Soc. 2003, 
125, 2507 and references therein. 
Part II  3.2 - Preparation of Chiral Ligands  
 
 
 156 
The diimines ligands (3.j) to (3.u) were prepared by reaction of (1R,2R)-
cyclohexanediamine with the appropriate aldehyde in refluxing EtOH.3. ,3.5 6
 
H2N NH2
N N
R2 R2
3.j: R2 = Ph, 85%
3.k: R2 = 1-Naph
3.l: R2 = 2-Naph
3.m: R2 = 3,5-tBu2Ph
3.n: R2 = o-Tol
3.o: R2 = p-Tol
R2CHO
EtOH, reflux
3.p: R2 = 2-Naph
3.q: R2 = p-EtPh
3.r: R2 = p-iPrPh
3.s: R2 = p-FPh
3.t: R2 = p-ClPh
3.u: R2 = p-BrPh, 91%  
 
Scheme 3.5 Preparation of the chiral diimines ligands (3.j) to (3.u). 
 
                                               
3.5 Hesemann, P.; Moreau, J. J. E.; Soto, T. Synth. Comm. 2003, 33, 183. 
3.6 In addition to the previously described diamine and diimine ligands, the commercially available 
oxazolidines (3.v) and (3.x) were also used in this work (Figure 3.A). 
 
Me Me
O
N N
O
R R
3.v: R = Ph
3.x: R = tBu  
 
Figure 3.A Commercially available oxazolidines ligands (3.v) and (3.x). 
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CHAPTER 4 
Results and Discussion 
 
4.1 - Addition of Enecarbamates to Aldehydes 
 
4.1.1 - Use of Benzaldehydes as Substrates 
 
Regarding the addition reaction of enecarbamates to aldehydes, the initial studies 
were performed with benzaldehyde and enecarbamate (1.37) (Table 4.1). 
 
Table 4.1 (Attempted) reaction of enecarbamate (1.37) with benzaldehyde. 
 
CHO HN
Ph
Cbz
+
N
Ph
Cbz
OH
conditions
(Table 4.1)
1.37 4.1  
 
Entrya L.A.b
Additive 
(eq.)b
TLC observationsc
1 - - SMs 
2d Cu(OTf)2 - SMs, 4.2 and 4.3 
3 Yb(OTf)3 - SMs, 4.2 and 4.3 
4 Sc(OTf)3 - SMs, 4.2 and 4.3 
5e - Et3N (1.2) SMs and 4.3 
6f - DMF (3.0) SMs and 4.3 
HNNH
Ph
Me
Ph
Cbz CBz
4.2
Ph
N
Cbz
4.3  
 
a The reactions were performed in CH2Cl2 at 0 oC to rt with 10 mol% of 
the catalyst, 1.0 eq. of benzaldehyde and 1.5 eq. of enecarbamate 
(1.37), unless otherwise stated; 
b “-“ stands for “not used”; 
c As judged by TLC at the end of the reaction; 
d The homocoupling enecarbamate (4.2) and the Cbz-protected imine 
(4.3) were isolated in 28% and 13% yields, respectively. 
 
 
As it can be seen, the reaction did not proceed in the absence of a catalyst or an 
additive (entry 1, Table 4.1). On the other hand, the use of a catalytic amount of 
Cu(OTf)2, which was expected to enhance the electrophilicity of the benzaldehyde, 
resulted in the isolation of the homocoupling enecarbamate (4.2) and the Cbz-imine 
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(4.3) in 28% and 13% yields, respectively (entry 2, Table 4.1). The use Yb(OTf)3 and 
Sc(OTf)3 resulted in similar observations (entry 3 & 4, respectively, Table 4.1). 
 
The formation of the enecarbamate (4.2) and imine (4.3) is most likely a direct 
consequence of the Lewis acidic sensitivity of enecarbamates and it was rationalized 
by the sequence shown in Scheme 4.1. 
 
Ph
N
Cbz
4.3
HN
Ph
Cbz
1.37
LA
HN
Ph
Cbz
1.37 NNH
Ph
Me
Ph
Cbz Cbz
4.4
LA HNNH
Ph
Me
Ph
Cbz Cbz
4.2
 
 
Scheme 4.1 LA-promoted formation of Cbz-imine (4.3) and  
homocoupled enecarbamate (4.2). 
 
Entries 5 and 6 in Table 4.1, where base-like additives such as Et3N and DMF were 
added, represent a conceptually different approach to promote the reaction in that it 
was the nucleophilicity of the enecarbamate (1.37) that was attempted to be enhanced. 
The idea behind the use of such additives was to form, even if in a small amount, the 
anionic species (4.5), which was expected to be a better nucleophile than 
enecarbamate (1.37). Disappointingly, however, this only promoted the formation of 
the Cbz-protected imine (4.3), presumably as a result of the ambidentate nature of 
(4.5) (Scheme 4.2). 
 
HN
Ph
Cbz
1.37
Additive N
Ph
Cbz
4.5
N
Ph
Cbz
4.6
HAdditive N
Ph
Cbz
4.3  
 
Scheme 4.2 Base-promoted formation of Cbz-imine (4.3). 
 
To counteract the weak nucleophilicity of enecarbamate (1.37), which is a general 
feature of this class of compounds, it was decided to use a more electrophilic substrate 
than benzaldehyde and nitro-benzaldehydes were chosen (Table 4.2). 
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Table 4.2 Reaction of enecarbamate (1.37) with nitrobenzaldehydes. 
 
CHO
HN
Ph
Cbz
+
N
Ph
OHconditions
(Table 4.2)
1.37 4.7
Cbz
NO2
NO2
HBr aq.
EtOH, 0 oC
O
Ph
OH
4.8a: p-nitro
4.8b: o-nitro
NO2
 
 
Entrya Aldehyde Catalystb
Yield 
(%) 
TLC observationsc
1 p-NO2PhCHO - 0 SMs 
2d  - 0 SMs 
3e  Cu(OTf)2 0 SMs, 4.2 and 4.3 
4  Sc(OTf)3 0 SMs, 4.2 and 4.3 
5  Yb(OTf)3 0 SMs, 4.2 and 4.3 
6  Mg(OTf)2 0 SMs, 4.2 and 4.3 
7  Ce(OTf)3 0 SMs, 4.2 and 4.3 
8e  BF3·Et2O 8 SMs, 4.2 and 4.3 
9f  Cu(OTf)2 + 1.a 9 SMs and minor 4.3 
10e o-NO2PhCHO BF3·Et2O 16 SMs, 4.2 and 4.3 
11g  Cu(OTf)2 + 1.a 15 SMs and minor 4.3 
NH HN
R
Ph Ph
R
R = 1-Naph
1.a
 
a The reactions were performed in CH2Cl2 at 0 oC to rt with 10 mol% of the 
catalyst, 1.0 eq. of the nitrobenzaldehyde and 1.5 eq. of enecarbamate (1.37), 
unless otherwise stated; 
b “-“ stands for “not used”; 
c As judged by TLC at the end of the reaction or, for entries 8 to 11, before the 
acidic hydrolysis; 
d The reaction was performed at reflux; 
e A stoichiometric amount of BF3·Et2O was used; 
f The β-hydroxy ketone (4.8a) was obtained with 36% ee. 
g The ee of β-hydroxy ketone (4.8b) was not determined. 
 
Initially p-nitrobenzaldehyde was used. In the absence of a catalyst, either at room 
temperature or at reflux, the reaction did not proceed and both SMs remained 
unchanged (entries 1 & 2, Table 4.2, respectively). The use of several LA as catalysts, 
namely Cu(OTf)2, Sc(OTf)3, Yb(OTf)3, Mg(OTf)2 and Ce(OTf)3 resulted in the 
formation of dimeric enecarbamate (4.2) and Cbz-imine (4.3) (entries 3 to 7, Table 
4.2, respectively). On the other hand, in the presence of a stoichiometric amount of 
Part II                                                     4.1 - Addition of Enecarbamates to Aldehydes 
 
 
 160
                                               
BF3·Et2O and after acidic hydrolysis,4.1 the expected β-hydroxy ketone (4.8a) was 
isolated, albeit in very poor yield (8%) (entry 8, Table 4.2). An important observation 
was made when a combination of Cu(OTf)2 and chiral diamine (1.a) was used (entry 
9, Table 4.2). While the reaction only delivered a 9% yield of the desired β-hydroxy 
ketone (4.8a), no formation of the dimeric enecarbamate (4.2) occurred and the Cbz-
imine (4.3) was present in only a very small amount, as judged by TLC. Thus, under 
these conditions the starting enecarbamate (1.37) is stable. A similar result was 
obtained when the same Cu(OTf)2-diamine (1.a) combination was used with o-
nitrobenzaldehyde; the expected β-hydroxy ketone (4.8b) was formed in a slightly 
higher yield (15%) and only a very small amount of the Cbz-imine (4.3) was observed 
by TLC plate (entry 11, Table 4.2). 
 
4.1.2 - Use of Ethyl Glyoxylate as the Substrate 
 
The yields obtained for the formation of β-hydroxy ketones 
(4.8a) and (4.8b) (vide supra, Table 4.2) correspond in good 
approximation to the amount of the catalyst used. This 
observation was rationalized by considering that the initial 
product, β-hydroxy imine (4.7), irreversibly traps the catalyst (as 
in (4.9)). This problem was addressed by the use of α,α’-
dicarbonyl compounds, which besides being highly reactive, are 
known to efficiently form five-membered chelate species (4.10) 
with transition metals (Figure 4.1).4.2
Ph Ph
N
Cbz
HO
M
L L
O O
M
L L
R1 R2
4.9
4.10
vs.
Figure 4.1 
4.1 The hydrolysis procedure facilitates the isolation and analysis of the reaction products and it will be 
used extensively in this work. 
4.2 For selected examples of the use of α,α’-dicarbonyl compounds in asymmetric catalysis, see: (a) 
aldol reactions with pyruvate esters: i) Evans, D. A.; Kozlowski, M. C.; Burgey, C. S.; Macmillan, D. 
W. C. J. Am. Chem. Soc. 1997, 119, 7893; ii) Evans, D. A.; Burgey, C. S.; Kozlowski, M. C.; Tregay, 
S. W. J. Am. Chem. Soc. 1999, 121, 686. (b) carbonly-ene reactions with ethyl glyoxylate: Evans, D. 
A.; Burgey, C. S.; Paras, N. A.; Vojkovsky, T.; Tregay, S. W. J. Am. Chem. Soc. 1998, 120, 5824. (c) 
hetero-Diels-Alder reactions with α-keto ester heterodienes: i) Evans, D. A.; Olhava, E. J.; Johnson, J. 
S.; Janey, J. M. Angew. Chem., Int. Ed. 1998, 37, 3372. ii) Thorhauge, J.; Johannsen, M.; Jørgensen, 
K. A. Angew. Chem., Int. Ed. 1998, 37, 2404. 
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4.1.2.1 - Catalyzed Addition Reaction of Enecarbamates to Ethyl 
Glyoxylate 
 
The reaction of enecarbamate (1.37) with ethyl glyoxylate,4.3 the simplest of the α,α’-
dicarbonyl compounds, was investigated (Table 4.3). Initially, we concentrated on the 
feasibility of the process rather than its enantioselectivity. 
 
Table 4.3 Reaction of enecarbamate (1.37) with ethyl glyoxylate - I. 
 
HN
Ph
Cbz
+EtO H
O
O
Ph
OH N
EtO
O
Cbz
1.37 4.13
conditions
(Table 4.3)
HBr aq.
EtOH, 0 oC
O
Ph
OH
4.14
EtO
O
 
 
Entrya Catalystb Yield (%) TLC observationsc
1 - 13 1.37 
2 Cu(OTf)2 18 4.2 and 4.3 
3 CuClO4·4CH3CN 67 4.2 and 4.3 
4 Sc(OTf)3 40 4.2 and 4.3 
5 Yb(OTf)3 59 4.2 and 4.3 
6 Ni(OTf)2 <58 4.2 and 4.3 
7d Cu(OTf)2 + 1.a 93 - 
 
a The reactions were performed in CH2Cl2 at 0 oC with 10 mol% of the 
catalyst, 1.0 eq. of enecarbamate (1.37) and 1.2 eq. of ethyl glyoxylate, 
and subjected to acidic hydrolysis after 1 h, unless otherwise stated; 
b “-“ stands for “not used”; 
c As judged by TLC before the acidic hydrolysis; 
d The β-hydroxy ketone (4.14) was obtained with 55% ee. 
 
Even in the absence of any catalyst the reaction afforded the expected β-hydroxy 
ketone (4.14) in 13% yield after acid hydrolysis (entry 1, Table 4.3). The catalytic use 
of several LA, namely Cu(OTf)2, CuClO4·4CH3CN, Sc(OTf)3, Yb(OTf)3 and 
Ni(OTf)2, also delivered the desired product in yields ranging 18-67% but extensive 
conversion of the starting enecarbamate (1.37) into the homocoupled enecarbamate 
(4.2) and the Cbz-protected imine (4.3) occurred (entries 2 to 6, Table 4.3). The best 
                                               
4.3 Ethyl glyoxylate is commercially available as a solution of the corresponding polymer. After 
removal of the solvent, monomeric ethyl glyoxylate is obtained by distillation of the polymeric residue 
with a catalytic amount of P2O5. 
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result was obtained when the catalyst prepared from Cu(OTf)2 and the C2-symmetric 
diamine (1.a) was used (93% yield, entry 7, Table 4.3). Formation of (4.2) and (4.3) 
was not observed under these conditions which can be ascribed to a decrease in the 
Lewis acidity of the copper ion when coordinated to the diamine ligand (1.a). 
 
4.1.2.2 - Enantioselective Catalyzed Addition Reaction of 
Enecarbamates to Ethyl Glyoxylate 
 
Having established the feasibility of the reaction of enecarbamates with ethyl 
glyoxylate to afford β-hydroxy ketones, the extension to an enantioselective version 
of this process was next investigated. 
 
4.1.2.2.1 - General Screening of Catalysts 
 
A preliminary screening was conducted where various LA/C2-symmetric chiral 
ligands combinations were tested. The results are shown in Table 4.4. 
 
Table 4.4 Reaction of enecarbamate (1.37) with ethyl glyoxylate - II. 
 
HN
Ph
Cbz
+EtO H
O
O
Ph
OH N
EtO
O
Cbz
1.37 4.13
conditions
(Table 4.4)
HBr aq.
EtOH, 0 oC
O
Ph
OH
4.14
EtO
O*
*
 
 
Entrya L.A. 
Chiral 
Ligand 
Yield 
(%) 
ee (%) 
1 LiClO4 3.d 21 0 
2 NaOTf 3.d trace nd 
3 Mg(OTf)2 3.b 5 38 
4b Sc(OTf)3 3.d 58 28 
5b,c Sc(OTf)3 3.d 40 17 
6b Sc(OTf)3 3.x 60 1 
7d FeCl2 3.d <38 2 
8b,e CoCl2 3.d 77 2 
9b,e CoCl2 3.x 73 1 
10 Ni(OTf)2 3.d 87 56 
11 Cu(OTf)2 1.a 93 55 
NH HN
R R
PhPh
MeMe
O
N N
O
R R
3.x: R = tBu
1.a: R = 1-Naph
3.b: R = 3,5-tBu2Ph
3.d: R = Ph
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Table 4.4 (cont.) 
 
Entrya L.A. 
Chiral 
Ligand 
Yield 
(%) 
ee (%) 
12 CuClO4·4CH3CN 1.a 90 35 
13 Zn(OTf)2 1.a 86 39 
14 Zn(OTf)2 3.i 62 16 
15d AgSbF6 3.j <14 18 
16 AgOTf 3.j <31 35 
17 Sn(OTf)2 3.d 44 8 
18b,e BiCl3 3.d <26 2 
19 La(OTf)3 3.d 70 0 
20 Ce(OTf)3 3.d 68 0 
21 Pr(OTf)3 3.d 61 0 
22 Nd(OTf)3 3.d 74 2 
23 Sm(OTf)3 3.d 82 0 
24 Sm(OTf)3 3.j 65 2 
25 Sm(OTf)3 3.x 88 0 
26 Ho(OTf)3 3.d 66 0 
27 Yb(OTf)3 3.b 40 2 
EtO
O
HO
Ph
HN
Cbz
4.15
EtO
O
HO
Ph
NH2
4.16
N N
R R
3.j: R = Ph
 
a The reactions were performed in CH2Cl2 at 0 oC with 10 mol% of the 
catalyst, 1.0 eq. of enecarbamate (1.37) and 1.2 eq. of ethyl glyoxylate 
and subjected to acidic hydrolysis after 1 h, unless otherwise stated; 
b Enecarbamate homocoupled product (4.2) and Cbz-imine (4.3) 
observed on TLC; 
c The reaction was performed at rt; 
d The isolated product was not completely pure; 
e The β-hydroxy enecarbamate (4.15) and β-hydroxy enamine (4.16) 
were formed. 
 
From these studies it emerged that copper(I), copper(II) and nickel(II) salts have the 
best catalytic activity for this reaction, affording the aldol-type product (4.14) in 
higher than 90% yield (entry 10 for Ni(OTf)2; entries 11 & 12 for Cu(OTf)2 and 
CuClO4·4CH3CN, Table 4.4, respectively) and with enantiomeric excesses as high as 
56% (entry 10 for Ni(OTf)2, Table 4.4). On the other hand, lithium(I), sodium(I), 
magnesium(II), iron(II), silver(I), and bismuth(III) do not seem to be efficient catalyst 
for this reaction (entries 1, 2, 3, 7, 15 & 16 and 18, Table 4.4, respectively). When the 
reaction was performed with scandium(III), cobalt(II) and bismuth(III) salts (entries 4 
to 6, 8 & 9 and 18, Table 4.4, respectively), the dimeric enecarbamate (4.2) was 
observed on TLC. Furthermore, the β-hydroxy enecarbamate (4.15) and the 
corresponding enamine (4.16) were also isolated or detected by TLC for these cases. 
These results imply that, under these stronger Lewis acidic conditions, the 
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intermediate β-hydroxy imine (4.13) is not stable and it isomerizes to the 
corresponding enecarbamate (4.15); acidic hydrolysis then partially removes the Cbz 
group delivering the starting β-hydroxy enecarbamate (4.15) and the β-hydroxy 
enamine (4.16) (Scheme 4.3). 
 
EtO
O
HO
Ph
HN
Cbz
* EtO
O
HO
Ph
NH2
*
4.15 4.16
EtO
O
HO
Ph
N
Cbz
*
4.13
acidic 
hydrolysis
EtO
O
HO
Ph
HN
Cbz
*
4.15
+
cat.
 
Scheme 4.3 L.A.-promoted formation of β-hydroxy enecarbamate (4.15) and enamine (4.16). 
 
Finally, when different lanthanide salts were used the desired product was produced 
in modest to good yields (40% to 88%), but with negligible enantiomeric excesses 
(<6%) (entries 19 to 27, Table 4.4). 
 
The good results obtained with the cooper and nickel salts prompted us to screen 
these metals more carefully. 
 
4.1.2.2.2 - Use of Copper(II)-Based Catalysts 
 
We started with copper(II) and the results are shown in Table 4.5. 
 
Table 4.5 Reaction of enecarbamate (1.37) with ethyl glyoxylate using Cu(II)-based catalysts. 
 
HN
Ph
Cbz
+EtO H
O
O
Ph
OH N
EtO
O
Cbz
1.37 4.13
conditions
(Table 4.5)
HBr aq.
EtOH, 0 oC
O
Ph
OH
R-4.14
EtO
O
*
 
 
Entrya L.A. 
Chiral 
Ligand 
Yield 
(%) 
ee (%)b
1 Cu(OTf)2 1.a 93 55 
2c  1.a 91 54 
3d  1.a 89 58 
4  3.b 74 59 
5e  3.b 44 47 
6  3.c 58 57 
NH HN
R R
PhPh
1.a: R =1-Naph
3.b: R = 3,5-tBu2Ph
3.c: R = tBu
3.d: R = Ph
3.e: R = o-FPh
3.f: R = o-OMePh  
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Table 4.5 (cont.) 
 
Entrya L.A. 
Chiral 
Ligand 
Yield 
(%) 
ee (%)b
7 Cu(OTf)2 3.d 96 46 
8  3.e 97 37 
9  3.f 94 31 
10b  3.v 85 31 
11b,d  3.v 91 31 
12b  3.x 70 73 
13  3.j 65 70 
14  3.k 66 28 
15  3.l 71 52 
16  3.m 68 17 
17  3.g 89 51 
18  3.h 91 50 
19  3.i quant. 62 
20b CuCl2 1.a 47 17 
21  3.b 55 26 
22  3.j 50 19 
23 Cu(SbF6)2 3.b 77 44 
NH HN
R R
3.g: R = Ph
3.h: R = 2-Naph
3.i: R = 3,5-tBu2-Ph
N N
R R
MeMe
O
N N
O
R R
3.v: R = Ph
3.x: R = tBu
3.j: R = Ph
3.k: R = 1-Naph
3.l: R = 2-Naph
3.m: R = 3,5-tBu2-Ph  
 
a The reactions were performed in CH2Cl2 at 0 oC with 10 
mol% of the catalyst, 1.0 eq. of enecarbamate (1.37) and 1.2 
eq. of ethyl glyoxylate and subjected to acidic hydrolysis after 
1 h, unless otherwise stated; 
b The absolute configuration is R, except for entries 10-12 and 
20; 
c 30 mol% of catalyst was used; 
d The reaction was performed at -20 oC; 
e The reaction was performed at -78 oC. 
 
The reaction proceeded smoothly in all cases to afford, after acidic hydrolysis, the 
expected β-hydroxy ketone (4.14) in moderate to excellent yields (44% to 
quantitative). The source of copper(II) proved to be an important parameter for 
obtaining high yields and Cu(OTf)2 systematically afforded the best results (entries 1 
to 19 versus entries 20 to 23, Table 4.5, respectively). Unfortunately, only moderate 
enantiomeric excesses (up to 73%) were obtained, regardless of the chiral ligand used. 
In the diamine ligand series (entries 1 to 9 and 17 to 19, Table 4.5), the use of 
sterically more demanding ligands resulted in marginal improvements in the 
enantioselectivity but it had occasionally a serious detrimental effect on the reaction 
yield (e.g., entry 6 (a catalyst prepared with a tert-butyl type ligand afforded the 
product in 58% yield and 57% ee) versus entry 7 (with a phenyl based ligand, the 
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product was obtained in 96% yield and 46% ee), Table 4.5). In this series of ligands, 
the best result (quantitative yield and 62% ee) was obtained with the bulky 
cyclohexyl-derived diamine ligand (3.i) (entry 19, Table 4.5). Interestingly, in the 
diimine ligand series (entries 13 to 16, Table 4.5), a somewhat opposite trend to that 
observed with the diamine ligands was noticed. The yields were, to some extent 
independent of the steric bulkiness of the ligand and less sterically demanding ligands 
afforded considerably higher enantiomeric excesses (e.g., entry 16 (where a catalyst 
containing a ligand with tert-butyl moieties afforded the expected product in 68% 
yield but only 17% ee) versus entry 13 (where a catalyst with phenyl groups delivered 
the product in 65% yield and 70% ee), Table 4.5). Notably, the highest enantiomeric 
excess (73%) was obtained with a catalyst complex prepared from Cu(OTf)2 and the 
widely used tert-butyl-Box ligand (3.x) (entry 12, Table 4.5). Attempts to increase the 
enantioselectivity by performing the reaction at lower temperatures resulted in only 
small improvements (e.g., entry 1 (55% ee at 0 oC) versus entry 3 (58% ee at -20 oC), 
Table 4.5). 
 
4.1.2.2.3 - Use of Copper(I)-Based Catalysts 
 
The use of copper(I) salts were then tested. The results are shown in Table 4.6. 
 
Table 4.6 Reaction of enecarbamate (1.37) with ethyl glyoxylate using Cu(I)-based catalysts. 
 
HN
Ph
Cbz
+EtO H
O
O
Ph
OH N
EtO
O
Cbz
1.37 4.13
conditions
(Table 4.6)
HBr aq.
EtOH, 0 oC
O
Ph
OH
(S)-4.14
EtO
O
*
 
 
Entrya L.A. 
Chiral  
Ligand 
Yield  
(%) 
ee (%)b
1b CuClO4·4CH3CN 1.a 90 35 
2  3.j 94 93 
3  3.k 92 73 
4  3.l 52 68 
5c  3.j 48 91 
6d  3.j 97 93 
7e  3.j quant. 94 
8e  3.n 97 81 
9e  3.p quant. 86 
N N
R R
3.j: R = Ph
3.k: R = 1-Naph
3.l: R = 2-Naph
3.n: R = o-Tol
3.p: R = m-Tol
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Table 4.6 (cont.) 
 
Entrya L.A. 
Chiral  
Ligand 
Yield  
(%) 
ee (%)b
10e CuClO4·4CH3CN 3.o 98 95 
11e,f  3.o 20 17 
12e,g  3.o traces nd 
13e  3.q 87 94 
14e  3.r 93 94 
15e  3.s 97 96 
16e  3.t 93 97 
17e  3.u 93 97 
18 CuSbF6 3.j 77 44 
19 CuPF6·4CH3CN 3.j 94 82 
20 CuOTf·½C6H5CH3 3.j 66 78 
N N
R R
3.o: R = p-Tol
3.q: R = p-EtPh
3.r: R = p-iPrPh
3.s: R = p-FPh
3.t: R = p-ClPh
3.u: R = p-BrPh
 
a The reactions were performed in CH2Cl2 at 0 oC with 10 mol% of the 
catalyst, 1.0 eq. of enecarbamate (1.37) and 1.2 eq. of ethyl glyoxylate 
and subjected to acidic hydrolysis after 1 h, unless otherwise stated; 
b The absolute configuration of the product is (S), except for entry 1 (R); 
c The reaction was performed at -78 oC; 
d 1.5 eq. of ethyl glyoxylate was used; 
e 2.0 eq. ethyl glyoxylate was used; 
f Toluene was used as the solvent; 
g Acetonitrile was used as the solvent. 
 
The copper(I)-diamine and copper(I)-diimine catalysts are equally efficient at 
promoting the addition reaction of enecarbamate (1.37) to ethyl glyoxylate, with the 
expected β-hydroxy ketone (4.14) being obtained in good to excellent yields after 
acidic hydrolysis (66% to quantitative) (Table 4.6). The source of copper(I) was 
important to the reaction yields, and CuClO4·4CH3CN afforded the best results (e.g., 
entry 2 (CuClO4·4CH3CN, 94%) versus entries 18 & 20 (CuSbF6, 77% and 
CuOTf·½C6H5CH3, 66%, respectively), Table 4.6). Furthermore, when diimine 
ligands were used, the β-hydroxy ketone (4.14) was formed with high to excellent 
enantiomeric excesses. The highest enantiomeric excess was obtained with a catalyst 
derived from CuClO4·4CH3CN and the para-halogenated-phenyl diimine ligands (3.t) 
and (3.u) (97% ee) (entries 16 & 17, respectively, Table 4.6). When the complex 
obtained from CuClO4·4CH3CN and diimine ligand (3.j) was used as the catalyst and 
the reaction was performed at -78 oC, the yield decreased markedly to 48%, although 
the expected β-hydroxy ketone (4.14) was still formed with 91 % enantiomeric excess 
(entry 5, Table 4.6). 
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4.1.2.2.4 - Use of Nickel(II)-Based Catalysts 
 
Finally, nickel(II) was briefly investigated (Table 4.7). 
 
Table 4.7 Reaction of enecarbamate (1.37) with ethyl glyoxylate using Ni(II)-based catalysts. 
 
HN
Ph
Cbz
+EtO H
O
O
Ph
OH N
EtO
O
Cbz
1.37 4.13
conditions
(Table 4.7)
HBr aq.
EtOH, 0 oC
O
Ph
OH
4.14
EtO
O
* *
 
 
Entrya L.A. Chiral Ligandb Yield (%) ee (%) 
1 Ni(OTf)2 - 58  
2  3.d 87 56 
3  3.u 71 5 
4  3.x 84 86 
 
a The reactions were performed in CH2Cl2 at 0 oC with 10 mol% of the 
catalyst, 1.0 eq. of enecarbamate (x.1) and 1.2 eq. of ethyl glyoxylate and 
subjected to acidic hydrolysis after 1 h; 
b “-“ stands for “not used”. 
 
The expected β-hydroxy ketone (4.14) was produced in moderate to good yields (58% 
to 84%). However, with the exception of the widely used catalyst derived from 
Ni(OTf)2 and the tert-butyl Box ligand (3.x), which afforded the product with good 
enantiomeric excess (86% ee) (entry 4, Table 4.7), the enantioselectivities obtained 
were only modest. On the other hand, a novel nickel(II)-based catalyst derived from 
Ni(OTf)2 and the diamine ligand (3.d) was unveiled. Remarkably, this new catalyst 
promoted the formation of ketone (4.14) in a more enantioselective manner than the 
corresponding copper(II)-based catalyst (entry 2, Table 4.7 (nickel(II), 56% ee) versus 
entry 7, Table 4.5, (copper(II), 46% ee)). Some applications of this new catalyst will 
be demonstrated later (vide infra, Section 4.2.1.2.2). 
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4.1.2.2.5 - Effect of the Solvent and the Catalyst Loading 
 
Having established that under the conditions studied the best catalytic system for the 
addition reaction is derived from CuClO4·4CH3CN and the diimine-type ligands (3.t) 
and (3.u), a brief evaluation of other variables that could affect the enantioselectivity 
of the process was performed. Accordingly, the solvent and the catalyst loading were 
investigated. The results are presented in Table 4.8. 
 
Table 4.8 Effect of the solvent and catalyst loading on the enantioselectivity of the reaction. 
 
HN
Ph
Cbz
+
EtO
H
O
O
1.37
O
Ph
OH
S-4.14
EtO
O
N N
R R
CuClO4 4CH3CN
(x mol%)
solvent
(table 4.8)
1)
2) HBr aq.
EtOH, 0 oC
 
 
Entrya Solvent Ligand 
Catalyst Loading 
(x mol%) Yield (%) ee (%) 
1 CH2Cl2 3.o 10 98 95 
2 PhMe 3.o 10 20 17 
3 CH3CN 3.o 10 traces nd 
4b CH2Cl2 3.u 10 93 97 
5b CH2Cl2 3.u 5 94 96 
6b CH2Cl2 3.u 2 96 95 
7b CH2Cl2 3.u 1 90 94 
 
a The reactions were performed in the specified solvent at 0 oC with x mol% of the catalyst, 
1.0 eq. of enecarbamate (1.37) and 2.0 eq. of ethyl glyoxylate and subjected to acidic 
hydrolysis after 1 h, unless otherwise stated 
b 1.2 eq. of ethyl glyoxylate was used. 
 
In toluene and acetonitrile, the catalytic activity of the resultant complexes decreased 
significantly and the β-hydroxy ketone (4.14) was formed only in low yields (up to 
20%) (entries 2 & 3, Table 4.8,). With a set of optimal conditions determined 
concerning the metal source, ligand, and the solvent, the catalyst loading was 
minimized (entries 4 to 7, Table 4.8). As shown, even when only 1.0 mol% of the 
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catalyst was used, the β-hydroxy ketone (4.14) was still formed in high yield (90%) 
and with only a slightly reduced enantiomeric excess (94%) (entry 7, Table 4.8). 
 
4.1.2.2.6 - Extension to Other Enecarbamates 
 
Having determined the optimal reaction conditions to perform the addition of the 
prototype enecarbamate (1.37) to ethyl glyoxylate in an enantioselective manner, this 
process was then extended to other enecarbamates (Table 4.9). 
 
Table 4.9 Reaction of various enecarbamates with ethyl glyoxylate. 
 
HN
+EtO H
O
O
3.1 to 3.4
3.6 to 3.11
3.14 & 3.15
O
R2
OH
x.30 to x.41
EtO
O
N N
R R
1)
2) HBr aq.
EtOH, 0 oC
3.u
R2
OR1
O
R3
CuClO4 4CH3CN
(10 mol%)
CH2Cl2, 0 oCR4
R3 R4
R = p-BrPh
 
 
Entrya Enecarbamate Product 
Yield 
(%) 
Syn:Anti 
ratiob
ee 
(%)b,c
1 3.1 4.17 94 - 93 
2 3.2 4.18 97 - 97 
3 3.3 4.19 quant - 96 
4 3.4 4.20 91 - 96 
5 E-3.6 anti-4.21 83 1:99 98 
6d E-3.6e anti-4.21 93 1:99 97 
7d E-3.6f anti-4.21 95 1:99 98 
8 Z-3.6 syn-4.21 82 98:2 98 
9 Z-3.6e syn-4.21 93 98:2 98 
10 Z-3.6f syn-4.21 96 98:2 98 
11 E-3.7 anti-4.22 96  2:98 98 
12 Z-3.7 syn-4.22 97 98:2 98 
      
Ar
HN
3.1: Ar = p-OMePh
3.2: Ar = p-ClPh
3.3: Ar = p-MePh
3.4: Ar = 2-Naph
Cbz
Ar
HN OR1
O
3.6: R1 = Bn, Ar = Ph
3.7: R1 = Bn, Ar = p-OMePh
3.8: R1 = Bn, Ar = p-ClPh
3.9: R1 = Et, Ar = p-OMePh
Me
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Table 4.9 (cont.) 
 
Entrya Enecarbamate Product 
Yield 
(%) 
Syn/Anti 
ratiob
ee 
(%)b,c
13 E-3.8 anti-4.23 85 2:98 98 
14 Z-3.8 syn-4.23 79 99:1 98 
15 E-3.9 anti-4.24 82 3:97 96 
16 Z-3.9 syn-4.24 96 99:1 98 
17g 3.10 4.25 22 - 84 
18 E-3.11h anti-4.26 58 1:99 98 
19 Z-3.11 syn-4.26 92 99:1 98 
20 E-3.13 anti-4.27 83 3:97i 97 
21d Z-3.13 syn-4.27 89 92:8i 98 
22d 3.14 anti-4.28 85 16:84i 94 
HN
Cbz
Me
3.13
HN
Cbz
3.14
Ph
HN
Cbz
Et
3.11
Ph
HN
Cbz
3.10
 
 
a The reactions were performed in CH2Cl2 at 0 oC with 10 mol% of the 
catalyst, 1.0 eq. of enecarbamate and 1.2 eq. of ethyl glyoxylate and 
subjected to acidic hydrolysis after 1 h, unless otherwise stated; 
b Determined by HPLC; 
c For entries 5-22 it corresponds to the enantiomeric excess of the major 
diastereomer. 
d The reaction performed at -20 oC; 
e 1 mol% of the catalyst was used and the reaction was quenched after 
approx. 36 h; 
f 0.1 mol% of the catalyst was used and the reaction was quenched after 
approx. 46 h; 
g The reaction was performed at rt and subjected to acidic hydrolysis after 
28 h. 
h 2.0 eq. of ethyl glyoxylate were used; 
i Determined by NMR analysis. 
 
The enecarbamates (3.1) to (3.4) reacted with ethyl glyoxylate to afford the 
corresponding β-hydroxy ketones (4.17) to (4.20) in excellent yields (>91%) and with 
high enantiomeric excess (up to 97%) (entries 1 to 4, Table 4.9). When α-methyl-
substituted enecarbamates (3.6) to (3.9) were used, the parent α-methyl-β-hydroxy 
benzophenones (4.21) to (4.24) were obtained in good yields (79% to 97%) (entries 5 
to 16, Table 4.9). Furthermore, these reactions proceeded with very high diastereo- 
and enantioselectivities: the syn:anti ratios of the two diastereomers was always 
higher than 3:97 and 98:2, respectively, and the major diastereomer was formed with 
>95% enantiomeric excess. Notably, E-enecarbamates afforded products with the anti 
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configuration whereas Z-enecarbamates delivered the syn-adducts.4.4 Decreasing the 
catalyst loading afforded slightly better yields, although lower temperature and 
prolonged reaction times were occasionally necessary. When 0.1 mol% of the catalyst 
was used and the reaction performed with E-(3.6) at -20 oC over approximately 46 h, 
anti-(4.21) was obtained in 95% yield, compared to 83% yield when using the 
standard conditions (entry 5 vs. entry 7, Table 4.9). The reaction could also be 
extended to more sterically demanding substrates. The α,α’-dimethyl enecarbamate 
(3.10) afforded the parent diketone (4.25) in good enantiomeric excess (84%) but in 
poor yield (22%) (entry 17, Table 4.9). On the other hand, the α-ethyl-substituted 
enecarbamates (3.11) delivered the corresponding α-ethyl-β-hydroxy benzophenone 
(4.26) with high diastereo- and enantioselectivities (entries 18 & 19, Table 4.9). The 
same trend regarding the high yields and good diastereo- and enantioselectivities of 
the β-hydroxy ketones products was observed for the aliphatic enecarbamates (3.13). 
On the other hand, the cyclohexanone-derived enecarbamate (3.14) reacted somewhat 
more sluggishly, affording the expected product (4.28) with a lower 
diastereoselectivity (syn:anti, 16:84) (entry 22, Table 4.9). 
 
4.1.2.3 - Mechanistic Considerations 
 
The catalyzed addition of enecarbamates to ethyl glyoxylate can be envisioned to take 
place either through an open, extended transition state or a closed, cyclic 6-membered 
transition state (Scheme 4.4 and Scheme 4.5, respectively).4.5
4.4 The relative configuration of the α-methyl-β-hydroxy diketone (4.21) was determined by analysis 
of the X-ray crystal structure of the corresponding lactone (4.a), which was prepared from the former 
via NaBH4 reduction and subsequent acid catalyzed cyclization (one pot) (Scheme 4.A). 
 
EtO
Ph
O
OOH
1) NaBH4
MeOH, 0 oC to rt
2) TsOH H2O
O
HO
O
Ph
X-ray
4.21
relative configuration
(anti)-4.21 4.a  
 
Scheme 4.A Determination of the relative configuration of α-methyl-β-hydroxy diketone (4.21). 
 
The relative configuration of similar products was determined by analogy of the respective 1H-NMR 
spectra to that of anti-(4.21). 
4.5 Diastereoselectivities in additions of π-based nucleophiles (e.g., silyl enol ethers, allylic 
organometallics, etc.) to aldehydes or ketones have been discussed extensively using open or cyclic 
transition state models. For aldol reactions, see: (a) Mahrwald, R. Chem Rev. 1999, 99, 1095. For 
allylations, see: (b) Yamamoto, Y.; Asao, N. Chem. Rev. 1993, 93, 2207. For effects of the olefin 
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In open, extended transition states the conformational freedom of the reactants 
complicates a detailed analysis of the reaction; thus it is not straight forward to predict 
which arrangement of the reactants (e.g., synclinal versus anticlinal) is favored. A 
tentative analysis, based on an intuitively more likely anticlinal disposition between 
the S-cis conformation of the ethyl glyoxylate and the enecarbamate is shown in 
Scheme 4.4. E-enecarbamates are used in transition states TS1 and TS2 whereas Z-
enecarbamates are used in TS3 and TS4. The steric interaction between the methyl 
group at the α position of the enecarbamate and the copper complex is expected to be 
larger in TS1 and TS4. Thus, TS2 and TS3 are predicted to be favored.  
 
E-enecarbamate
TS1
Z-enecarbamate
TS4
E-enecarbamate Z-enecarbamate
TS2 TS3
Me
EtO2C H
H
O
NHCbzR
H
EtO2C Me
H
O
RCbzHN
H
EtO2C Me
H
O
NHCbzR
Me
EtO2C H
H
O
RCbzHN
EtO2C
OH
Me
R
O
anti
EtO2C
OH
Me
R
O
syn
EtO2C
OH
Me
R
O
syn
EtO2C
OH
Me
R
O
anti
H
O
EtO
O
Cu
Me H
R NHCbz
H
O
EtO
O
Cu
H Me
CbzHN H
H
O
EtO
O
Cu
H Me
R NHCbz
H
O
EtO
O
Cu
Me H
CbzHN R
 
 
Scheme 4.4 Models for hypothetical open, extended transition states. 
 
Therefore, based on this type of transition state, both E- and Z- enecarbamates would 
stereoconvergently afford the syn-product, which contradicts the observed 
diastereoselectivity. Furthermore, no simultaneous proton transfer can occur in such 
                                                                                                                                            
geometry on the diastereoselectivity, see: (c) Keck, G. E.; Savin, K. A.; Cressman, E. N. K.; Abbott, 
D. E. J. Org. Chem. 1994, 59, 7889. (d) Roush, W. R.; Ando, K.; Powers, D. B.; Palkowitz, A. D.; 
Halterman, R. L. J. Am. Chem. Soc. 1990, 112, 6339. 
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open, extended transition states and hence formation of a high energy zwitterionic 
species would result for this process, making it unlikely. 
 
On the other hand, in a closed, cyclic 6-membered transition state, the proton transfer 
from the nitrogen to the oxygen of ethyl glyoxylate is expected to be an easy process 
since, as a consequence of the compact arrangement between the reactants, these two 
centers are close together. This proton transfer can occur more or less concertedly 
with the development of the new carbon-carbon bond thus avoiding, as far as 
possible, the formation of an energetically disfavored charged intermediate. Possible 
closed, cyclic 6-membered transition states, corresponding to such aza-ene type 
mechanism, are shown in (Scheme 4.5).4. ,4.6 7
 
Cbz Cbz
E-enecarbamate
TS5
E-enecarbamate
TS6
Z-enecarbamate
TS7
Z-enecarbamate
TS8
O
N
R
Me
H
H
O
EtO
H
O
O
EtO
H
H
R
N
H Me
O
N
R
H
H
Me
O
EtO
H
O
O
EtO
H
H
R
N
Me H
HO
N
EtO2C H
H
MeR
EtO2C R
OH
Me
O
H
HO
EtO2C H
Me
N
R
Cbz Cbz
Cbz
Cbz
EtO2C R
OH
Me
O
HO
N
EtO2C H
Me
HR
EtO2C R
OH
Me
O
Cbz
Me
HO
EtO2C H
H
N
R
Cbz
EtO2C R
OH
Me
O
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Scheme 4.5 Models for closed, cyclic 6-membered transition states. 
                                               
4.6 For a review of aza-ene reactions, see: Borzilleri, R. M.; Weinreb, S. M. Synthesis 1995, 347. 
4.7 A concerted aza-ene-type mechanism in Michael addition involving a chiral enamine has been 
previously proposed, see: (a) Ambroise, L.; Desmaële, D.; Mahuteau, J.; d’Angelo, J. Tetrahedron 
Lett. 1994, 35, 9705. (b) Bahmanyar, S.; Houk, K. N. J. Am. Chem. Soc. 2001, 123, 11273. 
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E-enecarbamates are used in transition states TS5 and TS6 whereas Z-enecarbamates 
are used in TS7 and TS8. TS5 and TS7 are expected to be disfavored with respect to 
TS6 and TS8 due to an unfavorable 1,3-diaxial type interaction between the R group 
of the enecarbamate and the ethyl component of ethyl glyoxylate. This prediction is in 
agreement with the simple diastereoselection observed: Z-enecarbamates 
stereoselectively afford 1,2-syn products whereas E-enecarbamates deliver 1,2-anti 
adducts. 
 
Such aza-ene type mechanism is in agreement with the Woodward-Hoffmann rules 
for pericyclic reactions,4.8 illustrated as a 6-electron, all-suprafacial [σ2+π2+π2] 
process in Scheme 4.6. In order to allow the σ-overlap to develop properly head on 
and the π-overlap sideways on, the transition state for this atom-transfer reaction is 
proposed to have an envelope-type conformation. 
 
N
R
Me
H
H O
HEtO2C
Cbz
N
O
H
R
Me
HO
OEt
Cu
Cbz
H
[σ2s +π2s+π2s]
(4q+2)s: 3
     (4r)a: 0
total: 3
 
 
Scheme 4.6 Analysis of the proposed aza-ene type mechanism for the catalyzed addition reaction 
of enecarbamates to ethyl glyoxylate according to the Woodward-Hoffmann rules for pericyclic 
reactions. 
 
To obtain more information about the reaction mechanism, the role of the proton at 
enecarbamate nitrogen was investigated. For this purpose the tertiary enecarbamate 
(4.29) was prepared and it was subsequently treated with ethyl glyoxylate in the 
presence of 10 mol% of CuClO4·4CH3CN/diimine (3.u) (Scheme 4.7). That the 
reaction did not proceed, even at room temperature, to afford zwitterionic (4.30) 
shows that a transferable proton at the enecarbamate nitrogen is a necessary condition 
for this process, a result that further supports an aza-ene type of mechanism. 
                                               
4.8 (a) R. B. Woodward and R. Hoffmann in “The Conservation of Orbital Symmetry” 1970, Verlag 
Chemie, Academidc Press, New York (b) Fleming, I. in “Pericyclic Reactions” 1999, 67, Oxford 
Science Publications, Oxford Chemistry Primers. 
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Scheme 4.7 (Attempted) reaction of tertiary enecarbamate (4.29) with ethyl glyoxylate. 
 
To gain an insight into the origin of the high stereoselectivity, we tried to gather 
information about the structure of the chiral copper(I) catalyst. However, all attempts 
to isolate it were unsuccessful. 
 
Nonetheless, a putative working model that explains the observed diastereo- and 
enantioselectivity for such aza-ene type reaction catalyzed by the [Cu(I)-(R,R)-
diimine (3.u))]·ClO4 complex is shown in Scheme 4.8. The key features of this model 
are that it assumes a four-coordinate (eventually distorted) tetrahedral geometry at the 
copper(I) metal center and a two point catalyst-enophile binding. Therefore, the imine 
nitrogens of the ligand and the ethyl glyoxylate oxygens are held in (approximately) 
orthogonal planes whereas the ethyl glyoxylate is “locked” in the S-cis conformation. 
On the other hand, the two imine nitrogens of the chiral ligand are held in a trans 
arrangement by the cyclohexane ring group. The likely consequence of these 
geometric constrains, is that one of the “arms” of the chiral C2 symmetric ligand 
effectively shields the Re-face of the ethyl glyoxylate hence leaving the Si-face 
available for approach by the Si-face of the enecarbamate. This model correctly 
correlates the chirality of the (R,R)-diimine ligand to the observed stereochemistry of 
the adduct (S)-(4.14). 
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Scheme 4.8 Working model to account for the observed absolute stereochemistry in the addition 
reaction of enecarbamates to ethyl glyoxylate catalyzed by Cu(I)-C2 symmetric diamine ligand 
 
4.1.2.5 - Diastereoselective Reductions of Cbz-Protected β-Hydroxy 
Imines to Cbz-Protected β-Hydroxy Amines 
 
Thus far, the primary product of the reaction of enecarbamates with ethyl glyoxylate, 
a protected β-hydroxy imine, was hydrolyzed to afford the corresponding β-hydroxy 
ketone. To further demonstrate the utility of enecarbamates as carbon nucleophiles, 
the (stereoselective) reduction of these β-hydroxy imine intermediates was 
investigated. If successful, this would allow the access to 1,3-hydroxy carbamates 
which could then be converted into the parent 1,3-amino alcohols. The latter are 
important compounds in organic chemistry, not only because they are useful synthetic 
intermediates but also important ligands for asymmetric catalysis.4.9
 
Whereas the stereoselective reduction of β-hydroxy ketones is well-known,4.10 there 
are relatively few examples concerning the corresponding process for 1,3-
iminoalcohols.4.11 Furthermore, the reduction of a single β-hydroxy imine 
stereoisomer to either the syn- or anti-1,3 amino alcohol through the use of different 
reagents and reactions conditions is even rarer.4.12
                                               
4.9 Hulst, R.; Heres, H.; Peper, N. C. M. W.; Kellogg, R. M. Tetrahedron: Asymmetry 1996, 7, 1373. 
(b) Li, X.; Yeung, C.-H.; Chan, A. S. C.; Yang, T.-K. Tetrahedron: Asymmetry 1999, 10, 759. (c) 
Evans, P. A.; Holmes, A. B.; McGeary, R. P.; Nadin, A.; Russell, K.; O’Hanlon, P. J.; Pearson, N. D. 
J. Chem. Soc., Perkin Trans. 1 1996, 123. 
4.10 For a review see: Hoveyda, A. H.; Evans, D. A.; Fu, G. C. Chem. Rev. 1993, 93, 1307. 
4.11 Some strategies to convert 1,3-hydroxy imines to either syn- or anti-1,3-amino alcohols by 
choosing an appropriate geometry of the imines or a suitable protecting group on the nitrogen have 
been reported, see: (a) Williams, D., R.; Osterhout, M., H. J. Am. Chem. Soc. 1992, 114, 8750. (b) 
Haddad, M.; Dorbais, J.; Larcheveque, M. Tetrahedron Lett. 1997, 38, 5981. 
4.12 To the best of the author’s knowledge this has only been accomplished with β-hydroxy N-sulfinly 
imines, see: Kochi, T.; Tang, T. P.; Ellman, J. A. J. Am. Chem. Soc. 2003, 125, 11276. 
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Therefore, the goal for this reduction step was twofold: i) to accomplish the reduction 
diastereoselectively and ii) to identify conditions to selectively access both syn- and 
anti-1,3-hydroxy carbamates from a common precursor. Our efforts towards these 
ends are presented in Table 4.10.4.13 We concentrated on some of the most commonly 
used reducing agents for the diastereoselective conversion of β-hydroxy ketones into 
the parent 1,3-diols.4.10
 
Table 4.10 Preparation of β-hydroxy carbamate (4.31) via the reduction of the β-imino alcohol 
intermediate (4.13). 
 
HN
Ph
Cbz
+EtO H
O
O
Ph
OH N
EtO
O
Cbz
1.37 4.13
conditions
(Table 4.10) HN
Ph
OH
4.31
EtO
O
Cbz
N N
R R
3.u
CuClO4 4CH3CN
(10 mol%)
CH2Cl2, 0 oC
R = p-BrPh
 
 
Entrya
Reagent 
(eq.) 
Additive 
(eq.)b
Solvent 
T 
(oC) 
t (h) 
Yield 
(%)c
syn:anti 
ratiod
1 Zn(BH4)2
(2.0) 
- Et2O 0 2 traces nd 
2 Zn(BH4)2
(1.0) 
- Et2O -78 1 <65 71:29 
3 Zn(BH4)2
(2.0) 
- Et2O -78 3 <48 86:14 
4 Zn(BH4)2
(1.0) 
- Et2O -78 3 <66 78:22 
5e Zn(BH4)2
(1.0) 
4Å MS Et2O -78 3 <75 78:22 
6 Zn(BH4)2
(1.0) 
- PhMe-Et2O 
(1:1) 
-78 1 <75 75:25 
7 NaBH4
(2.0) 
- EtOH 0 ½ <16 67:33 
8 NaBH4
(2.0) 
- EtOH -78 24 68 59:41 
 
                                               
4.13 Most of the results in this section should be credited to Ryosuke Matsubara. 
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Table 4.10 (cont.) 
 
Entrya
Reagent 
(eq.) 
Additive 
(eq.)b
Solvent 
T 
(oC) 
t (h) Yield 
(%)c
syn:anti 
ratiod
9 LiAlH(OtBu)3
(3.0) 
- Et2O 0 2 0 - 
10 LiAlH(OtBu)3
(5.0) 
- Et2O -78 20 traces nd 
11 LiAlH(OtBu)3
(5.0) 
LiI 
(5.0) 
Et2O -78 20 traces nd 
12 
9-BBN 
(3.0) 
- THF -20 16½ traces nd 
13 
Catecholborane 
(5.0) 
- THF -78 24 traces nd 
14 
K-Selectride 
(2.2) 
- THF -20 1.2 traces nd 
15 
K-Selectride 
(2.2) 
- THF -45 4 0 - 
16 
K-Selectride 
(2.2) 
- THF -78 4 0 - 
17 
L-Selectride 
(2.2) 
- THF -20 16½ <59 22:78 
18 
NaBH4
(2.0) 
ZnCl2
(1.5) 
MeOH -78 5½ traces nd 
19 
NaBH4
(2.2) 
Et2B(OMe) 
(1.1) 
THF-MeOH 
(4:1) 
-78 3 <60 94:6 
20 
NaBH4
(2.2) 
Et2B(OMe) 
(1.1) 
THF-MeOH 
(4:1) 
-45 3 <68 91:9 
21 
NaBH4
(2.2) 
Et2B(OMe) 
(2.2) 
THF-MeOH 
(4:1) 
-78 5½ 55 91:9 
22 
NaBH4
(2.2) 
Et2B(OMe) 
(2.2) 
THF-MeOH 
(4:1) 
-45 5½ 69 88:12 
23 
NaBH4
(2.2) 
Et2B(OMe) 
(2.2) 
THF-MeOH 
(3:2) 
-78 2 <37 nd 
24 
NaBH4
(3.0) 
Et2B(OMe) 
(3.0) 
THF-MeOH 
(4:1) 
-78 2 65 94:6 
 
a The 1st step of the reactions was performed in CH2Cl2 at 0 oC with 10 mol% of the catalyst, 1.0 eq. of 
enecarbamate (x.1) and 1.2 eq. of ethyl glyoxylate and the resulting crude β-imino alcohol (4.13) was 
subjected to the 2nd step (reduction) typically after 1 h; 
b “-“ stands for “not used”; 
c A small amount of unknown impurities was always present except in entries 15, 16 and 18; 
d “nd” stands for “not determined”; 
e An amount of 10 mg of 4Å MS per 0.1 mmol of substrate was used. 
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The use of Zn(BH4)24.14 was investigated under a variety of conditions (entries 1 to 6, 
Table 4.10). When the reaction was performed at 0 oC, extensive decomposition of 
the starting 1,3 hydroxy imine (4.13) was observed (entry 1, Table 4.10). On the other 
hand, when the reduction was carried at -78 oC the expected 1,3-hydroxy carbamate 
(4.31) was obtained in moderate to good yields (approximately 50% to 75%) and 
good syn-selectivities (syn:anti ratio up to 86:14) (entries 2 to 6, Table 4.10).4.15 
NaBH4 was able to deliver the 1,3-hydroxy carbamate (4.31) but it proved to be 
inferior to Zn(BH4)2, both with respect to the reaction yields (up to only 68%) (entry 
8, Table 4.10) and the diastereoselectivity (67:33, syn:anti ratio,) (entry 7, Table 
4.10). On the contrary, LiAlH(OtBu)3, 9-BBN, catecholborane and K-Selectride 
afforded only traces or none of the desired product under the conditions investigated 
(entries 9 to 16, Table 4.10). Interestingly, when L-Selectride was used instead of K-
Selectride, the expected 1,3-hydroxy carbamate (4.31) was produced in modest yield 
(approximately 60%) and with moderate anti-selectivity (syn:anti ratio, 22:78,) (entry 
17). The best result regarding the diastereoselectivity of this process was obtained 
with the combination NaBH4-Et2B(OMe)4.16 in a THF-MeOH mixture mainly at -78 
oC (entries 19 to 24, Table 4.10). After some optimization the expected 1,3-hydroxy 
carbamate (4.31) could be obtained with very high syn-selectivities (syn:anti ratio up 
to 94:6) although only in modest yield (around 60%) (entry 24, Table 4.10). 
 
The stereoselectivities observed in the above reduction are related with the ability of 
the several reducing agents to distinguish between the different conformations of the 
Cbz-protected β-hydroxy imine (4.13) in solution. In the cases where Zn(BH3)2 and 
NaBH4-Et2B(OMe) were used, the imine (4.13) is likely to be present as a stable 6-
4.14 (a) Nakata, T.; Tanaka, T.; Oishi, T. Tetrahedron Lett. 1983, 24, 2653. (b) Nakata, T.; Tani, Y.; 
Hatozaki, M.; Oishi, T. Chem. Pharm. Bull. 1984, 32, 1411. 
4.15 The relative configuration of the products (4.31) was determined by NOE experiments in the 
lactam (4.c) which was prepared from (4.31) via TBDMS protection of the alcohol functionality, 
followed by hydrogenolysis of the Cbz protecting group and in situ cyclization (Scheme 4.B). 
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Scheme 4.B Derivatization of (4.31) to determine the relative configuration. 
 
4.16 (a) Narasaka, K.; Pai, F.-C. Tetrahedron 1984, 40, 2233. (b) Chen, K.-M.; Hardtmann, G. E.; 
Prasad, K.; Repic, O.; Shapiro, M. J. Tetrahedron Lett. 1987, 28, 155. 
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membered cyclic chelate.4. ,4.14 16 Among the different conformers corresponding to 
such arrangement, the twisted-chair (4.33) is expected to be the most populated; the 
alternative twisted-chair conformer (4.32) is destabilized due to 1,3-axial type 
interactions between the ester group and the substituents on the metal (Zimmerman-
Traxler-type analysis). The achievement of the high syn-1,3-asymmetric induction 
observed can then be explained by the preferential approach of the reducing agent 
from the Si-face of conformer(4.33). This bias partially results from the 
stereoelectronic effects that control such type of reactions: additions to iminium-type 
ions proceed in such a way that the lone pair on the nitrogen develops antiperiplanar 
with respect to the incoming nucleophile.4.17 Thus, whereas hydride delivery to the 
Re-face of the iminium species (4.33) leads to the unfavorable twist-boat type 
intermediate (4.34), which affords the minor anti-(4.31) product, addition to the Si 
face proceeds through the more stable chair-type intermediate (4.36) hence delivering 
major syn-(4.31). In addition, it is likely that the axial H at the α position will also 
contribute in shielding the hydride approach from the Re face. 
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Scheme 4.9 Proposed chelation-controlled mechanism leading to the syn-(4.32) as the major 
product. 
                                               
4.17 A. J. Kirby in “Stereoelectronic Effects” 1996, 36, Oxford Science Publications, Oxford Chemistry 
Primers. 
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On the other hand, the slight preference for the formation of the anti-product observed 
when bulky L-Selectide was used should be rationalized by considering an open-chain 
model for the addition.4.18 Accordingly, the most stable conformer of the lithium-salt 
of the β-hydroxy imine (4.13) should be such that, in order to avoid Pitzer strain, all 
bonds are staggered. One can further assume, again for steric reasons, an anticlinal 
arrangement between the iminium group and the bulkiest substituent at the β position, 
presumably the ester. If so conformers (4.37) and (4.38), shown in Scheme 4.10, are 
likely to be almost equally populated, which would result in the formation of the 
diastereomeric products anti-(4.31) and syn-(4.31), respectively, in approximately 
equal amounts. The origin of the small difference in energy favoring (4.37) is perhaps 
the result of a preferred interaction between the iminium-phenyl and the H at the β 
position (Scheme 4.10). 
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Scheme 4.10 Proposed open-chain mechanism leading to the anti-(4.31) as the major product. 
 
 
 
                                               
4.18 For open-chain models dealing with 1,3-asymmetric induction and applications, see: (a) Brienne, 
M-J.; Ouannès, C.; Jacques, J. Bull. Soc. Chim. Fr. 1968, 3, 1036. (b) Leitereg, T. J.; Cram, D. J. J. 
Am. Chem. Soc. 1968, 90, 4011 and 4019. (c) Evans, D. A.; Duffy, J. L.; Dart, M. J. Tetrahedron Lett. 
1994, 35, 8537. (d) Evans, D. A.; Dart, M. J.; Duffy, J. L.; Yang, M. G. J. Am. Chem. Soc. 1996, 116, 
4322. (e) Bonini, C.; Esposito, V.; D’Auria, M.; Righi, G. Tetrahedron 1997, 53, 13419. 
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It should be noted that an argument favoring the conformer leading to the syn-
configured (4.31) could equally have been put forward. In fact, on the ground of 
electrostatic factors, conformer (4.38) is expected to be favored over (4.37) as the 
interaction between the dipoles associated with the iminium bond and the net dipole 
from the Cβ-OLi and Cβ-CO2Et is minimized in the former. 
 
 
4.2 - Addition to α,α’-Diketones 
 
Having developed a highly diastereo- and enantioselective catalyzed addition reaction 
of enecarbamates to ethyl glyoxylate, the possibility of extending this methodology to 
α,α’-diketones was next investigated. 
 
4.2.1 - Use of Butane-2,3-dione as Substrate 
 
4.2.1.1 - Catalyzed addition reaction of enecarbamates to Butane-2,3-
dione 
 
The initial studies were conducted with the C2-symmetrical butane-2,3-dione and 
enecarbamate (1.37). As with ethyl glyoxylate, the crude reaction mixtures were 
subjected to acidic hydrolysis to give diketone products as these are easier to handle 
and analyze. The results obtained are shown in Table 4.11. 
 
Identical reaction conditions to those that afforded the best results in the ethyl 
glyoxylate case (i.e., reaction performed at 0 oC using a catalyst derived from 
CuClO4·4CH3CN and dimine (3.u) and quenching the reaction after 1 h) were initial 
tested. However, under these conditions, the addition reaction did not proceed (entry 
1, Table 4.11). When a considerably longer reaction time was used the expected 
diketone (4.41) was isolated although in very low yield (5%) and modest 
enantiomeric excess (47% ee) (entry 2, Table 4.11). This marked difference in 
behavior between ethyl glyoxylate and butane-2,3-dione was ascribed to the less 
pronounced electrophilic character of the latter. Thus, while the weak Lewis acidic 
copper(I)-diimine (3.u) catalyst is able to promote the stereoselective addition of 
enecarbamates to ethyl glyoxylate, it seems that it can not provide enough activation 
in the diketone case. Therefore, somewhat harsher conditions were used, namely 
stronger Lewis acids and/or higher temperatures and/or longer reaction times. When 
BF3·OEt2 was used and the reaction was performed at room temperature over 9 h, the 
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expected diketone (4.41) was not formed, presumably due to extensive decomposition 
of the enecarbamate (1.37) under these conditions (entry 3, Table 4.11). 
 
Table 4.11 Reaction of enecarbamate (1.37) and butane-2,3-dione - I. 
 
NHCbz
+Me Me
O
O
O
Ph
Me
O
*
2) HBr aq.
EtOH, 0 oC
Ph
1) LA, ligand
(10 mol%)
CH2Cl2, t (h)
HO Me
1.37 4.41  
 
Entrya L.A. Ligand T (oC) t (h) Yield (%) ee (%) 
1 CuClO4·4CH3CN 3.j 0 1 0 - 
2 CuClO4·4CH3CN 3.i 0 9 5 47 
3 BF3·OEt2 - 0 to rt 9 0 - 
4 Cu(OTf)2 1.a 0 to rt 9 58 30 
5 Cu(OTf)2 3.d 0 to rt 9 61 22 
6b Cu(OTf)2 3.d 0 to rt 15 68 2 
7c Cu(OTf)2 3.d 0 to rt 9 63 42 
 
a The reactions were performed in CH2Cl2 at the stated temperature with 1.2 eq. of 
enecarbamate (1.37) being added to a solution of 10 mol% of the catalyst, and 1.0 eq. of 
butane-2,3-dione and subjected to acidic hydrolysis after the time stated, unless otherwise 
stated; 
b An amount of 10 mg of 3Å MS per 0.1 mmol of substrate was added to the (preformed) 
catalyst solution; 
c A solution of the catalyst was cannulated in three portions (1 h intervals) to an ice cold 
solution of the enecarbamate and the diketone. 
 
Better results were obtained when catalysts derived from Cu(OTf)2 and diamine 
ligands were used and the reactions performed at room temperature over longer 
reaction times; with these conditions diketone (4.41) was isolated in moderate yields 
(58% to 68%) and with modest enantiomeric excess (up to 30%) (entries 4 to 6, Table 
4.11). The use of bulkier diamine ligands had a (small) positive effect in the 
enantioselectivity of the reaction: diketone (4.41) was formed with 30% ee when the 
napthly-based (1.a) ligand was employed whereas the use of the corresponding 
phenyl-based (3.d) ligand delivered the product with 22% ee (entry 4 vs. entry 5, 
Table 4.11, respectively). The use of molecular sieves was detrimental both to the rate 
as well as on the enantioselectivity of the reaction (entry 6, Table 4.11). Notably, 
using an inverse addition procedure (where the catalyst solution was slowly added to 
a solution of the reactants) was advantageous for the reaction enantioselectivity: using 
these conditions, the diketone (4.41) was obtained with 42% ee (entry 7, Table 4.11). 
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4.2.1.2 - Enantioselective Catalyzed Addition Reaction of 
Enecarbamates to Butane-2,3-dione 
 
4.2.1.2.1 - General Screening of Catalysts 
 
Having determined that the catalyzed addition of enecarbamates to α,α’-diketones is 
feasible, the corresponding enantioselective version of this process was next 
investigated. The initial results concerning the effect of the metal centre are shown in 
Table 4.12.  
 
Table 4.12 Reaction of enecarbamate (1.37) and butane-2,3-dione - II. 
 
NHCbz
+
Me
Me
O
O
O
Ph
Me
O
*
2) HBr aq.
EtOH, 0 oC
Ph
HO Me
1.37 4.41
NH HN
Ph Ph
Ph Ph
1) L.A.,
(10 mol%)
CH2Cl2, 0 oC, 48h
 
 
Entrya L.A. Yield (%) ee (%) 
1 Cu(OTf)2 72 71 
2b Cu(OTf)2 85 74 
3 CuOTf·½PhH 14 57 
3 Ni(OTf)2 67 76 
4 Zn(OTf)2 31 75 
5 Co(OTf)2 5 45 
6 Sc(OTf)3 0 - 
 
a The reactions were performed in CH2Cl2 at 0 oC with 10 mol% of the catalyst (in a 
concentration of 7 mM),.1.0 eq. of enecarbamate (1.37) and 2.0 eq. of butane-2,3-dione 
and subjected to acidic hydrolysis after 48 h, unless otherwise stated; 
b A solution of the catalyst was added over 6 h to a -20 oC solution of the reactants 
(inverse addition) and kept at this temperature for approx. 60 h, after which it was 
subjected to acidic hydrolysis. 
 
When the reaction was performed in the presence of Cu(OTf)2-diamine (3.d) (10 
mol%) at 0 oC using two equivalents of butane-2,3-dione and quenched after 48 hours 
(acidic hydrolysis), the expected diketone (4.41) was formed in good yield (72%) and 
good enantiomeric excess (71%) (entry 1, Table 4.12). This result could be enhanced 
by performing the reaction at -20 oC and using an inverse addition protocol; with 
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these conditions diketone (4.41) was isolated in 85% yield and 76% ee (entry 2, Table 
4.12). In agreement with the preliminary screening, a comparison between catalysts 
derived from copper(II) and copper(I) triflates showed the former to be superior: the 
use of CuOTf·½PhH was detrimental, both with respect to the reaction yields (14%) 
and the enantioselectivity (57% ee) (entry 3, Table 4.12).We then investigated the use 
of other cationic transition metal triflates complexes of the same diamine (3.d) as 
catalysts for this reaction. The new nickel(II)-diamine (3.d) catalyst discovered during 
the ethyl glyoxylate studies (vide supra, section 4.1.2.2.4) proved to be as efficient as 
the corresponding copper(II) complex: whereas Cu(OTf)2 afforded a slightly better 
yield than Ni(OTf)2 (72% versus 67%, respectively), the obtained enantiomeric 
excess was slightly higher with the latter (76% versus 71%, respectively) (entry 1 
versus entry 3, Table 4.12). Zn(OTf)2 is was less efficient promoter of the addition 
reaction as the product diketone (4.41) was obtained in only 31% yield, although it 
does so with similar selectivity to Cu(OTf)2 and Ni(OTf)2: diketone (4.41) was 
formed with 74% ee (entry 4, Table 4.12). Co(OTf)2 afforded diketone (4.41) only in 
very low yield (5%) and with low enantiomeric excess (45%) (entry 5, Table 4.12). 
Finally, Sc(OTf)3 failed to catalyze the reaction under the conditions used (entry 6, 
Table 4.12). 
 
4.2.1.2.2 - Use of the Nickel(II)-Diamine (3.d) Catalyst 
 
Since Ni(OTf)2 delivered the highest enantiomeric excess and because it is relatively 
under-studied as a Lewis acid with respect to its first row neighbours, this LA was 
chosen for further studies. Furthermore, the choice of nickel allowed us to focus on 
the use of the new Ni(OTf)2-diamine (3.d) catalyst that was discovered previously 
(vide supra, section 4.1.2.2.4).4.19 The effect of the reaction temperature, catalyst 
loading and concentration were investigated and the results are presented in Table 
4.13. 
 
 
 
 
4.19 For representative examples of nickel(II) complexes as chiral L.A. in catalysis see: (a) Evans, D. 
A.; Downey, W.; Hubbs, J. L. J. Am. Chem. Soc. 2003, 125, 8706. (b) Kanemasa, S.; Oderaotoshi, Y.; 
Wada, E.; J. Am. Chem. Soc. 1999, 121, 8675. (c) Kanemasa, S.; Oderaotoshi, Y.; Tanaka, J.; Wada, 
E. J. Am. Chem. Soc. 1998, 120, 12355. (d) Suga, H.; Kakehi, A.; Mitsuda, M. Chem. Lett. 2002, 900. 
(e) Zhuang, W.; Hazell, R. G.; Jørgensen, K. A. Chem. Commun. 2001, 1240. (f) Suga, H.; Nakajima, 
T.; Itoh, K.; Kakehi, A. Org. Lett. 2005, 7, 1431. 
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Table 4.13 Reaction of enecarbamate (1.37) with butane-2,3-dione using the  
Ni(OTf)2-diamine(3.d) catalyst. 
 
NHCbz
+
Me
Me
O
O
O
Ph
Me
O
*
2) HBr aq.
EtOH, 0 oC
Ph
HO Me
1.37 4.41
NH HN
Ph Ph
Ph Ph
1) Ni(OTf)2,
x mol%
CH2Cl2, 0 oC
3.d
 
 
Entrya x mol% Catalyst (mM) Solvent Yield (%) ee (%) 
1 10 7 CH2Cl2 67 76 
2b 10 7 CH2Cl2 - - 
3c 10 7 CH2Cl2 27 49 
4d 10 7 CH2Cl2 94 84 
5 15 7 CH2Cl2 33 76 
6 5 7 CH2Cl2 15 79 
7 6 3 CH2Cl2 17 77 
8 6 12 CH2Cl2 20 69 
9 10 8 PhMe 47 75 
10 10 8 PhMe:CH2Cl2 (4:1) 46 80 
11 10 8 PhMe:CH2Cl2 (1:1) 32 80 
12 10 8 Et2O 26 70 
 
 
a The reactions were performed in the stated solvent at 0 oC with the x mol% of catalyst, 1.0 eq. of 
enecarbamate (1.37) and 2.0 eq. of butane-2,3-dione and subjected to acidic hydrolysis after 48 h, 
unless otherwise mentioned; 
b The reaction was performed at -30 oC; precipitate observed after approx. ½ h; the reaction was 
quenched after 72 h; 
c The reaction was performed at 40 oC; precipitate observed after approx. 17 h; the reaction was 
quenched after 24 h; 
d The reaction was quenched after 14 days. 
 
Attempts to improve the enantioselectivity by performing the reaction at a lower 
temperature (-30 oC) only led to disappointing results; under these conditions the 
reaction did not proceed at all, presumably because the catalyst is not stable at this 
temperature (entry 2, Table 4.13). No improvement resulted either by heating the 
reaction (40 oC) (entry 3, Table 4.13). When the reaction was allowed to proceed over 
14 days (!), noticeable improvements, particularly in the reaction yield, were 
observed: the diketone (4.41) was isolated in 94% yield and 84% enantiomeric excess 
(entry 4, Table 4.13). This result has as important corollaries that i) the Ni(OTf)2-
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diamine (3.d) is a useful Lewis acid for the activation of α,α’-diketones in the 
enantioselective addition with enecarbamates and ii) the reaction is only limited by 
the turnover frequency and not catalyst inhibition or decomposition. An increase in 
the catalyst loading (from 10 mol% to 15 mol%) surprisingly lead to a considerable 
decrease in the reaction yield (67% to 33%), although the enantiomeric excess of 
diketone (4.41) was unaffected (76%) (entry 5 versus entry 1, respectively, Table 
4.13). Reducing the catalyst loading (5 mol%) resulted in a pronounced reduction of 
the reaction yield (15%) whereas a minor improvement in the enantiomeric excess of 
the expected diketone (4.41) was observed (79%) (entry 6, Table 4.13). A 
simultaneous reduction in the loading and concentration of the catalyst (6 mol% and 3 
mM, respectively) had a dramatic negative effect on the reaction yield (17%) while 
the enantiomeric excess improved marginally (77%) (entry 7, Table 4.13). Decreasing 
the catalyst loading while performing the reaction at a higher catalyst concentration (6 
mol% and 12 mM, respectively) had a detrimental effect both on the 
enantioselectivity (69% ee) and the reaction yield (17%). Such marked variations of 
the reaction yield and enantioselectivity with the catalyst loading and concentration 
suggest a complex reaction mechanism, possibly due to aggregation phenomena in 
solution. The effect of solvent was also briefly investigated (entries 9 to 12, Table 
4.13). Toluene proved to be inferior to CH2Cl2 regarding the reaction yield (47%), 
although diketone (4.41) was obtained with good enantiomeric excess (75% ee) (entry 
9, Table 4.13). A mixture of toluene and CH2Cl2 (4:1) afforded diketone (4.41) with 
an improved enantiomeric excess (80%), but in reduced yield (46%) (entry 10, Table 
4.13). Similar results were obtained with a mixture of toluene and CH2Cl2 (1:1) (entry 
11, Table 4.13). Finally, when the reaction was performed in ether, diketone (4.41) 
was formed in low yield (26%) and with a decreased enantiomeric excess (70% ee) 
(entry 12, Table 4.13), possibly as a consequence of the coordinating properties of 
this solvent. 
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4.2.2 – Extension to Other Enecarbamates and α,α’-Diketones 
 
The use of other α,α’-diketones and enecarbamates in this process was also briefly 
examined. The results are shown in Table 4.14. 
 
Table 4.14 Reaction of various enecarbamates with butane-2,3-dione and pentane-2,3-dione. 
 
NHCbz
+
Me
R
O
O
O
Ar
R
O
*
2) HBr conc.
EtOH, 0 oC
Ar
HO Me
1.37: Ar = Ph
3.1: Ar = p-OMePh
3.2: Ar = p-ClPh
NH HN
Ph Ph
Ph Ph
(10 mol%)
CH2Cl2, 0 oC
4.42: R = Me, Ar = p-OMePh
4.43: R = Me, Ar = p-ClPh
4.44: R = Et, Ar = Ph
O
Ph
Me
O
*
HO Et
4.45
+
R = Me, Et
3.d
Ni(OTf)2,
 
Entrya α,α’-diketone Enecarbamate Yield (%) ee (%) 
1 Butane-2,3-dione 3.1 47 45 
2b  3.1 59 65 
3  3.2 20 75 
4b  3.2 90 82 
5c  3.1 84 35 
6c  3.2 44 38 
7 Pentane-2,3-dione 1.37 17:2d 84:63d
8b  1.37 87:12d 83:41d
 
a The reactions were performed in CH2Cl2 at 0 oC with 10 mol% of the catalyst (in a 
concentration of 7 mM), 1.0 eq. of the enecarbamates and 2.0 eq. of the α,α’-
diketone and subjected to acidic hydrolysis after 48 h, unless otherwise stated; 
b The reaction was quenched after 14 days; 
c The reaction was performed with Cu(OTf)2 instead of Ni(OTf)2; 
d The ratio corresponds to (4.44):(4.45). 
 
When enecarbamate (3.1) was used together with butane-2,3-dione and the reaction 
was quenched after 48 h, the expected diketone (4.42) was obtained, although in only 
moderate yield and modest enantiomeric excess (47% yield and 45% ee) (entry1, 
Table 4.14). A somewhat better result was achieved by extending the reaction time to 
14 days; under these conditions, diketone (4.42) was isolated in modest yield (59%) 
and with 65% enantiomeric excess (entry 2, Table 4.14). The same trend was 
observed when enecarbamate (3.2) was used in conjunction with butane-2,3-dione: 
quenching the reaction after 48 h delivered diketone (4.43) with a good enantiomeric 
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excess (75%) but poor yield (20%) whereas if the reaction was allowed to proceed for 
14 days a marked improvement in the reaction yield and enantiomeric excess was 
obtained (90% and 82% ee, respectively) (entries 3 & 4, Table 4.14). The use of the 
Cu(OTf)2-derived catalyst gave consistently lower enantiomeric excesses than the 
corresponding Ni(OTf)2 catalyst (35% ee versus 45% ee for enecarbamate (3.1) and 
38% ee versus 75 % ee for enecarbamate (3.2), respectively) (entry 5 versus entry 1 
and entry 6 versus entry 3, respectively, Table 4.14). The reaction of the 
unsymmetrical pentane-2,3-dione with enecarbamate (1.37) was also examined. In 
this case a dramatic increase in the overall yield of the addition was observed when 
the reaction was allowed to run for 14 days: a 19% overall yield for a 48 h reaction 
increased to >99% overall yield for the analogous 14 days reaction. However, no 
corresponding increase in the enantiomeric excess of the major isomer of (4.44) was 
observed and, in fact, the enantiomeric excess of the minor regioisomer (4.45) was 
reduced by almost 20%. Furthermore, the regioselectivity of the addition was also 
somewhat reduced for longer reaction times (8.5:1 versus 7.0:1). (entry 8 verus entry 
9, Table 4.14). 
 
4.2.3 – Mechanistic Considerations 
 
The striking effects that the catalyst loading and concentration have on the reaction 
yield and enantioselectivity (vide supra, Table 4.13) suggest a complex reaction 
mechanism, possibly due to the formation of dimeric or oligomeric catalyst structures. 
A simple way to detect and discuss aggregation phenomenon in asymmetric catalysis 
is through the evaluation of the so-called non-linear effects (NLEs). 
 
4.2.3.1 – NLEs in Asymmetric Catalysis: A Brief Overview 
 
The term NLEs refers to reactions where the product enantiomeric excess is not 
proportional to the enantiomeric purity of the chiral ligand used.4.20 Accordingly, if 
one plots the enantiomeric excess of the product of a certain asymmetric reaction as a 
function of the enantiomeric excess of the required chiral auxiliary, three basic 
scenarios may be envisioned to arise: the linear correlation, defined by Equation 4.1 is 
the intuitively expected result whereas the curves B and C represent NLEs cases. The 
4.20 (a) Guillaneux, D.; Zhao, S.-H.; Samuel, O.; Rainford, D.; Kagan, H. B. J. Am. Chem. Soc. 1994, 
116, 9430. For some reviews, see: (b) Girard, C.; Kagan, H. B. Angew. Chem. Int. Ed. 1998, 37, 2922. 
(c) Avalos, M.; Babiano, R.; Cintas, P.; Jiménez, J. L.; Palacios, J. C. Tetrahedron: Asymmetry 1997, 
8, 2997. (d) Kagan, H. B. Adv. Synth. Catal. 2001, 343, 227. 
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convex curve B represents a situation where the product is always formed with higher 
enantioselectivity that what is predicted by Equation 4.1 and hence we talk of a 
positive non-linear effect ((+)-NLE). The opposite applies to the concave curve C and 
in those cases we refer to a negative non-linear effect ((-)-NLE) (Figure 4.2). 
 
 
A
B
C
eeaux (%)
1000 25 50 75
eeprod (%)
0
25
50
75
100 Curve A: 
 
ligandproduct eeeeee 0=   Equation 4.1 
 
eeproduct: enantiomeric excess of product 
eeligand: enantiomeric excess of ligand 
ee0: enantiomeric excess of product for eeligand = 100% 
 
Curve B: (+)-NLE (also called asymmetric amplification) 
 
Curve C: (-)-NLE (also called asymmetric depletion) 
Figure 4.2 Basic types of NLEs in asymmetric catalysis. 
 
Kagan and co-workers developed several mathematical models to describe NLEs in 
asymmetric catalysis.4. a20  One of the simplest models developed, the reservoir model, 
assumes that part of the chiral ligand (of initial enantiomeric excess eeligand) may be 
involved in the competitive formation of catalytically inactive complexes in addition 
to the actual catalysts. A formulation of this model as applied to the case where the 
competent catalysts are of the form ML, where M stands for a metal centre and L for 
a chiral ligand, is shown in Scheme 4.11. 
 
M LR LS+ + MLR MLS+
products
(-eeo)
products
(eeo)
MnLRLR MnLSLS MnLRLS+ + + ...
reservoir of inactive species 
α mole of L with eereservoir
catalytically active species
1-α mole of L with eeeffective
1 mole of L
 with eeligand
 
 
Scheme 4.11 The reservoir model in NLE. 
 
Accordingly, a one-ligand system, consisting of enantiopure complexes MLR and 
MLS, which are the active catalysts, and a pool of complexes not directly involved in 
the catalytic cycle (e.g., the homochiral MLRLR and MLSLS and the meso MLRLS 
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complexes, the dimeric species (MLR)(MLR), (MLS)(MLS) and (MLR)(MLS), etc.) are 
in competition with each other. The two systems may or may not be interconnected by 
an equilibrium. 
 
Because the chiral ligand can be stored in the form of unproductive complexes (i.e., in 
“a reservoir”), the enantiomeric excess of the ligand entering the catalytic cycle may 
be different from its initial value. Thus, if α is the mole fraction of chiral ligand which 
is stored in the reservoir and eereservoir and eeeffective are the enantiomeric excesses of the 
chiral ligand which is in the reservoir and involved in the catalytic cycle, respectively, 
then it can be establish that eeeffective is given by Equation 4.2, 
 
α
α
−
−=
1
reservoirligand
effective
eeee
ee     Equation 4.2 
 
and therefore the enantiomeric excess of the product (eeproduct) is given by Equation 
4.3. 
 
α
α
−
−==
100
reservoirligand
effectiveproduct
eeee
eeeeeeee  Equation 4.3 
 
An alternative model to describe NLE in systems where the active catalyst is of the 
ML form, the so-called (ML)2 model, is shown in Scheme 4.12. This variation of the 
simpler ML2 model assumes that three dimeric species, two homochiral complexes 
(MLR)2 and (MLS)2 and a heterochiral complex (ML)R(ML)S, are first established in 
solution in the absence of the reactants.  
 
M LR LS+ + (MLR)2 (MLS)2+ (MLR)(MLS)
x y z
2 M´LR 2 M´LS M´LR M´LS+
x´ y´ z´
products
(-eeo)
kRR kSS=kRR kRS
kR kS=kR kR
products 
(racemic)
products
(eeo)
K
(R1) (R1) (R1)
R2 R2 R2
 
 
Scheme 4.12 The (ML)2 model in NLE. 
 
Part II  Chapter 4: Results and Discussion 
 
 
 193
At any fixed amount of the chiral ligands LR and LS (i.e., for a given eeligand), a steady 
state exists for the concentrations of these dimers in the mixture, in amounts x, y and 
z, respectively, which are related by means of the equilibrium constant K. The dimeric 
species are assumed to dissociate irreversibly, eventually with the intervention of a 
reactant R1, into the catalytically competent species, the monomeric complexes M´LR 
and M´LS. Upon reaction with a (second) reactant R2 the product is then formed. 
Racemic product is obtained from the heterochiral dimer pathway whereas 
enantiomeric products are produced from the two enantiopure dimers pathways in 
enantiomeric excesses eeo and -eeo. All reactions are assumed to be pseudo-zero order 
in substrate and pseudo-first order in the complexes concentration. For the cases 
where the rate limiting step is either the dissociation of the dimeric complexes (i.e., 
kR>>kRR) or the formation of the product (i.e., kRR>>kR), the enantiomeric excess of the 
resulting product (eeproduct) is given by Equation 4.4. 
 
β
β
g
eeeeee ligandoproduct +
+=
1
1
   Equation 4.4 
 
where the two new parameters, g and β, are given by Equation 4.5 and Equation 4.6, 
respectively. 
 
RR
RS
k
kg =        Equation 4.5 
 
2
222
4
)4(4
ligand
ligandligandligand
Kee
KeeKKeeKee
yx
z
+
++−+−=+=β  Equation 4.6 
 
with 
 
SR
SR
ligand LL
LLee +
−=  and 
xy
zK
2
=  
 
The parameter g expresses the relative reactivities of the hetero and homochiral 
complexes while β defines the relative amounts of the heterochiral and homochiral 
dimers. 
 
The above models are useful in providing insights about the structure of the active 
catalytic species as well as the reaction mechanism. The mathematical expressions 
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obtained may be used to fit experimental data points and thus quantitative parameters 
related to the different species that exist in solution may be extracted. 
 
Finally, it should be appreciated that although the two models discussed were treated 
separately, in practice they may merge or combine. Thus, a set of experimental data 
points may be fitted with several models and only a detailed kinetic investigation will 
provide all features of the mechanism and the origin of the NLE. 
 
4.2.3.2 - NLEs in the Reaction of Enecarbamate (1.37) to Butane-2,3-Dione 
Catalyzed by the C2-Symmetric Chiral Ni(II)-diamine (3.d) Complex 
 
The existence of a NLE in the Ni(OTf)2-diamine (3.d) catalyzed reaction of 
enecarbamate (1.37) with butane-2,3-dione was investigated. The non-enantiopure 
catalyst was prepared in situ by combining 7 mM stock solutions of racemic and 
enantiomerically pure (R,R)-diamine (3.d). The results are shown in Table 4.15. 
 
Table 4.15 Evaluation of NLE in the reaction of enecarbamate (1.37) to butane-2,3-dione 
catalyzed by Ni(OTf)2-diamine (3.d). 
 
NHCbz
+
Me
Me
O
O
O
Ar
Me
O
*
2) HBr aq.
EtOH, 0 oC
Ph
HO Me
NH HN
Ph Ph
Ph Ph
1) Ni(OTf)2,
CH2Cl2, 0 oC
1.37 4.31
(eeligand %)
3.d
 
 
Diamine (3.d) 
ee (%) 
Diketone (4.31) 
ee (%) 
Diketone (4.31) 
yield (%) 
10 58 32 
35 78 57 
50 79 52 
77 76 69 
100 76 67 
 
a The reactions were performed in CH2Cl2 at 0 oC with 10 mol% of 
the catalyst (in a concentration of 7 mM), 1.0 eq. of enecarbamate 
(1.37) and 2.0 eq. of the α,α’-diketone and subjected to acidic 
hydrolysis after 48 h; 
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As it can be seen in Figure 4.3, a strong (+)-NLE was observed. 
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Figure 4.3 NLE in the reaction of enecarbamate (1.37) with butane-2,3-dione catalyzed by 
Ni(OTf)2-diamine (3.d). 
 
These experimental data may be described by Equation 4.3 (i.e., the reservoir model) 
with ee0 = 76%, eereservoir = 0% and α = 0.89 (Figure 4.4). These parameters imply that 
a racemic, fairly populated reservoir is formed before or, in parallel to, the 
establishment of the steady state in the catalytic cycle. The simplest way to achieve 
this is via the formation of a thermodynamic stable and kinetically inactive meso 
complex of the type Ni{[(S,S)-(3.d)][(R,R)-(3.d)]}. If instead Equation 4.4 is used 
(i.e., the (ML)2 model), the values ee0 = 76%, K = 2800 and g = 0.01 give a curve that 
also fits the experimental results (Figure 4.4). These parameters translate into a large 
predominance of a heterochiral dimer of the type {Ni[(S,S)-(3.d)]}-{Ni[(R,R)-(3.d)]} 
which has a very low reactivity (kRS/kRR ≈ 1/100). This species can therefore act as a 
trap for the minor enantiomer of the ligand (i.e., a kind of reservoir effect). The more 
reactive homochiral-enriched dimers left will then afford the active catalysts 
{Ni[(S,S)-(3.d)]} and {Ni[(R,R)-(3.d)]} with an enantiomeric excess greater than the 
initial introduced thus resulting in a (+)-NLE. 
 
 
Part II                                                                            4.2 - Addition to α,α’-Diketones 
 
 
 196
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1
ee ligand
ee product
Experimental
(ML)2 model (K=2800; g=0.011)
Reservoir model (eeres=0; alfa=0.89)
Linear correlation
 
 
Figure 4.4 Description of the NLE observed according to the reservoir model and the (ML)2 
model. 
 
The influence of the enantiomeric excess of the chiral ligand (3.d) on the chemical 
yield of diketone (4.41) was also evaluated (vide supra, Table 4.15) and this is shown 
in Figure 4.5. 
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Figure 4.5 Effect of diamine (3.d) ee in α,α’-diketone (4.41) yield in the reaction of 
enecarbamate (1.37) with butane-2,3-dione catalyzed by Ni(OTf)2-diamine (3.d). 
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As it can be seen there is an approximate linear correlation between these two 
variables implying that the amount of the active catalysts in solution, presumably 
{Ni[(S,S)-(3.d)]}(OTf)2 and {Ni[(R,R)-(3.d)]}(OTf)2, increases with the enantiomeric 
excess of the chiral diamine ligand (3.d). This result further supports the preferential 
formation of the heterochiral complex Ni{[(S,S)-(3.d)][(R,R)-(3.d)]}(OTf)2 and/or the 
heterochiral dimer {Ni[(S,S)-(3.d)]}·{Ni[(R,R)-(3.d)]}(OTf)4 and that these species 
are kinetically inactive. 
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CHAPTER 5 
Concluding Remarks 
 
The catalytic asymmetric reactions of enecarbamates with α,α’-dicarbonyl 
compounds, particularly ethyl glyoxylate and butane-2,3-dione, were investigated. 
 
It was found that secondary enecarbamates reacted with ethyl glyoxylate in a highly 
diastereo- and enantioselective manner in the presence of chiral copper(I)-diimine 
catalysts to give optically active 1,3-hydroxy imines. These intermediates were 
subjected in situ to acid hydrolysis affording the corresponding β-hydroxy ketones 
with excellent optical purity (up to 97% ee) and in good to excellent yields (typically 
>90%). The most effective chiral catalyst found was obtained from CuClO4·4CH3CN 
and the C2-symmetric diimine ligand (3.u) (Scheme 5.1). The reaction proceeded 
smoothly even in the presence of only 0.1 mol% of the catalyst. 
 
NHCbz
Ph+
EtO
H
O
O
Ph
OH NHCbz
EtO
O
HBr aq.
EtOH, 0 oC O
Ph
OH
EtO
O
1.37: R = H
E-3.6: R = Me
Z-3.6: R = Me
N N
R R
3.u
R = p-BrPh
CuClO4 4CH3CN
(10 mol%)
CH2Cl2, 0 oC, 1 h
(1.0 eq.)(1.2 eq.)
R
       4.14: R = H, 93%, 
              97% ee
anti-4.21: R = Me, 98%, 
              syn:anti = 1:99
syn-4.21: R = Me, 98%, 
             syn:anti = 98:2
R R
4.13: R = H
 
Scheme 5.1 Examples of the reaction of enecarbamates with ethyl glyoxylate catalyzed by the 
Cu(I)-diimine (3.u) complex. 
 
The relative and absolute configuration of the aldol-type adducts were determined by 
derivatization. A concerted aza-ene mechanism was proposed based on the 
stereochemical outcome of the reaction. This process is believed to take place through 
an envelope transition state where the carbamate proton plays a key role. The 
observed chiral induction was rationalized by considering a tetrahedral chiral 
copper(I) centre, where the Re-face of the coordinated ethyl glyoxylate is shielded by 
the chiral ligand and the Si-face is left open to be approached by the Si-face of the 
enecarbamate. 
 
The chiral 1,3-imino alcohol intermediate (4.13) was also diastereoselectively reduced 
in situ into the corresponding 1,3-hydroxy carbamate (4.31). When chelating type 
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conditions were used (excess of NaBH4 and Et2B(OMe)) the syn-adduct (4.31) was 
obtained in good yield (65%) and high diastereomeric excess (94:6, syn:anti ratio). 
On the other hand, the use of L-Selectride delivered the corresponding anti-adduct as 
the major product, but only in moderate yield (<59%) and with modest diastereomeric 
excess (22:78, syn:anti ratio) (Scheme 5.2). 
 
HN
Ph
Cbz
+EtO H
O
O
1.37
NHCbz
Ph
OH
4.31
EtO
O
CuClO4 4CH3CN
(10 mol%)
CH2Cl2, 0 oC, 1 h
N N
R R
3.u
R = p-BrPh
(1.0 eq.)(1.2 eq.)
Conditions I
NaBH4 (3.0 eq.)
Et2B(OMe) (3.0 eq.)
THF:MeOH (4:1)
-78 oC, 2 h
I: 65%, syn:anti  = 94:6
and
II: <59%, syn:anti = 22:78
Conditions II
L-Seletride (2.2 eq.)
THF, -20 oC, 16½ h
(4.13)
 
 
Scheme 5.2 Diastereoselective reductions of enantiopure 1,3-hydroxy imine (4.13). 
 
The catalytic asymmetric addition reaction of secondary enecarbamates to α,α’-
diketones was also accomplished (with limitations, vide infra). A novel nickel(II)-
based catalyst, obtained from Ni(OTf)2 and the C2-symmetric diamine ligand (3.d), 
afforded the best enantioselectivities. When the symmetric butane 2,3-dione was used 
and the intermediate β-hydroxy imine was subjected in situ to acidic hydrolysis, the 
corresponding tertiary alcohol (4.41) was obtained in high yield (94%) and with good 
enantiomeric excess (84%) (Scheme 5.3). 
 
NH HN
Ph Ph
Ph Ph
HN
Ph
Cbz
+Me Me
O
O 2) HBr aq.
EtOH, 0 oC
O
Ph
4.41
Me
O
*
1.37
94%, 84% ee
Ni(OTf)2
(10 mol%)
CH2Cl2, 0 oC, 14 d
(1.0 eq.)(2.0 eq.)
3.d
OHMe
1)
 
 
Scheme 5.3 Addition reaction of enecarbamate (1.37) to butane-2,3-dione catalyzed by the Ni(II)-
diamine (3.d) complex. 
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However, the use of α,α’-diketones is, at the present, limited by the very low turnover 
frequency of the catalytic cycle: very long reaction times, typically around 14 days, 
were required for obtaining high yields and good enantioselectivities. Further studies 
are thus necessary to obtain a more efficient catalytic system. 
 
It was also found that the addition reaction of enecarbamate (1.37) to butane-2,3-
dione catalyzed by a non-enantiopure Ni(II)-diamine (3.d) complex shows a strong 
(+)-NLE. The observed deviations to linearity were ascribed to the preferential 
formation of heterochiral complexes Ni{[(S,S)-(3.d)][(R,R)-(3.d)]}(OTf)2 and/or the 
heterochiral dimer {Ni[(S,S)-(3.d)]}·{Ni[(R,R)-(3.d)]}(OTf)4, which are likely to be 
kinetically inactive species. Semi-quantitative data that supports these assumptions 
was obtained by using the reservoir and the (ML)2 models. 
 
Based on the type of products obtained, namely β-hydroxy ketones and β-hydroxy 
carbamate, it can be concluded that enecarbamates represent an alternative to the 
more commonly used aldol approach,5.1 namely the silyl enol ether-based Mukaiyama 
variation,5. b,c1  eventually followed by a reductive amination step. Thus an important 
question is whether a substantial synthetic benefit arises from the use of 
enecarbamates as nucleophiles. Whereas the latter are typically crystalline solids 
which can be stored at room temperature without special precautions, their 
preparation can be difficult, often requiring more than one step, harsh conditions and 
a final purification by flash chromatography. On the other hand, silyl enol ethers are 
readily synthesized on scale in one step from commercial materials in good yield and 
conveniently purified by distillation; however, usually they do not store well and thus 
are required to be prepared in situ.5. b,c1  In order to try differentiating between the use 
of enecarbamates and enolsilanes from a reactivity point of view, the TMS-enolate of 
acetophenone (5.1) was prepared5.2 and subjected to the conditions that afforded the 
best results when enecarbamate (1.37) was used (Scheme 5.4). 
 
5.1 For selected aldol-reactions reviews, see: (a) Evans, D. A.; Nelson, J. V.; Taber, T. Top. 
Stereochem. 1982, 13, 1. (b) Mukaiyama, T. Org. React. 1982, 28, 203. (c) Mukaiyama, T.; 
Kobayashi, S. Org. React. 1994, 46, 1. (d) Heathcock, C. H. in “Comprehensive Organic Synthesis” 
(Trost, B. M., Fleming, I. ed.) 1991, 1, 133, 181, 239, 301, Pergamon Press, New York. (e) Mahrwald, 
R. Chem. Rev. 1999, 99, 1095. (f) Carreira, E. M. in “Catalytic Asymmetric Synthesis” (2nd Edition) 
(Ojima, I. ed.), 2000, 513, Wiley-VCH, New York. 
5.2 For a general reference see: Colvin, E. W. in “Silicon Reagents in Organic Synthesis” 1988, 
Academic, New York. 
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Scheme 5.4 Comparison between enecarbamate (1.37) and enolsilane (5.1) in the catalyzed 
reactions with ethyl glyoxylate and butane-2,3-dione. 
 
These preliminary results suggest that for the ethyl glyoxylate case there is no 
noteworthy advantage in using enecarbamate (1.37) over enolsilane (5.1): the β-
hydroxy ketone (4.14) was obtained with comparable yields (93% versus 89%, 
respectively) and although with the latter a somewhat lower enantioselectivity was 
obtained (97% ee versus 78% ee, respectively), probably some fine-tuning of the 
Mukaiyama reaction conditions would lead to an increase in the enantioselectivity. In 
contrast to the ethyl glyoxylate case, the use of enecarbamate (1.37) with butane-2,3-
dione proved to be considerably superior to the Mukaiyama-type conditions: the 
chiral tertiary alcohol (4.41) was isolated in only 13% yield when silyl enol ether 
(5.1) was used whereas enecarbamate afforded the same product in 67% yield; the 
enantioselectivity was similar for both cases (73% ee and 76% ee, respectively). 
Hence, the use of enecarbamates over silyl enol ethers can in deed be beneficial, 
although there are situations where the distinction between the two types of 
nucleophiles is not clear-cut and the final choice will be based on a personal bias. 
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Finally it should be mentioned that while this writing was in progress, a new 
development concerning the use of enecarbamates in asymmetric catalysis was 
reported. Kobayashi and co-workers found that enecarbamates derived from 
aldehydes, such as (5.2), can react diastereo- and enantioselectively with ethyl 
glyoxylate in the presence of the Cu(I)-diamine (3.u) to give a polymeric structure, 
presumably (5.3), which can be converted in situ into the corresponding N,O-acetal 
monomer (5.4) by treatment with a catalytic amount of Sc(OTf)3 in EtOH (Scheme 
5.5).5.3
 
NHCbz
+EtO H
O
O
OH
EtO
O
CuClO4 4CH3CN
(1 mol%)
CH2Cl2, 0 oC, 3½ h
(1.0 eq.)(2.0 eq.)
E-5.2
Me EtO2C NHCbz
Me
O
n
5.3
Sc(OTf)3
EtOH
CH3CN Me NHCbz
OEt
95%, 12:88, syn:anti ratio
97% ee (anti)
5.4
N N
R R
3.u
R = p-BrPh
 
 
Scheme 5.5 Addition reaction of aldehyde-derived enecarbamate E-(5.2) to ethyl glyoxylate 
catalyzed by the Cu(I)-diimine (3.u) complex. 
 
In conclusion, enecarbamates are useful, versatile and atom-economic nucleophiles 
that can be use in asymmetric catalysis and which potential only now is starting to be 
unveiled. 
 
 
 
                                               
5.3 Matsubara, R.; Kawai, N.; Kobayashi, S. Angew. Chem. Int. Ed. 2006, 45, 3814. 
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CHAPTER 6 
Experimental 
 
6.1 - General 
 
All moisture and air sensitive reactions were carried out under an argon atmosphere 
using flame-dried glassware. Reaction solvents were distilled prior to use by standard 
procedures. 1H- and 13C-NMR spectra were recorded on a JEOL JNM-LA300, JNM-
LA400 or JNM-LA500 spectrometer in CDCl3 unless otherwise stated. Chemical 
shifts (δ) are reported in ppm. Tetramethylsilane (TMS) (δ = 0) and CDCl3 (δ = 77.0) 
were used as internal standards for 1H- and 13C-NMR, respectively. Coupling 
constants (J) are given in Hertz (Hz). Multiplicities of peaks are reported in the 
following way: s (singlet), d (doublet), t (triplet), q (quartet), quint (quintet), m 
(multiplet), br (broad), app (apparent) and combinations of these. IR spectra were 
measured with a JASCO FT/IR-610 spectrometer. Optical rotations were measured 
with a JASCO P-1010 polarimeter and the concentration (c) is given in g per 100 mL. 
Analytical high performance liquid chromatography (HPLC) was performed using the 
following apparatus: SHIMADZU LC-10AT (liquid chromatography), SHIMADZU 
SPD-10A (UV detector) and SHIMADZU C-R6A Chromatopac. Gas chromatography 
(GC) and mass spectrometry (MS) analysis was carried out using the following 
apparatuses: SHIMADZU GC-17A, SHIMADZU GCMS-QP5050A or BRUKER 
DIALATONICS® BIOTOF® II machine. Melting points of crystalline materials are 
uncorrected and were determined on a YAZAWA BY-1 apparatus. Merk silica gel 60 
(40-63 µm, 230-400 mesh) was used for column chromatography purification. 
Preparative thin layer chromatography (PTLC) was carried out using Wakogel B-5F. 
Materials to be separated by PTLC are applied as long streaks, developed and 
recovered by scraping the adsorbent from the plate and eluting with EtOAc. Unless 
otherwise stated, commercially available reagents, purchased from Tokyo Kasei 
Kogyo (TCI) and Aldrich and Fluka, were used without further purification. All 
compounds for which HRMS was performed exhibited clean 1H-NMR and showed 
only one spot on TLC. Molecular sieves were dried at 150-160 oC for at least 12 h and 
then allowed to reach room temperature under argon. Commercial NaH (as a 60% 
dispersion in oil) is washed with pentane (2 portions that cover the amount used) and 
the last traces of pentane are removed under high vacuum. 
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6.2 - Preparation of Enecarbamates and Chiral Ligands 
 
General procedure for the preparation of aromatic enecarbamates (GP 1):6.1  
The aromatic nitrile (63.0 mmol, 1.0 eq.) was added to a solution of the appropriated 
Grignard reagent in THF (69.3 mmol, 1.1 eq.) at ice bath temperature. The obtained 
solution was allowed to reach room temperature, stirred for ½ h and then refluxed for 
1 h. The resulting solution was cooled to ice bath temperature and the chloroformate 
reagent (75.6 mmol, 1.2 eq.) was dropwise added. After stirring at 0 oC for ½ h, the 
solution was allowed to reach room temperature, stirred for further 2 h and then 
quenched at ice bath temperature by addition of H2O (40 mL). After separation of the 
layers, the aqueous layer was extracted with EtOAc (2 portions of 40 mL). The 
combined organic layers were washed with brine (50 mL), dried (MgSO4) and the 
solvent was removed under vacuum affording a yellow oil which was purified by 
column chromatography (typically using as eluent hexane:EtOAc, 8:1). The obtained 
enecarbamates were then taken in petroleum ether (15 mL) and the obtained 
suspension was stirred for approx. 5 h.; filtration and drying under vacuum to remove 
the last traces of solvent finally afforded the pure enecarbamates. 
 
(1-Phenyl-vinyl)-carbamic acid benzyl ester (1.37) 
 
Obtained in 48%; mp 69.4-69.5 oC; 1H-NMR (CDCl3) δ 4.96 (s, 1H), 
5.16 (s, 2H), 5.63 (s, 1H), 6.33 (s, 1H), 7.25-7.45 (m, 10H); 13C-
NMR (CDCl3) δ 67.0, 99.6, 126.0, 128.3, 128.5, 128.6, 128.7, 136.0, 
138.1, 140.5, 153.7; IR (neat) 3310, 3060, 3033, 1739, 1701, 1634, 1523, 1452, 1227, 
1125, 1063, 857, 772, 740, 696, 596 cm-1; Anal. Calcd. for C16H15NO2: C, 75.87; H, 
5.97; N, 5.53. Found: C, 75.77; H, 6.16; N, 5.52. 
HN OBn
O
 
[1-(4-Methoxy-phenyl)-vinyl]-carbamic acid benzyl ester (3.1) 
 
Obtained in 43%; mp 54.7-54.8 oC; 1H-NMR (CDCl3) δ 3.81 (s, 
3H), 4.89 (d, 1H, J = 1.0 Hz), 5.18 (s, 2H), 5.54 (s, 1H), 6.26 
(s,1H), 6.85-6.90 (m, 2H), 7.30-7.40 (m, 7H); 13C-NMR (CDCl3) 
δ 55.3, 66.9, 98.4, 113.9, 127.2, 128.3, 128.5, 130.6, 136.0, 
140.1, 153.7, 160.0; IR (neat) 3330, 1736, 1632, 1608, 1509, 1456, 1219, 1179, 1126, 
1063, 1030, 834, 742, 698 cm-1; HRMS (EI); Exact mass calcd. for C17H17NO3 [M]+, 
HN OBn
O
OMe
6.1 Suen, Y. H.; Horeau, A.; Kagan, H. B. Bull. Soc. Chim. Fr. 1965, 5, 1454. 
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283.1208. Found 283.1208; Anal. Calcd for C17H17NO3: C, 72.07; H, 6.05; N, 4.94. 
Found: C, 71.84; H, 6.09; N, 4.91. 
 
[1-(4-Chloro-phenyl)-vinyl]-carbamic acid benzyl ester (3.2) 
 
Obtained in 47%; mp 79.0-79.1 oC; 1H-NMR (CDCl3) δ 4.96 (s, 
1H), 5.17 (s, 2H), 5.59 (s, 1H), 6.25 (s,1H), 7.28-7.43 (m, 9H); 13C-
NMR (CDCl3) δ 67.1, 100.6, 127.3, 128.3, 128.4, 128.6, 128.8, 
134.6, 135.8, 136.5, 139.7, 153.6; IR (neat) 3299, 1699, 1532, 
1239, 1059, 838, 741, 696 cm-1; HRMS (EI); Exact mass calcd for C16H14NO2 [M]+, 
287.0713. Found 287.0708. Anal. Calcd. for C16H14ClNO2: C, 66.79; H, 4.90; N, 4.87. 
Found: C, 66.53; H, 5.02; N, 4.91. 
HN OBn
O
Cl
 
(1-p-Tolyl-vinyl)-carbamic acid benzyl ester (3.3) 
 
Mp 52.8-53.0 oC; 1H-NMR (CDCl3) δ 2.34 (s, 3H), 4.93 (s, 1H), 
5.16 (s, 2H), 5.58 (s,1H), 6.30 (s, 1H), 7.40 (appd, 2H, J = 7.8 Hz), 
7.25-7.40 (m, 7H); 13C-NMR (CDCl3) δ 21.1, 66.9, 98.8, 125.8, 
128.3, 128.5, 129.3, 135.3, 136.0, 138.7, 140.4, 153.7; IR (neat) 
3398, 3327, 3032, 1736, 1361, 1508, 1454, 1383, 1219, 1063, 955, 825, 735 cm-1; 
LRMS (FAB) m/z = 268 [M+H]+; Anal. Calcd. for C17H17NO2: C, 76.38; H, 6.41; N, 
5.24. Found: C, 76.20; H, 6.48; N, 5.21. 
HN OBn
O
Me
 
(1-Naphthalen-2-yl-vinyl)-carbamic acid benzyl ester (3.4) 
 
Mp 100.3-101.5 oC; 1H-NMR (CDCl3) δ 5.11 (s, 1H), 5.19 (s, 2H), 
5.72 (s, 1H), 6.45 (s,1H), 7.30-7.60 (m, 8H), 7.76-7.86 (m, 4H); 
13C-NMR (CDCl ) δ 67.1, 100.4, 124.0, 124.7, 126.5, 127.6, 
128.2, 128.3, 128.4, 128.6, 133.1, 133.3, 135.3, 135.9, 140.5, 
153.8; IR (neat) 3282, 3046, 1701, 1622, 1527, 1226, 1106, 1064, 968, 884, 827, 694, 
583 cm
3
-1; HRMS (EI); Exact mass calcd for C H NO  [M]20 17 2 +, 303.1259. Found 
303.1251. Anal. Calcd. for C H NO : C, 79.19; H, 5.65; N, 4.62. Found: C, 79.49; 
H, 5.82; N, 4.64. 
20 17 2
HN OBn
O
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(Z)-(1-Phenyl-propenyl)-carbamic acid benzyl ester (3.6) 
 
Obtained in 14%; mp 73.5-74.0 oC; 1H-NMR (CDCl3) δ 1.79 (d, 
3H, J = 6.8 Hz), 5.13 (s, 2H), 5.79 (q, 1H, J = 6.8 Hz), 6.00 (brs, 
1H), 7.00-7.62 (m, 10H); 13C-NMR (C6D6) δ 13.5, 67.0, 119.5, 
126.0, 127.7, 128.5, 128.5, 135.0, 137.1, 139.2; IR (neat) 3385, 3296, 3032, 2941, 
1701, 1498, 1452, 1399, 1329, 1225, 1089, 1018, 916, 824, 760, 695 cm-1; HRMS 
(FAB); Exact mass calcd. for C17H18NO2 [M+H]+, 268.1338. Found 268.1339. 
HN OBn
O
Me
 
(E)-(1-Phenyl-propenyl)-carbamic acid benzyl ester (3.6) 
 
Obtained in 31%; mp 63.9-64.0 oC; 1H-NMR (CDCl3) δ 1.70 (d, 3H, 
J = 7.3 Hz), 5.11 (s, 2H), 5.90-6.25 (brs, 2H), 7.20-7.50 (m, 10H); 
13C-NMR (C6D6) δ 13.7, 66.7, 112.0, 128.0, 128.1, 128.5, 128.5, 
128.6, 129.1, 134.6, 137.0, 137.2, 153.9; IR (neat) 3398, 3316, 3032, 2938, 1713, 
1516, 1449, 1393, 1328, 1213, 1137, 1033, 922, 835, 771, 739, 699, 587 cm-1; HRMS 
(FAB); Exact mass calcd. for C17H18NO2 [M+H]+, 268.1338. Found 268.1347. 
HN OBn
O
Me
(Z)-[1-(4-Methoxy-phenyl)-propenyl]-carbamic acid benzyl 
ester (3.7) 
 
Obtained in 9%; mp 110-110.5 oC; 1H-NMR (CDCl3) δ 1.77 (d, 
3H, J = 6.9 Hz), 3.80 (s, 3H), 5.14 (s, 2H), 5.68 (q, 1H, J = 6.9 
Hz), 5.96 (brs, 1H), 6.84 (appd, 2H, J = 8.8 Hz), 7.32 (m, 7H); 13C-NMR (C6D6) δ 
13.5, 54.8, 66.9, 114.0, 117.6, 127.2, 128.5, 131.8, 134.6, 137.2, 154.1, 159.8; IR 
(neat) 3305, 3039, 2945, 2843, 1709, 1611, 1509, 1452, 1400, 1334, 1294, 1247, 
1176, 1089, 1029, 820, 742, 699, 590 cm-1; HRMS (FAB); Exact mass calcd. for 
C18H20NO3 [M+H]+, 298.1443. Found 298.1435. 
HN OBn
O
Me
OMe
 
(E)-[1-(4-Methoxy-phenyl)-propenyl]-carbamic acid benzyl 
ester (3.7) 
 
Obtained in 33%; mp 66.0-66.5 oC; 1H-NMR (CDCl3) δ 1.69 (d, 
3H, J = 7.1 Hz), 3.82 (s, 3H), 5.11 (s, 2H), 5.80-6.15 (m, 2H), 
6.85-6.95 (m, 2H), 7.20-7.50 (m, 7H); 13C-NMR (C6D6) δ 13.8, 54.7, 66.6, 111.1, 
114.0, 128.1, 128.5, 128.6, 129.5, 130.3, 134.4, 137.1, 153.9, 159.7; IR (neat) 3323, 
3033, 2941, 2843, 1719, 1609, 1509, 1296, 1247, 1177, 1135, 1027, 840, 739, 697 
HN OBn
O
Me
OMe
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cm-1; HRMS (FAB); Exact mass calcd. for C18H20NO3 [M+H]+, 298.1443. Found 
298.1452. 
(Z)-[1-(4-Chloro-phenyl)-propenyl]-carbamic acid benzyl 
ester (3.8) 
 
Obtained in 12%; mp 95.2-95.3 oC; 1H-NMR (C6D6) δ 1.48 (brs, 
3H), 5.02 (brs, 2H), 5.20-5.90 (brs, 2H), 6.60-7.40 (m, 9H); 13C-
NMR (C6D6) δ 13.4, 67.1, 119.8, 127.2, 128.3, 128.6, 133.4, 134.0, 136.9, 137.7, 
153.8; IR (neat) 3292, 3033, 2947, 1706, 1589, 1494, 1398, 1327, 1299, 1094, 1016, 
819, 741, 697 cm-1; HRMS (FAB); Exact mass calcd. for C17H17ClNO2 [M+H]+, 
302.0948. Found 302.0936. 
 
(E)-[1-(4-Chloro-phenyl)-propenyl]-carbamic acid benzyl ester 
(3.8) 
 
Obtained in 33%; mp 71.2-71.3 oC; 1H-NMR (C6D6) δ 1.44 (d, 3H, 
J = 7.4 Hz)), 5.02 (s, 2H), 5.47 (brs; 1H), 6.12 (brs, 1H), 6.70-6.80 
(m, 2H), 6.95-7.25 (m, 7H); 13C-NMR (C6D6) δ 13.5, 66.8, 128.6, 128.6, 128.7, 130.4, 
133.5, 133.8, 135.4, 136.9, 153.7; IR (neat) 3398, 3309, 3033, 2941, 1708, 1595, 
1517, 1497, 1458, 1393, 1327, 1219, 1138, 1093, 1034, 836, 740, 701 cm-1; HRMS 
(FAB); Exact mass calcd. for C17H17ClNO2 [M+H]+, 302.0948. Found 302.0943. 
HN OBn
O
Me
Cl
HN OBn
O
Cl
Me
 
(Z)-[1-(4-Methoxy-phenyl)-propenyl]-carbamic acid ethyl 
ester (3.9) 
 
Obtained in 9%; mp 57.1-57.2 oC; 1H-NMR (CDCl3) δ 1.25 
(brs, 3H), 1.75 (d, 3H, J = 7.1 Hz), 3.78 (s, 3H), 4.13 (q, 2H, J 
= 7.1 Hz), 5.66 (q, 1H, J = 7.1 Hz), 5.88 (brs, 1H), 6.80-6.85 (m, 2H), 7.28-7.36 (m, 
2H); 13C-NMR (CDCl3) δ 13.4, 14.5, 55.2, 61.2, 113.6, 117.4, 126.7, 131.1, 133.9, 
159.2; IR (neat) 3301, 2979, 1703, 1609, 1510, 1376, 1329, 1245, 1178, 1099, 1037, 
824, 774, 594, 448 cm-1; HRMS (EI); Exact mass calcd. for C13H17NO3 [M]+, 
235.1208. Found 235.1204. Anal. Calcd for C13H17NO3: C, 66.36; H, 7.28; N, 5.95. 
Found: C, 66.21; H, 7.32; N, 5.95. 
HN
OMe
OEt
O
Me
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(E)-[1-(4-Methoxy-phenyl)-propenyl]-carbamic acid ethyl ester 
(3.9) 
 
Obtained in 24%; mp 52.3-52.6 oC; 1H-NMR (CDCl3) δ 1.11 (t, 
3H, J = 7.1 Hz)), 1.57 (d, 3H, J = 7.3 Hz), 3.70 (s, 3H), 4.01 (q, 
2H, J = 7.1 Hz), 5.70-5.95 (m, 2H), 6.73-6.80 (m, 2H), 7.10-7.16 
(m, 2H); 13C-NMR (CDCl3) δ 13.7, 14.5, 55.2, 60.8, 111.6, 113.6, 129.1, 129.9, 
133.7, 154.3, 159.1; IR (neat) 3319, 2980, 1715, 1608, 1511, 1382, 1293, 1247, 1175, 
1138, 1037, 836, 614, 499 cm-1; HRMS (EI); Exact mass calcd. for C13H17NO3 [M]+, 
235.1208. Found 235.1201. 
HN
OMe
OEt
O
Me
 
(Z)-(1-Phenyl-but-1-enyl)-carbamic acid benzyl ester (3.11) 
 
Mp 60.3-60.8 oC; 1H-NMR (C6D6) δ 0.89 (t, 3H, J = 7.1 Hz), 2.03 
(brs, 2H), 5.04 (s, 2H), 5.30-5.55 (m, 2H), 7.00-7.25 (m, 8H), 7.28-
7.36 (m, 2H); 13C-NMR (C6D6) δ 13.6, 21.6, 67.0, 126.1, 126.8, 
127.4, 128.1, 128.5, 128.6, 133.5, 137.1, 139.2; IR (neat) 3294, 
3033, 2961, 2876, 1705, 1498, 1458, 1400, 1334, 1223, 1092, 1026, 753, 691 cm-1; 
HRMS (FAB); Exact mass calcd for C18H20NO2 [M+H]+, 282.1494. Found 282.1495. 
HN OBn
O
Et
 
(E)-(1-Phenyl-but-1-enyl)-carbamic acid benzyl ester (3.11) 
 
Mp 55.2-55.7 oC; 1H-NMR (C6D6) δ 0.87 (t, 3H, J = 7.4 Hz), 1.99 
(quint, 3H, J = 7.4 Hz), 5.01 (s, 2H), 5.56 (brs, 1H), 6.26 (brs, 1H), 
6.95-7.25 (m, 10H); 13C-NMR (C6D6) δ 15.1, 21.0, 66.6, 118.8, 126.4, 
126.9, 128.2, 128.5, 128.6, 128.6, 129.0, 133.6, 137.1, 137.5, 153.6; IR (neat) 3398, 
3319, 3032, 2962, 2876, 1723, 1514, 1454, 1367, 1327, 1219, 1134, 1039, 984, 922, 
857, 743, 698 cm-1; HRMS (FAB); Exact mass calcd. for C18H20NO2 [M+H]+, 
282.1494. Found 282.1481. 
HN OBn
O
Et
 
General procedure for the preparation of aliphatic enecarbamates (GP 2):6.2
To a solution of NaN3 (1.68 g, 25.8 mmol) in H2O (12 mL) was added a solution of 
the acid chloride (21.47 mmol) in THF (7 mL) dropwise at 0 oC. The mixture was 
vigorously stirred overnight, after which Et2O (15 mL) was added. After separation of 
the layers, the organic layer was washed with a saturated aqueous solution of Na2CO3 
(10 mL) and brine (10 mL) sequentially. The Et2O was removed under reduced 
6.2 Overman, L. E.; Taylor, G. F.; Jessup, P. J. Tetrahedron Lett. 1976, 36, 3089. 
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pressure (300 mmHg) (CAUTION: this procedure should be carried out behind a 
safety shield as occasionally explosions occurred) to give the crude acyl azide in 
THF. This solution was added very slowly over 15 h to refluxing THF (10 mL) at 80 
oC. After completion of the addition, the mixture was stirred at 80 oC until evolution 
of N2 gas stopped (approx. 2 h). The mixture was allowed to reach room temperature 
and the THF was evaporated (100 mmHg). The residue was distilled (65 oC , 100 
mmHg, 2 times) affording the corresponding isocyanate. Benzyl alcohol (1.11 g, 10.0 
mmol) was added dropwise at -78 oC. The frozen reaction mixture was allowed to 
warm to room temperature over 6 h and was stirred until no more starting isocyanate 
was detected by NMR analysis (typically 3 days). The mixture was purified by 
column chromatography or preparative thin layer chromatography to deliver the pure 
enecarbamate. 
(Z)-(1-Ethyl-propenyl)-carbamic acid benzyl ester (3.13) 
 
To a stirred solution of angelic methyl ester (9.4 g, 83 mmol) in 
MeOH and H2O (1:1, 50 mL) was added solid LiOH·H2O (3.8 g, 91 
mmol). The resulting solution was refluxed for 4 h, and then cooled to room 
temperature. The crude reaction mixture was washed with Et2O (2 portions of 15 mL) 
and then acidified with aqueous 3 M HCl solution to pH ~ 1. The resulting aqueous 
layer was extracted with EtOAc (3 portions of 25 mL) and the combined organic 
layers washed with H2O (25 mL), brine (25 mL), dried (MgSO4) and concentrated to 
afford crude angelic acid (7.5 g, 90%) as a brown solid that was used in the next step 
without purification. To a stirred solution of the crude acid (7.5 g, 74 mmol) in MeOH 
(23 mL) was added solid KOH (4.2 g, 74 mmol) at 0 oC. After stirring for ½ h at 0 oC, 
the reaction mixture was concentrated and the crude residue azeotroped with acetone 
(2 portions of 50 mL), then dried under vacuum over P2O5 for 48 h. To a suspension 
of the resulting potassium salt in Et2O (150 mL) at 0 oC was added oxalyl chloride (50 
g, 394 mmol), followed by DMF (0.1 mL). The reaction mixture was stirred for 4 h at 
0 oC, then filtered and concentrated. The residue was rediluted with CH2Cl2 (100 mL) 
and then concentrated to dryness (this procedure was repeated 3 times) affording the 
crude acid chloride which was used without further purification. Following GP 2, Z-
(3.13) was obtained as a white solid (930 mg, 85%); mp 33.0-33.5 oC; 1H-NMR 
(C6D6) δ 0.79 (t, 3H, J = 7.5 Hz), 1.45 (d, 3H, J = 7.0 Hz), 1.95 (q, 2H, J = 7.5 Hz), 
5.04 (s, 2H), 5.38 (brs, 1H), 5.72 (q, 1H, J = 7.0 Hz), 7.00-7.30 (m, 5H); 13C-NMR 
(C6D6) δ 11.9, 12.4, 22.7, 66.5, 128.2, 128.6, 128.6, 136.2, 137.3; IR (neat) 3322, 
3064, 3033, 2969, 2935, 2877, 1706, 1523, 1455, 1380, 1351, 1307, 1234, 1097, 
Et
HN OBn
O
Me
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1029, 998, 831, 738 cm-1; HRMS (FAB); Exact mass calcd. for C13H18NO2 [M+H]+, 
220.1338. Found 220.1347. 
 
(E)-(1-Ethyl-propenyl)-carbamic acid benzyl ester (3.13) 
 
To a solution of Z-3.13 (237 mg, 1.08 mmol) in THF (12 mL) was 
added KOtBu (145.5 mg, 1,29 mmol) at room temperature. After 
stirring for 14 h, the reaction was quenched by the addition of a 
saturated aqueous NH4Cl solution (10 mL) at room temperature and extracted with 
Et2O (2 portions of 10 mL).The organic layer was washed with brine (10 mL), dried 
(MgSO4) and concentrated under vacuum. The crude product obtained was purified 
by column chromatography on silica gel to deliver an approx. 1:1 mixture of 
geometric isomers (184 mg, 78%). These could be separated by careful preparative 
thin layer chromatography (toluene:Et2O, 10:1). E-(3.13) was obtained as a white 
solid (85 mg, 36%); mp 53.0-54.0 oC; 1H-NMR (C6D6) δ 0.95 (t, 3H, J = 7.5 Hz), 1.28 
(d, 3H, J = 6.8 Hz), 2.34 (brq, 2H, J = 7.5 Hz), 4.70 (q, 1H, J = 6.8 Hz), 5.05 (s, 2H), 
5.50 (brs, 1H), 5.72, 7.00-7.26 (m, 5H); 13C-NMR (C6D6) δ 11.7, 12.6, 27.9, 66.7, 
110.5, 128.2, 128.5, 128.6, 137.2, 137.3; IR (neat) 3305, 2967, 2751, 1693, 1515, 
1450, 1321, 1257, 1108, 966, 848, 738, 698 cm-1; HRMS (FAB); Exact mass calcd for 
C13H18NO2 [M+H]+, 220.1338. Found 220.1348. 
Et
HN OBn
O
Me
 
Cyclohex-1-enyl-carbamic acid benzyl ester (3.14) 
 
Obtained in 68%; mp 49.0-50.0 oC; 1H-NMR (C6D6) δ 1.26-1.45 (m, 
4H), 1.70-1.80 (m, 2H), 1.86-1.98 (m, 2H), 5.03 (s, 2H), 5.31 (brs, 
1H), 6.01 (brs, 1H), 7.00-7.25 (m, 5H); 13C-NMR (C6D6) δ 22.4, 22.8, 
24.1, 27.7, 66.4, 109.3, 128.2, 128.6, 128.6, 132.3, 137.3, 153.2; IR (neat) 3322, 
3058, 3033, 2931, 2838, 1706, 1538, 1452, 1380, 1348, 1305, 1232, 1062, 1037, 917, 
840, 804, 736, 696 cm-1; HRMS (FAB); Exact mass calcd. for C14H18NO2 [M+H]+, 
232.1338. Found 232.1342. 
HN OBn
O
 
General Procedure for the Preparation of Diamine Ligands (GP 3):6.3
To a solution of (R,R)-diphenylethylene diamine (0.53 g, 2.5 mmol) in CH2Cl2 (20 
mL) was added Et3N (0.7 mL, 5.0 mmol) at 0 oC. The substituted benzoly chloride 
(5.0 mmol) was added dropwise to the reaction mixture at 0 oC. A heavy suspension 
6.3 Kobayashi, S.; Matsubara, R.; Nakamura, Y.; Kitagawa, H.; Sugiura, M. J. Am. Chem. Soc. 2003, 
125, 2507 and references therein. 
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was obtained during the addition. After 1 h at ice bath temperature, the reaction 
mixture was allowed to warm to room temperature and stirred for further 5 h. The 
reaction was quenched by addition of 10% aqueous HCl (5 mL) and the mixture was 
extracted with CH2Cl2 (2 portions of 10 mL). The organic layer was washed with 
saturated aqueous NaHCO3 (2 portions of 15 mL), brine (10 mL) and dried (MgSO4). 
The solvent was evaporated to afford (R,R)-N,N’-dibenzoyl 1,2-diphenyletylene 
diamine in quantitative yield. In some cases the N,N’-diacyl diamine was insoluble in 
organic solvents. In such cases, a simple filtration of the reaction mixture followed by 
washing with water afforded the almost pure desired compound. The solid was dried 
effectively by azeotropic distillation with benzene. To a solution of the dried N,N’-
diacyl diamine (1.2 mmol) in THF (5 mL) was added BH3·THF (1.0 M, 30 eq.) at 0 
oC. The reaction mixture was refluxed for 10-20 h and cooled to room temperature. 
The reaction was quenched by careful addition of MeOH (4 mL) at 0 oC and the 
mixture was concentrated. MeOH (4 mL) and conc. HCl (10 mL) were added to the 
residue at ice bath temperature and the resulting mixture was refluxed for 2 h. The 
reaction mixture was alkalized with 10% aqueous NaOH and extracted with CH2Cl2 
(3 portions of 15 mL). The organic layer was washed with brine (20 mL) and dried 
(K2CO3). The solvent was evaporated and the residue was purified by 
chromatography or recrystallization to afford the diamine ligand in moderate to high 
yield. 
 
(1R,2R)-N,N’-Bis-naphthalen-1-ylmethyl-1,2-
diphenyl-ethane-1,2-diamine (1.a) 
 
This compound was best prepared according to the 
following procedure: To a suspension of (R,R)-1,2-
diphenylethylnene diamine (900 mg, 4.24 mmol) and K2CO3 (2.34 g, 16.9 mmol) in 
DMF (5 mL) was added a solution of 1-(chloromethyl)naphthalene (1.5 g, 8.46 mmol) 
in DMF (7 mL). The reaction mixture was stirred for 2 days at room temperature, 
after which it was quenched by addition of water (5 mL) and the mixture extracted 
with EtOAc (2 portions of 8 mL). The organic layers were washed several times with 
water, followed by brine (10 mL). The organic layer was dried (K2CO3), the solvent  
was evaporated and the residue was purified by column chromatography on silica gel 
to afford (1.a) as a colourless solid (1,2 g, 53%); mp 52.0-53.0 oC; 1H-NMR (CDCl3) 
δ 2.49 (brs, 2H), 3.78 (s, 2H), 3.89 (d, 2H, J = 13.0 Hz), 4.03 (d, 2H, J = 13.0 Hz), 
7.05-7.50 (m, 18H), 7.73 (d, 2H, J = 8.1Hz), 7.82 (d, 2H, J = 8.3 Hz), 7.92 (d, 2H, J = 
8.6 Hz); 13C-NMR (CDCl3) δ 49.5, 69.1, 124.0, 125.2, 125.5, 125.8, 126.1, 127.0, 
127.6, 128.0, 128.5, 131.9, 133.8, 136.1, 141.3; IR (KBr) 3310, 3053, 3033, 2911, 
NH HN
Ph Ph
Part II                                        6.2 - Preparation of Enecarbamates and Chiral Ligands 
 
 
 214
2840, 1594, 1504, 1455, 1262, 1111, 1073, 1021, 858, 780, 699, 565 cm-1; LRMS 
(EI) m/z = 492 [M]2+; Anal. Calcd for C36H32N2: C, 87.77, H, 6.55, N, 5.69. Found: C, 
85.57; H, 6.83; N, 5.67; [ ] +2.2 (c 0.99, CHCl24Dα 3). 
 
(1R,2R)-N,N’-Bis(3,5-di-tert-butyl-benzyl)-1,2-
diphenyl-ethane-1,2-diamine (3.b) 
 
Obtained in 48%; mp 115.0-117.0 oC; 1H-NMR 
(CDCl3) δ 2.18 (s, 36H), 3.49 (d, 2H, J = 12.8 Hz), 
3.62 (d, 2H, J = 12.8 Hz), 3.73 (s, 2H), 6.90-7.40 (m, 
18H); 13C-NMR (CDCl3) δ 31.5, 34.7, 52.0, 68.3, 77.2, 120.8, 122.4, 126.9, 127.9, 
128.1, 139.4, 141.5, 150.6; IR (KBr) 2963, 2903, 2866, 1599, 1475, 1455, 1362, 712, 
699 cm-1; LRMS (EI) m/z = 308 [M]2+; Anal. Calcd. for C44H60N2: C, 85.66, H, 9.80, 
N, 4.54. Found: C, 85.70; H, 9.90; N, 4.52; [ ]24Dα -10.3 (c 0.55, CHCl3). 
NH HN
Ph Ph
tBu
tButBu
tBu
 
(1R,2R)-N,N’-dibenzyl-1,2-diphenyl-ethane-1,2-diamine 
(3.d) 
 
Obtained in 67%; mp 64.0-65.2 oC; 1H-NMR (CDCl3) δ 
2.18 (brs), 3.42 (d, 2H, J = 13.3 Hz), 3.59 (d, 2H, J = 13.3 
Hz), 3.64 (s, 2H), 6.80-7.45 (m, 20H); 13C-NMR (CDCl3) δ 51.3, 68.3, 126.8, 126.9, 
128.0, 128.0, 128.1, 128.3, 140.5, 141.1; IR (KBr) 3310, 3085, 3062, 2830, 1494, 
1112, 739, 697 cm-1; LRMS (EI) m/z = 196 [M]2+; Anal. Calcd. for C28H28N2: C, 
85.67, H, 7.19, N, 7.14. Found: C, 85.94; H, 7.35; N, 7.12; [ ]24Dα -27.9 (c 1.0, CHCl3). 
NH HN
Ph Ph
 
General Procedure for the Preparation of Diimine Ligands (GP 4):6.4
The aldehyde (neat, 2.0 eq.) is added to a 0.2 M solution of (R,R)-1,2-
cyclohexyldiamine (1.0 eq) in EtOH. This mixture was heated to reflux for 1-2 h, 
after which H2O was added dropwise to the resulting solution at 0 oC (occasionally 
the product begins to crystallize upon cooling prior to addition of water). The 
resulting crystalline solid was collected by filtration and washed with a small portion 
of abs. EtOH. 
 
 
                                               
6.4 Zhang, W.; Jacobsen, E. N. J. Org. Chem. 1991, 56, 2297. 
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(1R,2R)-(N1-E,N2-E)-N1,N2-Dibenzylidenecyclohexane-
1,2-diamine (3.j) 
 
Obtained in 85%; mp 99.0-100.2 oC; 1H-NMR (CDCl3) δ 
1.50 (m, 2H), 1.86 (s, 6H), 3.42 (m, 2H), 7.29 (m, 2H), 7.33 
(d, 4H, J = 2.2 Hz), 7.59 (d, 4H, J = 2.2 Hz), 8.21 (s, 2H); 
13C-NMR (CDCl3) δ 24.46, 32.93, 73.76, 127.87, 128.32, 130.16, 136.33, 160.94; 
LRMS (FAB+) m/z = 291 [M+H]+; [ ]24Dα -202.0 (c 0.5, CHCl3). 
N N
 
(1R,2R)-(N1-E,N2-E)-N1,N2-bis-(4-bromo-
benzylidene)cyclohexane-1,2-diamine (3.u) 
 
Obtained in 91%; mp 124.3-125.5 oC; 1H-NMR (CDCl3) δ 
1.49 (m, 2H), 1.86 (s, 6H), 3.38 (m, 2H), 7.44 (s, 8H), 
8.11 (s, 2H); 13C-NMR (CDCl3) δ 24.42, 32.81, 73.77, 
124.69, 129.32, 131.67, 135.15, 159.74; LRMS (FAB+) m/z = 499 [M+H]+; [ ]24Dα -
266.0 (c 1.2, CHCl3). 
N N
Br Br
 
 
6.3 - Compounds from addition reactions 
 
Procedure to obtained monomeric ethyl glyoxylate: 
Polymeric ethyl glyoxylate (as a toluene solution) (30 g) was concentrated under 
vacuum (<1mmHg) at room temperature to completely remove the toluene. To the 
residue obtained was added P2O5 (ca. 300 mg) and this mixture was distilled at 
reduced pressure (150 mmHg, 80 oC), delivering monomeric ethyl glyoxylate as a 
pale yellow liquid. 
Note: The freshly distilled monomeric ethyl glyoxylate begins to polymerize within 
less than 30 min. into a viscous liquid and therefore it should be used immediately 
after distillation. 
 
General procedure for the catalysed reactions of enecarbamates with ethyl 
glyoxylate followed by acidic hydrolysis (GP 5): 
Metal salts (0.020 mmol, 10 mol%) were weighed in a dry-box into a dried two neck 
flask fitted with a 3-way tap. The ligand (best results obtained with diimine (3.u)) 
(0.022 mmol, 11 mol%) was added under a flow of argon, the flask sealed and 
evacuated-back-filled with argon (3 cycles). The specified solvent (typically CH2Cl2) 
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(1.5 mL) was added via syringe and the mixture obtained was stirred at room 
temperature over ca. 12 h under an argon atmosphere to ensure complete formation of 
the L.A.-ligand complex. After being cooled to the wanted temperature (usually 0 oC), 
a solution of freshly distilled ethyl glyoxylate (0.24 mmol, 1.2 eq.) in the specified 
solvent (typically CH2Cl2) (0.8 mL) and a solution of the enecarbamate (0.2 mmol, 
1.0 eq) in the specified solvent (typically CH2Cl2) (0.8 mL) were added sequentially 
in one portion. After stirring at that temperature for the stated time (usually 1 h), the 
reaction was quenched by addition of saturated aqueous NaHCO3 (1.5 mL) and then 
stirred at room temperature (exposed to air) for approx. 1-2 min. The reaction mixture 
was transferred to a separating funnel and extracted with CH2Cl2 (3 portion of 2 mL). 
The organic layers were combined, washed with brine (3 mL), dried (MgSO4) and the 
solvent removed under reduced pressure. The residue thus obtained was dissolved in 
EtOH (3 mL), cooled to 0 oC and hydrolyzed with a 48% HBr aqueous solution (0.3 
mL). The reaction mixture was stirred at room temperature for approx. 1½ min., after 
which it was cooled to 0 oC and quenched with saturated aqueous NaHCO3 (10 mL). 
The reaction mixture was transferred to a separating funnel and extracted with CH2Cl2 
(3 portions of 5 mL)).The organic layers were combined, washed with brine, dried 
(MgSO4) and the solvent removed under reduced pressure. The crude product was 
loaded onto preparative TLC plates with CH2Cl2 and purified by eluting with 
benzene:acetone, 5:1. 
 
(2S)-2-Hydroxy-4-oxo-4-phenyl-butyric acid ethyl ester 
(4.14) 
 
Obtained in 93% and 97% ee; 1H-NMR (CDCl3) δ 1.27 (t, 3H, 
J = 7.1 Hz), 3.29 (brs, 1H), 3.44 (dd, 1H, J = 6.1, 17.6 Hz), 3.52 (dd, 1H, J = 3.9, 17.6 
Hz), 4.25 (q, 2H, J = 7.1 Hz), 4.61-4.67 (m, 1H), 7.44-7.50 (m, 2H), 7.54-7.60 (m, 
1H), 7.92-7.98 (m, 2H); 13C-NMR (CDCl3) δ 14.0, 42.1, 61.8, 67.1, 128.1, 128.6, 
133.5, 136.4, 173.7, 197.5; IR (neat) 3475, 3063, 2983, 1737, 1687, 1597, 1580, 
1449, 1368, 1213, 1098, 1045, 860, 759, 690, 582, 499 cm-1; HRMS (FAB); Exact 
mass calcd. for C12H15O4 [M+H]+, 223.0970. Found 223.0972; HPLC, Daicel 
Chiralcel ADH, hexane:iPrOH 4:1, flow rate = 0.5 mLmin-1: tr = 19.9 min (S), tr = 
22.2 min (R). 
EtO
O
OOH
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(2S)-2-Hydroxy-4-(4-methoxy-phenyl)-4-oxo-butyric 
acid ethyl ester (4.17) 
 
Obtained in 94% and 93% ee; 1H-NMR (CDCl3) δ 1.28 (t, 
3H, J = 7.1 Hz), 3.41 (dd, 1H, J = 5.9, 17.4 Hz), 3.48 (dd, 1H, J = 4.0, 17.4 Hz), 3.48 
(brd, 1H, J = 6.8 Hz), 3.87 (s, 3H), 4.26 (q, 2H, J = 7.1 Hz), 4.60-4.70 (m, 1H), 6.91-
6.97 (m, 2H), 7.90-7.97 (m, 2H); 13C-NMR (CDCl3) δ 14.0, 41.7, 55.4, 61.7, 67.3, 
113.8, 129.5, 130.4, 163.8, 173.8, 196.1; IR (neat) 3483, 2979, 2841, 1739, 1677, 
1600, 1575, 1512, 1421, 1368, 1265, 1172, 1099, 1027, 988, 895, 834, 737, 579 cm-1; 
HRMS (FAB); Exact mass calcd. for C13H17O5 [M+H]+, 253.1076. Found 253.1097; 
HPLC, Daicel Chiralcel ADH, hexane:iPrOH = 4:1, flow rate = 0.4 mLmin-1: tr = 
43.1 min (S), tr = 45.7 min (R). 
EtO
O
OOH
OMe
(2S)-4-(4-Chloro-phenyl)-2-hydroxy-4-oxo-butyric acid 
ethyl ester (4.18) 
 
Obtained in 97% and 97% ee; 1H-NMR (CDCl3) δ 1.28 (t, 
3H, J = 7.1 Hz), 3.42 (dd, 1H, J = 6.1, 17.3 Hz), 3.49 (dd, 1H, J = 3.9, 17.3 Hz), 3.41-
3.47 (brd, 1H), 3.87 (s, 3H), 4.26 (q, 2H, J = 7.1 Hz), 4.62-4.70 (m, 1H), 7.42-7.48 
(m, 2H), 7.86-7.93 (m, 2H); 13C-NMR (CDCl3) δ 14.1, 42.2, 62.0, 67.1, 129.0, 129.6, 
134.8, 140.1, 173.7, 196.3; IR (neat) 3480, 2982, 1739, 1684, 1590, 1573, 1402, 
1213, 1093, 1045, 820, 531 cm-1; HRMS (FAB); Exact mass calcd. for C12H14ClO4 
[M+H]+, 257.0580. Found 257.0584; HPLC, Daicel Chiralcel ADH, hexane:iPrOH = 
4:1, flow rate = 0.5 mLmin-1: tr = 24.2 min (S), tr = 26.5 min (R). 
EtO
O
OOH
Cl
 
(2S)-2-Hydroxy-4-oxo-4-p-tolyl-butyric acid ethyl ester 
(4.19) 
 
Obtained in quantitative yield and 96% ee; 1H-NMR 
(CDCl3) δ 1.28 (t, 3H, J = 7.1 Hz), 2.41 (s, 3H), 3.44 (dd, 1H, J = 5.9, 17.4 Hz), 3.51 
(dd, 1H, J = 4.0, 17.4 Hz), 3.45-3.55 (brd, 1H), 4.26 (q, 2H, J = 7.1 Hz), 4.66 (dt, 1H, 
J = 4.2, 5.5 Hz), 7.26 (appd, 2H, J = 8.0 Hz), 7.85 (appd, 2H, J = 8.2 Hz); 13C-NMR 
(CDCl3) δ 14.0, 21.6, 42.0, 61.7, 67.2, 128.2, 129.3, 133.9, 144.4, 173.7, 197.1; IR 
(neat) 3483, 2981, 1742, 1682, 1606, 1405, 1365, 1212, 1098, 1044, 813, 578 cm-1; 
HRMS (FAB); Exact mass calcd. for C13H17O4 [M+H]+, 237.1127. Found 237.1120; 
HPLC, Daicel Chiralcel ADH, hexane:iPrOH = 4:1, flow rate = 0.3 mLmin-1: tr = 
36.1 min (S), tr = 38.1 min (R). 
EtO
O
OOH
Me
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(2S)-2-Hydroxy-4-naphthalen-2-yl-4-oxo-butyric acid 
ethyl ester (4.20) 
Obtained in 91% and 96% ee; 1H-NMR (CDCl3) δ 1.28 (t, 
3H, J = 7.1 Hz), 3.52 (d, 1H, J = 5.9 Hz), 3.59 (dd, 1H, J = 
6.1, 17.3 Hz), 3.66 (dd, 1H, J = 3.9 , 17.3 Hz), 4.28 (q, 2H, J= 7.1 Hz), 4.73 (dt, 1H , 
J = 4.2, 5.4 Hz), 7.50-7.65 (m, 2H), 7.82-8.20 (m, 4H), 8.45 (s, 1H); 13C-NMR 
(CDCl3) δ 14.1, 42.3, 61.9, 67.3, 123.6, 126.9, 127.8, 128.6, 128.8, 129.6, 130.2, 
132.4, 133.8, 135.8, 173.9, 197.5; IR (neat) 3481, 3058, 2982, 1741, 1681, 1627, 
1469, 1369, 1209, 1097, 1045, 859, 824, 749, 477 cm-1; HRMS (FAB); Exact mass 
calcd. for C16H17O4 [M+H]+, 273.1127. Found 273.1125; HPLC, Daicel Chiralcel 
ADH, hexane:iPrOH = 4:1, flow rate = 0.5 mLmin-1: tr = 27.0 min (S), tr = 30.4 min 
(R). 
EtO
O
OOH
(2S,2S)-2-Hydroxy-3-methyl-4-oxo-4-phenyl-butyric acid 
ethyl ester (4.21) EtO
O
OOH
Me  
Obtained in 96% and 98% ee; 1H-NMR (CDCl3) δ 1.26 (t, 3H, J 
= 7.0 Hz), 1.29 (d, 3H, J = 7.0 Hz), 3.28 (brs, 1H), 3.93 (dq, 1H, J = 4.2, 7.0 Hz), 4.25 
(q, 2H, J = 7.0 Hz), 4.58 (d, 1H, J = 4.2 Hz), 7.40-7.65 (m, 3H), 7.90-8.05 (m, 2H); 
13C-NMR (CDCl3) δ 12.1, 14.0, 44.3, 61.9, 71.6, 128.4, 128.7, 133.3, 135.7, 173.1, 
201.6; IR (neat) 3480, 3063, 2978, 2936, 1734, 1678, 1596, 1579, 1449, 1369, 1217, 
1133, 1062, 1023, 1001, 975, 952, 862, 794, 708 cm-1. 
 
(2S,3R)-2-Hydroxy-3-methyl-4-oxo-4-phenyl-butyric acid 
ethyl ester (4.21) EtO
O
OOH
Me  
Obtained in 95% and 98% ee; 1H-NMR (CDCl3) δ 1.20 (t, 3H, J 
= 7.1 Hz), 1.36 (d, 3H, J = 7.3 Hz), 3.61 (d, 1H, J = 8.3 Hz), 3.98 (dq, 1H, J = 4.6, 7.1 
Hz), 4.10-4.25 (m, 2H);, 4.39 (dd, 1H, J = 4.6, 8.3 Hz), 7.40-7.65 (m, 3H); 13C-NMR 
(CDCl3) δ 14.0, 14.1, 44.0, 61.5, 73.1, 128.3, 128.7, 133.4, 135.9, 173.1; IR (neat) 
3481, 3059, 2981, 2941, 1738, 1685, 1588, 1454, 1372, 1255, 1209, 1144, 1092, 
1024, 973, 701 cm-1. 
 
HRMS (FAB); Exact mass calcd for C13H17O4 [M+H]+, 237.1127. Found 237.1118; 
HPLC, Daicel Chiralcel AS+ADH+AD, hexane:iPrOH = 4:1, flow rate = 0.5 mLmin-
1: tr = 46.7 min (2S,3S), tr = 50.6 min (2R,3R), tr = 54.3 min (2S,3R), tr = 61.9 min 
(2R,3S). 
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(2S,3S)-2-Hydroxy-4-(4-methoxy-phenyl)-3-methyl-4-
oxo-butyric acid ethyl ester (4.22) 
 
Obtained in 97% and 98% ee; 1H-NMR (CDCl3) δ 1.28 (t, 
3H, J = 7.1 Hz), 1.29 (d, 3H, J = 7.1 Hz), 3.35 (brs, 1H), 3.84-3.96 (m, 4H), 4.27 (q, 
2H, J = 7.1 Hz), 4.58 (d, 1H, J = 4.2 Hz), 6.96 (appd, 2H, J = 9.0 Hz), 7.30-7.45 (m, 
5H), 7.95 (appd, 2H, J = 8.8 Hz); 13C-NMR (CDCl3) δ 12.3, 14.0, 43.7, 55.4, 61.8, 
71.7, 113.9, 128.5, 130.7, 163.7, 173.1, 200.4; IR (neat) 3477, 2979, 2935, 2850, 
1730, 1670, 1600, 1573, 1510, 1463, 1420, 1308, 1261, 1173, 1125, 1027, 976, 843, 
770, 604 cm-1. 
EtO
O
OOH
Me
OMe
 
(2S,3R)-2-Hydroxy-4-(4-methoxy-phenyl)-3-methyl-4-
oxo-butyric acid ethyl ester (4.22) 
 
Obtained in 96% and 98% ee; 1H-NMR (CDCl3) δ 1.19 (t, 
3H, J = 7.1 Hz), 1.36 (d, 3H, J = 7.3 Hz), 3.75 (d, 1H, J = 
9.3 Hz), 3.88 (s, 3H), 3.94 (dq, 1H, J = 4.6, 7.3 Hz), 4.15 (appdq, 2H, J = 3.2, 7.1 
Hz), 4.36 (dd, 1H, J = 4.6, 9.3 Hz), 6.92-6.99 (m, 2H), 7.90-7.97 (m, 2H); 13C-NMR 
(CDCl3) δ 14.0, 14.6, 43.2, 55.5, 61.4, 73.4, 113.9, 128.7, 130.8, 163.8, 173.2, 201.9; 
IR (neat) 3478, 2979, 2941, 2843, 1738, 1671, 1599, 1580, 1510, 1457, 1419, 1370, 
1308, 1257, 1216, 1172, 1092, 1026, 974, 841 cm-1. 
EtO
O
OOH
Me
OMe
 
HRMS (FAB); Exact mass calcd for C14H19O5 [M+H]+, 267.1232. Found 267.1232; 
HPLC, Daicel Chiralcel ADH, hexane:iPrOH = 4:1, flow rate = 0.2 mLmin-1: tr = 
60.5 min (2R,3R), tr = 65.4 min (2S,3S), tr = 75.2 min (2R,3S), tr = 78.9 min (2S,3R). 
(2S,3S)-4-(4-Chloro-phenyl)-2-hydroxy-3-methyl-4-oxo-
butyric acid ethyl ester (4.23) 
 
Obtained in 79% and 98% ee; 1H-NMR (CDCl3) δ 1.26 (t, 
3H, J = 7.0 Hz), 1.28 (d, 3H, J = 7.0 Hz), 3.27 (brs, 1H), 3.87 (dq, 1H, J = 4.4, 7.0 
Hz), 4.25 (q, 2H, J = 7.0 Hz), 4.55 (d, 1H, J = 4.4 Hz), 7.40-7.55 (m, 2H), 7.84-7.97 
(m, 2H); 13C-NMR (CDCl3) δ 12.1, 14.0, 44.4, 62.0, 71.5, 129.0, 129.8, 134.1, 139.7, 
173.1, 200.3; IR (neat) 3485, 2982, 2938, 1730, 1682, 1589, 1571, 1488, 1455, 1401, 
1217, 1132, 1092, 1013, 977, 843, 758, 692, 533, 478 cm-1. 
EtO
O
OOH
Me
Cl
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(2S,3R)-4-(4-Chloro-phenyl)-2-hydroxy-3-methyl-4-oxo-
butyric acid ethyl ester (4.23) 
 
Obtained in 85% and 98% ee; 1H-NMR (CDCl3) δ 1.21 (t, 
3H, J = 7.1 Hz), 1.34 (d, 3H, J = 7.1 Hz), 3.53 (d, 1H, J = 8.2 Hz), 3.91 (dq, 1H, J = 
5.0, 7.1 Hz), 4.08-4.24 (m, 2H), 4.38 (dd, 1H, J = 5.0, 8.2 Hz), 7.42-7.52 (m, 2H), 
7.80-7.95 (m, 2H); 13C-NMR (CDCl3) δ 13.9, 14.0, 44.1, 61.6, 73.0, 129.0, 129.8, 
134.3, 139.9, 173.0, 201.8; IR (neat) 3478, 3092, 2982, 2935, 1738, 1686, 1589, 
1455, 1402, 1255, 1208, 1144, 1092, 1022, 976, 842, 751, 527 cm-1. 
EtO
O
OOH
Me
Cl
 
HRMS (FAB); Exact mass calcd for C13H16ClO4 [M+H]+, 271.0737. Found 271.0745; 
HPLC, Daicel Chiralcel AS, hexane:iPrOH = 4:1, flow rate = 0.5 mLmin-1: tr = 15.1 
min (2S,3S), tr = 16.6 min (2S,3R), tr = 21.4 min (2R,3S), tr = 23.9 min (2R,3R). 
 
(2S,3S)-3-Benzoyl-2-hydroxy-pentanoic acid ethyl ester 
(4.26) EtO
O
OOH
Et  
Obtained in 92% and 98% ee; 1H-NMR (CDCl3) δ 0.93 (t, 3H, J 
= 7.5 Hz), 1.19 (t, 3H, J = 7.1 Hz), 1.70-2.05 (m, 2H), 3.18 (brs, 1H), 3.83 (dt, 1H, J 
= 5.3, 8.3 Hz), 4.19 (q, 2H, J = 7.1 Hz), 4.51, (d, 1H, J = 5.3 Hz), 7.42-7.54 (m, 2H), 
7.54-7.62 (m, 1H), 7.90-8.02 (m, 2H); 13C-NMR (CDCl3) δ 12.0, 13.9, 21.3, 51.2, 
61.9, 71.1, 128.3, 128.6, 133.2, 137.0, 173.6, 201.5; IR (neat) 3477, 2972, 2876, 
1738, 1675, 1596, 1447, 1372, 1255, 1220, 1118, 1023, 931, 849, 779, 701 cm-1. 
 
(2S,3R)-3-Benzoyl-2-hydroxy-pentanoic acid ethyl ester 
(4.26) EtO
O
OOH
Et  
Obtained in 58% and 98% ee; 1H-NMR (CDCl3) δ 1.04 (t, 3H, J 
= 7.6 Hz), 1.15 (t, 3H, J = 7.1 Hz), 1.80-1.95 (m, 2H),3.70 (d, 1H, J = 9.5 Hz), 3.83 
(dt, 1H, J = 4.2, 7.1 Hz), 4.09 (q, 2H, J = 7.1 Hz), 4.43 (dd, 1H, J = 4.2, 9.5 Hz), 7.46-
7.52 (m, 2H), 7.56-7.63 (m, 1H), 7.88-7.95 (m, 2H); 13C-NMR (CDCl3) δ 12.0, 13.9, 
22.3, 50.1, 61.4, 71.3, 128.3, 128.7, 133.5, 136.6, 173.4, 203.9; IR (neat) 3485, 3062, 
2966, 2941, 2875, 1738, 1682, 1596, 1579, 1448, 1368, 1268, 1208, 1134, 1100, 
1028, 914, 849, 785, 699 cm-1. 
 
HRMS (FAB); Exact mass calcd for C14H19O4 [M+H]+, 251.1283. Found 251.1277; 
HPLC, Daicel Chiralcel AS, hexane:iPrOH = 4:1, flow rate = 0.5 mLmin-1: tr = 13.7 
min (2S,3S), tr = 15.3 min (2S,3R), tr = 17.6 min (2R,3R), tr = 23.1 min (2R,3S). 
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(2S,3S)-2-Hydroxy-3-methyl-4-oxo-hexanoic acid ethyl ester 
(4.27) EtO Et
O
OOH
Me  
Obtained in 89% and 98% ee; 1H-NMR (C6D6) δ 0.89 (t, 3H, J = 
7.1 Hz), 0.99 (d, 3H, J = 7.2 Hz), 1.97-2.08 (m, 2H), 2.70 (dq, 1H, J = 4.9, 7.2 Hz), 
3.39 (d, 1H, J = 6.7 Hz), 3.80-4.00 (m, 2H), 4.11 (dd, 1H, J = 4.9, 6.7 Hz); 13C-NMR 
(CDCl3) δ 7.58, 12.8, 14.0, 34.6, 49.4, 61.3, 73.0, 173.5, 211.3; IR (neat) 3484, 2981, 
2940, 1739, 1716, 1459, 1409, 1375, 1268, 1209, 1108, 1066, 1025, 975, 862, 808, 
748 cm-1. 
 
(2S,3R)-2-Hydroxy-3-methyl-4-oxo-hexanoic acid ethyl ester 
(4.27) EtO Et
O
OOH
Me  
Obtained in 83% and 97% ee; 1H-NMR (C6D6) δ 0.87 (t, 3H, J = 
7.1 Hz), 0.93 (t, 3H, J = 7.3 Hz), 1.02 (d, 3H, J = 7.2 Hz), 1.95-2.22 (m, 2H), 2.65 
(dq, 1H, J = 4.4, 7.2 Hz), 3.05-3.23 (m, 1H), 3.80-4.00 (m, 2H), 4.38-4.47 (m, 1H); 
13C-NMR (C6D6) δ 7.7, 11.0, 14.0, 34.0, 49.5, 61.6, 71.7, 173.7, 209.9; IR (neat) 
2981, 2940, 1733, 1716, 1459, 1373, 1218, 1145, 1025, 977, 862, 800, 752 cm-1. 
 
HRMS (FAB); Exact mass calcd for C9H17O4 [M+H]+, 189.1127. Found 189.1120. 
 
(1S,2R)-Hydroxy-(2-oxo-cyclohexyl)-acetic acid ethyl ester (4.28) 
 
Obtained in 85% and 94% ee; 1H-NMR ((1S,1’R), tentative 
assignment) (C6D6) δ 0.95 (t, 3H, J = 7.1 Hz), 0.94-1.20 (m, 2H), 
1.30-1.42 (m, 2H), 1.56-1.84 (m, 3H), 2.02-2.12 (m, 1H), 2.60-2.70 (m, 1H), 3.35 (d, 
1H, J = 7.2 Hz), 3.84 (dd, 1H, J = 3.2, 7.2 Hz), 4.02 (dq, 2H, J = 1.9, 7.1 Hz); 13C-
NMR (CDCl3) δ 14.1, 24.8, 26.9, 30.1, 42.0, 53.7, 61.6, 71.1, 173.4, 211.2. 
EtO
O
OH O
 
1H-NMR distinguishable syn peaks (C6D6) δ 0.88 (t, 3H, J = 7.1 Hz), 2.12-2.21 (m, 
1H), 2.48-2.57 (m, 1H), 2.94 (d, 1H, J = 5.0 Hz), 4.60 (dd, 1H, J = 3.2, 5.0 Hz); 13C-
NMR distinguishable syn peaks (CDCl3) δ 14.2, 24.6, 27.1, 41.9, 53.8, 61.7, 69.2, 
173.6, 210.4. 
 
HRMS (FAB); Exact mass calcd for C10H17O4 [M+H]+, 201.1127. Found 201.1127. 
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Example of a procedure for the catalysed reaction of enecarbamates with ethyl 
glyoxylate followed by reduction: 
(2S,4R)-4-Benzyloxycarbonlyamino-2-hydroxy-4-phenyl-
butyric acid ethyl ester (4.31) EtO
O
OH NHCbz
 
A solution of ligand (3.u) (9.9 mg, 0.022 mmol) in CH2Cl2 (1.5 
mL) was added to CuClO4·4CH3CN (6.5 mg, 0.020 mmol) under argon. The yellow 
solution obtained was stirred at room tempearture over 8 h and cooled to 0 oC. Freshly 
distilled ethyl gyloxylate (100 μL, 0.40 mmol) in CH2Cl2 (0.8 mL) was added 
followed by a solution of enecarbamate (1.37) in CH2Cl2 (0.8 mL) in one portion. The 
reaction mixture was stirred at 0 oC for 1 h and then quenched by addition of saturated 
aqueous NaHCO3 (1.5 mL). After reaching room temperature, the mixture transferred 
into an extracting funnel and extracted with CH2Cl2 (3 portions of 2 mL). The organic 
layer was washed with brine (3 mL), dried (MgSO4) and the solvent removed under 
vacuum. The residue thus obtained was taken in benzene and concentrated under 
vacuum (three times) to remove the last traces of water. THF (2.0 mL) and MeOH 
(0.5 mL) were added to the residue and this solution was cooled to -78 oC. Diethyl 
methoxyborane (79μL, 0.6 mmol) was added and the mixture was stirred for 15 min. 
at this temperature, after which NaBH4 (22.7 mg, 0.6 mmol) was added in one 
portion. After stirring at -78 oC for 2 h the reaction was quenched by addition of 
AcOH (0.3 mL) and was allowed to warm to ice bath temperature. The mixture was 
alkalized at 0 oC by addition of saturated aqueous NaHCO3 and extracted with Et2O (2 
portions of 3 mL). The combined organic fractions were washed with brine (3 mL), 
dried (MgSO4) and then concentrated under vacuum. The crude product obtained was 
purified by preparative TLC to deliver (4.31) (46.5 mg, 65% over two steps, syn:anti 
= 94:6). 1H-NMR (CDCl3) δ 1.23 (t, 3H × 19/20, J = 7.1 Hz), 1.25 (t, 3H × 1/20, J = 
7.0 Hz), 1.95-2.40 (m, 2H), 3.33 (brs, 1H × 19/20), 3.51 (brs, 1H × 1/20), 4.00-4.40 
(m, 3H), 4.85-5.20 (m, 3H), 5.52 (d, 1H × 19/20, J = 7.3 Hz), 5.96 (d, 1H × 1/20, J = 
8.2 Hz), 7.00-7.60 (m, 10 H); 13C-NMR (CDCl3) δ 14.1, 40.3, 52.6, 61.8, 66.8, 68.4, 
126.4, 127.6, 128.1, 128.4, 128.7, 136.3, 141.4, 155.7, 174.4; LRMS (FAB) m/z = 
358 [M+H]+. 
 
13C-NMR distinguishable anti peaks (CDCl3) δ 40.2, 52.4, 67.8, 126.2, 127.4, 141.1, 
156.0, 174.3. 
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General procedure for the catalysed reactions of enecarbamates with butane-2,3-
dione followed by acidic hydrolysis (GP 6): 
Metal salts (typically Ni(OTf)2 and Cu(OTf)2) (0.020 mmol, 10 mol%) were weighed 
in a dry-box into a dried two neck flasks fitted with a 3-way tap. Diamine (3.d) (0.022 
mmol, 11 mol%) was added under a flow of argon, the flask sealed and evacuated-
back-filled with argon (3 cycles). CH2Cl2 (1.5 mL) was added via syringe and the 
mixture obtained was stirred at room temperature over ca. 12 h under an argon 
atmosphere to ensure complete formation of the catalyst. After being cooled to the 
wanted temperature (usually 0 oC), a solution of butane-2,3-dione (0.40 mmol, 2.0 
eq.) in CH2Cl2 (0.7 mL) and a solution of the enecarbamate (0.2 mmol, 1.0 eq) in 
CH2Cl2 (0.7 mL) were added sequentially in one portion. After stirring at that 
temperature for the stated time (best results were obtained for a 14 days period), the 
reaction was quenched by addition of saturated aqueous NaHCO3 (1.5 mL) and then 
stirred at room temperature (exposed to air) for approx. 1-2 min. The reaction mixture 
was transferred to a separating funnel and extracted with CH2Cl2 (3 portions of 2 mL). 
The organic layers were combined, washed with brine (3 mL), dried (MgSO4) and the 
solvent removed under reduced pressure. The residue thus obtained was dissolved in 
EtOH (3 mL), cooled to 0 oC and hydrolyzed with a 48% HBr aqueous solution (0.3 
mL). The reaction mixture was stirred at room temperature for approx. 1½ min., after 
which it was cooled to 0 oC and quenched with saturated aqueous NaHCO3 (10 mL). 
The reaction mixture was transferred to a separating funnel and extracted with CH2Cl2 
(3 portions of 5 mL). The organic layers were combined, washed with brine, dried 
(MgSO4) and the solvent removed under reduced pressure. The crude product was 
loaded onto preparative TLC plates with CH2Cl2 and purified by eluting with 
benzene:acetone, 7:1. 
 
3-Hydroxy-3-methyl-1-phenylpentane-1,4-dione (4.41) 
 
Obtained in 94% and 84% ee; 1H-NMR (CDCl3) δ 1.31 (s, 3H), 
2.31 (s, 3H), 3.17 (d, 1H, J = 17.9 Hz), 3.73 (d, 1H, J = 17.2 
Hz), 4.30-4.48 (brs, 1H), 7.41 (t, 2H, J = 7.6 Hz), 7.53 (t, 1H, J = 7.6 Hz) 7.87 (d, 2H, 
J = 8.2 Hz); 13C-NMR (CDCl3) δ 24.3, 25.2, 47.1, 78.2, 128.3, 128.7, 133.9, 136.1, 
200.6, 213.4, ; IR (neat) 3461, 1711, 1675 cm-1; HRMS (FAB); Exact mass calcd. for 
C12H15O3 [M+H]+, 207.1021. Found 207.1029. HPLC, Daicel Chiralcel ADH, 
hexane:iPrOH = 19:1, flow rate = 0.5 mLmin-1: tr = 26.9 min (major enantiomer), tr = 
28.1 min (minor enantiomer). 
Me
O
HO Me O
*
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3-Hydroxy-1-(4-methoxyphenyl)-3-methylpentane-1,4-
dione (4.42) 
 
Obtained in 59% and 65% ee; mp 123.0-124.0 oC; 1H-
NMR (CDCl3) δ 1.29 (s, 3H), 2.31, (s, 3H), 3.10 (d, 1H, J = 17.9 Hz), 3.69 (d, 1H, J = 
17.2 Hz), 3.81 (s, 3H), 4.41-4.62 (brs, 1H), 6.86, (d, 2H, J = 8.9 Hz), 7.85 (d, 2H, J = 
8.9 Hz); 13C-NMR (CDCl3) δ 24.4, 25.1, 46.7, 55.5, 78.3, 113.8, 129.2, 130.7, 164.1, 
199.01, 213.7; IR (neat) 3461, 1711, 1675 cm-1; Anal. Calcd. for C13H17O4: C, 66.09; 
H, 6.83. Found: C, 65.99; H, 6.70. HRMS (FAB); Exact mass calcd. for C13H17O4 
[M+H]+, 237.1127. Found 237.1134. HPLC, Daicel Chiralcel ADH, hexane:iPrOH = 
19:1, flow rate = 0.5 mLmin-1: tr = 53.1 min (major enantiomer), tr = 57.0 min (minor 
enantiomer). 
Me
O
HO Me O
*
OMe
1-(4-chlorophneyl)-3-hydroxy-3-methylpentane-1,4-dione 
(4.43) 
 
Obtained in 90% and 82% ee; 1H-NMR (CDCl3) δ 1.31 (s, 
3H), 2.30 (s, 3H), 3.14 (d, 1H, J = 18.0 Hz), 3.69 (d, 1H, J = 18.0 Hz), 4.21-4.49 (brs, 
1H), 7.38 (d, 2H, J = 8.9 Hz), 7.81 (d, 2H, J = 8.9 Hz); 13C-NMR (CDCl3) δ 23.9, 
24.8, 46.7, 77.9, 128.7, 129.4, 134.1, 140.1, 199.01, 212.8; IR (neat) 3462, 1714, 
1683 cm-1; HRMS (FAB); Exact mass calcd. for C12H14ClO3 [M+H]+, 241.0631. 
Found 241.0635. HPLC, Daicel Chiralcel ADH, hexane:iPrOH = 19:1, flow rate = 0.5 
mLmin-1: tr = 33.1 min (major enantiomer), tr = 36.8 min (minor enantiomer). 
Me
O
HO Me O
*
Cl
 
3-Hydroxy-3-methyl-1-
phenylhexane-1,4-dione (4.44) and 3-
ethyl-3-hydroxy-1-phenylpentane-
1,4-dione (4.45) (mixture) 
Et
O
HO Me O
*
Me
O
HO Et O
*
and
 
1H-NMR (CDCl3) (spectral data reported together; 1H of (4.45) is given as 1H 
integration whereas 1H for (4.44) is given as 7H (i.e., ration is 7:1)) 0.86 (t, 3H, J = 
7.6 Hz), 1.02 (t, 21H, J = 6.9 Hz), 1.30 (s, 21H), 1.69-1.78 (m 2H), 2.28 (s, 3H), 2.68-
2.81 (m, 14H), 3.14 (d, 7H, J = 17.9 Hz), 3.26 (d, 1H, J = 17.2 Hz), 3.59 (d, 1H, J = 
17.2 Hz), 3.77 (d, 7H, J = 17.8 Hz), 4.26-4.48 (brs (with br side peak), 7.3H), 7.27-
7.33 (brm, 2H), 7.40 (t, 14H, J = 8.3 Hz), 7.53 (appt, 8H, J = 7.6 Hz), 7.87 (appd, 
16H, J = 7.9 Hz); 13C-NMR (CDCl3) (for major product) δ 24.4, 25.1, 46.7, 55.5, 
78.3, 113.8, 129.2, 130.7, 164.1, 199.01, 213.7; IR (neat) 3462, 1709, 1672 cm-1; 
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Anal. Calcd. for C13H17O4: C, 66.09; H, 6.83. Found: C, 65.99; H, 6.70. HRMS 
(FAB); Exact mass calcd for C13H17O3 [M+H]+, 221.1178. Found 237.1176. 
 
HPLC, Daicel Chiralcel ADH, hexane:iPrOH = 9:1, flow rate = 0.2 mLmin-1: tr = 
47.6 min (major enantiomer for (4.44)), tr = 53.6 min (minor enantiomer for (4.44)), 
tr = 51.4 min (major enantiomer for (4.45)) and tr = 57.2 min (minor enantiomer for 
(4.45)). 
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CHAPTER 1 
Transannular Reactions - An Overview 
 
1.1 - Introduction 
 
Figure 1.1 Intramolecular and transannular 
reactions. 
FG2FG1
FG3
intramolecular
reaction
FG1 FG2
transannular
reaction
vs.
FG3
1.1 1.2
1.3 1.4
Intramolecular processes can in general be 
divided into two different categories: either 
the functional groups undergoing reaction 
are linked via one tether, a conventional 
intramolecular reaction (i.e., from (1.1) to 
(1.2)), or the reactive functional groups are 
tethered to each other at both termini, a 
transannular reaction (i.e., from (1.3) to 
(1.4)) (Figure 1.1). 
 
 
Transannular reactions can display significant advantages over their intermolecular 
and conventional intramolecular counterparts and thus have the potential to provide 
unique solutions in synthesis. Because medium- (i.e., 8-11) and (to a lesser extent) 
large-size (i.e., 12 or higher) alicyclic molecules can adopt stable puckered 
conformations where opposite sides of the ring are close to each other, bond forming 
processes can be greatly favored in these types of ring systems, taking place under 
often surprisingly mild conditions.1.1 Lower reaction temperatures, together with the 
constraints imposed by the connecting ring, provide a unique opportunity for 
achieving chemo-, regio- and stereoselectivity. Furthermore, by using more forcing 
conditions one can in principle carry out reactions that would be doomed to failure in 
the intermolecular and conventional intramolecular versions. 
 
Once the feasibility of employing a transannular reaction has been recognized, the 
main challenge often becomes the synthesis of the macrocyclic precursor. This has 
traditionally been a major problem, however, several methods are now available for 
the efficient preparation of medium and large rings,1.2 and so the problem of the 
precursor synthesis should no longer present a serious concern.  
1.1 For a general reference see: Eliel, S. T.; Wilen, S. H. in “Stereochemistry of Organic Compounds” 
1994, John Wiley & Sons, New York. 
1.2 For some reviews on macrocyclizations see: (a) Roxburgh, C. Tetrahedron 1995, 51, 9767. (b) 
Paterson, I.; Norcross, R. D. Chem. Rev. 1995, 95, 2041. (c) Williams, A. S. Synthesis 1999, 10, 1707. 
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Another apparent obstacle to a more generalized use of transannular processes is the 
somewhat limited ability to predict the regio- and stereochemical aspects of such 
reactions. Although forecasting the selectivity of chemical reactions by inspecting 
molecular models corresponding either to the starting materials or to the product has 
been successful for some transannular reactions,1.3 the truly significant geometries in 
kinetically driven reactions are the transition state structures. The problem can 
become even more complicated when other factors than sterics, namely 
stereoelectronics, are at play. For example, in transannular Diels-Alder (TADA) 
reactions, the endo effect can either antagonize or act in a synergetic manner with all 
the other effects and thus the ratio of TADA adducts can be rather difficult to predict. 
As computational methods progress and become more widely available, particularly 
transition-state molecular modeling, it is anticipated that predictive power will 
emerge, allowing transannular reactions to be incorporated with confidence in 
synthetic planning and enabling synthetic chemists to develop new and innovative 
strategies of molecular construction. 
 
 
 
 
 
(d) Griesbeck, A. G.; Henz, A.; Hirt, J. Synthesis 1996, 1261. (e) Illuminati, G.; Mandolini, L. Acc. 
Chem. Res. 1981, 14, 95.For selected examples see: (f) Trost, B. M.; Warner, R. W. J. Am. Chem. Soc. 
1982, 104, 6112. (g) McMurry, J. E.; Matz, J. R. Tetrahedron Lett. 1982, 23, 2723. (h) Takahashi, T.; 
Nemoto, H.; Tsuji, J. Tetrahedron Lett. 1983, 24, 2005. (i) Still, W. C.; Mobilio, D. J. J. Org. Chem. 
1983, 48, 4875. (j) Deslongchamps, P. Aldrichim. Acta 1984, 17, 59. (k) Yamamoto, H. J. Org. Chem. 
1996, 61, 4560. (l) Corey, E. J. J. Am. Chem. Soc. 1978, 100, 4620. (m) Mukaiyama, T. Chem. Lett. 
1976, 49. (n) Keck, G. E. J. Org. Chem. 1985, 50, 2394. (o) Masamune, S. J. Am. Chem. Soc. 1975, 
97, 3512. (p) Inaga, J.; Hirata, K.; Saeki, H.; Katsuki, T.; Yamaguchi, M. Bull. Chem. Soc. Jpn. 1979, 
52, 1989. (q) Mitsunobu, O. Synthesis 1981, 1. (r) Marshall, J. A. J. Org. Chem. 1998, 53, 1616. (s) 
Hayward, C. M.; Yohannes, D.; Danishefsky, S. J. J. Am. Chem. Soc. 1993, 115, 9345. (w) Smith, A. 
B. III; Ott, G. R. J. Am. Chem. Soc. 1996, 118, 13095. (t) Nicolau, K. C. J. Am. Chem. Soc. 1993, 
115, 4419. (u) Lipton, M. A. Tetrahedron Lett. 1993, 34, 7899. (v) Danishefsky, S. J. J. Am. Chem. 
Soc. 1997, 119, 2733. (u) Marshall, J. A.; DeHoff, B. S.; Crooks, S. L. Tetrahedron Lett. 1987, 28, 
527. 
1.3 For selected examples where the stereochemical outcome of reactions (e.g., reductions, enolate 
alkylations and cuprate additions) in macrocycles was successfully predicted based on simple 
conformational analysis see: (a) Still, W. C.; Galynker, I. Tetrahedron 1981, 37, 3981. (b) Neeland, 
E.; Ounsworth, J. P.; Sims, R. J.; Weiler, L. Tetrahedron Lett. 1987, 28, 35. 
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1.2 – Selected Uses of Transannular Reactions in Organic Synthesis 
 
Until fairly recently, the use of transannular reactions in organic synthesis was, to a 
great extent, limited to electrophilic cyclizations of cycloalkenes.1.4 Lately, however, 
several examples of different transannular processes, ranging from radical 
cyclizations, cycloisomerizations to cycloadditions, have been incorporated as key 
steps in complex total syntheses. This has been particularly significant in (often 
postulated) biomimmetic-inspired approaches, suggesting that Nature extensively 
uses transannular reactions in the biosynthesis of complex polycyclic systems. Some 
representative examples of such transannular processes are presented bellow with the 
focus being put on the formation of the macrocycle and the transannular step. 
 
In the last decade several groups have explored different elegant radical cascades 
strategies implying one or more cyclization(s) to access polycyclic natural product 
skeletons.1.5 Malacria and co-workers carried out a biomimetic, diastereoselective 
synthesis of racemic epi-elludol (1.7) from cycloundecadienyne (1.6) via a 
intramolecular-transannular radical cascade.1.6 The required highly strained eleven-
membered ring precursor (1.6) was efficiently prepared in 88% yield as a mixture of 
diastereomers from aldehyde (1.5) using a Nozaki-Hiyama-Kishi type ring-closure.1.7 
Under classical Bu3SnH-AIBN conditions the 4,6,5-cyclic framework was produced. 
Functional group manipulation then delivered the natural product (1.7) in good 
overall yield (47%) (Scheme 1.1). 
1.4 For reviews see: (a) Cope, A. C.; Martin, M. M.; McKervey, M. A., Q. Rev., Chem. Soc. 1966, 20, 
119. (b) Prelog, V.; Traynham, J. G. in “Molecular Rearrangements” (de Mayo, P. ed.) 1963, Wiley, 
New York. 
1.5 For selected examples of different strategies see: i) intramolecular-transannular (a) Winkler, J. 
D.; Sridar, V. J. Am. Chem. Soc. 1986, 108, 1708. (b) Aïssa, C.; Dhimane, A.-L.; Malacria, M. Snylett 
2000, 1585. (c) Winkler, J. D.; Sridar, V. Tetrahedron Lett. 1988, 29, 6219. ii) transannular-
intramolecular (d) Curran, D. P.; Shen, W. Tetrahedron 1993, 49, 755. (e) Booker-Milburn, K. I.; 
Dainty, R. F. Tetrahedron Lett. 1998, 39, 5097. iii) macrocyclization-transannular (f) Pattenden, G.; 
Wiedenau, P. Tetrahedron Lett. 1997, 38, 3647. (g) Begley, M. J.; Pattenden, G.; Smithies, A. J.; 
Tapolczay, D.; Walter, D. S. J. Chem. Soc. Perkin Trans 1 1996, 21. iv) completely transannular (h) 
Myers, A. G.; Condroski, K. R. J. Am. Chem. Soc. 1993, 115, 7926. (i) Myers, A. G.; Condroski, K. R. 
J. Am. Chem. Soc. 1995, 117, 3057. 
1.6 Elliot, M. R.; Dhimane, A.-L., Malacria, M. J. Am. Chem. Soc. 1997, 119, 3427. 
1.7 (a) Takai, K.; Tagashira, M.; Kuroda, T.; Oshima, K.; Utimoto, K.; Nozaki, H. J. Am. Chem. Soc. 
1986, 108, 6048. (b) Jin, H.; Uenishi, J.-I.; Christ, W, J.; Kishi, Y. J. Am. Chem. Soc. 1986, 108, 5644. 
(c) Crevisy, C.; Beau, J.-M. Tetrahedron Lett. 1991, 32, 3171. (d) Lu, Y.-F.; Harwig, C. W.; Fallis, A. 
G. J. Org. Chem. 1993, 58, 4202. (e) Elliot, M. R.; Dhimane, A.-L., Hamon, L.; Malacria, M. Eur. J. 
Org. Chem. 2000, 155. 
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Scheme 1.1 Preparation of epi-illudol (1.7) based on a transannular radical cyclization. 
 
One of the most powerful tools to emerge recently for the construction of complex 
polycyclic systems are transannular cycloaddition reactions, specially the transannular 
Diels-Alder (TADA). The Deslongchamps group in particular has clearly 
demonstrated the value of the TADA reaction is synthesis.1. ,1.8 9 TADA reactions often 
complement conventional intramolecular Diels-Alder variants (IMDA) since in cases 
where IMDA reactions are unsuccessful (e.g., due to poor dienophiles1. h,n,p8  or 
difficult dienes1. m,n8 ) or give the wrong regio- or stereochemistry, the TADA often 
proceeds efficiently. An example where is possible to compare the TADA with the 
                                               
1.8  For selected examples see. (a) Marsault, E.; Deslongchamps, P. Org. Lett. 2000, 2, 3317. (b) Toro, 
A.; L’Heureux, A.; Deslongchamps, P. Org. Lett. 2000, 2, 2737, (c) Lavoie, R.; Ouellet, S. G.; 
Dallaire, C.; Dory, Y. L.; Toro, A.; Deslongchamps, P. Tetrahedron 2000, 56, 5509. (d) Toro, A.; 
Nowak, P.; Deslongchamps. P. J. Am. Chem. Soc. 2000, 122, 4526. (e) Fortin, S.; Barriault, L.; Dory, 
Y. L.; Deslongchamps, P. J. Am. Chem. Soc. 2001, 123, 8210. (f) Baettig, K.; Pitteloud, R.; 
Deslongchamps, P.; Tetrahedron Lett. 1987, 28, 5249. (g) Baettig, K.; Marinier, A.; Pitteloud, R.; 
Deslongchamps, P. Tetrahedron Lett. 1987, 28, 5253. (h) Bérubé, G.; Deslongchamps, P. Tetrahedron 
Lett. 1987, 28, 5255. (j) Deslongchamps, P. Pure & Appl. Chem. 1992, 64, 1831. (k) Couturier, M.; 
Deslongchamps, P. Synlett 1996, 1140. (l) Marinier, A.; Deslongchamps, P. Can. J. Chem. 1992, 70, 
2351. (m) Marinier, A.; Deslongchamps, P. Tetrahedron Lett. 1988, 29, 6215. Couturier, M.; Dory, Y. 
L.; Rouillard, F.; Deslongchamps, P. Tetrahedron 1998, 54, 1529. (n) Toro, A.; Lemelin, C.-A.; 
Preville, P.; Belanger, G.; Deslongchamps, P. Tetrahedron 1999, 55, 4655. (o) Toro, A.; Wang, Y.; 
Deslongchamps, P. Tetrahedron Lett. 1999, 40, 2765. (p) Belanger, G.; Deslongchamps, P. Org. Lett. 
2000, 2, 285. 
1.9 For selected contributions from other groups see: (a) Takahashi, T.; Katsuya, S.; Doi, T.; Tsuji, J. J. 
Am. Chem. Soc. 1988, 110, 2674. (b) Takahashi, T.; Sakamoto, Y.; Doi, T. Tetrahedron Lett. 1992, 
33, 3519. (c) Woody, J. L.; Porco, J. A.; Taunton, J.; Lee, A. Y.; Vlardy, J.; Schreiber, S. L. J. Am. 
Chem. Soc. 1992, 114, 5898. (d) Marshall, J. S.; Wang, X.-J. J. Org. Chem. 1992, 57, 3387.; Jung, S. 
H.; Lee, Y.; S.; Park, H.; Kwon, D.-S. Tetrahedron Lett. 1995, 36, 1051. (e) Roush, W.; R.; Works, 
A.; B. Tetrahedron Lett. 1996, 37, 8065. (f) Moriyama, S.; Karakasa, T.; Inoue, T.; Kurashima, K.; 
Satsumabayashi, S.; Saito, T. Synlett 1996, 72. (g) Begley, M. J.; Grove, J. F. J. Chem. Soc., Perkin 
Trans. 1 1985, 861. (h) Evans, D.; Starr, J. T. Angew. Chem., Int. Ed. 2002, 41, 1787. 
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corresponding IMDA was reported by Roush and co-workers in their studies on the 
synthesis of Nargenicin A1 (Scheme 1.2).1.10 The keys steps in the synthesis are 
Yamaguchi macrolactonization1. p2  of hydroxy acid (1.8a) and the facile TADA 
reaction of the corresponding 18-membered macrolide. This sequence provides the 
desired cis-fused tricycle (1.9) in 66% yield, along with 14% yield of tricycle (1.10) 
which is epimeric at C-10. In contrast, the IMDA reaction of seco ester (1.8b) 
provided a mixture of trans-fused (1.11) in 56% yield and the desired cis-fused 
cycloadduct (1.12) in only 27% yield. 
 
RO2C Br
O
OOOP1
P2O
1) Cl3C6H5COCl
NEt3, THF, rt
2) DMAP
PhMe, 100 oC
O
OH
H
O
O
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+
O
OH
H
O
O
TBDPSO
O
Br
H
1.10, 13%
+
 
Scheme 1.2 The TADA and IMDA as key steps in a planned total synthesis of Nargenicin A1. 
 
 
 
                                               
1.10 Roush, W. R.; Koyama, K.; Curtin, M. L.; Moriarty, K. J. J. Am. Chem. Soc. 1996, 118, 7502. 
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The Sorensen group disclosed an impressive example of a double transannular Diels-
Alder reaction in the synthesis of the hexacycle FR182877 (Scheme 1.3).1.11 The 
macrocycle precursor (1.14) was obtained in high yield (80%) from (1.13) using the 
Trost-Tsuji conditions.1.12 After some functional group manipulation, required to 
introduce unsaturation between the two carbonyl functions, the obtained macrocycle 
(not shown) underwent a tandem TADA/transannular hetero-Diels Alder transforming 
a 19-membered ring carbocycle to the complex pentacycle (1.15) possessing no less 
than seven new contiguous stereocenters. 
 
OtBu
OOTMSO
O OMe
O
TESO OTES
Pd2dba3 (0.1 eq.)
THF, 40 oC
80% tBu
O
O
TESO
O
OTES
OTMS
1) KHMDS, PhSeBr
THF, -10 oC
91%
2) MCPBA
CH2Cl2, -78 oC 
then CHCl3, 40 oC
40%
CO2tBu
TESO
OTES
H
HH
H
H
H
OTMSO
1.13
1.14
1.15  
 
Scheme 1.3 A double TADA in the preparation of pentacycle (1.15). 
 
 
 
 
 
                                               
1.11 (a) Vosburg, D. A.; Vanderwal. C. D.; Sorensen, E. J. J. Am. Chem. Soc. 2003, 5393. (b) Vosburg, 
D. A.; Vanderwal. C. D.; Sorensen, E. J. J. Am. Chem. Soc. 2002, 124, 4552 (c) Sorensen, E. J. 
Bioorg. Med. Chem. 2003, 11, 3225. For a similar approach to FR182877 see also ref.1.9h. 
1.12 (a) Trost, B. M.; Brickner, S. J. J. Am. Chem. Soc. 1983, 105, 568. (b) Trost, B. M. Angew. Chem., 
Int. Ed. Engl. 1989, 28, 1173. (c) Tsuji, J.; Shimizu, I.; Minami, I.; Ohashi, Y. Tetrahedron Lett. 1982, 
23, 4809. (d) Tsuji, J. Tetrahedron 1986, 42, 4361. 
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White and co-workers recently reported the synthesis of the azaspirocyclic core (1.20) 
of pinnaic acid via the use of a stereospecific transannular nitrone 
cycloaddition.1. ,1.13 14 Ring closing metathesis (RCM)1.15 of azide (1.16) using Grubbs 
catalyst afforded the 14-membered macrocycle (1.17) in 21% yield as a E:Z mixture. 
The latter was then converted into nitrone (1.18) which, upon thermolysis, underwent 
a stereospecific transannular nitrone-olefin [3+2] cycloaddition to afford the 
tetracycle (1.19) which was easily converted to the key intermediate (1.20). Notably, 
also here the conventional intramolecular nitrone cycloaddition gave isoxazolidines of 
incorrect relative configuration. 
 
OO
N3
O
OO OO
O
N3
20 mol%
PhCHRuCl2(PCy3)2
CH2Cl2, rt
E:Z, 4:1
21%
N
O
O
O
PhMe, Δ
64%
N
OO
O
H
HN
MeO2C
HO
HO
H
1.16 1.17 1.18
1.191.20  
 
Scheme 1.4 Stereocontrolled entry to the spirocyclic core of pinnaic acid (1.20) via a transannular 
nitrone cycloaddition. 
 
 
 
 
                                               
1.13 White, J. D.; Blakemore, P. R.; Korf, E. A.; yokochi, A. F. T. Org. Lett. 2001, 3, 413. 
1.14 For examples of transannular cycloadditions in which the nitrone is external to the ring see: (a) 
Baggioline, E. G.; Lee, H. L.; Pizzolato, G.; Uskokovic, M. J. Am. Chem. Soc. 1982, 104, 6460. (b) 
Mihailovic, M. L.; Rajkovic, M. M.; Lorenc, L. B.; Pavlovic, V. D.; Milovanovic, A. Z.; Tinant, B.; 
Declercq, J.-P. Tetrahedron 1996, 52, 11995. 
1.15 Schwab, P.; Grubbs, R. H.; Ziller, J. W. J. Am. Chem. Soc. 1996, 118, 100. 
Part III                  1.2 – Selected Uses of Transannular Reactions in Organic Synthesis 
 
 
 234
Organometallic reactivities have been rarely used in a transannular fashion.1.16 One 
such example is the transannular PtCl2-catalyzed cycloisomerization of 1,5-enyne 
(1.22b) recently reported by Dhimane, Fensterbank, Malacria and co-workers.1.17 The 
1,5-enyne macrocycle (1.22a) was obtained in 38% from alcohol (1.21) using a 
Nozaki-Hiyama-Kishi-Takai Cr(II)-mediated process.1.18 Treatment of the benzoate 
(1.22b) with a catalytic amount of PtCl2 afforded racemic tricyclic (1.23) in a 
diastereoselective manner and high yield (85%). 
 
1) NIS, AgNO3
acetone, rt
2) IBX, DMSO
3) CrCl2
THF, rt
syringe pump
RO
1.22a: R = H, 38% based on 1.21
1.22b: R = COAr
10 mol%
PtCl2
PhMe, rt
1.21 1.23
85%
HO
ArO2C
 
 
Scheme 1.5 PtCl2-catalysed transannular cyclization of cycloundecenyne (1.22b). 
 
White and Hrnciar achieved the total synthesis of (+)-australine in a sequence that had 
as key steps the preparation of azacyclooctene (1.25), obtained from diene (1.24) via 
RCM with Grubbs catalyst, and a base-induced transannular ring-closing step of 
oxazolidinone (1.26) (Scheme 1.6).1.19
 
                                               
1.16 For (rare) examples see: (a) Transannular oxypalladation: Sasaki, T.; Kanematsu, K.; Kondo, A. J. 
Chem. Soc., Perkin Trans. 1 1976, 2516. (b) Transannular [3+2] cycloaddition: Yamago, S.; 
Nakamura, E. Tetrahedron 1986, 45, 3081. (c) Transannular cyclopalladation: Ohe, K.; Miki, K.; 
Yanagi, S.-I.; Tanaka, T.; Sawada, S.; Uemura, S. J. Chem. Soc., Perkin Trans. 1 2000, 3627. 
1.17 Blaszykowski, C.; Harrak, Y. H.; Goncalves, M.-H.; Cloarec, J.-M.; Dhimane, A.-L.; Fensterbank, 
L.; Malacria, M. Org. Lett. 2004, 6, 3771. 
1.18 (a) Okude, Y.; Hirano, S.; Hiyama, T.; Nozaki, H. J. Am. Chem. Soc. 1977, 99, 3179. (b) Okude, 
Y.; Hiyama, T.; Nozaki, H. Tetrahedron Lett. 1977, 3829. (c) Cintas, P. Synthesis 1992, 248. (d) 
Fürstner, A. Pure Appl. Chem. 1998, 70, 1071. (e) Takai, K.; Kuroda, T.; Nakatsukasa, S.; Oshima, 
K.; Nozaki, H. Tetrahedron Lett. 1985, 26, 5585. 
1.19 (a) White, J. D.; Hrnciar, P. J. Org. Chem. 2000, 65, 9129. See also (b) White, J. D. Hrnciar, P.; 
Yokochi, A. F. T. J. Am. Chem. Soc. 1998, 120, 7359. 
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Scheme 1.6 Transannular ring-opening of epoxide (1.26). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 236
Part III             Chapter 2: A Transannular Mannich Approach to Polycyclic Alkaloids 
 
 
 237
                                               
CHAPTER 2 
A Transannular Mannich Approach to Polycyclic Alkaloids 
 
2.1 - Introduction 
 
The development of methodology that allows the efficient generation of complex 
polycyclic skeletons from easily accessible starting materials is an important goal in 
organic synthesis. 
 
Among the few organic reactions that are noteworthy for the potential to generate 
complexity in their products is the intramolecular Mannich (IMM) reaction.2.1 The 
IMM reaction refers to the addition of a C-H activated carbon nucleophile (e.g., 
aldehydes or ketones, enol ethers, carboxylic acid derivatives, β-dicarbonyl 
compounds, arenes, etc.) to an iminium ion in an intramolecular fashion. The 
regioselectivity of the IMM is expected to be in accordance with the Baldwin 
selection rules for ring closure.2.2 Furthermore, the stereoselectivity in the addition to 
iminium ions is (often) governed by stereoelectronic factors in that the addition 
reaction proceeds so that there is an antiperiplanar arrangement between the incoming 
nucleophile and the developing electron pair in the product.2.3 Thus, the IMM 
cyclization of iminium ion (2.2) is expected to preferentially deliver the cis-conformer 
(2.1) initially, even though the alternate cis-(2.3) conformer or the trans-(2.4) system 
may be more stable (Scheme 1.1).  
 
 
2.1 For selected general reviews on the Mannich reaction see: (a) Arend, M.; Westermann, B.; Rish, N. 
Angew. Chem. Int. Ed. 1998, 37, 1044. (b) Tramontini, M.; Angiolini, L. Tetrahedron 1990, 46, 1791. 
(c) Tramontini, M. Synthesis 1973, 703. For a review on the IMM reaction see: (d) Overman, L. E.; 
Ricca, D. J. in “Comprehensive Organic Synthesis” (Trost, B. M.; Fleming, I., ed.) 1991, 2, 1007, 
Pergamon, Oxford. For selected reviews on the vinylogous Mannich reaction see: (e) Martin, S. F. 
Acc. Chem. Res. 2002, 35, 895. (f) Bur, S. K.; Martin, S. F. Tetrahedron 2001, 57, 3221. (g) 
Maryanoff, B. E.; Zhang, H.-C.; Cohen, J. H.; Turchi, I. J.; Maryanoff, C. A. Chem. Rev. 2004, 104, 
1431. 
2.2 (a) Baldwin, J. E. J. Chem. Soc., Chem. Commun. 1976, 734. (b) Baldwin, J. E. J. Chem. Soc., 
Chem. Commun. 1976, 736. 
2.3 Deslongchamps, P. in “Stereolelectronic Effects in Organic Chemistry”1983, Pergamon, Oxford. 
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Scheme 1.1 (Intramolecular) addition of nucleophiles to iminium ions. 
 
The predictable regio- and stereoselectivity of the IMM has contributed to its 
popularity among synthetic organic chemist, as shown by the countless syntheses of 
cyclic nitrogen compounds where it has already been used.2.4 In contrast, the 
transannular Mannich (TAM) variation remains virtually unexplored (Scheme 
2.2).2. ,2.5 6
 
                                               
2.4 For selected examples see: (a) Corey, E. J.; Balanson, R. D. J. Am. Chem. Soc. 1974, 96, 6516. (b) 
Carruthers, W.; Moses, R. C. J. Chem. Soc., Chem. Commun. 1987, 509. (c) Hong, C. Y.; Kado, N.; 
Overman, L. E. J. Am. Chem. Soc. 1993, 115, 11028. (d) Heerding, D. A.; Hong, C. Y.; Kado, N.; 
Look, G. C.; Overman, L. E. J. Org. Chem. 1993, 58, 6947. 
2.5 It is interesting to note that, to some extent, the feasibility of TAM processes has already been 
indirectly established in the form of the tandem cationic aza-Cope/Mannich cyclization.2.7 A 
celebrated example, by Overman and co-workers, is the total synthesis of (-)-strychnine.2.7a Treatment 
of azabicyclooctane (2.a) with paraformaldehyde afforded the diamine (2.d) in quantitative yield as a 
single diastereoisomer, through a cascade aza-Cope rearrangement of iminium ion (2.b) and a 
diastereoselective TAM cyclization of the medium-size 9-membered iminium ion (2.c) (Scheme 2.A). 
 
N
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HO
NR2
H
N
OtBu
HO
NR2
N
OtBu
HO
NR2
(CH2O)n
Na2SO4
CH3CN
80 oC
2.a
TAMaza-Cope
2.b 2.c
O
N
OtBu
R2N
quant.
2.d  
 
Scheme 2.A Tandem aza-Cope/Mannich cyclization of cyclooctane (2.a). 
 
2.6 (a) Knight, S. D.; Overman, L. E.; Pairaudeau, G. J. Am. Chem. Soc. 1995, 117, 5776. (b) Angle, S. 
R.; Fevig, J. M.; Knight, S. D.; Marquis Jr., R. W.; Overman, L. E. J. Am. Chem. Soc. 1993, 115, 
3966. (c) Overman, L. E.; Robertson, G. M.; Robichaud, A. J. J. Am. Chem. Soc. 1991, 113, 2598. (d) 
Overman, L. E.; Sworin, M.; Burk, R. M. J. Org. Chem. 1983, 48, 2685. 
Part III             Chapter 2: A Transannular Mannich Approach to Polycyclic Alkaloids 
 
 
 239
N
General azapolicyclic
skeleton
2.6
FG1 FG2
FG3
O LG
O
FG2
NHPG
2.7
FG1
FG3
Macrocyclic diketo-amine
2.5
IMM
O
FG2
FG1
OFG3
NH
TAM
?
 
 
Scheme 2.2 IMM and TAM reactions in the construction of azapolicyclic frameworks. 
 
Notably, TAM processes have been previously considered in the synthesis of 
azapolycyclic alkaloids but surprisingly were never implemented. For example, 
Heathcock and co-workers recognized that lycopodine (2.9) could arrive via a TAM 
condensation of the macrocycle (2.8) (Scheme 2.3).2.7 Although this analysis would 
retrosynthetically transform a tetracyclic system into a bicyclic system, and thus result 
in a considerable structural simplification according to some criteria, this strategy was 
never put into practice because “the postulated reactant (2.8) is more complicated than 
lycopodine (2.9) in having a 12-memberd ring”. 
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Scheme 2.3 Two Mannich-based approaches to lycopodine (2.9). 
 
Considering the advantages often associated with the use of transannular reactions in 
synthesis (vide Chapter 1), it is realistic to expect that the TAM reaction, if feasible, 
would constitute a powerful approach for the construction of azapolycyclic 
frameworks. We set ourselves to explore this possibility. 
                                               
2.7 Heathcock, C. H.; Kleinman, E.; Binkley, E. J. Am. Soc. Chem. 1982, 104, 1054. 
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2.2 – Project Description 
 
It is the goal of this project to investigate the hypothesis that the azapolycyclic 
framework of certain alkaloids can be accessed via a TAM of conveniently 
functionalized macrocycle precursors. 
 
The cylindricine alkaloids (2.11), by virtue of their tricyclic skeleton, were chosen as 
targets for testing the proposed novel methodology. A simplified retrosynthetic 
analysis of the general cylindricine skeleton based on the key TAM step is shown in 
Scheme 2.4.2.8 This analysis is interesting and unusual in that two simultaneous bond 
disconnections lead to the 13-membered macrocycle (2.12). Thus, this analysis seems 
to contradict the generally accepted guidelines according to which the retrosynthetic 
generation of such “difficult” ring sizes is not strategically advisable.  
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Scheme 2.4 The TAM approach to the tricyclic skeleton of the cylcindricines (2.11). 
 
However, if an efficient method for preparing the 13-membered ring (2.12) was 
available, then the tricyclic skeleton of the target could be assembled in a single 
operation, via a TAM. The deprotected macrocyclic amine (2.12) is predicted to 
chemoselectively condensate with the C-5 ketone to afford the corresponding 5-
membered iminium ion, which can then undergo a TAM reaction with enol form of 
the C-11 ketone. 
 
Formation of the correct configuration at C-5 and C-10 will depend upon steric 
(attack on the less-hindered Re-face of the iminium ion) and conformational (Re 
versus Si enol faces and E versus Z enol geometries) factors and these remain open 
questions (Figure 2.1). 
                                               
2.8 (a) Warren, S. in “The Disconnection Approach” 1996, Wiley, New York. (b) Warren, S. in 
“Designing Organic Syntheses – A Programmed Introduction to the Synthon Approach” 1994, Wiley, 
Cambridge. 
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Figure 2.1 Possible transition states for formation of the C-5―C-10 bond leading to the correct 
configuration. 
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CHAPTER 3 
The Cylindricine Alkaloids - An Overview 
 
3.1 - Isolation and Structure 
 
The cylindricines were first isolated in the early 1990s by Blackman and co-workers 
from the Tasmanian ascidian3.1 Clavelina cylindrical.3.2 The structures of the two 
most abundant members of this family of marine alkaloids, cylindricines A (3.1a) and 
B (3.1b), were established by spectral analysis and X-ray crystallography of the 
corresponding picrates.3.1a These studies reveled that both these natural products have 
a tricyclic framework with a cis-fused 1-azadecalin A/B-ring system, but whereas 
cylindricine A has a pyrroloquinoline skeleton, cylindricine B possess a 
pyridoquinoline framework. Interestingly, both cylindricines A and B produce the 
same 3:2 equilibrium mixture upon standing, presumably due to interconversion via 
the aziridinium intermediate (3.2). 3. a2  In addition to these alkaloids, other minor 
metabolites having the basic cylindricine A-type skeleton but with small structural 
differences were later isolated. Examples of these include cylindricines C (3.1c) to F 
(3.1f), which possess different functionalities at C-14. Cylindricines H (3.1h) can be 
seen as the acetate of the reduction product of cylindricine F (3.1f) whereas 
cylindricine I (3.1i) is the analogous isothiocyanate. Cylindricine J (3.1j) is a reduced 
isothiocyanate analogue of cylindricine B (3.1b). Finally, cylindricine K (3.1k) 
contains an α,β-unsaturated ketone functionality incorporated into the A-ring (Figure 
3.1). 
 
Regarding the absolute configurations of the cylindricines, these have not yet been 
established since the optical rotations of these compounds were not measured during 
the structural studies. Until re-isolation of these metabolites, the question of their 
absolute configuration will remain unanswered.3.3 Recent enantioselective total 
syntheses of these natural products allowed the conclusion that the enantiomeric 
3.1 Ascidians are marine  invertebrates of the phylum Chordata, subphylum Tunicata. 
3.2 (a) Blackman, A. J.; Li, C.; Hockless, D. C. R.; Skelton, B. W.; White, A. H. Tetrahedron 1993, 49, 
8645. (b) Li, C.; Blackman, A. J Aust. J. Chem. 1994, 47, 1355. (c) Li, C.; Blackman, A. J. Aust. J. 
Chem. 1995, 48, 955. 
3.3 It has been speculated, on the basis of recent enantioselective syntheses of a closely related 
alkaloid, lepadiformine (3.4a), that the cylindricine alkaloids in the natural series are enantiomeric to 
the structures drawn in Figure 3.1. 
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series presented in the original paper by Blackman corresponds to the (-)-
cylindricines. 
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3.1a: Cylindricine A, R1 = C6H13, R2 = Cl
3.1c: Cylindricine C, R1 = C6H13, R2 = OH
3.1d: Cylindricine D, R1 = C6H13, R2 = OMe
3.1e: Cylindricine E, R1 = C6H13, R2 = OAc
3.1f: Cylindricine F, R1 = C6H13, R2 = SCN
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Figure 3.1 The (-)-cylindricine alkaloids. 
 
Structurally related alkaloids to the cylindricines include fasicularin (3.3)3. ,3.4 5 and the 
lepadiformines (3.4a) and (3.4b).3. ,3.6 7 These differ mainly from the cylindricines in 
that they possess a trans-1-azadecaline A/B ring system (Figure 3.2). 
                                               
3.4 For the isolation of fasicularin (3.3), see: Patil, A. D.; Freyer, A. J.; Reichwein, R.; Carte, B.; 
Killmer, L. B.; Faucette, L.; Johnson, R. K. Tetrahedron Lett. 1997, 38, 363. 
3.5 For selected total syntheses of fasicularin (3.3) see: (a) Abe, H.; Aoyagi, S. Kibayashi, C. J. Am. 
Chem. Soc. 2000, 122, 4583. (b) Abe, H.; Aoyagi, S.; Kibayashi, C. J. Am. Chem. Soc. 2005, 127, 
1473. (c) Maeng, J.-H.; Funk, R. L. Org. Lett. 2002, 4, 331. (d) Dake, G. R.; Fenster, M. D. B.; 
Hurley, P. B.; Patrick, B. O. J. Org. Chem. 2004, 69, 5669. 
3.6 For isolation of lepadiformines (3.4a) and (3.4b), see: (a) Biard, J. F.; Guyot, S.; Roussakis, C.; 
Verbist, J. F.; Vercauteren, J.; Weber, J. F.; Boukef, K. Tetrahedron Lett. 1994, 35, 2691. (b) Jugé, 
M.; Grimaud, N.; Biard, J. F.; Sauviat, M. P.; Nabil, M.; Verbist, J. F.; Petit, J.-Y. Toxicon 2001, 39, 
1231. 
3.7 For an account on efforts involving the synthesis of lepadiformines (3.4a) and (3.4b), see: (a) 
Weinreb, S. M. Acc. Chem. Res. 2003, 36, 59. (b) Kibayashi, C.; Aoyagi, S.; Abe, H. Bull. Chem. Soc. 
Jpn. 2003, 76, 2059. For selected total synthesis of the lepadiformine alkaloids see: (c) Werner, K. M.; 
De Los Santos, J. M.; Weinreb, S. M.; Shang, M. J. Org. Chem. 1999, 64, 686. (d) Werner, K. M.; De 
Los Santos, J. M.; Weinreb, S. M. J. Org. Chem. 1999, 64, 4865. (e) Pearson, W. H.; Barta, N. S.; 
Kampf, J. W. Tetrahedron Lett. 1997, 38, 3369. (f) Pearson, W. H.; Ren, Y. J. Org. Chem. 1999, 64, 
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Figure 3.2 Structures of fasicularin (3.3) and lepadiformine (3.4). 
 
 
3.2 – Biological Activity 
 
No significant biological activity has been reported for any of the cylindricines other 
than that a 30 μM solution of the 3:2 equilibrium mixture of cylindricines A (3.1a) 
and B (3.1b) was found to cause significant mortality in the brine shrimp bioassay.3.2 
However, it should be appreciated that the closely related alkaloids fasicularin (3.3) 
and lepadiformines (3.4a) and (3.4b) were found to exhibit biological activity against 
a DNA-repair-deficient of yeast strain and to inhibit growth of murine leukemia and 
human solid tumor cell lines.4. a,4.4 8
 
 
3.3 - Selected Total Synthesis of the Cylindricine Alkaloid 
 
The unique structural motif of the cylindricine alkaloids has attracted an impressive 
array of synthetic efforts.3.9 Highlights of selected total syntheses of these marine 
natural products are presented in this section.  
 
 
                                                                                                                                            
688. (g) Abe, H.; Aoyagi, S.; Kibayashi, C. Tetrahedron Lett. 2000, 41, 1205. (h) Sun, P.; Sun, C.; 
Weinreb, S. M. J. Org. Chem. 2002, 67, 4337. 
3.8 (a) Raub, M. F.; Cardellina, II, J. H. J. Am. Chem. Soc. 1991, 113, 3178. (b) Dutta, S.; Abe, H. 
Aoyagi, S.; Kibayashi, C.; Gates, K. S. J. Am. Chem. Soc. 2005, 127, 15004. 
3.9 (a) For a review concerning total syntheses of the cylindricines, fasicularin and lepadiformine 
alkloids see: Weinreb, S. M. Chem. Rev. 2006, 106, 2531. (b) For a review on the synthesis of 
cylindricines see: Liu, J.; Hsung, R. P. Chemtracts 2005, 18, 321. 
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Heathcock and Liu reported a total synthesis of (±)-cylindricine A (3.1a) and B 
(3.1b)3.10 that closely resembled a previous total synthesis of these compounds by 
Snider and Liu (Scheme 3.1).3.11 One of the key steps in the Heathcock approach was 
a double Michael reaction of ammonia with dienone (3.6) to produce the 1-azadecalin 
(3.7) as a 1:1 cis:trans mixture. The latter was then converted to the vinylogous 
amides (3.8) and 10-epi-(3.8), which could be separated by HPLC. A highly 
stereoselective conjugate addition of hexyl Grignard to these vinylogous amides in the 
presence of BF3·OEt2 and CuBr·Me2S afforded ketones (3.9) and 9-epi-(3.9). 
Removal of the Teoc group with TBAF from both (3.9) and its trans-fused isomer 
convergently led to the more stable cis-azadecaline (3.10). The C-ring was then 
constructed by a nonstereoselective copper catalyzed N-chloroamine/olefin radical 
cyclization which afforded a mixture of racemic cylindricine A (3.1a) and the 
undesired C-13 epimer (3.11) in a 1:1 ratio. The latter could be recycled back to 
amino olefin (3.10) by zinc/HCl reduction. 
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Scheme 3.1 Highlights of the Heathcock synthesis of (±)-cylindricine A (3.1a). 
 
 
 
                                               
3.10 Liu, J. F.; Heathcock, C. H. J. Org. Chem. 1999, 64, 8263. 
3.11 Snider, B.; Liu; T. J. Org. Chem. 1997, 62, 5630. 
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Molander and Rönn reported an enantioselective total synthesis of (-)-cylindricine C 
(3.1c) also based on a double Michel addition, but performed in an intramolecular 
manner (Scheme 3.2).3.12 The chiral ketone (3.14), obtained from hydrazone (3.12) 
and the enantiomerically pure tosylate (3.13), was converted into dienone (3.16) via a 
sequence that included as the pivotal step a carbonylative Stille coupling with 
stananne (3.15). Ketal (3.16) was transformed into azide (3.17) by standard functional 
group transformations. Upon treatment with CrCl2 under slightly acidic conditions, 
the latter afforded the TBS-protected cylindricine (3.18) via a tandem sequence that 
included the reduction of the azide (3.17) to the corresponding amine, a double 
Michael addition and in situ epimerization at C-5 to afford the thermodynamically 
more stable cylindricine system. 
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Scheme 3.2 Highlights of the Molander synthesis of (-)-cylindricine C (3.1c). 
 
 
 
 
 
                                               
3.12 Molander, G. A.; Rönn, M. J. Org. Chem. 1999, 64, 5183. 
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Trost and Rudd reported a total synthesis of (+)-cylindricines C (3.1c), D (3.1d) and E 
(3.1e) where an efficient ruthenium-catalyzed diyne cyclization was used to access 
the key amino dienone substrate that Molander and Rönn previously employed in 
their approach to these compounds (Scheme 3.3).3.13 Using the methodology of 
Knochel, diyne (3.19) was coupled with enantiomerically pure iodide (3.20) to afford 
the ester (3.21). After some group manipulation involving the ester functionality, a 
chemoselective ruthenium-catalyzed hydrative cyclization was performed producing 
enone (3.22), which was then converted into dienone (3.23). The latter was converted 
into (+)-cylindricine (3.1c) using Molander’s intramolecular Michael approach (vide 
supra, Scheme 3.2). 
 
Br
MeO2C
I
NHBoc
1) Zn,
2) CuCN 2LiCl
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Scheme 3.3 Highlights of the Trost synthesis of (+)-cylindricine C (3.1c). 
 
 
 
 
 
 
                                               
3.13 Trost, B. M.; Rudd, M. T. Org. Lett. 2003, 5, 4599. 
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Kibayashi and co-workers reported an approach to (+)-cylindricine C (3.1c) involving 
a N-acyliminium ion/diene cyclization cascade as the key step (Scheme 3.4).3. ,3.14 15 
Enantiomerically pure lactam (3.24) underwent addition with diene-Grignard (3.25) to 
produce ketone (3.26). Upon treatment with formic acid, the latter underwent a 
stereoselective cyclization affording spirocycle (3.27) as a mixture of stereoisomers 
which, after functional group manipulation, were convergently and stereoselectively 
converted into β-alcohol (3.28). Functional group manipulation, which included a 
hydroxyl-directed epoxidation, afforded the diol (3.29). The latter was then converted 
into tricyclic ketone (3.30) in a sequence that included as the key step an 
intramolecular displacement reaction. Base-promoted epimerization finally afforded 
(+)-cylindricine C (3.1b). Hsung and co-workers used a similar approach in theirs 
total synthesis of (+)-cylindricine C.3.16
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Scheme 3.4 Highlights of the Kibayashi synthesis of (-)-cylindricine C (3.1c). 
                                               
3.14 Abe, H.; Aoyagi, S.; Kibayashi, C. J. Am. Chem. Soc. 2005, 127, 1473. 
3.15 For another approach to (+)-cyclindricines by the Kibayashi’s group see: Arai, T.; Abe, Hideki, 
Aoyagi, S.; Kibayashi, C. Tetrahedron Lett. 2004, 45, 5921. 
3.16 (a) Liu, J.; Swidorski, J. J.; Peters, S. D.; Hsung, R. P. J. Org. Chem. 2005, 70, 3898. (b) Liu, J.; 
Hsung, R. P.; Peters, S. D. Org. Lett. 2004, 6, 3989. 
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Ciufolini and co-workers prepared (-)-cylindricine C (3.1c) enantioselectively using a 
unique approach (Scheme 3.5).3.17 The synthesis started with enantiomerically pure 
sulphonamide (3.31) which, upon oxidation with PhI(OAc)2 and treatment with 
KHMDS, afforded adduct (3.32) in good selectivity (7:1 in favour of the latter). After 
complete reduction of the α,β-unsaturated system (not shown), the resulting 
sulphonamide was treated with tBuLi and the anion obtained was alkylated with 1-
octene oxide. Subsequent Dess-Martin oxidation afforded ketone (3.33). Subjection of 
the latter to DBU resulted in an isolable α,β-unsaturated ketone (not shown) which 
was subjected to Miyaura borylation conditions delivering boronic ester (3.34) as a 
single stereoisomer. Removal of the silyl ether protecting group followed by an 
hydroxyl-directed reductive amination with NaBH(OAc)3 delivered tricycle (3.35). 
Functional group manipulation, which included the oxidative conversion of the 
boronate to the alcohol, finally delivered (-)-cylindricine C (3.1c). 
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Scheme 3.5 Highlights of the Ciufolini synthesis of (-)-cylindricine C (3.1c). 
 
Recently, Shibasaki and co-workers reported a very short synthesis of (+)-cylindricine 
C (3.1c) using as the pivotal step the catalytic asymmetric Michael reaction of glycine 
Schiff base (3.36) to dienone (3.37) (Scheme 3.6).3.18 In the presence of the newly 
                                               
3.17 Canesi, S.; Bouchu, D.; Ciufolini, M. A. Angew. Chem., Int. Ed. 2004, 43, 4336. 
3.18 Shibuguchi, T.; Mihara, H.; Kuramochi, A.; Sakuraba, S.; Oshima, T.; Shibasaki, M. Angew. 
Chem., Int. Ed. 2006, 45, 4635. 
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developed two-center organocatalyst (3.38), the expected diketone (3.39) was 
obtained with fairly good enantiomeric excess (82%). Subsequent acid-promoted 
tandem cyclization using MgCl2 as additive produced a mixture of the desired 
tricyclic amine (3.40) together with the C5- and C2-epi compounds in a 84:9:7 ratio, 
respectively. The former was then easily converted to (+)-cylindricine C (3.1c) by 
functional group manipulation. 
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Scheme 3.6 Highlights of the Shibasaki synthesis of (+)-cylindricine C (3.1c). 
 
In addition to the previous total syntheses of the cylindricines, several groups have 
reported interesting approaches to epimeric structures. A notorious example is 
Weinreb and co-workers’ attempted total synthesis of (±)-cylindricine C (3.1c) by 
using an intramolecular nitrone-diene 1,3-dipolar cycloaddition as the key step 
(Scheme 3.7). The synthesis began with the sequential alkylations of acetone oxime 
with epoxide (3.41) and diene iodide (3.42) to afford oxime (3.43). Standard 
transformations converted the latter into nitrone (3.44) which upon heating underwent 
a cycloaddition to produce isoxazolidine (3.45). Reductive cleavage of the N-O bond, 
followed by a stereoselective tandem oxidation-Michael addition afforded the 
tricyclic core of 2-epi-cylindricine C, (±)-2-epi-(3.1c). However, all attempts made to 
converted the latter to the desired (±)-cylindricine C (3.1c) were unsuccessful. 
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Scheme 3.7 Weinreb’s synthesis of 2-epi-cylindricine C (3.1c). 
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CHAPTER 4 
Molecular Mechanics Calculations 
 
4.1 – Introduction4.1
 
Computational chemistry is among the most recent sub-disciplines of Chemistry to 
emerge and one of its fastest growing. In a nutshell, it involves developing computer 
software to solve chemical problems. 
 
A class of problems which can be solved by computational chemistry concerns single 
molecule calculations. In principle any physical observable property of the molecule 
can be accessed. Depending on the property of interest and on the nature of the 
molecular system being studied, the calculations can be performed either with 
molecular mechanics (MM), ab initio or semi-empirical methods. Arguably, the latter 
two, being quantum mechanical-based, can offer a fairly rigorous description of the 
molecule from both a structural and electronic point of view. They can, however, be 
prohibitive in terms of both time and computer memory. MM, on the other hand, by 
taking an alternative approach to the Born-Oppenheimer approximation, in that the 
electronic distribution associated with each atom is fixed and only nuclear motion is 
considered, allows much larger chemical systems to be investigated in considerably 
shorter times. 
 
In MM a molecule is represented as a collection of spheres joined by springs. The 
motions of the atoms are described by the laws of classical physics and simple 
potential energy functions are used. The molecular mechanics energy of a molecule, 
EMM, is then calculated as a sum of the bonding and non-bonding interactions present. 
Each bond length, angle and dihedral is considered individually and non-bonded 
interactions account for the influence of non-covalent forces (e.g., van der Waals and 
Coulombic) (Equation 4.1). 
 
 
4.1 (a) Cramer, J. C. in “Essentials of Computational Chemistry” 2003, Wiley, Chichester. (b) Jensen, 
F. in “Introduction to Computational Chemistry” 2003, Wiley, Chichester. (c) Hinchliffe, A. in 
“Molecular Modelling for Beginners” 2003, Wiley, Chichester. (d) Goodman, J. M. in “Chemical 
Applications of Molecular Modelling” 1998, The Royal Society of Chemistry, Cambridge. (e) Grant, 
G. H.; Richards, W. G. in “Computational Chemistry” 2004, 29, Oxford University Press, Oxford 
Chemistry Primers, Oxford. 
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EMM = Σ Σ Σ Σ Σ + -+ + + +
El Eθ Eω Enb
(Equation 4.1) 
 
 
 
where El, Eθ, Eω and Enb are, respectively, the total bond, angle, dihedral and non-
bonded energies. 
 
A molecular property which is usually of major interest to organic chemists is 
conformation.4.2 MM allows performing conformational searches so that all the 
possible conformations of a molecule and respective energies are obtained.4.3 The 
population ratios between the different conformations can then be calculated by using 
the Boltzmann equation (Equation 3.2). 
 
Boltzmann factor = ⎟⎠
⎞⎜⎝
⎛ Δ−
RT
EMMexp  Equation 4.2 
 
where ΔEMM (Jmol-1) is the difference in energy between two conformations, R is the 
gas constant (8.314 JK-1mol-1) and T (K) is the absolute temperature. 
 
Although a powerful tool, it is important to keep in mind the caveats of MM. One of 
the main limitations of MM concerns its parameterized nature, i.e., the results 
accuracy is dependent of the “quality” of the force field employed, i.e., the set of 
parameters (e.g., force constants, bond lengths, etc) and potential functions used. A 
second limitation of MM is that, by neglecting explicit representation of electrons, it 
can not, strictly speaking, be used to discuss transition states (TS) of processes where 
bonds are being made and/or broken. 
 
The latter limitation can, to some extent, be overcome by considering certain 
approximations. A TS is a minimum energy structure with respect to all but one 
degree of freedom, the reaction coordinate. Constraining the latter still leaves 3N-7 
degrees of freedom unchanged which, for large systems, usually account for most of 
the properties of the system. This argument provides the basis for one of the MM 
approaches to TS modeling , which consists in treating the TS as normal ground state 
(Figure 4.1).4.4
                                               
4.2 Eliel, E. L.; Wilen, S. H. in “Stereochemistry of Organic Compounds” 1994, Wiley, New York. 
4.3 Lipkowitz, K.; Peterson, M. Chem. Rev. 1993, 93, 2463. 
4.4 Eksterowicz, J. E.; Houk, K. N. Chem. Rev. 1993, 93, 2439. 
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Figure 4.1 MM approach to TS. 
 
Several approaches have been used to model TS using empirical force fields. The 
crudest one involves estimating a value for the reaction coordinate and using it to 
model the TS using an energy-minimized structure of the reactants or the products.4.5 
Since theoretical calculations have shown that geometrical parameters in TS 
structures have a relatively narrow range of values for a given type of reaction, this 
expedite assumption is not as a drastic as it might seem. In more sophisticated 
approaches, a combination of ab initio methods and MM is employed: quantum 
mechanics is used to treat the atoms involved in the bond-making/breaking processes 
whereas all the remaining atoms are considered using empirical force fields. 
 
Finally it is noted that MM works best when similar systems, e.g., epimers or 
diastereomeric TS, are being compared. In such cases, many of the errors in the force 
field tend to cancel and the differences in energy that are calculated are likely to be 
fairly reliable. 
                                               
4.5 For selected examples see: (a)  Terada, Y.; Yamamura, S. Tetrahedron Lett. 1979, 3303. (b) Shea, 
K. J.; Stoddard, G. J.; England, W. P.; Haffner, C. D. J. Am. Chem. Soc. 1992, 114, 2635. 
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4.2 – Results and Discussion 
 
The MM TS for the proposed transannular Mannich (TAM) reaction (vide Chapter 2) 
were accessed and quantified using the following approach. Conformational searches 
were first performed on energy-minimized structures of the two possible starting 
materials, the macrocyclic iminium E- and Z- enols. For each isomer a set of different 
conformers and their respective energy, EMM, were obtained, which allowed 
calculating the respective conformer ratio. Then, and in order to crudely model the 
TS, the C5–C10 distance in each of the conformers previously found was constrained. 
Because the reactants are being used to access the TS, the reaction coordinate takes 
the reagents→TS sense. Therefore, the C5–C10 distance was decreased since it 
corresponds to the bond being formed. The constrained energies found, EMMc, are 
assumed to be the TS energies corresponding to the Mannich reaction of each 
conformer and were then used to obtain the product distribution. An identical 
procedure, mutatis mutandis, was then applied to the possible reaction products, the 
cylindricines and their three C-5 and C-10 diastereomers (vide infra, Scheme 4.1). In 
these cases, because the reaction coordinate takes the products→TS sense, the C5–
C10 was increased. 
 
All the calculations were performed in Macromodel using MMFF as the force field 
and in vacuum. The initial energy minimization of the different structures was 
performed using TNCG and a maximum of 500 iterations. The structures thus 
obtained were then subjected to a conformational search using SUMM. Since 9 free 
torsions were found for the iminium-enols E and Z (to which corresponds 39 = 19683 
~ 20000 possible rotations), 20000 steps were used. Only conformers within 20 
kJmol-1 from the least energetic conformation found were considered. The distance 
C5–C10 was constrained to 2Å, with a force constant of 5000 kJmol-1Å-2. For 
convenience, the calculations were performed using a methyl group at C-2. 
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Since the intramolecular Mannich reaction can take place between the two faces of 
the iminium ion and the two faces of each enol isomer, there are four possible 
diastereomeric products (Scheme 4.1). 
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Scheme 4.1 Possible products of the TAM reaction and respective TS. 
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The MM TS corresponding to the various possible Mannich reactions were first 
accessed using the reactants as models (Table 4.1). 
 
Table 4.1 MM calculations for iminium Z- and E-enols. 
 
Conformer 
EMM
(kJmol-1) 
N1/Nx
(300 K) 
EMMc
(kJmol-1) 
TS 
type 
Product 
Formed 
Product 
Distribution 
(%) 
Iminium Z-enol 
1 198.8 1 551.4 III C10 inverted 0.02 
2 203.2 5.9 575.3 III C10 inverted - 
3 212.6 255.4 559.6 III C10 inverted - 
4 215.4 786.7 545.3 VII C5 and C10 inverted 0.23 
5 215.5 811.5 587.3 V C5 inverted - 
6 216.7 1326.0 539.8 I Cylindricine 2.07 
7 217.7 1994.8 583.9 III C10 inverted - 
 8 218.7 3293.5 530.2 VII C5 and C10 inverted 97.68 
Iminium E-enol 
1 188.1 1 577.7 VIII C5 and C10 inverted 0.02 
 2 190.5 2.7 556.7 II Cylindricine 87.47 
3 191.5 4.0 577.7 VIII C5 and C10 inverted 0.02 
4 203.2 422.2 583.2 VIII C5 and C10 inverted - 
5 204.5 738.1 583.2 VIII C5 and C10 inverted - 
6 205.4 1021.2 568.9 II Cylindricine 0.65 
7 206.2 1445.2 601.3 VI C5 inverted - 
8 206.3 1469.8 561.7 II Cylindricine 11.58 
9 206.4 1537.4 573.0 VIII C5 and C10 inverted 0.13 
10 206.9 1876.6 619.4 VI C5 inverted - 
11 207.9 2803.0 573.0 VIII C5 and C10 inverted 0.13 
 
The first scenario that is possible to consider from this data corresponds to the 
situation where the macrocyclic iminium ion affords exclusively only one of the 
iminum enol isomers (Scheme 4.2). The population distributions calculated for each 
iminium enol isomer for this case are shown in the respective sub-tables of Table 4.1. 
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Scheme 4.2  
As it can be seen each iminium enol is predicted to react very differently in the 
Mannich step of the TAM reaction: whereas the iminium E-enol is expected to afford 
the desired cylindricines almost exclusively (mainly via its conformers 2 and 8), the 
iminium Z-enol is predicted to produce mainly the diastereoisomer with the opposite 
configuration at C-5 and C-10 (mostly through its conformer 8). Intuitively, however, 
this is an unlikely scenario as the energy barriers corresponding to the formation of 
the two iminium enols are expected to be comparable. 
 
A more likely situation is shown in Scheme 4.3 and it considers the possibility that 
the two iminium enols are both present in the reaction mixture. These two isomers are 
assumed to interconvert and to react by first-order kinetics to give a different product. 
 
N
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NHO
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OMe
Product 1 Product 2
 
 
Scheme 4.3  
 
Two limiting cases can be considered for this scenario. 
 
On one hand, it is possible to envision the energy barrier for the interconversion of the 
two iminium enol intermediates being significantly higher than the energy barriers for 
the subsequent Mannich reaction (“anti Curtin-Hammett conditions”). In such case, 
the product ratio of the overall TAM reaction should reflect the relative energies of 
the iminium enol intermediates (Figure 4.2). Such a scenario is conceivable since, as 
result of the intrinsic limitations of MM to deal with TS, the high TS energies 
calculated are likely to be largely overestimated. This overestimation occurs because 
interactions which are considered by MM as fully non-bonding and repulsive will be 
partially bonding in the real TS. Assuming that the relative order of the calculated TS 
energies with respect to each conformer is correctly predicted, then the iminium E-
enol will react preferentially through its conformer 2 to deliver the cylindricines, 
whereas the reaction of the iminium Z-enol will proceed mainly via conformer 8 to 
afford the diastereomer with inverted C-5 and C-10 configuration. Since the energy of 
the former is significantly lower than the latter (190.5 kJmol-1 versus 218.7 kJ mol-1), 
and because these intermediates should be representative of the TS for the Mannich 
reaction (Hammond postulate), the cylindricines are expected be the main/exclusive 
product of the TAM reaction. 
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Figure 4.2 Mannich step in the TAM reaction under “anti Curtin-Hammett” conditions. 
 
On the other hand, it is possible that the Mannich reaction proceeds under Curtin-
Hammett conditions, in which case the product distribution will be determined by the 
transition state energies (Figure 4.3). The lowest TS found for the iminium Z-enol is 
predicted to produce the diastereoisomer with inverted configuration at C-5 and C-10 
whereas the lowest TS for the iminium E-enol is expected to deliver the desired 
cylindricines. Considering that the former is significantly lower in energy than the 
latter (EMMc of 530.2 kJmol-1 vs. 556.7 kJmol-1, respectively), the undesired 
diastereomer is anticipated to be the main/exclusive product of the TAM reaction.  
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Figure 4.3 The Mannich step in the TAM under Curtin-Hammett conditions. 
 
Unlike the previous “anti-Curtin-Hammett” case where the calculations were based 
on ground state energies, the current predictions are based on TS energies, for which 
MM is far less trustworthy. It is thus conceivable that, in reality, the lowest TS 
leading to the cylindricines is lower that the lowest TS leading to the undesired 
diastereomer. Therefore, the product distribution predicted under Curtin-Hammett 
conditions, where the undesired diastereomer is the main product, should either be 
disregarded all together or reluctantly accepted. 
 
It is important to stress that the previous predictions correspond to two limit 
scenarios. An intermediate situation where the energy barriers for the interconversion 
of the iminium enols and the Mannich reaction are comparable can not a priori be 
excluded. The experimental product ratio is thus necessary to clarify which particular 
case in operating. 
 
The MM TS were also accessed using the products as models (Table 4.2). 
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Table 4.2 MM calculations for products. 
 
Conformer 
EMM
(kJmol-1) 
N1/Nx
(300 K) 
EMMc
(kJmol-1) 
Cylindricines 
1 192.5 1 162.1 
2 193.0 1.2 170.3 
3 196.5 5.0 174.5 
4 200.2 22.0 177.7 
5 200.2 22.0 170.0 
6 202.5 54.8 190.5 
7 203.7 89.2 174.0 
8 204.4 117.9 181.9 
9 204.6 129.3 182.8 
10 205.0 151.0 174.8 
11 205.2 161.1 174.1 
12 205.2 162.0 183.4 
13 205.8 206.7 175.3 
14 207.8 465.8 179.6 
15 207.8 468.0 196.0 
16 209.0 756.4 179.6 
17 210.4 1313.6 190.5 
18 212.2 2687.6 181.2 
C-10 inverted  
1 200.3 1 183.9 
2 207.3 16.4 191.0 
3 212.4 127.1 195.8 
4 213.3 183.3 196.7 
5 213.3 183.4 197.1 
6 215.6 456.2 193.4 
C-5 inverted 
1 220.0 1 202.9 
2 221.6 1.9 204.6 
3 224.3 5.5 204.6 
4 226.0 10.8 208.8 
5 226.5 13.2 218.7 
6 229.2 39.5 212.7 
7 229.2 39.8 212.8 
8 231.1 85.1 224.0 
9 232.8 164.2 225.2 
10 235.0 408.2 217.2 
11 239.0 1988.1 231.7 
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Table 4.2 (cont.) MM calculations for products. 
 
Conformer 
EMM
(kJmol-1) 
N1/Nx
(300 K) 
EMMc
(kJmol-1) 
C-5 and C-10 inverted 
1 194.4 1 171.5 
2 197.0 2.8 175.3 
3 198.6 5.4 177.5 
4 201.6 17.8 179.7 
5 203.3 36.5 190.6 
6 204.1 48.8 182.8 
7 205.5 84.9 192.7 
8 209.2 384.8 183.4 
9 210.0 533.1 197.2 
10 210.8 711.6 183.7 
11 211.1 809.1 184.5 
12 211.5 950.8 188.2 
13 211.6 981.1 198.5 
14 212.6 1498.4 199.6 
15 212.7 1573.4 189.5 
16 213.1 1807.6 187.5 
17 213.6 2212.4 196.4 
18 213.7 2349.4 201.4 
 
The first point worth mentioning in these results is that the TS energies obtained are 
lower than the energy of the corresponding unconstrained conformers! This is a 
limitation of the force field used, since the energy of the C5–C10 bond being 
constrained (i.e., elongated) is not being considered for the calculation of the EMMc. 
However since this is systematic in this set of calculations, it is still possible to 
compare the obtained TS energies. 
 
Based on the above results, the products distribution can be calculated (Table 4.3).
 
Table 4.3  
 
Diastereoisomer 
EMM Product Distribution (%) 
(300 K)  
EMMc Product Distribution (%) 
(300 K) 
Cylindricine 66.2 97.7 
C10 inverted 2.9 - 
C5 inverted - - 
C10 and C5 inverted 30.9 2.3 
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In contrast with what was observed previously when the TS was modeled based on 
iminium enols reactancts, for the present case the lowest energy conformer of each set 
has the lowest energy TS. This is likely to be a consequence of the similar bond 
organization in the TS and in the rigid tricyclic structure of the products as opposed to 
the more flexible iminium enols. In this sense, it could be argue that the products 
should be a better model for the TS (i.e., a late TS), which may reinforce the present 
results in detriment of those obtained when the iminum enols were studied. 
 
According to the results on Table 4.3 the desired cylindricines are predicted to be 
obtained with moderate to good selectivity with respect to the diastereomer with 
inverted configuration at C-5 and C-10, depending on which set of energies is used in 
the calculations. For the reasons mentioned before, the more optimistic results 
obtained when the TS energies are used should be approach with more scepticism. 
 
An important corollary of the above results is that since the cylindricine skeleton has 
a lower energy than any of the possible byproducts, if the TAM could be performed 
under thermodynamic control, then the desired cylindricines could be obtained with 
some selectivity. 
 
 
4.3 - Conclusion 
 
The Mannich step in the planned TAM reaction was investigated using MM. In 
particular, MM was used to access the lowest energy conformers of the reactants, 
iminium E- and Z-enols, and of the products, cylindricines and the possible C-5 and 
C-10 diastereomers, and to crudely model the TS of the Mannich reaction. 
 
In should be emphasized that as result of the intrinsic limitations of MM in dealing 
with TS, all the results obtained should be approach with a healthy dose of scepticism. 
This is particularly true for the present case where the reaction coordinate was defined 
in terms of a single distance, for which a somewhat arbitrary value of 2Å was used. 
 
In the most reliable scenarios, where the energies of ground state species (i.e., 
intermediates or products) were used to access the product ratio, the desired 
cylindricines are predicted to be the main product of the reaction. This was both the 
case when the iminium enols were used as a model for the TS and “anti Curtin-
Hammett” conditions were assumed and when the TS was modelled after the 
products. Moderate to excellent selectivities in favour of the desired cylindricines 
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were predicted for these cases. On the other hand, when a Curtin-Hammett scenario 
for the Mannich reaction is assumed, the undesired diastereomer with inverted 
configuration at C-5 and C-10 is expected to be the main/exclusive product. 
Fortunately, it can be argue that this prediction is less trustworthy as it is based on 
MM TS energies. Hence, there is reason to be moderately optimistic that the TAM 
will afford the desired cylindricines as the main product. 
 
More reliable results could have been obtained by constraining more than one degree 
of freedom in the system and/or by using a higher level method for the calculations 
such as ab initio. 
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CHAPTER 5 
Results and Discussion 
 
5.1 - Studies Towards Macrocycle (2.12) Based on a RCM Reaction 
 
The metathesis reaction has recently established itself as extremely powerful tools in 
organic synthesis. The olefin ring-closing metathesis (RCM) in particular has 
emerged as a value method for ring formation.5. ,5.1 2 This reaction involves the 
conversion of an (acyclic) diene (5.1) into the corresponding cyclic alkene (5.2) under 
the action of a metal carbene species (Figure 5.1). 
 
FGs Olefin RCM FGs
5.1 5.2
1
2 3
4 2 3
 
 
Figure 5.1 Olefin RCM reaction. 
 
One of the most important applications of RCM in organic synthesis has been in 
macrocyclizations reactions.5.3 This RCM-based macrocylization approach is 
particularly important in those cases where the E/Z selectivity of the process, often 
one of RCM main limitations, is of no consequence, as for example when the 
resulting alkene system is to be hydrogenated. 
 
 
                                               
5.1 For reviews see: (a) Grubbs, R. H.; Miller, S. J.; Fu, G. C. Acc. Chem. Res. 1995, 28, 446. (b) 
Fürstner, A. Top. in Cat. 1998, 4, 285. (c) Hoveyda, A. H. Top. Organomet. Chem. 1998, 1, 105. (d) 
Deiters, A.; Martin, S. F. Chem. Rev. 2004, 104, 2199. (e) McReynolds, M. D.; Dougherty, J. M.; 
Hanson, P. R. Chem. Rev. 2004, 104, 2239. 
5.2 Soufflet, J.-P.; Commereuc, D.; Chauvin, Y. Compt. Rend. 1973, 276, 169. 
5.3 For selected examples see: (a) Yang, Z.; He, Y.; Vourloumis, D.; Vallberg, H.; Nicolaou, K. C. 
Angew. Chem. Int. Ed. Engl. 1997, 36, 166. (b) Meng, D.; Bertinato, P.; Balog, A.; Su, D.-S.; 
Kamenecka, T.; Sorensen, E. J.; Danishefsky, S. J. J. Am. Chem. Soc. 1997, 119, 10073. (c) Schinzer, 
D.; A. Bauer, A.; Böhm, O. M.; Limberg, A.; Cordes, M. Chem. Eur. J. 1999, 5, 2483. (d) Prunet, J. 
Angew. Chem. Int. Ed. 2003, 42, 2826. (e) Maleczka Jr., R. E.; Terrell, L. R.; Geng, F.; Ward III, J. S. 
Org. Lett. 2002, 4, 2841. (f) Fürstner, A.; Jeanjean, F.; Razon, P. Angew. Chem. Int. Ed. 2002, 41, 
2097. (g) Barluenga, S.; Lopez, P.; Moulin, E.; Winssinger, N. Angew. Chem. Int. Ed. 2004, 43, 3467.  
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Based on these considerations, diene (5.3) emerged as a suitable precursor to access 
the key macrocycle intermediate (2.12) (Scheme 5.1). 
 
2.12
N
O
C6H13RO
8
O
N
C6H13
PG3O(PG1)
O(PG2)
8
5.3
ROPG3
7
7
RCM and FGI
 
 
Scheme 5.1 The RCM approach towards key macrocycle (2.12). 
 
5.1.1 Synthetic Studies Towards Diene (5.3) via a Displacement Reaction 
 
5.1.1.1 Retrosynthetic Considerations 
 
The first strategy considered to access diene (5.3) explored the use of a SN2-type 
displacement reaction to combine (activated) amine (5.4) with alcohol (5.5) (Scheme 
5.2). The sense of disconnection shown would in principle allow the preparation of 
amine (5.4) from an α-amino acid (5.6) precursor. Alcohol (5.5) was planned to be 
access from allylic alcohol (5.7) with the required chirality being established by 
means of the Sharpless asymmetric epoxidation (SAE) reaction. Hence, the chirality 
of amine (5.4) would be derived from the chiral pool while that of alcohol (5.5) would 
be established by means of catalytic asymmetric synthesis. 
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Scheme 5.2 Simplified retrosynthetic analysis for diene (5.3) based on a displacement reaction. 
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Secondary alcohols such as (5.5) can be poor substrates in SN2-type displacement 
reactions with (activated) amines such as (5.4); however, it was argued that the 1,3-
conjoint electronic arrangement5.4 between the carbonyl and the hydroxyl 
functionalities in (5.5) would facilitate the coupling process between these two 
building blocks.5.5
 
5.1.1.2 Preparation of the Building Blocks Pertaining to the 
Displacement Approach 
 
For convenience, the initial studies were performed in the racemic series. 
 
The synthesis of rac-(5.5) began with the HWE reaction5.6 of heptaldehyde with 
ethylphosphonate in an aqueous solution of K2CO3 to afford the desired (E)-α,β-
unsaturated ethyl ester in a stereoselective manner and in high yield (95%).5. ,5.7 8 
DIBAL reduction of the latter proceeded in good yield (79%) delivering known 
allylic alcohol (5.8), which was then subjected to MCPBA epoxidation to produce the 
corresponding epoxyalcohol in 95% yield. Following the procedure of Kitching and 
co-workers,5.  9 treatment of the latter with Red-Al, afforded diol (5.9) in 77% yield, 
5.4 Functional groups, by virtue of their heteroatoms, modify the electronic properties of the adjacent 
hydrocarbon backbone. According to Ho,5.5 two situations are possible: either the alternating polarity 
pattern along a chain of atoms created by each of the functional groups (FGs) reinforce or oppose each 
other, corresponding to a conjoint or a disjoint electronic arrangement, respectively (Scheme 5.A). 
 
A A A DD D
A = FGs containg empty p orbitals or 
with a negative inductive effect
(e.g., COR, NO2, SiR3 and N+R3)
D = FGs with n and π electrons or 
with a positive inductive effect
(e.g., OR, NR2, Hal and alkly groups)
d d
a
d a
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a a
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between the two FGs
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between the two FGs  
 
Scheme 5.A Conjoint and disjoint electronic arrangements between FGs. 
 
5.5 Ho, T.-L. in “Polarity Control for Synthesis” 1990, Wiley, Illinois. 
5.6 For general references see: (a) Horner, L.; Hoffmann, H.; Wippel, H. G.; Klahre, G. Chem. Ber. 
1959, 92, 2499. (b) Wadsworth, W. S.; Emmons, W. D. J. Am. Chem. Soc. 1961, 62, 1733. For a 
review see (c) Maryanoff, B. E.; Reitz, A. B. Chem. Rev. 1988, 89, 863. 
5.7 Seguineau, P.; Villieras, J. Tetrahedron Lett. 1988, 29, 477. 
5.8 For an alternative procedure for the preparation of allylic alcohol (5.8), based on the stereoselective 
reduction of 2-nonyn-1-ol with LiAH4 see ref. 5.9. 
5.9 Kitching W.; Lewis, J. A.; Perkins, M. V.; Drew, R.; Moore, C. J.; Schurig, V.; König, W. A.; 
Francke, W. J. Org. Chem. 1989, 54, 3893. 
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presumably via an internal hydride delivery.5.10 After conversion of the 1,3-diol (5.9) 
to the O,O-benzylidene acetal (5.10),5.11 accomplished in good yield (75%) by 
reaction of the former with benzaldehyde in the presence of a catalytic amount of 
H2SO4, a regioselective reductive opening of the latter with DIBAL afforded the 
primary alcohol (5.11) in 98% yield.5.12 A subsequent Dess-Martin oxidation 
delivered the corresponding aldehyde which, without further purification, was reacted 
with the Grignard reagent (5.12)5.13 producing the alcohol (5.13) in good yield (79%). 
Treatment of the latter with Dess-Martin periodinate (DMP) delivered ketone (5.14) 
in excellent yield (97%) yield (Scheme 5.3). 
 
All that remained doing to prepare alcohol rac-(5.5) was to cleave the Bn protecting 
group from (5.14). Due to the C=C double bond in the latter, hydrogenolysis 
conditions, arguably the most commonly used method to convert benzylic ether into 
the corresponding alcohols,5.14 were excluded. Therefore, we concentrated in 
deprotection methods based on the so-called “push and pull principle”, namely the use 
of BF3·Et2O-SMe25. a15 , BBrMe25. b15  and AlCl3-N,N-dimethyaniline.5. c15  Unfortunately, 
all attempts to accomplish the removal of the Bn group from (5.14) using these 
conditions, led to failure as either extensive decomposition of the starting material 
was observed or complex mixtures were obtained. Interestingly, when ketone (5.14) 
was treated with SMe2 in the presence BF3·Et2O, the 1H-NMR of the crude product 
suggested that the sulfonium salt (5.15) was formed. The observation that only the 
(E)-α,β-unsaturated ketone (5.16) was recovered when the latter crude product was 
subjected to flash column chromatography further supported this assumption. 
 
5.10 For a study on reductive opening of allyl-alcohols epoxides see: Finan, J. M.; Kishi, Y. 
Tetrahedron Lett. 1982, 23, 2719. 
5.11 For an alternative preparation of benzylidene acetal (5.10), see: Nishigaichi, Y.; Takuwa, A. 
Tetrahedron Lett. 2002, 43, 3045. 
5.12 (a) For a similar example see: Takano, S.; Akiyama, M.; Sato, S.; Ogasawara, K. Chem. Lett. 1983, 
1593. (b) For a similar transformation, using orthoesters instead of benzylidene acetals, see: Takasu, 
M.; Naruse, Y.; Yamamoto, H. Tetrahedron Lett. 1988, 29, 1947. 
5.13 Grignard reagent (5.12) was prepared following a literature procedure: (a) For its preparation in 
Et2O see: Harding, K.; Burks, S. J. Org. Chem. 1984, 49, 40. (b) For its preparation in THF see: 
Nemoto, H.; Shiraki, M.; Fukumoto, K. J. Org. Chem. 1996, 61, 1347. 
5.14 Greene, T. W.; Wuts, P. G. M. in “Protective Groups in Organic Synthesis” 1999, Wiley, New 
York, 3rd ed.. 
5.15 (a) Fuji, K.; Kawabata, T.; Fujita, E. Chem. Pharm. Bull. 1980, 28, 3662. (b) Knops, H.-J.; Born, 
L. Tetrahedron Lett. 1983, 24, 2973. (c) Akiyama, T.; Hirofuji, H.; Ozaki, S. Tetrahedron Lett. 1991, 
32, 1321. 
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C6H13CHO
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K2CO3, H2O, 
rt
95%
2) Dibal
CH2Cl2, -78 oC
79%
C6H13
OH
1) MCPBA
CH2Cl2, 0 oC to rt
95%
5.8
2) Red-Al
THF, -30 oC to -10 oC
77%
C6H13
OH
5.9
HO
PhCHO
 H2SO4 cat.
DMSO, rt
75%
C6H13
O
O
Ph
Dibal
CH2Cl2, -60 oC to rt
DMP
CH2Cl2, 0 oC to rt
97%
2) MgBr
C6H13
OBnO
Me2S
BF3 Et2O
CH2Cl2, rt
C6H13
OMe2S
1)
C6H13
BnO OH
1) DMP
CH2Cl2, 0 oC to rt
97% (crude)
Et2O, rt
79%
C6H13
OHBnO
5.105.115.13
5.14 5.15
C6H13
O
5.16
5.12
(tentative structure)
13
98%
 
Scheme 5.3 Preparation of ketone (5.14). 
 
Although a setback with respect to the formation of the desired alcohol rac-(5.5), the 
(presumed) formation of sulfonium salt (5.15) was, at the time, taken as an 
encouraging signal towards our goal in that it showed that the 13-position of ketone 
(5.14) in is indeed susceptible of nucleophilic displacement. 
 
A simple solution to this problem, which allowed keeping the same overall synthetic 
strategy, was found by switching to the PMB protecting group (Scheme 5.4). The 
required PMB-acetal (5.17), obtained in high yield (97%) from diol (5.9) and the 
dimethylacetal of p-anisaldehyde in the presence of a catalytic amount of CSA by 
continuously distilling off MeOH, was converted into PMB-ketone (5.18) by a similar 
sequence of steps as used for the preparation of Bn-ketone (5.14). Removal of the 
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PMB group from (5.18) was accomplished in 60% yield by the use of DDQ, hence 
producing alcohol rac-(5.7).5. ,5. ,5.16 17 18
 
C6H13
OH
5.9
HO
C6H13
O
O
PMB
5.17
MeO
MeO
OMe
CSA cat.
DMF, rt, house vaccum
97% C6H13
OPMBO
5.18, 93% based on 5.17
as in Scheme 5.3
DDQ
CH2Cl2, H2O
C6H13
OOH
60%
rac-5.5
 
Scheme 5.4 Preparation of rac-(5.5). 
 
Importantly, Kitching and co-workers already demonstrated that both enantiomers of 
the epoxide obtained from allylic alcohol (5.8) can be obtained in pure form by means 
of the SAE reaction.5.9 Therefore, the present synthetic route can easily be adapted to 
prepare the required alcohol (R)-(5.5). 
 
 
                                               
5.16 Horita, K.; Yoshioka, T.; Tanaka, T.; Oikawa, Y.; Yonemitsu, O. Tetrahedron 1986, 42, 3021. 
5.  17 Alcohol rac-(5.5) was routinely prepared by the aldol reaction of the kinetic lithium enolate of 
allylacetone, obtained by treating the latter with LDA at -78 oC,5.18 with heptaldehyde (Scheme 5.B). 
 
O LDA then C6H13CHO
THF, -78 oC
C6H13
OOH
rac-5.5
68%
 
 
Scheme 5.B Preparation of alcohol rac-(5.5). 
 
5.18 For the preparation of the kinetic enolate of allyl acetone, see: Hoffmann, R. W.; Kahrs, B. C.; 
Schiffer, J.; Fleschhauer, J. J. Chem. Soc., Perkin Trans. 2 1996, 2407. 
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Regarding amine (5.4), it was decided to initially use simpler surrogates for this 
building block. Model amines to be employed were derived from amine (5.19). The 
latter was prepared from phenylalanine by initial reduction to phenylalalinol using the 
conditions reported by Meyers and McKennon (NaBH4-I2 in refluxing THF, 75% 
yield).5.19 Subsequent methylation of the hydroxyl functionality was accomplished 
using standard conditions for this transformation (NaH then MeI, 77% yield).5.20 The 
amino group was then conveniently functionalized (vide infra, section 5.1.1.3). 
 
HO2C NH2
Ph NaBH4, I2
THF, reflux
NH2
Ph
HO
 NaH then MeI
THF, 0 oC to rt
NH2
Ph
MeO
5.19
NH2
O(PG1)
~~
5.4
MeO
75% 77%
 
Scheme 5.5 Preparation of model amine (5.19). 
 
We were now in conditions to test the challenging coupling reaction between alcohol 
rac-(5.5) and a suitable form of amine (5.19). 
 
5.1.1.3 Model Studies Pertaining to the Displacement Reaction Strategy 
 
The displacement reaction was first attempted using Mitsunobu conditions. The 
Mitsunobu reaction is a useful method in organic synthesis whereby a hydroxy group 
is (stereospecifically) replaced by a variety of nucleophiles using the redox couple of 
a tertiary phosphine and a diazocompound.5.21
 
Ragnarsson and co-workers showed that the yields in Mitsunobu reactions correlate 
well with the pKa of the nucleophilic reagent,5.22 which typically has to be 
approximately 11 for the reaction to proceed satisfactorily. Therefore, and using as 
guides the pKas of N-methyltosylamide (11.7)5.23 and N-methyltriflamide (7.5),5.24 
                                               
5.19 McKennon, M. J.; Meyers, A. I. J. Org. Chem. 1993, 58, 3568. 
5.20 Model amine (5.19) was prepared from phenylalalinol using a modification of the following 
literature procedure: Meyers, A. I.; Poindexter, G. S.; Brich, Z. J. Org. Chem. 1978, 43, 892. 
5.21 For selected reviews on the Mistunobu reaction, see: (a) Mitsunobu, O. Synthesis 1981, 1. (b) 
Hughes, D. L. Org. Reactions 1992, 42, 335. (c) Castro, B. R. Org. Reactions 1983, 29, 1. 
5.22 (a) Koppel, I.; Koppel, J.; Degerbeck, F.; Grehn, L.; Ragnarsson, U. J. Org. Chem. 1991, 56, 7172. 
(b) Koppel, I.; Koppel, J.; Leito, , I.; Phil, V.; Wallin, A.; Grehn, L.; Ragnarsson, U. J. Chem. Soc., 
Perkin Trans 2 1993, 655. 
5.23 Dauphin, G.; Kergomard, A. Bull. Soc. Chim. Fr. 1961, 486. 
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tosylamide (5.20a) and triflamide (5.20b) were thought to be suitable amine-type 
nucleophiles for the intended Mitsunobu reaction. Toslyamide (5.20a) was prepared 
in 82% yield from model amide (5.19) by standard treatment with TsCl in the 
presence of pyridine; triflamide (5.20b) was obtained from the reaction of amine 
(5.19) with Tf2O in the presence of NiPr2Et at low temperature (-78 oC) in 97% yield 
(Scheme 5.6). 
 
NH2
Ph
MeO
TsCl, pyridine
CH2Cl2, 0 oC to rt
or
NH(EWG)
Ph
MeO
5.20a: EWG = Ts, 82%
5.20b: EWG = Tf, 97%
5.20c: EWG = H+BF4-, quantitative (crude)
Tf2O, NPr2Et
CH2Cl2, -78 oC
or
HBF4
Et2O, 0 oC to rt
5.19
 
 
Scheme 5.6 Preparation of (protected/activated) amines (5.20). 
 
The Mitsunobu reaction of alcohol rac-(5.5) with activated amines (5.20) was then 
investigated under a variety of conditions (Scheme 5.7). 
 
NH(EWG)
Ph
MeO
5.20a: EWG = Ts
5.20b: EWG = Tf
5.20c: EWG = H+BF4-
C6H13
OOH
rac-5.5
+
N
C6H13
EWG
5.21
MeO
O
Ph
Phosphine: PPh3 or PBu3 or PMe3
Diazo: DEAD or DIAD or ADDP or TMAD
(Base: Imidazole)
THF, 0 oC or rt or reflux
N
C6H13
5.22: R = Et or iPr
O
HN
RO O
RO O
NN
O(R')RN NR(R')
;
5.23: R = R' = Me
 or R = cHexyl  
 
Scheme 5.7 (Attempted) Mitsunobu reaction between alcohol rac-(5.5) and amines (5.20). 
 
 
                                                                                                                                            
5.24 Trepka, R. D.; Harrington, J. K.; Belisle, J. W. J. Org. Chem. 1974, 39, 1094. 
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Under standard Mitsunobu conditions (1.5 equivalents equimolar excess of alcohol, 
PPh3 and DEAD (or DIAD) relative to the protected amine component; various orders 
of addition) the desired amine (5.21) was never produced. P(O)Ph3 and alkylated 
hydrazine derivatives (5.22) were occasionally isolated and/or detected by mass 
spectrometry. 
 
In an attempt to promote the desired reaction, and to simultaneously avoid the 
formation of the latter hydrazo by-products, it was argued that the nucleophilicity of 
the hydrazide anion had to be decreased. This could in theory be accomplished by 
using a salt of amine (5.19) which would provide a proton to quench the hydrazo 
anion.5.25 Ideally, a non-nucleophilic counter anion is desirable and so the 
tetrafluoroborate salt (5.20c) emerged as a good candidate. This salt, prepared by 
treating amine (5.19) with HBF4, proved to be very hygroscopic and typically it was 
dried over phosphorous P2O5 before use. Unfortunately, the use of the amine salt 
(5.20c) also failed to deliver amine (5.21) (Scheme 5.7). 
 
In the early 1990s, various modifications of the 
classical Mitsunobu conditions were reported: the 
Tsunoda-Itô group introduced several more reactive 
azodicarboxamides/phospines redox systems to be 
used in Mitsunobu couplings, such as ADDP/PBu3 
and TMAD/PBu3 (Figure 5.2);5.26 another variation 
that emerged with respect to the original Mitsunobu 
conditions consists in the use of exogenous weak 
bases5. a27  (in particular, Falk and co-workers 
described the application of ADDP/PMe3 in the 
presence of imidazole as being useful in problematic 
Mitsunobu reactions).5. b27
Figure 5.2 Structures of ADDP 
and TMAD. 
N N
N
O
N
O
ADDP
N N
N
O
N
O
Me
MeMe
Me
TMAD
 
These improved Mitsunobu conditions were also tested, namely the use of ADDP and 
TMAD combined with PBu3 or PMe3, with and without imidazole. Disappointingly, 
once again rac-(5.5) alcohol proved to be refractory with respect to the desired 
5.25 For a precedent for this type of approach see: Sammes, P, G.; Smith, S. J. Chem. Soc., Perkin 
Trans 1 1984, 2415.  
5.26 (a) Tsunoda, T.; Yamamiya, Y.; Itô, S. Tetrahedron Lett. 1993, 34, 1639. (b) Tsunoda, T.; Otsuka, 
O.; Yamamiya, Y.; Itô, S. Chem. Lett. 1994, 539. 
5.27 (a) Campbell, D. A.; Bermak, J. C. J. Org. Chem. 1994, 59, 658. (b) Lai, J.-Y.; Yu, J.; Hawkins, 
D.; Falck, J. R. Tetrahedron Letts. 1995, 36, 5691. 
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displacement reaction and amine (5.21) was never isolated. Under these conditions, 
compounds tentatively identified as oxadiazoles (5.23) were occasionally obtained 
from the crude reaction mixture and/or identified by MS (Scheme 5.7). 
 
As a last effort, the desired displacement reaction was attempted using “conventional” 
SN2 conditions.5.28 For this case, and in addition to amine (5.19), model amine (5.25) 
was also employed. The latter was readily prepared by the following sequence: 
reductive amination5.29 of amine (5.19) with p-methoxybenzaldehyde and NaBH4 
delivered the known amine (5.24)5.30 followed by methylation of the hydroxy 
functionality using standard conditions (NaH then MeI) (Scheme 5.8). 
 
NH2
Ph
HO
5.19
CHOMeO1)
2) NaBH4
MeOH, 0 oC
NHPMB
Ph
HO
5.24, 92% 
(based on 5.19)
4 Å MS
PhMe, 90 oC
NaH then MeI
THF, 0 oC to rt
NHPMB
Ph
MeO
5.25
80%
 
 
Scheme 5.8 Preparation of model amine (5.25). 
 
The use of standard SN2 conditions requires the conversion of the hydroxyl group into 
a labile nucleofuge, such as the corresponding mesylates and triflates. Accordingly, 
treatment of alcohol rac-(5.5) with MsCl in pyridine at -5 oC to 0 oC afforded 
mesylate (5.26a), which was used as the crude product. Triflate (5.26b), obtained by 
treatment of rac-(5.5) with Tf2O in the presence of 2,6-lutidine at -78 oC,5.31 was also 
used directly in subsequent reactions (Scheme 5.9). 
                                               
5.28 For selected examples where amines are prepared by a SN2 reaction from triflates or mesylates see: 
(a) Bloch, R.; Brillet-Fernandez, C.; Mandville, G. Tetrahedron: Asymmetry 1994, 5, 745. (b) Short, 
R. P.; Kennedy, R. M.; Masamune, S. J. Org. Chem. 1989, 54, 1755. (c) Feenstra, R. W.; 
Stokkingreef, E. H. M.; Nivard, R. J. F.; Ottenheijm, H. C. J. Tetrahedron 1988, 44, 5583. (d) Walker, 
M. A. Tetrahedron 1997, 53, 14591. (e) Effenberger, V. F.; Burkard, U.; Willfahrt, J. Angew. Chem. 
1983, 95, 50. (f) Kowollik, W.; Janairo, G.; Voelter, W. J. Org. Chem. 1988, 53, 3943. 
5.29 For an excellent review on reductive amination, see:Baxter, E. W.; Reitz, A. B. Organic Reactions 
2002, 59, 1. 
5.30 Dondoni, A.; Perrone, D.; Merino, P. J. Org. Chem. 1995, 60, 8074. 
5.31 (a) Feenstra, R. W.; Stokkingreef, E. H. M.; Nivard, R. J. F.; Ottenheijm, H. C. J. Tetrahedron 
Lett. 1987, 28, 1215. (b) Stang, P. J.; Treptow, W. Synthesis 1980, 283. These papers acknowledge the 
importance of using either 2,6-lutidine or 2,6-di-tbutyl-4-methyl-pyridine as bases in the preparation 
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The coupling reaction between mesylate (5.26a) or triflate (5.26b) and amines (5.19) 
or (5.25) was then tested. Two set of conditions were used: either the two reactants 
were simply stirred together in CH2Cl2 at various temperatures (conditions A) or the 
displacement reaction was performed using the conditions reported by Otera and co-
workers,5.32 i.e., the reaction was carried in the presence of an excess CsF in DMF at 
50 oC (conditions B). Not totally unexpectedly, the desired secondary amine (5.21) 
was never produced and typically the elimination product, (E)-α,β-unsaturated ketone 
(5.16), was obtained (Scheme 5.9). 
 
NHR
Ph
MeO
C6H13
OOH
rac-5.5
C6H13
OOR
5.26a: R = Ms
5.26b: R = Tf
N
C6H13
R
5.21
MeO
O
Ph
MsCl
pyridine, 0 oC
or
5.19: R = H
5.25: R = PMB
C6H13
O
5.16
Tf2O, 2,6-lutidine
CH2Cl2, -78 oC
Conditions B:
5.19 or 5.25, CsF
DMF, 50 oC
Conditions A:
5.19 or 5.25 
CH2Cl2, -78 oC to 0 oC (to reflux)
 
 
Scheme 5.9 (Attempted) SN2 reaction between alcohol rac-(5.5) and amines (5.19) and (5.25). 
 
In view of these disappoint results, the displacement approach was abandoned. 
 
 
 
 
 
 
 
                                                                                                                                            
of labile triflates. (c) For a general reference regarding triflates see: Stang, P. J.; Hanack, M.; 
Subramanian, L. R. Synthesis 1982, 85. 
5.32 Otera, J. ; Nakazawa, K.; Sekoguchi, K.; Orita, A. Tetrahedron 1997, 53, 13633.  
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5.1.2 Synthetic Studies Towards Diene (5.3) via the Opening of a Lactam 
 
5.1.2.1 Retrosynthetic Considerations 
 
In another approach investigated, diene (5.3) was envisioned to derive, after 
functional group manipulation, from the opening of chiral lactam (5.27). The latter 
was to be prepared from amide (5.28) by means of an intramolecular displacement 
reaction. Amide (5.28) would be derived from the reaction between chiral amine 
(5.29) and chiral lactone (5.30) (Scheme 5.10). Thus, in the present synthetic plan the 
sense of the coupling partners is the opposite with respect to the “displacement 
reaction approach” previous investigated (vide supra, Section 5.1.1). 
 
H
N
C6H13
O(PG1)
O(PG2)
5.3
MeO
1 N
C6H13 O(PG2)
5.27
MeO
O
MeO
H
N
C6H13 O(PG2)
5.28
1
O
LG
H2N
C6H13 O(PG2)
1
O O
MeO
5.295.30
5 2
2
5
2
5
52
1
 
 
Scheme 5.10 Simplified retrosynthetic analysis for diene (5.3) based on the opening of a lactam. 
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5.1.2.2 Preparation of the Building Blocks Pertaining to the Lactam 
Opening Approach 
 
For convenience, initial studies were again performed using racemic materials. 
 
The synthesis of lactone rac-(5.30) was accomplished as depicted in Scheme 5.11. 
Following a literature procedure by Larcheveque and Lalande,5.33 glutamic acid was 
first treated with NaNO2 in an aqueous solution of H2SO4 to afford lactone (5.31) in 
60% yield. Reduction of the carboxylic acid functionality with BH3·THF delivered the 
corresponding hydroxymethyl-γ-butyrolactone (not shown) in 71% yield.5. ,5.33 34 
Methylation using standard conditions (NaH followed by treatment with MeI) finally 
produced lactone rac-(5.30) in 80% yield. 
 
HO2C CO2H
NH2
NaNO2, H2SO4 aq.
H2O, 0 oC to rt
OHO2C
1) BH3 THF
THF, 0 oC to rt
71%
O
2) NaH then MeI
THF, 0 oC to rt
80%
O O
MeO
5.31 rac-5.30
60%
 
 
Scheme 5.11 Preparation of lactone rac-(5.30). 
 
The second building block required to implement the current strategy, amine rac-
(5.29), was prepared according to the sequence shown in Scheme 5.12. Following a 
procedure by Weiler and Huckin,5.35 treatment of ethylacetoacetate with NaH (1 eq.) 
followed by BuLi (1 eq.) generated the corresponding dianion which, upon reaction 
with allyl bromide, afforded the γ-allylated product in good yield (91%). Protection of 
the keto functionality as the corresponding dioxalane (5.32) was accomplished using 
the conditions reported by Baldwin and co-workers (ethyleneglycol in the presence of 
a catalytic amount of TsOH in refluxing benzene)5.36 and proceeded in good yield 
(77%). Reduction of the ester group with LiAlH4, followed by Dess-Martin 
oxidization of the resulting crude alcohol underwent uneventfully delivering the 
known aldehyde (5.33) in excellent overall yield. This compound proved somewhat 
unstable and was best kept frozen in a benzene matrix. Aldeyhde (5.33) was 
                                               
5.33 (a) Larcheveque, M.; Lalande, J. Tetrahedron 1984, 40, 1061. (b) For a slightly different 
procedure, see: Ravid, U.; Silverstein, R. M.; Smith, L. R. Tetrahedron 1978, 34, 1449. 
5.34 (S)- and (R)-Hydroxymethyl-γ-butyrolactone are commercially available from Fluka. 
5.35 Huckin, S. N.; Weiler, L. J. Am. Chem. Soc. 1974, 96, 1082. 
5.36 Baldwin, S. W.; Wilson, J. D.; Aubé, J. J. Org. Chem. 1985, 50, 4432. 
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converted into secondary alcohol (5.36) in 75% yield by means of a Grignard reaction 
with hexylMgBr. Conversion of the latter into the corresponding azide (not shown) 
was accomplished with diphenylphosphoryl azide (DPPA) using standard Mitsunobu 
conditions (PPh3/DIAD) in high yield (93%).5.37 The high nucleophilicity of the azide 
anion, together with its “needle” shape no doubt were key factors for the success of 
this transformation and this stands in sharp contrast with the results obtained in 
Section 5.1.1.3. It is interesting to note that the source of the azide anion is of key 
importance for the high yield obtained in this displacement reaction: when ZnN6·2Py, 
prepared from Zn(NO3)2, NaN3 and pyridine according to the procedure of Rollin and 
Viaud,5.38 was used not only was the reaction more sluggish, but it could never be 
driven to completion. The desired rac-(5.29) amine was finally obtained in high yield 
(92%) by reduction of the corresponding azide with LiAlH4. 
 
OEt
O O
1) NaH then BuLi
Br
THF, 0 oC to rt
91%
2) HO
OH
TsOH cat.
PhH
77%
OEt
OOO
CHO
OO
1) LiAlH4
Et2O, 0 oC to rt
93%
2) DMP
CH2Cl2, 0 oC to rt
quantitaive
5.32 5.33
C6H13MgBr
Et2O, rt
75%
OO
5.34
C6H13
OH
1) PPh3, DIAD
(PhO)2P(O)N3
THF, 0 oC
93%OO
rac-5.29
C6H13
NH2
2) LiAH4
Et2O, 0 oC to rt
92%
 
Scheme 5.12 Preparation of amine rac-(5.29). 
 
 
 
 
 
 
 
                                               
5.37 Lal, B.; Pramanik, B. N.; Manhas, M. S.; Bose, A. K. Tetrahedron Lett. 1977, 1977. 
5.38 Rollin, P.; Viaud, M. C. Synthesis 1990, 130. 
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5.1.2.3 Implementation of the Lactam Opening Approach 
 
We were now ready to test the coupling of amine rac-(5.29) and lactone rac-(5.30). 
After some unsuccessful attempts, it was found that the desired amide (5.35) could be 
obtained in excellent yield (94%) when the reaction between rac-(5.29) and rac-
(5.30) was performed using the conditions reported by Weinreb and co-workers 
(AlMe3 in refluxing toluene)5.39 (Scheme 5.13). Presumably, under these conditions a 
nucleophilic aluminum-amide species is formed which, due to the Lewis acidic nature 
of aluminum, activated the lactone towards ring opening. Treatment of lactam (5.35) 
with MsCl in the presence of NEt3 afforded the corresponding mesylate (not shown) 
which was directly subjected to a tBuOK-promoted intramolecular aminocyclization 
affording the desired lactam (5.36) in 51% yield. Due to the ambidentate nature of the 
amide anion generated, imine (5.37), the product of O-alkylation was also isolated in 
13% yield. The two alkylation products, lactam (5.36) and imine (5.37), were readily 
separated by flash chromatography. 
 
OO
5.29
C6H13
NH2
O O
MeO
rac-5.30
AlMe3 then
PhMe, 0 oC to reflux MeO
H
N
C6H13
5.35
O
OH
O O
1) MsCl, NEt3
CH2Cl2, 0 oC
95% (crude)
2) tBuOK
PhMe, rt
N
C6H13
5.36, 51%
MeO
O
O O
N
C6H13
O OO
MeO
+
5.37, 13%
94%
 
Scheme 5.13 Preparation of lactam (5.36). 
 
                                               
5.39 (a) Basha, A.; Lipton, M.; Weinreb, S. M. Tetrahedron Lett. 1977, 4171. 
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The distinction between the products of N- and O-alkylation, lactam (5.36) and imine 
(5.37), respectively, was made by comparison with reported spectral data for similar 
compounds. In particular, the 13C signal for the lactam carbon and the characteristic 
infrared (IR) frequency of the lactam carbonyl were considered. Hence, the values 
obtained for (5.36) at 176.2 ppm and 1684 cm-1, respectively, are in good agreement 
to the values reported by Taguchi and co-workers for pyrrolidinone (5.38) (176.5 ppm 
and 1685 cm-1),5. a40  to that of pyrrolidinones (5.39) (174.4 ppm)5. d40  and (5.41) (1688 
cm-1)5. b40 . On the other hand, the values produced by iminotetrahydrofuran (5.37) at 
170.3 ppm and 1725 cm-1 are closer to the tabulated values for iminoethers (5.40) 
(169.2 ppm) and reported by Saegusa and co-workers for (5.42) (1712 cm-1).5. c40
 
N
C6H13
5.36
13C 176.2 ppm
IR (neat) 1684 cm-1
MeO
O
O O
N
C6H13
O OO
MeO
N O
tBuMeO
5.38
13C 176.5 ppm
 IR (neat) 1685 cm-1
N O
Bn
O
NBn
5.39
13C 174.4 ppm
5.40
13C 169.2 ppm
N O
Me
5.41
IR (neat) 1688 cm-1
O
NtBu
5.42
IR (neat) 1712 cm-1
5.37
13C 170.3 ppm
IR (neat) 1725 cm-1
 
Figure 5.3 (Selected) 13C and IR values for pyrrolidinones and iminotetrahydrofurans. 
 
The next step in the planned synthetic route consisted in the opening of lactam (5.36). 
Several conditions were investigated for this transformation and the most important 
are shown in Scheme 5.14.  
 
 
 
 
                                               
5.40 (a) Fujita, M.; Kitagawa, O.; Yamada, Y.; Izawa, H.; Hasegawa, H.; Taguchi, T. J. Org. Chem. 
2000, 65, 1108. (b) Dolphin, D.; Wick, A. in “Tabulation of Infrared Spectral Data” 1977, John Wiley, 
New York. (c) Saegusa, T.; Taka-Ishi, N.; Ito, Y. Synthesis 1970, 475. (d) Deyrup, J. A.; Gingrich, H. 
L. J. Org. Chem. 1977, 42, 1015. 
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R
H
N
C6H13
O O
N
C6H13
5.36
MeO
O
O O
MeO
Conditions A (Hydrolitic): 
e.g.: i) LiOH or Ba(OH)2 aq.
MeO
OHTHF or , rt to reflux
Conditions B (Transamidation): 
AlMe3, HCl NH(OMe)Me
PhMe, rt to reflux
Conditions C (via alkly imidates): 
e.g.: i) MeO+BF4-, CH2Cl2, rt
ii) H+ aq., 0 oC to rt
Conditions D (reductive): 
e.g.: BH3 NH3 then BuLi
THF, 0 oC to reflux
5.43a: Conditions A, R = CO2H or CO2R
5.43b: Conditions B, R = C(O)N(OMe)Me
5.43c: Conditions C, R = CO2Et
5.43d: Conditions D, R = CH2OH
 
Scheme 5.14 (Attempted) opening of lactam (5.36). 
 
We began with hydrolytic methods, which were expected to afford the carboxylic acid 
(5.43a) (or an equivalent form) (conditions A). Basic hydrolysis with KOH or 
Ba(OH)2 in THF or 2-methoxyethanol (at room temperature or at reflux) yielded only 
starting material.5. a,b41  The same disappointing result was obtained by the use of 
Gassaman’s “anhydrous KOH” method in refluxing THF.5. c41  The LiOOH protocol of 
Evans, which capitalizes in the enhanced nucleophilicity of the peroxide anion and is 
reported to be notoriously insensitive to substrate steric effects, also failed to promote 
the lactam-opening and only lactam (5.36) was recovered.5. d41  Acidic hydrolysis was 
also tried: 5. e41  aqueous HCl (6 M) at room temperature cleaved the dioxalane 
protecting group affording the corresponding ketone; under reflux extensive 
decomposition occurred. 
 
Transamidation of lactam (5.36) to the corresponding Weinreb amide (5.43b) was 
next attempted by treating the former with HN(OMe)Me and AlMe3 in refluxing 
toluene (conditions B).5. ,5.  42 43 Unfortunately, the starting lactam proved to be inert 
towards these conditions. 
                                               
5.41 For selected examples see: (a) Ames, D. E.; Islip, P. J. J. Chem. Soc. 1961, 351. (b) Corey, E. J.; 
Hertler, W. R. J. Am. Chem. Soc. 1960, 82, 1657. (c) Gassman, P. G.; Hodgson, P. K. G.; Balchunis, 
R. J. J. Am. Chem. Soc. 1976, 98, 1275. (d) Evans, D. A.; Britton, T. C.; Ellman, J. A. Tetrahedron 
Lett. 1987, 28, 6141. (e) Knight, D. W.; Lewis, N.; Share, A. C.; Haigh, D. J. Chem. Soc., Perkin 
Trans 1 1998, 3673. 
5.42 For the analogous conversion of esters/lactones to the corresponding Weinreb amide, see: (a) Ref. 
5.39. (b) Levin, J. I.; Turos, E.; Weinreb, S. M. Synth. Commu. 1982, 12, 989. (c) Shimizu, T.; Osako, 
K.; Nakata, T. Tetrahedron Lett. 1997, 38, 2685. (d) Williams, J. M.; Jobson, R. B.; Yasuda, N.; 
Marchesini, G.; Dolling, U.-H.; Grabowski, E. J. J. Tetrahedron Lett. 1995, 36, 5461. 
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Amides/lactams can undergo O-alkylation with Meerwein’s reagents (e.g., 
trimethyloxonium tetrafluoroborate) to afford the corresponding iminoether 
fluoroborates which can be hydrolyzed in aqueous acid or base (conditions C).5. a,b44  In 
1998, Charette and Chua reported a conceptually similar approach involving the use 
of Tf2O and (excess) EtOH to convert tertiary amides into the corresponding alkyl 
imidates, which upon aqueous work up undergo hydrolysis to carboxylic esters.5. c44  
Disappointingly, for the case of lactam (5.36), both set of conditions only produced an 
intractable mixture. 
 
The final attempt to open lactam (5.36) was performed with LiH2NBH3,5. a45  prepared 
in situ from the BH3·NH3, BuLi and LiBHEt3 (conditions D).5. b45  This reagent is 
reported to convert tertiary amides into the corresponding primary alcohol in good 
yields. However, the only identifiable product obtained when lactam (5.36) was 
subjected to these reductive conditions was the corresponding pyrrolidine. 
 
On the basis of these disappointingly results, the lactam-opening approach was 
discontinued. 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.43 For general reviews concerning the use of Weinreb’s amide, see: (a) Singh, J.; Satyamurthi, N.; 
Aidhen, I. S. J. Prakt. Chem. 2000, 342, 340. (b) Sibi, M. P. Org. Prep. Proc. Int. 1993, 25, 15. (c) 
Mentzel, M.; Hoffmann, H. M. R. J. Prakt. Chem. 1997, 339, 517. 
5.44 (a) Meerwein, H.; Hinz, G.; Fuchs, O.; Sassa, H. J.; Schrodt, H.; Spille, J. Chem. Ber. 1956, 89, 
2060. (b) Meerwein, H.; Behling, J.; Grethe, G.; Rogalski, W. J. Am. Chem. Soc. 1967, 89, 4991. (c) 
Charette, A. B.; Chua, P. Synlett 1998, 163. 
5.45 (a) Myers, A. G.; Yang, B. H.; Kopecky, D. J. Tetrahedron Lett. 1996, 37, 3623. (b) Brown, H. C.; 
Kim, S. C. Synthesis 1977, 635. 
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5.1.3 Synthetic Studies Towards Diene (5.3) via the Addition of 
Organometallic Reagents to a Chiral Aldimine 
 
5.1.3.1 Retrosynthetic Considerations 
 
An alternative strategy investigated to prepare diene (5.3) had as the key step the 
addition of an organometallic reagent (5.45) to the azomethine carbon of chiral 
aldimine (5.44) (Scheme 5.15).5.46
 
N
C6H13
PGO(PG1)
O(PG2)
813
5.3
R1O
5.45
N R1
O(PG1)
1
13
5.44
R1O
R2Mor
a
b
 
 
Scheme 5.15 Simplified retrosynthetic analysis for diene (5.3) based on a stereoselective 
organometallic addition to chiral aldimine (5.44). 
 
The use of chiral aldimine (5.44), which has a (potential) metal-chelating β-hydroxy 
functionality, would in principle allow the diastereofacial selectivity of the addition to 
be determined by the judicious choice of the organometallic reagent used. Hence, 
both C13-epimers could in theory be selectively prepared depending on the addition 
reaction proceeding under chelation control or nonchelation control. 
 
In spite of the attractiveness of this strategy, organometallic additions to the C=N 
bonds of imines can be severely limited both by the poor electrophilicty of the 
azomethine carbon and by the tendency of α-enolizable imines such as (5.44) to 
undergo deprotonation rather then addition.5.46 Therefore, model studies were initially 
conducted to establish the feasibility of such an approach. 
 
 
                                               
5.46 For selected reviews concerning the addition of organometallic reagents to C=N bonds see: (a) 
Enders, D.; Reinhold, U. Tetrahedron: Asymmetry 1997, 8, 1895. (b) Volkmann, R. A. in 
“Comprehensive Organic Synthesis” (Trost. B. M.; Fleming, I., ed.) 1991, 1, 355, Pergamon, New 
York. (c) Volkmann, R. A. In “Comprehensive Organic Synthesis” (Trost. B. M.; Fleming I., ed.) 
1991, 2, 975, Pergamon, New York. (d) Bloch, R. Chem. Rev. 1998, 98, 1407. (d) Denmark, S. E.; 
Nicaise, O. J. C. J. Chem. Soc., Chem. Commun. 1996, 999. (e) Kobayashi, S.; Ishitani, H. Chem. Rev. 
1999, 99, 1069. 
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5.1.3.2 Model Studies Pertaining to the Aldimine Approach 
 
Model studies were conducted with aldimines (S)-(5.46a) and (S)-(5.46b). These 
compounds were readily prepared by condensation of enantiomerically pure amine 
(S)-(5.19) with heptaldehyde and aldehyde (5.33), respectively, in the presence of 
anhydrous Na2SO4 (Scheme 5.16). It should be appreciated that each of these imines 
represents different senses of disconnection with respect to accessing diene (5.3). 
Thus, whereas the use of hexyladimine (5.46a) corresponds to disconnection a in 
Scheme 5.15, aldimine (5.46b) embodies the alternative disconnection b. 
 
C6H13CHO or
N
Ph
MeO
R
5.46a: R = C6H13
NH2
Ph
MeO
(S)-5.19
CHO
OO
5.33
CH2Cl2, 0 oC to rt
Na2SO4
5.46b: R =
O O
 
 
Scheme 5.16 Preparation of model aldimines (5.46a) and (5.46b). 
 
The crude imines obtained were used for the subsequent reaction without further 
purification. The imine linkages were assumed to have the (E)-configuration based 
upon their 1H-NMR spectra which showed only a single resonance for the imine 
proton. A mixture of E and Z imines would be expected to exhibit different chemical 
shifts. 
 
With imines (S)-(5.46a) and (S)-(5.46b) in hand, the (diastereoselective) addition of 
several organometallic reagents was investigated. 
 
A class of organometallic reagents that performs particularly well in 1,2-addition to 
the azamethine linkage is allylic organometallics.5.47 The expected homoallylic 
                                               
5.47 For a review on allylic reagents see: (a) Yamamoto, Y.; Asao, N. Chem. Rev. 1993, 93, 2207. For 
selected examples related with the use of allylic organometallics with imines see: (b) Alvaro, G.; 
Boga, C. Savoia, D.; Umani-Ronchi, A. J. Chem. Soc. Perkin Trans. 1 1996, 875. (c) Tanaka, M.; 
Inoue, K.; Pokorski, U.; Taniguchi, M.; Torii, S. Tetrahedron Lett. 1990, 31, 3023. (d) Bocoum, A.; 
Savoia, D.; Ulmani-Ronchi, A. J. Chem. Soc., Chem. Commun. 1993, 1542. (e) Ukaji, Y.; Kume, K.; 
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amines can then be further elaborated owing to the various possible transformations 
of the C=C double bond of the allyl moiety. Therefore, this type of reagents was the 
first to be investigated using hexylaldimine (S)-(5.46a) as substrate (Table 5.1). 
 
Table 5.1 Addition of (selected) allylic organometallics reagents to aldimine (S)-(5.46a). 
 
N
H
Ph
MeO
C6H13
N
Ph
MeO
C6H13
M
conditions
(table 5.1)
(S)-5.46a 5.47  
 
Entry Conditions Conditions Yield (%) dra
1 
MgBr
 
(4 eq.) 
THF 
-78 oC to rt 44 5:1 
2 
MgBr
, CeCl3
CeCl2
" "
 
(2 eq.) 
THF 
-50 oC to rt 
52 9:1 
3 
MgBr
, CuI 
CuMgBr" "
 
(5 eq.) 
THF 
-78 oC to rt 
0 - 
4 
MgBr
, CuI, BF3·Et2O 
Cu BF3" "
 
(5 eq.) 
THF 
-78 oC to rt 
56 2:1 
 
a Based on 1H-NMR. 
 
 
 
                                                                                                                                            
Watai, T.; Fujisawa, T. Chem. Lett. 1991, 173. (f) Basilie, T.; Bocoum, A.; Savoia, D.; Ulmani-
Ronchi, A. J. Org. Chem. 1994, 59, 7766. (g) Bocoum, A.; Boga, C.; Savoia, D.; Umani-Ronchi, A. 
Tetrahedron Lett. 1991, 32, 1367. (h) Yamamoto, Y.; Nishii, S.; Maruyama, K.; Komatsu, T.; Ito, W. 
J. Am. Chem. Soc. 1986, 108, 7780. 
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The reaction of model imine (S)-(5.46a) with allylMgBr afforded amine (5.47) in 
moderate yield (44%) and with good diastereomeric ratio (dr 5:1), as determined by 
1H-NMR (entry 1, Table 5.1). Hoping to increase the yield and the selectivity of the 
addition reaction, less basic allylic reagents were used next. “AllylCeCl2”, prepared in 
situ from anhydrous CeCl3 and allylMgBr, reacted with imine (S)-(5.46a) delivering 
amine (5.47) in somewhat better yield (52%) and with an improved diastereomeric 
ratio (dr 9:1) (entry 2, Table 5.1).5.48 “AllylCu·BF3”, which presumably activates 
imines by N-coordination, was generated in situ from allylMgBr, CuI and 
BF3.Et2O;5.49 its reaction with imine (S)-(5.46a) proceeded smoothly affording the 
expected secondary amine in moderate yield (56%) and in poor diastereomeric ratio 
(dr 2:1) (entry 4, Table 5.1). As expected, activation of the C=N imine bond by 
complexation with BF3 is critical for the reaction to proceed, as demonstrated by the 
fact that “allylCuMg”, prepared in situ from allylMgBr and CuI, failed to give the 
addition product (5.47) (entry 3, Table 5.1). 
 
A more convergent approach involving hexylaldimine (S)-(5.46a) that would avoid 
the need to manipulate the allylic double bond involves the reaction of the former 
imine with the kinetic enolate of allylacetone (5.48) (conditions A, Scheme 5.17). The 
reaction of imine (S)-(5.46a) with the kinetic lithium enolate of allylacetone, obtained 
by treating the latter with LDA at -78oC,5.18 failed to deliver the desired secondary 
amine (5.50a) and instead only the starting imine was recovered. Similar 
disappointing results were obtained with the less basic cerium,5.50 boron and 
5.48 For selected examples of the use of organocerium reagents with imines see: (a) Matsumoto, T.; 
Kobayashi, Y.; Takemoto, Y.; Ito, Y.; Kamijo, T.; Harada, H.; Terashima, S. Tetrahedron Lett. 1990, 
31, 4175. (b) Kobayashi, Y.; Matsumoto, T.; Takemoto, Y. Nakatani, K.; Ito, Y.; Kaimijo, T.; Harada, 
H.; Terashima, S. Chem. Pharm. Bull. 1991, 39, 2550. (c) Reetz, M. T.; Jarger, R.; Drewlies, R.; 
Hübel, M. Angew. Chem. Int. Ed. Engl. 1991, 30, 103. (d) Ukaji, Y.; Watai, T.; Sumi, T.; Fujisawa, T. 
Chem. Lett. 1991, 1555. (e) Higashiyama, K.; Fujikura, H.; Takahashi, H. Chem. Pharm. Bull. 1995, 
43, 722. 
5.49 For selected examples regarding the reaction of imines with organocopper reagents complexed 
with BF3 see: (a) Wada, M.; Sakurai, Y.; Akiba, K. Tetrahedron Lett. 1984, 25, 1079. (b) Cainelli, G.; 
Giacomini, D.; Panunzio, M.; Zarantonello, P. Tetrahedron Lett. 1992, 33, 7783. (c) Yamamoto, Y. 
Angew. Chem. Int. Ed. Engl. 1986, 25, 947. (d) Ishimaru, K.; Tsuru, K.; Yabuta, K.; Wada, M.; 
Yamamoto, Y.; Akiba, K. Tetrahedron: Asymmetry 1994, 5, 2261. 
5.50 For the use of cerium enolates in aldol reactions see: (a) Imamoto, T.; Kusumoto, T.; Yokoyama, 
M. Tetrahedron Lett. 1983, 24, 5233. (b) Fukuzawa, S.; Tsuruta, T.; Fujinami, T.; Sakai, S. J. Chem. 
Soc., Perkin Trans 1 1987, 1473. (c) Imamoto, T.; Kusumoto, T.; Tawarayama, Y.; Sugiura, Y.; Mita, 
T.; Hatanaka, Y.; Yokoyama, M. J. Org. Chem. 1984, 49, 3904. (d) Imamoto, T.; sugiura, Y.; 
Takiyama, N. Tetrahedron Lett. 1984, 25, 4233. 
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aluminium enolates, prepared from the previous lithium species by transmetallation 
with anhydrous CeCl3, B(nBu)2OTf and AlMe2Cl, respectively, in THF at -78 oC. 
 
N
H
Ph
MeO
C6H13
5.50a: R1 =
N
Ph
MeO
C6H13
(S)-5.46a
OM
R1
O
M = Li, CeCl2, B(nBu)2, AlMe2
5.48
THF, -78 oC to rt
Conditions A:
Conditions B:
OM
R1
5.49a: R2 = OEt, M = Zn in Et2O:PhH (1:1), 0 oC to rt
5.49b: R2 = StBu, M = B(nBu)2, Et2O, 0 oC to rt
5.49c: R2 = StBu, M = SnCl, THF, 0 oC to rt 
5.49d: R2 = OMe, M = TMS, TiCl4, CH2Cl2, 0 oC to rt
5.50b: R1 = OEt
5.50c: R1 = StBu
5.50d: R1 = OMe
 
 
Scheme 5.17 (Attempted) reaction of aldimine (S)-(5.46a) with various enolates. 
 
The condensation of imine (S)-(5.46a) with several ester enolates was also explored 
(conditions B, Scheme 5.17).5. ,5.51 52 The reaction of the (preformed) Reformatsky 
reagent (5.49a)5.53 with aldimine (S)-(5.46a) failed to produce the expected ester 
(5.50b) and only led to the recovery of the starting aldimine. The boron (5.49b)5.54 
                                               
5.51 For selected reviews on the reaction of ester enolates with imines, see: (a) Hart, D. J.; Ha, D.-C. 
Chem. Rev. 1989, 89, 1447. (c) Cole, D. C. Tetrahedron 1994, 50, 9517. 
5.52 For selected examples involving the reaction of chiral imines with various ester enolates see: (a) 
Overman, L. E.; Osawa, T. J. Am. Chem. Soc. 1985, 107, 1698. (b) Furukawa, M.; Okawara, T.; 
Noguchi, Y.; Terawaki, Y. Chem. Pharm. Bull. 1978, 26, 260. (c) Yamada, T.; Suzuki, H.; 
Mukaiyama, T. Chem. Lett. 1987, 293. (d) Ojima, I.; Inaba, S. Tetrahedron Lett. 1980, 21, 2077. (e) 
Ojima, I.; Inaba, S. Tetrahedron Lett. 1980, 21, 2081. (f) Badorrey, R.; Cativiela, C.; Díaz-de-
Villegas, M. D.; gálvez, J. A. Tetrahedron Lett. 2003, 44, 9189. (g) Hattori, K.; Yamamoto, H. 
Tetrahedron 1994, 50, 2785. 
5.53 For selected examples regarding the reaction of Reformatsky reagents with imines see: (a) Blicke, 
F. F.; Gould, W. A. J. Org. Chem. 1958, 23, 1102. (b) Dardoize, F.; Moreau, J.-L.; Gaudemar, M. 
Bull. Soc. Chim. Fr. 1972, 3841. (c) Bosch, J.; Domingo, A.; Lopez, F.; Rubiralta, M. J. Heterocycl. 
Chem. 1980, 17, 241. (d) Luche, J.-L.; Kagan, H. B. Bull. Soc. Chim. Fr. 1971, 2260. 
5.54 For selected examples involving the use of boron ester enolates of thioesters in imine-aldol 
reactions, see: (a) Otsuka, M.; Narita, M.; Yoshida, M.; Kobayashi, S.; Ohno, M.; Umezawa, Y.; 
Morishida, H.; Saito, S.; Takita, T.; Umezawa, H. Chem. Pharm. Bull. 1985, 33, 520. (b) Otsuka, M.; 
Yoshida, M.; Kobayashi, S.; Ohno, M.; Umezawa, Y.; Morishima, H. Tetrahedron Lett. 1981, 22, 
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and the tin (5.49c)5.55 ester enolates, generated from the corresponding thioester with 
B(nBu)2OTf and NiPrEt2 in CH2Cl2 and by treating the lithium enolate of 
butylthioacetate with SnCl2 in THF, respectively, afforded the same disappointing 
result. The ketene acetal (5.49d)5.56 in the presence of TiCl4 also failed to react with 
imine (S)-(5.46a). 
 
The complementary entry to diene (5.3), based on the use of aldimine (S)-(5.46b) and 
a hexylorganometallic reagent, was next investigated (Scheme 5.18). Whereas the 
reaction with hexylMgBr,5.57 hexylLi,5.58 hexylZnBr and “hexylCu·BF3”,5.49 prepared 
in situ from the corresponding Grignard reagent, CuI and BF3·Et2O, only lead to 
recovery of the starting imine, the “hexylCeCl2” reagent,5.48 generated in situ from 
hexylMgBr and anhydrous CeCl3, afforded the desired amine (5.51) in good yield 
(60%) and with high diastereomeric ratio (9:1, based on 13C-NMR). 
 
N
Ph
MeO
(S)-5.46b
OO
"C6H13CeCl2"
THF, -50 oC to 0 oC
N
H
Ph
MeO
OO
C6H13
5.51, dr 9:1 (13C NMR)
60%
 
 
Scheme 5.18 Reaction of model imine (S)-(5.46b) with “hexylCeCl2”. 
 
 
 
 
                                                                                                                                            
2109. (c) Shibasaki, M.; Ishida, Y.; Iwasaki, G.; Iimori, T. J. Org. Chem. 1987, 52, 3489. (d) Iimori, 
T.; Ishida, Y.; Shibasaki, M. Tetrahedron Lett. 1986, 27, 2153. 
5.55 For a precedents for the use of tin ester enolates of thioesters with aldimines, see: (a) Yamasaki, 
N.; Murakami, M.; Mukaiyama, T. Chem. Lett. 1986, 1013. (b) Yamada, T.; Suzuki, H.; Mukaiyama, 
T. Chem. Lett. 1987, 213. (c) Mukaiyama, T.; Suzuki, H.; Yamada, T. Chem. Lett. 1986, 915. 
5.56 For selected examples regarding the reaction of ketene acetals with imines see: (a) Colvin, E. W.; 
Mcgarry, D.; Nugent, M. J. Tetrahedron 1988, 44, 4157. (b) Ikeda, K.; Achiwa, K.; Sekiya, M. 
Tetrahedron Lett. 1983, 24, 4707. (c) Colvin, E. W.; Mcgarry, D. G. J. Chem. Soc., Chem. Commun. 
1985, 539. (d) Ojima, I.; Inaba, S.; Nagai, M. Synthesis 1981, 545. (e) Ojima, I.; Inaba, S.; Yoshida, K. 
Tetrahedron Lett. 1977, 3643. 
5.57 For selected examples involving the use of Grignard reagents to imines see: (a) Franz, T.; Hein, 
M.; Veith, U.; Jäger, V.; Peters, E. M.; Peters, K.; Von Schnering, H. G. Angew. Chem. Int. Ed. Engl. 
1994, 33, 1298. (b) Ref. 5.48d. 
5.58 For selected examples involving the use of lithium reagents to imines see: (a) Hashimoto, Y.; 
Takaoki, K.; Sudo, A.; Ogasawara, T.; Saigo, K. Chem. Lett. 1995, 235. (b) Ref. 5.48d. (c) Hashimoto, 
Y. Kobayashi, N.; Kai, A.; Saigo, K. Synlett 1995, 961. 
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The present results, where only the cerium species succeeded in adding to the 
azomethine carbon, can be ascribed to the decreased reactivity of alkly 
organometallics with respect to their allylic counterparts and also to an increase in the 
acidity of the α-protons of the azamethine group in (S)-(4.46b) due to the inductive 
effect of the dioxalane oxygens. Therefore, the more basic lithium, magnesium, zinc, 
and, presumably, the copper reagent are likely to result only in α-deprotonation 
instead of the expected addition. 
 
Although no attempts were made to determine the absolute configuration of the main 
diastereomer in each of the previous reactions, there are enough precedents in the 
literature to allow speculation on the sense of the addition for the various 
organometallic reagents used. Like for carbonyl compounds, the stereoselectivity in 
the addition of organometallics to imines possessing an adjacent asymmetric center 
can be predicted/rationalised in terms of a chelation-controlled mechanism or an 
open-chain model.5.59
 
For the reaction of allyl reagents with imine (S)-(5.46a) under chelation-controlled 
conditions, a compact Zimmerman-Traxler cyclic chair transition state (5.52) may be 
proposed. Thus, allyl-magnesium and cerium reagents are likely to simultaneously 
coordinate the nitrogen and the oxygen atoms of aldimine imine (5.46a). The phenyl 
group is disposed externally and the attack then proceeds to the Si face of the imine 
(Scheme 5.19). Based on these assumptions, the main product of the reaction of imine 
(S)-(5.46a) with allylMgBr and “allylCeCl2” is predicted to have the (S,R) 
configuration. 
 
M
N
C6H13
MeO
Ph
HN
C6H13
MeO
Ph
H
N
H
Ph
MeO
C6H13H
5.52 (S,R)-5.47
H
 
 
Scheme 5.19 Cyclic TS (5.52) for the addition of allylic organometallics to imine (S)-(5.46a) 
under chelation-controlled conditions. 
 
 
                                               
5.59 See for example, Evans, D. A.; Nelson, J. V.; Taber, T. R. Top. Stereochem. 1982, 13, 1. 
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Cram’s cyclic model (5.53),5.60 where one equivalent of the Lewis acidic 
organometallic reagent coordinate simultaneously to the nitrogen and the oxygen 
atoms of the imine forming an intermediate chelate, is more general and it can be 
invoked both in the case of (coordinating) allyl and hexyl organometalics; attack of a 
second equivalent of organometallic reagent then occurs from the less hindered face 
of this chelate (Scheme 5.20). Based on these assumptions, the main product of the 
reaction of imine (S)-(4.46a) with allylMgBr and “allylCeCl2” as well as that of imine 
(S)-(4.46b) with “hexylCeCl2” is (also) predicted to have the (S,R) configuration. 
 
N
O
R1
M
N
R1
H
M
O
Ph
Me
HPh
Me
R2M
M (S)-5.46a: R1 = C6H13
(S,R)-5.47
H
M = MgBr, CeCl2
N
H
Ph
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Scheme 5.20 Chelation-controlled additions of organometallics to aldimines (S)-(5.48). 
 
On the other hand, in the reaction of aldimine (S)-(5.46a) with the “allylcopper·BF3” 
reagent, the simultaneous chelation of the two hetero atoms to the metal is unlikely to 
occur since the nitrogen lone pair is presumably “tied up” by the LA. In such cases, 
the “open-chain” model (5.54) may be invoked.5.60 The reaction can then (also) 
proceed via an internal delivery of the (allyl) reagent to the Re face of the imine 
affording the (S,S)-product (Scheme 5.21). 
 
                                               
5.60 (a) Cram, D. J.; Elhafez, F. A. A. J. Am. Chem. Soc. 1952, 74, 5828. (b) Cram, D. J.; Kopecky, K. 
R. J. Am. Chem. Soc. 1959, 81, 2748. For reviews dealing with 1,2-asymmetric induction models for 
addition to C=X bonds, see: (c) Mengel, A.; Reiser, O. Chem. Rev. 1999, 99, 1191. (d) Gung, B. W. 
Tetrahedron 1996, 52, 5263. (e) Ager, D. J.; East, M. B. Tetrahedron 1992, 48, 2803. (f) Reetz, M. T. 
Angew. Chem. Int. Ed. Engl. 1984, 23, 556. (g) Wipf, P.; Kim, Y. J. Am. Chem. Soc. 1994, 116, 
11678. 
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Scheme 5.21 Non-chellation controlled addition of allylcopper BF3·reagent to (S)-(5.46a). 
 
5.1.3.3 Implementation of the Aldimine Strategy 
 
Encouraged by the results obtained in the model studies involving aldimine (5.46b) 
(vide supra, Section 5.1.3.2), this strategy was then implemented so as to access diene 
(5.3). 
 
One of the synthetic routes developed to prepare the required amine building block is 
shown in Scheme 5.22. Chiral lactone (S)-(5.30), obtained by standard methylation 
(NaH then MeI, 80% yield) of commercially available (S)-hydroxymethyl-γ-
butyrolactone, was opened to the Weinreb amide (5.55) in high yield (90%) using the 
conditions reported by Shimizu and co-workers (AlMe2Cl-MeONHMe·HCl in CH2Cl2 
at room temperature).5. c,5.42 43 A Mitsunobu reaction with PPh3, DIAD and DPPA 
delivered the corresponding azide (not shown) with concomitant inversion of the 
stereochemistry. A one pot azide-reduction/Boc protection afforded the N-Boc amine 
(5.56) in high yield (93%). Reaction of the latter with allylMgBr, immediately 
followed by NaBH4 reduction of keto functionality (to prevent isomerization of the 
double bond into conjugation with the carbonyl functionality) afforded alcohol (5.57) 
in excellent combined yield (93%). Exposure of the latter to a solution of HCl in 
ether, cleaved the carbamate protecting group affording the corresponding 
hydrochloric salt in 88% yield, which was directly treated with TBDMSCl in the 
presence of (excess) NEt3 and a catalytic amount of DMAP producing silyl ether 
(5.58) in 65% yield (based on alcohol (5.57). 
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Scheme 5.22 Preparation of amine (5.58). 
 
Condensation of amine (5.58) with aldehyde (5.33) in the presence of Na2SO4 
afforded aldimine (5.59), which was directly subjected to the reaction with various 
hexylorganometallic reagents (Scheme 5.23). Unfortunately, and in spite of extensive 
efforts, the addition reaction did not proceed, even when the “hexylCeCl2” reagent 
that proved successful in the model studies with imine (S)-(5.46b) was used. 
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Scheme 5.23 (Attempted) reaction of aldimines (5.59) with various hexylorganometallics. 
 
In view of these results the present approach was suspended. 
 
 
5.2 - Studies Towards Macrocycle (2.12) Based on a Ring 
Enlargement Reaction 
 
Whereas the previous RCM strategy relied on ring formation, an alternative approach 
to the synthesis of macrocyles involves ring enlargement processes.5.61 One of the 
most used approaches in this context involves the cleavage of a “bridge” (i.e., a single 
or a double bond) in a bicyclic framework such as (5.60) to afford the corresponding 
ring-expanded system (5.61) (Scheme 5.24). 
 
5.60 5.61
FG1 FG1
FG2
FG3
 
 
Scheme 5.24 Ring enlargement via the cleavage of “bridge” in a bicyclic system. 
                                               
5.61 Hesse, M. in “Ring Enlargement in Organic Synthesis” 1991, VCH, Weinheim. 
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5.2.1 Retrosynthetic Considerations 
 
Based on this type of ring-enlargement arguments, the key macrocycle diketone 
(2.12) was envisioned to derive from bicycle (5.62) by oxidative cleavage of the 
central double bond. 
 
2.12
N
O
C6H13RO
O
PG
N
C6H13
OR
PG
[O]
5.62
FG1
5.63
FG2
" "
 
 
Scheme 5.25 The ring-enlargement approach of bicycle (5.62) to key macrocycle (2.12). 
 
Bicyclic (5.62) is unusual in that it contains two “difficult-size” rings, namely a 7- 
and a 8-membered ring. 8-Membered rings in particular, due to the high degree of 
ring strain and the transannular interactions present are, arguably, the most difficult to 
assemble.5. ,5.62 63 However, it was argued, on the basis of the Thorpe-Ingold effect, 
that the a functionalized cycloheptene (5.63) would be a convenient precursor to 
access the bicyclic (5.62): the (cis)-double bond of the cycloheptene ring (together 
with the eventual side chains) was/were expected to provide a favorable entropic 
contribution for the demanding cyclization process.  
 
In view of the uncertainty in accessing the desired bicyclic system via the 
construction of an 8-membered ring, model studies were initially undertaken. 
 
 
 
 
 
 
 
 
                                               
5.62 Eliel, E. L.; Wilen, S. H. in “Stereochemistry of Organic Compounds” 1994, Wiley, New York. 
5.63 For leading reference concerning synthetic approaches to 8-membered rings see: Petasis, N. A.; 
Patane, M. A. Tetrahedron 1992, 48, 5757. 
Part III  Chapter 5: Results and Discussion 
 
 
 297
5.2.2 Model Studies Pertaining to the Ring-Enlargement Approach 
 
Bicyclic amine (5.64) was chosen as a simpler surrogate of (5.62) to test the 
feasibility of such approach (Figure 5.4). 
 
N
C6H13
OR
PG
5.62
N
PG
5.64
~~
 
 
Figure 5.4 Bicyclic (protected) amine (5.64) as a model for bicyclic (protected) amine (5.62). 
 
We began our studies by preparing a convenient functionalized cycloheptene 
derivative, bromo alcohol (5.67), which would be used as departure point in the 
present approach. For this purpose, cycloheptanone was reacted with the Vilsmeier 
salt Me2N+=CHBr·Br-,5.64 generated in situ by the reaction of PPh3, Br2 and DMF, to 
afford the known bromoaldeyhde (5.65)5.65 in good yield (79%) and in multigram 
amounts. Alternatively, the above Vilsmeier salt was prepared in situ from PBr3 and 
DMF. This approach, although delivering the bromoaldehyde (5.65) in significantly 
lower yield (approximately 49%), has the advantage that, apart from an aqueous work 
up, no purification is required. The bifunctional bromoaldehyde (5.65) was then 
converted to diene (5.66) in 71% yield via a Wittig methelenation reaction with the 
ylide obtained from treating methyltriphenylphosphoniumbromide with BuLi. 
Subsequent regioselective 9-BBN hydroboration followed by basic H2O2 oxidation 
delivered alcohol (5.67), in high yield (83%) (Scheme 5.26). 
 
O
PPh3, Br2
DMF
PhH, rt to reflux
79%
Br
CHO
BuLi, Ph3PCH3Br
Et2O, rt to reflux
then 5.65
5.65
71%
Br
5.66
9-BBN then
NaOH, H2O2
Br
OH
5.67
83%or
 PPh3, PBr3
CHCl3, rt to reflux
42%
 
Scheme 5.26 Preparation of bromoalcohol (5.67). 
                                               
5.64 The Vilsmeier salt Me2N+=CHBr·Br- is commercially available from Fluka, but it is fairly 
expensive and is not particularly shelf-stable, even when refrigerated. 
5.65 Miyaura, N.; Ishiyama, T.; Sasaki, H.; Ishikawa, M.; Satoh, M.; Suzuki, A. J. Am. Chem. Soc. 
1989, 111, 314. 
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The first route considered to access the [7,8]-bicyclic system explored the use of the 
intramolecular Suzuki-Miyaura cross-coupling reaction5.66 of tosylamide (5.69), 
which was prepared in 70% via a Mitsunobu reaction between alcohol (5.67) and the 
N-allylsulfonamide (5.68).5.67 Tosly amide (5.69) was subjected to sequential 
hydroboration/intramolecular B-alkly Suzuki cross coupling reaction. Various (high-
dilution) conditions were tested for the cross-coupling step (Scheme 5.27). 
 
NH2 NHTs
5.68
AcOH, NaOTs
NaOCl aq.
H2O, 0 oC to rt
89%
PPh3, DIAD, 5.67
THF, 0 oC to rt
70%
Br
N
5.69
N
Ts
5.70
 9-BBN
THF, 0 oC to rt 
then
Conditions A: 
CsCO3, PdCl2(dppf), AsPh3, H2O
THF/DMF, 50 oC
or 
Conditions B: 
TlOEt, PdCl2(dppf), AsPh3, H2O
THF/DMF, 50 oC
or
Conditions C: 
NaOMe, Pd(PPh3)4, H2O
THF, 50 oC
Ts
 
Scheme 5.27 (Attempted) preparation of diene (5.70). 
 
In the first set of reaction conditions, the borane was slowly added to a diluted 
solution of CsCO3, PdCl2(dppf) and AsPh3 in THF/DMF/H2O. Under a second set of 
reaction conditions, the borane was treated with TlOEt and the resulting mixture was 
                                               
5.66 (a) Ref. 5.65. For selected reviews on the Suzuki-Miyaura cross-coupling see: (b) Miyaura, N.; 
Suzuki, A. Chem. Rev. 1995, 95, 2457. (c) Chemler, S. R.; Trauner, D.; Danishefsky, S. J. Angew. 
Chem. Int. Ed. 2001, 40, 4544. 
5.67 For selected examples of intramolecular macrocyclization by means of a Suzuki-Miyaura reaction, 
see: (a) Kallan, N.; Halcomb, R. L. Org. Lett. 2000, 2687. (b) Chemler, S. R.; Danishefsky, S. J. Org. 
Lett. 2000, 2, 2695. 
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added dropwise to a dilute solution of Pd(dppf)Cl2 and AsPh3 in THF/DMF/H2O.5.68 
Finally, the cross-coupling reaction was carried out using the classical Suzuki reaction 
conditions, i.e., Pd(PPh3)4 and NaOMe in THF/H2O. Disappointingly, the desired 
bicyclic Ts-amide (5.70) was never formed. 
 
The previous results were rationalized by arguing that the “folding” of the 
hydroborated side chain to reach the oxidatively-added palladium was entropically 
too demanding to take place in a system like (5.69). If so, this limitation could be 
overcome by moving the centers of reactivity away from the cycloheptene ring. 
 
To test this hypothesis, triene (5.71) was prepared (Scheme 5.28). Using 
bromoalcohol (5.67) as the departure point, a Kumada-type cross coupling reaction 
with vinylmagnesiumbromide in the presence of catalytic Pd(PPh3)4 afforded the 
corresponding dieneol (not shown) in (less than) 84 % yield (contaminated with an 
inseparable impurity).5.69 Interestingly, the analogous Stille coupling with 
tributylvinylstananne failed to produce the desired dieneol. Upon subjection to 
standard Mitsunobu reaction conditions (PPh3, DIAD) with Ts-amide (5.66), the latter 
dienealcohol delivered the desired cycloheptene derivative (5.71) in good yield 
(76%), together with a small amount (approximately in 5% yield) of the 
hydrazocompound (5.72). Finally, triene (5.71) was subjected to the RCM reaction 
using the 2nd generation Grubbs catalyst (5.73). Under these conditions, the desired 
1,3-diene (5.74) was produced in 62% yield clearly demonstrating the power of the 
RCM reaction in the preparation of difficult medium-sized ring systems. Thus, the 
feasibility in accessing the [7,8]-bicyclic system via the construction of the 
corresponding 8-membered ring was confirmed. 
 
5.68 For the use of TlOEt, see: Frank, S. A.; Chen, H.; Kunz, R. K.; Schnaderbeck, M. J.; Roush, W. R. 
Org. Lett. 2000, 2, 2691. 
5.69 For similar precedents see: (a) Carreno, M. C.; Urbano, A.; Di Vitta, C. J. Org. Chem. 1998, 63, 
8320. (b) Atsuta, H.; Fujiwara, K.; Murai, A. Synlett 1997, 307. 
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Scheme 5.28 Preparation of diene (5.74). 
 
This encouraging result prompted us to test the preparation of the desired [7,8]-
bicyclic amine (5.64) by means of an intramolecular SN2-type reaction (Scheme 5.29). 
For this purpose, bromoalcohol (5.67) was subjected to a Suzuki-Miyaura cross 
coupling reaction with (hydroborated) N-Boc-allylamine (5.75) yielding alcohol 
(5.76) in 95%. The latter was tosylated under standard conditions (TsCl, NEt3 and 
catalytic DMAP); upon treatment with NaH, the tosylate underwent an intramolecular 
displacement reaction producing the desired [7,8]-bicyclic system (5.77) in an 
impressive 72% yield.  
 
The ozonolysis of [7,8]-bicyclic (5.77), followed by reductive work-up with SMe2 
proceeded uneventfully affording the macrocyclic diketone (5.78) quantitatively. 
With this compound in hand, the proposed TAM reaction was attempted. The latter 
diketone (5.78) was treated with (excess) TFA in the presence of SMe2. To our 
disappointment, at the time of this writing, only the dienol salt (5.79) has been 
isolated (Scheme 5.29). 
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Scheme 5.29 Preparation of macrocyclic diketone (5.78) and its (attempted) TAM reaction. 
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CHAPTER 6 
Concluding Remarks 
 
A novel methodology, based on the hypothesis that the polycyclic framework of 
certain alkaloids can be accessed via a transannular Mannich (TAM) reaction of a 
conveniently functionalized macrocycle precursor, was investigated with respect to 
the total synthesis of the cylindricine alkaloids (2.11) (Scheme 6.1). 
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Scheme 6.1 The proposed TAM reaction for accessing the cylindricines (2.11) and the 
approaches considered for preparing the key precursor, macrocycle (2.12). 
 
The transition state (TS) for the TAM reaction was modeled using molecular 
mechanics (MM). Although the obtained predictions should be approached with care, 
moderate to excellent selectivities in favor of the desired cylindricines were predicted 
for the most trustworthy scenarios (late TS or early TS with “anti-Curtin-Hammett” 
conditions). 
 
On the synthetic front, two general approaches for accessing the key macrocyclic 
precursor (2.12) were considered, namely the RCM of diene (5.3) and the ring-
enlargement reaction of [7,8]-bicycle (5.62) (Scheme 6.1). 
 
In one of the approaches investigated, lactam (5.36), a tentative advanced 
intermediary to diene (5.3), was prepared via the intramolecular aminocyclization of 
amide (5.35), which in turned was convergently obtained from the reaction of amine 
rac-(5.29) and lactone rac-(5.30). Unfortunately, and in spite of extensive 
experimentation, the opening of the lactam moiety in (5.36) did not proceed (Scheme 
6.2). 
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Scheme 6.2 (Attempted) lactam-opening approach to diene (5.3). 
 
Another synthetic route considered to access diene (5.3) explored the (stereoselective) 
addition of an organometallic reagent to the azamethine linkage of a chiral aldimine. 
During the various model studies performed, a particularly promising result was 
obtained when (model) aldimine (S)-(5.46b), prepared from amine (S)-(5.19) and 
aldehyde (5.33), was reacted with “hexylCeCl2”. Under these conditions, the addition 
product, amine (5.51), was delivered in good yield (60%) and with high 
diastereomeric ratio (9:1) (Scheme 6.3). Although no attempts were made to secure 
the stereochemical outcome of the reaction, it is likely, based on literature precedents, 
that the addition proceeded with chellation-control; thus, amine (5.51) has presumably 
been formed with the (S,R) configuration. 
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Scheme 6.3 Model studies pertaining to the aldimine approach. 
 
Disappointingly, when a similar strategy was attempted with aldimine (5.59), 
prepared by condensation of amine (5.58) with aldehyde (5.33), the expected amine 
(5.60) was not produced. 
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Scheme 6.4 (Attempted) aldimine approach to diene (5.3). 
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Regarding the use of the ring-enlargement approach, it was found that the basic [7,8]-
bicycle framework of (protected) amine (5.62), the planned precursor of key 
macrocycle (2.12), could be assembled through the formation of the corresponding 8-
membered ring. Accordingly, the RCM reaction of triene (5.71),which was readily 
prepared from the key building block bromoalcohol (5.67), delivered diene (5.74) in 
62% yield. Alternatively, and of greater interest, bicycle (5.77) was prepared by 
means of an intramolecular displacement reaction of the mesylated form of alcohol 
(5.76) (Scheme 6.5). 
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Scheme 6.5 Model studies pertaining to the ring-enlargement approach. 
 
The TAM reaction in model macrocycle diketone (5.78), obtained from (5.77) via 
oxidative cleavage of the central double bond, was (very) briefly tested. At the time of 
this writing, only the salt (5.79) has been isolated (Scheme 6.6). (Hypothetical) 
conditions that promote the desired TAM reaction are yet to be found and further 
studies are currently in progress. 
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Scheme 6.6 (Attempted) TAM reaction of macrocycle diketone (5.78). 
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Finally, it should be added that good progresses towards the preparation of the [7,8]-
bicyclic amine (5.62) have already been accomplished. Thus, chiral cycloheptene 
derivatives (6.3) and (6.2), putative advanced intermediates in a highly convergent 
planned synthesis of (5.62), were obtained in high yields by means of a sequence that 
had as the key step the Suzuki-Miyaura cross coupling between cycloheptene alcohol 
(6.1) and known chiral oxazolidine (6.2) (Scheme 6.7).6. ,6. ,6.1 2 3  
 
Regarding the (intramolecular) formation of the N1-C13 bond leading to the 8-
memberd ring, the exact method to be used remains an open question at the time of 
this writing. Importantly, however, the high modular nature of the present approach 
allows the substrates for several different conceivable methods for this difficult 
transformation (e.g., intramolecular reductive amination, Michael addition, 
Mitsunobu reaction, etc) to be prepared from the same building blocks. 
 
6.1 The known chiral oxazolidine (6.2) was readily prepared from L-serine, in a sequence that has as 
the key intermediate the well known Garner aldehyde (6.b) (Scheme 6.A).6.2,6.3
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Scheme 6.A Preparation of chiral oxazolidine (6.2). 
 
6.2 Campbell, A. D.; Raynham, T. M.; Taylor, R. J. K. Synthesis 1998, 1707. 
6.3 (a) Garner, P.; Park, J. M. J. Org. Chem. 1987, 52, 2361. (b) For a recent review on the Garner 
aldehyde, see: (b) Liang, X.; Andersch, J.; Bols, M. J. Chem. Soc., Perkin Trans 1 2001, 2136. 
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Scheme 6.7 Preparation of cycloheptene alcohol (6.3) and ketone (6.4), putative advanced 
intermediates in a planned synthesis of [7,8]-bicyclic amine (5.62). 
 
In conclusion, several strategies were investigated to prepare macrocycle diketone 
(2.12), the key intermediate that would allow testing if the framework of the 
cylindricine alkaloids could be accessed by means of a TAM reaction. Although the 
synthesis of (2.12) is yet to be achieved, good progresses have been made. The ring-
enlargement approach, in particular, delivered very promising results in that 
macrocycle diketone (5.78), which contains the basic framework of (5.12) has been 
prepared. The TAM of (5.78) reaction is currently being studied. Furthermore, chiral 
cycloheptene derivatives (6.3) and (6.4), tentative intermediates in a planned 
synthesis of key macrocyclic diketone (2.12), have been prepared.  
 
Finally, it is noted that while this work was in progress, Evans and Scheerer reported 
on the attempted total synthesis of clavolonine (6.6) from the macrocyclic amine (6.5) 
using the same TAM reaction concept.6.4 Although several conditions were 
investigated, the desired alkaloid (6.6) was never formed; instead a range of different 
                                               
6.  4 Evans, D. A.; Scheerer, J. R. Angew. Chem. Int. Ed. 2005, 44, 6038. 
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products, compounds (6.7) to (6.9), resulting from various others transannular 
processes, were isolated (Scheme 6.8). 
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Scheme 6.8 Transannular reactions of macrocyclic amine (6.5). 
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CHAPTER 7 
Experimental 
 
7.1 - General 
 
All moisture- and air- sensitive reactions were carried out under an argon atmosphere 
using oven-dried or flame-dried glassware. Et2O, THF and toluene were distilled 
under nitrogen from sodium-benzophenone. CH2Cl2, NEt3, pyridine and iPr2NH were 
distilled under nitrogen from CaH2. Anhydrous DMSO and DMF were purchased 
from Aldrich and stored over 4Å MS under argon. 1H-NMR (200 MHz, 300 MHz) 
and 13C-NMR (75 MHz) spectra were recorded on either a Bruker AC-200 (200 MHz) 
or a Varian Mercury 300 (300 MHz) spectrometers at ambient temperature. Chemical 
shifts (δ) are reported in ppm. Undeuterated solvents residues were used as internal 
standard (for CHCl3, 1H: 7.27 ppm and 13C: 77.0 ppm). Coupling constants (J) are 
given in Hertz (Hz).1 Multiplicities of peaks are reported in the following way: s 
(singlet), d (doublet), t (triplet), q (quartet), m (multiplet), br (broad), ´t´ (pseudo-
triplet), ´q´(pseudo-quartet) and combinations of these. (Note: for 1H (200 MHz) no 
coupling constants are reported). Optical rotations were measured with a Perkin 
Elmer 241 Polarimeter at ambient temperature and the concentration (c) is given in g 
per 100 mL. Electron impact (EI) low resolution mass spectra (LRMS) were 
performed with a VG Trio-2 single quadropole instrument at the Department of 
Chemistry, Technical University of Denmark. Melting points of crystalline materials 
were determined on a Heidolph capillary melting point apparatus and are uncorrected. 
Analytical thin layer chromatography (TLC) analyses were performed using 0.25 mm 
Merk Kiselgel aluminum-backed 60 F254 silica gel plates. Visualization was achieved 
by using (some of) the following sequential steps: i) exposure to UV light, ii) brief 
exposure to iodine vapors, iii) deeping on a solution of either 5-10% of 
phosphormolybdic acid in EtOH, basic KnMnO4 or ninydridin and iv) gentle heating. 
Merk silica gel 60 (40-63 µm, 230-400 mesh) was used for flash chromatography 
purification. Known compounds were characterized by 1H- and/or 13C-NMR. New 
compounds are typically characterized by 1H- and 13C-NMR. Molecular sieves were 
dried at 150-160 oC for at least 12 h and then allowed to reach room temperature 
under argon. Unless otherwise stated, commercially available reagents, purchased 
from Aldrich, Fluka, Merk or TCI were used without further purification. “Aqueous 
½ saturated brine” and “aqueous 1/3 saturated NaHCO3” refer to a water:brine, 1:1 
7.1 For 1H-NMR (200 MHz) spectra no coupling constants are reported. 
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(v:v) and water:saturated NaHCO3, 2:1 (v:v) solutions, respectively. The following 
cooling baths were used: dry ice slurried in acetone (approximately -78 oC). 
Commercial NaH (as a 55-60% dispersion in oil) was washed with pentane (2 
portions that cover the amount of NaH dispersion used) and the last traces of pentane 
are removed under high vacuum. 
 
 
7.2 – General Experimental Procedures 
 
Procedure for the preparation of demetallated silica gel: 
Silica gel (1 Kg) was slurried in aqueous 10% HCl (2 L). The resulting yellow 
aqueous phase was decanted off and the remaining silica gel was washed with 1 L 
batches of distilled water until the washings reached pH 4 (typically 15-20 washes are 
required). The obtained silica gel was then treated with a solution of aqueous 25% 
ammonia (1 mL) in water (1 L). The aqueous phase was decanted off and the 
remaining silica gel was oven-dried at 160 oC for 2 days with occasional manual 
stirring. 
 
Tetrakis(triphenylphosphine)palladium Pd(PPh3)4
 
Following a literature procedure,7.2 a vigorously stirred yellow suspension of PdCl2 
(500 mg, 2.8 mmol, 1.0 eq.), PPh3 (3.70 g, 14.1 mmol, 5.0 eq.) in dry DMSO 
(previously degassed by bubbling argon for approximately ½ h) was inserted in an oil 
bath previously heated to 150 oC. After 10-15 min. at this temperature, an orange 
solution is obtained. The oil bath was then removed and N2H4·H2O (565 mg, 11.3 
mmol, 4 eq.) was immediately added dropwise with vigorous gas evolution observed. 
After addition, the mixture was allowed to slowly reach room temperature. An initial 
transient black color faded away into a golden and then into a bright yellow 
coloration. After 5-10 min., some crystals started forming. The stirring was stopped, 
the reaction flask was covered with silver foil and this mixture was left to rest at room 
temperature under argon overnight. The obtained mixture was filtered and the 
resulting crystals were rinsed with cold EtOH (2 portions of 35 mL) and cold Et2O (3 
portions of 15 mL). The title compound was obtained as bright yellow crystals (3.0 g, 
92%) which were best kept refrigerated, under argon and protected from light. Mp 
116-118 oC (lit. 116 oC). 
7.2 Komiya, S. In ”Synthesis of Organometallic Compounds: A Practical Guide” 1997, Wiley, New 
York. 
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Preparation of anhydrous CeCl3: 
Stirred powdered CeCl3·7H2O was slowly heated to 140 oC over 3½ h under vacuum 
(0.5 mm), kept at these conditions overnight and allowed to reach room temperature 
under an argon atmosphere. 
 
 
7.3 – Preparation of Compounds 
 
(E)-Ethyl non-2-enoate C6H13 CO2Et
 
Following a literature procedure,7.3 a biphasic system of K2CO3 (8.3 g, 60 mmol, 2.0 
eq.), H2O (6 mL), triethylphosphonoacetate (8.1 g, 36 mmol, 1.2 eq.) and 
heptaldehyde (3.4 g, 30 mmol, 1.0 eq.) was stirred vigorously for 20 h at room 
temperature under an argon atmosphere. H2O (15 mL) was then added and the 
mixture was carefully decanted. The solid residue was washed with hexane (3 
portions of 10 mL). After separation of the layers, the aqueous layer was extracted 
with hexane (3 portions of 10 mL). The combined organic layers were dried (MgSO4), 
the solvent evaporated affording a colorless oil. Purification by reduced-pressure 
distillation (56-59 oC, 0.4 mm) afforded the title compound as a colorless oil (5.3 g, 
95%). 
 
Rf (hexane: EtOAc, 4:1 (v:v)) 0.53; 13C-NMR (CDCl3, 75 MHz) δ 167.0, 149.6, 
121.5, 60.3, 32.4, 31.8, 29.0, 28.2, 22.8, 14.5, 14.3. 
(E)-2-Nonen-1-ol (5.8) C6H13 OH
 
To a -78 oC cold solution of the (E)-ethyl non-2-enoate (2.5 g, 13.6 mmol, 1.0 eq.) in 
CH2Cl2 (50 mL) was dropwise added a solution of Dibal in toluene (30 mL, 35.3 
mmol, 2.6 eq.). The obtained solution was stirred at this temperature for 2½h, after 
which MeOH (15 mL) was carefully added. After vigorous stirring for 5-10 min. at 
room temperature, a gel-like biphasic system formed. A saturated aqueous solution of 
Rochelle’s salt (50 mL) was then added and the resulting mixture was stirred at room 
temperature until a clear biphasic system was obtained (approximately 2 h). The 
layers were separated and the aqueous layer was further extracted with CH2Cl2 (2 
portions of 15 mL). The combined organic layers were washed with brine and dried 
(MgSO4). Evaporation of the solvent under vacuum followed by purification by 
7.3 Villieras, J.; Rambaud, M. Synthesis 1983, 300. 
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distillation at reduced pressure (Vigreaux) (45-47 oC, 0.3 mm; lit.6.4 102-104 oC, 12 
mm.) delivered the known (E)-allylic alcohol (5.8) (1.5 g, 79%). 
 
Rf (hexane: EtOAc, 4:1 (v:v)) 0.25; 1H-NMR (CDCl3, 200 MHz) δ 5.61 (m, 2H), 4.05 
(d, 2H), 1.95 (q, 3H), 1.15-1.40 (m, 8H), 0.85 (t, 3H). 
 
(E)-2,3-epoxy-1-nonanol 
C6H13 OH
O
 
Following a literature procedure,7.5 (E)-2-nonen-1-ol (5.8) (1.4 g, 
10 mmol, 1.0 eq.) and MCPBA (83%, 2.69 g, 13 mmol, 1.3 eq.) were stirred in 
CH2Cl2 (41 mL) for ca. 3 h at room temperature, after which the reaction mixture was 
washed thoroughly with saturated Na2CO3 aqueous solution (3 portions of 30 mL) and 
brine (3 portions of 30 mL). The organic layer was dried (Na2SO4), and the solvent 
removed under vacuum to afford the title compound as a white solid which appeared 
as white needles after recrystallisation from (hot) hexane(1.5 g, 95%). 
 
Rf (hexane: EtOAc, 4:1 (v:v)) 0.1; 13C-NMR (CDCl3, 75 MHz) δ 62.0, 58.7, 56.3, 
31.9, 31.8, 29.3, 26.1, 22.8, 14.3. 
Nonane-1,3-diol (5.9) 
 
Following a literature procedure,7.5 (E)-2,3-epoxy-1-nonanol (8.4 g, 
53.5 mmol, 1.0 eq.) was dissolved in THF (85 mL) and the obtained solution cooled 
to -30 oC (dry ice/CCl4 bath). A solution of Red-Al (3.5 M in toluene, 46 mL, 3 eq.) 
was dropwise added and the reaction mixture obtained was stored at -10 oC for 2 days 
under an argon .atmosphere. The reaction was allowed to reach ice bath temperature, 
carefully quenched with H2O (150 mL) and extracted well with ether (5 portions of 
200 mL). The combined organic layers were washed with brine (250 mL), dried 
(Na2SO4) and the solvent removed under vacuum. Vigreaux distillation at reduced 
pressure (92-94 oC, 0.8 mm (lit.7.5 104-105 oC, 1 mm)) afforded the title compound as 
a colorless oil (6.6 g, 77%). 
C6H13
OHHO
 
Rf (hexane: EtOAc, 1:1 (v:v)) 0.2; 13C-NMR (CDCl3, 75 MHz) δ 72.5, 62.0, 38.5, 
38.1, 32.0, 29.5, 25.7, 22.8, 14.3. 
7.4 Kitiching, W.; Lewis, J. A.; Perkins, M. V.; Drew, R.; Moore, C. J.; Schurig, V.; König, W. A.; 
Francke, W. J. Org. Chem. Soc. 1989, 54, 3893. 
7.5 Kitching, W.; Lewis, J. A.; Perkins, M. V.; Drew, R.; Moore, C. J.; Schurig, V.; König, W. A.; 
Francke, W. J. Org. Chem. 1989, 54, 3893. 
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4-Hexyl-2-phenyl-1,3-dioxane (5.11) 
 
A mixture of nonane-1,3-diol (5.9) (500 mg, 3.1 mmol, 1.0 eq.), 
benzaldehyde (497 mg, 4.7 mmol, 1.5 eq.) and approximately 5 drops 
of concentrated H2SO4 in dry DMSO (13 mL) was stirred at room 
temperature under argon for 3 days, after which 4 Å MS (approximately 0.5 g) were 
added and stirring continued for further 2 days. The mixture was then carefully 
decanted and the MS were washed with DMSO (2 portions of 4 mL). H2O (200 mL) 
was added to the combined organic layers and this mixture extracted with Et2O (3 
portions of 100 mL). The combined organic layers were washed with brine (100 mL), 
dried (MgSO4) and the solvent removed under reduced pressure to afford a yellow oil. 
Purification by flash chromatography (hexane:EtOAc, 4:1 (v:v)) afforded the title 
compound as faint yellow oil (0.58 g, 75%). 
C6H13
O
O
Ph
 
Rf (hexane: EtOAc, 1:1 (v:v)) 0.73; 1H-NMR (d-DMSO, 200 MHz) δ 7.30-7.42 (m, 
5H), 5.42 (s, 1H), 4.10 (dd, 1H), 3.85 (dd, 1H), 3.75-3.82 (m, 1H), 1.20-1.60 (m, 
12H), 0.83 (t, 3H); 13C-NMR (d-DMSO, 75 MHz) δ 139.8, 129.1, 128.6, 126.7, 101.0, 
77.0, 67.0, 36.2, 31.9, 31.7, 29.4, 25.1, 22.8, 14.6. 
3-(Benzyloxy)nonan-1-ol (5.11) 
 
To a solution of 4-hexyl-2-phenyl-1,3-dioxane (5.10) (565 mg, 2.3 
mmol, 1.0 eq.) in CH2Cl2 (23 mL) at -60 oC was dropwise added over 15 min. a 
solution of Dibal in CH2Cl2 (1 M, 6.8 mL, 3 eq.). The obtained solution was allowed 
to reach room temperature slowly over 3 h, after which time it was cooled to ice bath 
temperature and carefully quenched with aqueous 1 M HCl (8 mL). The resulting 
mixture was stirred at room temperature until a biphasic system could distinctively be 
seen (approximately ½ h), and then partitioned between H2O (100 mL) and EtOAc 
(100 mL). The aqueous layer was further extracted with EtOAc (100 mL) and the 
combined organic layers were washed with saturated NaHCO3 aqueous solution (80 
mL), brine (80 mL) and dried (Na2SO4).Removal of the solvent under vacuum 
afforded alcohol (5.12) (564 mg, 98%) as colorless oil which typically was used 
directly in subsequent reactions. 
C6H13
BnO OH
 
Rf (hexane: EtOAc, 1:1 (v:v)) 0.52; 1H-NMR (d-DMSO, 200 MHz) δ 7.25-7.33 (m, 
5H), 4.42 (s, 2H), 4.35 (t, 1H), 3.5 (´q´, 3H), 1.52-1.71 (m, 2H), 1.40-1.50(m, 2H), 
1.19-1.35 (m, 8H), 0.81 (t, 3H); 13C-NMR (d-DMSO, 75 MHz) δ 139.9, 128.8, 128.1, 
127.8, 76.4, 70.6, 58.3, 39.4, 37.8, 34.2, 32.0, 29.6, 25.3, 22.8. 
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3-(Benzyloxy)nonanal 
 
To a 0 oC cold suspension of DMP (1.1 g, 2.6 mmol, 1.2 eq.) in 
CH2Cl2 (10.5 mL) was dropwise added a solution of 3-
(benzyloxy)nonan-1-ol (5.11) (522 mg, 2.1 mmol, 1.0 eq.) in CH2Cl2 (9 mL). The 
resulting mixture was stirred at ice bath temperature for ½ h, allowed to reach room 
temperature and stirred for 1 h further. The reaction was then quenched by addition of 
10% Na2S2O3 aqueous solution (15 mL) and NaHCO3 aqueous solution (44 mL) and 
stirred until an homogenous biphasic system was obtained (approximately 20 min.). 
After separation of the layers, the aqueous layer was extracted with EtOAc (2 portions 
of 30 mL); the combined organic layers were washed with brine (60 mL), dried 
(Na2SO4) and the solvent removed under vacuum to afford the title compound as a 
pale yellow oil (505 mg, 97%), which was used without further purification. 
C6H13
BnO O
 
Rf (hexane: EtOAc, 1:1 (v:v)) 0.70; 1H-NMR (d-DMSO, 200 MHz) δ 9.68 (s, 1H), 
7.21-7.38 (m, 5H), 4.50 (s, 2H), 3.92 (quint, 1H), 2.97 (d, 2H), 1.39-1.62 (m, 2H), 
1.13-1.36 (m, 8), 0.83 (t, 3H); 13C-NMR (d-DMSO, 75 MHz) δ 203.2, 139.4, 128.8, 
128.2, 128.0, 74.4, 70.6, 48.4, 34.3, 31.9, 29.4, 25.2, 22.7, 14.6. 
 
7-(Benzyloxy)tridec-1-en-5-ol (5.13) 
 
i) Preparation of the Grignard reagent (5.12): A solution of 
4-bromobutene (511 mg, 3.8 mmol, 2.5 eq.) in Et2O (2.7 mL) was dropwise added at 
room temperature under an argon atmosphere to a stirred mixture of Mg turnings (198 
mg, 8.2 mmol, 5.0 eq.; activated by the addition of a crystal of I2) in Et2O (5 mL). 
Dropwise addition was regulated to maintain a gentle reflux. After the alkyl bromide 
addition was completed, the mixture was stirred an additional ½ h at room 
temperature. 
C6H13
OBn OH
 
ii) Preparation of 7-(benzyloxy)tridec-1-en-5-ol (5.13):To a chilled (0 oC) mixture of 
3-(benzyloxy)nonanal (0.37 g, 1.5 mmol, 1.0 eq.) in Et2O (7 mL) was dropwise added 
the above (decanted) Grignard solution. After addition, the mixture was stirred at 
room temperature for 1½ h, refluxed for 15 min., re-cooled to ice bath temperature 
and quenched by the careful addition of saturated NH4Cl aqueous solution (7 mL). 
The reaction mixture was partitioned between EtOAc (100 mL) and H2O (100 mL) 
and the aqueous layer was extracted with EtOAc (2 portions of 25 mL). The 
combined organic layers were washed with ½ saturated NaHCO3 aqueous solution 
(80 mL), brine (80 mL), dried (MgSO4) and the solvent was removed under reduced 
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(29 mg, 0.13 m
pressure. Purification by flash chromatography (hexane:EtOAc, 2:1 (v:v)) delivered 
the title compound as a pale yellow oil (361 mg, 79%). 
 
Rf (hexane: EtOAc, 2:1 (v:v)) 0.56; 1H-NMR (d-DMSO, 200 MHz) δ 7.20-7.38 (m, 
5H), 5.78 (m, 1H), 4.94 (´d´, 1H), 4.85 (´d´, 1H), 4.43 (d, 1H), 4.40 (s, 1H), 4.25 (dd, 
1H), 3.56-63 (m, 1H), 3.46-3.55 (m, 1H), 1.90-2.18 (m, 2H), 1.15-1.56 (m, 14H), 0.83 
(t, 3H); 13C-NMR (d-DMSO, 75 MHz) (selection) δ 141.3, 140.0, 128.8, 128.2, 128.0, 
115.1, 76.7, 69.1, 43.0, 37.8, 34.2, 32.0, 29.6, 25.3, 29.5, 22.8, 14.6. 
 
7-(Benzyloxy)tridec-1-en-5-one (5.15) 
C6H13
OBn O
 
To a 0 oC cold suspension of DMP (310 mg, 0.73 mmol, 1.4 
eq.) in CH2Cl2 (2.9 mL) was dropwise added a solution of 7-(benzyloxy)tridec-1-en-
5-ol (5.14) (161 mg, 0.53 mmol, 1.0 eq.) in CH2Cl2 (2.5 mL). The resulting mixture 
was stirred at ice bath temperature for ½ h, allowed to reach room temperature and 
stirred for 1 h further. The reaction was then quenched by addition of 10% Na2S2O3 
aqueous solution (5 mL) and NaHCO3 aqueous solution (15 mL) and stirred until an 
homogenous biphasic system was obtained (approximately 20 min.). After separation 
of the layers, the aqueous layer was extracted with EtOAc (2 portions of 15 mL); the 
combined organic layers were washed with brine (40 mL), dried (Na2SO4) and the 
solvent removed under vacuum to afford the title compound as a pale yellow oil (160 
mg, quantitative), which was used without further purification. 
 
Rf (hexane: EtOAc, 2:1 (v:v)) 0.71; 1H-NMR (d-DMSO, 200 MHz) δ 7.20-7.37 (m, 
5H), 5.75 (m, 1H), 4.96 (´d´, 1H), 4.80 (´d´, 1H), 4.40 (s, 2H), 3.80 (quint., 1H), 2.65 
(dd, 1H), 2.45-2.60 (m, 3H), 2.18 (q, 2H), 1.15-1.56 (m, 10H), 0.83 (t, 3H); 13C-NMR 
(d-DMSO, 75 MHz) δ 209.3, 138.4, 128.8, 128.5, 127.9, 126.2, 114.3, 75.4, 72.4, 
47.5, 43.6, 34.8, 32.5, 31.0, 30.4, 22,4, 22.3, 14.4. 
 
4-Hexyl-2-(4-methoxybenzyl)-1,3-dioxane (5.18) 
 
A solution of nonane-1,3-diol (5.9) (500 mg, 3.1 mmol, 1.0 eq.), 
anisaldehyde dimethyl acetal (710 mg, 3.9 mmol, 1.25 eq.) and CSA 
mol, 4 mol% with respect to the diol) in DMF (20 mL) is stirred at 60 
oC under house vacuum. After reaching room temperature, the resulting solution was 
partitioned between H2O (250 mL) and Et2O (120 mL). The aqueous layer was 
extracted with Et2O (2 portions of 50 mL). The combined organic layers were washed 
with brine (100 mL), dried (Na2SO4) and the solvent removed under vacuum. 
C6H13
O
O
PMB
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Purification by flash chromatography (hexane:EtOAc, 2:1 (v:v)) delivered the title 
compound as a colorless oil (850 mg, 97%). 
 
Rf (hexane: EtOAc, 2:1 (v:v)) 0.55; 1H-NMR (d-DMSO, 200 MHz) δ 7.33 (d, 2H), 
6.84 (d, 2H), 5.40 (s, 1H), 4.13 (dd, 1H), 3.63-3.9 (m, 5H), 1.21-1.58 (m, 12H), 0.82 
(t, 3H); 13C-NMR (d-DMSO, 75 MHz) δ 159.9, 132.3, 127.9, 113.9, 100.9, 77.0, 66.9, 
55.8, 36.3, 32.0, 31.6, 29.4, 25.1, 22.8, 14.6. 
3-(4-Methoxybenzyloxy)nonan-1-ol 
 
To a solution of 4-hexyl-2-(4-methoxybenzyl)-1,3-dioxane (5.18) 
(480 mg, 1.7 mmol, 1.0 eq.) in CH2Cl2 (17 mL) at -60 oC was dropwise added over 15 
min. a solution of Dibal in CH2Cl2 (1 M, 4.3 mL, 2.5 eq.). The obtained solution was 
allowed to reach room temperature slowly over 3½ h, after which time it was cooled 
to ice bath temperature and carefully quenched with aqueous 1 M HCl (6 mL). The 
resulting mixture was stirred at room temperature until a biphasic system could 
distinctively be seen (approximately ½ h), and then partitioned between H2O (100 
mL) and EtOAc (100 mL). The aqueous layer was further extracted with EtOAc (100 
mL) and the combined organic layers were washed with saturated NaHCO3 aqueous 
solution (80 mL), brine (80 mL) and dried (Na2SO4).Removal of the solvent under 
vacuum afforded alcohol (5.12) (486 mg, quantitative) as a colorless oil which 
typically was used directly in the reaction. 
C6H13
PMBO OH
 
Rf (hexane: EtOAc, 1:1 (v:v)) 0.39; 1H-NMR (d-DMSO, 200 MHz) δ 7.21 (d, 2H), 
6.83 (d, 2H), 4.38 (s, 2H), 4.30 (t, 1H), 3.67 (s, 3H), 3.45 (q, 3H), 1.50-1.63 (m, 2H), 
1.36-1.48 (m, 2H), 1.21-1.32 (m, 8H), 0.80 (t, 3H); 13C-NMR (d-DMSO, 75 MHz) 
(selection) δ 159.2, 131.9, 129.7, 114.2, 76.0, 70.3, 58.3, 55.7, 37.8, 34.3, 32.0, 29.6, 
25.3, 22.8, 14.6. 
 
3-(4-Methoxybenzyloxy)nonanal 
 
To a 0 oC cold suspension of DMP (929 mg, 2.2 mmol, 1.3 eq.) in 
CH2Cl2 (9 mL) was dropwise added a solution of 3-(4-methoxybenzyloxy)nonan-1-ol 
(486 mg, 1.7 mmol, 1.0 eq.) in CH2Cl2 (7 mL). The resulting mixture was stirred at 
ice bath temperature for ½ h, allowed to reach room temperature and stirred for 1 h 
further. The reaction was then quenched by addition of 10% Na2S2O3 aqueous 
solution (15 mL) and NaHCO3 aqueous solution (44 mL) and stirred until an 
homogenous biphasic system was obtained (approximately 20 min.). After separation 
C6H13
PMBO O
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of the layers, the aqueous layer was extracted with EtOAc (2 portions of 30 mL); the 
combined organic layers were washed with brine (60 mL), dried (Na2SO4) and the 
solvent removed under vacuum to afford the title compound as a pale yellow oil (450 
mg, 95%), which was used without further purification. 
 
Rf (hexane: EtOAc, 1:1 (v:v)) 0.61; 1H-NMR (d-DMSO, 200 MHz) δ 9.63 (s, 1H), 
7.20 (d, 2H), 6.83 (d, 2H), 4.40 (s, 2H), 3.85 (quint., 1H), 3.73 (s, 3H), 2.51-2.54 (m, 
2H), 1.41-1.60 (m, 2H), 1.20-1.35 (m, 8H), 0.82 (t, 3H); 13C-NMR (d-DMSO, 75 
MHz) δ 203.2, 159.3, 131.3, 129.9, 114.3, 74.0, 70.3, 55.7, 48.4, 34.3, 31.9, 29.4, 
25.2, 22.7, 14.6. 
 
7-(4-Methoxybenzyloxy)tridec-1-en-5-ol 
 
i) Preparation of the Grignard reagent (5.12): A solution of 
4-bromobutene (530 mg, 3.9 mmol, 2.5 eq.) in Et2O (2.7 mL) was dropwise added at 
room temperature under an argon atmosphere to a stirred mixture of Mg turnings (191 
mg, 7.9 mmol, 4.9 eq.; activated by the addition of a crystal of I2) in Et2O (5 mL). 
Dropwise addition was regulated to maintain a gentle reflux. After the alkyl bromide 
addition was completed, the mixture was stirred an additional ½ h at room 
temperature. 
C6H13
PMBO OH
 
ii) Preparation of 7-(4-methoxybenzyloxy)tridec-1-en-5-ol: To a chilled (0 oC) 
mixture of 3-(4-methoxybenzyloxy)nonanal (440 g, 1.6 mmol, 1.0 eq.) in Et2O (7 mL) 
was dropwise added the above (decanted) Grignard solution. After addition, the 
mixture was stirred at room temperature for 1½ h, refluxed for 15 min., re-cooled to 
ice bath temperature and quenched by the careful addition of saturated NH4Cl 
aqueous solution (7 mL). The reaction mixture was partitioned between EtOAc (100 
mL) and H2O (100 mL) and the aqueous layer was extracted with EtOAc (2 portions 
of 25 mL). The combined organic layers were washed with ½ saturated NaHCO3 
aqueous solution (80 mL), brine (80 mL), dried (MgSO4) and the solvent was 
removed under reduced pressure. Purification by flash chromatography 
(hexane:EtOAc, 2:1 (v:v)) delivered the title compound as a pale yellow oil (508 mg, 
95%). 
 
Rf (hexane: EtOAc, 2:1 (v:v)) 0.39; 1H-NMR (d-DMSO, 200 MHz) δ 7.27 (d, 2H), 
6.94 (d, 2H), 5.85 (m, 1H), 4.92-5.05 (m, 2H), 4.38-4.47 (m, 3H), 3.80 (s, 3H), 3.59-
3.77 (m, 1H), 3.51-3.59 (m, 1H), 2.00-2.31 (m, 2H), 1.23-1.62 (m, 14H), 0.92 (t, 3H); 
13C-NMR (DMSO, 75 MHz) (selection) δ 160.3, 140.3, 131.6, 128.7, 116.7, 116.0, 
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77.5, 73.1, 65.5, 43.1, 36.5, 32.3, 31.8, 28.7, 24.1, 22.7, 14.5. 
7-(4-Methoxybenzyloxy)tridec-1-en-5-one (5.18) 
C6H13
PMBO O
 
To a 0 oC cold suspension of DMP (870 mg, 2.1 mmol, 1.4 
eq.) in CH2Cl2 (9 mL) was dropwise added a solution of 7-(4-
methoxybenzyloxy)tridec-1-en-5-ol (508 mg, 1.5 mmol, 1.0 eq.) in CH2Cl2 (6 mL). 
The resulting mixture was stirred at ice bath temperature for ½ h, allowed to reach 
room temperature and stirred for 1 h further. The reaction was then quenched by 
addition of 10% Na2S2O3 aqueous solution (16 mL) and NaHCO3 aqueous solution 
(45 mL) and stirred until an homogenous biphasic system was obtained 
(approximately 20 min.). After separation of the layers, the aqueous layer was 
extracted with EtOAc (2 portions of 40 mL); the combined organic layers were 
washed with brine (80 mL), dried (Na2SO4) and the solvent removed under vacuum to 
afford the title compound as a tanned yellow oil (487 mg, 96%), which was used 
without further purification. 
 
Rf (hexane: EtOAc, 2:1 (v:v)) 0.54; 1H-NMR (d-DMSO, 200 MHz) δ 7.22 (d, 2H), 
6.90 (d, 2H), 5.80 (m, 1H), 4.93-5.01 (m, 2H), 4.40 (s, 2H), 3.82 (t, 1H), 3.78 (s, 3H), 
2.75 (dd, 1H), 2.52-2.60 (m, 3H), 2.23 (q, 2H), 1.41-1.56 (m, 2H), 1.21-1.39 (m, 
10H), 0.90 (t, 3H); 13C-NMR (d-DMSO, 75 MHz)δ 211.2, 161.0, 131.5, 132.1, 129.1, 
116.3, 114.4, 73.1, 71.9, 56.6, 48.5, 43.2, 35.3, 32.0, 29.3, 29.1, 23.6, 22.6, 14.6.  
 
7-Hydroxytridec-1-en-5-one rac-(5.5) 
 
Procedure 1: To a mixture of 7-(4-
methoxybenzyloxy)tridec-1-en-5-one (5.18) (120 mg, 0.36 
mmol, 1.0 eq.), H2O (0.17 mL) and CH2Cl2 (2.8 mL) was added DDQ (123 mg, 0.54 
mmol, 1.5 eq.) in one portion. After stirring at room temperature for 2 h, CH2Cl2 (7 
mL) was added and the resulting mixture was filtrated through Celite. The resulting 
filtrate was washed with saturated NaHCO3 aqueous solution (10 mL). The organic 
layer was further washed with brine (2 portions of 6 mL), dried (Na2SO4) and the 
solvent was removed under vacuum. Purification by flash chromatography 
(demetallated silica gel; CH2Cl2:EtOAc, 9.5:5, (v:v)) delivered the title compound as 
a viscous pale yellow oil (46 mg, 60%). 
C6H13
HO O
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Procedure 2: i) Preparation of LDA: To a -78 oC solution of iPr2NH (4.8 mL, 33.7 
mmol, 1.28 eq.) in THF (34 mL) was dropwise added over 30 min. a solution of BuLi 
in hexanes (1.6 M, 20.9 mL, 33.5 mL, 1.27 eq.). After addition, the resulting faint 
yellow solution was allowed to slowly reach 0 oC over 15 min after which it re-cooled 
to -78 oC and diluted with THF (200 mL). 
 
ii) Preparation of 7-hydroxytridec-1-en-5-one rac-(5.7): To the above LDA solution at 
-78 oC was dropwise added over 10 min. a solution of allylacetone (3.0 g, 30.6 mmol, 
1.2 mmol) in THF (31 mL). After addition, the resulting solution was stirred for 3 
min. and then a solution of heptaldehyde (3.0 g, 26.4 mmol, 1.0 eq.) in THF (29 mL) 
was dropwise added over 5 min. After addition, the resulting solution was stirred at -
78 oC for 3 min. and then quenched at this temperature with saturated NH4Cl aqueous 
solution (45 mL). The reaction mixture was allowed to reach room temperature and 
partitioned between H2O (200 mL) and Et2O (200 mL). The aqueous layer was further 
extracted with Et2O (2 portions of 100 mL). The combined organic layers were 
washed with brine (200 mL), dried (Na2SO4) and the solvent removed under vacuum. 
Purification of the resulting residue by flash chromatography (CH2Cl2:EtOAc, 9.5:5, 
(v:v)) afforded the title compound as a viscous pale yellow oil (3.9 g, 69%). 
 
Rf (CH2Cl2: EtOAc, 9.5:0.5 (v:v)) 0.50; 1H-NMR (d-DMSO, 200 MHz) δ 5.78 (m, 
1H), 4.85-5.02 (m, 2H), 4.50 (d, 1H), 3.75-3.85 (m, 1H), 2.38-2.55 (m, 4H), 2.18 (q, 
2H), 1.20-1.38 (m, 10H), 0.83 (t, 3H). 13C-NMR (d-DMSO, 75 MHz) δ 209.6, 138.3, 
115.6, 67.5, 51.0, 42.4, 38.0, 32.0., 29.4, 27.8, 25.7, 22.8, 14.7. 
Phenylalalinol 
 
Following a literature procedure,7.6 to an ice cold mixture of 
phenylalanine (20 g, 121 mmol, 1.0 eq.) and NaBH4 (11 g, 292 
mmol, 2.4 eq.) in THF (340 ml) was dropwise added, under an argon atmosphere and 
over a period of 1 h, a solution of I2 (32.3 g, 127 mmol, 1.1 eq.) in THF (90 ml) 
(caution: strong gas evolution seen). After addition of the I2 was completed and gas 
evolution had ceased, the mixture was gently refluxed for 18 h and the cooled to room 
temperature. MeOH was carefully added until the mixture became clear 
(approximately 25 ml of MeOH were required). After stirring for ½ h, the solvent was 
removed under reduced pressure affording a white paste which was dissolved by 
addition of a 20% aqueous NaOH solution (250 mL). The resulting solution was 
NH2
Ph
OH
7.6 McKennon, M. J.; Meyers, A. I. J. Org. Chem. 1993, 58, 3568. 
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stirred for 4 h, and extracted with CH2Cl2 (3 portions of 300 mL). The combined 
organic layers were washed with brine (100 mL), dried (Na2SO4) and concentrated in 
vacuum affording a white solid. Recrystallization from hot toluene delivered the title 
compound as colorless crystals (13.7 g, 75%). 
 
Mp 92-94 oC (lit.7.6 90-92 oC). 
1-Methoxy-3-phenylpropan-2-amine rac-(5.19) and (S)-1-
Methoxy-3-phenylpropan-2-amine (5.19) 
 
Following a literature procedure,7.7 a solution of phenylalalinol (4 g, 
26.5 mmol, 1.0 eq.) in THF (80 mL) was dropwise added to a stirred 
suspension of (pentane washed) NaH (1.24 g of a 55% dispersion in 
oil; corresponding to 0.68 g of NaH, 28.3 mmol, 1.1 eq.) in THF (30 
mL) at room temperature under argon. The resulting pale yellow 
mixture was stirred overnight and then a solution of MeI (3.69 g, 26 mmol, 0.98 eq.) 
in THF (32 mL) was added dropwise over ½ h. After stirring for 3½ h, the reaction 
mixture was poured into ice cold brine (200 mL) and the aqueous layer was extracted 
with Et2O (3 portions of 150 mL). The combined organic layers were dried (Na2SO4) 
and concentrated under vacuum affording a tan oil. Purification by reduced pressure 
bulb-to-bulb distillation (Toven, 90-100 oC, 0.1-0.2 mm) delivered the title compound 
as a colorless oil (3.39 g, 77%). 
NH2
Ph
MeO
NH2
Ph
MeO
 
Mp 149-152 oC (lit.7.7 151-152 oC); 1H-NMR (CDCl3, 200 MHz) δ 7.05-7.23 (m, 5H), 
3.12-3.35 (m, 6H), 2.72 (dd, 2H), 2.50 (dd, 2H), 1.30 (brs, 2H). 
 
(S)-Methoxy-3-phenylpropan-2-amine (5.19) was prepared by an identical procedure 
starting from commercially available (S)-phenylalanine 
 
[ ]20Dα +19.3 (c 2.0, EtOH) (lit.7.7 [ ]20Dα +19.7 (c 2.5, EtOH)). 
 
 
 
 
 
 
                                               
7.7 Meyers, A. I.; Poindexter, G.; Brich, Z. B. J. Org. Chem. 1978, 43, 892. 
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N-(1-Methoxy-3-phenylpropan-2-yl)-4-methylbenzene 
sulfonamide (5.20a) 
 
To an ice cold solution of 1-methoxy-3-phenylpropan-2-amine 
(5.20) (0.5 g, 3 mmol, 1.0 eq.) and NEt3 (0.46 mL, 3.3 mmol, 1.1 eq.) in CH2Cl2 (9 
mL) was dropwise added a solution of TsCl (627 mg, 3.3 mmol, 1.1 eq.) in CH2Cl2 (6 
mL). After addition, the reaction mixture was allowed to reach room temperature, 
stirred for 20 h and then partitioned between CH2Cl2 (20 mL) and a 2 N H2SO4 
aqueous solution (25 mL). The combined organic layers were washed with H2O (25 
mL), brine (15 mL), dried (MgSO4) and concentrated under vacuum. Purification by 
flash chromatography (hexane:EtOAc, 1:1 (v:v)) delivered the title compound (786 
mg, 82%) as a viscous colorless oil. 
NHTs
Ph
MeO
 
1H-NMR (CHCl3, 200 MHz) δ 7.70 (d, 2H), 7.33 (d, 2H), 7.09-7.24 (m, 5H), 5.83 
(brs, 1H), 3.72-3.79 (m, 1H), 3.60 (dd, 1H), 3.51 (dd, 1H), 3.23 (s, 3H), 2.95 (dd, 1H), 
2.78 (dd, 1H), 2.56 (s, 3H). 
 
Trifluoro-N-(1-methoxy-3-phenylpropan-2-yl)methane 
sulfonamide (5.20b) 
 
To a -78 oC cold solution of 1-methoxy-3-phenylpropan-2-amine 
(5.19) (0.4 g, 2.4 mmol, 1.0 eq.) and NiPr2Et (0.42 mL, 2.4 mmol, 
1.0 eq.) in CH2Cl2 (11 mL) was dropwise added over 10 min. a solution of Tf2O (0.4 
mL, 2.4 mmol, 1.0 eq.) in CH2Cl2 (1.5 mL). After stirring at -78 oC for ½ h, an ice 
bath was inserted and stirring continued for ½ h further. The resulting solution was 
washed with 1 M HCl aqueous solution (2 portions of 8 mL); the organic layer was 
further washed with H2O (2 portions of 8 mL), brine (10 mL), dried (Na2SO4) and the 
solvent removed under vacuum. The title compound was obtained as a pale yellow oil 
(692 mg, 97%) which was used without further purification. 
NHTf
Ph
MeO
Salt (5.21c) 
 
To an ice cold solution of 1-methoxy-3-phenylpropan-2-amine 
(5.19) (0.3 g, 1.8 mmol, 1.0 eq.) in Et2O (1.5 mL) was added 
HBF4 (54% in Et2O, 296 mg of solution, 1.8 mmol of HBF4, 1.0 eq.). During addition 
a white precipitate formed. The obtained suspension was stirred at 0 oC for 5 min., 
after which period the cooling bath removed and stirring continued at room 
temperature for 10 min. further. The solvent was removed under reduced pressure (the 
NH HBF4
Ph
MeO
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vacuum should be “broken” to an argon atmosphere) affording the title compound as 
white crystals (454 mg, quantitative). Note: This salt proved to be very hygroscopic 
and was dried in vacuum over P2O5 before being used. 
 
2-(4-Methoxybenzylamino)-3-phenylpropan-1-ol (5.24) 
 
Following a literature procedure,7.8 a mixture of phenylalalinol 
(1.36 g, 9.0 mmol, 1.0 eq.), p-anisaldehyde (1.32 g, 9.7 mmol, 1.08 
eq.) and 4 Å powdered MS (0.9 g) in toluene (23 mL) was heated for 2½ h at 95 oC, 
after which it was concentrated to dryness. The residue was taken in acetone (10 mL) 
and filtrated through Celite. The filtrate was concentrated under reduced pressure 
affording the corresponding imine as a viscous bright yellow oil. An ice cold solution 
of the crude imine in MeOH (23 mL) was treated with NaBH4 (0.51 g, 13.5 mmol, 1.5 
eq.). The resulting solution was stirred at this temperature for 45 min., quenched by 
the addition of acetone (4 mL), filtered through a short pad of Celite, and 
concentrated. The residue was dissolved in EtOAc (40 mL) and washed with H2O (20 
mL). The resulting aqueous layer was further extracted with EtOAc (2 portions of 20 
mL). The combined organic layers were dried (Na2SO4), the solvent was removed 
under vacuum to afford a yellow solid. Recrystallisation (cyclohexane:Et2O, 1:1 
(v:v)) delivered the title compound (2.24 g, 92 %) as a white solid. 
NHPMB
Ph
HO
 
Mp 86-88 oC (lit.7.8 85-86 oC); 1H NMR (CDCl3, 300 MHz) δ 7.15-7.37 (m, 7H), 
6.79-6.86 (m, 2H), 3.78 (s, 3H), 3.71 (s, 2H), 3.64 (dd, 1H, J = 3.8, 10.8 Hz), 3.35 
(dd, 1H, J = 5.2, 10.8 Hz), 2.90-2.98 (m, 1H), 2.78 (dd, 1H, J = 7.0, 13.2 Hz), 2.75 
(dd, 1H, J = 7.0, 13.2 Hz), 2.02-2.48 (m, 2H). 
 
N-(4-Methoxybenzyl)-1-methoxy-3-phneylpropan-2-amine 
(5.25) 
 
A solution of 2-(4-methoxybenzylamino)-3-phenylpropan-1-ol (1 
g, 3.69 mmol, 1.0 eq.) in THF (15 mL) was dropwise added to a stirred suspension of 
(pentane washed) NaH (1.24 g of a 55% dispersion in oil, corresponding to 0.68 g of 
NaH, 28.3 mmol, 1.1 eq.) in THF (4 mL) at room temperature under argon. The 
resulting pale yellow mixture was stirred for 5 h and then a solution of MeI (514 g, 
3.62 mmol, 0.98 eq.) in THF (3 mL) was added dropwise. After stirring for 3½ h, the 
reaction mixture was poured into cold brine (30 mL) and the aqueous layer was 
NHPMB
Ph
MeO
7.8 Dondoni, A.; Perrone, D.; Merino, P. J. Org. Chem. 1995, 60, 8074 
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extracted with Et2O (3 portions of 50 mL). The combined organic layers were dried 
(Na2SO4) and concentrated under vacuum affording a viscous yellow oil. Purification 
by flash chromatograph afforded the title compound as pale yellow oil (842 mg, 80% 
yield). 
5-Oxo-tetrahydrofuran-2-carboxylic acid (5.31) 
O OHO2C  
Following a literature procedure,7.9 to a suspension of glutamic 
acid (29.4 g, 200 mmol, 1.0 eq.) in H2O (300 mL) at 10 oC are added simultaneously 
and at the same rate, over a 2 h period, a solution of NaNO2 (16.8 g, 243 mmol, 1.2 
eq.) in H2O (240 mL) and an aqueous 1 N H2SO4 solution (240 mL). The mixture was 
then allowed to reach room temperature and stirred overnight. The obtained solution 
was concentrated under vacuum (TH2O bath < 45 oC). The syrup residue produced was 
extracted with hot EtOAc (4 portions of 200 mL). The combined organic layers were 
dried (MgSO4) and concentrated under vacuum affording the tile compound (15.8 g, 
60% yield) as a pale yellow oil that was used directly. 
 
1H-NMR (CHCl3, 200 MHz) δ 5.00-5.10 (m, 1H), 2.51-2.65 (m, 3H), 2.20-2.40 (m, 
2H); 13C (CHCl3, 75 MHz) δ 181.0, 174.0, 77.1, 27.4, 25.5. LRMS (EI) m/z = 131 
[M+]. 
 
4-Hydroxymethyl-4-butyrolactone  
 
Following a literature procedure,7.9 to chilled  solution of the crude 5-
oxo-tetrahydrofuran-2-carboxylic acid (5.33) (15 g, 115 mmol, 1.0 
eq.) in THF (115 mL) was dropwise added, over 2 h, a solution of BH3·SMe2 (2 M in 
THF, 72 mL, 143 mmol, 1.2 eq.) (caution: strong gas evolution). After stirring at 
room temperature for 3 h, the solution was cooled to ice bath temperature, MeOH (90 
mL) was carefully added and the resulting solution was concentrated under reduced 
pressure. The yellow oil obtained was re-dissolved in MeOH (150 mL), re-
concentrated under vacuum and the oil obtained was purified by reduced pressure 
bulb-to-bulb distillation (Toven 120-130 oC, 0.4 mm; lit.7.9 122-130 oC, 0.6 mm). The 
title compound was delivered as a colorless oil (9.5 g, 71%). 
O O
OH
 
1H NMR (CDCl3, 200 MHz) δ 2.2-2.8 (m, 4H), 3.60-4.10 (m, 3H), 4.6 (m, 1H). 
LRMS (EI) m/z = 117 [M+]. 
7.9 Larcheveque, M.; Lalande, J. Tetrahedron 1984, 40, 1061. 
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γ-(Methoxymethyl)- γ-butyrolactone rac-(5.30) and  
(S)-γ-(Methoxymethyl)- γ-butyrolactone (5.30) 
 
Following a literature procedure,7.10 a solution of 4-hydroxymethyl-
4-butyrolactone (2.0 mL, 21.3 mmol, 1.0 eq.) in THF (8 mL) was 
dropwise added over approximately 5 min. to a stirred suspension 
of (pentane washed) NaH (1.1 g of a 60% NaH dispersion in oil; 
corresponding to 660 mg of NaH, 27.5 mmol, 1.2 eq.) in THF (39 mL) at 0 oC under 
argon. After addition, the resulting gelatinous mixture was allowed to reach room 
temperature and stirred for 5 h (note: occasional external stirring was necessary). The 
mixture was then re-cooled to 0 oC and a solution of MeI (9.1 g, 63.9 mmol, 3 eq.) in 
THF (8 mL) was added dropwise over 5 min.. The pale yellow mixture obtained was 
stirred overnight at room temperature. The reaction was quenched by addition of ½ 
saturated aqueous NH4Cl (50 mL) at 0 oC and extracted with CH2Cl2 (100 mL). The 
aqueous layers was further extracted with CH3Cl (100 mL). The combined organic 
layers were washed with brine (30 mL), dried (Na2SO4) and concentrated under 
vacuum to afford a pale yellow oil (2.2 g, 80%) that was used without further 
purification. 
O O
MeO
O O
MeO
 
1H NMR (CDCl3, 200 MHz) 1.82-2.70 (m, 4H), 3.42 (s, 3H), 3.55 (d, 2H), 4.40-4.75 
(m, 1H). LRMS (EI) m/z = 130 [M+]. 
 
(S)-γ-(Methoxymethyl)-γ-butyrolactone (5.32) was prepared by an identical procedure 
starting from the commercially available (S)-hydroxymethyl-γ-butyrolactone. 
+27.7 (c 0.80, CHCl[ ]20Dα 3) (lit.7.10 [ ]20Dα +27.9 (c 0.86, CHCl3)). 
 
Ethyl 3-oxohept-6-enoate  
 
Following a literature procedure,7.11 ethylacetoacetate (6.0 g, 
46.1 mmol, 1.0 eq.) was added dropwise over 15 min. to a stirred suspension of 
(pentane washed) NaH (2.2 g of a 60% NaH dispersion in oil; corresponding to 1.22 g 
of NaH, 50.7 mmol, 1.1 eq.) in THF (115 mL) at 0 oC. After stirring at this 
temperature for 15 min., a solution of BuLi (1.6 M in hexanes, 30.5 mL, 1.05 eq.) was 
added dropwise over 25 min.. The resulting orange solution was stirred for further 15 
min. at 0 oC, after which a solution of freshly distilled allyl bromide (4.4 mL, 50.7 
OEt
OO
                                               
7.10  Nemoto, H.; Nagai, M.; Fukumoto, K. J. Org. Chem. 1985, 50, 2764. 
7.11 Huckin, S. N.; Weiler, L. J. Am. Chem. Soc. 1974, 96, 1082. 
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mmol, 1.1 eq.) in THF (9 mL) was added in a dropwise manner over 15 min. at this 
temperature. The solution was allowed to slowly warm to room temperature, stirred 
for 15 min., recooled to 0 oC and carefully quenched with an aqueous solution of HCl 
(9 mL of concentrated HCl in 23 mL of H2O). The reaction mixture was then 
partitioned between H2O (20 mL) and Et2O (90 mL) and the aqueous layer was 
extracted with Et2O (2 portions of 30 mL). The combined organic layers were washed 
with H2O until neutral (typically 5-6 washes of 120 mL H2O were required). The 
organic layer was dried (MgSO4) and the solvents were removed under vacuum. 
Purification by distillation under reduced pressure (44-46 oC, 0.2 mm; lit.6.11 99-100 
oC, 15 mm) afforded the title compound as a colorless oil (7.1 g, 91%). 
 
1H-NMR (CDCl3, 200 MHz) δ 5.7-5.8 (m, 1H), 4.8-5.1 (m, 2H), 4.1 (q, 2H), 3.4 (s, 
2H), 2.6 (t, 2H), 2.2-2.3 (m, 2H), 1.2 (t, 3H). 
 
Ethyl 3,3-(ethylenedioxy)-6-heptenoate (5.32) 
 
Following the procedure reported by Baldwin and co-
workers,7.12 a mixture of ethyl 3-oxohept-6-enoate (11.8 g, 69.3 mmol, 1.0 eq.), 
ethylene glycol (12.9 g, 208 mmol, 3 eq.) and a few crystals of TSOH·H2O in benzene 
(500 mL) was refluxed over 15 h with mechanical removal of H2O (Dean-Stark 
separator). During this period the collecting arm in the Dean Stark separator was 
emptied 4 times. The resulting mixture was cooled to room temperature, washed with 
saturated NaHCO3 aqueous solution (3 portions of 250 mL), brine (150 mL), dried 
(Na2SO4) and concentrated under reduced pressure to afford a tan oil. Purification by 
bulb-to-bulb distillation at reduced pressure (Toven 130-135 oC, 0.1 mm) yielded the 
title compound as a faint yellow oil (11.4 g, 77%). 
OEt
OOO
 
Rf (hexane:EtOAc, 3:2 (v:v)) 0.44; 1H-NMR (CDCl3, 200 MHz) δ 5.7-5.9 (m, 1H), 
4.9-5.1 (2H, m), 4.2 (t, 2H), 3.9-4.0 (m, 4H), 2.6 (s, 2H), 2.1-2.3 (m, 2H), 1.9-2.0 (m, 
2H), 1.3 (t, 3H). 
 
 
 
 
 
 
7.12 Baldwin, S. W.; Wilson, J. D.; Aubé, J. J. Org. Chem. 1985, 50, 4432. 
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3,3-(Ethylenedioxy)-6-hepten-1-ol 
 
Following a literature procedure,7.12 to a stirred mixture of 
LiAH4 (2.18 g, 57.2 mmol, 1.07 eq.) in Et2O (125 mL) was dropwise added over 20 
min. a solution of ethyl 3,3-(ethylenedioxy)-6-heptenoate (5.32) (11.4 g, 53.3 mmol, 
1.0 eq.) in Et2O (10 mL) at 0 oC. After stirring for 3½ h at room temperature, the 
reaction was recooled to 0 oC and carefully quenched by sequential addition of H2O 
(2.4 mL), 10% NaOH aqueous solution (3.2 mL) and H2O (6.5 mL). The mixture 
obtained was stirred overnight at room temperature. After filtration, the salts were 
filtered and washed thoroughly with Et2O (4 portions of 100 mL) and the combined 
ethereal solutions concentrated. The residue was taken in CH2Cl2 (200 mL), dried 
(Na2SO4) and concentrated to yield the title alcohol as a pale yellow oil (8.53 g, 93%) 
which was used directly in the next step. 
OH
OO
 
Rf (hexane:EtOAc, 3:2 (v:v)) 0.18; 1H-NMR (CDCl3, 200 MHz) δ 5.7-5.9 (m, 1H), 
4.8-5.1 (m, 2H), 3.9-4.0 (m, 4H), 3.7 (t, 2H), 2.7 (brs, 1H), 2.0-2.2 (m, 2H), 1.9 (t, 
2H), 1.6 (m, 2H). 
 
3,3-(Ethylenedioxy)-6-heptenal (5.33) 
 
To a 0 oC cold suspension of DMP (13.3 g, 31.4 mmol, 1.2 eq.) 
in CH2Cl2 (125 mL) was dropwise added a solution of 3,3-(ethylenedioxy)-6-hepten-
1-o (4.5 g, 26.1 mmol, 1.0 eq.) in CH2Cl2 (104 mL). The resulting mixture was stirred 
at ice bath temperature for ½ h, allowed to reach room temperature and stirred for 1 h 
further. The reaction was then quenched by addition of 10% Na2S2O3 aqueous 
solution (225 mL) and NaHCO3 aqueous solution (540 mL) and stirred until an 
homogenous biphasic system was obtained (approximately 20 min.). After separation 
of the layers, the aqueous layer was extracted with EtOAc (2 portions of 150 mL); the 
combined organic layers were washed with brine (150 mL), dried (Na2SO4) and the 
solvent removed under vacuum to afford the known aldehyde as a pale yellow oil (4.4 
g, quantitative), which was used without further purification. 
O
OO
 
Rf (hexane:EtOAc, 3:2, (v:v)) 0.38; 1H-NMR (CDCl3, 200 MHz) δ 5.7-5.9 (m, 1H), 
4.8-5.0 (m, 2H), 3.9 (s, 4H), 2.8 (s, 2H), 2.0-2.2 (m, 2H), 1.7-1.8 (m, 2H). 
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1-(2-(But-3-enyl)-1,3-dioxalan-2-yl)octan-2-ol (5.34) 
 
To a ice cold solution of hexylmagnesium bromide (2 M in 
Et2O, 15.5 mmol, 1.15 eq.) in Et2O (12 mL) was dropwise 
added over 20 min. a solution of 3,3-(ethylenedioxy)-6-heptenal (5.33) (2.30 g, 13.5 
mmol, 1.0 eq.) in Et2O (13 mL). The resulting solution was allowed to reach room 
temperature, stirred for 1 h, recooled to 0 oC and quenched with saturated NH4Cl 
aqueous solution (10 mL). After separation of the layers, the aqueous layer was 
extracted with Et2O (20 ml). The combined organic layers were washed with brine 
(25 mL), dried (Na2SO4), the solvent removed under vacuum affording a pale yellow 
oil. Purification by bulb-to-bulb distillation at reduced pressure (Toven 120-130 oC, 
0.05 mm) yielded the title compound as a faint yellow oil (2.6 g, 75%). 
 
Rf (hexane: EtOAc, 3:2 (v:v)) 0.47; 1H-NMR (CDCl3, 300 MHz) δ 5.75 (ddt, J = 17.0, 
10.2, 6.5 Hz, 1H), 4.95 (d´q´, J = 1.6, 17.0 Hz, 1H), 4.85 (d´q´, J = 1.6, 10.2 Hz, 1H), 
3.88-3.96 (m, 4 H), 3.75-3.83 (m, 1H), 3.47 (brs, 1H), 2.01-2.10 (m, 2H), 1.62-1.75 
(m, 4H), 1.16-1.28 (m, 10H), 0.79-0.83 (m, 3H); 13C-NMR (CDCl3, 75 MHz) δ 138.3, 
114.7, 112.1, 68.1, 65.1, 64.9, 43.1, 37.7, 36.7, 32.1, 29.6, 28.3, 25.7, 22.8, 14.3. 
 
2-(2-Azidooctyl)-2-(but-3-enyl)-1,3-dioxalane 
 
To a 0 oC cold solution of 1-(2-(but-3-enyl)-1,3-dioxalan-2-
yl)octan-2-ol (5.34) (1.30 g, 5.1 mmol, 1.0 eq.) and PPh3 
(2.71 g, 10.1 mmol, 2 eq.) in THF (39 mL) was dropwise added over 20 min. DIAD 
(2.10 g, 10.1 mmol, 2 eq.). The resulting beige suspension was stirred for 5 min., after 
which DPPA (1.54 g, 5.6 mmol, 1.1 eq.) was dropwise added over 15 min.. After 
stirring at 0 oC for 36 h, the suspension was filtered and the solid residue rinsed with 
cold THF (2 portions of 15 mL). The combined filtrates were concentrated under 
vacuum and the obtained residue was purified by flash chromatography 
(hexane:EtOAc, 3:2 (v:v)). The title compound was obtained as a pale yellow oil 
(1.33 g, 93%). 
C6H13
OO OH
C6H13
OO N3
 
Rf (hexane: EtOAc, 3:2 (v:v)) 0.65; 1H-NMR (CDCl3, 300 MHz) δ 5.75 (ddt, J = 6.5, 
10.2, 16.8 Hz, 1H), 4.96 (d´q´, J = 1.6, 16.8 Hz, 1H), 4.88 (d´q´, J = 1.6, 10.2 Hz, 
1H), 3.87-3.94 (m, 4 H), 3.30-3.80 (m, 1H), 2.02-2.11 (m, 2H), 1.19-1.75 (m, 14H), 
0.77-0.86 (m, 3H); 13C-NMR (CDCl3, 75 MHz) δ 138.4, 114.7, 110.4, 65.2, 65.1, 
58.9, 41.5, 37.0, 36.0, 31.9, 29.2, 28.3, 26.2, 14.3. 
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To a ice cold solution of γ-(methoxym
1-(2-(But-3-enyl)-1,3-dioxolan-2-yl)octan-2-amine rac-
(5.29). 
C6H13
OO NH2
 
To a 0 oC cold suspension of LiAH4 (472 mg, 12.4 mmol, 
2.8 eq.) in Et2O (32 mL) was dropwise added over 20 min. a solution of 2-(2-
azidooctyl)-2-(but-3-enyl)-1,3-dioxalane (1.25 g, 4.44 mmol, 1.0 eq.) in Et2O (34 
mL). The resulting mixture was stirred for 1½h at 0 oC and for 3 h further at room 
temperature, after which it was recooled to 0 oC and carefully quenched by sequential 
dropwise addition of H2O (0.5 mL), 10% NaOH aqueous solution (0.5 mL) and H2O 
(1 mL). After stirring for 5 min. the mixture was filtered, the salts washed thoroughly 
with EtOAc (2 portions of 15 mL). The combined organic layers were washed with 
brine (40 mL), dried (Na2SO4) and concentrated under vacuum to afford the title 
compound as a pale yellow oil (1.04 g, 92%) which was used without further 
purification.  
 
Rf (hexane: EtOAc, 3:2 (v:v)) 0.0; 1H-NMR (CDCl3, 300 MHz) δ 5.78 (ddt, J = 6.5, 
10.1, 17.0 Hz, 1H), 4.96 (d´q´, J = 1.4, 17.0 Hz, 1H), 4.84 (d´q´, J = 1.4, 10.1 Hz, 
1H), 3.82-3.94 (m, 4 H), 2.83-2.95 (m, 1H), 2.21-2.39 (brs, 2H), 2.00-2.13 (m, 2H), 
1.50-1.78 (m, 4H), 1.17-1.38 (m, 10H), 0.77-0.86 (m, 3H); 13C-NMR (CDCl3, 75 
MHz) δ 138.6, 114.6, 111.8, 65.1, 64.8, 47.6, 44.1, 39.0, 36.8, 32.0, 29.6, 28.4, 26.2, 
22.8, 14.3; LRMS (EI) m/z = 170 [M+-C6H13]. 
 
N-(1-(2-(but-3-enyl)-1,3-dioxalan-2-
yl)octan-2-yl)-4-hydroxy-5-
methoxypentanamide (5.35) 
MeO
H
N
OH
O O
O
C6H13
 
ethyl)-γ-butyrolactone rac-(5.30) (2.0 g, 15.3 
mmol, 1.0 eq.) in toluene (40 mL) was dropwise added over 20 min. a solution of 
AlMe3 (2 M in hexanes, 9.2 mL, 1.2 eq.). After being stirred for 15 min. at room 
temperature, a solution of 1-(2-(but-3-enyl)-1,3-dioxolan-2-yl)octan-2-amine rac-
(5.29) (4.11 g, 16.1 mmol, 1.05 eq.) was dropwise added over 15 min. at 0 oC. The 
resulting solution was stirred at room temperature for 15 min., refluxed for 1½ h, 
recooled to 0 oC, very carefully quenched with saturated NH4Cl aqueous solution (25 
mL) and extracted with EtOAc (150 mL). The aqueous layer was further extracted 
with EtOAc (100 mL). The combined organic layers were washed with brine (100 
mL), dried (Na2SO4) and the solvents removed under vacuum to afford the title 
compound as a pale yellow oil (5.52 g, 94%). 
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f (CHCl3: MeOH, 9:1 (v:v)) 0.45; 1H-NMR (CDCl3, 300 MHz) δ 5.84 (brs, 1H), 
 
n-2-
 Preparation of 5-(1-(2-(but-3-enyl)-1,3-dioxolan-2-yl)octan-2-ylamino)-1-methoxy-
) Preparation of 1-(1-(2-but-3-enyl)-1,3-dioxolan-2-yl)octan-2-yl)-5-
N
R
5.74 (ddt, J = 6.6, 10.0, 16.8 Hz, 1H), 4.95 (‘d’, J = 16.9 Hz, 1H), 4.87 (‘d’, J = 10.0 
Hz, 1H), 3.65-3.95 (m, 6H), 3.20-3.37 (m, 5H), 2.27 (t, J = 7.0 Hz, 2H), 2.00-2-09 
(m, 2H), 1.75-1.84 (m, 2H), 1.56-1.68 (m, 4H), 1.39-1.47 (m, 2H), 1.17-1.25 (m, 8H), 
0.78-0.82 (m, 3H); 13C-NMR (CDCl3, 75 MHz) δ 171.4, 137.1, 113.4, 109.9, 71.3, 
68.8, 68.7, 58.0, 45.2, 39.7, 35.7, 35.0, 32.5, 32.1, 30.0, 29.8, 28.2, 24.5, 21.7, 13.0; 
LRMS (EI) m/z = 385 [M+]. 
 
O
 
 
 
 
 
1-(1-(2-But-3-enyl)-1,3-dioxolan-2-yl)octan-2-yl)-5-(methoxymethyl)pyrrolidi
one (5.36) and 1-(2-(but-3-enyl)-1,3-dioxolan-2-yl)-N-(5-(methoxymethy)-
dihydrofuran-2(3H)-ylidene)octan-2-amine (5.37) 
 
i)
5-oxopentan-2-yl methanesulfonate: To an ice cold solution of N-(1-(2-(but-3-enyl)-
1,3-dioxalan-2-yl)octan-2-yl)-4-hydroxy-5-methoxypentanamide (5.37) (5.58 g, 14.4 
mmol, 1.0 eq.) and NEt3 (3 mL, 21.7 mmol, 1.5 eq.) in CH2Cl2 (72 mL) was dropwise 
added MsCl (1.35 mL, 17.5 mmol, 1.2 eq.). The reaction mixture was stirred at 0 oC 
for 1 h after which period it was washed with an 0.5 M HCl aqueous solution (50 
mL), ½ saturated NaHCO3 aqueous solution (200 mL), H2O (60 mL), brine (60 mL) 
and dried (Na2SO4). Removal of the solvent under vacuum delivered the title 
compound as a pale yellow oil (6.4 g, 95%) which was used directly. 
 
ii
(methoxymethyl)pyrrolidin-2-one (5.38) and 1-(2-(but-3-enyl)-1,3-dioxolan-2-yl)-N-
(5-(methoxymethy)-dihydrofuran-2(3H)-ylidene)octan-2-amine (5.39): A mixture of 
5-(1-(2-(but-3-enyl)-1,3-dioxolan-2-yl)octan-2-ylamino)-1-methoxy-5-oxopentan-2-yl 
methanesulfonate (6.3 g, 13.7 mmol, 1.0 eq.) and tBuOK (3.25 g, 28.9 mmol, 2 eq.) in 
toluene (110 mL) was stirred at room temperature for 1½ h, after which it was 
partitioned between a saturated KHSO4 aqueous solution (340 mL) and EtOAc (400 
mL). The aqueous layer was further extracted with EtOAc (2 portions of 100 mL). 
The combined organic layers were washed with saturated NaHCO3 aqueous solution 
(2 portions of 200 mL), brine (100 mL), dried (Na2SO4) and the solvents removed 
C6H13
5.38
MeO
N
O O C6H13
O OO
MeO
5.39
and
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or 1-(1-(2-but-3-enyl)-1,3-dioxolan-2-yl)octan-2-yl)-5-(methoxymethyl)pyrrolidin-
OH, 9:1 (v:v)) 0.88; 1H-NMR (CDCl3, 300 MHz) δ 5.68-5.83 (m, 1H), 
or 1-(2-(but-3-enyl)-1,3-dioxolan-2-yl)-N-(5-(methoxymethy)-dihydrofuran-2(3H)-
40; 1H-NMR (CDCl3, 300 MHz) δ 5.68-5.84 (m, 1H), 
(S)-N-(1-methoxy-3-phenylpropan-2-yl)dec-1-en-4-amine 
(5.
 Preparation of aldimine (S)-(5.46a): A mixture of (S)-1-
e
.2) Preparation of (S)-N-(1-methoxy-3-phenylpropan-2-yl)dec-1-en-4-amine (5.47) 
under vacuum. The residue obtained was purified by flash chromatography 
(hexane:EtOAc 3:2, (v:v)) to afford 1-(1-(2-but-3-enyl)-1,3-dioxolan-2-yl)octan-2-
yl)-5-(methoxymethyl)pyrrolidin-2-one (5.36) (2.59 g, 51%) and 1-(2-(but-3-enyl)-
1,3-dioxolan-2-yl)-N-(5-(methoxymethy)-dihydrofuran-2(3H)-ylidene)octan-2-amine 
(5.37) (654 mg, 13%). 
 
F
2-one (5.36):  
Rf (CHCl3: Me
4.95 (‘d’, J = 17.2 Hz, 1H), 4.86 (‘d’, J = 10.2 Hz, 1H), 3.52-4.07 (m, 6H), 3.25-3.38 
(m, 5H), 1.62-2.45 (m, 12H), 1.14-1.20 (m, 8H), 0.78-0.82 (m, 3H); 13C-NMR 
(CDCl3, 75 MHz) (selected) δ 176.2, 138.3, 114.4, 111.5, 75.3, 65.0, 59.1, 58.0, 51.5, 
49.3, 39.8, 38.0, 37.7, 36.6, 33.4, 32.0, 29.3, 28.3, 27.1, 22.8, 14.3; IR (neat): 1684 
cm-1; LRMS (EI) m/z = 367 [M+]. 
 
F
ylidene)octan-2-amine (5.37):  
Rf (CHCl3: MeOH, 9:1 (v:v)) 0.
4.82-5.00 (m, 2H), 4.40-4.49 (m, 1H), 3.72-3.91 (m, 5H), 3.26-3.47 (m, 5H), 2.42-
2.2.56 (m, 2H), 1.57-2.19 (m, 10H), 1.09-1.35 (m, 8H), 0.77-0.82 (m, 3H); 13C-NMR 
(CDCl3, 75 MHz) (selected) δ 170.3, 139.2, 115.3, 111.8, 80.3, 74.8, 64.8, 59.6, 52.5, 
41.8, 36.736.4, 33.4, 32.2, 29.7, 29.5, 29.1, 28.3, 26.5, 22.9, 14.3; IR (neat): 1725 cm-
1; LRMS (EI) m/z = 367 [M+]. 
 
47) 
 
i)
methoxy-3-phenylpropan-2-amine (5.19) (150 mg, 0.91 mmol, 
 (114 mg, 1.0 mmol, 1.1 eq.) and Na1.0 eq.), heptaldehyd 2SO4 (258 mg, 1.8 mmol, 2 
eq.) in CH2Cl2 (2 mL) was stirred at room temperature for 2½h. After filtration, the 
filtrate was concentrated at reduced pressure affording the crude aldimine (5.46a) 
which was used directly in the subsequent reaction. 
 
ii
(via reaction with allylMgBr): A solution of allylmagnesiumbromide (0.7 M in Et2O, 
1.3 mL, 3 eq.) was dropwise added to a -78 oC cold solution of crude aldimine (5.46a) 
(78 mg, 0.3 mmol, 1.0 eq.) in THF (1.8 mL).The resulting mixture was stirred at the 
N
H
Ph
MeO
C6H13
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.2) Preparation of (S)-N-(1-methoxy-3-phenylpropan-2-yl)dec-1-en-4-amine (5.47) 
.3) Preparation of (S)-N-(1-methoxy-3-phenylpropan-2-yl)dec-1-en-4-amine (5.47) 
same temperature for 3 h after, allowed to slowly reach room temperature and 
quenched by careful addition of H2O (2 mL). The aqueous layer was extracted with 
EtOAc (2 portions of 5 mL). The combined organic layers were washed with brine (3 
mL), dried (Na2SO4) and the solvents removed under vacuum affording a pale yellow 
oil. Purification by flash chromatography (hexane:EtOAc 4:1, (v:v)) delivered the title 
compound as a pale yellow oil (40 mg, 44%). 
 
ii
(via reaction with “allylCeCl2”): A suspension of (freshly prepared) CeCl3 (160 mg, 
0.65 mmol, 2.0 eq.) in THF (3.5 mL) was stirred for 15 h at room temperature under 
argon. After this ageing period, the suspension was cooled to -50 oC and a solution of 
allylmagnesiumbromide (0.7 M in Et2O, 0.9 mL, 2.0 eq.) was dropwise added. The 
resulting mixture was stirred at the same temperature for ½ h, after which a solution 
of (freshly prepared) crude aldimine (5.46a) (83 mg, 0.32 mmol, 1.0 eq.) in THF (1 
mL) was dropwise added. Stirring continued for 2 h at the same temperature, the 
reaction was then slowly warmed to room temperature, stirred for an additional 3 h 
and poured into brine (10 mL) and EtOAc (15 mL). The aqueous layer was extracted 
with EtOAc (2 portions of 5 mL); the combined organic layers were washed with 
brine (10 mL), dried (Na2SO4) and concentrated in vacuum to afford a tan residue. 
Purification by flash chromatography (hexane:EtOAc 4:1, (v:v)) delivered the title 
compound as a pale yellow oil (51 mg, 52%). 
 
ii
(via reaction with “allylCuBF3”): To a suspension of CuI (366 mg, 1.92 mmol, 5.0 
eq.) in THF (3 mL) at – 55 oC was dropwise added over 5 min. a solution of 
allylmagnesiumbromide (0.7 M in Et2O, 2.7 mL, 2.0 eq.). The resulting mixture was 
cooled to -78 oC, stirred for 15 min. and BF3.OEt2 (0.24 ml, 1.92 mmol, 5.0 eq.) was 
dropwise added. After stirring 5 min. at the same temperature, a solution of crude 
aldimine (5.46a) (100 mg, 0.38 mmol, 1.0 eq.) in THF (1.5 mL) was dropwise added. 
Stirring continued for 3 h at the same temperature, the reaction was then slowly 
warmed to room temperature, stirred for an additional 3 h and poured into saturated 
NaHCO3 aqueous solution (10 mL) and EtOAc (20 mL). The aqueous layer was 
further extracted with EtOAc (2 portions of 5 mL). The combined organic layers were 
washed with H2O (10 mL), brine (10 mL), dried (Na2SO4) and concentrated under 
vacuum to afford a tan oil. Purification by flash chromatography (hexane:EtOAc 4:1, 
(v:v)) delivered the title compound as a pale yellow oil (64 mg, 56%). 
 
 
Part III  7.3 – Preparation of Compounds 
 
 
 334
f (hexane: EtOAc, 1:1 (v:v)) 0.63; 1H-NMR (CDCl3, 300 MHz) (the two 
(S)-1-(2-(But-3-neyl)-1,3-dioxalan-2-yl)-N-(1-
metho
 
aration of aldimine (S)-(5.4bb): A mixture of 
ine (5.19) (500 mg, 3.0 mmol, 1.0 eq.), 3,3-
-3-neyl)-1,3-dioxalan-2-yl)-N-(1-methoxy-3-
hneylpropan-2-yl)octan-2-amine (5.51): A suspension of (freshly prepared) CeCl3 
z) (the two 
iastereomers are reported together) δ 7.09-7.23 (m, 5H), 5.73 (ddt, J = 6.5, 10.1, 16.7 
R
diastereomers are reported together) δ 7.15-7.29 (m, 5H), (5.78 (ddt, J = 7.1, 10.2, 
17.2 Hz), 5.60 (ddt, J = 7.3, 10.7, 17.4 Hz), 1H), (5.00-5.08 (m), 4.84-4.94 (m), 1H), 
(3.31 (s), 3.30 (s), 3H), 3.21 (dd, J = 1.7, 5.0 Hz, 2H), 2.96 (m, 1H), 2.70 (d, J = 6.8 
Hz, 2H), 2.60 (m, 1H), (2.13 (´t´, J = 6.9 Hz), 2.02 (m), 2H), 1.08-1.38 (m, 10H), 0.86 
(t, J = 6.7 Hz, 3H); 13C-NMR (CDCl3, 75 MHz) (selection) δ 139.2, 137.9, 129.2, 
128.2, 127.0, 116.3, 80.1, 59.7, 53.1, 52.6, 41.6, 39.7, ;36.0, 31.9, 29.7, 23.5, 22.9, 
13.8; LRMS (EI) m/z = 258 [M+-C2H5O]. 
 
Ph C6H13
xy-3-phneylpropan-2-yl)octan-2-amine (5.51) 
i) Prep
(1-(S)-methoxy-3-phenylpropan-2-am
(ethylenedioxy)-6-heptenal (5.33) (542 mg, 3.2 mmol, 1.05 eq.) and Na2SO4 (860 mg, 
7.1 mmol, 2.3 eq.) in CH2Cl2 (3.5 mL) was stirred at room temperature for 3 h. After 
filtration, the filtrate was concentrated at reduced pressure affording the crude 
aldimine (S)-(5.4bb) which was used directly in the subsequent reaction. 
 
ii) Preparation of (S)-1-(2-(but
p
(781 mg, 3.17 mmol, 5.0 eq.) in THF (16 mL) was stirred for 15 h at room 
temperature under argon. After this ageing period, the suspension was cooled to -50 
oC and a solution of hexylmagnesiumbromide (2 M in Et2O, 1.58 mL, 5.0 eq.) was 
dropwise added. The resulting mixture was stirred at the same temperature for ½ h, 
after which a solution of (freshly prepared) crude aldimine (5.46b) (200 mg, 0.63 
mmol, 1.0 eq.) in THF (2 mL) was dropwise added. Stirring continued for 2 h at the 
same temperature, the reaction was then slowly warmed to room temperature, stirred 
for an additional 10 h and poured into brine (20 mL) and EtOAc (30 mL). The 
aqueous layer was extracted with EtOAc (2 portions of 15 mL); the combined organic 
layers were washed with brine (15 mL), dried (Na2SO4) and concentrated in vacuum. 
Purification of the residue obtained by flash chromatography (hexane:EtOAc 1:1, 
(v:v)) delivered the title compound as a pale yellow oil (153 mg, 60%). 
 
Rf (hexane: EtOAc, 1:1 (v:v)) 0.15; 1H-NMR (CDCl3, 300 MH
d
Hz, 1H), 4.93 (dq, J = 1.7, 16.7 Hz, 1H), 4.86 (´d´, J = 10.1 Hz, 1H), 3.81-3.84 (m, 
4H), 3.24 (s, 3H), 3.15-3.17 (brd, 2H), 2.60-2.88 (m, 4H), 1.91-2.1 (m, 2H), 1.50-1.75 
N
HMeO
OO
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(S)-4-Hydroxy-N,5-dimethoxy-N-methylpentanamide 
(5.55) 
 
ice cold suspension of HCl·NH(OMe)Me (4.10 g, 
H Cl2 (85 mL) was dropwise added over 15 min. a solution 
of AlMe2Cl (1 M in hex
NMR (CDCl3, 300 MHz) δ 3.75-3.82 (m, 1H), 
.68 (s, 3H), 3.26-3.40 (m, 5H), 3.17 (s, 3H), 2.60 (´t´, J = 7.4 Hz, 2H), 1.64-1.89 (m, 
(m, 4H), 1.1-1.41 (m, 10H), 0.78-0.83 (m, 3H); 13C-NMR (CDCl3, 75 MHz) 
(selection) δ 140.3, 138.7, 129.6, 128.5, 126.2, 114.6, 111.6, 75.3, 65.0, 64.7, 59.1, 
56.8, 51.7, 42.0, 38.3, 36.7, 36.1, 32.1, 29.8, 28.4, 25.6, 22.9, 14.3; LRMS (EI) m/z = 
358 [M+-C2H5O]. 
 
O
To an 
42.1 mmol, 4.0 eq.) in C 2
ane, 42.2 mL, 4.0 eq.) during which gas evolution was 
observed. The mixture was slowly warmed to room temperature and stirred at for 1½ 
h further. A solution of (S)-γ-(methoxymethyl)-γ-butyrolactone (5.30) (1.37 g, 10.5 
mmol, 1.0 eq.) in CH2Cl2 (85 mL) was added dropwise over ½ h and the mixture was 
stirred overnight, cooled to 0 oC, carefully quenched with a saturated NH4Cl aqueous 
solution (150 mL). The salts were filtered (a short pad of Celite was used) and washed 
with CH2Cl2 (2 portions of 20 mL). The filtrates were combined, the layers were 
separated and the aqueous layer extracted with CH2Cl2 (2 portions of 30 mL). The 
combined organic layers were washed with brine (150 mL), dried (Na2SO4) and the 
solvent removed in vacuum. The residue obtained was filtered through a short column 
of silica gel (CHCl3:MeOH, 9:1, (v:v)) affording the title compound as a pale yellow 
oil (1.81 g, 90%). The title compound was obtained as a colorless oil (1.42 g, 82%). 
Note: High vacuum should be avoided 
 
Rf (CHCl3: MeOH, 9:1 (v:v)) 0.67; 1H-
3
2H); 13C-NMR (CDCl3, 75 MHz) δ 174.5, 78.6, 70.0, 61.4, 59.2, 32.5, 28.4, 28.1. 
LRMS (EI) m/z = 192 [M+H]+; [ ]25Dα +9.3 (c 1.9, CHCl3). 
 
(R)-4- o-N,5-dimethoxy-N-methylpentaAzid namide  
 
y-N-
ethylpentanamide (5.55) (1.53 g, 8.0 mmol, 1.0 eq.) and 
l,
a solution of DIAD (2.91 
N
To an ice cold solution of (S)-4-hydroxy-N,5-dimethox
m
PPh3 (3.77 g, 14.4 mmo  1.8 eq.) in THF (61 mL) was dropwise added over 15 min. 
g, 14.4 mmol, 1.8 eq.) in THF (1 mL). The resulting mixture 
was stirred for 20 min, after which a solution of DPPA (2.42 g, 8.8 mmol, 1.1 eq.) in 
THF (2 mL) was dropwise added. After stirring for 6½ h at room temperature, most 
of the solvent was removed under vacuum and the residue was purified by flash 
MeO OH
Me OMe
O
N
MeO N3
Me OMe
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.57 (m, 3H), 3.33 (s, 3H), 3.12 (s, 3H), 2.50 (´t´, J = 8.0 Hz, 2H), 1.57-1.88 (m, 2H); 
 
(R)-tert-Butyl 1-methoxy-5-(methoxy(methyl)amino)-
5-oxopenta-2-ylcarbamate (5.56) 
of (R)-4-azido-N,5-
imethoxy-N-methylpentanamide (1.16g, 5.37 mmol, 1.0 
m
(12 mL) was subjected to a 
 
.65-3.78 (m, 1H) (partial overlap with s at 3.67 ppm), 367 (s, 3H) (partial overlap 
chromatography (hexane:EtOAc 3:2, (v:v)). The title compound was obtained as a 
colorless oil (1.42 g, 82%). Note: High vacuum should be avoided. 
 
Rf (hexane: EtOAc, 3:2 (v:v)) 0.15; 1H-NMR (CDCl3, 300 MHz) δ 3.64 (s, 3H), 3.35-
3
13C-NMR (CDCl , 75 MHz) δ 173.6, 75.6, 61.5, 61.2, 59.3, 32.5, 28.4, 26.0; 
[ ]25Dα +14.5 (c 2.1, CHCl ). 
3
3
O
 
A vigorously stirred suspension 
d
eq.), Boc2O (1.41 g, 6.45 mol, 1.2 eq.), and 5% Pd on carbon (320 mg) in EtOAc 
atmosphere of H2 (balloon) overnight at room temperature 
and filtrated through a Celite pad, which was rinsed with EtOAc (2 portions of 5 mL). 
The combined filtrates were evaporated at reduced pressure and the residue was 
purified by flash chromatography (CHCl3:MeOH 9:1, (v:v)) affording the title 
compound as a pale yellow oil (1.45 g, 93%). Note: High vacuum should be avoided. 
 
Rf (CHCl3:MeOH, 9:1 (v:v)) 0.48; 1H-NMR (CDCl3, 300 MHz) δ 4.79 (brs, 1H),
3
with m at 3.65-3.78 ppm), 3.35-3.24 (m, 2H), 3.32 (s, 3H), 3.17 (s, 3H), 2.50 (´t´, J = 
7.3 Hz, 2H), 1.70-1.96 (m, 2H), 1.43 (s, 9H); 13C-NMR (CDCl3, 75 MHz) δ 173.6, 
156.5, 80.8, 75.6, 61.9, 61.0, 53.3, 32.7, 28.7, 27.4, 26.1; [ ]25Dα +13.2 (c 2.3, CHCl3). 
 
tert-Butyl (2R)-5-hydroxy-1-methoxyoct-7-en-2-
ylcarbamate (5.57) 
tert-butyl 1-methoxy-5-oxooct-7-en-2-
magnesiumbromide (1 M, 11.6 mL, 2.6 eq.) was 
m
N
 
i) Preparation of (R)-
ylcarbamate: A solution of allyl
dropwise added over 15 in. to a -78 oC cold solution of (R)-tert-butyl 1-methoxy-5-
(methoxy(methyl)amino)-5-oxopenta-2-ylcarbamate (5.56) (1.3 g, 4.48 mmol, 1.0 
eq.) in THF (18 mL). The mixture was stirred at this temperature for 3½ h, diluted 
with Et2O (50 mL) and quenched (still at -78 oC) with aqueous 1 M KHSO4 solution 
(25 mL). Partitioned between EtOAc (160 mL) and aqueous 1 M KHSO4 solution (25 
mL). The organic layer was washed with ½ saturated NaHCO3 aqueous solution (60 
MeO NHBoc
Me OMe
OH
NHBoc
OMe
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-2-ylcarbamate (5.57): 
o a solution of (crude) (R)-tert-butyl 1-methoxy-5-oxooct-7-en-2-ylcarbamate (1.15 
2-5.86 (m, 1H), 
.88-5.11 (m, 2H), 4.69 (brs, 1H), (4.06 (m) and 3.52-3.74 (m), 2H), 3.24-3.33 (m, 
rt-Butyl (2R)-5-(tert-butyldimethylsilyloxy)-1-
methoxyoct-7-en-2-ylcarbamate (5.58) 
hoxyoct-1-en-4-ol 
 salt: a solution of HCl (2 M in Et2O, 6.0 mL, 5.0 eq.) was dropwise 
i
-
lcarbamate (5.58): to a solution of the crude (7R)-7-amino-8-methoxyoct-1-en-4-ol 
mL), brine (50 mL) and dried (Na2SO4). Removal of the solvents under reduced 
pressure delivered (R)-tert-butyl 1-methoxy-5-oxooct-7-en-2-ylcarbamate (1.15 g, 
95%) which was used immediately in the subsequent reaction.  
 
ii) Preparation of tert-butyl (2R)-5-hydroxy-1-methoxyoct-7-en
T
g, 4.24 mmol, 1.0 eq.) in MeOH (23 mL) at 0 oC was (portionwise) added NaBH4 
(185 mg, 4.88 mmol, 1.15 eq.). The mixture was stirred at the same temperature of 45 
min., quenched with saturated NH4Cl aqueous solution (7 mL), diluted with EtOAc 
(100 mL) and filtrated. The filtrate was washed with brine (2 portions of 50 mL), 
dried (Na2SO4) and concentrated under vacuum to afford the title compound as a pale 
yellow oil (1.14 g, 98%) which was used without further purification. 
 
Rf (hexane:EtOAc, 3:2 (v:v)) 0.18; 1H-NMR (CDCl3, 300 MHz) δ 5.6
4
5H), 2.04-2.2.27 (m, 2H), 1.29-1.54 (m, 13H); 13C-NMR (CDCl3, 75 MHz) δ 
(selected) 156.5, 142.3, 112.6, 79.2, 72.4, 69.8, 53.3, 51.0, 44.2, 32.5, 28.8, 26.3; 
[ ]25Dα +14.6 (c 2.1, CHCl3). 
 
teOTBDMS
 
i) Preparation of (7R)-7-amino-8-met
hydrochloric
added to an ice cold solut on of (crude) tert-butyl (2R)-5-hydroxy-1-methoxyoct-7-en-
2-ylcarbamate (5.57) (625 mg, 2.29 mmol, 1.0 eq.) in CH2Cl2 (6.0 mL). After stirring 
at room temperature for 24 h, the solvents were removed under vacuum affording a 
light tan oil that was used directly in the next step (quantitative yield was assumed). 
 
ii) Preparation of tert-butyl (2R)-5-(tert-butyldimethylsilyloxy)-1-methoxyoct-7-en-2
y
hydrochloric salt and imidazole (760 mg, 11.16 mmol, 5 eq.) in DMF (5 mL) was 
added a solution of TBDMSCl (431.5 mg, 2.86 mmol, 1.25 eq.) in DMF (2 mL). 
After stirring at stirred at room temperature for 48 h (for convenience), the mixture 
was diluted with CH2Cl2 (100 ml), washed with 0.2 M KHSO4 aqueous solution (2 
portions of 20 mL), H2O (50 mL), “aqueous ½ saturated brine” (40 mL), dried 
(Na2SO4) and concentrated under vacuum. Purification by (short) flash 
chromatography (CHCl3:MeOH 9:1, (v:v)) delivered the title compound as a faint 
NHBoc
OMe
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CDCl3, 300 MHz) (the two 
iastereomers are reported together) δ 5.75 (ddt, J = 7.3, 11.0, 17.8 Hz, 1H), 5.0 (´d´, 
ept-1-enecarbaldeyhde (5.65) 
 
 
lution of PPh3 (53.6 g, 0.2 mol, 2.3 eq.) in benzene (255 mL) was 
 
obtained was allo
 an ice cold solution of DMF (14.4 mL; 225.7 mmol) in CHCl3 (60 
L) was added dropwise freshly distilled PBr3 (17.9 mL, 188.5 mmol) over a period 
                                               
yellow oil (428 mg, 65% based on carbamate (5.57). 
 
Rf (CHCl3:MeOH, 9:1 (v:v)) 0.20; 1H-NMR (
d
J = 17.8 Hz, 1H) (partial overlap with ´d´at 4.9 ppm), 4.9 (´d´, J = 11.0 Hz, 1H) 
(partial overlap with ´d´at 5.0 ppm), 3.61-3.70 (m, 1H), 3.33-3.38 (m, 1H), 3.30 (s, 
3H), 3.18 (td, J = 1.5, 7.5 Hz, 1H), 2..89-2.96 (m, 1H), 2.17 (´t´, J = 5.9 Hz, 2H), 
1.32-1.57 (m, 4H), 0.84 (s, 9H), 0.00 (s, 6H); 13C-NMR (CDCl3, 75 MHz) δ 139.5, 
139.4, 121.4, 121.3, 76.4, 76.1, 63.4, 55.8, 55.7, 46.3, 46.1, 37.6, 37.4, 33.6, 33.1, 
30.4, 22.6; [ ]25Dα +18.4 (c 2.0, CHCl3). 
 
(Z)-2-Bromo-cyclohBr
Procedure A: Following a literature procedure,7.13 to an ice coldCHO
so
added Br2 (10.5 mL, 0.2 mol, 2.3 eq.) dropwise over 15 min.. The yellow mixture 
wed to reach room temperature and stirred for further 20 min., after 
which DMF (50.9 mL, 0.66 mol, 7.4 eq.) was added dropwise at room temperature 
over 15 min. After stirring for 1½ h, a solution of cycloheptanone (10.5 mL, 90 mmol, 
1.0 eq.) in benzene (35 mL) was added dropwise at over 10 min., the pale yellow 
suspension obtained was stirred for 2 h and then refluxed for 3½ h. During reflux, a 
deep reddish color developed. After cooling to room temperature, the dark mixture 
was poured into iced-H2O (400 mL), stirred for 5 min., after which small portions of 
Na2CO3 were added until pH 8-9 was reached (approximately 26 g of Na2CO3 was 
used). After separation of the layers, the aqueous layer was extracted with benzene (3 
portions of 100 mL) and the combined organic layers were washed with brine (120 
mL), dried (Na2SO4) and concentrated under vacuum to a tan solid. Purification by 
bulb-to-bulb distillation at reduced pressure (Toven 75-80 oC, 0.2 mm.) delivered the 
title compound as a viscous pale yellow oil (14.3 g, 79%) which was kept in a frozen 
benzene matrix. 
 
Procedure B: To
m
of ½ h. The resulting suspension was stirred for 20 min. at 0 oC and 45 min further at 
room temperature. A solution of cycloheptanone (8.86 mL, 75.0 mmol) in CHCl3 (30 
7.13 Miyaura, N.; Ishiyama, T.; Sasaki, H.; Ishikawa, M.; Satoh, M.; Suzuki, A. J. Am. Chem. Soc. 
1989, 111, 314. 
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c, 1:1 (v:v)) 0.71; 1H-NMR (CDCl3, 300 MHz) δ 9.92 (s, 1H), 2.98-
.05 (m, 2H), 2.47-2.51 (m, 2H), 1.76-1.84 (m, 2H), 1.1.62-1.69 (m, 2H), 1.41-1.49 
(Z)-1-Bromo-1-vinyl-cycloheptene (5.66) 
 
enylphosphoniumbromide 
5.2 g, 70.4 mmol, 1.1 eq.) in Et2O (210 mL) was dropwise added a 
L
room temperatu
3, 300 MHz) δ 6.74 (dd, J = 17.3, 
0.9 Hz, 1H), 5.19 (d, J = 17.3 Hz, 1H), 5.08 (d, J = 10.9 Hz, 1H), 2.76-2.82 (m, 2H), 
mL) was added dropwise over a period of ½ h, resulting in an orange suspension 
which was refluxed for 3 h. On heating the mixture changes from a pale orange 
suspension to a clear red solution which grows darker until a blackish red solution 
was obtained. The solvent was removed by evaporation in vacuum affording a dark 
oily residue, which was very carefully quenched with iced H2O (150 mL) (note: this 
process is extremely exothermic!). The mixture was neutralized with solid NaHCO3. 
The mixture was filtered and the aqueous layer extracted with Et2O (3 portions of 100 
mL). The combined organic layers were washed with saturated NaHCO3 aqueous 
solution (100 mL), H2O (100 mL), dried (MgSO4) and evaporated in vacuum to afford 
the title compound as a viscous yellow oil (6.40 g, 42%) which was kept in a frozen 
benzene matrix. 
 
Rf (hexane:EtOA
3
(m, 2H); 13C-NMR (CDCl3, 75 MHz) δ 193.5, 148.6, 140.7, 44.5, 31.6, 25.9, 25.4, 
25.03. 
 
Br
To an ice cold suspension of methyltriph
(2
solution of Bu i (1.6 M in hexanes, 44.0 mL, 1.1 eq.) over 25 min.. After stirring at 
re for 15 min, the yellow suspension was refluxed for 4 h, cooled to 
room temperature and treated with a solution of (Z)-2-bromo-cyclohept-1-
enecarbaldeyhde (5.65) (13.0 g, 64.0 mmol, 1.0 eq.) in Et2O (80 mL) over 20 min. 
The mixture was refluxed for 4 h and (for convenience) stirred at room temperature 
overnight. The suspension was filtered, the solid was rinsed with cold Et2O (3 
portions of 100 mL). The combined filtrates were concentrated under vacuum to 
afford a deep tan oil which was filtered through a short column of silica (packed and 
eluted with Et2O). The title compound was obtained as a yellow oil (9.1 g, 71%) 
which was used without further purification. 
 
Rf (hexane:EtOAc, 1:1 (v:v)) 0.76; 1H-NMR (CDCl
1
2.31-2.36 (m, 2H), 1.66-1.74 (m, 2H), 1.38-1.55 (m, 4H); 13C-NMR (CDCl3, 75 MHz) 
δ 138.9, 138.0, 127.9, 114.6, 42.0, 31.7, 28.1, 25.6, 25.4. 
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17.3 mmol, 1.0 eq.)
f (hexane:EtOAc, 3:1 (v:v)) 0.14; 1H-NMR (CDCl3, 300 MHz) δ 6.72 (dd, J = 17.3, 
-Allyl-4-methylbenzenesulfonamide (5.68) 
Following a literature procedure,7.1 an aqueous solution of NaOCl (12% in weight, 
p 61-62 oC (lit.7.1 62-64 oC); 1H-NMR (CDCl3, 300 MHz) δ 7.76 (´d, J = 8.4 Hz, 
                                               
(Z)-2-(2-Bromocyclohept-1-enyl)ethanol (5.67) 
 
To a solution of (Z)-1-bromo-1-vinyl-cycloheptene (5.66) (3.5 g, 
 in THF (18 mL) was dropwise added a solution of 9-BBN (4.5 g, 
18.2 mmol, 1.05 eq.) in THF (40 mL). The mixture was stirred at room temperature 
overnight and then carefully quenched with MeOH (16 mL). The mixture was cooled 
to ice bath temperature and treated sequentially with an aqueous 3 M NaOH solution 
(24 mL), and an aqueous 30% H2O2 solution (24 mL). The mixture was refluxed for 
3½ h and cooled to room temperature. The aqueous layer was saturated with K2CO3 
and the mixture extracted repeatedly with Et2O (4 portions of 50 mL).The organic 
layers were combined, washed with brine (100 mL), dried (MgSO4) and concentrated 
under vacuum. Purification by flash chromatography (hexane:Et2O 1:3, (v:v)) 
followed by bulb-to-bulb distillation at reduced pressure (Toven 110-110 oC, 0.2 mm.) 
delivered the title compound as a colorless oil (3.2 g, 83%). 
 
R
10.9 Hz, 1H), 5.19 (dd, J = 1.2, 17.3 Hz, 1H), 5.08 (dd, J = 1.2, 10.9 Hz, 1H), 3.61 
(´q´, J = 6.0, 6.7 Hz, 2H), 2.44 (t, J = 6.7 Hz, 2H), 2.29-2.33 (m, 2H), 2.20-2.32 (m, 
2H), 1.64-1.73 (m, 2H), 1.35-1.47 (m, 4H); 13C-NMR (CDCl3, 75 MHz) δ 138.6, 
124.6, 60.6, 43.5, 41.5, 33.9, 31.7, 25.9, 25.7. 
 
Br
OH
NNHTs
 
32.5 g of solution, 52.5 mmol, 1.5 eq.) was added dropwise over 1 h to a chilled 
solution of allylamine (2.63 mL, 35.0 mmol, 1.0 eq.), acetic acid (2.0 mL; 35.0 mL, 
1.0 eq.) and sodium benzenesulfinate (12.47 g, 70 mmol, 2.0 eq.) in H2O (155 mL). 
The resulting mixture was stirred at room temperature overnight, recooled to 0 oC, 
acidified to pH 1 with a 1M HCl aqueous solution (approximately 80 mL used), 
stirred for 10 min. The title compound was obtained by filtration and dried in a 
vacuum desiccator (6.58 g, 89%). 
 
M
2H), 7.31 (´d´, J = 8.4 Hz), 5.65-5.78 (m, 1H), 5.07-5.20 (m, 2H), 4.62 (brt, J = 6.1 
Hz), 3.58 (tt, J = 1.5, 5.8 Hz), 2.43 (s, 3H). 
 
7.1 Scully Jr., F. E.; Bowdring, K. J. Org. Chem. 1981, 46, 5077.  
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(Z)-N-Allyl-N-(2-(2-bromocyclohept-1-enyl)ethyl)-4-
meth
o an ice cold solution of (Z)-2-(2-bromocyclohept-1-
 
f (hexane:EtOAc, 2:1 (v:v)) 0.60; 1H-NMR (CDCl3, 300 MHz) δ 7.71 (´d´, J = 8.3 
(Z)-2-(2-vinylcyclohept-1-enyl)ethanol 
o a suspension of (Z)-2-(2-bromocyclohept-1-enyl)ethanol 
mmol, 7 mol%) in T
f (hexane:Et2O 1:1 (v:v)) 0.24; 1H-NMR (CDCl3, 300 MHz) δ 6.78 (dd, J = 11.0, 
Br
ylbenzenesulfonamide (5.69) 
 N
Ts
T
enyl)ethanol (5.67) (1.0 g, 4.56 mmol, 1.0 eq.), PPh3 (2.99 g, 11.4 mmol, 2.5 eq.) and 
N-Allyl-4-methylbenzenesulfonamide (5.68) (1.25 g, 5.93 mmol, 1.3 eq.) in THF (25 
mL) was added dropwise DIAD (1.84 g, 9.12 mmol, 2.0 eq.) over 1 h. The solution 
obtained was stirred at room temperature for 26 h (for convenience), after which the 
solvent was removed under vacuum to afford a light tanned oil. Purification by flash 
chromatography (hexane:Et2O, 3:1 (v:v)) afforded the title compound as colorless 
viscous oil (1.3 g, 70 %). 
 
R
Hz, 2H), 7.30 (´d´, J = 8.3 Hz, 2H), 5.60-5.73 (m, 1H), 5.23 (d´q´, J =1.4, 17.1 Hz, 
1H), 5.16 (d´q´, J = 1.4, 10.0 Hz, 1H), 3.85 (d, J = 6.5 Hz, 2H), 3.13-3.18 (m, 2H), 
2.67-2.70 (m, 2H), 2.42 (d, J = 7.5 Hz, 2H) (overlap with s at 2.42 ppm), 2.42 (s, 3H) 
(overlap with t at 2.42 ppm), 2.20-2.23 (m, 2H), 1.67-1.75 (m, 2H), 1.43-1.58 (m, 
4H); 13C-NMR (CDCl3, 75 MHz) δ 143.4, 138.5, 137.5, 133.2, 129.9, 127.4, 124.5, 
119.4, 50.8, 44.4, 41.3, 39.6, 34.0, 31.5, 25.9, 25.7, 21.8. 
 
OH
 
T
(5.67) (850 mg, 3.88 mmol, 1.0 eq.) and Pd(PPh3)4 (314 mg, 0.27 
HF (5.7 mL) was dropwise added a solution of vinyl bromide (1 
M in THF, 10.2 mL, 2.6 eq.) at room temperature. The mixture was gently refluxed 
for 3h 45 min. The resulting solution was recooled to 0 oC, carefully quenched with 
saturated NH4Cl aqueous solution (5 mL) and diluted with Et2O (25 mL). The 
aqueous layer was extracted with Et2O (2 portions of 5 mL). The combined organic 
layers were washed with brine (10 mL), dried (Na2SO4) and the solvents removed 
under vacuum. Purification of the obtained residue by flash chromatography 
(hexane:Et2O, 1:1 (v:v)) delivered the title compound (546 mg, 84%, with a minor 
impurity) 
 
R
17.2 Hz, 1H), 5.19 (dd, J = 1.0, 17.2 Hz, 1H), 5.01 (dd, J = 1.0, 11.0, 1H), 3.67 (t, J = 
6.3 Hz, 2H), 2.51 (t, J = 6.3 Hz, 2H), 2.36-2.39 (m, 2H), 2.27-2.30 (m, 2H), 1.41-1.51 
(m, 2H), 1.70-1.79 (m, 4H); 13C-NMR (CDCl3, 75 MHz) δ 139.2, 138.5, 138.2, 115.7, 
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(Z)-N-Allyl-4-methyl-N-(2-(2-vinylcyclohept-1-
enyl)ethyl)b
o an ice cold solution of (Z)-2-(2-vinylcyclohept-1-
0
f (hexane:Et2O, 3:1 (v:v)) 0.40; 1H-NMR (CDCl3, 300 MHz) δ 7.70 (´d´, J = 8.0 Hz, 
(5Z,6aZ)-tert-butyl 1,2,8,9,10,11-hexahydro-4H-
 mixture of (Z)-N-Allyl-4-methyl-N-(2-(2-vinylcyclohept-1-
enyl)ethyl)benzenesulf
61.4, 37.0, 33.2, 33.1, 32.8, 28.2, 27.9. 
 
enzenesulfonamide (5.71) 
 NTs
T
enyl)ethanol (100 mg, .60, 1.0 eq.), PPh3 (394 mg, 1.5 mmol, 2.5 eq.) and N-Allyl-4-
methylbenzenesulfonamide (5.68) (172 mg, 0.81 mmol, 1.35 eq.) in THF (4 mL) was 
added dropwise DIAD (243 mg, 1.2 mmol, 2.0 eq.) over 1 h. The solution obtained 
was stirred at room temperature for 26 h (for convenience), after which the solvent 
was removed under vacuum to afford a light tanned oil. Purification by flash 
chromatography (hexane:Et2O, 3:1 (v:v)) afforded the title compound as colorless 
viscous oil (1.3 g, 70 %). 
 
R
2H), 7.29 (´d´, J = 8.0 Hz, 2H), 6.59 (dd, J = 10.9, 17.1 Hz, 1H), 5.57-5.76 (m, 1H), 
4.95-5.24 (m, 4H), 3.83 (d, J = 6.5 Hz, 2H), 3.04-3.10 (m, 2H), 2.38-2.43 (m, 5H; 
includes a s at 2.42 ppm corresponding to 3H), 2.27-2.30 (m, 2H), 2.18-2.22 (m, 2H), 
1.66-1.75 (m, 2H), 1.36-1.47 (m, 4H). 13C-NMR (CDCl3, 75 MHz) δ 143.0, 139.1, 
138.6, 137.9, 137.1, 133.9, 28.2, 127.8, 116.3, 115.9, 51.4, 51.2, 33.1, 33.0, 31.8, 
28.3, 28.0,25.7 21.2. 
 
N
Boc
cyclohepta[d]azocine-3(7H)-carboxylate (5.74) 
 
A
onamide (5.71) (80 mg, 0.22 mmol, 1.0 eq.) and 2nd generation 
Grubbs catalyst (25 mg, 0.029 mmol, 13 mol%) in degassed CH2Cl2 (37 mL) was 
refluxed under argon for 3 h, after which time an aqueous solution of P(CH2OH)3 (1.5 
M, 0.48 mL, 25 eq.) was added and the resulting biphasic system was further refluxed 
overnight. The mixture was washed with H2O (15 mL) and the aqueous layer 
extracted with CH2Cl2 (8 mL). The combined organic layers were washed with brine 
(25 mL), dried (Na2SO4) and the solvent was removed under vacuum to afford a 
yellow residue. Purification by flash chromatography (hexane:Et2O, 3:1 (v:v); 
demetallated silica gel) delivered the title compound as a viscous colorless oil (46 mg, 
62%). 
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f (hexane:Et2O, 3:1 (v:v)) 0.29; 1H-NMR (CDCl3, 200 MHz) δ 7.75 (´d´, 2H), 7.35 
tert-Butyl allylcarbamate (5.75). 
Following a literature procedure,7.2 to an ice cold solution of allylamine (2.3 mL, 30.6 
f (hexane:EtOAc 2:1 (v:v)) 0.39; 1H-NMR (CDCl3, 300 MHz) δ 5.70-5.71 (m, 1H), 
(Z)-tert-Butyl 3-(2-(2-hydroxyethyl)cyclohept-1-
tert-butyl allylcarbamate (5.75) (1.6 g, 10.2 mmol, 1.5 eq.) 
                                               
R
(´d´, 2H), 5.93 (d, 1H), 5.48-5.59 (m, 1H), 3.44-3.52 (brs, 2H), 3.15 (t, 2H), 2.42 (s, 
3H), 1.19-2.23 (m, 12H); 13C-NMR (CDCl3, 75 MHz) δ 143.6, 138.6, 137.1, 136.2, 
129.8, 128.0, 127.3, 123.2, 46.4, 43.7, 37.2, 35.8, 33.0, 32.5, 26.7, 26.3, 21.7. 
 
NHBoc
 
mmol, 1.0 eq.) in CH2Cl2 (45 mL) was portionwise added a solution of Boc2O (6.68 g, 
30.6 mmol, 1.0 eq.) in CH2Cl2 (5 mL). The resulting solution was stirred overnight at 
room temperature, diluted with CH2Cl2 (40 mL) and washed with aqueous 5% citric 
acid solution (2 portions of 50 mL), H2O (25 mL), brine (25 mL), dried (Na2SO4) 
and the solvent removed under vacuum to afford a white solid. Recrystallization from 
(hot) hexane (8 mL) delivered the title compound as white crystals (3.1 g, 67%). 
 
R
5.11 (dq, J = 1.6, 17.2 Hz, 1H), 5.04 (dq, J = 1.6, 10.2 Hz, 1H), 4.55 (brs, 1H), 3.65 
(brt, J = 4.9 Hz, 2H), 1.38 (s, 9H). 
 
enyl)propylcarbamate (5.76) 
 
To an ice cold solution of 
in THF (41 mL) was dropwise added a solution of 9-BBN (0.5 M in THF, 27.4 mL, 
2.0 eq.) and the resulting solution was stirred at room temperature for 20 h. The 
reaction flask was covered with silver foil and an aqueous solution of K3PO4 (3 M, 
4.70 mL, 2.05 eq.), a solution of (Z)-2-(2-bromocyclohept-1-enyl)ethanol (5.??) (1.5 
g, 6.8 mmol, 1.0 eq.) in degassed DMF (57 mL) and PdCl2(dppf) (320 mg, 6% molar) 
were sequentially added and the resulting mixture was stirred at room temperature 
overnight. Partitioned between ½ saturated NaHCO3 aqueous solution (300 mL) and 
Et2O (300 mL), the aqueous layer was extracted with Et2O (2 portions of 60 mL). The 
combined organic layers were washed with brine (200 mL), dried (Na2SO4) and the 
solvent was removed under reduced pressure affording a tan residue. Purification by 
flash chromatography (hexane:EtoAc, 1:1 (v:v)) delivered the title compound as a 
viscous pale yellow oil (1.9 g, 95%). 
7.2 Rocheblave, L.; Bihel, F.; De Michelis, C.; Priem, G.; Courcambeck, J.; Bonnet, B.; Chermann, J.-
C.; Kraus, J.-L. J. Med. Chem. 2002, 45, 3321. 
OH
NHBoc
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-NMR (CDCl3, 300 MHz) δ 4.67 (brs, 1H), 3.62 
(Z)-2-(2-(3-(tert-Butoxycarbonylamino)propyl) 
cyclohept
 solution of (Z)-tert-butyl 3-(2-(2-hydroxyethyl)cyclohept-
 (
f (hexane:EtOAc, 1:1 (v:v)) 0.45; 1H-NMR (CDCl3, 300 MHz) δ 7.78 (´d´, J = 8.3 
 
)-tert-Butyl 1,2,5,6,8,9,10,11-octahydro-4H-
ert-butoxycarbonylamino)propyl)cyclohept-1-enyl)ethyl 4-
Rf (hexane:EtOAc 1:1 (v:v)) 0.35; 1H
(t, J = 6.7 Hz, 2H), 3.09 (brq, J = 5.6 Hz, 2H), 2.30 (t, 6.7 Hz, 2H), 2.03-2.14 (m, 6H), 
1.81 (brs, 1H), 1.66-1.75 (m, 2H), 1.40-1.54 (m, 15H); 13C-NMR (CDCl3, 75 MHz) δ 
156.3, 139.8, 133.2, 79.3, 60.9, 40.8, 38.2, 34.1, 33.9, 32.9, 32.3, 28.9, 28.7, 27.2, 
27.1. 
 
-1-enyl)ethyl 4-methybenzenesulfonate 
 
A
1-enyl)propylcarbamate 5.76) (250 mmg, 0.84 mmol, 1.0 eq.), NEt3 (0.23 mL, 1.68 
mmol, 2.0 eq.), DMAP (12 mg,0.1 mmol, 0.1 eq), TsCl (195 mg, 1.0 mmol, 1.2 eq.) 
in CH2Cl2 (3 mL) was stirred overnight at room temperature. The mixture was 
partitioned between Et2O (30 mL) and 0.5 M HCl aqueous solution (15 mL). The 
organic layer was washed with 0.5 M HCl aqueous solution (15 mL), H2O (15 mL), 
brine (15 mL), dried (Na2SO4) and the solvent was removed under vacuum. The 
residue obtained was purified by flash chromatography (hexane:Et2O 1:2, (v:v)) to 
afford the title compound as a colorless oil (305 mg, 80%). 
 
R
Hz, 2H), 7.34 (´d´, J = 8.3 Hz, 2H), 4.56 (brs, 1H), 3.98 (t, J = 7.2 Hz, 2H), 3.00-3.11 
(m, 2H), 2.45 (s, 3H), 2.36 (t, J = 7.2 Hz, 2H), 1.91-2.09 (m, 6H), 1.60-1.70 (m, 2H), 
1.44 (s, 9H), 1.24-1.40 (m, 6H); 13C-NMR (CDCl3, 75 MHz) δ 156.2, 144.9, 140.7, 
133.4, 131.0, 130.0, 128.1, 79.2, 69.0, 40.8, 34.8, 34.1, 34.1, 32.7, 32.5, 28.9, 28.7, 
26.9, 26.8, 21.9. 
(Z
cyclohepta[d]azocine-3(7H)-carboxylate (5.77) 
 
A solution of (Z)-2-(2-(3-(t
methybenzenesulfonate (300 mg, 0.66 mmol, 1.0 eq.) in THF (9 mL) was dropwise 
added to an ice cold suspension of (pentane washed) NaH (115 mg of a 60% NaH 
dispersion in oil, corresponding to 65 mg NaH, 2.9 mmol, 4.3 eq.) in THF (28 mL). 
The resulting mixture was refluxed over 3½ h, recooled to 0 oC, carefully quenched 
with a saturated NH4Cl aqueous solution (5 mL) and extracted with a pentane:Et2O 
1:1 (v:v) solution (2 portions of 60 mL). The combined organic layers were washed 
with brine (20 mL), dried (Na2SO4) and the solvents were removed under vacuum. 
The residue obtained was purified by flash chromatography (pentane:Et2O, 2:1 (v:v); 
OTs
NHBoc
N
Boc
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f (hexane:Et2O, 1:2 (v:v)) 0.68; 1H-NMR (CDCl3, 300 MHz) δ 3.26-3.48 (m, 2H), 
tert-Butyl 4,10-dioxoazacyclotridecane-1-carboxylate (5.78) 
 solution of (Z)-tert-Butyl 1,2,5,6,8,9,10,11-octahydro-4H-
n
f (hexane:Et2O, 1:2 (v:v)) 0.17; 1H-NMR (CDCl3, 300 MHz) δ 3.40 (t, J = 5.8 Hz, 
Salt (5.79) 
 solution of tert-butyl 4,10-dioxoazacyclotridecane-1-
u
vacuum to approxima
demetallated silica gel). The title compound was obtained as a colorless oil (132 mg, 
72%). 
 
R
3.09-3.26 (m, 2H), 2.02-2.29 (m, 8H), 1.61-1.81 (m, 4H); 1.38-1.56 (m, 13H); 13C-
NMR (CDCl3, 75 MHz) δ 155.2, 131.7, 130.4, 79.4, 49.2, 48.3, 33.7, 32.5, 32.2, 31.8, 
28.6, 28.5, 29.0, 27.3, 26.6. 
 
 
A
cyclohepta[d]azocine-3(7H)-carboxylate (5.77) (60 mg, 0.21 
mmol, 1.0 eq.) in CH2Cl2 (4 mL) and MeOH (1.3 mL) was 
d Ocooled to -78 oC a 3 was bubbled until a persistent pale blue color was seen 
(typically 15 min.). Argon was then bubbled for 5 min., DMS (79 μL, 1.1 mmol, 5 
eq.) was added and stirring continued at the same temperature for 10 min. The 
reaction was allowed to warm to room temperature over 2 h, partitioned between 
CH2Cl2 (10 mL) and aqueous ½ saturated brine (10 mL). The organic layer was dried 
(Na2SO4), the solvent removed under vacuum affording a colorless oil (67 mg, 
quantitative). 
 
R
2H), 3.17 (t, J = 6.3 Hz, 2H), 2.68 (t, J = 5.8 Hz, 2H), 2.32-2.41 (m, 4H), 2.28 (t, J = 
7.4 Hz, 2H), 1.52-1.73 (m, 6H), 1.4 (s, 9H), 1.24 (´quint´, J = 6.9 Hz, 2H); 13C-NMR 
(CDCl3, 75 MHz) δ 212.5, 210.6, 156.4, 80.1, 49.1, 44.3, 42.7, 42.1, 41.9, 38.5, 28.7, 
26.8, 23.9, 23.3, 22.3. 
 
 
A
carboxylate (5.78) (20 mg, 0.064 mmol, 1.0 eq.), TFA (95 μL, 
1.24 mmol, 19.4 eq.), SMe2 (50 μL, 0.69 mmol, 10.8 eq.) in 
CH2Cl2 (0.5 mL) was stirred at 0 oC for 2 h and 24 h at room 
tion was diluted with toluene (25 mL) and concentrated under 
tely 1/5 of its initial volume, after which this procedure was 
repeated. Removal of the solvent under reduced pressure delivered the crude salt 
(5.79) (38 mg). 
 
temperature. The sol
N
O
O
Boc
N
H
O O
H
H H
tBuSMe2, 2CF3CO2
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3, 200 MHz) δ 11.0 (brs, 2H), 4.15 (brt, 2H), 3.85 (t, 2H), 3.15 (t, 1H-NMR (CDCl
2H), [2.8 (s, 6H) (from tBuS+Me2)], 2.80 (t, 2H), 2.10-2.50 (m, 6H), 1.65-1.85 (m, 
4H), [1.60 (s, 9H) (from tBuS+Me2)]; 13C-NMR (CDCl3, 75 MHz) δ 178.3, 
[160.1,160.9, 160.1, 159.4], 157.0, 122.5, 118.9, 113.1, 58.5, 54.1, 43.4, 34.6, 30.7, 
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Indole 25, an advanced intermediate in a projected enantioselective total synthesis of lyngbyatoxin A 1,
was prepared from allylic alcohol 11 in 9 steps and >95% ee, key transformations being the
enantiospeciﬁc rearrangement of vinyl epoxide 14 and the Hemetsberger–Knittel reaction of azide 24.
Introduction
The Hawaiian blue–green alga Lyngbya majuscula Gomont is
implicated in the occasional outbreaks of a severe contact
dermatitis commonly known as “swimmers’ itch”.1 One of the
causative agents for this condition is lyngbyatoxin A 1 (Fig. 1), an
alkaloid ﬁrst isolated in 1979 by Moore and co-workers from the
lipid extract of seaweed.2
Fig. 1 Structure of lyngbyatoxin A.
Lyngbyatoxin A is also a potent tumor promoter3 and, like
other indolactam alkaloids, exerts its biological activity through
activation of protein kinase C (PKC), a family of phosphory-
lating enzymes involved in the regulation of important cellular
processes.4 Investigation of the structural requirements for the
selective activation/inhibition of each PKC isotype is currently
an important goal in pharmaceutical research.5 This interesting
biological proﬁle combinedwith a challengingmolecular structure
makes lyngbyatoxin A and its analogues worthy targets for the
synthetic community.5,6
A critical step in any enantioselective approach towards lyng-
byatoxin A concerns the installation of the quaternary carbon at
C-14.7,8 We have previously addressed this issue by means of the
Jung rearrangement9 of chiral vinyl epoxides carrying an indole
moiety, but this approach was plagued by substantial loss of
enantiomeric purity during the rearrangement step.10 Herein we
report a successful (>95% ee) “second generation” approach to
this problem, involving epoxide rearrangement prior to formation
of the indole unit.
According to the simpliﬁed retrosynthetic analysis shown in
Scheme 1, the target molecule was envisioned to arise from indole
Department of Chemistry, Technical University of Denmark, Building 201,
Kemitorvet, DK-2800, Kgs. Lyngby, Denmark. E-mail: dt@kemi.dtu.dk;
Fax: +45-45933968
2 via functional group manipulation. Key intermediate 2 would
be obtained from aldehyde 3 by means of a Hemetsberger–Knittel
reaction,11 while the quaternary carbon stereocentre was planned
tobe accessed via the enantiospeciﬁc Jung rearrangement9 of chiral
vinyl epoxide 4, itself available from allylic alcohol 5 by means
of the Sharpless asymmetric epoxidation reaction;12 a suitably
functionalised acetophenone 6 was to be the starting point for
the synthesis.
Scheme 1 Simpliﬁed retrosynthetic analysis for lyngbyatoxin A.
Results and discussion
After considerable experimentation to determine which functional
groups on the aromatic ring would be compatible with the above
strategy, the combination X = Br, Y = I (Scheme 1) was chosen.
Since the quaternary centre was planned to be installed by a
“chirality transfer” process, the enantiomeric purity of the starting
vinyl epoxide is critical, and this was the ﬁrst issue to be addressed
(Scheme 2).
Following a literature procedure,13 p-aminoacetophenone 7
was treated with ICl to afford the corresponding iodinated
aniline 8 in good yield. Amine–halogen exchange was then
accomplished under Sandmeyer conditions14 (NaNO2 followed
by CuBr, in conc. HBr) to deliver ketone 9 in 86% yield. A
Horner–Wadsworth–Emmons reaction15 with the sodium salt of
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Scheme 2 Reagents and conditions: (a) ICl, CaCO3 aq., MeOH, rt, 86%;
(b) NaNO2 aq., HBr conc., −10 ◦C to 0 ◦C, then CuBr, HBr conc., 80 ◦C,
86%; (c) NaH, (EtO)2P(O)CH2CO2Et, THF, 0
◦C to rt, 64%; (d) DIBAL,
Et2O, 0
◦C to rt, 96%; (e) L-(+)-DET, 4 A˚MS, Ti(OiPr)4, tBuOOH,CH2Cl2,
−20 ◦C; quant. (crude), 92–94% ee.
triethylphosphonoacetate delivered a mixture of the correspond-
ing E : Z a,b-unsaturated esters in an unoptimised 3.7 : 1 ratio.
These isomers could be separated easily by ﬂash chromatography,
allowing the isolation of pure E-unsaturated ester 10 in 64%
yield. Reduction of the ester functionality with DIBAL proceeded
uneventfully, providing allylic alcohol 11 in excellent yield. We
were then pleased to ﬁnd that the key asymmetric epoxidation
step12 delivered 12 as a highly crystalline product in essentially
quantitative yield and with 92–94% ee, as determined by chiral
HPLC. A single recrystallisation from hot hexane–Et2O 2 : 1 (v :
v) yielded material which was enantiomerically pure within the
limits of detection.
Having secured our ﬁrst chiral intermediate, we proceeded to
investigate the installation of the all-carbon quaternary centre of
the target (Scheme 3).8
Scheme 3 Reagents and conditions: (a) (COCl)2, DMSO then Et3N,
CH2Cl2, −78 ◦C; (b) Ph3PCH3Br, KHMDS, THF, 0 ◦C; (c) BF3·Et2O,
CH2Cl2, −78 ◦C, 52% (based on 12); (d) NaBH4, MeOH, 0 ◦C to rt, 81%.
Conversion of allylic epoxide 12 to vinyl epoxide 14 was
accomplished using the conditions previously reported9,10 for this
type of substrate. Swern oxidation16 of 12 delivered epoxy aldehyde
13, which upon Wittig reaction17 with KHMDS as base gave 14.
Due to the lability of compounds 13 and 14, these were either used
directly or submitted to rapid ﬁltration through a short column
of silica gel. Subjection of vinyl epoxide 14 to the conditions
developed by Jung for the rearrangement reaction9 (BF3·Et2O,
CH2Cl2, −78 ◦C) delivered aldehyde 15 as the sole product in 52%
yield based on 12. Aldehyde 15 was not suitable for prolonged
storage, even at low temperature, so it was routinely subjected to
NaBH4 reduction to the corresponding primary alcohol 16. To
determine if the rearrangement had proceeded with complete 1,2-
chirality transfer, alcohol 16 was derivatized with the Alexakis
reagent 17a18 to the phosphorous adduct 17b. Whereas the 31P-
NMR spectrum of racemic 17b, prepared by MCPBA epoxidation
of 11 followed by an identical sequence of steps, showed two peaks
of equal intensity at 139.0 and 138.8 ppm, only the higher-ﬁeld
peak was present for 17b produced via the Sharpless epoxidation.
This result implies that the desired vinyl migration in conformer
19, where themigrating group is correctly alignedwith the adjacent
vacant p orbital, proceeds signiﬁcantly faster than conformer
equilibration. The latter process would result in the population
of conformer 21, thus leading to vinyl migration onto the
enantiotopic face of the planar carbocation and in the undesired
formation of ent-15 (Scheme 4).
Scheme 4 Intermediate 18 is formed from 14 and BF3·Et2O, giving 15 via
conformer 19.
With the quaternary centre installed in an enantioselective
manner, we then attended to the construction of the indole nucleus
(Scheme 5).19
Treatment of the (crude) primary alcohol 16 with TBSCl and
imidazole20 delivered silyl ether 22 in 80% yield based on 15.
Our annelation strategy calls for a benzaldehyde derivative, and
we planned to introduce the required formyl group via a regio-
and chemo-selective halogen–lithium exchange.21 Somewhat un-
expectedly, this step proved to be very problematic. When the
standard conditions for this transformation were used (BuLi,
DMF, THF–Et2O or THF, −100 ◦C or −78 ◦C, respectively),
only a complex mixture, containing at best trace amounts of the
expected aldehyde 22, was obtained. After extensive model studies
with o-bromoiodobenzene, we eventually found that when the
reaction was carried out in toluene at approximately −100 ◦C the
competing benzyne formation was comparatively slow, and thus
the initially formed lithiated species could be successfully trapped
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Scheme 5 (a) TBSCl, imid., DMF, rt, 80% (based on 15); (b) BuLi then
DMF, PhMe, approx.−100 ◦C, 65–71%; (c)N3CH2CO2Et,NaOEt, EtOH,
−15 ◦C to −10 ◦C, 60%; (d) xylene, 140 ◦C, 69%.
with DMF.22 Using these conditions, aldehyde 23 was ﬁnally
obtained reproducibly in 65–71% yield. Subsequent NaOEt-
promoted condensation with excess ethyl azidoacetate at low
temperature afforded azide 24 in 60% yield, thus setting the
stage for the planned Hemetsberger–Knittel reaction.11 This was
accomplished by heating 24 in xylene, which smoothly furnished
indole 25 in 69% yield.
Indole 25 is conveniently functionalised so as to allow its
conversion into lyngbyatoxin A: the C-3 indolic position is
intrinsically nucleophilic,23 whereas the bromine at C-4 provides
a suitable handle for insertion of the amino functionality;24
furthermore, the TBDMS-protected alcohol moiety will allow the
construction of the linalyl appendage (Fig. 2).
Fig. 2 Planned manipulations to convert indole 25 into lyngbyatoxin A.
Conclusion
The synthesis of enantiomerically pure indole 25, a late key
intermediate in the enantioselective total synthesis of lyngbyatoxin
A, was accomplished in 9 steps from the readily available allylic
alcohol 11. The salient features of this route are (i) Sharpless
asymmetric epoxidation for initial introduction of chirality, (ii)
completely enantiospeciﬁc Jung rearrangement of chiral epoxide
14 to install the all-carbon quaternary centre of the target
molecule, (iii) formylation of 22 via chemo- and regio-selective
halogen–lithium exchange, and (iv) clean formation of the indole
nucleus through the Hemetsberger–Knittel reaction. To the best
of our knowledge, this is the ﬁrst example of stereocontrolled
generation of the characteristic all-carbon quaternary centre of
lyngbyatoxin A, thus solving a long-standing problem in the
synthesis of this biologically signiﬁcant alkaloid.
Experimental
General
All moisture- and air-sensitive reactions were carried out under an
argon atmosphere using oven-dried or ﬂame-dried glassware. Re-
action solvents were distilled prior to use by standard procedures.
Et2O, THF and toluene were distilled under nitrogen from sodium
benzophenone. CH2Cl2 and NEt3 were distilled under nitrogen
from CaH2. Anhydrous DMSO and DMF were purchased from
Aldrich and stored over 4 A˚ molecular sieves, under argon.
1H-NMR (300 MHz and 500 MHz) and 13C-NMR (75 MHz)
spectra were recorded on either a Varian Mercury 300 (300 MHz)
or a Varian Inova 500 (500 MHz) spectrometers at ambient
temperature. 31P-NMR (202 MHz) spectra were recorded on a
Varian Inova 500 (500MHz) spectrometer at ambient temperature.
Chemical shifts (d) are reported in ppm. Undeuterated solvent
residues were used as internal standard (CHCl3, 1H: 7.27 ppm and
13C: 77.0 ppm). H3PO4 (30% aq., 0.0 ppm) was used as external
standard for 31P-NMR. Coupling constants (J) are given in Hertz
(Hz). Optical rotations were measured with a Perkin Elmer 241
polarimeter at ambient temperature, and the concentration (c)
is given in g per 100 mL. Analytical high performance liquid
chromatography (HPLC) was performed using a Varian 9012
solvent delivery system with a Varian 9065 polychrome diode
array detector. HPLC grade solvents were obtained from LAB-
SCAN. Electron impact (EI) low resolution mass spectra (LRMS)
were performed with a VG Trio-2 single quadrupole instrument at
the Department of Chemistry, Technical University of Denmark.
Melting points of crystalline materials were determined on a
Heidolph capillary melting point apparatus and are uncorrected.
Analytical thin layer chromatography (TLC) analyses were per-
formed using 0.25 mm Merck Kieselgel aluminium-backed 60
F254 silica gel plates. Visualization was achieved by i) exposure
to UV light, ii) brief exposure to iodine vapors, iii) dipping into
a solution of 5–10% of phosphomolybdic acid in EtOH, and iv)
gentle heating. Merck silica gel 60 (40–63 lm, 230–400 mesh)
was used for ﬂash chromatography puriﬁcation. Preparative thin
layer chromatography (PTLC) was performed on 20 × 20 cm,
1500 lm glass-backed plates with ﬂuorescent indicator (Aldrich).
Microanalyses were performed at the Microanalysis Laboratory,
Institute of Physical Chemistry, University of Vienna, Austria.
Molecular sieveswere dried at 150–160 ◦C for at least 12 h and then
allowed to reach room temperature under argon. Unless otherwise
stated, commercially available reagents, purchased from Aldrich,
Fluka orMerck, were usedwithout further puriﬁcation. “Aqueous
1
2
saturated brine” and “aqueous 1
3
saturated NaHCO3” refer to
a water–brine, 1 : 1 (v : v) and water–saturated NaHCO3, 2 : 1
(v : v) solutions, respectively. The following cooling baths were
used: ether–liquid nitrogen (ca. −110 to −85 ◦C); acetone–dry
ice (typically for −78 ◦C but also for temperatures above); ortho-
dichlorobenzene–liquid nitrogen (ca. −25 ◦C). Commercial NaH
(as a 60% dispersion in oil) was washed with pentane (2 portions
that cover the amount of NaH dispersion used), and the last traces
of pentane were removed under high vacuum.
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4-Bromo-3-iodoacetophenone (9). i) Preparation of the diazo-
nium salt. To a suspension of 4-acetyl-2-iodoaniline 813 (8.45 g,
32.3 mmol) in aqueous 47% HBr (77 mL) at −10 ◦C was added
dropwise, over 15 min, a solution of NaNO2 (2.65 g, 38.0 mmol,
1.18 eq.) in water (35 mL). The deep-tan mixture obtained was
stirred for 10 min at this temperature, after which the temperature
was allowed to increase from −5 ◦C to 0 ◦C and stirring continued
for a further 1.5 h. The obtained mixture was then kept at
ice bath temperature. ii) Sandmeyer reaction. To a vigorously
stirred (purple) mixture of CuBr (5.57 g, 38.8 mmol, 1.2 eq.) in
aqueous 47% HBr (42 mL) at 60 ◦C was added portion-wise,
over 50 min, the above diazonium suspension (caution: signiﬁcant
frothing occurred during additions), after which the temperature
was increased to 80 ◦C and stirring continued for a further 25 min.
The resulting darkmixturewas cooled to ice-bath temperature and
partitioned between water (400 mL) and EtOAc (400 mL). The
aqueous layer was extracted with EtOAc (2 portions of 150 mL)
and the combined organic layers were washed with aqueous 1 M
HCl (300 mL), aqueous saturated NaHCO3 (200 mL), aqueous 12
saturated brine (250 mL), dried (MgSO4) and concentrated under
vacuum to afford a light-tan solid residue which was puriﬁed by
ﬂash chromatography (hexane–EtOAc, 1 : 1 (v : v)). The title
compound was obtained as a pale yellow solid (9.0 g, 86%). Rf
(hexane–EtOAc, 1 : 1 (v : v)) 0.55;mp 79–82 ◦C; 1H-NMR (CDCl3,
300MHz) d 8.39 (d, J = 2.0Hz, 1H), 7.76 (dd, J = 8.2, 2.0Hz, 1H),
7.71 (d, J = 8.2 Hz, 1H), 2.57 (s, 3H); 13C-NMR (CDCl3, 75 MHz)
d 196.0, 140.3, 137.1, 135.7, 133.1, 129.1, 101.9, 26.8; LRMS (EI)
m/z = 324 [M]+; Anal. Calcd. for C8H6BrIO: C, 29.57; H, 1.86.
Found: C, 29.18; H, 2.01.
(E)-Ethyl 3-(4-bromo-3-iodophenyl)but-2-enoate (10). To an
ice-cold suspension of NaH (766 mg, 31.9 mmol, 1.3 eq.) in
THF (45 mL) was added dropwise , over 15 min, a solution of
triethylphosphonoacetate (7.16 g, 31.9 mmol, 1.3 eq.) in THF
(5 mL) during which gas evolution was observed. The resulting
pale yellow solution was stirred at ice bath temperature for 15 min
and at room temperature for a further 15 min, after which a
solution of 4-bromo-3-iodoacetophenone 9 (7.98 g, 24.6 mmol,
1.0 eq.) in THF (35 mL) was added dropwise at room temperature
over 10 min. The dark-tan mixture obtained was stirred at
room temperature overnight (for convenience), after which it was
partitioned between Et2O (450 mL) and aqueous 12 saturated brine
(500 mL). The aqueous layer was extracted with Et2O (2 portions
of 100 mL) and the combined organic phases were washed with
brine (200 mL), dried (MgSO4) and the solvent removed under
vacuum to afford a dark tan oil. Puriﬁcation by (repeated) ﬂash
chromatography (hexane–Et2O, 3 : 1 (v : v)) delivered pure (E)-
(6.2 g, 64% as a white solid) and (Z)-(1.7 g, 17% as a yellow
oil) isomers. Combined yield: 81%. For (E)-ethyl 3-(4-bromo-3-
iodophenyl)but-2-enoate 10: Rf (hexane–Et2O, 3 : 1 (v : v)) 0.51;
mp 39–42 ◦C; 1H-NMR (CDCl3, 300 MHz) d 7.93 (d, J = 2.2 Hz,
1H), 7.59 (d, J = 8.3 Hz, 1H), 7.28 (dd, J = 2.2, 8.3 Hz, 1H), 6.08
(q, J = 1.3 Hz, 1H), 4.21 (q, J = 7.1 Hz, 2H), 2.50 (d, J = 1.3 Hz,
3H), 1.31 (t, J = 7.1 Hz, 2H); 13C-NMR (CDCl3, 75 MHz) d 166.5,
152.8, 142.8, 138.2, 132.8, 130.5, 127.5, 118.6, 101.7, 60.4, 18.0,
14.6; LRMS (EI) m/z = 394 [M]+; Anal. Calcd. for C12H12BrIO2:
C, 36.49; H, 3.06. Found: C, 36.63; H, 3.15.
(E)-3-(4-Bromo-3-iodophenyl)but-2-en-1-ol (11). To an ice-
cold solution of (E)-ethyl 3-(4-bromo-3-iodophenyl)but-2-enoate
10 (5.83 g, 14.8 mmol, 1.0 eq.) in Et2O (45 mL) was added
dropwise, over 20 min, a solution of DIBAL in toluene (1.0 M,
34.5 mL, 2.3 eq.). The solution obtained was allowed to reach
room temperature and stirred for a further 2.5 h, after which it
was re-cooled to ice bath temperature, diluted with Et2O (60 mL)
and quenched by careful addition of brine (50 mL). After vigorous
stirring for 5 min a gel-type biphasic system formed, to which was
then carefully added aqueous 4 M HCl (80 mL), and the mixture
was stirred at 0 ◦C for 10 min and then at room temperature
until a clear biphasic system was obtained (typically 20 min). The
aqueous layer was extracted with Et2O (2 portions of 40 mL), the
combined organic layers were washed with brine (40 mL), dried
(MgSO4) and the solvent removed under vacuum to afford a very
pale yellow oil. Puriﬁcation by ﬂash chromatography (hexane–
EtOAc, 1 : 1 (v : v)) afforded the title compound as a white solid
(5.0 g, 96%). Rf (hexane–EtOAc, 1 : 1 (v : v)) 0.30; mp 62–64 ◦C;
1H-NMR (CDCl3, 300 MHz) d 7.81 (d, J = 2.2 Hz, 1H), 7.47 (d,
J = 8.4 Hz, 1H), 7.15 (dd, J = 2.2, 8.4 Hz, 1H), 5.88 (tq, J =
1.4, 6.6 Hz, 1H), 4.26–4.30 (m, 2H), 1.94–1.95 (m, 3H); 13C-NMR
(CDCl3, 75 MHz) d 143.6, 137.8, 135.5, 132.5, 128.4, 128.3, 127.1,
101.5, 60.1, 16.1; LRMS (EI) m/z = 352 [M]+; Anal. Calcd. for
C10H10BrIO: C, 34.03; H, 2.86. Found: C, 33.98; H, 2.72.
((2S,3S)-3-(4-Bromo-3-iodophenyl)-3-methyloxiran-2-yl)metha-
nol (12). To a suspension of powdered 4 A˚ molecular sieves
(472 mg) in CH2Cl2 (47 mL) at −25 ◦C was added dropwise
a solution of L-(+)-diethyl tartrate (124 mg, 0.60 mmol, 7.5
mol%) in CH2Cl2 (1.5 mL), followed by Ti(OiPr)4 (117 lL,
0.4 mmol, 5 mol%) and ﬁnally a freshly prepared solution of
tBuOOH in toluene25 (4.2 ml, 15.9 mmol, 2.0 eq.) with 5 min
intervals between additions. After 1.5 h at −25 ◦C, a solution of
(E)-3-(4-bromo-3-iodophenyl)but-2-en-1-ol 11 (2.8 g, 7.93 mmol,
1.0 eq.) in CH2Cl2 (7 mL) was added dropwise over 20 min and
stirring continued for a further 4 h at this temperature. The
reaction was quenched at −25 ◦C by addition of aqueous 10%
NaOH in brine (0.73 mL) followed by Et2O (4.5 mL). After
stirring at −25 ◦C for 5 min, this suspension was allowed to reach
5 ◦C over 10 min, and then mgSO4 (633 mg) and Celite (84 mg)
were simultaneously added. After stirring at room temperature for
10 min, the suspension was ﬁltered through a short pad of Celite,
and the ﬁltrate was concentrated under vacuum to afford a turbid
pale yellow oil which was then taken up in toluene (2 portions
of 150 mL) and concentrated under vacuum. The crude product
was obtained as a white solid (2.91 g, quantitative, 92–94% ee),
which typically was used without further puriﬁcation. If desired,
it can be re-crystallized from hot hexane–Et2O, 2 : 1 (v : v)
(approximately 300 mL) affording the title compound as white
needles (2.6 g, 91%, >99% ee). Rf (hexane–EtOAc, 1 : 1 (v : v);
double elution) 0.50; mp 59–61 ◦C; 1H-NMR (CDCl3, 300 MHz)
d 7.75 (d, J = 2.1 Hz, 1H), 7.50 (d, J = 8.3 Hz, 1H), 7.11 (dd, J =
2.1, 8.3 Hz, 1H), 3.88 (dd, J = 4.4, 12.2 Hz, 1H), 3.75 (dd, J =
6.3, 12.2 Hz, 1H), 2.96 (dd, J = 4.4, 6.3, 1H), 1.93 (bs, 1H), 1.59
(s, 3H); 13C-NMR (CDCl3, 75 MHz) d 143.1, 137.2, 132.7, 129.0,
126.7, 101.5, 66.1, 61.3, 59.9, 17.7; LRMS (EI) m/z = 368 [M]+;
[a]25D −9.2 (c 2.2, CHCl3); Anal. Calcd. for C10H10BrIO2: C, 32.55;
H, 2.73. Found: C, 32.61; H, 2.67. HPLC retention times (Rt):
For the (2S,3S) enantiomer: Rt (OD-H column; hexane–iPrOH,
97 : 3 (v : v); 0.6 mL min−1) = 57.7 min.
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rac-3-(4-Bromo-3-iodophenyl)-3-methyloxiran-2-yl)methanol
(12). To an ice-cold suspension of commercial MCPBA (722 mg,
approximately 3.68 mmol of MCPBA, approximately 1.3 eq.)
in CH2Cl2 (6 mL) was added dropwise a solution of (E)-3-(4-
bromo-3-iodophenyl)but-2-en-1-ol 11 (1.0 g, 2.83 mmol, 1.0 eq.)
in CH2Cl2 (6 mL). The suspension obtained was stirred at ice
bath temperature for 15 min and then allowed to reach room
temperature, stirred for a further 3.5 h, after which it was re-
cooled to −5 ◦C and ﬁltered through a short pad of Celite. To
the pale yellow ﬁltrate obtained was added Ca(OH)2 (80 mg)
and this suspension was stirred for 5 min at −5 ◦C, after
which a small portion of Na2SO4 was added and stirring was
continued for a further 5 min at this temperature. After ﬁltration
through a short pad of Celite, the solvent was removed under
vacuum to afford a viscous yellow oil which, upon standing
under high vacuum, crystallized. Puriﬁcation by short-column
chromatography ﬁltration (silica gel; fast elution; hexane–EtOAc,
1 : 1 (v : v) with 2% NEt3) afforded the title compound as a white
solid (950 mg, 91%). HPLC retention times (Rt): For the (2R,3R)
enantiomer: Rt (OD-H column; hexane–iPrOH, 97 : 3 (v : v);
0.6 mL min−1) = 51.7 min. For the (2S,3S) enantiomer: Rt (OD-H
column; hexane–iPrOH, 97 : 3 (v : v); 0.6 mL min−1) = 57.7 min.
(2R,3S)-3-(4-Bromo-3-iodophenyl)-3-methyloxirane-2-carbalde-
hyde (13). A solution of oxalyl chloride (1.78 mL, 20.28 mmol,
2.0 eq.) in CH2Cl2 (90 mL) was cooled to −78 ◦C and treated
with a solution of DMSO (2.9 mL, 40.8 mmol, 4.0 eq.) in
CH2Cl2 (7 mL) over 15 min, during which period gas evolution
was observed. After stirring at this temperature for 15 min, a
solution of ((2S,3S)-3-(4-bromo-3-iodophenyl)-3-methyloxiran-
2-yl)methanol 12 (3.76 g, 10.19 mmol, 1.0 eq.) in CH2Cl2
(25 mL) was added dropwise over a period of 0.5 h, after which
a turbid-white mixture was obtained. This mixture was stirred
at −78 ◦C for 0.5 h, after which pre-cooled Et3N (11.26 mL,
81.52 mmol, 8.0 eq.) was added dropwise over 10 min, and the
resulting mixture was then allowed to warm to −30 ◦C over 1 h.
The yellow mixture obtained was poured at this temperature onto
hexane (140 mL) and CH2Cl2 (200 mL) and gently shaken with
pH 7 phosphate buffer (80 mL). The layers were separated and
the aqueous layer extracted with CH2Cl2 (2 portions of 30 mL).
The combined organic layers were washed with aqueous 1 M
KHSO4 (2 portions of 150 mL), aqueous 13 saturated NaHCO3
(2 portions of 30 mL), brine (150 mL) and dried (Na2SO4).
Removal of the solvent under vacuum afforded a thick yellow oil
which was crudely puriﬁed via a short-column chromatography
ﬁltration (silica gel; fast elution; hexane–EtOAc, 1 : 1 (v : v)
with 2% NEt3) to afford a thick pale yellow oil that eventually
crystallized upon standing in the cold (3.40 g) and was used
without further puriﬁcation. Rf (hexane–EtOAc, 1 : 1 (v : v))
0.57; 1H-NMR (CDCl3, 300 MHz) d 9.64, (d, J = 4.0 Hz, 1H),
7.96 (d, J = 2.2 Hz, 1H), 7.73 (d, J = 8.3 Hz, 1H), 7.40 (dd, J =
2.2, 8.3 Hz, 1H), 3.48 (d, J = 4.0, 1H), 1.82 (s, 3H); 13C-NMR
(CDCl3, 75 MHz) d 205.6, 142.2, 137.5, 132.9, 129.2, 127.3, 101.1,
66.2, 62.0, 16.9; LRMS (EI) m/z = 366 [M]+.
(2R,3S)-3-(4-bromo-3-iodophenyl)-2-methyl-3-vinyloxirane (14).
To an ice-cold slurry of methyltriphenylphosphonium bromide
(4.97 g, 13.90mmol, 1.5 eq.) inTHF (100mL)was addeda solution
of KHMDS in toluene (0.5 M, 24.1 mL, 1.3 eq.) over 15 min.
The bright-yellow suspension obtained was allowed to reach room
temperature and stirred for a further 1.5 h, after which it was re-
cooled to 0 ◦C and a solution of (crudely puriﬁed) (2R,3S)-3-(4-
bromo-3-iodophenyl)-3-methyloxirane-2-carbaldehyde 13 (3.33 g,
9.1mmol, 1.0 eq.) in THF (17mL)was then added dropwise over a
10 min period. The tan suspension obtained was allowed to reach
room temperature and stirred for a further 1.5 h, after which it
was re-cooled to ice bath temperature and ﬁltered through a short
Celite pad to afford a deep-red solution. Removal of the solvent
under vacuum afforded a tan oil, which was crudely puriﬁed by
short-column chromatography ﬁltration (silica gel; fast elution;
Et2O) to afford a tan oil that was used without further puriﬁcation
(2.97 g). Rf (hexane–Et2O, 3 : 1 (v : v)) 0.60; 1H-NMR (CDCl3,
300 MHz) d 7.84 (d, J = 2.2 Hz, 1H), 7.57 (d, J = 8.3 Hz, 1H),
7.19 (dd, J = 2.2, 8.3 Hz, 1H), 5.82 (sept, J = 7.0, 10.5, 17.3 Hz,
1H), 5.51 (ddd, J = 0.9, 1.4, 17.3 Hz, 1H), 5.44 (ddd, J = 0.8, 1.4,
10.5 Hz, 1H), 3.24 (d, J = 7.0 Hz, 1H), 1.62 (s, 3H); 13C-NMR
(CDCl3, 75 MHz) d 143.4, 137.2, 133.8, 132.7, 132.5, 126.7, 121.7,
121.7, 101.5, 67.0, 61.3, 17.5; LRMS (EI) m/z =364 [M]+.
(R)-2-(4-bromo-3-iodophenyl)-2-methylbut-3-enal (15). To a
−78 ◦C cooled solution of (crudely puriﬁed) (2R,3S)-3(4-bromo-
3-iodophenyl)-2-methyl-3-vinyloxirane 14 (2.81 g, 7.70 mmol,
1.0 eq.) in CH2Cl2 (110 mL) was added BF3·Et2O (1.1 mL,
8.68 mmol, 1.12 eq.) and the resulting deep-pinkish solution was
stirred at this temperature for 10 min, after which it was poured
onto Et2O (300 mL) and aqueous 13 saturated NaHCO3 (200 mL).
The layers were separated and the aqueous phase was extracted
with Et2O (2 portions of 60mL). The combined Et2O extracts were
washed with brine (100 mL), dried (Na2SO4) and concentrated to
a golden oil, which was then puriﬁed by ﬂash chromatography
(hexane–Et2O, 3 : 1 (v : v)) to afford the title compound as a
pale yellow oil (1.9 g, 52% based on allylic alcohol 12) that was
either best kept frozen in a benzene matrix under argon or used
immediately.Rf (hexane–Et2O, 3 : 1 (v : v)) 0.47; 1H-NMR (CDCl3,
300 MHz) d 9.52, (s, 1H), 7.71 (d, J = 2.2 Hz, 1H), 7.60 (d, J =
8.3 Hz, 1H), 7.07 (ddd, J = 0.4, 2.2, 8.3, Hz, 1H), 6.12 (ddd, J =
0.40, 10.7, 17.6 Hz, 1H), 5.46 (d, J = 10.7, 1H), 5.20 (d, J =
17.6, 1H), 1.51 (s, 3H); 13C-NMR (CDCl3, 75 MHz) d 198.5 141.1,
139.5, 137.4, 133.1, 129.2, 129.0, 118.7, 102.2, 57.4, 20.4; LRMS
(EI) m/z = 337 [M − C2H3]+; [a]25D +27.8 (c 1.3, CHCl3).
(R)-2-(4-Bromo-3-iodophenyl)-2-methylbut-3-en-1-ol (16). A
solution of (R)-2-(4-bromo-3-iodophenyl)-2-methylbut-3-enal 15
(1.18 g, 3.23 mmol, 1.0 eq.) in MeOH (35 mL) at 0 ◦C was treated
with NaBH4 (114 mg, 3.0 mmol, 0.9 eq.). After stirring for 15 min
at ice bath temperature, the solution was allowed to warm to
room temperature and stirred for a further 2 h, at which time
it was concentrated to half of its initial volume and partitioned
between water (15 mL) and Et2O (50 mL). The aqueous layer
was extracted with Et2O (20 mL) and EtOAc (20 mL) and the
combined organic phases were washed with brine (10 mL), dried
(NaSO4) and concentrated under vacuum to afford a yellow oil
residue which typically was used without further puriﬁcation.
For analytical purposes the crude product was puriﬁed by ﬂash
chromatography on silica gel (hexane–EtOAc, 1 : 1 (v : v)) (960mg,
81%). Rf (hexane–EtOAc, 1 : 1 (v : v)) 0.52; 1H-NMR (CDCl3,
300 MHz) d 7.81 (d, J = 2.3 Hz, 1H), 7.55 (d, J = 8.4 Hz, 1H),
7.20 (dd, J = 2.3, 8.4 Hz, 1H), 5.98 (dd, J = 10.8, 17.6 Hz, 1H),
5.30 (dd, J = 0.9, 10.8, 2H), 5.14 (dd, J = 0.9, 17.6, 1H), 3.74
(s, 2H), 1.38 (s, 3H); 13C-NMR (CDCl3, 75 MHz) d 145.9, 142.6,
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139.3, 132.6, 128.7, 127.9, 115.9, 101.7, 69.7, 46.8, 22.9; LRMS
(EI) m/z = 368 [M]+.
Determination of the ee of alcohol (16) using theAlexakis reagent.
To the Alexakis reagent18 (0.10 mL of a 0.2 M solution in benzene,
0.02 mmol, 1.1 eq.) was added a solution of (R)-2-(4-bromo-
3-iodophenyl)-2-methylbut-3-en-1-ol 16 (7.0 mg, 0.018 mmol,
1.0 eq.) in benzene (0.2 mL) and the resulting solution was
left stirring at room temperature under argon for 15 h. The
resulting solution was then transferred into an NMR tube and
approximately 100 lL of C6D6 were added for locking. For rac-17:
31P-NMR (C6D6, 202 MHz) d 139.0 and 138.8 (equal intensities).
For 17: 31P-NMR (C6D6, 202 MHz) d 138.8.
(R)-(2-(4-Bromo-3-iodophenyl)-2-methylbut-3-enyloxy)(tert-
butyl)dimethylsilane (22). To a solution of TBDMSCl (131 mg,
0.89 mmol, 1.3 eq.) and imidazole (122 mg, 1.77 mmol, 2.6 eq.) in
DMF (0.65 mL) was added a solution of (crude) (R)-2-(4-bromo-
3-iodophenyl)-2-methylbut-3-en-1-ol 16 (245 mg, 0.66 mmol,
1.0 eq.) in DMF (1.35 mL) at room temperature. After stirring
at this temperature for 7 h, the resulting solution was partitioned
between aqueous 1MHCl (15mL) andEt2O (25mL). The organic
layer was washed with a second portion of aqueous 1 M HCl
(15 mL) and the combined acidic layers were extracted with Et2O
(10 mL). The combined organic layers were washed with aqueous
1
2
saturated NaHCO3 (25 mL), brine (15 mL), dried (Na2SO4)
and concentrated under vacuum to afford a pale yellow residue.
Puriﬁcation by ﬂash chromatography on silica gel (hexane–Et2O,
3 : 1 (v : v)) delivered the title compound as a clear oil (254 mg,
80% based on 15). Rf (hexane–Et2O 3 : 1 (v : v)) 0.69; 1H-NMR
(CDCl3, 300 MHz) d 7.89 (d, J = 2.2 Hz, 1H), 7.55 (d, J = 8.4 Hz,
1H), 7.23 (dd, J = 2.2, 8.4 Hz, 1H), 6.04 (dd, J = 10.9, 17.6 Hz,
1H), 5.21 (dd, J = 1.2, 10.9 Hz, 1H), 5.10 (dd, J = 1.2, 17.6 Hz,
1H), 3.70 (s, 2H), 1.37 (s, 3H), 0.88 (s, 9H), 0.01 (s, 3H), 0.00 (s,
3H); 13C-NMR (CDCl3, 75 MHz) d 152.3, 148.8, 145.1, 137.5,
134.5, 132.5, 119.7, 106.3, 75.7, 51.9, 31.4, 28.2, 23.8, 0.0; LRMS
(EI) m/z = 482 [M]+; [a]25D −10.9 (c 2.3, CHCl3).
(R)-2-Bromo-5-(2-((tert-butyldimethylsilyloxy)methyl)but-3-en-
2-yl)benzaldehyde (23). To a −105 ◦C to −100 ◦C cooled slurry
of (R)-(2-(4-bromo-3-iodophenyl)-2-methylbut-3-enyloxy)(tert-
butyl)dimethylsilane 22 (429 mg, 0.89 mmol, 1.0 eq.) in toluene
(14.8 mL) was added a solution of nBuLi in hexanes (1.6 M,
1.02 mmol, 0.64 mL, 1.15 eq.) over approximately 8 s. After
stirring at this temperature for 2 min, DMF (193 lL, 2.49 mmol,
2.8 eq.) was added over 5 s. The resulting pale yellow solution was
stirred at −103 ◦C to −95 ◦C for 1.5 h and then allowed to reach
−40 ◦C over 0.5 h, after which the cooling bath was replaced
by a water bath and stirring was continued for a further 10 min.
The resulting pale yellow solution was then partitioned between
Et2O (80 mL) and water (15 mL) and the aqueous layer was
extracted with Et2O (2 portions of 20 mL). The combined organic
layers were washed with 1
2
brine (20 mL), dried (Na2SO4) and
concentrated under vacuum affording a pale yellow oil residue.
Puriﬁcation by ﬂash chromatography on silica gel (hexane,
hexane–Et2O, 6 : 1 (v : v)) delivered the title compound as a
colorless oil (242 mg, 71%). Rf (1st elution, hexane–Et2O, 6 : 1 (v :
v); 2nd elution, hexane) 0.71; 1H-NMR (d-acetone, 300 MHz) d
10.34 (s, 1H), 7.95 (d, J = 2.5 Hz, 1H), 7.73 (d, J = 8.4 Hz, 1H),
7.65 (dd, J = 2.5, 8.4 Hz, 1H), 6.16 (dd, J = 10.9, 17.6 Hz, 1H),
5.23 (dd, J = 1.2, 10.9 Hz, 1H), 5.17 (dd, J = 1.2, 17.6 Hz, 1H),
3.86 (d, J = 0.8 Hz, 2H), 1.45 (s, 3H), 0.84 (s, 9H), 0.02 (s, 3H),
0.00 (s, 3H); 13C-NMR (CDCl3, 75 MHz) d 191.3, 146.5, 143.6,
135.3, 133.6, 133.1, 129.0, 124.0, 113.9, 70.2, 46.8, 25.5, 22.2,
18.0, −6.2; LRMS (EI) m/z = 384 [M]+.
(R,Z)-Ethyl-2-azido-3-(2-bromo-5-(2-((tert-butyldimethylsilyl-
oxy)methyl)but-3-en-2-yl)phenyl)acrylate (24). Sodium metal
(35.9 mg, 1.56 mmol, 6.0 eq.) was dissolved in EtOH
(1.0 mL). To the resulting solution was slowly added, at
−15 ◦C and over 1 h, a solution of (R)-2-bromo-5-(2-((tert-
butyldimethylsilyloxy)methyl)but-3-en-2-yl)benzaldehyde 23
(100 mg, 0.26 mmol, 1.0 eq.) and ethyl azidoacetate (0.71 mL of a
2.39 M solution in EtOH, 1.69 mmol, 6.5 eq.). During addition
a milky pale yellowish suspension formed. The temperature was
then allowed to rise from −15 ◦C to −10 ◦C and stirring was
continued for a further 18 h. The orange suspension obtained was
then stirred at room temperature for 0.5 h, re-cooled to ice bath
temperature, quenched with aqueous saturated NH4Cl (0.7 mL)
and gently partitioned between Et2O–EtOAc (1 : 1 (v : v)) (30 mL)
and aqueous 1
2
saturated NH4Cl (10 mL). The deep-tan aqueous
layer was further extracted with Et2O–EtOAc (1 : 1 (v : v)) (3
portions of 10 mL); the combined organic layers were washed
with aqueous 1
2
saturated brine (10 mL) and dried (Na2SO4). The
obtained tan solution was then concentrated to approximately
5 mL and ﬁltered through a short column of silica gel (Et2O).
After removal of the solvent under vacuum, a reddish oil was
obtained which was puriﬁed by PTLC (hexane–Et2O, 3 : 1 (v : v)).
The title compound was obtained as a colourless oil (78 mg, 60%).
Rf (1st elution, hexane–Et2O, 3 : 1 (v : v); 2nd elution, pentane)
0.63 (note: the Rf values for the starting material and the product
are very similar); 1H-NMR (CDCl3, 300 MHz) d 8.14 (d, J =
2.4 Hz, 1H), 7.55 (d, J = 8.5 Hz, 1H), 7.30 (d, J = 2.6 Hz, 1H),
7.23 (dd, J = 2.6, 8.5 Hz, 1H), 6.11 (dd, J = 10.9, 17.6 Hz, 1H),
5.23 (dd, J = 1.2, 10.9 Hz, 1H), 5.13 (dd, J = 1.2, 17.6 Hz, 1H),
4.43 (q, J = 7.1 Hz, 2H), 3.77 (d, J = 1.6 Hz, 2H), 1.46 (t, J =
7.1 Hz, 3H; partial overlap with s at d = 1.43 ppm), 1.43 (s, 3H;
partial overlap with s at d = 1.46 ppm), 0.88 (s, 9H), 0.02 (s, 3H),
0.00 (s, 3H); 13C-NMR (CDCl3, 75 MHz) d 169.0, 150.6, 149.3,
137.8, 137.7, 136.0, 135.4, 132.7, 129.6, 128.3, 119.5, 76.0, 68.1,
52.3, 31.4, 28.2, 23.9, 19.9, 0.0.
(R)-Ethyl-4-bromo-7-(1-tert-butyldimethylsilyoxy)-2-methylbut-
3-en-2-yl)-1H-indole-2-carboxylate (25). A solution of (R,Z)-
ethyl 2-azido-3-(2-bromo-5-(1-tert-butyldimethylsilyoxy)-2-
methylbut-3-en-2-yl)phenyl)acrylate 24 (74 mg, 0.14 mmol) in
meta-xylene (1.3 mL) was added dropwise over 1 h to reﬂuxing
meta-xylene (3.7 mL). The obtained solution was reﬂuxed for a
further 3.5 h, after which the solvent was removed under vacuum
to afford a tan oil. Puriﬁcation by PTLC (hexane–Et2O, 5 : 1 (v :
v)) afforded the title compound as a pale yellow oil (45 mg, 69%).
Rf (hexane–Et2O, 5 : 1 (v : v)) 0.27; 1H-NMR (CDCl3, 300 MHz)
d 9.87, (brs, 1H), 7.33 (d, J = 7.9 Hz, 1H), 7.28 (d, J = 2.3 Hz,
1H), 7.18 (d, J = 7.9 Hz, 1H), 6.24 (dd, J = 10.8, 17.7 Hz, 1H),
5.40 (dd, J = 1.1, 10.8 Hz, 1H), 5.31 (dd, J = 1.1, 17.7 Hz, 1H),
4.45 (q, J = 7.1 Hz, 2H), 4.02 (d, J = 10.0 Hz, 1H), 3.87 (d, J =
10.0 Hz, 1H), 1.51 (s, 3H), 1.46 (t, J = 7.1 Hz), 0.87 (s, 9 H), 0.01
(s, 3 H), 0.00 (s, 3 H); 13C-NMR (CDCl3, 75 MHz) d 167.3, 149.3,
141.7, 134.5, 134.0, 133.0, 129.8, 129.0, 120.5, 120.4, 113.9, 76.2,
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66.8, 52.3, 31.6, 28,8, 24.1, 20.1, 0.0; LRMS (EI) m/z = 465 [M]+;
[a]25D +22.7 (c 2.15 in CHCl3).
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Abstract: A regioselective aromatic Claisen rearrangement was
used to prepare 17a, the precursor of triflate 17e. The intramolecu-
lar Heck reaction of 17e is promoted only by bidentate phosphine
ligands, giving exclusively and in excellent yield 20, the product of
a 5-endo-trig cyclization, despite the possibility for a 6-exo-trig
pathway.
Key words: intramolecular Heck reaction, 5-endo-trig cyclization,
regioselective Claisen rearrangement
‘Teleocidin B’, first isolated in 1960 by Takashima and
Sakai from the mycelia of Streptomyces mediocidicus,1 is
comprised of four diastereomeric compounds, teleocidins
B-1 to B-4 (1a–d).2 The teleocidins B are related to other
natural products, namely lyngbyatoxin A (2a; aka teleoci-
din A-1) and (–)-indolactam V (2b), but are structurally
more complex in that they possess two quaternary carbon
centers embedded within a 6-membered cyclic framework
bridging the 6- and 7-positions of the indole nucleus
(Figure 1).3,4
Figure 1 Structures of teleocidins B (1a–d), lyngbyatoxin A (2a)
and indolactam V (2b).
‘Teleocidin B’ has a strong irritating and vesicatory action
on human skin1 and is also a potent tumor promoter.2a
Like the other indolactam alkaloids, the teleocidins B ex-
ert their biological activity by mimicking 1,2-diacyl-
glycerols in the activation of protein kinase C (PKC).5a
Since activation of PKC is a crucial step in the regulation
of several essential cellular processes, the teleocidins B
constitute a leading target in pharmaceutical research.5
As part of ongoing studies towards the total synthesis of
the teleocidins B, we envisioned that the quaternary car-
bon center at C14 could be stereoselectively installed via
an intramolecular asymmetric Heck reaction (IAHR;
Scheme 1).6 In this reaction, best results are usually ob-
tained with conditions that promote the formation of cat-
ionic intermediates, where the chiral ligand is believed to
remain fully chelated therefore maximizing the possibility
for asymmetric induction. Typically, this is accomplished
by combining a bidentate chiral ligand with triflates as
electrophiles.6–8 With respect to the regioselectivity in the
cyclization step (4 to 3), we expected that, in accordance
with the Baldwin rules9a,b and in line with what is usually
observed in metal-catalyzed cross-coupling reactions,9c,d
the desired 6-exo-trig cyclization to C14 would be favored
over the alternative 5-end-trig to C19.
Scheme 1 Key step for formation of the carbocyclic framework of
the teleocidins B.
To test the feasibility of this approach we started by inves-
tigating how the severe steric bulk, derived from the
neighboring quaternary carbon center at C17, would af-
fect the formation of the six-membered carbocycle skele-
ton. To this end, we turned our attention to a simplified
model target, indole 5. A simplified retrosynthetic analy-
sis of 5 is shown in Scheme 2. As before, the carbocyclic
moiety in indole 5 was envisioned to be formed via an in-
tramolecular Heck reaction (IHR) of 6 (as the correspond-
ing triflate).6 Indole 6 can be prepared by an aromatic
Claisen rearrangement of 7,10,11 which in turn could be ob-
tained via a Hemetsberger–Knittel reaction12 of the corre-
sponding azidocinnamate (not shown) prepared from
ethyl azidoacetate (8), 4-hydroxybenzaldehyde (9) and
geranyl bromide (10).10
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Scheme 2 Retrosynthetic analysis for model indole 5.
Following a literature procedure, etherification of 4-hy-
droxybenzaldehyde (9) with geranyl bromide (10) and
K2CO3 was accomplished in refluxing acetone in quanti-
tative yield (Scheme 3).13 Subsequent NaOEt-promoted
condensation of 11 with ethyl azidoacetate (8) at low tem-
perature afforded azide 12 in good yield. Thermolysis of
12 in refluxing toluene gave the known indole 13 in excel-
lent yield and high purity.10
When this substrate was subjected to the usual conditions
for the aromatic Claisen rearrangement (refluxing in di-
methylaniline, entry 1, Table 1), only an equimolar in-
separable mixture of 14 and 15 was obtained, presumably
formed through further rearrangements of the expected in-
dole 17a. These so-called abnormal aromatic Claisen
rearrangements14 can in principle be avoided by trapping
the phenolic oxygen in 17a. Traditionally this has been ac-
complished by in situ conversion to the corresponding ac-
etate.15a,b Using the conditions developed by Kishi
(NaOAc in refluxing Ac2O),15a we hoped to obtain the re-
arranged indole as the corresponding N,O-diacetate 17b.
The desired rearranged product was indeed produced, but
as the O-acetate 17c and only in poor yield. The main
product was instead the N-acylated compound 16 (entry
2). Performing the reaction in a refluxing mixture of Ac2O
and dimethylaniline inverted the previous ratio, delivering
the known 17c as the main product together with a small
amount of the N-acylated by-product 16 (entry 3).10 The
highest selectivity for the desired product was obtained
using the conditions developed by Fukuyama, reflux in a
mixture of HMDS and dimethylaniline,15c thus trapping
17a as the corresponding TMS ether 17d. Subsequent in
situ acidic hydrolysis yielded 17a (entry 4) in 88% over
the two steps.16
As previously noticed by others, notably Moody and co-
workers, the Claisen rearrangement is completely regiose-
lective for the 7-position of the indole nucleus.10,17 We
have calculated the relative energies for 18 and 19
N
H NH
HO
Br
5 6
CO2R
IHR
aromatic
Claisen
N
H
O CO2R
Hemetsberger–
Knittel
CHO
HO
N3 CO2R
7
8
9
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6
78
11
Scheme 3 Preparation and product distribution in the Claisen rear-
rangement of indole 13 (see Table 1).
N
H
O CO2Et
NR1O CO2EtNO CO2Et
Ac
CHO
OR
N
H
HO CO2Et NHHO CO2Et
10, K2CO3
acetone, reflux
quant.
8, NaOEt
EtOH, –15 °C
N3
CO2Et
O
9: R = H
11: R = geranyl PhMe, reflux
quant. (crude)
see
Table 1
14 15
16
17a: R1 = R2 = H
17b: R1 = R2 = Ac
17c: R1 = Ac, R2 = H
17d: R1 = TMS, R2 = H
76%
12
13
products
shown below
11 R2
Table 1 Conditions Investigated for the Aromatic Claisen Rear-
rangement of Indole 13
Entry Reaction conditionsa Product distributionb
1 Dimethylaniline 55% of 14 and 15 
(1:1 inseparable mixture)
2 NaOAc (1.5 equiv) in Ac2O, 
170 °C
45% of 16
33% of 17c
5% of 13
3 Ac2O in dimethylaniline 
(1:1, v/v)
<5% of 16
61% of 17c
4c i) HMDS (10 equiv) in 
dimethylaniline
ii) aq HCl–EtOH (0 °C)
88% of 17a
a
 Unless stated otherwise, all reactions were performed at 195 °C in a 
closed vessel.
b
 Isolated yields.
c
 See ref. 16 for experimental details.
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(Figure 2), simplified versions of the two possible inter-
mediates in the Claisen rearrangement at C7 and C5, re-
spectively. In accordance with the Bell–Evans–Polanyi
principle18 the relative energies of high-energy intermedi-
ates should correlate well with the relative barriers for the
two possible rearrangements. We found a difference of 40
kJ mol–1 in favor of 18, in good agreement with the ob-
served selectivity.19 The reason for the high energy differ-
ence between superficially similar intermediates is that
only 18 preserves an aromatic pyrrole moiety in its struc-
ture.
Figure 2 Simplified versions of the two possible intermediates in
the Claisen rearrangement.
Having installed the C11 quaternary carbon we proceeded
by converting 17a into the corresponding triflate 17e. This
was accomplished in good yield by treating 17a with Tf2O
in the presence of pyridine at low temperature
(Scheme 4).
For the cyclization of 17e we started by investigating the
use of rac-BINAP (entry 1, Table 2). To our surprise, the
product was not the expected cyclohexadieno-indole 5.
Instead, NMR analysis indicated the cyclopentadieno-in-
dole 20, presumably obtained via what is normally con-
sidered to be a disfavored 5-endo-trig cyclization mode.
Whereas 5-endo-type products in IHR are not unprece-
dented they are rare, being confined to special substrates
such as N-vinyl-2-haloarylamines20, aryl/alkenyl halides
containing an appropriate a,b-unsaturated carbonyl
group21 or 1,1-difluoro-1-alkenes.22 Furthermore, their
formation can frequently be rationalized by alternative
mechanisms other than a direct 5-endo cyclization.23 Ad-
ditionally, when this cyclization mode operates, it typical-
ly requires harsher conditions and often produces only
low yields of the products,24 whereas in our case indole 20
was obtained in high yield and the reaction was complete
in about 3.5 h.
In order to obtain a better understanding of this process,
and in particular if the regioselectivity of the cyclization
could be reversed into the desired 6-exo mode, we
screened several readily available ligands (Table 2). We
started by investigating the use of the classic PPh3 [with
and without LiCl as additive, entries 2 and 3, respectively,
and in the form of Pd(PPh3)4, entry 4], AsPh3 (entry 5) and
then moved on to bulkier ligands such as P(t-Bu)3 (entry
6) and biphenyl dicyclohexyl phosphine (entry 7). How-
ever, all of these monodentate ligands failed to deliver
product and only starting material was recovered. This
suggests that for this system, and in line with the generally
accepted mechanism for the cationic pathway in the Heck
reaction, a bidentate ligand is required for the stability of
the active catalyst.
Hence we subsequently investigated bidentate ligands
other than rac-BINAP. In contrast to the monodentate
ligands, all the bidentate phosphines screened succeeded
in promoting the cyclization reaction, but again only the
5-endo product 20 was obtained (entries 8–13). The in-
complete conversion, even after long reaction times, ob-
served when dppbz and triphos were used (entries 12 and
13, respectively) together with the fact that a slightly fast-
er reaction was observed for dppe and dppp (entries 10
N
H
O
N
H
O
18 19
Scheme 4 Formation of cyclopentadieno-indole (20) via a 5-endo-
trig intramolecular Heck reaction.
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H
RO CO2Et
17a: R = H Tf2O, pyridine
CH2Cl2, –30 °C to 0 °C
75%
N
H
CO2Et
see 
Table 2
20
17e: R = Tf
8
13
13
8
Table 2 Ligands Screened for the IHR of Indole 17e
Entry Conditionsa,b Resultsc
1 Pd(OAc)2, rac-Binap, 3.5 h 88% of 20
2 Pd(OAc)2, PPh3, TEA, 28 h –
3 Pd(OAc)2, PPh3, LiCl, TEA, 28 h –
4 Pd(PPh3)4, LiCl, Et3N, 28 h –
5 Pd2(dba)3, AsPh3, 30 h Traces of 20d
6 Pd(OAc)2, P(t-Bu)3, 30 h Traces of 20d
7 Pd(OAc)2, biphenyl dicyclohexyl 
phosphine, 43 h
Traces of 20d
8 Pd(OAc)2, dppf, 3.5 h 88% of 20
9 Pd(OAc)2, dppb, 3.5 h 85% of 20
10 Pd(OAc)2, dppp, 2.5 h 88% of 20
11 Pd(OAc)2, dppe, 2.5 h 94% of 20
12 Pd(OAc)2, dppbz, 24 h 20:17ee
2.6:1
13 Pd(OAc)2, triphos, 24 h 20:17ee
1:1.8
a
 All reactions were performed in refluxing THF and unless stated 
otherwise, K2CO3 was used as the base.
b
 For experimental details, see ref.25,
c
 Isolated yields; ‘–’ stands for only starting material 17e recovered.
d
 As judged by TLC.
e
 Ratio based on crude 1H NMR.
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and 11, respectively) suggests that ideally the ligand bite
angle should be slightly less than 90°.
To the best of our knowledge, this is the first example
where, having available the possibility for a 6-exo-trig
path, the IHR occurs exclusively to afford high yields (up
to 94%) of the 5-endo-trig cyclized product. This result is
likely to be a consequence of two factors: i) the steric bulk
of the neighboring quaternary carbon, which positions and
eventually locks the C12–C13 double bond of 17e in the
proximity of the oxidatively added Pd; and ii) in the mi-
gratory insertion step, occurring in the coordination
sphere of Pd, the bond formation is initiated at a long C–
C distance, and can thus occur in geometries that are dis-
tinctly different from those allowed in systems for which
the Baldwin rules were originally developed.9a,b
Finally, it is noted that this serendipitous finding could po-
tentially be used as an entry to natural products such as the
trekentrins [e.g., cis-trekentrin A (21)]26 and the herbin-
doles [e.g., herbindole B (22)]27 (Figure 3), taking full ad-
vantage of the regioselective Claisen rearrangement–5-
endo-trig Heck cyclization sequence.
Figure 3 Examples of natural products containing a 6,7-cyclopen-
tena-indole core.
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Butane-2,3-dione was activated towards nucleophilic addi-
tion of enecarbamates by a series of metal triflate complexes
of aC2-symmetric diamine to give stereogenic, aldol-like, t-
alcohols, a novel nickel(II) triflate complex was identified as
a good catalyst for this asymmetric transformation, and an
aquo nickel(II) complex was identified by XRD techniques.
Our group has previously demonstrated the utility of enecarba-
mates as nucleophiles for C–C bond formation in asymmetric
copper catalysed reactions of aldimines and aldehydes that
afford stereogenic secondary 1,3-imino alcohols and amines.1
Although enecarbamates provide a range of potential synthetic
utilities, their use as nucleophiles in asymmetric catalysis has
only recently been reported.1
Herein, we report that simple diketones 1a and 1b can be
activated towards nucleophilic addition of enecarbamates 2a–c
with a reasonable degree of stereocontrol by a novel Lewis acidic
cationic Ni(II) diamine complex, providing access to otherwise
synthetically demanding stereogenic tertiary alcohols 4a–e.2 A
crystal structure of a stable Ni(II) bis-aquo complex of ligand 5
revealed an octahedral geometry at the nickel.3
We initially chose to investigate cationic transition metal
triﬂate complexes 6a–f of a C2-symmetric diamine 5, prepared
in situ in CH2Cl2,4 as catalysts for the addition of 2a to 1a, see
Scheme 1. Enecarbamate 2a was previously shown as a useful
enecarbamate in work concerned with aldimine or aldehyde
substrates.1
Scheme 1 Aldol-like reaction of enecarbamate 2a with diketone 1a,
and catalyst preparation.
The substrates were added to the catalyst solution, corre-
sponding to ca. 0.07 M with respect to 2a, i.e., concentration
† Electronic supplementary information (ESI) available: experimental
details and analytical data. See http://dx.doi.org/10.1039/b505404d
with respect to 6 is 0.007 M.5 The crude reaction mixtures were
treated with 3 N HClaq to give the easier to handle and analyse
diketone product 4a.6
Catalyst 6a resulted in the formation of product 4a in a
promising yield of 67%, the ee of this tertiary alcohol was 76%.
Scandium(III) triﬂate in combination with 5 failed to catalyse
the reaction under the conditions employed (Table 1, entry 2),
and cobalt(II) triﬂate gave only a very small amount of the
desired product (5% yield) with 45% ee (Table 1, entry 3).
Whilst copper(II) triﬂate gave a slightly better yield thannickel(II)
triﬂate the ee was slightly lower (Table 1, entry 4 versus entry 1),
and comparison between catalysts derived from copper(II) and
copper(I) triﬂates revealed the 2+ oxidation state to be superior
(Table 1, entry 4 versus entry 5). That zinc(II) triﬂate catalyses the
reaction (Table 1, entry 6)with similar selectivity to nickel(II) and
copper(II) triﬂates (Table 1, entries 1 & 4 respectively), suggests
similar modes of operation.
Since the best ee was obtained with nickel and, as it is
relatively under-studied as a Lewis acid with respect to it’s ﬁrst
row neighbours, we selected nickel for further elaboration, even
though a slightly better yield was obtained with Cu(OTf)2.7
Previously, our group has reported the use of copper complexes
as asymmetric catalysts,1 wewerekeen to expand the scopeof our
study to other Lewis acidic, metal containing, species which also
led us to focus our efforts on the understanding and application
of a previously unreported nickel(II) triﬂate diamine complex.
For nickel(II) triﬂate variation of catalyst loading and reaction
temperature did not give any signiﬁcant improvement in either
yield or ee (see Table 2 versus Table 1, entry 1), whilst good
improvements were observed for extended reaction times,
CH2Cl2 was also shown to be the best solvent of those tried.
Surprisingly an increase in catalyst loading from 10 to 15
mol% resulted in a reduction in yield (67 versus 33%, Table 1,
entry 1 and Table 2, entry 1, respectively), although ee was
unaffected.
Similarly a reduction in catalyst loading lead to a further
reduction in yield but a slight improvement in ee (Table 2, entry 5
versusTable 1, entry 1 and Table 2, entry 1). The reaction did not
proceed at −30 ◦C even after 72 h (Table 2, entry 3). Although
the reaction did proceed a little at −20 ◦C, albeit in equimolar
conversion to catalyst loading (Table 2, entry 7). Toluene proved
to be slightly inferior toCH2Cl2 (Table 2, entry 8). A reduction of
catalyst loading to 6 mol% and concentration to 0.006 M gave a
reduced ee (41%) along with a dramatically reduced yield (11%)
Table 1 Transition metal-triﬂate catalysed reaction of 1a with 2a
Entry Catalyst Yield (%) EE (%)
1 6a 67 76
2 6b — —
3 6c 5 45
4 6d 72 71
5 6ea 14 57
6 6f 31 75
a Cu(I)(OTf)·0.5 PhH was used. Yield refers to isolated yield of hydrol-
ysed ketone product.
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Table 2 Ni(OTf)2 + 5 catalysed reactions of 1a with 2a–c; Y = yield of diketone; Tol = toluene; M = Ni(II) unless otherwise stated.
Entry Producta Temperature/◦C X Catalyst/mM Solvent Y (%) Ee (%)
1 4a 0 15 7 CH2Cl2 33 76
2 4a b 39 10 7 CH2Cl2 27 49
3 4ac −30 10 7 CH2Cl2 — —
4 4a 0 6 12 CH2Cl2 20 69
5 4a 0 5 7 CH2Cl2 15 79
6 4a 0 6 3 CH2Cl2 17 77
7 4a −20 6 6 CH2Cl2 6 74
8 4a 0 10 8 Tol 47 75
9 4a 0 6 6 Tol 11 41
10 4a 0 10 8 4 : 1 Tol : CH2Cl2 46 80
11 4a 0 10 7 1 : 1 Tol : CH2Cl2 32 80
12 4a 0 10 9 1 : 4 Tol : CH2Cl2 15 79
13 4a 0 10 8 Et2O 26 70
14 4a 0 6 6 THF — —
15 4a 0 6 6 CH3CN 8 <2
16 4a d 0 10 7 CH2Cl2 94 84
17 4b 0 10 7 CH2Cl2 47 45
18 4b d 0 10 7 CH2Cl2 59 65
19 4c 0 10 7 CH2Cl2 20 75
20 4c d 0 10 7 CH2Cl2 90 82
21e 4a 0 10 8 4 : 1 Tol : CH2Cl2 53 48
22e 4b 0 10 7 CH2Cl2 84 35
23e 4c 0 10 7 CH2Cl2 44 38
a Reaction time was 48 h unless stated otherwise. b Black precipitate after 17 h, quenched at 24 h. c Reaction time was 72 h, no conversion was observed
during the course of the reaction. d Reaction time was 336 h. e M = Cu(II).
(Table 2, entry 9). Mixtures of toluene and CH2Cl2 (Table 2,
entries 10, 11 & 12) gave higher enantiomeric excesses than use
of either solvent alone, but yields were reduced. For comparison
6d was also used as a catalyst under the same conditions as entry
10 (Table 2, entry 21), as in Table 1 the yield using a copper(II)
triﬂate derived catalyst is slightly higher than that using nickel
(53 versus 46%) and the ee is somewhat lower (48 versus 80%).
That concentration (of nickel complex), solvent and temperature
can have such a signiﬁcant inﬂuence on yield and ee might be
due the formation of dimeric or oligomeric catalyst structures
in solution. Dramatic concentration, solvent and temperature
effects have been previously reported in other (Lewis acid) nickel
catalysed reactions.8 Trimeric nickel complexes were structurally
conﬁrmed for related nickel tmeda complexes in the solid state
by Handley et al. who note the solution equilibrium between
monomeric and trimeric diamine chelated complexes of nickel
halides.9
The reaction to form 3a was repeated as per Table 1,
entry 1 and monitored with time by 1H NMR spectroscopy.
We observed that over the ﬁrst 48 h the reaction seemed
to be, approximately, pseudo ﬁrst order with respect to the
enecarbamate concentration. The observed initial rate constant
(kobsd) was calculated from the data obtained over the ﬁrst 40 h to
be 3 × 10−6 s−1 which implies a reaction half-life of 64.2 h.10 This
reaction was continued for ﬁve half lives with aliquots taken at
various times (see the electronic supplementary information). At
74% conversion (by 1H NMR) the remaining reaction mixture
was puriﬁed, which gave 4a in 83% ee. Repetition of this 14 d
reaction gave 4a in 94% yield and 84% ee (Table 2, entry 16).
Enecarbamates 2b and 2c where also subjected to the same reac-
tion conditions (Table 2, entries 17–20), a marked improvement
in yield and ee was observed by extending the reaction time
from 48 to over 300 h. The results obtained after 48 h for the
nickel catalysed formation of 4b and 4c (Table 2 entries 17 and
19 respectively) can be compared with those using copper(II)
(Table 2, entries 22 and 23) under the same conditions. For
the comparisons given here copper(II) triﬂate derived catalyst
6d was found to consistently give lower enantiomeric excesses
than the corresponding nickel(II) triﬂate catalyst, yet under the
same conditions higher yields are obtained with the copper
catalyst, the largest difference in yield (37%) was observed for
the formation of 4b. Obviously 14 d reactions are not practical
in an everyday sense but these results show two principle
important points: (i) 6a is indeed a useful Lewis acid catalyst for
activation of diketones to reaction with enecarbamates, and (ii)
reactions are only limited by turnover frequency and not catalyst
inhibition or decomposition.11 A related study by Evans et al.
concerning copper catalysed enolsilane addition to pyruvate
esters revealed that addition of TMSOTf greatly enhanced
reaction rate (catalyst turnover), by assisting the intermolecular
silylation of the respective product.12 In our case the addition
of TMSOTf to the reaction of 1a with 2a might affect an
intermolecular silylation giving the corresponding TMS-ether
of 3a. Under the same conditions as those for Table 1, entry
1 in the presence of 1 equivalent of TMSOTf the reaction did
not proceed at all, after the usual work-up only acetophenone
and benzylcarbamate (i.e., hydrolysis of 2a) were observed. It
is also worth noting that the TMS-enolate of acetopheneone
was subjected to the same reaction conditions as those given in
Table 1, entry 1 (i.e., enecarbamate {NH-cbz} was substituted
for TMS-enolate {OSiMe3}), following acidic work-up diketone
4a was isolated in 13% yield and 73% ee, that is ee is only a little
lower for the TMS-enolate but the yield of the same product
under the same conditions is greatly reduced.
Having established for, nickel(II) triﬂate mediated catalysis of
enecarbamate additions to a symmetrical dimethyl ketone 1a,
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that longer reaction times can provide signiﬁcant improvements
in yield and slight improvements in ee, and that enecarbamate
2a is a better acetophenone-enolate analogue than the corre-
sponding TMS-enolate, we next examined the unsymmetrical
diketone, pentane-2,3-dione 1b, under the same reaction condi-
tions as Table 1 entry 1 and Table 2 entry 16 (see Scheme 2).
Scheme 2 Aldol-like reaction of enecarbamate 2a with diketone 1b;
effect of long reaction time.
For the same reaction conditions as for the formation of
4a a much more dramatic increase in overall yield of the two
products (4d & 4e) was observed, i.e., 19% overall yield for a 48 h
reaction increases to>99% combined yield for the analogous 14
d reaction. However it should be noted that no corresponding
increase in ee was observed, the minor product’s ee was reduced
by 20%, the major product’s ee was only 1% lower. Also that
selectivity between addition to the ethyl or methyl ketone is
reduced a little for longer reaction times (8.5 : 1 versus 7.0 : 1
respectively).
The non-linear effect of ligand ee was examined with respect
to catalyst 6a, for the formation of 4a. The in situ catalyst
preparation was carried out with mixtures of racemic and single
enantiomer (R,R)-5, reactions were performed under the same
conditions as that given in Table 1, entry 1 accept stock solutions
of ligand were added. Fig. 1 shows the relationship between
ligand and product enantiomeric excesses, a strong positive non-
linear effect was observed.
Fig. 1 Non-linear effect of ligand 5 in reactions under the same
conditions as Table 1, entry 1.
Enantiomeric excess of 5 and yield of product 4a follows the
approximate trend that lower ee gives lower yield (see supple-
mentary information). That a strong positive non-linear effect
was observed, is good evidence for the favourable formation
of heterochiral bis-chelated Ni(OTf)2 complexes or heterochiral
dimers of complex 6a, and that these structures are not active
catalysts. Since use of excess ligand served to reduce the efﬁcacy
of a catalyst prepared from single enantiomer 6a (ee and yield
were reduced) we surmised bis-chelated metal complexes were
likely the origin of deactivation, although this would necessitate
the presence of freeNi(OTf)2 in the non-linear effect experiments
and hence a non-chiral pathway might be observed.
In order to clarify this further an experiment was performed
employing 30 mol% of 33.3% ee ligand in combination with
20 mol% nickel(II) triﬂate, two proposed outcomes are given in
Scheme 3.
Scheme 3 Proposed outcomes of mixing excess low ee ligand and
Ni(OTf)2.
Use of this catalyst mixture resulted in isolation of 4a in 72%
ee and 47% yield, that is ee is approximately the same as Table 1,
entry 1 but the yield is reduced, suggesting that the same active
catalyst species is present but to a lesser extent than in the 10
mol% single enantiomer case.
Using the same conditions as Scheme 3 the reaction was
repeated with slightly higher ee 5 (50% ee), in this case product
4a was obtained in an improved 75% yield and the ee remained
almost unchanged (74% ee). More active catalyst is present with
50% ee ligand yet no reduction in ee was observed which implies
the lack of a competitive achiral pathway. These results lead
us to tentatively suggest that the formation of 2 : 1 R,R : S,S
trimeric structures, similar to the TMEDAcomplexes previously
reported,3c also play a role in a complicated deactivation
equilibrium in the large non-linear effect we observed. To
elucidate this and/or related structures by XRD or other means
is currently the focus of attention for this program of research,
we hope to report more details regarding this at a later date.
To date, elucidation of the anhydrous catalyst structure 6a
by single crystal X-ray diffraction has not proved successful.
However, a racemic model for the binding of 5 to Ni(II) (the
correspondingNi(II) bromide complex 7) was easily synthesized.
Compound 7 was converted, via a non-anhydrous silver triﬂate
mediated halide abstraction, to the bis-aquo complex 8 (see
Scheme 4). Compound 8 was successfully crystallised from
CH2Cl2–hexane–Et2O after many trials (see Fig. 2).‡ Other than
identifying the almost complete absence of 5, no useful NMR
data could be obtained from 7 or 8.
Scheme 4 Synthesis of a nickel(II) bromide complex of a racemic
diamine ligand and subsequent halide abstraction.
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Fig. 2 Representation of the crystal structure of 8, protons omitted
for clarity. Selected bond distances (A˚), angles (◦) and torsions (◦):
Ni(1)–O(1) = 2.107(1), Ni(1)–O(4) = 2.105(1), Ni(1)–O(7) = 2.044(1),
Ni(1)–O(8) = 2.084(1), Ni(1)–N(1) = 2.075(1), Ni(1)–N(2) = 2.083(1),
O(8)–Ni(1)–O(7) = 89.17(5), N(2)–Ni(1)–N(1) = 85.08(5), N(2)–C(10)–
C(17)–N(1) = 53.7(2).
The crystal structure of 8 (Fig. 2) shows an octahedral
nickel(II) complex where the two triﬂate moieties are bound
directly to the metal, the ligand is bound equatorially, and two
equatorial ancillary water ligands completed the octahedron.
This is in contrast to a related nickel(II) bisoxazoline complex
reported by Evans et al. where a square pyramidal structure
was observed, one triﬂate was bonded with nickel(II) the other
was more dissociated (in the solid state).7a It is likely that the
ﬂexibility of the benzyl arms of ligand 5 allow for satisfactory
completion of the octahedron about nickel, maintaining a C2
environment at the metal. Efﬁcient chiral relay through the
amino nitrogens upon coordination was also conﬁrmed for
compound 8 (see supplementary information for more details).
Owing to the novelty of nickel(II) catalysed enecarbamate
additions to carbonyls further studies into improved activity and
selectivity of nickel(II) are underway in our laboratory. Altering
the electronic properties of the metal by changing the ligand
or counter ion might facilitate the higher turnover frequencies
desirable for a broadly applicable catalytic system.
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Abstract—Catalytic asymmetric addition reactions of enecarbamates with ethyl glyoxylate have been developed using CuClO4$4CH3CN
and a diimine ligand as the catalyst. Highly diastereo- and enantioselective addition reactions of a-mono-substituted enecarbamates have
been also achieved. These reactions afforded the corresponding adducts with high selectivity; that is, syn adducts from Z-enecarbamates and
anti adducts from E-enecarbamates. The proposed reaction mechanism is an aza-ene type pathway, where the proton of an enecarbamate’s
N–H group plays an important role, not only for accelerating the reaction but also for providing a transition state suitable for the highly
selective chiral induction.
q 2004 Elsevier Ltd. All rights reserved.
1. Introduction
Enamides and enecarbamates are potentially useful nucleo-
philes, which bear amide and carbamate moieties after
undergoing nucleophilic additions. While enamides are
readily prepared,1 are easy to handle, and can be stored at
room temperature, their use in organic synthesis is limited.2
Recently, we have reported the first catalytic enantio-
selective addition of enamides and enecarbamates to imines,
which afforded imine 4 in high yield with high selectivity
(Scheme 1).3 A C2-symmetric copper catalyst prepared
from Cu(OTf)2 and diamine ligand 3a, derived from 1,2-
diphenyl ethylenediamine, catalyzed the reaction effi-
ciently.4 Imine 4 is a versatile compound, which can be
converted into 1,3-diamides, 5-membered lactams, 3-keto
1-amides, etc. The use of aldehydes instead of imines as
substrates for this reaction might lead to 1,3-ketoalcohols,
1,3-iminoalcohols, and 1,3-aminoalcohols, etc.
The objective of this research effort is to investigate the
reactions of enamides with aldehydes.5 The reaction of ethyl
glyoxylate with enecarbamates would lead to products
which have a-hydroxy g-imino ester functionalities
(Scheme 2). In the absence of a Lewis-acid catalyst, the
reaction of ethyl glyoxylate (1.2 equiv.) with enecarbamate
2a (1.0 equiv.) proceeded at 0 8C for 1.5 h to give 6a, which
was hydrolized to 7a by treatment with HBr aq. (13% yield,
0040–4020/$ - see front matter q 2004 Elsevier Ltd. All rights reserved.
doi:10.1016/j.tet.2004.07.045
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Scheme 1.
Scheme 2.
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entry 1 in Table 1). Use of copper (II) triflate as a catalyst
(10 mol%) resulted in the formation of 8 and 9, which
indicated that an equilibrium between 2a and 8 existed
under Lewis acidic conditions and caused a self-coupling
reaction between 2a and 8 to form 9 (ca. 30% yield, entry 2
in Table 1). A similar phenomenon was observed when
other Lewis acids such as CuClO4$4CH3CN, Sc(OTf)3, and
Yb(OTf)3 were employed as catalysts (entries 2–5 in
Table 1). It is noted that a complex derived from
Cu(OTf)2 and diamine ligand 3a did not accelerate the
formation of 8 from 2a at all, and that 7a was isolated in
high yield with modest enantioselectivity (93% yield, 55%
ee, entry 6 in Table 1). This result would be attributed to
lower Lewis acidity of the copper coordinated to diamine
ligand 3a.
These results prompted us to screen various metals in the
presence of a range of diamine ligands, and the results are
summarized in Table 2. The use of Sc(OTf)3, CoCl2, or
Zn(OTf)2 was found to accelerate the reaction of enecarba-
mates with ethyl glyoxylate selectively (58–86% yields),
and in these cases the enecarbamate self-coupling
Table 1. Reaction of enecarbamate 2a with ethyl glyoxylate (5). Initial results
Entry Catalyst Yield (%)a ee (%)
1 None 13 —
2 Cu(OTf)2 18 —
3 CuClO4$4CH3CN 67 —
4 Sc(OTf)3 40 —
5 Yb(OTf)3 59 —
6b Cu(OTf)2C3a 93 55
a Yield of 7a following an acidic work-up.
b 15 min.
Table 2. Reaction of enecarbamate 2a with 5 using various catalysts
Entry Metal Ligand Yield (%) ee (%)
1 Cu(OTf)2 3a 93 55
2 CuClO4$4CH3CN 3a 90 35
3 LiClO4 3d 21 0
4 NaOTf 3d Trace —
5 Mg(OTf)2 3b 5 38
6 Sc(OTf)3 3d 58 28
7 Sc(OTf)3 3h 60 1
8 FeCl2 3d 38 2
9 CoCl2 3d 77 2
10 CoCl2 3h 73 1
11 Zn(OTf)2 3a 86 39
12 Zn(OTf)2 3i 62 16
13 AgSbF6 3i 14 18
14 AgOTf 3i 31 35
15 Sn(OTf)2 3d 44 8
16 La(OTf)3 3d 70 0
17 Ce(OTf)3 3d 68 0
18 Pr(OTf)3 3d 61 0
19 Nd(OTf)3 3d 74 2
20 Sm(OTf)3 3d 72 0
21 Sm(OTf)3 3i 65 2
22 Sm(OTf)3 3h 88 0
23 Ho(OTf)3 3d 66 0
24 Yb(OTf)3 3b 40 2
25 Lu(OTf)3 3d 53 6
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compound 9 was not observed. Ag (I) and Sn (II) salts were
less active catalysts for this reaction. When various
lanthanide salts were employed as catalysts (entries 16–25
in Table 2) in the presence of diamine ligand (commonly
3d), the desired adducts were formed in moderate to high
yields (40–88% yields), albeit enantioselectivities were
negligible (!6% ee).
The copper complexes showed the best catalytic activity in
this reaction, which led to the selection of Cu (I) and (II) in
the parallel screening of ligand types. Diamine ligands 3a–f
derived from diphenyl ethylenediamine, box-type ligands
3g and 3h, diimine ligands 3i–3t derived from cyclohexyl
diamine, and diamine ligands 3v–3x derived from
cyclohexyl diamine were all used in conjunction with the
Cu (I) and Cu (II). Among Cu (II) complexes (Table 3), a
complex prepared from Cu(OTf)2 and box ligand 3h gave
the highest enantioselectivity (73% ee).6
Preliminary tests using CuClO4$4CH3CN as a Lewis acid
revealed that a catalyst derived from Cu (I) and diimine
ligand 3i exhibited good facial discrimination (entry 2 in
Table 4, 93% ee).7 Alternate counter anions KPF6 and
KOTf gave adducts with lower selectivities (82% ee and
78% ee, respectively, entries 3 and 4 in Table 4). When
1-naphthyl and 2-naphthyl-substituted ligands 3j and 3k
were examined (entries 5 and 6 in Table 4), moderate
enantioselectivities were observed (73% ee and 68% ee,
Table 3. Reactions of enecarbamate 2a with 5 using various copper(II) catalysts
Entry Metal Ligand Yield (%) ee (%)a
1 Cu(OTf)2 3a 93 55
2b Cu(OTf)2 3a 91 54
3c Cu(OTf)2 3a 89 58
4 Cu(OTf)2 3b 74 59
5d Cu(OTf)2 3b 44 47
6 Cu(OTf)2 3c 58 57
7 Cu(OTf)2 3d 96 46
8 Cu(OTf)2 3e 97 37
9 Cu(OTf)2 3f 94 31
10 Cu(OTf)2 3g 85 31
a
11c Cu(OTf)2 3g 91 31
a
12 Cu(OTf)2 3h 70 73
a
13 Cu(OTf)2 3i 65 70
14 Cu(OTf)2 3j 66 28
15 Cu(OTf)2 3k 71 52
16 Cu(OTf)2 3l 68 17
17 Cu(OTf)2 3v 89 51
18 Cu(OTf)2 3w 91 50
19 Cu(OTf)2 3x Quant 62
20 CuCl2 3a 47 17
21 CuCl2 3b 55 26
22 CuCl2 3i 50 19
a
23 Cu(SbF6)2 3b 77 44
a The absolute configuration is R except in entries 10–12 and 22 (S).
b Catalyst (30 mol%) was used.
c K20 8C.
d K78 8C.
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respectively). The reaction catalyzed by a copper complex
derived from CuClO4$4CH3CN and ligand 3i proceeded at
K78 8C to give a lower yield (48% yield, entry 7 in
Table 4). Use of excess amounts of ethyl glyoxylate (1.5 and
2.0 equiv.) gave higher yields, 91% and quantitative yields,
respectively (entries 8 and 9 in Table 4). Ligands bearing
para-substituents on the phenyl arms led to higher
enantiomeric excesses in the Cu (I)-catalyzed reaction
(compare entry 12 with entries 2, 10 and 11 in Table 4).
Finally, the Cu (I) complex of para-bromo ligand 3t was
found to give the highest stereoselectivity (97% ee, entry 19
in Table 4). The ligand 3t gave rise to the best
stereoselectivity in catalysis, presumably due to a strong
steric contribution from the para substituent of the ancilary
phenyl groups about the C2 environment of the catalysts.
Solvents other than dichloromethane were tested (toluene
and acetonitrile, entries 13 and 14 in Table 4, respectively),
but the catalytic activity of the resultant Cu (I) complexes
was decreased significantly.
The optimal ligand, metal source, and solvent (3t,
CuClO4$4CH3CN and CH2Cl2, respectively) were, there-
fore, employed in experiments where the loadings of both
metal and ligand were reduced (entries 1–4 in Table 5).
Only 1 mol% of the catalyst (CuClO4$4CH3CN 1 mol%,
ligand 3t 1.1 mol%) afforded 7a in good yield with a slightly
reduced enantiomeric excess (90% yield, 94% ee, entry 4 in
Table 5). Other enecarbamates (2b–e) derived from
Table 4. Reactions of enecarbamate 2a with 5 using various copper(l) catalysts
Entry Metal Ligand Yield (%) ee (%)a
1 CuClO4$4CH3CN 3a 90 35
a
2 CuClO4$4CH3CN 3i 94 93
3 CuPF6$4CH3CN 3i 94 82
4 CuOTf$0.5C6H5CH3 3i 66 78
5 CuClO4$4CH3CN 3j 92 73
6 CuClO4$4CH3CN 3k 52 68
7b CuClO4$4CH3CN 3i 48 91
8c CuClO4$4CH3CN 3i 97 93
9d CuClO4$4CH3CN 3i Quant 94
10d CuClO4$4CH3CN 3m 97 81
11d CuClO4$4CH3CN 3n Quant 86
12d CuClO4$4CH3CN 3o 98 95
13d,e CuClO4$4CH3CN 3o 20 17
14d,f CuClO4$4CH3CN 3o Trace —
15d CuClO4$4CH3CN 3p 87 94
16d CuClO4$4CH3CN 3q 93 94
17d CuClO4$4CH3CN 3r 97 96
18d CuClO4$4CH3CN 3s 93 96.5
19d CuClO4$4CH3CN 3t 93 97.0
a The absolute configuration is S except in entry 1 (R).
b K78 8C.
c Ethyl glyoxylate (1.5 equiv.) was used.
d Ethyl glyoxylate (2.0 equiv.) was used.
e Toluene was used as a solvent.
f Acetonitrile was used as a solvent.
Table 5. Catalytic asymmetric reactions of various enecarbamates 2 with 5
Entry 2 x (mol%) Yield (%) ee (%)
1 2a (RZPh) 10 93 97
2 2a 5 94 96
3 2a 2 96 95
4 2a 1 90 94
5 2b (RZPMP) 10 94 93
6 2c (RZPCP) 10 97 97
7 2d (RZPMeP) 10 Quant 96
8 2e (RZ2-Nap) 10 91 96
Cbz, benzyloxycarbonyl; PMP, p-methoxyphenyl; PCP, p-chlorophenyl; PMeP, p-methylphenyl; 2-Nap, 2-naphthyl.
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aromatic ketones also reacted with ethyl glyoxylate to
provide the corresponding adducts 7b–e in high yields (91%
to quant.) with high enantioselectivities (93–97% ee). It is
noteworthy that all reactions were complete within only 1 h
at 0 8C.
The Cu (I)-catalyzed protocol was able to furnish the
potentially useful b-iminoalcohols in high ee, and sub-
sequent reduction was then performed in order to demon-
strate the utility of this enecarbamate process. Whilst the
diastereoselective reduction of 1,3-ketoalcohols is well
known,8 there are relatively few reports concerning the
diastereoselective reduction of 1,3-iminoalcohols.9
Attempts for the selective reduction of 6a are summarized
in Table 6 (6a was prepared freshly as per entry 1 in
Table 5). It has been previously reported that chelation of
1,3-ketoalcohols is often crucial for stereoselective
reduction. Considering that b-iminoalcohols might coordi-
nate in an analogous fashion, similar protocols were
adopted. The use of Zn(BH4)2
8b as a reducing agent resulted
in around 60% yield with modest syn-selectivities.
Reduction of 6a did not proceed at K78 8C when
LiAlH(OtBu)3
8g was employed as a reductant, (6a was
completely recovered). Sodium borohydride in the presence
of ZnCl2
10 atK78 8C gave benzylalcohol mainly, and only
a trace amount of the desired product was observed (entry 5
in Table 6). Although benzylalcohol is assumed to be
derived from the Cbz group attached to the nitrogen, the
precise mechanism for the formation of benzylalcohol
remains unclear. Additionally, K-selectride also formed a
considerable amount of benzylalcohol even at K78 8C
(entries 8–10 in Table 6), while L-selectride afforded the
desired product in moderate yield (ca. 59% yield) with
modest anti-selectivity (syn/antiZ22/78, entry 11 in
Table 6). Satisfactory selectivity was observed (syn/antiZ
94/6) when NaBH4 was used in the presence of Et2B(OMe)
which is known to aid chelation of 1,3-ketoalcohols in a
THF/MeOH mixtures,8d and a slightly modified procedure
was used (entry 13 in Table 6). Optimization studies showed
that a threefold excess of reductants at K78 8C over 2 h
afforded 10 in 65% yield with high anti-selectivity (94/6,
entry 18 in Table 6). The relative configuration of 10 was
assigned on the basis of NMR NOE experiments performed
in the cyclic derivative 12 (Scheme 3).
Diastereoselection in addition reactions of a-mono-substituted
Scheme 3. (i) TBDMSOTf, 2,6-lutidine, CH2Cl2, 92% (ii) Pd/C, H2, AcOH, AcOEt, quant
Table 6. Selective reduction of 6a into 10
Entry Reagent (equiv.) Additive (equiv.) Solvent Temperature Time (h) Yield (%)a syn/anti
1 Zn(BH4)2 (1.0) — Et2O K78 1 !65 71/29
2 Zn(BH4)2 (1.0) — Et2O K78 3 !66 78/22
3 Zn(BH4)2 (1.0) MS4A
b Et2O K78 3 !75 78/22
4 Zn(BH4)2 (1.0) — Toluene–Et2O
c K78 1 !75 75/25
5 NaBH4 (2.0) ZnCl2 (1.5) MeOH K78 5.5 Trace —
6 LiAlH(OtBu)3 (5.0) — Et2O K78 20 Trace —
7 LiAlH(OtBu)3 (5.0) LiL (5.0) Et2O K78 20 Trace —
8 K-Selectride (2.2) — THF K20 1.2 0 —
9 K-Selectride (2.2) — THF K45 4 0 —
10 K-Selectride (2.2) — THF K78 4 0 —
11 L-Selectride (2.2) — THF K20 16.5 !59 22/78
12 9-BBN (3.0) — THF K20 16.5 Trace —
13 NaBH4 (2.2) Et2B(OMe) (1.1) THF–MeOH
d K78 3 !60 94/6
14 NaBH4 (2.2) Et2B(OMe) (1.1) THF–MeOH
d K45 3 !68 91/9
15 NaBH4 (2.2) Et2B(OMe) (2.2) THF–MeOH
d K78 5.5 55 91/9
16 NaBH4 (2.2) Et2B(OMe) (2.2) THF–MeOH
d K45 5.5 69 88/12
17 NaBH4 (2.2) Et2B(OMe) (2.2) THF–MeOH
e K78 2 !37 NDf
18 NaBH4 (3.0) Et2B(OMe) (3.0) THF–MeOH
d K78 2 65 94/6
a The yields from 2. A small amount of unknown compounds was contained except in entries 15, 16, and 18.
b 10 mg/0.1 mmol.
c Toluene/Et2OZ1/1.
d THF/MeOHZ4/1.
e THF/MeOHZ3/2.
f Not determined.
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enecarbamates with carbonyls is of great interest not
only from a synthetic point of view but also from a
mechanistic aspect. In our recent report syn-adducts were
obtained from both (E)- and (Z)-enecarbamates 2h and
imine 1 catalyzed by a complex derived from Cu (II) and
diamine ligand 3a (Scheme 4).3 Unlike their silicon enolate
analogues, both geometric isomers of 2h are stable on silica
gel and separable by a standard chromatography technique.
The a-substituted enecarbamate 2f reacted with ethyl
glyoxylate smoothly in the presence of CuClO4$4CH3CN
and diimine ligand 3t to afford 6f in good yield (entries 1
and 4 in Table 7). It is noted that anti- and syn-adducts were
obtained from the E- and Z-enecarbamates, respectively.
The diastereoselectivities were excellent (syn/antiZ1/99
and 98/2, respectively) and the enantiomeric excess of the
major diastereomer was 98% ee in both cases. The same
tendency on selectivity was observed for enecarbamates
derived from para-substituted propiophenone (entries 7–12
in Table 7). The enecarbamates having an ethyl group at the
a-position also gave similar diastereo- and enantio-
selectivities (entries 13 and 14 in Table 7). This reaction
could be applied to aliphatic ketone-derived enecarbamates
(entries 15–17 in Table 7). The reaction of enecarbamate 2l
derived from cyclohexanone afforded the desired product 6l
in good yield (85% yield) with slightly lower diastereo-
selectivity (syn/antiZ16/84). Although prolonged reaction
time (6–46 h) and lower temperature (K20 8C) were
sometimes necessary, decrease of the catalyst loading
Scheme 4. 2h–E: 77% y, syn/antiZ86/14, 94% ee (syn) 2h–Z: 63% y, syn/antiZ68/32, 32% ee (syn)
Table 7. Reactions of enecarbamates derived from a-substituted ketones
Entry 2 Product Yield (%)a syn/antib Ee (%)c
1 2fE 7f 83 1/99 98
2d 2fEe 7f 93 1/99 97
3d 2fEf 7f 95 1/99 98
4 2fZ 7f 82 98/2 98
5 2fZe 7f 93 98/2 98
6 2fZf 7f 96 98/2 98
7 2gE 7g 96 2/98 98
8 2gZ 7g 97 98/2 98
9 2hE 7g 82 3/97 96
10 2hZ 7g 96 99/1 98
11 2iE 7i 85 2/98 98
12 2iZ 7i 79 99/1 98
13 2jEg 7j 58 1/99 98
14 2jZ 7j 92 99/1 98
15d 2kE 7k 83 3/97h 97
16d 2kZ 7k 89 92/8h 98
17 2l 7l 85 16/84h 94
a Isolated yield of ketone product.
b Determined by HPLC.
c Ee of the major diastereomer, determined by HPLC.
d K20 8C.
e 1 mol% of catalyst was used.
f 0.1 mol% of catalyst was used.
g 5 (1.0 equiv.) and 2 (2.0 equiv.) were used.
h Determined by NMR analysis.
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gave slightly better yields as shown in entries 1–6 of Table
7. Thus, the (E)- and (Z)-enecarbamates 2f reacted with
ethyl glyoxylate in the presence of only 0.1 mol% of the
catalyst to afford the corresponding adducts in excellent
yield (95 and 96%, respectively) with high diastereo-
selectivity (syn/antiZ1/99 and 98/2, respectively) and
enantioselelctivity (98% ee in both cases). The relative
configuration of adduct 7f was determined by the X-ray
crystal structure analysis of 14, which was synthesized from
7f by reduction and subsequent cyclization in one pot
(Scheme 5). The relative configuration of other adducts,
general formula 7, was determined by an analogy of the 1H
NMR spectrum of 7f.
In a bid to elucidate the reaction mechanism, enecarbamate
2m, which has a tertiary amide moiety, was used to assess
the role of the proton attached to the nitrogen. It was
interesting to find that no reaction occurred in the presence
of 10 mol% of the catalyst even at room temperature
(Scheme 6). That the reaction proceeded stereospecifically
when a-substituted enecarbamates bear N–H functionalities
suggests a concerted aza-ene type reaction mechanism;11
that is, a hydrogen atom attached to the nitrogen of
enecarbamates would accelerate the reaction rate consider-
ably through an intramolecular hydrogen transfer pathway.
Two possible modes of a nucleophilic attack exist; an open
transition state model or a concerted 6-membered ring
fashion. Possible open transition states are shown in
Figure 1; E-enecarbamates are used in TS-1 and TS-2,
while Z-enecarbamates are used in TS-3 and TS-4. The
steric interaction between the methyl group at the a-position
of an enecarbamate and the copper complex is believed to
be large, TS-2 would be favorable over TS-1. Similarly,
since TS-3 would predominate over TS-4, syn-adducts are
obtained in both cases. This contradicts the experimental
results (syn-products from Z-enecarbamates, anti-products
from E-enecarbamates). Possible concerted cyclic transition
states are shown in Figure 2; TS-5 and TS-7 are derived
from Z-enecarbamates, TS-6 and TS-8 are derived from
E-enecarmates. In TS-7 and TS-8, since the steric
interaction between the R group of enecarbamates and
ethyl glyoxylate would be large, TS-5 and TS-6 are believed
to predominate over TS-7 and TS-8, respectively. This
explains the observed stereoselectivity and the role of the
Scheme 6.
Scheme 5.
Figure 1. Possible acyclic transition state models.
Figure 2. Possible cyclic transition state models.
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N–H proton of enecarbamates. Attempts to crystallize
model systems for X-ray diffraction are now under way.
In conclusion, catalytic asymmetric addition reactions of
enecarbamates with ethyl glyoxylate have been developed
using CuClO4$4CH3CN and diimine ligand 3t as a catalyst.
The products were 1,3-iminoalcohols, which were con-
verted to the corresponding 1,3-amidealcohols diastereo-
selectively, employing NaBH4 and Et2B(OMe) in the
reduction. We have also developed highly diastereo- and
enantioselective addition reactions of a-mono-substituted
enecarbamates. These reactions afforded the corresponding
adducts with high selectivity; that is, syn adducts from
Z-enecarbamates and anti adducts from E-enecarbamates.
The reaction proceeded smoothly in the presence of only
0.1 mol% of the catalyst to afford 1,3-iminoalcohols in high
yields with high diastereo- and enantioselectivities. Aro-
matic ketone-derived enecarbamates as well as those
derived from aliphatic and cyclic ketones were also found
to be good substrates. The proposed reaction mechanism is
an aza-ene type pathway, where the proton of an
enecarbamate’s N–H group plays an important role, not
only accelerating the reaction but also providing a transition
state suitable for the highly selective chiral induction.
2. Experimental
2.1. General
Melting points are uncorrected. 1H and 13C NMR spectra
were recorded on a JEOL JNM-LA300, JNM-LA400, or
JNM-LA500 spectrometer in CDCl3 unless otherwise noted.
Tetramethylsilane (TMS) served as internal standard (dZ0)
for 1H NMR, and CDCl3 was used as internal standard
(dZ77.0) for 13C NMR. IR spectra were measured with
a JASCO FT/IR-610. Optical rotations were measured
with a JASCO P-1010 polarimeter. High-performance
liquid chromatography was carried out using following
apparatuses; SHIMADZU LC-10AT (liquid chromato-
graph), SHIMADZU SPD-10A (UV detector), and
SHIMADZU C-R6A Chromatopac. Gas chromatography
and mass spectrometry analysis were carried out using
the following apparatuses; SHIMADZU GC-17A,
SHIMADZU GCMS-QP5050A. Column chromatography
was conducted on Silica gel 60 (Merck), and preparative
thin-layer chromatography was carried out using
Wakogel B-5F. All reactions were carried out under
argon atmosphere in dried glassware. All solvents were
dried and distilled by standard procedures. Enecarba-
mates 2a–j were prepared according to the method
reported by Kagan et al.1a Enecarbamates 2k and 2l
were prepared by using a modified procedure reported
by Machida et al.1b,12 Enecarbamate 2m was prepared
from 2a. Diamine ligands 3a–f were prepared according
to the reported method.4b Diimine ligands 3i–t were
prepared from commercially available (1R,2R)-(C)-1,2-
diaminocyclohexane L-tartrate according to the reported
method.13 Diamine ligands 3v–x were prepared by
reduction of 3i, 3k, and 3l, respectively using NaBH4
in MeOH.
3. Enecarbamates
3.1. Analytical data for enecarbamates 2a–j
3.1.1. (1-Phenyl-vinyl)-carbamic acid benzyl ester (2a).
Mp 69.4–69.5 8C; 1H NMR (CDCl3) dZ4.96 (s, 1H), 5.16
(s, 2H), 5.63 (s, 1H), 6.33 (s, 1H), 7.25–7.45 (m, 10H); 13C
NMR (CDCl3) dZ67.0, 99.6, 126.0, 128.3, 128.5, 128.6,
128.7, 136.0, 138.1, 140.5, 153.7; IR (neat) 3310, 3060,
3033, 1739, 1701, 1634, 1523, 1452, 1227, 1125, 1063, 857,
772, 740, 696, 596 cmK1; HRMS (EI). Exact mass calcd for
C16H15NO2 [M]
C, 253.1103. Found 253.1093. Anal. Calcd
for C16H15NO2: C, 75.87; H, 5.97; N, 5.53. Found: C, 75.77;
H, 6.16; N, 5.52.
3.1.2. [1-(4-Methoxy-phenyl)-vinyl]-carbamic acid ben-
zyl ester (2b). Mp 54.7–54.8 8C; 1H NMR (CDCl3) dZ3.81
(s, 3H), 4.89 (d, 1H, JZ1.0 Hz), 5.18 (s, 2H), 5.54 (s, 1H),
6.26 (s, 1H), 6.85–6.90 (m, 2H), 7.30–7.40 (m, 7H); 13C
NMR (CDCl3) dZ55.3, 66.9, 98.4, 113.9, 127.2, 128.3,
128.5, 130.6, 136.0, 140.1, 153.7, 160.0; IR (neat) 3330,
1736, 1632, 1608, 1509, 1456, 1219, 1179, 1126, 1063,
1030, 834, 742, 698 cmK1; HRMS (EI). Exact mass calcd
for C17H17NO3 [M]
C, 283.1208. Found 283.1208. Anal.
Calcd for C17H17NO3: C, 72.07; H, 6.05; N, 4.94. Found: C,
71.84; H, 6.09; N, 4.91.
3.1.3. [1-(4-Chloro-phenyl)-vinyl]-carbamic acid benzyl
ester (2c). Mp 79.0–79.1 8C; 1H NMR (CDCl3) dZ4.96 (s,
1H), 5.17 (s, 2H), 5.59 (s, 1H), 6.25 (s, 1H), 7.28–7.43 (m,
9H); 13C NMR (CDCl3) dZ67.1, 100.6, 127.3, 128.3,
128.4, 128.6, 128.8, 134.6, 135.8, 136.5, 139.7, 153.6; IR
(neat) 3299, 1699, 1532, 1239, 1059, 838, 741, 696 cmK1;
HRMS (EI). Exact mass calcd for C16H14ClNO2 [M]
C,
287.0713. Found 287.0708. Anal. Calcd for C16H14ClNO2:
C, 66.79; H, 4.90; N, 4.87. Found: C, 66.53; H, 5.02; N,
4.91.
3.1.4. (1-p-Tolyl-vinyl)-carbamic acid benzyl ester (2d).
Mp 52.3–53 8C; 1H NMR (CDCl3) dZ2.34 (s, 3H), 4.93 (s,
1H), 5.16 (s, 2H), 5.58 (s, 1H), 6.30 (s, 1H), 7.14 (apparent
d, 2H, JZ7.8 Hz), 7.25–7.40 (m, 7H); 13C NMR (CDCl3)
dZ21.1, 66.9, 98.8, 125.8, 128.3, 128.5, 129.3, 135.3,
136.0, 138.7, 140.4, 153.7; IR (neat) 3398, 3327, 3032,
1736, 1361, 1508, 1454, 1383, 1321, 1219, 1124, 1063, 955,
852, 825, 735 cmK1; LRMS (FAB) m/zZ268 (MCHC);
Anal. Calcd for C17H17NO2: C, 76.38; H, 6.41; N, 5.24.
Found: C, 76.20; H, 6.48; N, 5.21.
3.1.5. (1-Naphthalen-2-yl-vinyl)-carbamic acid benzyl
ester (2e). Mp 100.3–101.5 8C; 1H NMR (CDCl3) dZ5.11
(s, 1H), 5.19 (s, 2H), 5.72 (s, 1H), 6.45 (s, 1H), 7.30–7.60
(m, 8H), 7.76–7.86 (m, 4H); 13C NMR (CDCl3) dZ67.1,
100.4, 124.0, 124.7, 126.5, 127.6, 128.2, 128.3, 128.4,
128.6, 133.1, 133.3, 135.3, 135.9, 140.5, 153.8; IR (neat)
3282, 3046, 1701, 1622, 1527, 1226, 1106, 1064, 968, 884,
827, 694, 583 cmK1; HRMS (EI). Exact mass calcd for
C20H17NO2 [M]
C, 303.1259. Found 303.1251. Anal. Calcd
for C20H17NO2: C, 79.19; H, 5.65; N, 4.62. Found: C, 79.49;
H, 5.82; N, 4.64.
3.1.6. (Z)-(1-Phenyl-propenyl)-carbamic acid benzyl
ester (2fZ). Mp 73.5–74.0 8C; 1H NMR (CDCl3) dZ1.79
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(d, 3H, JZ6.8 Hz), 5.13 (s, 2H), 5.79 (q, 1H, JZ6.8 Hz),
(6.00 (brs, 1 H), 7.00–7.62 (m, 10 H); 13C NMR (C6D6) dZ
13.5, 67.0, 119.5, 126.0, 127.7, 128.5, 128.5, 135.0, 137.1,
139.2; IR (neat) 3385, 3296, 3032, 2941, 1701, 1498, 1452,
1399, 1329, 1225, 1089, 1018, 916, 824, 760, 695 cmK1;
HRMS (FAB). Exact mass calcd for C17H18NO2 [MCH]
C,
268.1338. Found 268.1339.
3.1.7. (E)-(1-Phenyl-propenyl)-carbamic acid benzyl
ester (2fE). Mp 63.9–64.0 8C; 1H NMR (CDCl3) dZ1.70
(d, 3H, JZ7.3 Hz), 5.11 (s, 2H), 5.90–6.25 (br, 2H), 7.20–
7.50 (m, 10H); 13C NMR (C6D6) dZ13.7, 66.7, 112.0,
128.0, 128.1, 128.5, 128.5, 128.6, 129.1, 134.6, 137.0,
137.2, 153.9; IR (neat) 3398, 3316, 3032, 2938, 1713, 1516,
1449, 1393, 1328, 1213, 1137, 1033, 922, 835, 771, 739,
699, 587 cmK1; HRMS (FAB). Exact mass calcd for
C17H18NO2 [MCH]
C, 268.1338. Found 268.1347.
3.1.8. (Z)-[1-(4-Methoxy-phenyl)-propenyl]-carbamic
acid benzyl ester (2gZ). Mp 110–110.5 8C; 1H NMR
(CDCl3) dZ1.77 (d, 3H, JZ6.9 Hz), 3.80 (s, 3H), 5.14 (s,
2H), 5.68 (q, 1H, JZ6.9 Hz), 5.96 (brs, 1H), 6.84 (apparent
d, 2H, JZ8.8 Hz), 7.32 (m, 7H); 13C NMR (C6D6) dZ13.5,
54.8, 66.9, 114.0, 117.6, 127.2, 128.5, 131.8, 134.6, 137.2,
154.1, 159.8; IR (neat) 3305, 3039, 2945, 2843, 1709, 1611,
1509, 1452, 1400, 1334, 1294, 1247, 1176, 1089, 1029, 820,
742, 699, 590 cmK1; HRMS (FAB). Exact mass calcd for
C18H20NO3 [MCH]
C, 298.1443. Found 298.1435.
3.1.9. (E)-[1-(4-Methoxy-phenyl)-propenyl]-carbamic
acid benzyl ester (2gE). Mp 66.0–66.5 8C; 1H NMR
(CDCl3) dZ1.69 (d, 3H, JZ7.1 Hz), 3.82 (s, 3H), 5.11 (s,
2H), 5.80–6.15 (m, 2H), 6.85–6.95 (m, 2H), 7.20–7.50 (m,
7H); 13C NMR (C6D6) dZ13.8, 54.7, 66.6, 111.1, 114.0,
128.1, 128.5, 128.6, 129.5, 130.3, 134.4, 137.1, 153.9,
159.7; IR (neat) 3323, 3033, 2941, 2843, 1719, 1609, 1509,
1296, 1247, 1177, 1135, 1027, 840, 739, 697 cmK1; HRMS
(FAB). Exact mass calcd for C18H20NO3 [MCH]
C,
298.1443. Found 298.1452.
3.1.10. (Z)-[1-(4-Methoxy-phenyl)-propenyl]-carbamic
acid ethyl ester (2hZ). Mp 57.1–57.2 8C; 1H NMR
(CDCl3) dZ1.25 (brs, 3H), 1.75 (d, 3H, JZ7.1 Hz), 3.78
(s, 3H), 4.13 (q, 2H, JZ7.1 Hz), 5.66 (q, 1H, JZ7.1 Hz),
5.88 (brs, 1H), 6.80–6.85 (m, 2H), 7.28–7.36 (m, 2H); 13C
NMR (CDCl3) dZ13.4, 14.5, 55.2, 61.2, 113.6, 117.4,
126.7, 131.1, 133.9, 159.2; IR (neat) 3301, 2979, 1703,
1609, 1510, 1376, 1329, 1245, 1178, 1099, 1037, 824, 774,
594, 448 cmK1; HRMS (EI). Exact mass calcd for
C13H17NO3 [M]
C, 235.1208. Found 235.1204. Anal.
Calcd for C13H17NO3: C, 66.36; H, 7.28; N, 5.95. Found:
C, 66.21; H, 7.32; N, 5.95.
3.1.11. (E)-[1-(4-Methoxy-phenyl)-propenyl]-carbamic
acid ethyl ester (2hE). 1H NMR (CDCl3) dZ1.11 (t, 3H,
JZ7.1 Hz), 1.57 (d, 3H, JZ7.3 Hz), 3.70 (s, 3H), 4.01 (q,
2H, JZ7.1 Hz), 5.70–5.95 (m, 2H), 6.73–6.80 (m, 2H),
7.10–7.16 (m, 2H); 13C NMR (CDCl3) dZ13.7, 14.5, 55.2,
60.8, 111.6, 113.6, 129.1, 129.9, 133.7, 154.3, 159.1; IR
(neat) 3319, 2980, 1715, 1608, 1511, 1382, 1293, 1247,
1175, 1138, 1037, 836, 614, 499 cmK1; HRMS (EI). Exact
mass calcd for C13H17NO3 [M]
C, 235.1208. Found
235.1201.
3.1.12. (Z)-[1-(4-Chloro-phenyl)-propenyl]-carbamic
acid benzyl ester (2iZ). Mp 95.2–95.3 8C; 1H NMR
(C6D6) dZ1.48 (br, 3H), 5.02 (brs, 2H), 5.20–5.90 (br,
2H), 6.60–7.40 (m, 9H); 13C NMR (C6D6) dZ13.4, 67.1,
119.8, 127.2, 128.3, 128.6, 133.4, 134.0, 136.9, 137.7,
153.8; IR (neat) 3292, 3033, 2947, 1706, 1589, 1494k 1398,
1327, 1299, 1094, 1016, 819, 741, 697 cmK1; HRMS
(FAB). Exact mass calcd for C17H17ClNO2 [MCH]
C,
302.0948. Found 302.0936.
3.1.13. (E)-[1-(4-Chloro-phenyl)-propenyl]-carbamic
acid benzyl ester (2iE). Mp 71.2–71.3 8C; 1H NMR
(C6D6) dZ1.44 (d, 3H, JZ7.4 Hz), 5.02 (s, 2H), 5.47
(brs, 1H), 6.12 (brs, 1H), 6.70–6.80 (m, 2H), 6.95–7.25 (m,
7H); 13C NMR (C6D6) dZ13.5, 66.8, 128.6, 128.6, 128.7,
130.4, 133.5, 133.8, 135.4, 136.9, 153.7; IR (neat) 3398,
3309, 3033, 2941, 1708, 1595, 1517, 1497, 1458, 1393,
1327, 1219, 1138, 1093, 1034, 836, 740, 701 cmK1; HRMS
(FAB). Exact mass calcd for C17H17ClNO2 [MCH]
C,
302.0948. Found 302.0943.
3.1.14. (Z)-(1-Phenyl-but-1-enyl)-carbamic acid benzyl
ester (2jZ). Mp 60.3–60.8 8C; 1H NMR (C6D6) dZ0.89 (t,
3H, JZ7.1 Hz), 2.03 (br, 2H), 5.04 (s, 2H), 5.30–5.55 (m,
2H), 7.00–7.25 (m, 8H), 7.28–7.36 (m, 2H); 13C NMR
(C6D6) dZ13.6, 21.6, 67.0, 126.1, 126.8, 127.4, 128.1,
128.5, 128.6, 133.5, 137.1, 139.2; IR (neat) 3294, 3033,
2961, 2876, 1705, 1498, 1458, 1400, 1334, 1223, 1092,
1026, 753, 691 cmK1; HRMS (FAB). Exact mass calcd for
C18H20NO2 [MCH]
C, 282.1494. Found 282.1495.
3.1.15. (E)-(1-Phenyl-but-1-enyl)-carbamic acid benzyl
ester (2jE). 1H NMR (C6D6) dZ0.87 (t, 3H, JZ7.4 Hz),
1.99 (quint, 3H, JZ7.4 Hz), 5.01 (s, 2H), 5.56 (brs, 1H),
6.26 (brs, 1H), 6.95–7.25 (m, 10H); 13C NMR (C6D6) dZ
15.1, 21.0, 66.6, 118.8, 126.4, 126.9, 128.2, 128.5, 128.6,
128.6, 129.0, 133.6, 137.1, 137.5, 153.6; IR (neat) 3398,
3319, 3032, 2962, 2876, 1723, 1514, 1454, 1367, 1327,
1219, 1134, 1039, 984, 922, 857, 743, 698 cmK1; HRMS
(FAB). Exact mass calcd for C18H20NO2 [MCH]
C,
282.1494. Found 282.1481.
3.2. Preparation and analytical data for enecarbamates
2k and 2l
3.2.1. Enecarbamate 2kE and 2kZ. To a solution of NaN3
(1.675 g, 25.8 mmol) in H2O (12 mL) was added a solution
of 1514 (2.85 g, 21.47 mmol) in THF (7 mL) dropwise at
0 8C. The mixture was vigorously stirred overnight and
Et2O was added. After separation of the phases, the organic
layer was washed with a saturated Na2CO3 aqueous solution
and brine sequentially. Et2O was evaporated under reduced
pressure of 300 mm Hg (Caution!) to give the crude adduct
16 in THF. This solution was added to boiling THF (10 mL)
at 80 8C very slowly for over 1.5 h. After completion of the
addition, the mixture was stirred at 80 8C until evolution of
N2 gas stopped (for about 2 h). The mixture was allowed to
cool to room temperature (rt), and THF was evaporated at
100 mm Hg. The residue was distilled 2 times (65 8C,
100 mm Hg) to give pure 17 (1.113 g, 47% yield). Benzyl
alcohol was added to 17 (1.113 g, 10.0 mmol) at K78 8C.
The freezed reaction mixture was allowed to warm to rt for
over 6 h, and was stirred until 17 was not detected in NMR
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analysis (about over 3 days). The mixture was chromato-
gaphed on silica gel to afford geometric isomer 2kZ as a
white solid (1.86 g, 85% yield). To a solution of 2kZ
(237 mg, 1.079 mmol) in THF (12 mL) was added KOtBu
(145.5 mg, 1.29 mmol) at rt. The reaction mixture was kept
stirred for 14 h. The reaction was quenched by addition of a
saturated NH4Cl aqueous solution at rt, and the product was
extracted with Et2O. The organic layer was washed with brine,
dried over anhydrous MgSO4, and concentrated under
vacuum. The crude mixture was purified by chromatography
on silica gel to afford almost 1:1 geometric mixture 2k
(184 mg, 78% yield). The mixture was separated by careful
thin layer chromatography on silica gel (eluent: toluene/
Et2OZ10/1) to afford geometric isomer 2kE (Scheme 7).
3.2.2. Enecarbamate 2l. According to the procedure
mentioned above, 2l was obtained. The boiling point of
the corresponding isocyanate was 78 8C/40 mm Hg.
3.2.3. (Z)-(1-Ethyl-propenyl)-carbamic acid benzyl ester
(2kZ). Mp 33.0–33.5 8C; 1H NMR (C6D6) dZ0.79 (t, 3H,
JZ7.5 Hz), 1.45 (d, 3H, JZ7.0 Hz), 1.95 (q, 2H, JZ
7.5 Hz), 5.04 (s, 2H), 5.38 (brs, 1H), 5.72 (q, 1H, JZ
7.0 Hz), 7.00–7.30 (m, 5H); 13C NMR (C6D6) dZ11.9,
12.4, 22.7, 66.5, 128.2, 128.6, 128.6, 136.2, 137.3; IR (neat)
3322, 3064, 3033, 2969, 2935, 2877, 1706, 1523, 1455,
1380, 1351, 1307, 1234, 1097, 1029, 998, 831, 738 cmK1;
HRMS (FAB). Exact mass calcd for C13H18NO2 [MCH]
C,
220.1338. Found 220.1347.
3.2.4. (E)-(1-Ethyl-propenyl)-carbamic acid benzyl ester
(2kE). Mp 53.0–54.0 8C; 1H NMR (C6D6) dZ0.95 (t, 3H,
JZ7.5 Hz), 1.28 (d, 3H, JZ6.8 Hz), 2.34 (brq, 2H, JZ
7.5 Hz), 4.70 (q, 1H, JZ6.8 Hz), 5.05 (s, 2H), 5.50 (brs, 1H),
7.00–7.26 (m, 5H); 13C NMR (C6D6) dZ11.7, 12.6, 27.9,
66.7, 110.5, 128.2, 128.5, 128.6, 137.2, 137.3; IR (neat) 3305,
2967, 2751, 1693, 1515, 1450, 1321, 1257, 1108, 966, 848,
738, 698 cmK1; HRMS (FAB). Exact mass calcd for
C13H18NO2 [MCH]
C, 220.1338. Found 220.1348.
3.2.5. Cyclohex-1-enyl-carbamic acid benzyl ester (2l).
Mp 49.0–50.0 8C; 1H NMR (C6D6) dZ1.26–1.45 (m, 4H),
1.70–1.80 (m, 2H), 1.86–1.98 (m, 2H), 5.03 (s, 2H), 5.31
(brs, 1H), 6.01 (brs, 1H), 7.00–7.25 (m, 5H); 13C NMR
(C6D6) dZ22.4, 22.8, 24.1, 27.7, 66.4, 109.3, 128.2, 128.6,
128.6, 132.3, 137.3, 153.2; IR (neat) 3322, 3058, 3033,
2931, 2838, 1706, 1538, 1452, 1380, 1348, 1305, 1232,
1062, 1037, 917, 840, 804, 736, 696 cmK1; HRMS (FAB).
Exact mass calcd for C14H18NO2 [MCH]
C, 232.1338.
Found 232.1342.
3.3. Preparation and analytical data for enecarbamte 2m
NaH (60%, 94.7 mg, 2.37 mmol) freshly washed with
pentane was added to a flask, followed by addition of
DMF (2.0 mL). The suspension was cooled to 0 8C, and 2a
(300 mg, 1.18 mmol) in DMF (3.0 mL) was added. The
mixture was stirred for 30 min at rt, and then cooled to 0 8C.
MeI (0.30 mL, 4.74 mmol) was added and the reaction
mixture was stirred overnight at rt until the starting material
disappeared. The reaction was quenched by addition of
saturated aqueous NH4Cl, and the aqueous layer was extracted
with AcOEt. The organic layer was washed with water twice
and brine, and then dried over MgSO4. The solvents were
evaporated and the residue was purified by chromatography on
silica gel to afford 2m (307.8 mg, 97% yield).
3.3.1. Methyl-(1-phenyl-vinyl)-carbamic acid benzyl
ester (2m). Mp 34.0–35.0 8C; 1H NMR (CDCl3) dZ3.21
(s, 3H), 5.04 (s, 2H), 5.16 (s, 1H), 5.46 (s, 1H), 6.80–7.40
(m, 10H); 13C NMR (CDCl3) dZ37.6, 67.2, 110.0, 125.5,
127.5, 127.6, 128.2, 128.3, 128.5, 136.3, 137.2, 148.1,
155.5; IR (neat) 3032, 2954, 2888, 1703, 1626, 1446, 1389,
1337, 1203, 1146, 1027, 955, 902, 777, 696 cmK1; HRMS
(FAB). Exact mass calcd for C17H18NO2 [MCH]
C,
268.1338. Found 268.1349.
4. Typical procedure for distillation of ethyl glyoxylate
Ethyl glyoxylate was purchased from Tokyo Kasei Kogyo
(TCI) as a polymer form in toluene. The ethyl glyoxylate
toluene solution (30 g) was added to the flame dried
flask. Toluene was evaporated completely under vacuum
(!1 mm Hg) at rt, and P2O5 (ca. 300 mg) was added to the
polymeric ethyl glyoxylate. The mixture was distilled to
give almost-toluene-free monomeric ethyl glyoxylate as a
slightly yellow liquid (150 mm Hg, 80 8C). Monomeric
ethyl glyoxylate easily polymerizes within 30 min to give
viscous liquid. Therefore, distilled ethyl glyoxylate should
be used immediately after purification.
5. Addition reactions of enecarbamates to ethyl
glyoxylate
5.1. Typical procedure for addition reactions of
enecarbamates to ethyl glyoxylate using a chiral copper
catalyst prepared from CuClO4$4CH3CN and chiral
diimine ligand 3t
Ligand 3t (9.9 mg, 0.022 mmol) in CH2Cl2 (1.5 mL) was
added to the CuClO4$4CH3CN (6.5 mg, 0.020 mmol) flask
under argon The yellow solution was stirred for over 12 h,
and cooled to 0 8C. Freshly distilled ethyl glyoxylate
(100 mL, 0.40 mmol) in CH2Cl2 (0.8 mL) was added to
the mixture, and then enecarbamate 2 (0.20 mmol) in
CH2Cl2 (0.8 mL) was added in one portion. The reaction
mixture was stirred at 0 8C, and was quenched by addition of
saturated aqueous NaHCO3. The reaction mixture was
allowed to warm to rt, and was extracted with CH2Cl2. The
Scheme 7.
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organic layer was washed with brine and dried over
anhydrous MgSO4. After the solvent was evaporated, the
residue was dissolved in EtOH (3.0 mL), and a 48% HBr
aqueous solution (0.3 mL) was added to the solution. The
mixture was stirred at rt for 1.5 min, and then the reaction
was quenched by addition of saturated aqueous NaHCO3 at
0 8C. The reaction mixture was allowed to warm to rt. The
mixture was extracted with CH2Cl2, and the organic layer
was washed with brine and dried over anhydrous MgSO4.
After the solvents were evaporated, the crude product was
purified by chromatography on silica gel to afford the
desired compound 7.
5.2. Analytical data for 7
5.2.1. (2S)-2-Hydroxy-4-oxo-4-phenyl-butyric acid ethyl
ester (7a). 1H NMR (CDCl3) dZ1.27 (t, 3H, JZ7.1 Hz),
3.29 (brs, 1H), 3.44 (dd, 1H, JZ6.1, 17.6 Hz), 3.52 (dd, 1H,
JZ3.9, 17.6 Hz), 4.25 (q, 2H, JZ7.1 Hz), 4.61–4.67 (m,
1H), 7.44–7.50 (m, 2H), 7.54–7.60 (m, 1H), 7.92–7.98 (m,
2H); 13C NMR (CDCl3) dZ14.0, 42.1, 61.8, 67.1, 128.1,
128.6, 133.5, 136.4, 173.7, 197.5. IR (neat) 3475, 3063,
2983, 1737, 1687, 1597, 1580, 1449, 1368, 1213, 1098,
1045, 860, 759, 690, 582, 499 cmK1; HRMS (FAB). Exact
mass calcd for C12H15O4 [MCH]
C, 223.0970. Found
223.0972; HPLC, Daicel Chiralcel ADH, hexane/iPrOHZ
4/1, flow rateZ0.5 mL/min: tRZ19.9 min (S), tRZ22.2 min
(R).
5.2.2. (2S)-2-Hydroxy-4-(4-methoxy-phenyl)-4-oxo-
butyric acid ethyl ester (7b). 1H NMR (CDCl3) dZ1.28
(t, 3H, JZ7.1 Hz), 3.41 (dd, 1H, JZ5.9, 17.4 Hz), 3.48 (dd,
1H, JZ4.0, 17.4 Hz), 3.48 (brd, 1H, JZ6.8 Hz), 3.87 (s,
3H), 4.26 (q, 2H, JZ7.1 Hz), 4.60–4.70 (m, 1H), 6.91–6.97
(m, 2H), 7.90–7.97 (m, 2H); 13C NMR (CDCl3) dZ14.0,
41.7, 55.4, 61.7, 67.3, 113.8, 129.5, 130.4, 163.8, 173.8,
196.1. IR (neat) 3483, 2979, 2841, 1739, 1677, 1600, 1575,
1512, 1465, 1421, 1368, 1265, 1172, 1099, 1027, 988, 895,
834, 737, 579 cmK1; HRMS (FAB). Exact mass calcd for
C13H17O5 [MCH]
C, 253.1076. Found 253.1097; HPLC,
Daicel Chiralcel ADH, hexane/iPrOHZ4/1, flow rateZ
0.4 mL/min: tRZ43.1 min (S), tRZ45.7 min (R).
5.2.3. (2S)-4-(4-Chloro-phenyl)-2-hydroxy-4-oxo-butyric
acid ethyl ester (7c). 1H NMR (CDCl3) dZ1.28 (t, 3H, JZ
7.1 Hz), 3.42 (dd, 1H, JZ6.1, 17.3 Hz), 3.49 (dd, 1H, JZ
3.9, 17.3 Hz), 3.41–3.47 (brd, 1H), 4.26 (q, 2H, JZ7.1 Hz),
4.62–4.70 (m, 1H), 7.42–7.48 (m, 2H), 7.86–7.93 (m, 2H);
13C NMR (CDCl3) dZ14.1, 42.2, 62.0, 67.1, 129.0, 129.6,
134.8, 140.1, 173.7, 196.3. IR (neat) 3480, 2982, 1739,
1684, 1590, 1573, 1402, 1213, 1093, 1045, 820, 531 cmK1;
HRMS (FAB). Exact mass calcd for C12H14ClO4 [MCH]
C,
257.0580. Found 257.0584; HPLC, Daicel Chiralcel ADH,
hexane/iPrOHZ4/1, flow rateZ0.5 mL/min: tRZ24.2 min
(S), tRZ26.5 min (R).
5.2.4. (2S)-2-Hydroxy-4-oxo-4-p-tolyl-butyric acid ethyl
ester (7d). 1H NMR (CDCl3) dZ1.28 (t, 3H, JZ7.1 Hz),
2.41 (s, 3H), 3.44 (dd, 1H, JZ5.9, 17.4 Hz), 3.51 (dd, 1H,
JZ4.0, 17.4 Hz), 3.45–3.55 (brs, 1H), 4.26 (q, 2H, JZ
7.1 Hz), 4.66 (dt, 1H, JZ4.2, 5.5 Hz), 7.26 (apparent d, 2H,
JZ8.0 Hz), 7.85 (apparent d, 2H, JZ8.2 Hz); 13C NMR
(CDCl3) dZ14.0, 21.6, 42.0, 61.7, 67.2, 128.2, 129.3, 133.9,
144.4, 173.7, 197.1. IR (neat) 3483, 2981, 1742, 1682, 1606,
1405, 1365, 1212, 1098, 1044, 813, 578 cmK1; HRMS
(FAB). Exact mass calcd for C13H17O4 [MCH]
C,
237.1127. Found 237.1120; HPLC, Daicel Chiralcel ADH,
hexane/iPrOHZ4/1, flow rateZ0.3 mL/min: tRZ36.1 min
(S), tRZ38.2 min (R).
5.2.5. (2S)-2-Hydroxy-4-naphthalen-2-yl-4-oxo-butyric
acid ethyl ester (7e). 1H NMR (CDCl3) dZ1.28 (t, 3H,
JZ7.1 Hz), 3.52 (d, 1H, JZ5.9 Hz), 3.59 (dd, 1H, JZ6.1,
17.3 Hz), 3.66 (dd, 1H, JZ3.9, 17.3 Hz), 4.28 (q, 2H, JZ
7.1 Hz), 4.73 (dt, 1H, JZ4.2, 5.4 Hz), 7.50–7.65 (m, 2H),
7.82–8.20 (m, 4H), 8.45 (s, 1H); 13C NMR (CDCl3) dZ
14.1, 42.3, 61.9, 67.3, 123.6, 126.9, 127.8, 128.6, 128.8, 129.6,
130.2, 132.4, 133.8, 135.8, 173.9, 197.5. IR (neat) 3481, 3058,
2982, 1741, 1681, 1627, 1469, 1369, 1209, 1097, 1045, 859,
824, 749, 477 cmK1; HRMS (FAB). Exact mass calcd for
C16H17O4 [MCH]
C, 273.1127. Found 273.1125; HPLC,
Daicel Chiralcel ADH, hexane/iPrOHZ4/1, flow rateZ
0.5 mL/min: tRZ27.0 min (S), tRZ30.4 min (R).
5.2.6. (2S)-2-Hydroxy-3-methyl-4-oxo-4-phenyl-butyric
acid ethyl ester (7f, syn/anti mixture). 1H NMR syn
(CDCl3) dZ1.26 (t, 3H, JZ7.0 Hz), 1.29 (d, 3H, JZ
7.0 Hz), 3.28 (br, 1H), 3.93 (dq, 1H, JZ4.2, 7.0 Hz), 4.25
(q, 2H, JZ7.0 Hz), 4.58 (d, 1H, JZ4.2 Hz), 7.40–7.65 (m,
3H), 7.90–8.05 (m, 2H); anti (CDCl3) dZ1.20 (t, 3H, JZ
7.1 Hz), 1.36 (d, 3H, JZ7.3 Hz), 3.61 (d, 1H, JZ8.3 Hz),
3.98 (dq, 1H, JZ4.6, 7.1 Hz), 4.10–4.25 (m, 2H), 4.39 (dd,
1H, JZ4.6, 8.3 Hz), 7.40–7.65 (m, 3H); 13C NMR syn
(CDCl3) dZ12.1, 14.0, 44.3, 61.9, 71.6, 128.4, 128.7, 133.3,
135.7, 173.1, 201.6; anti (CDCl3) dZ14.0, 14.1, 44.0, 61.5,
73.1, 128.3, 128.7, 133.4, 135.9, 173.1; IR (neat) syn 3480,
3063, 2978, 2936, 1734, 1678, 1596, 1579, 1449, 1369,
1217, 1133, 1062, 1023, 1001, 975, 952, 862, 794, 708; anti
3481, 3059, 2981, 2941, 1738, 1685, 1588, 1454, 1372,
1255, 1209, 1144, 1092, 1024, 973, 701 cmK1; HRMS
(FAB). Exact mass calcd for C13H17O4 [MCH]
C,
237.1127. Found 237.1118; HPLC, Daicel Chiralcel ASC
ADHCAD, hexane/iPrOHZ4/1, flow rateZ0.5 mL/min:
tRZ46.7 min (2S,3S), tRZ50.6 min (2R,3R), tRZ54.3 min
(2S,3R), tRZ61.9 min (2R,3S).
5.2.7. (2S)-2-Hydroxy-4-(4-methoxy-phenyl)-3-methyl-4-
oxo-butyric acid ethyl ester (7g, syn/anti mixture). 1H
NMR syn (CDCl3) dZ1.28 (t, 3H, JZ7.1 Hz), 1.29 (d, 3H,
JZ7.1 Hz), 3.35 (br, 1H), 3.84–3.96 (m, 4H), 4.27 (q, 2H,
JZ7.1 Hz), 4.58 (t, 1H, JZ4.2 Hz), 6.96 (apparent d, 2H,
JZ9.0 Hz), 7.30–7.45 (m, 5H), 7.95 (apparent d, 2H, JZ
8.8 Hz); anti (CDCl3) dZ1.19 (t, 3H, JZ7.1 Hz), 1.36 (d,
3H, JZ7.3 Hz), 3.75 (d, 1H, JZ9.3 Hz), 3.88 (s, 3H), 3.94
(dq, 1H, JZ4.6, 7.3 Hz), 4.15 (apparent dq, 2H, JZ3.2,
7.1 Hz), 4.36 (dd, 1H, JZ4.6, 9.3 Hz), 6.92–6.99 (m, 2H),
7.90–7.97 (m, 2H); 13C NMR syn (CDCl3) dZ12.3, 14.0,
43.7, 55.4, 61.8, 71.7, 113.9, 128.5, 130.7, 163.7, 173.1,
200.4; anti (CDCl3) dZ14.0, 14.6, 43.2, 55.5, 61.4, 73.4,
113.9, 128.7, 130.8, 163.8, 173.2, 201.9; IR (neat) syn 3477,
2979, 2935, 2850, 1730, 1670, 1600, 1573, 1510, 1463,
1420, 1308, 1261, 1173, 1125, 1027, 976, 843, 770, 604;
anti 3478, 2979, 2941, 2843, 1738, 1671, 1599, 1580, 1510,
1457, 1419, 1370, 1308, 1257, 1216, 1172, 1092, 1026, 974,
841 cmK1; HRMS (FAB). Exact mass calcd for C14H19O5
[MCH]C, 267.1232. Found 267.1232; HPLC, Daicel
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Chiralcel ADH, hexane/iPrOHZ4/1, flow rateZ0.2 mL/min:
tRZ60.5 min (2R,3R), tRZ65.4 min (2S,2S), tRZ75.2 min
(2R,3S), tRZ78.9 min (2S,3R).
5.2.8. (2S)-4-(4-Chloro-phenyl)-2-hydroxy-3-methyl-4-
oxo-butyric acid ethyl ester (7i, syn/anti mixture). 1H
NMR syn (CDCl3) dZ1.26 (t, 3H, JZ7.0 Hz), 1.28 (d, 3H,
JZ7.0 Hz), 3.27 (brs, 1H), 3.87 (dq, 1H, JZ4.4, 7.0 Hz),
4.25 (q, 2H, JZ7.0 Hz), 4.55 (d, 1H, JZ4.4 Hz), 7.40–7.55
(m, 2H), 7.84–7.97 (m, 2H); anti (CDCl3) dZ1.21 (t, 3H,
JZ7.1 Hz), 1.34 (d, 3H, JZ7.1 Hz), 3.53 (d, 1H, JZ
8.2 Hz), 3.91 (dq, 1H, JZ5.0, 7.1 Hz), 4.08–4.24 (m, 2H),
4.38 (dd, 1H, JZ5.0, 8.2 Hz), 7.42–7.52 (m, 2H), 7.80–7.95
(m, 2H); 13C NMR syn (CDCl3) dZ12.1, 14.0, 44.4, 62.0,
71.5, 129.0, 129.8, 134.1, 139.7, 173.1, 200.3; anti (CDCl3)
dZ13.9, 14.0, 44.1, 61.6, 73.0, 129.0, 129.8, 134.3, 139.9,
173.0, 201.8; IR (neat) syn 3485, 2982, 2938, 1730, 1682,
1589, 1571, 1488, 1455, 1401, 1217, 1132, 1092, 1013, 977,
843, 758, 692, 533, 478; anti 3478, 3092, 2982, 2935, 1738,
1686, 1589, 1455, 1402, 1255, 1208, 1144, 1092, 1022, 976,
842, 751, 527 cmK1; HRMS (FAB). Exact mass calcd for
C13H16ClO4 [MCH]
C, 271.0737. Found 271.0745; HPLC,
Daicel Chiralcel AS, hexane/iPrOHZ4/1, flow rateZ
0.5 mL/min: tRZ15.1 min (2S,3S), tRZ16.6 min (2S,3R),
tRZ21.4 min (2R,3S), tRZ23.9 min (2R,3R).
5.2.9. (2S)-3-Benzoyl-2-hydroxy-pentanoic acid ethyl
ester (7j, syn/anti mixture). 1H NMR syn (CDCl3) dZ
0.93 (t, 3H, JZ7.5 Hz), 1.19 (t, 3H, JZ7.1 Hz), 1.70–2.05
(m, 2H), 3.18 (brs, 1H), 3.83 (dt, 1H, JZ5.3, 8.3 Hz), 4.19
(q, 2H, JZ7.1 Hz), 4.51 (d, 1H, JZ5.3 Hz), 7.42–7.54 (m,
2H), 7.54–7.62 (m, 1H), 7.90–8.02 (m, 2H); anti (CDCl3)
dZ1.04 (t, 3H, JZ7.6 Hz), 1.15 (t, 3H, JZ7.1 Hz), 1.80–
1.95 (m, 2H), 3.70 (d, 1H, JZ9.5 Hz), 3.83 (dt, 1H, JZ4.2,
7.1 Hz), 4.09 (q, 2H, JZ7.1 Hz), 4.43 (dd, 1H, JZ4.2,
9.5 Hz), 7.46–7.52 (m, 2H), 7.56–7.63 (m, 1H), 7.88–7.95
(m, 2H); 13C NMR syn (CDCl3) dZ12.0, 13.9, 21.3, 51.2,
61.9, 71.1, 128.3, 128.6, 133.2, 137.0, 173.6, 201.5; anti
(CDCl3) dZ12.0, 13.9, 22.3, 50.1, 61.4, 71.3, 128.3, 128.7,
133.5, 136.6, 173.4, 203.9; IR (neat) syn 3477, 2972, 2876,
1738, 1675, 1596, 1447, 1372, 1255, 1220, 1118, 1023, 931,
849, 779, 701; anti 3485, 3062, 2966, 2941, 2875, 1738,
1682, 1596, 1579, 1448, 1368, 1268, 1208, 1134, 1100,
1028, 914, 849, 785, 699 cmK1; HRMS (FAB). Exact mass
calcd for C14H19O4 [MCH]
C, 251.1283. Found 251.1277;
HPLC, Daicel Chiralcel AS, hexane/iPrOHZ4/1, flow
rateZ0.5 mL/min: tRZ13.7 min (2S,3S), tRZ15.3 min
(2S,3R), tRZ17.6 min (2R,3R), tRZ23.1 min (2R,3S).
5.2.10. (2S)-2-Hydroxy-3-methyl-4-oxo-hexanoic acid
ethyl ester (7k, syn/anti mixture). 1H NMR syn (C6D6)
dZ0.89 (t, 3H, JZ7.1 Hz), 0.99 (d, 3H, JZ7.2 Hz), 1.97–
2.08 (m, 2H), 2.70 (dq, 1H, JZ4.9, 7.2 Hz), 3.39 (d,
1H, JZ6.7 Hz), 3.80–4.00 (m, 2H), 4.11 (dd, 1H, JZ
4.9, 6.7 Hz); anti (C6D6) dZ0.87 (t, 3H, JZ7.1 Hz), 0.93 (t,
3H, JZ7.3 Hz), 1.02 (d, 3H, JZ7.2 Hz), 1.95–2.22 (m, 2H),
2.65 (dq, 1H, JZ4.4, 7.2 Hz), 3.05–3.23 (m, 1H), 3.80–4.00
(m, 2H), 4.38–4.47 (m, 1H); 13C NMR syn (CDCl3) dZ
7.58, 12.8, 14.0, 34.6, 49.4, 61.3, 73.0, 173.5, 211.3; anti
(C6D6) dZ7.7, 11.0, 14.0, 34.0, 49.5, 61.6, 71.7, 173.7,
209.9; IR (neat) syn 3484, 2981, 2940, 1739, 1716, 1459,
1409, 1375, 1268, 1209, 1108, 1066, 1025, 975, 862, 808,
748; anti 3488, 2981, 2940, 1733, 1716, 1459, 1373, 1218,
1145, 1025, 977, 862, 800, 752 cmK1; HRMS (FAB). Exact
mass calcd for C9H17O4 [MCH]
C, 189.1127. Found
189.1120.
5.2.11. (1S)-Hydroxy-(2-oxo-cyclohexyl)-acetic acid
ethyl ester (7l, syn/anti mixture). 1H NMR anti
((1S,1 0R), tentatively assignment) (C6D6) dZ0.95 (t, 3H,
JZ7.1 Hz), 0.94–1.20 (m, 2H), 1.30–1.42 (m, 2H), 1.56–
1.84 (m, 3H), 2.02–2.12 (m, 1H), 2.60–2.70 (m, 1H), 3.35
(d, 1H, JZ7.2 Hz), 3.84 (dd, 1H, JZ3.2, 7.2 Hz), 4.02 (dq,
2H, JZ1.9, 7.1 Hz); distingishable syn peaks dZ0.88 (t,
3H, JZ7.1 Hz), 2.12–2.21 (m, 1H), 2.48–2.57 (m,1H), 2.94
(d, 1H, JZ5.0 Hz), 4.60 (dd, 1H, JZ3.2, 5.0 Hz); 13C NMR
anti (CDCl3) dZ14.1, 24.8, 26.9, 30.1, 42.0, 53.7, 61.6,
71.1, 173.4, 211.2; distinguishable syn peaks dZ14.2, 24.6,
27.1, 41.9, 53.8, 61.7, 69.2, 173.6, 210.4; HRMS (FAB).
Exact mass calcd for C10H17O4 [MCH]
C, 201.1127. Found
201.1127.
6. Determination of the ee’s of 7k and 7l
In order to determine the ee’s of 7k and 7l whose ee’s could
not be determined by HPLC analysis as their UV absorbance
were very weak, they were converted to 18 and 19,
respectively (Scheme 8).
6.1. Synthesis of 18
To a solution of 7k (17.9 mg, 0.095 mmol) in CH2Cl2
(0.4 mL) was added a solution of Et3N (19.9 mL,
0.143 mmol) in CH2Cl2 (0.3 mL) followed by a solution
of BzCl (16.6 mL, 0.143 mmol) in CH2Cl2 (0.3 mL) and
DMAP (catalytic amount) at 0 8C. The reaction mixture was
stirred for 5 h at 0 8C, and water was added, followed by
addition of a 1N HCl aqueous solution. The reaction mixture
was extracted with Et2O, and the organic phase was washed
with a saturated NaHCO3 aqueous solution and brine, and
dried over anhydrous MgSO4. After evaporation of solvents,
the crude adduct was purified by chromatography on silica
gel to afford 18 (22.2 mg, 80% yield). 19 was also
synthesized by using the same method mentioned above
(74% yield).
6.1.1. (1S)-Benzoic acid 1-ethoxycarbonyl-2-methyl-3-
oxo-pentyl ester (18, syn/anti mixture). 1H NMR syn
(CDCl3) dZ1.09 (t, 3H, JZ7.1 Hz), 1.23 (t, 3H, JZ7.1 Hz),
Scheme 8.
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1.25 (t, 3H, JZ7.1 Hz), 2.59 (q, 2H, JZ7.1 Hz), 3.23
(quint, 1H, JZ7.1 Hz), 4.22 (q, 1H, JZ7.1 Hz), 4.22 (q, 1H,
JZ7.1 Hz), 5.39 (d, 1H, JZ7.1 Hz), 7.35–7.50 (m, 2H),
7.50–7.60 (m, 1H), 7.92–8.04 (m, 2H); anti dZ1.05 (t, 3H,
JZ7.3 Hz), 1.24 (t, 3H, JZ7.1 Hz), 1.26 (t, 3H, JZ7.1 Hz),
2.57 (q, 2H, JZ7.3 Hz), 3.21 (dq, 1H, JZ5.1, 7.1 Hz), 4.21
(q, 2H, JZ7.1 Hz), 5.69 (d, 1H, JZ5.1 Hz), 7.42 (apparent
t, 2H, JZ7.5 Hz), 7.50–7.60 (m, 1H), 7.95–8.05 (m, 2H);
13C NMR anti (CDCl3) dZ7.7, 11.6, 14.1, 34.1, 47.1, 61.8,
72.6, 128.4, 129.2, 129.8, 133.4, 165.6, 168.9, 209.6;
distinguishable syn peaks dZ12.6, 35.0, 61.6, 73.9, 129.1,
129.9, 130.2, 133.7, 209.7; IR (neat) 2981, 2940, 1725,
1602, 1454, 1375, 1348, 1280, 1211, 1103, 1070, 1027, 977,
713 cmK1; HRMS (FAB). Exact mass calcd for C16H21O5
[MCH]C, 293.1389. Found 293.1380; HPLC, Daicel
Chiralcel ADHCADH, hexane/iPrOHZ19/1, flow rateZ
0.5 mL/min: tRZ42.7 min (1R,2R), tRZ51.3 min (1S,2S),
tRZ54.7 min (1S,2R), tRZ56.8 min (1R,2S).
6.1.2. (1S)-Benzoic acid ethoxycarbonyl-(2-oxo-cyclo-
hexyl)-methyl ester (19, syn/anti mixture). 1H NMR anti
((1S,1 0R) tentatively assignment) (CDCl3) dZ1.26 (t, 3H,
JZ7.1 Hz), 1.60–1.85 (m, 3H), 1.85–2.20 (m, 3H), 2.25–
2.60 (m, 2H), 3.14–3.30 (m, 1H), 4.23 (q, 2H, JZ7.1 Hz),
5.51 (d, 1H, JZ4.8 Hz), 7.40–7.50 (m, 2H), 7.52–7.61 (m,
1H), 7.98–8.14 (m, 2H); distinguishable syn peaks dZ1.27
(t, 3H, JZ7.0 Hz), 2.96–3.10 (m, 1H), 4.23 (q, 2H, JZ
7.0 Hz), 5.86 (d, 1H, JZ3.3 Hz); 13C NMR anti (CDCl3)
dZ14.0, 24.6, 26.8, 29.5, 41.8, 51.7, 61.5, 70.9, 128.4,
129.4, 129.9, 133.3, 165.9, 169.2, 207.5; syn dZ14.1, 26.7,
27.8, 41.7, 51.6, 61.6, 70.1, 128.3, 129.6, 129.8, 133.2,
165.5, 169.6, 207.3; HRMS (FAB). Exact mass calcd for
C17H21O5 [MCH]
C, 305.1389. Found 305.1382; HPLC,
Daicel Chiralcel ADHCAS, hexane/iPrOHZ9/1, flow
rateZ0.9 mL/min: tRZ25.2 min (1S,1
0R), tRZ27.4 min
(syn, the absolute configuration was not determined.), tRZ
29.9 min (1R,1 0S), tRZ36.6 min (syn).
7. Reduction of 6a
7.1. Procedure for the synthesis of 10
Ligand 3t (9.9 mg, 0.022 mmol) in CH2Cl2 (1.5 mL) was
added to the CuClO4$4CH3CN (6.5 mg, 0.020 mmol) flask
under argon The yellow solution was stirred for over 8 h,
and cooled to 0 8C. Freshly distilled ethyl glyoxylate
(100 mL, 0.40 mmol) in CH2Cl2 (0.8 mL) was added to
the mixture, and then enecarbamate 2a (50.7 mg,
0.20 mmol) in CH2Cl2 (0.8 mL) was added in one portion.
The reaction mixture was stirred at 0 8C for 1 h. The
reaction was quenched by addition of saturated aqueous
NaHCO3. The reaction mixture was allowed to warm to rt,
and was extracted with CH2Cl2. The organic layer was
washed with brine and dried over anhydrous MgSO4. The
solvent was evaporated, and then the residue was dried with
benzene azeotropy three times and then under vacuum. THF
(2.0 mL) and MeOH (0.5 mL) were added to the residue,
and then the solution was cooled to K78 8C. Diethyl
methoxyborane (79 mL, 0.6 mmol) was added, and the
mixture was stirred for 15 min. To the mixture was added
NaBH4 (22.7 mg, 0.6 mmol) in one portion. The mixture
was stirred for 2 h atK78 8C. The reaction was quenched by
addition of AcOH (0.3 mL) and was allowed to warm to rt.
The mixture was alkalized at 0 8C by addition of saturated
aqueous NaHCO3. The mixture was extracted with Et2O
twice. The organic layer was washed with brine and dried
over anhydrous MgSO4. After the solvents were evaporated,
the crude product was purified by chromatography on silica
gel to afford the desired compound 10 (46.5 mg, 65% yield
in two steps, syn/antiZ94/6).
7.1.1. 4-Benzyloxycarbonylamino-2-hydroxy-4-phenyl-
butyric acid ethyl ester: (10, syn/antiZ94/6). 1H NMR
(CDCl3) dZ1.23 (t, 3H x 19/20, JZ7.1 Hz), 1.25 (t, 3H x
1/20, JZ7.0 Hz), 1.95–2.40 (m, 2H), 3.33 (brs, 1H x 19/20),
3.51 (brs, 1H x 1/20), 4.00–4.40 (m, 3H), 4.85–5.20 (m,
3H), 5.52 (d, 1H x 19/20, JZ7.3 Hz), 5.96 (d, 1H x 1/20,
JZ8.2 Hz), 7.00–7.60 (m, 10H); 13C NMR (CDCl3) syn:
dZ14.1, 40.3, 52.6, 61.8, 66.8, 68.4, 126.4, 127.6, 128.1,
128.4, 128.7, 136.3, 141.4, 155.7, 174.4; anti: (distinguish-
able peak) 40.2, 52.4, 67.8, 126.2, 127.4, 141.1, 156.0,
174.3; LRMS (FAB) m/zZ358 [MCH]C
7.2. Determination of relative configuration of
compound 10
7.2.1. Synthesis of 11. To a solution of 10 (31.3 mg,
0.088 mmol) in CH2Cl2 (0.6 mL) was added 2,6-lutidine
(12.0 mg, 0.114 mmol) in CH2Cl2 (0.2 mL) and
TBDMSOTf (27.8 mg, 0.105 mmol) in CH2Cl2 (0.2 mL)
successively at 0 8C. The reaction mixture was allowed to
warm to rt, and was stirred for 10 h. H2O was added and the
mixture was extracted with CH2Cl2. The organic layer was
washed with brine and dried over anhydrous MgSO4. After
the solvent was evaporated, the crude product was purified
on silica gel column chromatography to give 11 (37.9 mg,
92% yield).
7.2.2. 4-Benzyloxycarbonylamino-2-(tert-butyl-di-
methyl-silanyloxy)-4-phenyl-butyric acid ethyl ester
(11, diastereomer mixture). 1H NMR (CDCl3) dZsyn:
K0.03 (s, 3H), 0.02 (s, 3H), 0.90 (s, 9H), 1.15–1.27 (m, 3H),
2.00–2.35 (m, 2H), 3.90–4.30 (m, 3H), 4.80–5.15 (m, 3H),
5.50 (brs, 1H), 7.15–7.40 (m, 10 H); anti: (distinguishable
peak) dZK0.02 (s, 3H), 0.03 (s, 3H), 5.62 (brd, 1H, JZ
7.7 Hz); 13C NMR (CDCl3) syn: dZK5.4, K5.0, 14.0,
18.1, 25.7, 41.0, 52.9, 61.0, 66.6, 70.3, 126.4, 127.4, 128.0,
128.1, 128.4, 128.6, 136.4, 141.8, 155.3, 173.2; anti:
(distinguishable peak) K5.0, 14.1, 41.8, 52.3, 69.8, 126.0,
127.3, 128.6, 142.2, 155.6, 173.1; IR (neat) 3343, 2940,
1720, 1518, 1254, 1131, 1038, 839, 781, 699 cmK1; HRMS
(FAB). Exact mass calcd for C26H38NO5Si [MCH]
C,
472.2519. Found 472.2508.
7.2.3. Synthesis of 12. To a solution of 11 (21.4 mg,
0.0454 mmol) in AcOEt (2.0 mL) was added AcOH
(16.8 mg, 0.0.272 mmol) and 5% wet Pd/C (9.7 mg,
10 mol%) at rt. After replacement of argon by hydrogen,
the mixture was stirred at rt until the starting material
completely disappeared (11 h). Pd/C was filtered off and
saturated aqueous NaHCO3 was added to the filtrate. The
mixture was extracted with AcOEt, and then the organic
layer was washed with brine and dried over anhydrous
MgSO4. After the solvent was evaporated, the crude product
was purified on silica gel column chromatography to give 12
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(13.4 mg, quantitative yield). Diastereomers 12 were
separated by silica gel column chromatography.
7.2.4. (3S,5R)-3-(tert-Butyl-dimethyl-silanyloxy)-5-phe-
nyl-pyrrolidin-2-one (12-major). 1H NMR (CDCl3) dZ
0.14 (s, 3H), 0.16 (s, 3H), 0.91 (s, 9H), 2.21 (ddd, 1H, JZ5.1,
7.1, 13.2 Hz), 2.46 (ddd, 1H, JZ5.1, 7.5, 13.2 Hz), 4.38 (dd,
1H, JZ5.1, 7.1 Hz), 4.83 (dd, 1H, JZ5.0, 7.5 Hz), 6.02 (brs,
1H), 7.20–7.43 (m, 5H); 13C NMR (CDCl3) dZK5.1,K4.5,
18.3, 25.8, 41.5, 55.1, 69.9, 125.5, 127.9, 129.0, 142.1, 176.3;
IR (neat) 3226, 2927, 2892, 2855, 1715, 1496, 1471, 1331,
1253, 1151, 1091, 1028, 963, 880, 839, 780, 699 cmK1;
HRMS (FAB). Exact mass calcd for C16H26NO2Si [MCH]
C,
292.1733. Found 292.1733 (Scheme 9).
7.2.5. (3S,5S)-3-(tert-Butyl-dimethyl-silanyloxy)-5-phe-
nyl-pyrrolidin-2-one (12-minor). 1H NMR (CDCl3) dZ
0.15 (s, 3H), 0.20 (s, 3H), 0.91 (s, 9H), 1.94 (dt, 1H, JZ9.2,
12.6 Hz), 2.75–2.87 (m, 1H), 4.42 (dd, 1H, JZ7.9, 9.2 Hz),
4.53 (dd, 1H, JZ6.2, 8.6 Hz), 5.76 (brs, 1H), 7.30–7.40 (m,
5H); 13C NMR (CDCl3) dZK5.1, K4.5, 18.3, 25.8, 42.0,
53.9, 70.8, 126.1, 128.1, 128.9, 176.0; IR (neat) 3220, 2936,
2858, 2359, 1717, 1463, 1330, 1247, 1151, 882, 838, 781,
698 cmK1; HRMS (FAB). Exact mass calcd for
C16H26NO2Si [MCH]
C, 292.1733. Found 292.1736
(Scheme 10).
8. Determination of the absolute and relative
configuration of 7f
8.1. Determination of the relative configuration of 7f
To a solution of anti-7f (45.6 mg, 0.193 mmol) in MeOH
(1.0 mL) was added NaBH4 (14.6 mg, 0.39 mmol) at 0 8C.
The reaction mixture was stirred for 10 min, and the
reaction was quenched by addition of acetone. The mixture
was kept stirred for 5 min, and then saturated NH4Cl
aqueous solution was added. The mixture was extracted
with CH2Cl2 three times, and the extract was dried over
anhydrous MgSO4. The solvents were evaporated to give a
crude keto alcohol. To a solution of the crude product in
CH2Cl2 (1 mL) was added TsOH$H2O, and the reaction
mixture was stirred for 13.5 h at rt. The reaction was
quenched by addition of a saturated NaHCO3 aqueous
solution, and was extracted with CH2Cl2 three times. The
extract was dried over anhydrous MgSO4. The solvents
were evaporated to give a residue, followed by purification
on silica gel chromatography to afford 14 as a diastereomer
mixture (19.8 mg, 53% yield, 14/epi-14Z55/45). 14 was
recrystallized from CH2Cl2/hexane to give single crystals
which were suitable for X-ray structure analysis. From syn-
7f, 20 was obtained as a diastereomer mixture (84% yield,
20/epi-20Z86/14) according to the same procedure as
mentioned above. The relative stereochemisty of 20 was
determined by NOE analysis. Lactones 14 and 20 were used
for determination of the absolute configuration as follows.
8.1.1. (3S,4R,5S)-3-Hydroxy-4-methyl-5-phenyl-di-
hydro-furan-2-one (14). Mp 150–151 8C; 1H NMR
(CDCl3) dZ0.65 (d, 3H, JZ7.3 Hz), 2.75 (brs, 1H), 2.98–
3.08 (m, 1H), 4.79 (d, 1H, JZ6.8 Hz), 5.57 (d, 1H, JZ
4.6 Hz), 7.25–7.30 (m, 2H), 7.30–7.38 (m, 1H), 7.38–7.45
(m, 2H); 13C NMR (CDCl3) dZ7.4, 41.1, 72.1, 80.2, 125.2,
128.2, 128.6, 135.1, 177.0; IR (neat) 3443, 2963, 1758,
1452, 1414, 1294, 1194, 1148, 1051, 956, 754, 701, 622,
478 cmK1; HRMS (FAB). Exact mass calcd for C11H13O3
[MCH]C, 193.0865. Found 193.0872.
8.1.2. (3S,4R,5R)-3-Hydroxy-4-methyl-5-phenyl-di-
hydro-furan-2-one (epi-14). 1H NMR (CDCl3) dZ1.22
(d, 3H, JZ7.1 Hz), 2.62 (tq, 1H, JZ5.1, 6.8 Hz), 2.86 (brs,
1H), 4.47 (d, 1H, JZ6.8 Hz), 5.26 (d, 1H, JZ5.1 Hz), 7.20–
7.45 (m, 5H); 13C NMR (CDCl3) dZ10.8, 43.2, 69.7, 85.8,
125.3, 128.6, 128.8, 137.7, 176.9; IR (neat) 3430, 3039,
2924, 2857, 1772, 1455, 1275, 1202, 1143, 1093, 986, 889,
805, 742, 702 cmK1; HRMS (FAB). Exact mass calcd for
C11H13O3 [MCH]
C, 193.0865. Found 193.0864.
8.1.3. (3S,4S,5R)-3-Hydroxy-4-methyl-5-phenyl-di-
hydro-furan-2-one (20). 1H NMR (CDCl3) dZ0.87 (d,
3H, JZ7.0 Hz), 2.70–2.92 (m, 1H), 3.18 (brs, 1H), 4.24 (d,
1H, JZ9.9 Hz), 5.63 (d, 1H, JZ8.1 Hz), 7.05–7.18 (m, 2H),
7.30–7.45 (m, 3H); 13C NMR (CDCl3) dZ13.3, 42.1, 72.2,
82.4, 125.7, 128.5, 128.6, 135.5, 177.5; IR (neat) 3362,
2970, 1776, 1455, 1334, 1184, 1145, 1096, 991, 897, 755,
701, 464 cmK1; HRMS (FAB). Exact mass calcd for
C11H13O3 [MCH]
C, 193.0865. Found 193.0872.
8.1.4. (3S,4S,5S)-3-Hydroxy-4-methyl-5-phenyl-dihydro-
furan-2-one (epi-20). 1H NMR (CDCl3) dZ1.24 (d, 3H,
JZ6.4 Hz), 2.41 (tq, 1H, JZ6.4, 10.6 Hz), 3.24 (brs, 1H),
4.25 (d, 1H, JZ11.0 Hz), 4.87 (d, 1H, JZ10.1 Hz), 7.30–
7.50 (m, 5H); 13C NMR (CDCl3) dZ13.3, 47.5, 74.7, 84.1,
126.5, 128.8, 129.2, 136.2, 176.8; IR (neat) 3319, 2967,
2921, 1776, 1459, 1318, 1237, 1152, 1110, 981, 765, 700,
540 cmK1; HRMS (FAB). Exact mass calcd for C11H13O3
[MCH]C, 193.0865. Found 193.0857.
8.2. Determination of the absolute configuration of 7f
Lactones 14 and 20 were converted into 21 and 22
respectively, by using a standard method as shown below
(Scheme 11).
Dd (dSKdR) in the
1H NMR analysis showed minus values
for all H2, H3, and H4. As expected from an analogy of 7a,
the absolute configuration of C3 was determined to be S.15
Scheme 9.
Scheme 10.
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From the knowledge of the absolute stereochemistry of 14
and 20, the absolute configurations of both anti-7f and syn-
7f were determined.
8.2.1. (3S,4S,5S,2 0R)-3,3,3-Trifluoro-2-methoxy-2-
phenyl-propionic acid 4-methyl-2-oxo-5-phenyl-tetra-
hydro-furan-3-yl ester (21R). 1H NMR (CDCl3) dZ0.66
(d, 3H, JZ7.1 Hz), 3.10–3.26 (m, 1H), 3.54 (d, 3H, JZ
0.9 Hz), 5.67 (d, 1H, JZ4.8 Hz), 6.04 (d, 1H, JZ7.1 Hz),
7.20–7.30 (m, 2H), 7.30–7.50 (m, 6H), 7.55–7.68 (m, 2H);
13C NMR (CDCl3) dZ8.4, 39.3, 55.5, 73.3, 80.1, 125.2,
127.8, 128.5, 128.5, 128.7, 129.9, 131.0, 134.4, 165.7,
170.4; IR (neat) 3063, 3033, 2987, 2947, 2850, 1802, 1754,
1504, 1455, 1364, 1245, 1179, 1111, 1089, 1057, 975,
698 cmK1; HRMS (FAB). Exact mass calcd for C21H20F3O5
[MCH]C, 409.1263. Found 409.1277.
8.2.2. (3S,4S,5S,2 0S)-3,3,3-Trifluoro-2-methoxy-2-
phenyl-propionic acid 4-methyl-2-oxo-5-phenyl-tetra-
hydro-furan-3-yl ester (21S). 1H NMR (CDCl3) dZ0.47
(d, 3H, JZ7.1 Hz), 3.00–3.20 (m, 1H), 3.66 (d, 3H, JZ
0.9 Hz), 5.66 (d, 1H, JZ5.0 Hz), 6.07 (d, 1H, JZ7.1 Hz),
7.20–7.30 (m, 2H), 7.30–7.50 (m, 6H), 7.60–7.70 (m, 2H);
13C NMR (CDCl3) dZ8.1, 39.4, 55.8, 73.0, 80.2, 125.2,
127.3, 128.5, 128.5, 128.7, 129.9, 131.6, 134.4, 165.7,
170.8; IR (neat) 3065, 2941, 2857, 1802, 1755, 1497, 1455,
1393, 1367, 1243, 1178, 1125, 1058, 977, 705 cmK1;
HRMS (FAB). Exact mass calcd for C21H20F3O5 [MCH]
C,
409.1263. Found 409.1277.
8.2.3. (3S,4R,5R,2 0R)-3,3,3-Trifluoro-2-methoxy-2-
phenyl-propionic acid 4-methyl-2-oxo-5-phenyl-
tetrahydro-furan-3-yl ester (22R). 1H NMR (C6D6) dZ
0.30 (d, 3H, JZ7.0 Hz), 2.38–2.50 (m, 1H), 3.46 (d, 3H, JZ
0.9 Hz), 4.91 (d, 1H, JZ8.6 Hz), 5.37 (d, 1H, JZ11 Hz),
6.65–6.73 (m, 2H), 6.96–7.05 (m, 3H), 7.08–7.12 (m, 1H),
7.18–7.24 (m, 2H), 7.91 (apparent d, 2H, JZ7.9 Hz); 13C
NMR (C6D6) dZ12.7, 39.0, 55.4, 74.2, 81.6, 125.9, 128.6,
128.7, 128.8, 130.0, 132.1, 135.3, 166.0, 170.6; IR (neat)
3033, 2974, 2945, 2850, 1800, 1757, 1497, 1453, 1340,
1243, 1170, 1116, 1056, 998, 909, 757, 699 cmK1; HRMS
(FAB). Exact mass calcd for C21H20F3O5 [MCH]
C,
409.1263. Found 409.1245.
8.2.4. (3S,4R,5R,2 0S)-3,3,3-Trifluoro-2-methoxy-2-
phenyl-propionic acid 4-methyl-2-oxo-5-phenyl-tetra-
hydro-furan-3-yl ester (22S). 1H NMR (C6D6) dZ0.28
(d, 3H, JZ6.9 Hz), 2.15–2.35 (m, 1H), 3.65 (d, 3H, JZ
0.7 Hz), 4.83 (d, 1H, JZ8.2 Hz), 5.61 (d, 1H, JZ10.6 Hz),
6.64–6.72 (m, 2H), 6.90–7.05 (m, 3H), 7.05–7.25 (m, 3H),
7.80–7.90 (m, 2H); 13C NMR (C6D6) dZ12.5, 39.4, 55.7,
73.6, 81.8, 122.2, 125.9, 127.9, 128.6, 128.8, 128.8, 130.0,
132.6, 135.2, 166.3, 171.2; IR (neat) 3065, 3033, 2945,
2851, 1800, 1759, 1496, 1454, 1342, 1273, 1247, 1172,
1123, 1081, 1057, 994, 903, 795, 763, 723 cmK1; HRMS
(FAB). Exact mass calcd for C21H20F3O5 [MCH]
C,
409.1263. Found 409.1282.
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